primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
101887044,10188704,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,4,F,,20200219.0,20140522,20200226,PER,,US-SA-2014SA020757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200226.0,,HP,US,US,2020,Q1,Elderly
101887044,10188704,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,4,F,,20200219.0,20140522,20200226,PER,,US-SA-2014SA020757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200226.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Asthenia,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Carbon dioxide abnormal,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Chronic obstructive pulmonary disease,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Condition aggravated,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Feeding disorder,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Infection,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Lethargy,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Nasal congestion,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Oxygen saturation decreased,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Productive cough,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Sinus congestion,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Sputum discoloured,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
116604457,11660445,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Wheezing,,2020,Q1,7,F,20160601.0,20200127.0,20151026,20200207,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122099",ACTELION,,74.0,YR,,F,Y,65.76,KG,20200207.0,,HP,US,US,2020,Q1,Elderly
118696568,11869656,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Cardiac pacemaker insertion,,2020,Q1,8,F,20151218.0,20200128.0,20151228,20200206,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20200206.0,,CN,US,US,2020,Q1,Adult
118696568,11869656,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Myocarditis,,2020,Q1,8,F,20151218.0,20200128.0,20151228,20200206,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20200206.0,,CN,US,US,2020,Q1,Adult
118696568,11869656,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Myositis,,2020,Q1,8,F,20151218.0,20200128.0,20151228,20200206,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20200206.0,,CN,US,US,2020,Q1,Adult
118696568,11869656,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Rhabdomyolysis,,2020,Q1,8,F,20151218.0,20200128.0,20151228,20200206,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20200206.0,,CN,US,US,2020,Q1,Adult
118696568,11869656,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Cardiac pacemaker insertion,,2020,Q1,8,F,20151218.0,20200128.0,20151228,20200206,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20200206.0,,CN,US,US,2020,Q1,Adult
118696568,11869656,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Myocarditis,,2020,Q1,8,F,20151218.0,20200128.0,20151228,20200206,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20200206.0,,CN,US,US,2020,Q1,Adult
118696568,11869656,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Myositis,,2020,Q1,8,F,20151218.0,20200128.0,20151228,20200206,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20200206.0,,CN,US,US,2020,Q1,Adult
118696568,11869656,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Rhabdomyolysis,,2020,Q1,8,F,20151218.0,20200128.0,20151228,20200206,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20200206.0,,CN,US,US,2020,Q1,Adult
126257614,12625761,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (WITH MEALS AND HS)",,,,,,,,,,,,2020,Q1,Epistaxis,,2020,Q1,4,F,20160209.0,20200319.0,20160805,20200323,EXP,,US-PFIZER INC-2016172478,PFIZER,,63.0,YR,,F,Y,127.75,KG,20200323.0,,MD,US,US,2020,Q1,Adult
126257614,12625761,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (WITH MEALS AND HS)",,,,,,,,,,,,2020,Q1,Myocardial infarction,,2020,Q1,4,F,20160209.0,20200319.0,20160805,20200323,EXP,,US-PFIZER INC-2016172478,PFIZER,,63.0,YR,,F,Y,127.75,KG,20200323.0,,MD,US,US,2020,Q1,Adult
128264192,12826419,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Cholecystitis,,2020,Q1,2,F,20160923.0,20200227.0,20161006,20200305,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-080557,BRISTOL MYERS SQUIBB,,38.0,YR,,M,Y,81.0,KG,20200305.0,,HP,US,US,2020,Q1,Adult
1296291719,12962917,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2020,Q1,Acute respiratory failure,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2020,Q1,Fluid overload,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2020,Q1,Haemoptysis,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2020,Q1,Hyperkalaemia,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2020,Q1,Iron deficiency anaemia,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2020,Q1,Pleural effusion,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2020,Q1,Pneumonia,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2020,Q1,Pulmonary oedema,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2020,Q1,Sepsis,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2020,Q1,Tumour lysis syndrome,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2020,Q1,Acute respiratory failure,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2020,Q1,Fluid overload,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2020,Q1,Haemoptysis,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2020,Q1,Hyperkalaemia,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2020,Q1,Iron deficiency anaemia,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2020,Q1,Pleural effusion,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2020,Q1,Pulmonary oedema,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2020,Q1,Sepsis,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
1296291719,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2020,Q1,Tumour lysis syndrome,,2020,Q1,19,F,20160826.0,20200305.0,20161122,20200306,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20200306.0,,MD,US,US,2020,Q1,Elderly
131155053,13115505,9,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Cholecystitis,,2020,Q1,3,F,20160923.0,20200305.0,20170113,20200306,EXP,,US-SEATTLE GENETICS-2016SGN01555,SEATTLE GENETICS,,38.0,YR,,M,Y,81.0,KG,20200306.0,,MD,US,US,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Drug ineffective,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Gait disturbance,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Hepatic enzyme increased,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Musculoskeletal stiffness,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Peripheral swelling,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Pharyngitis,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Poor venous access,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Pruritus,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Swelling,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Therapeutic response decreased,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Tremor,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
138674322,13867432,10,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,2,F,,20200113.0,20170814,20200127,EXP,,"CA-DEPOMED, INC.-CA-2017DEP001657",ASSERTIO THERAPEUTICS,,62.0,YR,,M,Y,,,20200127.0,,HP,CA,CA,2020,Q1,Adult
140006245,14000624,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 IU,QD",,,,,,,,72.0,IU,,QD,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 IU,QD",,,,,,,,72.0,IU,,QD,2020,Q1,Exposure during pregnancy,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 IU,QD",,,,,,,,72.0,IU,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 IU,QD",,,,,,,,72.0,IU,,QD,2020,Q1,Infection,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 IU,QD",,,,,,,,72.0,IU,,QD,2020,Q1,Postpartum haemorrhage,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 IU,QD",,,,,,,,72.0,IU,,QD,2020,Q1,Product use issue,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU,QD",,,,,,,,90.0,IU,,QD,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU,QD",,,,,,,,90.0,IU,,QD,2020,Q1,Exposure during pregnancy,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU,QD",,,,,,,,90.0,IU,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU,QD",,,,,,,,90.0,IU,,QD,2020,Q1,Infection,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU,QD",,,,,,,,90.0,IU,,QD,2020,Q1,Postpartum haemorrhage,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU,QD",,,,,,,,90.0,IU,,QD,2020,Q1,Product use issue,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU,QD",,,,,,,,86.0,IU,,QD,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU,QD",,,,,,,,86.0,IU,,QD,2020,Q1,Exposure during pregnancy,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU,QD",,,,,,,,86.0,IU,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU,QD",,,,,,,,86.0,IU,,QD,2020,Q1,Infection,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU,QD",,,,,,,,86.0,IU,,QD,2020,Q1,Postpartum haemorrhage,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
140006245,14000624,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU,QD",,,,,,,,86.0,IU,,QD,2020,Q1,Product use issue,,2020,Q1,5,F,20170420.0,20200127.0,20170922,20200131,EXP,IE-EMA-DD-20171205-NGEVHPROD-111818,IE-SA-2017SA122907,SANOFI AVENTIS,,35.0,YR,A,F,Y,91.0,KG,20200131.0,,MD,IE,IE,2020,Q1,Adult
146997987,14699798,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,7,F,20110627.0,20200131.0,20180330,20200204,EXP,,US-PFIZER INC-2018129976,PFIZER,,37.0,YR,,F,Y,,,20200204.0,,LW,US,US,2020,Q1,Adult
146997987,14699798,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Chronic kidney disease,,2020,Q1,7,F,20110627.0,20200131.0,20180330,20200204,EXP,,US-PFIZER INC-2018129976,PFIZER,,37.0,YR,,F,Y,,,20200204.0,,LW,US,US,2020,Q1,Adult
146997987,14699798,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Gastrooesophageal reflux disease,,2020,Q1,7,F,20110627.0,20200131.0,20180330,20200204,EXP,,US-PFIZER INC-2018129976,PFIZER,,37.0,YR,,F,Y,,,20200204.0,,LW,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Alanine aminotransferase increased,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Aspartate aminotransferase increased,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Asthenia,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Blood magnesium decreased,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Blood potassium increased,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Chest discomfort,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Condition aggravated,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Dizziness,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Flank pain,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Fluid retention,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Headache,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Hypokalaemia,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Hypoxia,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Malaise,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Mental status changes,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Nausea,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Nephrolithiasis,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Oxygen saturation decreased,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Paraesthesia oral,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Presyncope,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Productive cough,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Pulmonary arterial hypertension,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Pyrexia,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Sinusitis,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Urinary tract infection,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,Viral infection,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
148071927,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q1,White blood cell count increased,,2020,Q1,7,F,20170105.0,20200226.0,20180425,20200306,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200306.0,,HP,US,US,2020,Q1,Adult
149645864,14964586,25,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Autoimmune hepatitis,,2020,Q1,4,F,20170619.0,20200302.0,20180601,20200309,EXP,,JP-CELGENEUS-JPN-20180507948,CELGENE,,79.0,YR,,M,Y,54.8,KG,20200309.0,,HP,JP,JP,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Acute kidney injury,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Adrenomegaly,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Blood pressure increased,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Chest pain,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Colitis,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Device related infection,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Heparin-induced thrombocytopenia,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Hypertensive crisis,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Klebsiella infection,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Malignant neoplasm progression,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Meningitis,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Metastases to meninges,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Pulmonary oedema,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Retinal detachment,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Tachycardia,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
1549343214,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q1,Urosepsis,,2020,Q1,14,F,20180419.0,20200319.0,20181012,20200324,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200324.0,,CN,DE,DE,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Acidosis,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Acute myocardial infarction,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Anaemia,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Aphasia,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Back pain,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Blood loss anaemia,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Clostridium difficile colitis,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Diarrhoea,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Gait disturbance,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Gastroenteritis,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Gastrointestinal haemorrhage,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Haematotoxicity,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Hyperkalaemia,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Influenza,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Internal haemorrhage,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Intervertebral disc disorder,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Lethargy,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Limb discomfort,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Metabolic acidosis,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Pain in extremity,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Pulmonary oedema,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Renal failure,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Respiratory failure,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Sciatica,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Sepsis,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Septic shock,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Supraventricular tachycardia,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
155658254,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2020,Q1,Thrombocytopenia,,2020,Q1,4,F,2018.0,20200304.0,20181030,20200309,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20200309.0,,MD,US,US,2020,Q1,Elderly
1565076311,15650763,16,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, ONCE A DAY  (25/75: + 20U 20U / D)",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Chest pain,,2020,Q1,11,F,,20200129.0,20181123,20200211,EXP,,PT-AUROBINDO-AUR-APL-2018-056484,AUROBINDO,,54.0,YR,,F,Y,,,20200211.0,,CN,PT,PT,2020,Q1,Adult
1565076311,15650763,16,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, ONCE A DAY  (25/75: + 20U 20U / D)",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Headache,,2020,Q1,11,F,,20200129.0,20181123,20200211,EXP,,PT-AUROBINDO-AUR-APL-2018-056484,AUROBINDO,,54.0,YR,,F,Y,,,20200211.0,,CN,PT,PT,2020,Q1,Adult
1565076311,15650763,16,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, ONCE A DAY  (25/75: + 20U 20U / D)",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Ischaemic stroke,,2020,Q1,11,F,,20200129.0,20181123,20200211,EXP,,PT-AUROBINDO-AUR-APL-2018-056484,AUROBINDO,,54.0,YR,,F,Y,,,20200211.0,,CN,PT,PT,2020,Q1,Adult
156562242,15656224,172,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Anxiety,,2020,Q1,2,F,2009.0,20191222.0,20181126,20200127,PER,,US-HORIZON-VIM-0803-2018,HORIZON,,40.0,YR,A,F,Y,121.6,KG,20200127.0,,LW,US,US,2020,Q1,Adult
156562242,15656224,172,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Chronic kidney disease,,2020,Q1,2,F,2009.0,20191222.0,20181126,20200127,PER,,US-HORIZON-VIM-0803-2018,HORIZON,,40.0,YR,A,F,Y,121.6,KG,20200127.0,,LW,US,US,2020,Q1,Adult
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Acute kidney injury,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Adrenomegaly,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Blood pressure increased,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Chest pain,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Colitis,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Device related infection,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Heparin-induced thrombocytopenia,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Hypertensive crisis,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Klebsiella infection,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Malignant neoplasm progression,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Meningitis,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Metastases to meninges,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Pulmonary oedema,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Retinal detachment,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Retinopathy,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Tachycardia,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156620015,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2020,Q1,Urosepsis,,2020,Q1,5,F,20180419.0,20200127.0,20181127,20200130,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200130.0,,MD,DE,DE,2020,Q1,Elderly
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Acidosis,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Acute kidney injury,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Acute respiratory distress syndrome,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Alkalosis hypochloraemic,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Anaemia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Asthenia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Bandaemia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Blood creatinine increased,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Blood urea increased,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Bronchial haemorrhage,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Bronchitis chronic,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Concomitant disease aggravated,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Constipation,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Cough,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Cystic fibrosis,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Diarrhoea,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Dysphagia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Dyspnoea,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Fungal disease carrier,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Gastroenteritis norovirus,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Gastrointestinal disorder,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Generalised oedema,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Glucose tolerance impaired,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Granulocytosis,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Haematuria,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Haemoptysis,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Hypercapnia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Hyperglycaemia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Hypernatraemia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Hypertension,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Hypertriglyceridaemia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Hypervolaemia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Hypokalaemia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Hypoxia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Ill-defined disorder,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Infective exacerbation of bronchiectasis,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Insomnia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Intensive care unit acquired weakness,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Iron deficiency,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Leukocytosis,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Metabolic acidosis,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Muscle atrophy,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Paresis,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Pneumonia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Pyrexia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Respiratory failure,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Sepsis,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Stenotrophomonas test positive,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Tachycardia,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Thrombocytosis,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
156873576,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q1,Weight decreased,,2020,Q1,6,F,20160303.0,20200121.0,20181205,20200123,PER,,PHHY2017US177182,NOVARTIS,,37.0,YR,,M,Y,68.44,KG,20200123.0,,MD,US,US,2020,Q1,Adult
157035622,15703562,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, DAILY (25/75: + 20U 20 U/ D)",,,U,U,,,,,,,,2020,Q1,Chest pain,,2020,Q1,2,F,,20200129.0,20181210,20200207,EXP,,PT-AUROBINDO-AUR-APL-2018-059436,AUROBINDO,,54.0,YR,,F,Y,,,20200208.0,,PH,PT,PT,2020,Q1,Adult
157035622,15703562,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, DAILY (25/75: + 20U 20 U/ D)",,,U,U,,,,,,,,2020,Q1,Ischaemic stroke,,2020,Q1,2,F,,20200129.0,20181210,20200207,EXP,,PT-AUROBINDO-AUR-APL-2018-059436,AUROBINDO,,54.0,YR,,F,Y,,,20200208.0,,PH,PT,PT,2020,Q1,Adult
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Arthritis,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Blood pressure increased,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Brain natriuretic peptide abnormal,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Disease progression,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Dysphagia,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Fall,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Haemoglobin decreased,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Pleural effusion,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Pulmonary arterial hypertension,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Rib fracture,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Scratch,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Subarachnoid haemorrhage,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Syncope,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Acidosis,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Cardiac disorder,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Carotid artery stenosis,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Haematuria,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Hyperkalaemia,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Hypertension,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Hypomagnesaemia,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Nausea,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Overdose,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Pyelonephritis,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Serum sickness,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Underdose,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
159403375,15940337,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,5,F,201511.0,20200127.0,20190208,20200204,EXP,,US-ASTRAZENECA-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20200204.0,,,US,US,2020,Q1,Elderly
159403375,15940337,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Chronic kidney disease,,2020,Q1,5,F,201511.0,20200127.0,20190208,20200204,EXP,,US-ASTRAZENECA-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20200204.0,,,US,US,2020,Q1,Elderly
159403375,15940337,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Chronic kidney disease-mineral and bone disorder,,2020,Q1,5,F,201511.0,20200127.0,20190208,20200204,EXP,,US-ASTRAZENECA-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20200204.0,,,US,US,2020,Q1,Elderly
159403375,15940337,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,End stage renal disease,,2020,Q1,5,F,201511.0,20200127.0,20190208,20200204,EXP,,US-ASTRAZENECA-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20200204.0,,,US,US,2020,Q1,Elderly
159403375,15940337,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Nephrogenic anaemia,,2020,Q1,5,F,201511.0,20200127.0,20190208,20200204,EXP,,US-ASTRAZENECA-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20200204.0,,,US,US,2020,Q1,Elderly
159403375,15940337,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Renal failure,,2020,Q1,5,F,201511.0,20200127.0,20190208,20200204,EXP,,US-ASTRAZENECA-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20200204.0,,,US,US,2020,Q1,Elderly
159403375,15940337,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Renal injury,,2020,Q1,5,F,201511.0,20200127.0,20190208,20200204,EXP,,US-ASTRAZENECA-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20200204.0,,,US,US,2020,Q1,Elderly
159403375,15940337,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Secondary hyperthyroidism,,2020,Q1,5,F,201511.0,20200127.0,20190208,20200204,EXP,,US-ASTRAZENECA-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20200204.0,,,US,US,2020,Q1,Elderly
160068976,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,6,F,2006.0,20200203.0,20190222,20200213,EXP,,US-ASTRAZENECA-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20200213.0,,,US,US,2020,Q1,Adult
160068976,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Chronic kidney disease,,2020,Q1,6,F,2006.0,20200203.0,20190222,20200213,EXP,,US-ASTRAZENECA-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20200213.0,,,US,US,2020,Q1,Adult
160068976,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,End stage renal disease,,2020,Q1,6,F,2006.0,20200203.0,20190222,20200213,EXP,,US-ASTRAZENECA-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20200213.0,,,US,US,2020,Q1,Adult
160068976,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Renal failure,,2020,Q1,6,F,2006.0,20200203.0,20190222,20200213,EXP,,US-ASTRAZENECA-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20200213.0,,,US,US,2020,Q1,Adult
160068976,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Renal injury,,2020,Q1,6,F,2006.0,20200203.0,20190222,20200213,EXP,,US-ASTRAZENECA-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20200213.0,,,US,US,2020,Q1,Adult
160068976,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Tubulointerstitial nephritis,,2020,Q1,6,F,2006.0,20200203.0,20190222,20200213,EXP,,US-ASTRAZENECA-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20200213.0,,,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blindness,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood creatinine increased,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose abnormal,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose decreased,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose fluctuation,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Cataract,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diarrhoea,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fall,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Gout,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Haematoma,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypertension,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemic unconsciousness,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Impaired healing,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Incorrect dose administered,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Incorrect product administration duration,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Injection site bruising,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Limb asymmetry,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Malaise,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Nail discolouration,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Nausea,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Pelvic fracture,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Pelvic pain,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Renal disorder,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Renal failure,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Retinopathy,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Visual impairment,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
160687768,16068776,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C991690C,,,,,SOLUTION FOR INJECTION,,2020,Q1,Wrong technique in product usage process,,2020,Q1,8,F,2015.0,20191231.0,20190313,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201903004205,ELI LILLY AND CO,,54.0,YR,,M,Y,190.0,KG,20200110.0,,CN,US,US,2020,Q1,Adult
161233862,16123386,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,"UNK, SINGLE",,,,,,,,,,INJECTION,QD,2020,Q1,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q1,2,F,20190308.0,20200304.0,20190327,20200317,EXP,,US-VERTEX PHARMACEUTICALS-2019-002484,VERTEX,,20.0,YR,,F,Y,45.0,KG,20200317.0,,HP,US,US,2020,Q1,Youth
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Heart rate irregular,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Syncope,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Pulmonary congestion,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Renal disorder,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Syncope,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Pulmonary congestion,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Pulmonary oedema,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Renal disorder,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Syncope,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Acute kidney injury,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Arrhythmia,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Bradycardia,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Dehydration,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Dizziness,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Drug interaction,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Haematocrit increased,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Hypotension,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Hypovolaemia,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Mucosal dryness,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Oedema peripheral,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Presyncope,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Pulmonary congestion,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Renal disorder,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Skin disorder,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q1,Syncope,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Acute kidney injury,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Arrhythmia,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Bradycardia,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Dehydration,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Dizziness,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Drug interaction,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Haematocrit increased,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Hypotension,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Hypovolaemia,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Mucosal dryness,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Oedema peripheral,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Presyncope,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Pulmonary congestion,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Renal disorder,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Skin disorder,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,2,SS,Lispro,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2020,Q1,Syncope,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Abdominal pain,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Acute kidney injury,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Anaemia,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Back pain,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Candida infection,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Chondrocalcinosis pyrophosphate,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Chronic kidney disease,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Diarrhoea,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Dyspnoea,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Flank pain,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Hydronephrosis,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Hyperkalaemia,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Hypomagnesaemia,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Infection,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Melaena,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Nephrolithiasis,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Pyelonephritis,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Pyuria,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Sepsis,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Syncope,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Ureterolithiasis,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Urinary tract infection,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1615902921,16159029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q1,Vomiting,,2020,Q1,21,F,20190102.0,20200306.0,20190404,20200316,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200316.0,,HP,US,US,2020,Q1,Adult
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pulmonary congestion,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal disorder,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Syncope,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Pulmonary congestion,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Renal disorder,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q1,Syncope,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Acute kidney injury,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Adrenomegaly,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Blood pressure increased,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Chest pain,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Colitis,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Device related infection,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Heparin-induced thrombocytopenia,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Hypertensive crisis,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Klebsiella infection,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Malignant neoplasm progression,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Meningitis,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Metastases to meninges,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Pulmonary oedema,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Retinal detachment,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Retinopathy,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Tachycardia,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162405146,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q1,Urosepsis,,2020,Q1,6,F,20180419.0,20200116.0,20190425,20200122,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200122.0,,MD,DE,DE,2020,Q1,Elderly
162543567,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,7,F,20190415.0,20200319.0,20190430,20200330,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200330.0,,MD,JP,JP,2020,Q1,Adult
162543567,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Ascites,,2020,Q1,7,F,20190415.0,20200319.0,20190430,20200330,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200330.0,,MD,JP,JP,2020,Q1,Adult
162543567,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Condition aggravated,,2020,Q1,7,F,20190415.0,20200319.0,20190430,20200330,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200330.0,,MD,JP,JP,2020,Q1,Adult
162543567,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Fall,,2020,Q1,7,F,20190415.0,20200319.0,20190430,20200330,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200330.0,,MD,JP,JP,2020,Q1,Adult
162543567,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Oedema,,2020,Q1,7,F,20190415.0,20200319.0,20190430,20200330,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200330.0,,MD,JP,JP,2020,Q1,Adult
162543567,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Pulmonary arterial hypertension,,2020,Q1,7,F,20190415.0,20200319.0,20190430,20200330,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200330.0,,MD,JP,JP,2020,Q1,Adult
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Arthritis,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Brain natriuretic peptide abnormal,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Disease progression,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Dysphagia,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Fall,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Pleural effusion,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Pulmonary arterial hypertension,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Rib fracture,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Scratch,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Subarachnoid haemorrhage,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Syncope,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
162784608,16278460,8,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,12 UNITS,,,,,,,,,,UNKNOWN,,2020,Q1,Anaemia,,2020,Q1,8,F,20190417.0,20200226.0,20190506,20200303,EXP,,US-CELGENEUS-USA-20190411233,CELGENE,,74.0,YR,,M,Y,,,20200303.0,,HP,US,US,2020,Q1,Elderly
162784608,16278460,8,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,12 UNITS,,,,,,,,,,UNKNOWN,,2020,Q1,Gastrointestinal haemorrhage,,2020,Q1,8,F,20190417.0,20200226.0,20190506,20200303,EXP,,US-CELGENEUS-USA-20190411233,CELGENE,,74.0,YR,,M,Y,,,20200303.0,,HP,US,US,2020,Q1,Elderly
162784608,16278460,8,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,12 UNITS,,,,,,,,,,UNKNOWN,,2020,Q1,Hepatic failure,,2020,Q1,8,F,20190417.0,20200226.0,20190506,20200303,EXP,,US-CELGENEUS-USA-20190411233,CELGENE,,74.0,YR,,M,Y,,,20200303.0,,HP,US,US,2020,Q1,Elderly
162985884,16298588,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,SHORT-TERM INSULIN ANALOG LISPRO,,,U,U,,,,,,,,2020,Q1,Concomitant disease aggravated,,2020,Q1,4,F,2017.0,20200122.0,20190510,20200204,EXP,,CZ-AUROBINDO-AUR-APL-2019-024861,AUROBINDO,,63.0,YR,,M,Y,,,20200204.0,,HP,CZ,CZ,2020,Q1,Adult
162985884,16298588,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,SHORT-TERM INSULIN ANALOG LISPRO,,,U,U,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,4,F,2017.0,20200122.0,20190510,20200204,EXP,,CZ-AUROBINDO-AUR-APL-2019-024861,AUROBINDO,,63.0,YR,,M,Y,,,20200204.0,,HP,CZ,CZ,2020,Q1,Adult
162985884,16298588,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,SHORT-TERM INSULIN ANALOG LISPRO,,,U,U,,,,,,,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,4,F,2017.0,20200122.0,20190510,20200204,EXP,,CZ-AUROBINDO-AUR-APL-2019-024861,AUROBINDO,,63.0,YR,,M,Y,,,20200204.0,,HP,CZ,CZ,2020,Q1,Adult
162985884,16298588,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,SHORT-TERM INSULIN ANALOG LISPRO,,,U,U,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,4,F,2017.0,20200122.0,20190510,20200204,EXP,,CZ-AUROBINDO-AUR-APL-2019-024861,AUROBINDO,,63.0,YR,,M,Y,,,20200204.0,,HP,CZ,CZ,2020,Q1,Adult
162985884,16298588,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,SHORT-TERM INSULIN ANALOG LISPRO,,,U,U,,,,,,,,2020,Q1,Therapy non-responder,,2020,Q1,4,F,2017.0,20200122.0,20190510,20200204,EXP,,CZ-AUROBINDO-AUR-APL-2019-024861,AUROBINDO,,63.0,YR,,M,Y,,,20200204.0,,HP,CZ,CZ,2020,Q1,Adult
163881483,16388148,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-10 UNITS,,,,,,,,,,,,2020,Q1,Bacteraemia,,2020,Q1,3,F,20180206.0,20191001.0,20190604,20200124,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,94.1,KG,20200124.0,,MD,US,US,2020,Q1,Elderly
163881483,16388148,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-10 UNITS,,,,,,,,,,,,2020,Q1,Pyrexia,,2020,Q1,3,F,20180206.0,20191001.0,20190604,20200124,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,94.1,KG,20200124.0,,MD,US,US,2020,Q1,Elderly
163881483,16388148,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-10 UNITS,,,,,,,,,,,,2020,Q1,Vascular device infection,,2020,Q1,3,F,20180206.0,20191001.0,20190604,20200124,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,94.1,KG,20200124.0,,MD,US,US,2020,Q1,Elderly
164288413,16428841,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2020,Q1,Cellulitis,,2020,Q1,3,F,2018.0,20200120.0,20190613,20200127,EXP,,PHHY2019GB134083,NOVARTIS,,85.0,YR,,M,Y,,,20200127.0,,HP,GB,GB,2020,Q1,Elderly
164288413,16428841,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2020,Q1,Labelled drug-drug interaction medication error,,2020,Q1,3,F,2018.0,20200120.0,20190613,20200127,EXP,,PHHY2019GB134083,NOVARTIS,,85.0,YR,,M,Y,,,20200127.0,,HP,GB,GB,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Arthritis,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Brain natriuretic peptide abnormal,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Disease progression,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Dysphagia,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Fall,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Pleural effusion,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Pulmonary arterial hypertension,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Rib fracture,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Scratch,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Subarachnoid haemorrhage,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Syncope,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Acidosis,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Cardiac disorder,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Carotid artery stenosis,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Diabetes mellitus,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Fluid overload,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Haematuria,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Hyperkalaemia,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Hypertension,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Hypomagnesaemia,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Nausea,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Pyelonephritis,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Serum sickness,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Underdose,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Abdominal pain upper,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Amylase increased,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Blood creatine phosphokinase MB increased,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Blood creatine phosphokinase increased,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Bronchitis,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Chest pain,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Connective tissue disorder,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dry eye,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dry mouth,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dry skin,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Embolism,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Headache,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Myocardial infarction,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Nausea,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pain,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Prescribed underdose,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pruritus,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Acute lymphocytic leukaemia recurrent,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Bone pain,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Catheter site infection,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Deep vein thrombosis,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Dry mouth,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Herpes virus infection,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Meningitis staphylococcal,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Muscle spasms,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Neck pain,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Night sweats,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Pulmonary embolism,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Sinusitis,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Tremor,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
167079113,16707911,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2020,Q1,Cytokine release syndrome,,2020,Q1,3,F,20190723.0,20191231.0,20190815,20200102,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20200102.0,,MD,US,US,2020,Q1,Elderly
167079113,16707911,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,3,F,20190723.0,20191231.0,20190815,20200102,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20200102.0,,MD,US,US,2020,Q1,Elderly
167079113,16707911,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2020,Q1,Neutropenia,,2020,Q1,3,F,20190723.0,20191231.0,20190815,20200102,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20200102.0,,MD,US,US,2020,Q1,Elderly
167079113,16707911,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2020,Q1,Pyrexia,,2020,Q1,3,F,20190723.0,20191231.0,20190815,20200102,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20200102.0,,MD,US,US,2020,Q1,Elderly
167079113,16707911,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2020,Q1,Sepsis,,2020,Q1,3,F,20190723.0,20191231.0,20190815,20200102,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20200102.0,,MD,US,US,2020,Q1,Elderly
168193526,16819352,33,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Encephalopathy,,2020,Q1,6,F,20190911.0,20200108.0,20190917,20200113,EXP,,US-GILEAD-2019-0428171,GILEAD,,58.0,YR,A,F,Y,70.6,KG,20200113.0,,MD,US,US,2020,Q1,Adult
168193526,16819352,33,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Somnolence,,2020,Q1,6,F,20190911.0,20200108.0,20190917,20200113,EXP,,US-GILEAD-2019-0428171,GILEAD,,58.0,YR,A,F,Y,70.6,KG,20200113.0,,MD,US,US,2020,Q1,Adult
168288762,16828876,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 2-12 UNITS UNDER THE SKIN 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,INJECTION,,2020,Q1,Dysphagia,,2020,Q1,2,F,20190825.0,20200219.0,20190919,20200304,EXP,,US-JNJFOC-20190925116,JOHNSON AND JOHNSON,,80.0,YR,,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Elderly
168288762,16828876,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 2-12 UNITS UNDER THE SKIN 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,INJECTION,,2020,Q1,Hospitalisation,,2020,Q1,2,F,20190825.0,20200219.0,20190919,20200304,EXP,,US-JNJFOC-20190925116,JOHNSON AND JOHNSON,,80.0,YR,,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Elderly
168288762,16828876,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 2-12 UNITS UNDER THE SKIN 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,INJECTION,,2020,Q1,Viral infection,,2020,Q1,2,F,20190825.0,20200219.0,20190919,20200304,EXP,,US-JNJFOC-20190925116,JOHNSON AND JOHNSON,,80.0,YR,,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Elderly
169315997,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q1,Blood glucose increased,,2020,Q1,7,F,201709.0,20200326.0,20191017,20200331,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200331.0,,CN,US,US,2020,Q1,Elderly
169315997,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q1,Bursitis infective,,2020,Q1,7,F,201709.0,20200326.0,20191017,20200331,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200331.0,,CN,US,US,2020,Q1,Elderly
169315997,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q1,Cardiac operation,,2020,Q1,7,F,201709.0,20200326.0,20191017,20200331,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200331.0,,CN,US,US,2020,Q1,Elderly
169315997,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q1,Coronary artery stenosis,,2020,Q1,7,F,201709.0,20200326.0,20191017,20200331,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200331.0,,CN,US,US,2020,Q1,Elderly
169315997,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q1,Haemarthrosis,,2020,Q1,7,F,201709.0,20200326.0,20191017,20200331,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200331.0,,CN,US,US,2020,Q1,Elderly
169315997,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q1,Haematoma,,2020,Q1,7,F,201709.0,20200326.0,20191017,20200331,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200331.0,,CN,US,US,2020,Q1,Elderly
169315997,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q1,Haemorrhage,,2020,Q1,7,F,201709.0,20200326.0,20191017,20200331,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200331.0,,CN,US,US,2020,Q1,Elderly
169315997,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q1,Neuralgia,,2020,Q1,7,F,201709.0,20200326.0,20191017,20200331,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200331.0,,CN,US,US,2020,Q1,Elderly
169356412,16935641,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNIT/ML, TID",,,,,,,,,,,,2020,Q1,Psychotic disorder,,2020,Q1,2,F,20190922.0,20200306.0,20191018,20200316,EXP,,US-VERTEX PHARMACEUTICALS-2019-009932,VERTEX,,40.0,YR,,M,Y,57.0,KG,20200316.0,,MD,US,US,2020,Q1,Adult
169385034,16938503,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,4,F,20190903.0,20200217.0,20191019,20200221,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200221.0,,HP,US,US,2020,Q1,Adult
169385034,16938503,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,4,F,20190903.0,20200217.0,20191019,20200221,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200221.0,,HP,US,US,2020,Q1,Adult
169385034,16938503,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,4,F,20190903.0,20200217.0,20191019,20200221,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200221.0,,HP,US,US,2020,Q1,Adult
169385034,16938503,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,4,F,20190903.0,20200217.0,20191019,20200221,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200221.0,,HP,US,US,2020,Q1,Adult
169388474,16938847,19,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Abscess,,2020,Q1,4,F,20190909.0,20200111.0,20191020,20200114,PER,,PHHO2019US009197,NOVARTIS,,59.0,YR,,F,Y,65.9,KG,20200114.0,,MD,US,US,2020,Q1,Adult
169388474,16938847,20,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Abscess,,2020,Q1,4,F,20190909.0,20200111.0,20191020,20200114,PER,,PHHO2019US009197,NOVARTIS,,59.0,YR,,F,Y,65.9,KG,20200114.0,,MD,US,US,2020,Q1,Adult
169445033,16944503,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Tubulointerstitial nephritis,,2020,Q1,3,F,20190730.0,20200307.0,20191022,20200311,PER,,PHHO2019US007959,NOVARTIS,,40.0,YR,,F,Y,90.22,KG,20200311.0,,HP,US,US,2020,Q1,Adult
169445033,16944503,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Tubulointerstitial nephritis,,2020,Q1,3,F,20190730.0,20200307.0,20191022,20200311,PER,,PHHO2019US007959,NOVARTIS,,40.0,YR,,F,Y,90.22,KG,20200311.0,,HP,US,US,2020,Q1,Adult
1696951021,16969510,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,12.0,DF,INJECTION,,2020,Q1,Heart injury,,2020,Q1,21,F,20191021.0,20200309.0,20191029,20200312,EXP,,CN-EISAI MEDICAL RESEARCH-EC-2019-064326,EISAI,,62.0,YR,,M,Y,69.0,KG,20200312.0,,MD,CN,CN,2020,Q1,Adult
170271264,17027126,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 TO 6 UNITS,,,U,,,,,,,,,2020,Q1,Muscular weakness,,2020,Q1,4,F,20180918.0,20200311.0,20191113,20200318,EXP,,NVSC2019US026680,NOVARTIS,,58.0,YR,,M,Y,97.0,KG,20200318.0,,MD,US,US,2020,Q1,Adult
170275305,17027530,27,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Abdominal pain,,2020,Q1,5,F,20191028.0,20200109.0,20191113,20200116,EXP,,US-CELGENEUS-USA-20191103123,CELGENE,,72.0,YR,,F,Y,87.0,KG,20200116.0,,MD,US,US,2020,Q1,Elderly
170282684,17028268,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U,,,,,,,,,,,,2020,Q1,Fall,,2020,Q1,4,F,20191023.0,20200114.0,20191113,20200127,EXP,,US-ACTELION-A-NJ2019-198073,ACTELION,,79.0,YR,,F,Y,64.4,KG,20200127.0,,HP,US,US,2020,Q1,Elderly
170282684,17028268,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U,,,,,,,,,,,,2020,Q1,Hip fracture,,2020,Q1,4,F,20191023.0,20200114.0,20191113,20200127,EXP,,US-ACTELION-A-NJ2019-198073,ACTELION,,79.0,YR,,F,Y,64.4,KG,20200127.0,,HP,US,US,2020,Q1,Elderly
170282684,17028268,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U,,,,,,,,,,,,2020,Q1,Joint injury,,2020,Q1,4,F,20191023.0,20200114.0,20191113,20200127,EXP,,US-ACTELION-A-NJ2019-198073,ACTELION,,79.0,YR,,F,Y,64.4,KG,20200127.0,,HP,US,US,2020,Q1,Elderly
170282684,17028268,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U,,,,,,,,,,,,2020,Q1,Small cell lung cancer extensive stage,,2020,Q1,4,F,20191023.0,20200114.0,20191113,20200127,EXP,,US-ACTELION-A-NJ2019-198073,ACTELION,,79.0,YR,,F,Y,64.4,KG,20200127.0,,HP,US,US,2020,Q1,Elderly
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Abdominal pain,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Abscess,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Adrenal insufficiency,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Alanine aminotransferase increased,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Ascites,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Asthenia,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Blood alkaline phosphatase increased,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Blood bilirubin increased,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Blood potassium decreased,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Blood pressure diastolic abnormal,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Blood pressure increased,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Depression,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Diverticulitis,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Endometrial disorder,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Enterococcus test positive,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Fibrosis,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Gamma-glutamyltransferase increased,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Gastrointestinal disorder,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Generalised oedema,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Heart rate increased,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Hepatic congestion,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Herpes zoster,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Hypersensitivity,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Hypotension,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Increased appetite,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Influenza,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Infusion related reaction,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Injection site extravasation,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Intensive care unit acquired weakness,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Intervertebral disc protrusion,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Joint effusion,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Joint swelling,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Micturition disorder,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Myelopathy,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Myopathy,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Nasopharyngitis,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Nausea,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Nerve compression,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Neuropathy peripheral,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Neutropenia,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Osteoarthritis,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Pancytopenia,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Peripheral sensorimotor neuropathy,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Peritonitis,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Pneumonia,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Pseudomonal bacteraemia,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Rheumatoid arthritis,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Septic shock,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Therapeutic response decreased,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Vomiting,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Weight decreased,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170382832,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q1,Weight increased,,2020,Q1,2,F,,20200311.0,20191115,20200316,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200316.0,,HP,CA,CA,2020,Q1,Adult
170431932,17043193,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q1,Bronchopulmonary aspergillosis allergic,,2020,Q1,2,F,20191011.0,20200124.0,20191118,20200129,EXP,,US-VERTEX PHARMACEUTICALS-2019-011252,VERTEX,,10.0,YR,,F,Y,,,20200129.0,,HP,US,US,2020,Q1,Child
170431932,17043193,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q1,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q1,2,F,20191011.0,20200124.0,20191118,20200129,EXP,,US-VERTEX PHARMACEUTICALS-2019-011252,VERTEX,,10.0,YR,,F,Y,,,20200129.0,,HP,US,US,2020,Q1,Child
170765345,17076534,40,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,8 U,,,U,,,,,,,,,2020,Q1,Stroke in evolution,,2020,Q1,5,F,20190928.0,20200113.0,20191126,20200121,PER,,US-SA-2019SA325117,SANOFI AVENTIS,,73.0,YR,E,F,Y,106.5,KG,20200121.0,,PH,US,US,2020,Q1,Elderly
170765345,17076534,40,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,8 U,,,U,,,,,,,,,2020,Q1,Syncope,,2020,Q1,5,F,20190928.0,20200113.0,20191126,20200121,PER,,US-SA-2019SA325117,SANOFI AVENTIS,,73.0,YR,E,F,Y,106.5,KG,20200121.0,,PH,US,US,2020,Q1,Elderly
170998192,17099819,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,,2020,Q1,Herpes zoster,,2020,Q1,2,F,20191114.0,20200108.0,20191202,20200121,EXP,,US-ROCHE-2482986,ROCHE,,45.0,YR,,M,Y,79.45,KG,20200121.0,,CN,US,US,2020,Q1,Adult
170998192,17099819,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,,2020,Q1,Multiple sclerosis relapse,,2020,Q1,2,F,20191114.0,20200108.0,20191202,20200121,EXP,,US-ROCHE-2482986,ROCHE,,45.0,YR,,M,Y,79.45,KG,20200121.0,,CN,US,US,2020,Q1,Adult
171040262,17104026,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200131.0,20191203,20200212,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20200212.0,,MD,CZ,CZ,2020,Q1,Adult
171040262,17104026,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,,20200131.0,20191203,20200212,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20200212.0,,MD,CZ,CZ,2020,Q1,Adult
171040262,17104026,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Weight increased,,2020,Q1,2,F,,20200131.0,20191203,20200212,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20200212.0,,MD,CZ,CZ,2020,Q1,Adult
171419802,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Arthritis,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Dysphagia,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Fall,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Scratch,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Subarachnoid haemorrhage,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Tachycardia,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171478516,17147851,74,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,2 UNITS/ML,,,,,,,,,,UNKNOWN,,2020,Q1,Pneumonia,,2020,Q1,6,F,20191203.0,20200123.0,20191212,20200225,PER,,US-CELGENEUS-USA-20191204070,CELGENE,,77.0,YR,,F,Y,62.2,KG,20200225.0,,HP,US,US,2020,Q1,Elderly
171512105,17151210,24,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Hypokalaemia,,2020,Q1,5,F,20191117.0,20200115.0,20191213,20200121,EXP,,US-CELGENEUS-USA-20191205012,CELGENE,,75.0,YR,,M,Y,79.3,KG,20200121.0,,MD,US,US,2020,Q1,Elderly
171512105,17151210,24,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Influenza,,2020,Q1,5,F,20191117.0,20200115.0,20191213,20200121,EXP,,US-CELGENEUS-USA-20191205012,CELGENE,,75.0,YR,,M,Y,79.3,KG,20200121.0,,MD,US,US,2020,Q1,Elderly
171512105,17151210,24,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Plasma cell myeloma,,2020,Q1,5,F,20191117.0,20200115.0,20191213,20200121,EXP,,US-CELGENEUS-USA-20191205012,CELGENE,,75.0,YR,,M,Y,79.3,KG,20200121.0,,MD,US,US,2020,Q1,Elderly
171512105,17151210,24,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Pneumonia,,2020,Q1,5,F,20191117.0,20200115.0,20191213,20200121,EXP,,US-CELGENEUS-USA-20191205012,CELGENE,,75.0,YR,,M,Y,79.3,KG,20200121.0,,MD,US,US,2020,Q1,Elderly
171512105,17151210,24,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Septic shock,,2020,Q1,5,F,20191117.0,20200115.0,20191213,20200121,EXP,,US-CELGENEUS-USA-20191205012,CELGENE,,75.0,YR,,M,Y,79.3,KG,20200121.0,,MD,US,US,2020,Q1,Elderly
171512105,17151210,24,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Viraemia,,2020,Q1,5,F,20191117.0,20200115.0,20191213,20200121,EXP,,US-CELGENEUS-USA-20191205012,CELGENE,,75.0,YR,,M,Y,79.3,KG,20200121.0,,MD,US,US,2020,Q1,Elderly
171728242,17172824,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q1,Acute myocardial infarction,,2020,Q1,2,F,20191213.0,20200206.0,20191218,20200208,EXP,,US-TAKEDA-2019TUS071567,TAKEDA,,61.0,YR,,F,Y,133.79,KG,20200208.0,,MD,US,US,2020,Q1,Adult
171728242,17172824,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q1,Asthma,,2020,Q1,2,F,20191213.0,20200206.0,20191218,20200208,EXP,,US-TAKEDA-2019TUS071567,TAKEDA,,61.0,YR,,F,Y,133.79,KG,20200208.0,,MD,US,US,2020,Q1,Adult
171728242,17172824,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q1,Pneumonia,,2020,Q1,2,F,20191213.0,20200206.0,20191218,20200208,EXP,,US-TAKEDA-2019TUS071567,TAKEDA,,61.0,YR,,F,Y,133.79,KG,20200208.0,,MD,US,US,2020,Q1,Adult
171728242,17172824,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q1,Pyrexia,,2020,Q1,2,F,20191213.0,20200206.0,20191218,20200208,EXP,,US-TAKEDA-2019TUS071567,TAKEDA,,61.0,YR,,F,Y,133.79,KG,20200208.0,,MD,US,US,2020,Q1,Adult
171829482,17182948,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50-60 U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2020,Q1,Vitamin B1 deficiency,,2020,Q1,2,F,20191016.0,20200114.0,20191220,20200122,EXP,,US-CELGENEUS-USA-20191205924,CELGENE,,78.0,YR,,M,Y,90.0,KG,20200122.0,,MD,US,US,2020,Q1,Elderly
171891242,17189124,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"35 U, UNKNOWN",,,,,,,20563.0,35.0,IU,INJECTION,,2020,Q1,Arthralgia,,2020,Q1,2,F,20191216.0,20191218.0,20191223,20200109,EXP,,US-ELI_LILLY_AND_COMPANY-US201912010083,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200109.0,,CN,US,US,2020,Q1,Elderly
171891242,17189124,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"35 U, UNKNOWN",,,,,,,20563.0,35.0,IU,INJECTION,,2020,Q1,Arthropathy,,2020,Q1,2,F,20191216.0,20191218.0,20191223,20200109,EXP,,US-ELI_LILLY_AND_COMPANY-US201912010083,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200109.0,,CN,US,US,2020,Q1,Elderly
171891242,17189124,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"35 U, UNKNOWN",,,,,,,20563.0,35.0,IU,INJECTION,,2020,Q1,Wrong technique in product usage process,,2020,Q1,2,F,20191216.0,20191218.0,20191223,20200109,EXP,,US-ELI_LILLY_AND_COMPANY-US201912010083,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200109.0,,CN,US,US,2020,Q1,Elderly
171891242,17189124,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"35 U, UNKNOWN",,,,, C989316P,,20563.0,35.0,IU,INJECTION,,2020,Q1,Arthralgia,,2020,Q1,2,F,20191216.0,20191218.0,20191223,20200109,EXP,,US-ELI_LILLY_AND_COMPANY-US201912010083,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200109.0,,CN,US,US,2020,Q1,Elderly
171891242,17189124,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"35 U, UNKNOWN",,,,, C989316P,,20563.0,35.0,IU,INJECTION,,2020,Q1,Arthropathy,,2020,Q1,2,F,20191216.0,20191218.0,20191223,20200109,EXP,,US-ELI_LILLY_AND_COMPANY-US201912010083,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200109.0,,CN,US,US,2020,Q1,Elderly
171891242,17189124,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"35 U, UNKNOWN",,,,, C989316P,,20563.0,35.0,IU,INJECTION,,2020,Q1,Wrong technique in product usage process,,2020,Q1,2,F,20191216.0,20191218.0,20191223,20200109,EXP,,US-ELI_LILLY_AND_COMPANY-US201912010083,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200109.0,,CN,US,US,2020,Q1,Elderly
171891242,17189124,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"35 U, UNKNOWN",,,,, C989315C,,20563.0,35.0,IU,INJECTION,,2020,Q1,Arthralgia,,2020,Q1,2,F,20191216.0,20191218.0,20191223,20200109,EXP,,US-ELI_LILLY_AND_COMPANY-US201912010083,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200109.0,,CN,US,US,2020,Q1,Elderly
171891242,17189124,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"35 U, UNKNOWN",,,,, C989315C,,20563.0,35.0,IU,INJECTION,,2020,Q1,Arthropathy,,2020,Q1,2,F,20191216.0,20191218.0,20191223,20200109,EXP,,US-ELI_LILLY_AND_COMPANY-US201912010083,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200109.0,,CN,US,US,2020,Q1,Elderly
171891242,17189124,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"35 U, UNKNOWN",,,,, C989315C,,20563.0,35.0,IU,INJECTION,,2020,Q1,Wrong technique in product usage process,,2020,Q1,2,F,20191216.0,20191218.0,20191223,20200109,EXP,,US-ELI_LILLY_AND_COMPANY-US201912010083,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200109.0,,CN,US,US,2020,Q1,Elderly
172108172,17210817,14,C,INSULIN LISPRO (HUMALOG),,2,Subcutaneous,DOSE: 0-20 UNITS?BEFORE MEALS AND NIGHTLY,,,,,,,,,,,QID,2020,Q1,Bacteraemia,,2020,Q1,2,F,20191219.0,20191231.0,20191227,20200103,EXP,,US-ABBVIE-19P-163-3208128-00,ABBVIE,,48.0,YR,,M,Y,102.6,KG,20200103.0,,MD,US,US,2020,Q1,Adult
172108172,17210817,14,C,INSULIN LISPRO (HUMALOG),,2,Subcutaneous,DOSE: 0-20 UNITS?BEFORE MEALS AND NIGHTLY,,,,,,,,,,,QID,2020,Q1,Sepsis,,2020,Q1,2,F,20191219.0,20191231.0,20191227,20200103,EXP,,US-ABBVIE-19P-163-3208128-00,ABBVIE,,48.0,YR,,M,Y,102.6,KG,20200103.0,,MD,US,US,2020,Q1,Adult
172108172,17210817,14,C,INSULIN LISPRO (HUMALOG),,2,Subcutaneous,DOSE: 0-20 UNITS?BEFORE MEALS AND NIGHTLY,,,,,,,,,,,QID,2020,Q1,Upper respiratory tract infection,,2020,Q1,2,F,20191219.0,20191231.0,20191227,20200103,EXP,,US-ABBVIE-19P-163-3208128-00,ABBVIE,,48.0,YR,,M,Y,102.6,KG,20200103.0,,MD,US,US,2020,Q1,Adult
172108172,17210817,14,C,INSULIN LISPRO (HUMALOG),,2,Subcutaneous,DOSE: 0-20 UNITS?BEFORE MEALS AND NIGHTLY,,,,,,,,,,,QID,2020,Q1,Vascular device infection,,2020,Q1,2,F,20191219.0,20191231.0,20191227,20200103,EXP,,US-ABBVIE-19P-163-3208128-00,ABBVIE,,48.0,YR,,M,Y,102.6,KG,20200103.0,,MD,US,US,2020,Q1,Adult
172144533,17214453,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,AMP IV,,2020,Q1,Device malfunction,,2020,Q1,3,F,20191217.0,20200225.0,20191230,20200303,PER,,US-JNJFOC-20191233219,JOHNSON AND JOHNSON,,46.0,YR,,M,Y,97.61,KG,20200303.0,,CN,US,US,2020,Q1,Adult
172144533,17214453,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,AMP IV,,2020,Q1,Underdose,,2020,Q1,3,F,20191217.0,20200225.0,20191230,20200303,PER,,US-JNJFOC-20191233219,JOHNSON AND JOHNSON,,46.0,YR,,M,Y,97.61,KG,20200303.0,,CN,US,US,2020,Q1,Adult
172236781,17223678,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,6.0,IU,,TID,2020,Q1,Acute myocardial infarction,,2020,Q1,1,I,,20191222.0,20200102,20200102,EXP,,US-USP-000075,USPHARMA,"SAEED M, GIL GS, LOPEZ PD, VISCO F, PEKLER G, MUSHIYEV S. CHEST PAIN INDUCED BY INTRAVENOUS NITROGLYCERIN. AM J THER. 2019 DEC 17. DOI:10.1097/MJT.0000000000000699",54.0,YR,A,,Y,,,20200102.0,,MD,US,US,2020,Q1,Adult
172236781,17223678,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,6.0,IU,,TID,2020,Q1,Product use in unapproved indication,,2020,Q1,1,I,,20191222.0,20200102,20200102,EXP,,US-USP-000075,USPHARMA,"SAEED M, GIL GS, LOPEZ PD, VISCO F, PEKLER G, MUSHIYEV S. CHEST PAIN INDUCED BY INTRAVENOUS NITROGLYCERIN. AM J THER. 2019 DEC 17. DOI:10.1097/MJT.0000000000000699",54.0,YR,A,,Y,,,20200102.0,,MD,US,US,2020,Q1,Adult
172236941,17223694,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20191223.0,20200102,20200102,EXP,,US-ELI_LILLY_AND_COMPANY-US201912012195,ELI LILLY AND CO,,30.0,YR,,M,Y,,,20200102.0,,CN,US,US,2020,Q1,Young Adult
172236941,17223694,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,1,I,,20191223.0,20200102,20200102,EXP,,US-ELI_LILLY_AND_COMPANY-US201912012195,ELI LILLY AND CO,,30.0,YR,,M,Y,,,20200102.0,,CN,US,US,2020,Q1,Young Adult
172236941,17223694,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C997208A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20191223.0,20200102,20200102,EXP,,US-ELI_LILLY_AND_COMPANY-US201912012195,ELI LILLY AND CO,,30.0,YR,,M,Y,,,20200102.0,,CN,US,US,2020,Q1,Young Adult
172236941,17223694,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C997208A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,1,I,,20191223.0,20200102,20200102,EXP,,US-ELI_LILLY_AND_COMPANY-US201912012195,ELI LILLY AND CO,,30.0,YR,,M,Y,,,20200102.0,,CN,US,US,2020,Q1,Young Adult
172253441,17225344,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU, QD",6480.0,IU,Y,,,,209196.0,12.0,IU,,QD,2020,Q1,Hypoglycaemic coma,,2020,Q1,1,I,20190625.0,20191226.0,20200102,20200102,EXP,IT-MINISAL02-596206,IT-SA-2019SA360155,SANOFI AVENTIS,,85.0,YR,E,M,Y,,,20200102.0,,PH,IT,IT,2020,Q1,Elderly
172324942,17232494,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C979579H,,20563.0,,,INJECTION,,2020,Q1,Upper limb fracture,,2020,Q1,2,F,,20200103.0,20200103,20200108,EXP,,US-ELI_LILLY_AND_COMPANY-US201912014362,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20200108.0,,CN,US,US,2020,Q1,Elderly
172324942,17232494,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,INJECTION,,2020,Q1,Upper limb fracture,,2020,Q1,2,F,,20200103.0,20200103,20200108,EXP,,US-ELI_LILLY_AND_COMPANY-US201912014362,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20200108.0,,CN,US,US,2020,Q1,Elderly
172335111,17233511,2,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",6480.0,IU,Y,U,,,,12.0,IU,,QD,2020,Q1,Hypoglycaemic coma,,2020,Q1,1,I,20190625.0,20191223.0,20200104,20200104,EXP,,IT-AUROBINDO-AUR-APL-2020-000411,AUROBINDO,,85.0,YR,,M,Y,,,20200105.0,,PH,IT,IT,2020,Q1,Elderly
172339721,17233972,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20191203.0,20200106,20200106,EXP,,US-MALLINCKRODT-T201908440,MALLINCKRODT,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57:1220-413",61.0,YR,,F,Y,,,20200106.0,,MD,US,US,2020,Q1,Adult
172339721,17233972,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Incorrect route of product administration,,2020,Q1,1,I,2018.0,20191203.0,20200106,20200106,EXP,,US-MALLINCKRODT-T201908440,MALLINCKRODT,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57:1220-413",61.0,YR,,F,Y,,,20200106.0,,MD,US,US,2020,Q1,Adult
172410871,17241087,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,6 UNITS 3 TIMES PER DAY,,,,,,,,,,,,2020,Q1,Acute myocardial infarction,,2020,Q1,1,I,,20191224.0,20200107,20200107,EXP,,US-ALVOGEN-2020-ALVOGEN-102297,ALVOGEN,"SAEED M, GIL GS, LOPEZ PD, VISCO F, PEKLER G, MUSHIYEV S. CHEST PAIN INDUCED BY INTRAVENOUS NITROGLYCERIN. AM J THER. 2019 DEC 17",54.0,YR,,M,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172411281,17241128,7,C,INSULINA LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Decreased appetite,,2020,Q1,1,I,20191030.0,20191221.0,20200107,20200107,EXP,IT-MINISAL02-595997,IT-ACCORD-167875,ACCORD,,78.0,YR,,F,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Elderly
172411281,17241128,7,C,INSULINA LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20191030.0,20191221.0,20200107,20200107,EXP,IT-MINISAL02-595997,IT-ACCORD-167875,ACCORD,,78.0,YR,,F,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Elderly
172411281,17241128,7,C,INSULINA LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Off label use,,2020,Q1,1,I,20191030.0,20191221.0,20200107,20200107,EXP,IT-MINISAL02-595997,IT-ACCORD-167875,ACCORD,,78.0,YR,,F,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Elderly
172411281,17241128,7,C,INSULINA LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,20191030.0,20191221.0,20200107,20200107,EXP,IT-MINISAL02-595997,IT-ACCORD-167875,ACCORD,,78.0,YR,,F,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Elderly
172450252,17245025,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IU, UNK",,,,,,,,100.0,IU,,,2020,Q1,Rash,,2020,Q1,2,F,,20200123.0,20200108,20200219,PER,,US-ALEXION PHARMACEUTICALS INC.-A201919468,ALEXION,,40.0,YR,,M,Y,126.8,KG,20200219.0,,CN,US,US,2020,Q1,Adult
172466283,17246628,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Blood glucose decreased,,2020,Q1,3,F,201912.0,20200120.0,20200108,20200127,PER,,US-EISAI MEDICAL RESEARCH-EC-2019-067480,EISAI,,66.0,YR,,F,Y,89.3,KG,20200127.0,,CN,US,US,2020,Q1,Elderly
172466283,17246628,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Essential hypertension,,2020,Q1,3,F,201912.0,20200120.0,20200108,20200127,PER,,US-EISAI MEDICAL RESEARCH-EC-2019-067480,EISAI,,66.0,YR,,F,Y,89.3,KG,20200127.0,,CN,US,US,2020,Q1,Elderly
172466283,17246628,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Toothache,,2020,Q1,3,F,201912.0,20200120.0,20200108,20200127,PER,,US-EISAI MEDICAL RESEARCH-EC-2019-067480,EISAI,,66.0,YR,,F,Y,89.3,KG,20200127.0,,CN,US,US,2020,Q1,Elderly
172474133,17247413,38,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q1,Skin infection,,2020,Q1,3,F,20191227.0,20200116.0,20200108,20200123,EXP,,US-TAKEDA-2019TUS074519,TAKEDA,,63.0,YR,,M,Y,,,20200123.0,,MD,US,US,2020,Q1,Adult
172502851,17250285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,1,I,,20191227.0,20200109,20200109,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1238,EMCURE,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM J THER.. 2019;26(4):E543-E546",72.0,YR,,F,Y,,,20200109.0,,PH,US,US,2020,Q1,Elderly
172502851,17250285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2020,Q1,Cardiac arrest,,2020,Q1,1,I,,20191227.0,20200109,20200109,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1238,EMCURE,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM J THER.. 2019;26(4):E543-E546",72.0,YR,,F,Y,,,20200109.0,,PH,US,US,2020,Q1,Elderly
172502851,17250285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,1,I,,20191227.0,20200109,20200109,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1238,EMCURE,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM J THER.. 2019;26(4):E543-E546",72.0,YR,,F,Y,,,20200109.0,,PH,US,US,2020,Q1,Elderly
172502851,17250285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,,20191227.0,20200109,20200109,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1238,EMCURE,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM J THER.. 2019;26(4):E543-E546",72.0,YR,,F,Y,,,20200109.0,,PH,US,US,2020,Q1,Elderly
172502851,17250285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2020,Q1,Hypovolaemic shock,,2020,Q1,1,I,,20191227.0,20200109,20200109,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1238,EMCURE,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM J THER.. 2019;26(4):E543-E546",72.0,YR,,F,Y,,,20200109.0,,PH,US,US,2020,Q1,Elderly
172502851,17250285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20191227.0,20200109,20200109,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1238,EMCURE,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM J THER.. 2019;26(4):E543-E546",72.0,YR,,F,Y,,,20200109.0,,PH,US,US,2020,Q1,Elderly
172502851,17250285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20191227.0,20200109,20200109,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1238,EMCURE,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM J THER.. 2019;26(4):E543-E546",72.0,YR,,F,Y,,,20200109.0,,PH,US,US,2020,Q1,Elderly
172505091,17250509,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20191203.0,20200109,20200109,EXP,,US-MALLINCKRODT-T201908742,MALLINCKRODT,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57:1220-413",37.0,YR,,M,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172505091,17250509,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Incorrect route of product administration,,2020,Q1,1,I,2018.0,20191203.0,20200109,20200109,EXP,,US-MALLINCKRODT-T201908742,MALLINCKRODT,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57:1220-413",37.0,YR,,M,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172505091,17250509,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20191203.0,20200109,20200109,EXP,,US-MALLINCKRODT-T201908742,MALLINCKRODT,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57:1220-413",37.0,YR,,M,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172505091,17250509,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Incorrect route of product administration,,2020,Q1,1,I,2018.0,20191203.0,20200109,20200109,EXP,,US-MALLINCKRODT-T201908742,MALLINCKRODT,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57:1220-413",37.0,YR,,M,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172542841,17254284,13,SS,Lispro Insulin,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,,20200102.0,20200109,20200109,EXP,,US-SUNOVION-2020SUN000063,SUNOVION,"GUMMIN, DAVID D,; MOWRY, JAMES B.; SPYKER, DANIEL A.; BROOKS, DANIEL E.; BEUHLER, MICHAEL C.; RIVERS, LAURA J.; HASHEM, HEBA, A.; RYAN, MARK L.. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57:12:1220-1413",61.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172560201,17256020,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Intercepted product prescribing error,,2020,Q1,1,I,,20191213.0,20200110,20200110,EXP,,US-ELI_LILLY_AND_COMPANY-US201912009061,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200110.0,,CN,US,US,2020,Q1,Adult
172577061,17257706,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Peripheral swelling,,2020,Q1,1,I,201912.0,20191213.0,20200110,20200110,PER,,US-009507513-1912USA006946,MERCK,,32.0,YR,,F,Y,,,20200110.0,,MD,US,US,2020,Q1,Young Adult
172591691,17259169,15,SS,LISPRO-INSULIN,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2020,Q1,Suspected suicide,,2020,Q1,1,I,,20200103.0,20200110,20200110,EXP,,US-GLAXOSMITHKLINE-US2020GSK001265,GLAXOSMITHKLINE,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, HASHEM HA, RYAN ML. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019",61.0,YR,,F,Y,,,20200110.0,,HP,US,US,2020,Q1,Adult
172598025,17259802,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, TID",,,,,,,,2.0,IU,LIQUID,TID,2020,Q1,Bacteraemia,,2020,Q1,5,F,20191220.0,20200304.0,20200110,20200318,PER,,US-AMGEN-USACT2019216516,AMGEN,,70.0,YR,E,M,Y,82.0,KG,20200318.0,,MD,US,US,2020,Q1,Elderly
172598025,17259802,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,LIQUID,,2020,Q1,Bacteraemia,,2020,Q1,5,F,20191220.0,20200304.0,20200110,20200318,PER,,US-AMGEN-USACT2019216516,AMGEN,,70.0,YR,E,M,Y,82.0,KG,20200318.0,,MD,US,US,2020,Q1,Elderly
172606641,17260664,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 IU IN THE MORNING - 20 IU AT NOON - 22 IU IN THE EVENING,,,N,,,,209196.0,,,,,2020,Q1,Dermatitis bullous,,2020,Q1,1,I,2019.0,20200107.0,20200113,20200113,EXP,FR-AFSSAPS-RN20191965,FR-SA-2020SA003972,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20200113.0,,PH,FR,FR,2020,Q1,Adult
172606641,17260664,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 IU IN THE MORNING - 20 IU AT NOON - 22 IU IN THE EVENING,,,N,,,,209196.0,,,,,2020,Q1,Eczema,,2020,Q1,1,I,2019.0,20200107.0,20200113,20200113,EXP,FR-AFSSAPS-RN20191965,FR-SA-2020SA003972,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20200113.0,,PH,FR,FR,2020,Q1,Adult
172606641,17260664,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 IU IN THE MORNING - 20 IU AT NOON - 22 IU IN THE EVENING,,,N,,,,209196.0,,,,,2020,Q1,Pruritus,,2020,Q1,1,I,2019.0,20200107.0,20200113,20200113,EXP,FR-AFSSAPS-RN20191965,FR-SA-2020SA003972,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20200113.0,,PH,FR,FR,2020,Q1,Adult
172627011,17262701,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12 IU PER DAY,6480.0,IU,Y,, UNKNOWN,,,12.0,IU,,,2020,Q1,Hypoglycaemic coma,,2020,Q1,1,I,20190625.0,20200107.0,20200113,20200113,EXP,IT-MINISAL02-596206,IT-TEVA-2020-IT-1166951,TEVA,,85.0,YR,,M,Y,,,20200113.0,,PH,IT,IT,2020,Q1,Elderly
172630811,17263081,13,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Delirium,,2020,Q1,1,I,20191220.0,20200106.0,20200113,20200113,EXP,,CA-CELGENEUS-CAN-20200101542,CELGENE,,63.0,YR,,M,Y,,,20200113.0,,PH,CA,CA,2020,Q1,Adult
172630811,17263081,13,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Sepsis,,2020,Q1,1,I,20191220.0,20200106.0,20200113,20200113,EXP,,CA-CELGENEUS-CAN-20200101542,CELGENE,,63.0,YR,,M,Y,,,20200113.0,,PH,CA,CA,2020,Q1,Adult
172667671,17266767,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200106.0,20200114,20200114,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202001001473,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200114.0,,CN,DE,DE,2020,Q1,Elderly
172667671,17266767,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D069892,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200106.0,20200114,20200114,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202001001473,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200114.0,,CN,DE,DE,2020,Q1,Elderly
172716321,17271632,36,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"8 U, QD",,,U,,,,,,,,QD,2020,Q1,Syncope,,2020,Q1,1,I,20191126.0,20200108.0,20200115,20200115,EXP,,US-SA-2020SA010249,SANOFI AVENTIS,,73.0,YR,E,F,Y,106.5,KG,20200115.0,,PH,US,US,2020,Q1,Elderly
172716401,17271640,2,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Mononeuropathy,,2020,Q1,1,I,,20191025.0,20200115,20200115,EXP,,IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2019-09287,ALKEM,"CHRISTENSEN MMH, BRUUN HAASTRUP M, OHLENSCHLAEGER T, ESBECH P, ET AL.. INTERACTION POTENTIAL BETWEEN CLARITHROMYCIN AND INDIVIDUAL STATINS - A SYSTEMATIC REVIEW. BASIC CLIN PHARMACOL TOXICOL.. 2019;UNK:UNK",42.0,YR,,M,Y,,,20200115.0,,MD,DK,IT,2020,Q1,Adult
172716401,17271640,2,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Rhabdomyolysis,,2020,Q1,1,I,,20191025.0,20200115,20200115,EXP,,IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2019-09287,ALKEM,"CHRISTENSEN MMH, BRUUN HAASTRUP M, OHLENSCHLAEGER T, ESBECH P, ET AL.. INTERACTION POTENTIAL BETWEEN CLARITHROMYCIN AND INDIVIDUAL STATINS - A SYSTEMATIC REVIEW. BASIC CLIN PHARMACOL TOXICOL.. 2019;UNK:UNK",42.0,YR,,M,Y,,,20200115.0,,MD,DK,IT,2020,Q1,Adult
172722482,17272248,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,2,F,2018.0,20200106.0,20200115,20200116,EXP,,US-APOTEX-2020AP005737,APOTEX,"GUMMIN DD, MOWRYJB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, HASHEM HA, RYAN ML. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. DOI: 10.1080/15563650.2019.1677022. CLINICAL TOXICOLOGY. 2019;57 (12):1220-1413",61.0,YR,,F,Y,,,20200116.0,,MD,US,US,2020,Q1,Adult
172722701,17272270,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20200106.0,20200115,20200115,EXP,,US-APOTEX-2020AP005904,APOTEX,"GUMMIN DD, MOWRYJB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, HASHEM HA, RYAN ML. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. DOI: 10.1080/15563650.2019.1677022. CLINICAL TOXICOLOGY. 2019;57 (12):1220-1413",37.0,YR,,M,Y,,,20200115.0,,MD,US,US,2020,Q1,Adult
172722701,17272270,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,UNK,,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20200106.0,20200115,20200115,EXP,,US-APOTEX-2020AP005904,APOTEX,"GUMMIN DD, MOWRYJB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, HASHEM HA, RYAN ML. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. DOI: 10.1080/15563650.2019.1677022. CLINICAL TOXICOLOGY. 2019;57 (12):1220-1413",37.0,YR,,M,Y,,,20200115.0,,MD,US,US,2020,Q1,Adult
172755211,17275521,13,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Infusion site discharge,,2020,Q1,1,I,,20190627.0,20200116,20200116,EXP,,CA-AUROBINDO-AUR-APL-2019-038592,AUROBINDO,,53.0,YR,,F,Y,48.0,KG,20200116.0,,PH,CA,CA,2020,Q1,Adult
172755211,17275521,13,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Infusion site erythema,,2020,Q1,1,I,,20190627.0,20200116,20200116,EXP,,CA-AUROBINDO-AUR-APL-2019-038592,AUROBINDO,,53.0,YR,,F,Y,48.0,KG,20200116.0,,PH,CA,CA,2020,Q1,Adult
172755211,17275521,13,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Neutrophil count decreased,,2020,Q1,1,I,,20190627.0,20200116,20200116,EXP,,CA-AUROBINDO-AUR-APL-2019-038592,AUROBINDO,,53.0,YR,,F,Y,48.0,KG,20200116.0,,PH,CA,CA,2020,Q1,Adult
172777822,17277782,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,2,F,2018.0,20200111.0,20200116,20200123,EXP,,US-PFIZER INC-2020015779,PFIZER,"GUMMIN, D.. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57 (12):10.1080/15563650.2019.1677022",61.0,YR,,F,Y,,,20200123.0,,MD,US,US,2020,Q1,Adult
172792081,17279208,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Anti-insulin antibody positive,,2020,Q1,1,I,,20200109.0,20200116,20200116,EXP,,CN-SA-2020SA007933,SANOFI AVENTIS,SHEN Y.; SONG X.; REN Y.. INSULIN AUTOIMMUNE SYNDROME INDUCED BY EXOGENOUS INSULIN INJECTION: A FOUR-CASE SERIES. BMC ENDOCRINE DISORDERS. 2019;19 (1):UNK,79.0,YR,E,M,Y,,,20200116.0,,HP,CN,CN,2020,Q1,Elderly
172792081,17279208,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood insulin increased,,2020,Q1,1,I,,20200109.0,20200116,20200116,EXP,,CN-SA-2020SA007933,SANOFI AVENTIS,SHEN Y.; SONG X.; REN Y.. INSULIN AUTOIMMUNE SYNDROME INDUCED BY EXOGENOUS INSULIN INJECTION: A FOUR-CASE SERIES. BMC ENDOCRINE DISORDERS. 2019;19 (1):UNK,79.0,YR,E,M,Y,,,20200116.0,,HP,CN,CN,2020,Q1,Elderly
172792081,17279208,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,,20200109.0,20200116,20200116,EXP,,CN-SA-2020SA007933,SANOFI AVENTIS,SHEN Y.; SONG X.; REN Y.. INSULIN AUTOIMMUNE SYNDROME INDUCED BY EXOGENOUS INSULIN INJECTION: A FOUR-CASE SERIES. BMC ENDOCRINE DISORDERS. 2019;19 (1):UNK,79.0,YR,E,M,Y,,,20200116.0,,HP,CN,CN,2020,Q1,Elderly
172792081,17279208,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200109.0,20200116,20200116,EXP,,CN-SA-2020SA007933,SANOFI AVENTIS,SHEN Y.; SONG X.; REN Y.. INSULIN AUTOIMMUNE SYNDROME INDUCED BY EXOGENOUS INSULIN INJECTION: A FOUR-CASE SERIES. BMC ENDOCRINE DISORDERS. 2019;19 (1):UNK,79.0,YR,E,M,Y,,,20200116.0,,HP,CN,CN,2020,Q1,Elderly
172792081,17279208,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Insulin C-peptide increased,,2020,Q1,1,I,,20200109.0,20200116,20200116,EXP,,CN-SA-2020SA007933,SANOFI AVENTIS,SHEN Y.; SONG X.; REN Y.. INSULIN AUTOIMMUNE SYNDROME INDUCED BY EXOGENOUS INSULIN INJECTION: A FOUR-CASE SERIES. BMC ENDOCRINE DISORDERS. 2019;19 (1):UNK,79.0,YR,E,M,Y,,,20200116.0,,HP,CN,CN,2020,Q1,Elderly
172792081,17279208,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Insulin autoimmune syndrome,,2020,Q1,1,I,,20200109.0,20200116,20200116,EXP,,CN-SA-2020SA007933,SANOFI AVENTIS,SHEN Y.; SONG X.; REN Y.. INSULIN AUTOIMMUNE SYNDROME INDUCED BY EXOGENOUS INSULIN INJECTION: A FOUR-CASE SERIES. BMC ENDOCRINE DISORDERS. 2019;19 (1):UNK,79.0,YR,E,M,Y,,,20200116.0,,HP,CN,CN,2020,Q1,Elderly
172795402,17279540,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"15 IU, TID",,,U,,,,209196.0,15.0,IU,SOLUTION FOR INJECTION,Q8H,2020,Q1,Blood glucose decreased,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"15 IU, TID",,,U,,,,209196.0,15.0,IU,SOLUTION FOR INJECTION,Q8H,2020,Q1,Blood glucose increased,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"15 IU, TID",,,U,,,,209196.0,15.0,IU,SOLUTION FOR INJECTION,Q8H,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"15 IU, TID",,,U,,,,209196.0,15.0,IU,SOLUTION FOR INJECTION,Q8H,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,10 IU,,,U,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose decreased,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,10 IU,,,U,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,10 IU,,,U,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,10 IU,,,U,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172819061,17281906,11,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Localised infection,,2020,Q1,1,I,20181115.0,,20191229,20191229,DIR,,,FDA-CTU,,59.0,YR,,M,N,85.3,KG,20191218.0,N,MD,US,US,2020,Q1,Adult
172819061,17281906,11,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Therapy cessation,,2020,Q1,1,I,20181115.0,,20191229,20191229,DIR,,,FDA-CTU,,59.0,YR,,M,N,85.3,KG,20191218.0,N,MD,US,US,2020,Q1,Adult
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Abdominal distension,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Abdominal pain,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Acute kidney injury,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Anaemia,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Anal incontinence,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Anxiety,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Ascites,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Asthenia,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Blood albumin decreased,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Blood bilirubin decreased,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Blood calcium decreased,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Blood glucose increased,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Blood magnesium decreased,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Blood phosphorus decreased,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Blood sodium decreased,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Carbon dioxide decreased,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Confusional state,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Constipation,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Decreased appetite,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Depression,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Diabetic ketoacidosis,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Diarrhoea,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Dyspnoea,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Hypertension,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Hypoalbuminaemia,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Hypoxia,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Mental disorder,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Mental impairment,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Metabolic encephalopathy,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Nausea,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Neoplasm malignant,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Pain,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Peritonitis,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Protein total decreased,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Urinary tract infection,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172863402,17286340,10,C,INSULINE LISPRO,,2,Subcutaneous,"20 OT, TID BEFORE MEALS (100 UNIT/ML SOLUTION PEN INJECTOR AS DIRECTED)",,,U,,,,,,,,TID,2020,Q1,Vomiting,,2020,Q1,2,F,201807.0,20200212.0,20200118,20200224,EXP,,NVSC2020US008978,NOVARTIS,,65.0,YR,,F,Y,111.0,KG,20200224.0,,HP,US,US,2020,Q1,Elderly
172869021,17286902,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12IU AT BREAKFAST, 12IU AT DINNER, 12IU AT LUNCH",,,,,,,,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20191109.0,20200114.0,20200120,20200120,EXP,ES-AEMPS-585631,ES-SA-2020SA010568,SANOFI AVENTIS,,57.0,YR,A,M,Y,60.5,KG,20200120.0,,PH,ES,ES,2020,Q1,Adult
172869021,17286902,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12IU AT BREAKFAST, 12IU AT DINNER, 12IU AT LUNCH",,,,,,,,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Nausea,,2020,Q1,1,I,20191109.0,20200114.0,20200120,20200120,EXP,ES-AEMPS-585631,ES-SA-2020SA010568,SANOFI AVENTIS,,57.0,YR,A,M,Y,60.5,KG,20200120.0,,PH,ES,ES,2020,Q1,Adult
172877192,17287719,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"UNK UNK, UNKNOWN",,,,, C997208A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,2,F,20200113.0,20200114.0,20200120,20200121,EXP,,US-ELI_LILLY_AND_COMPANY-US202001007001,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172877192,17287719,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"UNK UNK, UNKNOWN",,,,, C997208A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,2,F,20200113.0,20200114.0,20200120,20200121,EXP,,US-ELI_LILLY_AND_COMPANY-US202001007001,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172896341,17289634,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,, C939454C,,20563.0,,,INJECTION,,2020,Q1,Hypoacusis,,2020,Q1,1,I,20200110.0,20200110.0,20200120,20200120,EXP,,US-ELI_LILLY_AND_COMPANY-US202001004703,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200120.0,,CN,US,US,2020,Q1,Elderly
172896341,17289634,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,, C939454C,,20563.0,,,INJECTION,,2020,Q1,Injury associated with device,,2020,Q1,1,I,20200110.0,20200110.0,20200120,20200120,EXP,,US-ELI_LILLY_AND_COMPANY-US202001004703,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20200120.0,,CN,US,US,2020,Q1,Elderly
172931922,17293192,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, QD (DAILY AT DINNER,STARTED 20 YEARS AGO)",,,,,,,,15.0,DF,,QD,2020,Q1,Epistaxis,,2020,Q1,2,F,201912.0,20200128.0,20200121,20200201,EXP,,NVSC2020MX012347,NOVARTIS,,61.0,YR,,M,Y,114.0,KG,20200201.0,,CN,COUNTRY NOT SPECIFIED,MX,2020,Q1,Adult
172931922,17293192,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, QD (DAILY AT DINNER,STARTED 20 YEARS AGO)",,,,,,,,15.0,DF,,QD,2020,Q1,Influenza,,2020,Q1,2,F,201912.0,20200128.0,20200121,20200201,EXP,,NVSC2020MX012347,NOVARTIS,,61.0,YR,,M,Y,114.0,KG,20200201.0,,CN,COUNTRY NOT SPECIFIED,MX,2020,Q1,Adult
172931922,17293192,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, QD (DAILY AT DINNER,STARTED 20 YEARS AGO)",,,,,,,,15.0,DF,,QD,2020,Q1,Productive cough,,2020,Q1,2,F,201912.0,20200128.0,20200121,20200201,EXP,,NVSC2020MX012347,NOVARTIS,,61.0,YR,,M,Y,114.0,KG,20200201.0,,CN,COUNTRY NOT SPECIFIED,MX,2020,Q1,Adult
172931922,17293192,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, QD (DAILY AT DINNER,STARTED 20 YEARS AGO)",,,,,,,,15.0,DF,,QD,2020,Q1,Pulmonary thrombosis,,2020,Q1,2,F,201912.0,20200128.0,20200121,20200201,EXP,,NVSC2020MX012347,NOVARTIS,,61.0,YR,,M,Y,114.0,KG,20200201.0,,CN,COUNTRY NOT SPECIFIED,MX,2020,Q1,Adult
172933823,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Blood glucose increased,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Cholelithiasis,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Food intolerance,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Headache,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Malaise,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Nausea,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Pituitary enlargement,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Vision blurred,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172935521,17293552,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U, UNK,,,,,,,2020,Q1,Cerebrovascular accident,,2020,Q1,1,I,,20200120.0,20200121,20200121,EXP,,NVSC2020PT013531,NOVARTIS,,42.0,YR,,F,Y,,,20200121.0,,HP,PT,PT,2020,Q1,Adult
172935521,17293552,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U, UNK,,,,,,,2020,Q1,Treatment noncompliance,,2020,Q1,1,I,,20200120.0,20200121,20200121,EXP,,NVSC2020PT013531,NOVARTIS,,42.0,YR,,F,Y,,,20200121.0,,HP,PT,PT,2020,Q1,Adult
172951281,17295128,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Cerebrovascular accident,,2020,Q1,1,I,,20200110.0,20200121,20200121,EXP,,PT-MYLANLABS-2020M1004817,MYLAN,"COCHICHO J, SILVA J, NARANJO S, RAIMUNDO R, MENDES A, VIANA S, ET AL.. AVC NO DOENTE JOVEM: UM CASO DE INVESTIGA??O ETIOL?GICA COM M?LTIPLAS RESPOSTAS.. MEDICINA INTERNA - CONGRESSOS NACIONAIS 25CNMI19. 2019",42.0,YR,,F,Y,,,20200121.0,,MD,PT,PT,2020,Q1,Adult
172951281,17295128,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Treatment noncompliance,,2020,Q1,1,I,,20200110.0,20200121,20200121,EXP,,PT-MYLANLABS-2020M1004817,MYLAN,"COCHICHO J, SILVA J, NARANJO S, RAIMUNDO R, MENDES A, VIANA S, ET AL.. AVC NO DOENTE JOVEM: UM CASO DE INVESTIGA??O ETIOL?GICA COM M?LTIPLAS RESPOSTAS.. MEDICINA INTERNA - CONGRESSOS NACIONAIS 25CNMI19. 2019",42.0,YR,,F,Y,,,20200121.0,,MD,PT,PT,2020,Q1,Adult
172983341,17298334,3,C,Insulin lispro,INSULIN LISPRO,1,,6 UNITS 3 TIMES PER DAY,,,,,,,,,,,,2020,Q1,Acute myocardial infarction,,2020,Q1,1,I,,20200109.0,20200122,20200122,EXP,,"US-EVUS PHARMACEUTICALS, LLC-EPL202001-000006",EVUS PHARMACEUTICALS,"SAEED M, GIL G, LOPEZ P, VISCO F, PEKLER G, MUSHIYEV S. CHEST PAIN INDUCED BY INTRAVENOUS NITROGLYCERIN. AM J THER. 2019;1-3.",54.0,YR,,M,Y,,,20200122.0,,,COUNTRY NOT SPECIFIED,US,2020,Q1,Adult
172983341,17298334,3,C,Insulin lispro,INSULIN LISPRO,1,,6 UNITS 3 TIMES PER DAY,,,,,,,,,,,,2020,Q1,Product use in unapproved indication,,2020,Q1,1,I,,20200109.0,20200122,20200122,EXP,,"US-EVUS PHARMACEUTICALS, LLC-EPL202001-000006",EVUS PHARMACEUTICALS,"SAEED M, GIL G, LOPEZ P, VISCO F, PEKLER G, MUSHIYEV S. CHEST PAIN INDUCED BY INTRAVENOUS NITROGLYCERIN. AM J THER. 2019;1-3.",54.0,YR,,M,Y,,,20200122.0,,,COUNTRY NOT SPECIFIED,US,2020,Q1,Adult
172987221,17298722,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Dehydration,,2020,Q1,1,I,,20200113.0,20200121,20200121,EXP,,CA-JNJFOC-20200125688,JOHNSON AND JOHNSON,,61.0,YR,,F,Y,79.0,KG,20200121.0,,PH,CA,CA,2020,Q1,Adult
172987221,17298722,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200113.0,20200121,20200121,EXP,,CA-JNJFOC-20200125688,JOHNSON AND JOHNSON,,61.0,YR,,F,Y,79.0,KG,20200121.0,,PH,CA,CA,2020,Q1,Adult
172987221,17298722,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,,20200113.0,20200121,20200121,EXP,,CA-JNJFOC-20200125688,JOHNSON AND JOHNSON,,61.0,YR,,F,Y,79.0,KG,20200121.0,,PH,CA,CA,2020,Q1,Adult
172987221,17298722,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Nausea,,2020,Q1,1,I,,20200113.0,20200121,20200121,EXP,,CA-JNJFOC-20200125688,JOHNSON AND JOHNSON,,61.0,YR,,F,Y,79.0,KG,20200121.0,,PH,CA,CA,2020,Q1,Adult
172987221,17298722,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Vomiting,,2020,Q1,1,I,,20200113.0,20200121,20200121,EXP,,CA-JNJFOC-20200125688,JOHNSON AND JOHNSON,,61.0,YR,,F,Y,79.0,KG,20200121.0,,PH,CA,CA,2020,Q1,Adult
173073891,17307389,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, UNKNOWN",,,,, C938255F,,,15.0,IU,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200114.0,20200123,20200123,EXP,,US-ELI_LILLY_AND_COMPANY-US202001006461,ELI LILLY AND CO,,53.0,YR,,M,Y,,,20200123.0,,CN,US,US,2020,Q1,Adult
173073891,17307389,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, UNKNOWN",,,,, C938255F,,,15.0,IU,,,2020,Q1,Laziness,,2020,Q1,1,I,,20200114.0,20200123,20200123,EXP,,US-ELI_LILLY_AND_COMPANY-US202001006461,ELI LILLY AND CO,,53.0,YR,,M,Y,,,20200123.0,,CN,US,US,2020,Q1,Adult
173073891,17307389,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, UNKNOWN",,,,, C938255F,,,15.0,IU,,,2020,Q1,Retinopathy,,2020,Q1,1,I,,20200114.0,20200123,20200123,EXP,,US-ELI_LILLY_AND_COMPANY-US202001006461,ELI LILLY AND CO,,53.0,YR,,M,Y,,,20200123.0,,CN,US,US,2020,Q1,Adult
173098361,17309836,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"4 INTERNATIONAL UNIT, TID",,,,,,,,4.0,IU,INJECTION,TID,2020,Q1,Disseminated intravascular coagulation,,2020,Q1,1,I,20181229.0,20200114.0,20200123,20200123,EXP,,CN-009507513-2001CHN006524,MERCK,"YUXIAN C, QIAOYAN G, MEI G. ONE CASE OF DISSEMINATED INTRAVASCULAR COAGULATION CAUSED BY THE COMBINED ADMINISTRATION OF MULTIPLE DRUGS SUCH AS TIGECYCLINE. CHINESE JOURNAL OF PHARMACOEPIDEMIOLOGY. 2019;28(12):834-6",69.0,YR,,M,Y,,,20200123.0,,HP,CN,CN,2020,Q1,Elderly
173161111,17316111,15,SS,LISPRO INSULIN,INSULIN LISPRO,1,Oral,"UNK UNKNOWN, UNKNOWN",,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20200114.0,20200124,20200124,EXP,,US-ENDO PHARMACEUTICALS INC-2020-000301,ENDO,,61.0,YR,,F,Y,,,20200124.0,,MD,US,US,2020,Q1,Adult
173167381,17316738,13,SS,LISPRO INSULIN,INSULIN LISPRO,1,Oral,"UNKNOWN, UNKNOWN",,,D,, UNKNOWN,,,,,,,2020,Q1,Death,,2020,Q1,1,I,2018.0,20200120.0,20200124,20200124,EXP,,US-PERRIGO-20US001033,PERRIGO,,61.0,YR,,F,Y,,,20200124.0,,PH,US,US,2020,Q1,Adult
173171231,17317123,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Oral,INGESTION,,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,,20200117.0,20200124,20200124,EXP,,US-BAUSCH-BL-2020-001742,BAUSCH AND LOMB,"GUMMIN D, MOWRY J, SPYKER D, BROOKS D, BEUHLER M, RIVERS L, HASHEM H, RYAN M. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019 NOV 21;57(12):1220-1413. DOI:10.1080/15563650.2019.1677022",61.0,YR,,F,Y,,,20200124.0,,MD,US,US,2020,Q1,Adult
173184072,17318407,13,SS,INSULIN (LISPRO),INSULIN LISPRO,1,Oral,,,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,2,F,,20200120.0,20200124,20200203,EXP,,US-ASTRAZENECA-2020SE10427,ASTRAZENECA,,61.0,YR,,F,Y,,,20200203.0,,HP,US,US,2020,Q1,Adult
173184072,17318407,13,SS,INSULIN (LISPRO),INSULIN LISPRO,1,Oral,,,,D,,,,,,,,,2020,Q1,Toxicity to various agents,,2020,Q1,2,F,,20200120.0,20200124,20200203,EXP,,US-ASTRAZENECA-2020SE10427,ASTRAZENECA,,61.0,YR,,F,Y,,,20200203.0,,HP,US,US,2020,Q1,Adult
173198402,17319840,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Liver disorder,,2020,Q1,2,F,20191007.0,20200124.0,20200125,20200129,EXP,IT-MINISAL02-587117,IT-MYLANLABS-2020M1008298,MYLAN,,78.0,YR,,M,Y,85.0,KG,20200129.0,,MD,IT,IT,2020,Q1,Elderly
173198402,17319840,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Rhabdomyolysis,,2020,Q1,2,F,20191007.0,20200124.0,20200125,20200129,EXP,IT-MINISAL02-587117,IT-MYLANLABS-2020M1008298,MYLAN,,78.0,YR,,M,Y,85.0,KG,20200129.0,,MD,IT,IT,2020,Q1,Elderly
173291341,17329134,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20200113.0,20200127,20200127,EXP,,US-GENUS_LIFESCIENCES-USA-POI0580202000132,GENUS LIFESCIENCES,GUMMIN D. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57(12):1220-1413.,37.0,YR,,M,Y,,,20200124.0,,MD,US,US,2020,Q1,Adult
173295292,17329529,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,14 U,,,U,,,,,,,,,2020,Q1,Asthenia,,2020,Q1,2,F,20191218.0,20200212.0,20200127,20200218,PER,,US-SA-2020SA018256,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20200218.0,,MD,US,US,2020,Q1,Elderly
173295292,17329529,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,14 U,,,U,,,,,,,,,2020,Q1,Back pain,,2020,Q1,2,F,20191218.0,20200212.0,20200127,20200218,PER,,US-SA-2020SA018256,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20200218.0,,MD,US,US,2020,Q1,Elderly
173295292,17329529,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,14 U,,,U,,,,,,,,,2020,Q1,Condition aggravated,,2020,Q1,2,F,20191218.0,20200212.0,20200127,20200218,PER,,US-SA-2020SA018256,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20200218.0,,MD,US,US,2020,Q1,Elderly
173295292,17329529,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,14 U,,,U,,,,,,,,,2020,Q1,Gait disturbance,,2020,Q1,2,F,20191218.0,20200212.0,20200127,20200218,PER,,US-SA-2020SA018256,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20200218.0,,MD,US,US,2020,Q1,Elderly
173322981,17332298,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN (SLIDING)",,,U,,,,20563.0,,,INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,202001.0,20200122.0,20200127,20200127,EXP,,US-ELI_LILLY_AND_COMPANY-US202001010441,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
173322981,17332298,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN (SLIDING)",,,U,, C933643D,,20563.0,,,INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,202001.0,20200122.0,20200127,20200127,EXP,,US-ELI_LILLY_AND_COMPANY-US202001010441,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
173341491,17334149,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C933644C,,20563.0,,,INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,201912.0,20200123.0,20200128,20200128,EXP,,US-ELI_LILLY_AND_COMPANY-US202001011521,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200128.0,,CN,US,US,2020,Q1,Elderly
173341491,17334149,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C933644C,,20563.0,,,INJECTION,,2020,Q1,Product storage error,,2020,Q1,1,I,201912.0,20200123.0,20200128,20200128,EXP,,US-ELI_LILLY_AND_COMPANY-US202001011521,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200128.0,,CN,US,US,2020,Q1,Elderly
173354301,17335430,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C939454C,,20563.0,,,INJECTION,,2020,Q1,Arthritis,,2020,Q1,1,I,,20200123.0,20200128,20200128,EXP,,US-ELI_LILLY_AND_COMPANY-US202001011119,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20200128.0,,CN,US,US,2020,Q1,Adult
173354301,17335430,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C939454C,,20563.0,,,INJECTION,,2020,Q1,Gait disturbance,,2020,Q1,1,I,,20200123.0,20200128,20200128,EXP,,US-ELI_LILLY_AND_COMPANY-US202001011119,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20200128.0,,CN,US,US,2020,Q1,Adult
173354301,17335430,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C939454C,,20563.0,,,INJECTION,,2020,Q1,Neuropathy peripheral,,2020,Q1,1,I,,20200123.0,20200128,20200128,EXP,,US-ELI_LILLY_AND_COMPANY-US202001011119,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20200128.0,,CN,US,US,2020,Q1,Adult
173454641,17345464,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"22 U, TID",,,U,U, C938255F,,,22.0,IU,INJECTION,TID,2020,Q1,Blood glucose increased,,2020,Q1,1,I,2019.0,20200117.0,20200129,20200129,EXP,,US-ELI_LILLY_AND_COMPANY-US202001008630,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20200129.0,,CN,US,US,2020,Q1,Elderly
173454641,17345464,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"22 U, TID",,,U,U, C938255F,,,22.0,IU,INJECTION,TID,2020,Q1,Drug ineffective,,2020,Q1,1,I,2019.0,20200117.0,20200129,20200129,EXP,,US-ELI_LILLY_AND_COMPANY-US202001008630,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20200129.0,,CN,US,US,2020,Q1,Elderly
173454641,17345464,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"22 U, TID",,,U,U, C938255F,,,22.0,IU,INJECTION,TID,2020,Q1,Myocardial infarction,,2020,Q1,1,I,2019.0,20200117.0,20200129,20200129,EXP,,US-ELI_LILLY_AND_COMPANY-US202001008630,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20200129.0,,CN,US,US,2020,Q1,Elderly
173454641,17345464,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"22 U, TID",,,U,U, C938255F,,,22.0,IU,INJECTION,TID,2020,Q1,Pleural effusion,,2020,Q1,1,I,2019.0,20200117.0,20200129,20200129,EXP,,US-ELI_LILLY_AND_COMPANY-US202001008630,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20200129.0,,CN,US,US,2020,Q1,Elderly
173454641,17345464,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"22 U, TID",,,U,U, C938255F,,,22.0,IU,INJECTION,TID,2020,Q1,Wrong product administered,,2020,Q1,1,I,2019.0,20200117.0,20200129,20200129,EXP,,US-ELI_LILLY_AND_COMPANY-US202001008630,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20200129.0,,CN,US,US,2020,Q1,Elderly
173459031,17345903,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Oral,,,,D,,,,,,,UNKNOWN,,2020,Q1,Completed suicide,,2020,Q1,1,I,,20200117.0,20200129,20200129,EXP,,US-JNJFOC-20200138920,JOHNSON AND JOHNSON,"RYAN M, MOWRY J, SPYKER D, BROOKS D, BEUHLER M, RIVERS BS L, HASHEM H, GUMMIN D. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLIN TOXICOL. 2019;VOL. 57, NO. 12:1220-1413.",61.0,YR,,F,Y,,,20200129.0,,MD,US,US,2020,Q1,Adult
173459031,17345903,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Oral,,,,D,,,,,,,UNKNOWN,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20200117.0,20200129,20200129,EXP,,US-JNJFOC-20200138920,JOHNSON AND JOHNSON,"RYAN M, MOWRY J, SPYKER D, BROOKS D, BEUHLER M, RIVERS BS L, HASHEM H, GUMMIN D. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLIN TOXICOL. 2019;VOL. 57, NO. 12:1220-1413.",61.0,YR,,F,Y,,,20200129.0,,MD,US,US,2020,Q1,Adult
173506931,17350693,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,ROUTE: INGESTION AND PARENTERAL,,,D,,,,,,,,,2020,Q1,Completed suicide,Completed suicide,2020,Q1,1,I,,20200122.0,20200130,20200130,EXP,,US-ALVOGEN-2020-ALVOGEN-102562,ALVOGEN,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLIN TOXICOL (PHILA). 2019 DEC;57(12):1220-1413.",37.0,YR,,M,Y,,,20200130.0,,MD,US,US,2020,Q1,Adult
173510901,17351090,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 IU,,,,, UNKNOWN,,,24.0,IU,SUSPENSION FOR INJECTION,,2020,Q1,Anaemia,,2020,Q1,1,I,20200104.0,20200126.0,20200130,20200130,EXP,GB-MHRA-MIDB-8EBE4951-0BDB-462A-B5E7-9126919135B5,GB-TEVA-2020-GB-1176706,TEVA,,73.0,YR,,M,Y,,,20200130.0,,PH,GB,GB,2020,Q1,Elderly
173510901,17351090,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 IU,,,,, UNKNOWN,,,24.0,IU,SUSPENSION FOR INJECTION,,2020,Q1,Gastrointestinal haemorrhage,,2020,Q1,1,I,20200104.0,20200126.0,20200130,20200130,EXP,GB-MHRA-MIDB-8EBE4951-0BDB-462A-B5E7-9126919135B5,GB-TEVA-2020-GB-1176706,TEVA,,73.0,YR,,M,Y,,,20200130.0,,PH,GB,GB,2020,Q1,Elderly
173518901,17351890,3,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,U,,,,,,,,2020,Q1,Insulin autoimmune syndrome,,2020,Q1,1,I,,20200120.0,20200130,20200130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202001013266,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20200130.0,,HP,CN,CN,2020,Q1,Elderly
173522961,17352296,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, QD",,,U,,,,,24.0,IU,,QD,2020,Q1,Anaemia,,2020,Q1,1,I,20200104.0,20200129.0,20200130,20200130,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-007644,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,,,20200130.0,,PH,GB,GB,2020,Q1,Elderly
173522961,17352296,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, QD",,,U,,,,,24.0,IU,,QD,2020,Q1,Gastrointestinal haemorrhage,,2020,Q1,1,I,20200104.0,20200129.0,20200130,20200130,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-007644,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,,,20200130.0,,PH,GB,GB,2020,Q1,Elderly
173528082,17352808,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"5 U, UNKNOWN",,,U,U,,,,5.0,IU,INJECTION,,2020,Q1,Product dose omission,,2020,Q1,2,F,20200125.0,20200129.0,20200131,20200211,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013615,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200211.0,,CN,US,US,2020,Q1,Elderly
173528082,17352808,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"5 U, UNKNOWN",,,U,U,,,,5.0,IU,INJECTION,,2020,Q1,Skin wrinkling,,2020,Q1,2,F,20200125.0,20200129.0,20200131,20200211,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013615,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200211.0,,CN,US,US,2020,Q1,Elderly
173528082,17352808,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"5 U, UNKNOWN",,,U,U, C914383G,,,5.0,IU,INJECTION,,2020,Q1,Product dose omission,,2020,Q1,2,F,20200125.0,20200129.0,20200131,20200211,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013615,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200211.0,,CN,US,US,2020,Q1,Elderly
173528082,17352808,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"5 U, UNKNOWN",,,U,U, C914383G,,,5.0,IU,INJECTION,,2020,Q1,Skin wrinkling,,2020,Q1,2,F,20200125.0,20200129.0,20200131,20200211,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013615,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200211.0,,CN,US,US,2020,Q1,Elderly
173560281,17356028,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,TID,2020,Q1,Hyperkalaemia,,2020,Q1,1,I,,20200121.0,20200131,20200131,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-00359,HIKMA,"CAMPBELL T, LIEBMAN S. PLANT-BASED DIETARY APPROACH TO STAGE 3 CHRONIC KIDNEY DISEASE WITH HYPERPHOSPHATAEMIAKIDNEY DISEASE WITH HYPERPHOSPHATAEMIA. BMJ CASE REP; DOI:10.1136/BCR-2019-232080. 2019;12:232080:.",69.0,YR,,,Y,,,20200131.0,,MD,US,US,2020,Q1,Elderly
173560281,17356028,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,TID,2020,Q1,Hyperphosphataemia,,2020,Q1,1,I,,20200121.0,20200131,20200131,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-00359,HIKMA,"CAMPBELL T, LIEBMAN S. PLANT-BASED DIETARY APPROACH TO STAGE 3 CHRONIC KIDNEY DISEASE WITH HYPERPHOSPHATAEMIAKIDNEY DISEASE WITH HYPERPHOSPHATAEMIA. BMJ CASE REP; DOI:10.1136/BCR-2019-232080. 2019;12:232080:.",69.0,YR,,,Y,,,20200131.0,,MD,US,US,2020,Q1,Elderly
173560281,17356028,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,TID,2020,Q1,Weight increased,,2020,Q1,1,I,,20200121.0,20200131,20200131,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-00359,HIKMA,"CAMPBELL T, LIEBMAN S. PLANT-BASED DIETARY APPROACH TO STAGE 3 CHRONIC KIDNEY DISEASE WITH HYPERPHOSPHATAEMIAKIDNEY DISEASE WITH HYPERPHOSPHATAEMIA. BMJ CASE REP; DOI:10.1136/BCR-2019-232080. 2019;12:232080:.",69.0,YR,,,Y,,,20200131.0,,MD,US,US,2020,Q1,Elderly
173567951,17356795,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,Y, C933643D,,,,,INJECTION,,2020,Q1,Influenza,,2020,Q1,1,I,20200127.0,20200130.0,20200131,20200131,EXP,,US-ELI_LILLY_AND_COMPANY-US202001014581,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20200131.0,,CN,US,US,2020,Q1,Adult
173588081,17358808,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,U,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,,20200120.0,20200202,20200202,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK045547,GLENMARK,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, OSTERTHALER KM, BANNER W. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019",61.0,YR,,F,Y,,,20200202.0,,MD,US,US,2020,Q1,Adult
173591881,17359188,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2020,Q1,Cataract,,2020,Q1,1,I,20200120.0,20200121.0,20200203,20200203,EXP,,US-ELI_LILLY_AND_COMPANY-US202001009367,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200203.0,,CN,US,US,2020,Q1,Elderly
173591881,17359188,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2020,Q1,Fall,,2020,Q1,1,I,20200120.0,20200121.0,20200203,20200203,EXP,,US-ELI_LILLY_AND_COMPANY-US202001009367,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200203.0,,CN,US,US,2020,Q1,Elderly
173591881,17359188,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2020,Q1,Pain,,2020,Q1,1,I,20200120.0,20200121.0,20200203,20200203,EXP,,US-ELI_LILLY_AND_COMPANY-US202001009367,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200203.0,,CN,US,US,2020,Q1,Elderly
173591881,17359188,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2020,Q1,Rib fracture,,2020,Q1,1,I,20200120.0,20200121.0,20200203,20200203,EXP,,US-ELI_LILLY_AND_COMPANY-US202001009367,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200203.0,,CN,US,US,2020,Q1,Elderly
173591881,17359188,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C933644C,,20563.0,,,INJECTION,,2020,Q1,Cataract,,2020,Q1,1,I,20200120.0,20200121.0,20200203,20200203,EXP,,US-ELI_LILLY_AND_COMPANY-US202001009367,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200203.0,,CN,US,US,2020,Q1,Elderly
173591881,17359188,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C933644C,,20563.0,,,INJECTION,,2020,Q1,Fall,,2020,Q1,1,I,20200120.0,20200121.0,20200203,20200203,EXP,,US-ELI_LILLY_AND_COMPANY-US202001009367,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200203.0,,CN,US,US,2020,Q1,Elderly
173591881,17359188,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C933644C,,20563.0,,,INJECTION,,2020,Q1,Pain,,2020,Q1,1,I,20200120.0,20200121.0,20200203,20200203,EXP,,US-ELI_LILLY_AND_COMPANY-US202001009367,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200203.0,,CN,US,US,2020,Q1,Elderly
173591881,17359188,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C933644C,,20563.0,,,INJECTION,,2020,Q1,Rib fracture,,2020,Q1,1,I,20200120.0,20200121.0,20200203,20200203,EXP,,US-ELI_LILLY_AND_COMPANY-US202001009367,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200203.0,,CN,US,US,2020,Q1,Elderly
173594611,17359461,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Condition aggravated,,2020,Q1,1,I,201908.0,20191111.0,20200203,20200203,EXP,,US-ROCHE-2472524,ROCHE,,40.0,YR,,F,Y,72.64,KG,20200203.0,,MD,US,US,2020,Q1,Adult
173594611,17359461,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Eye disorder,,2020,Q1,1,I,201908.0,20191111.0,20200203,20200203,EXP,,US-ROCHE-2472524,ROCHE,,40.0,YR,,F,Y,72.64,KG,20200203.0,,MD,US,US,2020,Q1,Adult
173594611,17359461,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,1,I,201908.0,20191111.0,20200203,20200203,EXP,,US-ROCHE-2472524,ROCHE,,40.0,YR,,F,Y,72.64,KG,20200203.0,,MD,US,US,2020,Q1,Adult
173594611,17359461,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Feeling abnormal,,2020,Q1,1,I,201908.0,20191111.0,20200203,20200203,EXP,,US-ROCHE-2472524,ROCHE,,40.0,YR,,F,Y,72.64,KG,20200203.0,,MD,US,US,2020,Q1,Adult
173594611,17359461,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Memory impairment,,2020,Q1,1,I,201908.0,20191111.0,20200203,20200203,EXP,,US-ROCHE-2472524,ROCHE,,40.0,YR,,F,Y,72.64,KG,20200203.0,,MD,US,US,2020,Q1,Adult
173594611,17359461,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Multiple sclerosis relapse,,2020,Q1,1,I,201908.0,20191111.0,20200203,20200203,EXP,,US-ROCHE-2472524,ROCHE,,40.0,YR,,F,Y,72.64,KG,20200203.0,,MD,US,US,2020,Q1,Adult
173594611,17359461,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Muscle spasms,,2020,Q1,1,I,201908.0,20191111.0,20200203,20200203,EXP,,US-ROCHE-2472524,ROCHE,,40.0,YR,,F,Y,72.64,KG,20200203.0,,MD,US,US,2020,Q1,Adult
173594611,17359461,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Muscle twitching,,2020,Q1,1,I,201908.0,20191111.0,20200203,20200203,EXP,,US-ROCHE-2472524,ROCHE,,40.0,YR,,F,Y,72.64,KG,20200203.0,,MD,US,US,2020,Q1,Adult
173594611,17359461,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,1,I,201908.0,20191111.0,20200203,20200203,EXP,,US-ROCHE-2472524,ROCHE,,40.0,YR,,F,Y,72.64,KG,20200203.0,,MD,US,US,2020,Q1,Adult
173594611,17359461,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Road traffic accident,,2020,Q1,1,I,201908.0,20191111.0,20200203,20200203,EXP,,US-ROCHE-2472524,ROCHE,,40.0,YR,,F,Y,72.64,KG,20200203.0,,MD,US,US,2020,Q1,Adult
173594611,17359461,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Weight increased,,2020,Q1,1,I,201908.0,20191111.0,20200203,20200203,EXP,,US-ROCHE-2472524,ROCHE,,40.0,YR,,F,Y,72.64,KG,20200203.0,,MD,US,US,2020,Q1,Adult
173601961,17360196,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS QHS, 2-10 UNITS TID AC, 42 UNITS TID AC",,,,,,,,,,,,2020,Q1,Asthenia,,2020,Q1,1,I,20200117.0,20200122.0,20200203,20200203,EXP,,US-ACCORD-170771,ACCORD,,50.0,YR,,M,Y,117.93,KG,20200203.0,,HP,US,US,2020,Q1,Adult
173601961,17360196,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS QHS, 2-10 UNITS TID AC, 42 UNITS TID AC",,,,,,,,,,,,2020,Q1,Blood pressure decreased,,2020,Q1,1,I,20200117.0,20200122.0,20200203,20200203,EXP,,US-ACCORD-170771,ACCORD,,50.0,YR,,M,Y,117.93,KG,20200203.0,,HP,US,US,2020,Q1,Adult
173601961,17360196,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS QHS, 2-10 UNITS TID AC, 42 UNITS TID AC",,,,,,,,,,,,2020,Q1,Chills,,2020,Q1,1,I,20200117.0,20200122.0,20200203,20200203,EXP,,US-ACCORD-170771,ACCORD,,50.0,YR,,M,Y,117.93,KG,20200203.0,,HP,US,US,2020,Q1,Adult
173601961,17360196,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS QHS, 2-10 UNITS TID AC, 42 UNITS TID AC",,,,,,,,,,,,2020,Q1,Feeling cold,,2020,Q1,1,I,20200117.0,20200122.0,20200203,20200203,EXP,,US-ACCORD-170771,ACCORD,,50.0,YR,,M,Y,117.93,KG,20200203.0,,HP,US,US,2020,Q1,Adult
173601961,17360196,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS QHS, 2-10 UNITS TID AC, 42 UNITS TID AC",,,,,,,,,,,,2020,Q1,Speech disorder,,2020,Q1,1,I,20200117.0,20200122.0,20200203,20200203,EXP,,US-ACCORD-170771,ACCORD,,50.0,YR,,M,Y,117.93,KG,20200203.0,,HP,US,US,2020,Q1,Adult
173601961,17360196,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS QHS, 2-10 UNITS TID AC, 42 UNITS TID AC",,,,,,,,,,,,2020,Q1,Tremor,,2020,Q1,1,I,20200117.0,20200122.0,20200203,20200203,EXP,,US-ACCORD-170771,ACCORD,,50.0,YR,,M,Y,117.93,KG,20200203.0,,HP,US,US,2020,Q1,Adult
173610602,17361060,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,2,F,,20200306.0,20200203,20200312,PER,,US-SA-2020SA023693,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200312.0,,CN,US,US,2020,Q1,Elderly
173610602,17361060,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200306.0,20200203,20200312,PER,,US-SA-2020SA023693,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200312.0,,CN,US,US,2020,Q1,Elderly
173610602,17361060,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Product dose omission,,2020,Q1,2,F,,20200306.0,20200203,20200312,PER,,US-SA-2020SA023693,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200312.0,,CN,US,US,2020,Q1,Elderly
173621012,17362101,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,2,F,20200113.0,20200207.0,20200203,20200213,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-006553,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,102.0,KG,20200213.0,,HP,US,US,2020,Q1,Elderly
173621012,17362101,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Pyelonephritis,,2020,Q1,2,F,20200113.0,20200207.0,20200203,20200213,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-006553,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,102.0,KG,20200213.0,,HP,US,US,2020,Q1,Elderly
173621012,17362101,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Respiratory failure,,2020,Q1,2,F,20200113.0,20200207.0,20200203,20200213,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-006553,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,102.0,KG,20200213.0,,HP,US,US,2020,Q1,Elderly
173635112,17363511,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Aphasia,,2020,Q1,2,F,20160304.0,20200217.0,20200203,20200221,EXP,,US-GILEAD-2018-0344642,GILEAD,,64.0,YR,A,F,Y,88.0,KG,20200221.0,,HP,US,US,2020,Q1,Adult
173635112,17363511,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Confusional state,,2020,Q1,2,F,20160304.0,20200217.0,20200203,20200221,EXP,,US-GILEAD-2018-0344642,GILEAD,,64.0,YR,A,F,Y,88.0,KG,20200221.0,,HP,US,US,2020,Q1,Adult
173635112,17363511,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Depressed level of consciousness,,2020,Q1,2,F,20160304.0,20200217.0,20200203,20200221,EXP,,US-GILEAD-2018-0344642,GILEAD,,64.0,YR,A,F,Y,88.0,KG,20200221.0,,HP,US,US,2020,Q1,Adult
173635112,17363511,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Somnolence,,2020,Q1,2,F,20160304.0,20200217.0,20200203,20200221,EXP,,US-GILEAD-2018-0344642,GILEAD,,64.0,YR,A,F,Y,88.0,KG,20200221.0,,HP,US,US,2020,Q1,Adult
173688492,17368849,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, DAILY",,,,, C898344D,,20563.0,30.0,IU,INJECTION,QD,2020,Q1,Chronic obstructive pulmonary disease,,2020,Q1,2,F,2019.0,20200129.0,20200204,20200210,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013757,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200210.0,,CN,US,US,2020,Q1,Elderly
173688492,17368849,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, DAILY",,,,, C898344D,,20563.0,30.0,IU,INJECTION,QD,2020,Q1,Limb discomfort,,2020,Q1,2,F,2019.0,20200129.0,20200204,20200210,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013757,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200210.0,,CN,US,US,2020,Q1,Elderly
173688492,17368849,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, DAILY",,,,, C898344D,,20563.0,30.0,IU,INJECTION,QD,2020,Q1,Neoplasm malignant,,2020,Q1,2,F,2019.0,20200129.0,20200204,20200210,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013757,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200210.0,,CN,US,US,2020,Q1,Elderly
173688492,17368849,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, DAILY",,,,, C898344D,,20563.0,30.0,IU,INJECTION,QD,2020,Q1,Nephropathy,,2020,Q1,2,F,2019.0,20200129.0,20200204,20200210,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013757,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200210.0,,CN,US,US,2020,Q1,Elderly
173688492,17368849,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, DAILY",,,,, C898344D,,20563.0,30.0,IU,INJECTION,QD,2020,Q1,Neuromyopathy,,2020,Q1,2,F,2019.0,20200129.0,20200204,20200210,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013757,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200210.0,,CN,US,US,2020,Q1,Elderly
173688492,17368849,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, DAILY",,,,, C898344D,,20563.0,30.0,IU,INJECTION,QD,2020,Q1,Peripheral artery occlusion,,2020,Q1,2,F,2019.0,20200129.0,20200204,20200210,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013757,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200210.0,,CN,US,US,2020,Q1,Elderly
173688492,17368849,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Chronic obstructive pulmonary disease,,2020,Q1,2,F,2019.0,20200129.0,20200204,20200210,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013757,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200210.0,,CN,US,US,2020,Q1,Elderly
173688492,17368849,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Limb discomfort,,2020,Q1,2,F,2019.0,20200129.0,20200204,20200210,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013757,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200210.0,,CN,US,US,2020,Q1,Elderly
173688492,17368849,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Neoplasm malignant,,2020,Q1,2,F,2019.0,20200129.0,20200204,20200210,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013757,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200210.0,,CN,US,US,2020,Q1,Elderly
173688492,17368849,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Nephropathy,,2020,Q1,2,F,2019.0,20200129.0,20200204,20200210,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013757,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200210.0,,CN,US,US,2020,Q1,Elderly
173688492,17368849,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Neuromyopathy,,2020,Q1,2,F,2019.0,20200129.0,20200204,20200210,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013757,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200210.0,,CN,US,US,2020,Q1,Elderly
173688492,17368849,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Peripheral artery occlusion,,2020,Q1,2,F,2019.0,20200129.0,20200204,20200210,EXP,,US-ELI_LILLY_AND_COMPANY-US202001013757,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200210.0,,CN,US,US,2020,Q1,Elderly
173715431,17371543,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,D,,,,,,,,,2020,Q1,Completed suicide,Completed suicide,2020,Q1,1,I,,20200122.0,20200205,20200205,EXP,,US-ALVOGEN-2020-ALVOGEN-102610,ALVOGEN,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLIN TOXICOL (PHILA). 2019 DEC;57(12):1220-1413.",61.0,YR,,F,Y,,,20200205.0,,MD,US,US,2020,Q1,Adult
173721931,17372193,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,INJECTION,,2020,Q1,Finger deformity,,2020,Q1,1,I,,20200127.0,20200205,20200205,EXP,,US-ELI_LILLY_AND_COMPANY-US202001012262,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
173721931,17372193,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,INJECTION,,2020,Q1,Neuropathy peripheral,,2020,Q1,1,I,,20200127.0,20200205,20200205,EXP,,US-ELI_LILLY_AND_COMPANY-US202001012262,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
173721931,17372193,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C938257C,,20563.0,,,INJECTION,,2020,Q1,Finger deformity,,2020,Q1,1,I,,20200127.0,20200205,20200205,EXP,,US-ELI_LILLY_AND_COMPANY-US202001012262,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
173721931,17372193,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C938257C,,20563.0,,,INJECTION,,2020,Q1,Neuropathy peripheral,,2020,Q1,1,I,,20200127.0,20200205,20200205,EXP,,US-ELI_LILLY_AND_COMPANY-US202001012262,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
173749581,17374958,4,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20200107.0,,20200204,20200204,DIR,,,FDA-CTU,,55.0,YR,,F,N,71.1,KG,20200204.0,N,HP,US,US,2020,Q1,Adult
173749581,17374958,4,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Mental status changes,,2020,Q1,1,I,20200107.0,,20200204,20200204,DIR,,,FDA-CTU,,55.0,YR,,F,N,71.1,KG,20200204.0,N,HP,US,US,2020,Q1,Adult
173749581,17374958,4,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Myocardial infarction,,2020,Q1,1,I,20200107.0,,20200204,20200204,DIR,,,FDA-CTU,,55.0,YR,,F,N,71.1,KG,20200204.0,N,HP,US,US,2020,Q1,Adult
173749581,17374958,4,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Therapy cessation,,2020,Q1,1,I,20200107.0,,20200204,20200204,DIR,,,FDA-CTU,,55.0,YR,,F,N,71.1,KG,20200204.0,N,HP,US,US,2020,Q1,Adult
173768781,17376878,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, SLIDING SCALE",,,,, C939454C,,,,,INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,20200116.0,20200123.0,20200206,20200206,EXP,,US-ELI_LILLY_AND_COMPANY-US202001011698,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Young Adult
173768781,17376878,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, SLIDING SCALE",,,,, C939454C,,,,,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,1,I,20200116.0,20200123.0,20200206,20200206,EXP,,US-ELI_LILLY_AND_COMPANY-US202001011698,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Young Adult
173825871,17382587,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20200114.0,20200206,20200206,EXP,,US-ENDO PHARMACEUTICALS INC-2020-000992,ENDO,,37.0,YR,,M,Y,,,20200206.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Bronchospasm,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Death,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Deep vein thrombosis,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Diarrhoea,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Fatigue,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Muscular weakness,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Pneumocystis jirovecii pneumonia,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Pneumonia,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Pulmonary embolism,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173912771,17391277,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Arthritis,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Dysphagia,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Fall,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Rib fracture,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Scratch,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Subarachnoid haemorrhage,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Syncope,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Tachycardia,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173945611,17394561,8,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-BAXTER-2020BAX002710,BAXTER,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173945611,17394561,8,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Cytokine release syndrome,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-BAXTER-2020BAX002710,BAXTER,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173945611,17394561,8,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Intestinal perforation,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-BAXTER-2020BAX002710,BAXTER,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173945611,17394561,8,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Neutropenia,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-BAXTER-2020BAX002710,BAXTER,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173945611,17394561,8,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Pneumonitis,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-BAXTER-2020BAX002710,BAXTER,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173945611,17394561,8,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Sepsis,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-BAXTER-2020BAX002710,BAXTER,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173956541,17395654,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"82 IU, QD",,,U,,,,,82.0,IU,,QD,2020,Q1,Cerebral haemorrhage,,2020,Q1,1,I,20190818.0,20200203.0,20200210,20200210,EXP,IT-MINISAL02-586960,NVSC2020IT027691,NOVARTIS,,77.0,YR,,M,Y,,,20200210.0,,HP,IT,IT,2020,Q1,Elderly
173956541,17395654,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"82 IU, QD",,,U,,,,,82.0,IU,,QD,2020,Q1,Haematuria,,2020,Q1,1,I,20190818.0,20200203.0,20200210,20200210,EXP,IT-MINISAL02-586960,NVSC2020IT027691,NOVARTIS,,77.0,YR,,M,Y,,,20200210.0,,HP,IT,IT,2020,Q1,Elderly
173956541,17395654,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"82 IU, QD",,,U,,,,,82.0,IU,,QD,2020,Q1,Medication error,,2020,Q1,1,I,20190818.0,20200203.0,20200210,20200210,EXP,IT-MINISAL02-586960,NVSC2020IT027691,NOVARTIS,,77.0,YR,,M,Y,,,20200210.0,,HP,IT,IT,2020,Q1,Elderly
173956541,17395654,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"82 IU, QD",,,U,,,,,82.0,IU,,QD,2020,Q1,Overdose,,2020,Q1,1,I,20190818.0,20200203.0,20200210,20200210,EXP,IT-MINISAL02-586960,NVSC2020IT027691,NOVARTIS,,77.0,YR,,M,Y,,,20200210.0,,HP,IT,IT,2020,Q1,Elderly
173974292,17397429,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Liver disorder,,2020,Q1,2,F,20191007.0,20200212.0,20200210,20200216,EXP,IT-MINISAL02-587117,NVSC2020IT028551,NOVARTIS,,78.0,YR,,M,Y,85.0,KG,20200217.0,,HP,IT,IT,2020,Q1,Elderly
173974292,17397429,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Rhabdomyolysis,,2020,Q1,2,F,20191007.0,20200212.0,20200210,20200216,EXP,IT-MINISAL02-587117,NVSC2020IT028551,NOVARTIS,,78.0,YR,,M,Y,85.0,KG,20200217.0,,HP,IT,IT,2020,Q1,Elderly
173989191,17398919,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-FRESENIUS KABI-FK202001276,FRESENIUS KABI,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173989191,17398919,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Cytokine release syndrome,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-FRESENIUS KABI-FK202001276,FRESENIUS KABI,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173989191,17398919,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Intestinal perforation,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-FRESENIUS KABI-FK202001276,FRESENIUS KABI,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173989191,17398919,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Neutropenia,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-FRESENIUS KABI-FK202001276,FRESENIUS KABI,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173989191,17398919,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Pneumonitis,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-FRESENIUS KABI-FK202001276,FRESENIUS KABI,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173989191,17398919,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Sepsis,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-FRESENIUS KABI-FK202001276,FRESENIUS KABI,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
174006201,17400620,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, UNKNOWN",,,,, C939454C,,20563.0,15.0,IU,INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200206.0,20200211,20200211,EXP,,US-ELI_LILLY_AND_COMPANY-US202002003482,ELI LILLY AND CO,,49.0,YR,,M,Y,,,20200211.0,,CN,US,US,2020,Q1,Adult
174006201,17400620,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, UNKNOWN",,,,, C939454C,,20563.0,15.0,IU,INJECTION,,2020,Q1,Dizziness,,2020,Q1,1,I,,20200206.0,20200211,20200211,EXP,,US-ELI_LILLY_AND_COMPANY-US202002003482,ELI LILLY AND CO,,49.0,YR,,M,Y,,,20200211.0,,CN,US,US,2020,Q1,Adult
174006201,17400620,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, UNKNOWN",,,,, C939454C,,20563.0,15.0,IU,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,1,I,,20200206.0,20200211,20200211,EXP,,US-ELI_LILLY_AND_COMPANY-US202002003482,ELI LILLY AND CO,,49.0,YR,,M,Y,,,20200211.0,,CN,US,US,2020,Q1,Adult
174032221,17403222,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Pancreatic carcinoma,,2020,Q1,1,I,,20200207.0,20200211,20200211,EXP,,NVSC2020FR033410,NOVARTIS,,72.0,YR,,M,Y,,,20200211.0,,HP,FR,FR,2020,Q1,Elderly
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Ascites,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Bilirubin conjugated increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood albumin decreased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood alkaline phosphatase increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood bilirubin increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood sodium decreased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Cardiometabolic syndrome,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Cholestasis,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Faeces pale,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Gamma-glutamyltransferase increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic cirrhosis,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic enzyme increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic fibrosis,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatomegaly,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Muscle spasms,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Non-alcoholic steatohepatitis,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Platelet count decreased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Portal hypertension,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Pruritus,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Splenomegaly,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Varices oesophageal,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Weight decreased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Weight loss poor,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Ascites,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Bilirubin conjugated increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood albumin decreased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood alkaline phosphatase increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood bilirubin increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood sodium decreased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Cardiometabolic syndrome,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Cholestasis,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Faeces pale,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Gamma-glutamyltransferase increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic cirrhosis,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic enzyme increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic fibrosis,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatomegaly,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Muscle spasms,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Non-alcoholic steatohepatitis,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Platelet count decreased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Portal hypertension,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Pruritus,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Splenomegaly,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Varices oesophageal,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Weight decreased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174038841,17403884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q1,Weight loss poor,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,DE-SA-2020SA032440,SANOFI AVENTIS,"MICHEL M., KALLIGA E., LABENZ C., STRAUB B.K., WORNS M.A., GALLE P.R., ET AL.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,A,M,Y,,,20200211.0,,HP,DE,DE,2020,Q1,Adult
174076481,17407648,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200210.0,20200212,20200212,EXP,,NVSC2020CZ037024,NOVARTIS,,54.0,YR,,M,Y,,,20200212.0,,HP,CZ,CZ,2020,Q1,Adult
174076481,17407648,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200210.0,20200212,20200212,EXP,,NVSC2020CZ037024,NOVARTIS,,54.0,YR,,M,Y,,,20200212.0,,HP,CZ,CZ,2020,Q1,Adult
174076481,17407648,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q1,Weight increased,,2020,Q1,1,I,,20200210.0,20200212,20200212,EXP,,NVSC2020CZ037024,NOVARTIS,,54.0,YR,,M,Y,,,20200212.0,,HP,CZ,CZ,2020,Q1,Adult
174087403,17408740,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,3,F,20200201.0,20200217.0,20200212,20200226,EXP,,NVSC2020JP028745,NOVARTIS,,60.0,YR,,M,Y,,,20200226.0,,HP,JP,JP,2020,Q1,Adult
174126421,17412642,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200210.0,20200213,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-008134",BOEHRINGER INGELHEIM,TANAKA H. UTILITY OF METFORMIN AND ITS PROPER USE. -.,48.0,YR,,M,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Adult
174126421,17412642,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Intentional self-injury,,2020,Q1,1,I,,20200210.0,20200213,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-008134",BOEHRINGER INGELHEIM,TANAKA H. UTILITY OF METFORMIN AND ITS PROPER USE. -.,48.0,YR,,M,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Adult
174126421,17412642,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200210.0,20200213,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-008134",BOEHRINGER INGELHEIM,TANAKA H. UTILITY OF METFORMIN AND ITS PROPER USE. -.,48.0,YR,,M,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Adult
174126421,17412642,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Overdose,,2020,Q1,1,I,,20200210.0,20200213,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-008134",BOEHRINGER INGELHEIM,TANAKA H. UTILITY OF METFORMIN AND ITS PROPER USE. -.,48.0,YR,,M,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Adult
174126421,17412642,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Pneumonia aspiration,,2020,Q1,1,I,,20200210.0,20200213,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-008134",BOEHRINGER INGELHEIM,TANAKA H. UTILITY OF METFORMIN AND ITS PROPER USE. -.,48.0,YR,,M,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Adult
174126421,17412642,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,,20200210.0,20200213,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-008134",BOEHRINGER INGELHEIM,TANAKA H. UTILITY OF METFORMIN AND ITS PROPER USE. -.,48.0,YR,,M,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Adult
174187781,17418778,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U, UNKNOWN,,,,,INJECTION,,2020,Q1,Panniculitis,,2020,Q1,1,I,,20200212.0,20200214,20200214,EXP,,US-ELI_LILLY_AND_COMPANY-US202002006836,ELI LILLY AND CO,,13.0,YR,,M,Y,,,20200214.0,,CN,US,US,2020,Q1,Child
174206681,17420668,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2-3 U, TID (AFTER MEALS)",,,,,,,20563.0,3.0,IU,INJECTION,TID,2020,Q1,Fall,,2020,Q1,1,I,201907.0,20200203.0,20200214,20200214,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001980,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20200214.0,,CN,US,US,2020,Q1,Elderly
174206681,17420668,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2-3 U, TID (AFTER MEALS)",,,,,,,20563.0,3.0,IU,INJECTION,TID,2020,Q1,Upper limb fracture,,2020,Q1,1,I,201907.0,20200203.0,20200214,20200214,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001980,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20200214.0,,CN,US,US,2020,Q1,Elderly
174206681,17420668,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2-3 U, TID (AFTER MEALS)",,,,, C938257C,,20563.0,3.0,IU,INJECTION,TID,2020,Q1,Fall,,2020,Q1,1,I,201907.0,20200203.0,20200214,20200214,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001980,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20200214.0,,CN,US,US,2020,Q1,Elderly
174206681,17420668,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2-3 U, TID (AFTER MEALS)",,,,, C938257C,,20563.0,3.0,IU,INJECTION,TID,2020,Q1,Upper limb fracture,,2020,Q1,1,I,201907.0,20200203.0,20200214,20200214,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001980,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20200214.0,,CN,US,US,2020,Q1,Elderly
174248591,17424859,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,78.0,IU,,,2020,Q1,Liver injury,,2020,Q1,1,I,20200108.0,20200210.0,20200217,20200217,EXP,FR-AFSSAPS-TS20200060,FR-ACCORD-172608,ACCORD,,73.0,YR,,M,Y,,,20200217.0,,MD,FR,FR,2020,Q1,Elderly
174251151,17425115,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN DOSE WAS 46 UNITS/DAY,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200207.0,20200217,20200217,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,NAGASE T.; IWAYA K.; KOGURE K.; ZAKO T.; MISUMI Y.; KIKUCHI M.; ET AL. INSULIN-DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019;UNK:UNK,81.0,YR,E,M,Y,,,20200217.0,,HP,JP,JP,2020,Q1,Elderly
174251151,17425115,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN DOSE WAS 46 UNITS/DAY,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Lipohypertrophy,,2020,Q1,1,I,,20200207.0,20200217,20200217,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,NAGASE T.; IWAYA K.; KOGURE K.; ZAKO T.; MISUMI Y.; KIKUCHI M.; ET AL. INSULIN-DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019;UNK:UNK,81.0,YR,E,M,Y,,,20200217.0,,HP,JP,JP,2020,Q1,Elderly
174251151,17425115,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN DOSE WAS 46 UNITS/DAY,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Secondary amyloidosis,,2020,Q1,1,I,,20200207.0,20200217,20200217,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,NAGASE T.; IWAYA K.; KOGURE K.; ZAKO T.; MISUMI Y.; KIKUCHI M.; ET AL. INSULIN-DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019;UNK:UNK,81.0,YR,E,M,Y,,,20200217.0,,HP,JP,JP,2020,Q1,Elderly
174251151,17425115,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,REDUCED TO 24 UNITS/DAY,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200207.0,20200217,20200217,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,NAGASE T.; IWAYA K.; KOGURE K.; ZAKO T.; MISUMI Y.; KIKUCHI M.; ET AL. INSULIN-DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019;UNK:UNK,81.0,YR,E,M,Y,,,20200217.0,,HP,JP,JP,2020,Q1,Elderly
174251151,17425115,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,REDUCED TO 24 UNITS/DAY,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Lipohypertrophy,,2020,Q1,1,I,,20200207.0,20200217,20200217,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,NAGASE T.; IWAYA K.; KOGURE K.; ZAKO T.; MISUMI Y.; KIKUCHI M.; ET AL. INSULIN-DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019;UNK:UNK,81.0,YR,E,M,Y,,,20200217.0,,HP,JP,JP,2020,Q1,Elderly
174251151,17425115,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,REDUCED TO 24 UNITS/DAY,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Secondary amyloidosis,,2020,Q1,1,I,,20200207.0,20200217,20200217,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,NAGASE T.; IWAYA K.; KOGURE K.; ZAKO T.; MISUMI Y.; KIKUCHI M.; ET AL. INSULIN-DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019;UNK:UNK,81.0,YR,E,M,Y,,,20200217.0,,HP,JP,JP,2020,Q1,Elderly
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Bronchitis,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Death,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Dementia,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Drug ineffective,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Ear infection,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Gait disturbance,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Hepatic enzyme increased,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Hepatic steatosis,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Joint swelling,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Liver disorder,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Liver injury,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Loss of personal independence in daily activities,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Musculoskeletal stiffness,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Nasopharyngitis,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Noninfective encephalitis,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Peripheral swelling,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Pharyngitis,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Poor venous access,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Pruritus,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Rheumatoid arthritis,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Seizure,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Swelling,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Therapeutic product effect decreased,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Therapeutic response decreased,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Tremor,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174287111,17428711,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,,20200204.0,20200217,20200217,EXP,E2B_02852742,"CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000097",ASSERTIO THERAPEUTICS,,62.0,YR,,F,Y,,,20200217.0,,HP,CA,CA,2020,Q1,Adult
174290671,17429067,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U, ASKU,,20563.0,,,,,2020,Q1,Blindness,,2020,Q1,1,I,,20200205.0,20200217,20200217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202002001657,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20200217.0,,CN,DE,DE,2020,Q1,Elderly
174290671,17429067,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U, ASKU,,20563.0,,,,,2020,Q1,Gait inability,,2020,Q1,1,I,,20200205.0,20200217,20200217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202002001657,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20200217.0,,CN,DE,DE,2020,Q1,Elderly
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Ascites,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Bilirubin conjugated increased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood albumin decreased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood alkaline phosphatase increased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood bilirubin increased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood sodium decreased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Cardiometabolic syndrome,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Cholestasis,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Condition aggravated,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Faeces pale,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Gamma-glutamyltransferase increased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic cirrhosis,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic enzyme increased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic fibrosis,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatomegaly,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Muscle spasms,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Non-alcoholic steatohepatitis,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Platelet count decreased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Portal hypertension,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Pruritus,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Splenomegaly,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Varices oesophageal,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Weight decreased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Weight loss poor,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Ascites,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Bilirubin conjugated increased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood albumin decreased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood alkaline phosphatase increased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood bilirubin increased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood sodium decreased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Cardiometabolic syndrome,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Cholestasis,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Condition aggravated,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Faeces pale,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Gamma-glutamyltransferase increased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic cirrhosis,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic enzyme increased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic fibrosis,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatomegaly,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Muscle spasms,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Non-alcoholic steatohepatitis,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Platelet count decreased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Portal hypertension,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Pruritus,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Splenomegaly,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Varices oesophageal,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Weight decreased,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174293382,17429338,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Weight loss poor,,2020,Q1,2,F,,20200213.0,20200218,20200220,EXP,,DE-PFIZER INC-2020062771,PFIZER,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA.. ZEITSCHRIFT FUR GASTROENTEROLOGIE.. 2020;58(1):10.1055/A-1062-8788",46.0,YR,,M,Y,107.0,KG,20200220.0,,HP,DE,DE,2020,Q1,Adult
174332021,17433202,15,SS,Insulin lispro,INSULIN LISPRO,1,Oral,UNK,,,D,, UNK,,,,,,,2020,Q1,Suspected suicide,,2020,Q1,1,I,,20200213.0,20200219,20200219,EXP,,US-NOVAST LABORATORIES LTD.-2020NOV000032,NOVAST,,61.0,YR,,F,Y,,,20200219.0,,HP,US,US,2020,Q1,Adult
174362981,17436298,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,INJECTION,,2020,Q1,Headache,,2020,Q1,1,I,20190516.0,20190520.0,20200219,20200219,PER,,US-LANTHEUS-LMI-2019-00395,LANTHEUS MEDICAL IMAGING,,67.0,YR,,F,Y,87.0,KG,20200206.0,,HP,US,US,2020,Q1,Elderly
174362981,17436298,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,INJECTION,,2020,Q1,Nausea,,2020,Q1,1,I,20190516.0,20190520.0,20200219,20200219,PER,,US-LANTHEUS-LMI-2019-00395,LANTHEUS MEDICAL IMAGING,,67.0,YR,,F,Y,87.0,KG,20200206.0,,HP,US,US,2020,Q1,Elderly
174362981,17436298,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,INJECTION,,2020,Q1,Respiratory rate increased,,2020,Q1,1,I,20190516.0,20190520.0,20200219,20200219,PER,,US-LANTHEUS-LMI-2019-00395,LANTHEUS MEDICAL IMAGING,,67.0,YR,,F,Y,87.0,KG,20200206.0,,HP,US,US,2020,Q1,Elderly
174362981,17436298,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,INJECTION,,2020,Q1,Throat tightness,,2020,Q1,1,I,20190516.0,20190520.0,20200219,20200219,PER,,US-LANTHEUS-LMI-2019-00395,LANTHEUS MEDICAL IMAGING,,67.0,YR,,F,Y,87.0,KG,20200206.0,,HP,US,US,2020,Q1,Elderly
174369591,17436959,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"78 IU, QD",,,,,,,,78.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Liver injury,,2020,Q1,1,I,20200108.0,20200213.0,20200219,20200219,EXP,FR-AFSSAPS-TS20200060,FR-SA-2020SA040274,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20200219.0,,MD,FR,FR,2020,Q1,Elderly
174369921,17436992,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Abdominal pain,,2020,Q1,1,I,,20200211.0,20200219,20200219,EXP,,CA-TEVA-2020-CA-1185648,TEVA,,72.0,YR,,F,Y,,,20200219.0,,HP,CA,CA,2020,Q1,Elderly
174369921,17436992,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,1,I,,20200211.0,20200219,20200219,EXP,,CA-TEVA-2020-CA-1185648,TEVA,,72.0,YR,,F,Y,,,20200219.0,,HP,CA,CA,2020,Q1,Elderly
174369921,17436992,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Pyrexia,,2020,Q1,1,I,,20200211.0,20200219,20200219,EXP,,CA-TEVA-2020-CA-1185648,TEVA,,72.0,YR,,F,Y,,,20200219.0,,HP,CA,CA,2020,Q1,Elderly
174369921,17436992,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Small intestinal obstruction,,2020,Q1,1,I,,20200211.0,20200219,20200219,EXP,,CA-TEVA-2020-CA-1185648,TEVA,,72.0,YR,,F,Y,,,20200219.0,,HP,CA,CA,2020,Q1,Elderly
174369921,17436992,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Urinary tract obstruction,,2020,Q1,1,I,,20200211.0,20200219,20200219,EXP,,CA-TEVA-2020-CA-1185648,TEVA,,72.0,YR,,F,Y,,,20200219.0,,HP,CA,CA,2020,Q1,Elderly
174373381,17437338,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD",6480.0,IU,Y,U,,,,12.0,IU,INJECTION,QD,2020,Q1,Hypoglycaemic coma,,2020,Q1,1,I,20190625.0,20200215.0,20200219,20200219,EXP,IT-MINISAL02-596206,IT-MYLANLABS-2020M1018225,MYLAN,,85.0,YR,,M,Y,,,20200219.0,,PH,IT,IT,2020,Q1,Elderly
174375151,17437515,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"SYRINGE, USE TWO EACH DAY",,,U,,,,,,,,,2020,Q1,Anaemia,,2020,Q1,1,I,20200107.0,20200110.0,20200219,20200219,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002725,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,100.23,KG,20200219.0,,HP,US,US,2020,Q1,Adult
174375151,17437515,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"SYRINGE, USE TWO EACH DAY",,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,20200107.0,20200110.0,20200219,20200219,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002725,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,100.23,KG,20200219.0,,HP,US,US,2020,Q1,Adult
174375151,17437515,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"SYRINGE, USE TWO EACH DAY",,,U,,,,,,,,,2020,Q1,Melaena,,2020,Q1,1,I,20200107.0,20200110.0,20200219,20200219,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002725,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,100.23,KG,20200219.0,,HP,US,US,2020,Q1,Adult
174375151,17437515,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-3 UNITS, QHS",,,U,,,,,,,,,2020,Q1,Anaemia,,2020,Q1,1,I,20200107.0,20200110.0,20200219,20200219,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002725,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,100.23,KG,20200219.0,,HP,US,US,2020,Q1,Adult
174375151,17437515,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-3 UNITS, QHS",,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,20200107.0,20200110.0,20200219,20200219,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002725,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,100.23,KG,20200219.0,,HP,US,US,2020,Q1,Adult
174375151,17437515,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-3 UNITS, QHS",,,U,,,,,,,,,2020,Q1,Melaena,,2020,Q1,1,I,20200107.0,20200110.0,20200219,20200219,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002725,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,100.23,KG,20200219.0,,HP,US,US,2020,Q1,Adult
174375151,17437515,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 UNITS, TID",,,U,,,,,,,,,2020,Q1,Anaemia,,2020,Q1,1,I,20200107.0,20200110.0,20200219,20200219,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002725,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,100.23,KG,20200219.0,,HP,US,US,2020,Q1,Adult
174375151,17437515,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 UNITS, TID",,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,20200107.0,20200110.0,20200219,20200219,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002725,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,100.23,KG,20200219.0,,HP,US,US,2020,Q1,Adult
174375151,17437515,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 UNITS, TID",,,U,,,,,,,,,2020,Q1,Melaena,,2020,Q1,1,I,20200107.0,20200110.0,20200219,20200219,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-002725,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,100.23,KG,20200219.0,,HP,US,US,2020,Q1,Adult
174386521,17438652,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,General physical health deterioration,,2020,Q1,1,I,,20200214.0,20200220,20200220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013922,BRISTOL MYERS SQUIBB,,81.0,YR,,M,Y,,,20200220.0,,MD,DE,DE,2020,Q1,Elderly
174386521,17438652,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,,20200214.0,20200220,20200220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013922,BRISTOL MYERS SQUIBB,,81.0,YR,,M,Y,,,20200220.0,,MD,DE,DE,2020,Q1,Elderly
174386521,17438652,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Polydipsia,,2020,Q1,1,I,,20200214.0,20200220,20200220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013922,BRISTOL MYERS SQUIBB,,81.0,YR,,M,Y,,,20200220.0,,MD,DE,DE,2020,Q1,Elderly
174386521,17438652,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Polyuria,,2020,Q1,1,I,,20200214.0,20200220,20200220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013922,BRISTOL MYERS SQUIBB,,81.0,YR,,M,Y,,,20200220.0,,MD,DE,DE,2020,Q1,Elderly
174426612,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Anxiety,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Depression,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Dry mouth,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Feeling abnormal,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Increased insulin requirement,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Temperature intolerance,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q1,Vertigo,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174447071,17444707,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,1,I,,20200218.0,20200221,20200221,EXP,,DE-009507513-2002DEU007003,MERCK,,56.0,YR,,F,Y,,,20200221.0,,MD,DE,DE,2020,Q1,Adult
174447071,17444707,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,,,,,,,,,2020,Q1,Taste disorder,,2020,Q1,1,I,,20200218.0,20200221,20200221,EXP,,DE-009507513-2002DEU007003,MERCK,,56.0,YR,,F,Y,,,20200221.0,,MD,DE,DE,2020,Q1,Adult
174447931,17444793,7,C,Insulin lispro,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,1,I,,20200219.0,20200221,20200221,EXP,,DE-TEVA-2020-DE-1189870,TEVA,,56.0,YR,,F,Y,,,20200221.0,,MD,DE,DE,2020,Q1,Adult
174447931,17444793,7,C,Insulin lispro,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,,,,,,,,,2020,Q1,Taste disorder,,2020,Q1,1,I,,20200219.0,20200221,20200221,EXP,,DE-TEVA-2020-DE-1189870,TEVA,,56.0,YR,,F,Y,,,20200221.0,,MD,DE,DE,2020,Q1,Adult
174485031,17448503,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,1,I,,20200215.0,20200223,20200223,EXP,DE-BFARM-20001474,DE-ACCORD-173502,ACCORD,,56.0,YR,A,F,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Adult
174485031,17448503,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,,,,,,,,,2020,Q1,Taste disorder,,2020,Q1,1,I,,20200215.0,20200223,20200223,EXP,DE-BFARM-20001474,DE-ACCORD-173502,ACCORD,,56.0,YR,A,F,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Adult
174488581,17448858,7,C,Insulin lispro,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,, UNKNOWN,,,,,,TID,2020,Q1,Paraesthesia,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,DE-DRREDDYS-GER/GER/20/0119827,DR REDDYS,,56.0,YR,,F,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Adult
174488581,17448858,7,C,Insulin lispro,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,, UNKNOWN,,,,,,TID,2020,Q1,Taste disorder,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,DE-DRREDDYS-GER/GER/20/0119827,DR REDDYS,,56.0,YR,,F,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Adult
174523581,17452358,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6-6-6 UNITS,,,D,,,,,,,INJECTION,TID,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200210.0,20200224,20200224,EXP,,BAUSCH-BL-2020-004447,BAUSCH AND LOMB,"DEY M, SAHOO I, CHAWLA S, RAJPUT M. PREGNANCY WITH PRIOR CORONARY ARTERY DISEASE: SPECIFIC CONCERNS. MEDICAL JOURNAL ARMED FORCES INDIA. 2018 FEB 03;76:109-111. DOI:HTTPS://DOI.ORG/10.1016/J.MJAFI.2017.11.006",35.0,YR,,F,Y,,,20200224.0,,HP,COUNTRY NOT SPECIFIED,,2020,Q1,Adult
174523581,17452358,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6-6-6 UNITS,,,D,,,,,,,INJECTION,TID,2020,Q1,Maternal exposure during pregnancy,,2020,Q1,1,I,,20200210.0,20200224,20200224,EXP,,BAUSCH-BL-2020-004447,BAUSCH AND LOMB,"DEY M, SAHOO I, CHAWLA S, RAJPUT M. PREGNANCY WITH PRIOR CORONARY ARTERY DISEASE: SPECIFIC CONCERNS. MEDICAL JOURNAL ARMED FORCES INDIA. 2018 FEB 03;76:109-111. DOI:HTTPS://DOI.ORG/10.1016/J.MJAFI.2017.11.006",35.0,YR,,F,Y,,,20200224.0,,HP,COUNTRY NOT SPECIFIED,,2020,Q1,Adult
174523581,17452358,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6-6-6 UNITS,,,D,,,,,,,INJECTION,TID,2020,Q1,Normal newborn,,2020,Q1,1,I,,20200210.0,20200224,20200224,EXP,,BAUSCH-BL-2020-004447,BAUSCH AND LOMB,"DEY M, SAHOO I, CHAWLA S, RAJPUT M. PREGNANCY WITH PRIOR CORONARY ARTERY DISEASE: SPECIFIC CONCERNS. MEDICAL JOURNAL ARMED FORCES INDIA. 2018 FEB 03;76:109-111. DOI:HTTPS://DOI.ORG/10.1016/J.MJAFI.2017.11.006",35.0,YR,,F,Y,,,20200224.0,,HP,COUNTRY NOT SPECIFIED,,2020,Q1,Adult
174524382,17452438,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNIT, QD",,,U,,,,,100.0,DF,,QD,2020,Q1,Transplant rejection,,2020,Q1,2,F,20200212.0,20200228.0,20200224,20200309,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000149,VELOXIS PHARMACEUTICALS,,70.0,YR,,F,Y,59.1,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
174536122,17453612,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Amnesia,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Cerebrovascular accident,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Debridement,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Fall,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Joint injury,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Visual impairment,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U, D079391A,,,,,INJECTION,,2020,Q1,Amnesia,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U, D079391A,,,,,INJECTION,,2020,Q1,Cerebrovascular accident,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U, D079391A,,,,,INJECTION,,2020,Q1,Debridement,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U, D079391A,,,,,INJECTION,,2020,Q1,Fall,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U, D079391A,,,,,INJECTION,,2020,Q1,Joint injury,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U, D079391A,,,,,INJECTION,,2020,Q1,Visual impairment,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Amnesia,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Cerebrovascular accident,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Debridement,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Fall,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Joint injury,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174536122,17453612,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q1,Visual impairment,,2020,Q1,2,F,201909.0,20200219.0,20200224,20200302,EXP,,US-ELI_LILLY_AND_COMPANY-US202002005843,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174538061,17453806,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25|75 E/ML, NACH SCHEMA (AFTER SCHEME)",,,,,,,,,,,,2020,Q1,General physical health deterioration,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-009172",BOEHRINGER INGELHEIM,,81.0,YR,,M,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Elderly
174538061,17453806,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25|75 E/ML, NACH SCHEMA (AFTER SCHEME)",,,,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-009172",BOEHRINGER INGELHEIM,,81.0,YR,,M,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Elderly
174538061,17453806,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25|75 E/ML, NACH SCHEMA (AFTER SCHEME)",,,,,,,,,,,,2020,Q1,Polydipsia,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-009172",BOEHRINGER INGELHEIM,,81.0,YR,,M,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Elderly
174538061,17453806,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25|75 E/ML, NACH SCHEMA (AFTER SCHEME)",,,,,,,,,,,,2020,Q1,Polyuria,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-009172",BOEHRINGER INGELHEIM,,81.0,YR,,M,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Elderly
174551381,17455138,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, BID",,,Y,U, C999324C,,20563.0,35.0,IU,INJECTION,BID,2020,Q1,Blood glucose decreased,,2020,Q1,1,I,20200212.0,20200213.0,20200225,20200225,PER,,US-ELI_LILLY_AND_COMPANY-US202002006594,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200225.0,,CN,US,US,2020,Q1,Elderly
174551381,17455138,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, BID",,,Y,U, C999324C,,20563.0,35.0,IU,INJECTION,BID,2020,Q1,Cold sweat,,2020,Q1,1,I,20200212.0,20200213.0,20200225,20200225,PER,,US-ELI_LILLY_AND_COMPANY-US202002006594,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200225.0,,CN,US,US,2020,Q1,Elderly
174551381,17455138,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, BID",,,Y,U, C999324C,,20563.0,35.0,IU,INJECTION,BID,2020,Q1,Tremor,,2020,Q1,1,I,20200212.0,20200213.0,20200225,20200225,PER,,US-ELI_LILLY_AND_COMPANY-US202002006594,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200225.0,,CN,US,US,2020,Q1,Elderly
174582811,17458281,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,,,2020,Q1,Hepatitis E,,2020,Q1,1,I,2018.0,20200214.0,20200225,20200225,EXP,,NVSC2020CZ051250,NOVARTIS,,50.0,YR,,M,Y,,,20200225.0,,HP,CZ,CZ,2020,Q1,Adult
174582811,17458281,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,2018.0,20200214.0,20200225,20200225,EXP,,NVSC2020CZ051250,NOVARTIS,,50.0,YR,,M,Y,,,20200225.0,,HP,CZ,CZ,2020,Q1,Adult
174624491,17462449,7,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"100 E/3ML, 4-4-4-0",,,U,,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,1,I,,20200214.0,20200226,20200226,EXP,,DE-AUROBINDO-AUR-APL-2020-009282,AUROBINDO,,56.0,YR,,F,Y,,,20200226.0,,MD,DE,DE,2020,Q1,Adult
174624491,17462449,7,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"100 E/3ML, 4-4-4-0",,,U,,,,,,,,,2020,Q1,Taste disorder,,2020,Q1,1,I,,20200214.0,20200226,20200226,EXP,,DE-AUROBINDO-AUR-APL-2020-009282,AUROBINDO,,56.0,YR,,F,Y,,,20200226.0,,MD,DE,DE,2020,Q1,Adult
174630801,17463080,14,SS,Insulin (lispro),INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2020,Q1,Suspected suicide,,2020,Q1,1,I,,20200213.0,20200226,20200226,EXP,,US-TARO-2020TAR00319,TARO,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, ET.AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLIN TOXICOL (PHILA). 2019;57 (12):1220-1413",61.0,YR,,F,Y,,,20200226.0,,MD,US,US,2020,Q1,Adult
174630801,17463080,14,SS,Insulin (lispro),INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20200213.0,20200226,20200226,EXP,,US-TARO-2020TAR00319,TARO,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, ET.AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLIN TOXICOL (PHILA). 2019;57 (12):1220-1413",61.0,YR,,F,Y,,,20200226.0,,MD,US,US,2020,Q1,Adult
174638751,17463875,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,1,I,,20200216.0,20200226,20200226,EXP,DE-ADRED-04277-01,DE-BAUSCH-BL-2020-005200,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200226.0,,MD,DE,DE,2020,Q1,Adult
174638751,17463875,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,,,,,,,,,2020,Q1,Taste disorder,,2020,Q1,1,I,,20200216.0,20200226,20200226,EXP,DE-ADRED-04277-01,DE-BAUSCH-BL-2020-005200,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200226.0,,MD,DE,DE,2020,Q1,Adult
174644722,17464472,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,2,F,,20200224.0,20200226,20200302,EXP,,DE-EMD SERONO-E2B_90075254,EMD SERONO INC,,56.0,YR,,F,Y,,,20200302.0,,MD,DE,DE,2020,Q1,Adult
174644722,17464472,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,,,,,,,,,2020,Q1,Taste disorder,,2020,Q1,2,F,,20200224.0,20200226,20200302,EXP,,DE-EMD SERONO-E2B_90075254,EMD SERONO INC,,56.0,YR,,F,Y,,,20200302.0,,MD,DE,DE,2020,Q1,Adult
174644761,17464476,7,C,Insulin lispro,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,U,,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,1,I,,20200217.0,20200226,20200226,EXP,DE-ADRED-04277-01,DE-TORRENT-00016840,TORRENT,,56.0,YR,A,F,Y,,,20200226.0,,MD,DE,DE,2020,Q1,Adult
174644761,17464476,7,C,Insulin lispro,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,U,,,,,,,,,2020,Q1,Taste disorder,,2020,Q1,1,I,,20200217.0,20200226,20200226,EXP,DE-ADRED-04277-01,DE-TORRENT-00016840,TORRENT,,56.0,YR,A,F,Y,,,20200226.0,,MD,DE,DE,2020,Q1,Adult
174646161,17464616,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"100 INTERNATIONAL UNIT, OTHER",,,U,U,,,20563.0,100.0,IU,,,2020,Q1,Blood glucose fluctuation,,2020,Q1,1,I,20190724.0,20200214.0,20200226,20200226,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202002007679,ELI LILLY AND CO,,75.0,YR,,F,Y,73.0,KG,20200226.0,,PH,DE,DE,2020,Q1,Elderly
174646161,17464616,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"100 INTERNATIONAL UNIT, OTHER",,,U,U,,,20563.0,100.0,IU,,,2020,Q1,Decreased appetite,,2020,Q1,1,I,20190724.0,20200214.0,20200226,20200226,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202002007679,ELI LILLY AND CO,,75.0,YR,,F,Y,73.0,KG,20200226.0,,PH,DE,DE,2020,Q1,Elderly
174646161,17464616,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"100 INTERNATIONAL UNIT, OTHER",,,U,U,,,20563.0,100.0,IU,,,2020,Q1,Dizziness,,2020,Q1,1,I,20190724.0,20200214.0,20200226,20200226,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202002007679,ELI LILLY AND CO,,75.0,YR,,F,Y,73.0,KG,20200226.0,,PH,DE,DE,2020,Q1,Elderly
174646161,17464616,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"100 INTERNATIONAL UNIT, OTHER",,,U,U,,,20563.0,100.0,IU,,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20190724.0,20200214.0,20200226,20200226,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202002007679,ELI LILLY AND CO,,75.0,YR,,F,Y,73.0,KG,20200226.0,,PH,DE,DE,2020,Q1,Elderly
174646161,17464616,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"100 INTERNATIONAL UNIT, OTHER",,,U,U,,,20563.0,100.0,IU,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20190724.0,20200214.0,20200226,20200226,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202002007679,ELI LILLY AND CO,,75.0,YR,,F,Y,73.0,KG,20200226.0,,PH,DE,DE,2020,Q1,Elderly
174646161,17464616,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"100 INTERNATIONAL UNIT, OTHER",,,U,U,,,20563.0,100.0,IU,,,2020,Q1,Nausea,,2020,Q1,1,I,20190724.0,20200214.0,20200226,20200226,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202002007679,ELI LILLY AND CO,,75.0,YR,,F,Y,73.0,KG,20200226.0,,PH,DE,DE,2020,Q1,Elderly
174646161,17464616,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"100 INTERNATIONAL UNIT, OTHER",,,U,U,,,20563.0,100.0,IU,,,2020,Q1,Product administration error,,2020,Q1,1,I,20190724.0,20200214.0,20200226,20200226,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202002007679,ELI LILLY AND CO,,75.0,YR,,F,Y,73.0,KG,20200226.0,,PH,DE,DE,2020,Q1,Elderly
174675741,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,D,,,,209196.0,,,,,2020,Q1,Blood glucose fluctuation,,2020,Q1,1,I,20190724.0,20200219.0,20200227,20200227,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20200227.0,,PH,DE,DE,2020,Q1,Elderly
174675741,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,D,,,,209196.0,,,,,2020,Q1,Decreased appetite,,2020,Q1,1,I,20190724.0,20200219.0,20200227,20200227,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20200227.0,,PH,DE,DE,2020,Q1,Elderly
174675741,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,D,,,,209196.0,,,,,2020,Q1,Dizziness,,2020,Q1,1,I,20190724.0,20200219.0,20200227,20200227,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20200227.0,,PH,DE,DE,2020,Q1,Elderly
174675741,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,D,,,,209196.0,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20190724.0,20200219.0,20200227,20200227,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20200227.0,,PH,DE,DE,2020,Q1,Elderly
174675741,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,D,,,,209196.0,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20190724.0,20200219.0,20200227,20200227,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20200227.0,,PH,DE,DE,2020,Q1,Elderly
174675741,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,D,,,,209196.0,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20190724.0,20200219.0,20200227,20200227,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20200227.0,,PH,DE,DE,2020,Q1,Elderly
174675741,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,D,,,,209196.0,,,,,2020,Q1,Product administration error,,2020,Q1,1,I,20190724.0,20200219.0,20200227,20200227,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20200227.0,,PH,DE,DE,2020,Q1,Elderly
174688651,17468865,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, TID",,,,,,,,25.0,IU,,TID,2020,Q1,Pancreatitis acute,,2020,Q1,1,I,20160320.0,20190611.0,20200227,20200227,PER,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004335",AEGERION,,16.0,YR,,F,Y,,,20200227.0,,HP,US,US,2020,Q1,Youth
174688811,17468881,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 IU, QD, CONTINUOUS VIA PUMP",,,,,,,,45.0,IU,,QD,2020,Q1,Pneumonia,,2020,Q1,1,I,201501.0,20190705.0,20200227,20200227,PER,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004393",AEGERION,,35.0,YR,,F,Y,,,20200227.0,,MD,US,US,2020,Q1,Adult
174689232,17468923,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID WITH MEALS",,,,,,,,,,,TID,2020,Q1,Condition aggravated,,2020,Q1,2,F,20180716.0,20200312.0,20200227,20200324,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
174689232,17468923,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID WITH MEALS",,,,,,,,,,,TID,2020,Q1,Diabetes mellitus,,2020,Q1,2,F,20180716.0,20200312.0,20200227,20200324,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
174689232,17468923,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID WITH MEALS",,,,,,,,,,,TID,2020,Q1,Drug ineffective for unapproved indication,,2020,Q1,2,F,20180716.0,20200312.0,20200227,20200324,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
174689232,17468923,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID WITH MEALS",,,,,,,,,,,TID,2020,Q1,Hypertriglyceridaemia,,2020,Q1,2,F,20180716.0,20200312.0,20200227,20200324,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
174689232,17468923,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID WITH MEALS",,,,,,,,,,,TID,2020,Q1,Insulin resistance,,2020,Q1,2,F,20180716.0,20200312.0,20200227,20200324,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
174689232,17468923,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID WITH MEALS",,,,,,,,,,,TID,2020,Q1,Off label use,,2020,Q1,2,F,20180716.0,20200312.0,20200227,20200324,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
174689232,17468923,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"85 IU, BID",,,,,,,,85.0,IU,,BID,2020,Q1,Condition aggravated,,2020,Q1,2,F,20180716.0,20200312.0,20200227,20200324,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
174689232,17468923,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"85 IU, BID",,,,,,,,85.0,IU,,BID,2020,Q1,Diabetes mellitus,,2020,Q1,2,F,20180716.0,20200312.0,20200227,20200324,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
174689232,17468923,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"85 IU, BID",,,,,,,,85.0,IU,,BID,2020,Q1,Drug ineffective for unapproved indication,,2020,Q1,2,F,20180716.0,20200312.0,20200227,20200324,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
174689232,17468923,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"85 IU, BID",,,,,,,,85.0,IU,,BID,2020,Q1,Hypertriglyceridaemia,,2020,Q1,2,F,20180716.0,20200312.0,20200227,20200324,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
174689232,17468923,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"85 IU, BID",,,,,,,,85.0,IU,,BID,2020,Q1,Insulin resistance,,2020,Q1,2,F,20180716.0,20200312.0,20200227,20200324,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
174689232,17468923,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"85 IU, BID",,,,,,,,85.0,IU,,BID,2020,Q1,Off label use,,2020,Q1,2,F,20180716.0,20200312.0,20200227,20200324,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200324.0,,HP,US,US,2020,Q1,Adult
174689361,17468936,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 UNITS, OD",,,,,,,,,,,QD,2020,Q1,Herpes zoster,,2020,Q1,1,I,20190528.0,20190906.0,20200227,20200227,PER,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004479",AEGERION,,40.0,YR,,F,Y,60.3,KG,20200227.0,,MD,US,US,2020,Q1,Adult
174689621,17468962,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 IU, BID",,,,,,,,80.0,IU,,BID,2020,Q1,Cough,,2020,Q1,1,I,201910.0,20191206.0,20200227,20200227,PER,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004634",AEGERION,,55.0,YR,,M,Y,,,20200227.0,,HP,US,US,2020,Q1,Adult
174689621,17468962,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 IU, BID",,,,,,,,80.0,IU,,BID,2020,Q1,Neuropathy peripheral,,2020,Q1,1,I,201910.0,20191206.0,20200227,20200227,PER,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004634",AEGERION,,55.0,YR,,M,Y,,,20200227.0,,HP,US,US,2020,Q1,Adult
174700041,17470004,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 IU, TID (EACH MEAL) (75 IU IN ONE DAY)",,,U,,,,,25.0,IU,,TID,2020,Q1,Blood glucose increased,,2020,Q1,1,I,201811.0,20200214.0,20200227,20200227,EXP,,IT-BAUSCH-BL-2020-005044,BAUSCH AND LOMB,,63.0,YR,,M,Y,77.0,KG,20200227.0,,MD,IT,IT,2020,Q1,Adult
174700041,17470004,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 IU, TID (EACH MEAL) (75 IU IN ONE DAY)",,,U,,,,,25.0,IU,,TID,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,201811.0,20200214.0,20200227,20200227,EXP,,IT-BAUSCH-BL-2020-005044,BAUSCH AND LOMB,,63.0,YR,,M,Y,77.0,KG,20200227.0,,MD,IT,IT,2020,Q1,Adult
174700041,17470004,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 IU, TID (EACH MEAL) (75 IU IN ONE DAY)",,,U,,,,,25.0,IU,,TID,2020,Q1,Product dose omission,,2020,Q1,1,I,201811.0,20200214.0,20200227,20200227,EXP,,IT-BAUSCH-BL-2020-005044,BAUSCH AND LOMB,,63.0,YR,,M,Y,77.0,KG,20200227.0,,MD,IT,IT,2020,Q1,Adult
174700041,17470004,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 IU, TID (EACH MEAL), 48 IU IN ONE DAY",,,U,,,,,16.0,IU,,TID,2020,Q1,Blood glucose increased,,2020,Q1,1,I,201811.0,20200214.0,20200227,20200227,EXP,,IT-BAUSCH-BL-2020-005044,BAUSCH AND LOMB,,63.0,YR,,M,Y,77.0,KG,20200227.0,,MD,IT,IT,2020,Q1,Adult
174700041,17470004,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 IU, TID (EACH MEAL), 48 IU IN ONE DAY",,,U,,,,,16.0,IU,,TID,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,201811.0,20200214.0,20200227,20200227,EXP,,IT-BAUSCH-BL-2020-005044,BAUSCH AND LOMB,,63.0,YR,,M,Y,77.0,KG,20200227.0,,MD,IT,IT,2020,Q1,Adult
174700041,17470004,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 IU, TID (EACH MEAL), 48 IU IN ONE DAY",,,U,,,,,16.0,IU,,TID,2020,Q1,Product dose omission,,2020,Q1,1,I,201811.0,20200214.0,20200227,20200227,EXP,,IT-BAUSCH-BL-2020-005044,BAUSCH AND LOMB,,63.0,YR,,M,Y,77.0,KG,20200227.0,,MD,IT,IT,2020,Q1,Adult
174700241,17470024,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Adrenal adenoma,,2020,Q1,1,I,,20200213.0,20200227,20200227,EXP,,IT-NOVOPROD-713110,NOVO NORDISK,,73.0,YR,,F,Y,,,20200227.0,,MD,IT,IT,2020,Q1,Elderly
174700241,17470024,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Adrenal insufficiency,,2020,Q1,1,I,,20200213.0,20200227,20200227,EXP,,IT-NOVOPROD-713110,NOVO NORDISK,,73.0,YR,,F,Y,,,20200227.0,,MD,IT,IT,2020,Q1,Elderly
174700241,17470024,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Decreased appetite,,2020,Q1,1,I,,20200213.0,20200227,20200227,EXP,,IT-NOVOPROD-713110,NOVO NORDISK,,73.0,YR,,F,Y,,,20200227.0,,MD,IT,IT,2020,Q1,Elderly
174700241,17470024,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200213.0,20200227,20200227,EXP,,IT-NOVOPROD-713110,NOVO NORDISK,,73.0,YR,,F,Y,,,20200227.0,,MD,IT,IT,2020,Q1,Elderly
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Ascites,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Bilirubin conjugated increased,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood albumin decreased,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood alkaline phosphatase increased,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood bilirubin increased,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood sodium decreased,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Cardiometabolic syndrome,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Cholestasis,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Faeces pale,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Gamma-glutamyltransferase increased,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic cirrhosis,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic enzyme increased,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic fibrosis,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatomegaly,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Muscle spasms,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Non-alcoholic steatohepatitis,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Platelet count decreased,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Portal hypertension,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Pruritus,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Splenomegaly,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Varices oesophageal,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Weight decreased,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174713701,17471370,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Weight loss poor,,2020,Q1,1,I,,20200215.0,20200228,20200228,EXP,,DE-AUROBINDO-AUR-APL-2020-009578,AUROBINDO,"MICHEL, M. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200228.0,,HP,DE,DE,2020,Q1,Adult
174716131,17471613,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,6-6-6 UNITS,,,U,,,,,,,INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200213.0,20200228,20200228,EXP,,SD-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-238449,RANBAXY,"DEY M, SAHOO I, CHAWLA S, RAJPUT M. PREGNANCY WITH PRIOR CORONARY ARTERY DISEASE: SPECIFIC CONCERNS. MED-J-ARMED-FORCES-INDIA. 2020;75:109-111",35.0,YR,,F,Y,,,20200228.0,,HP,SD,SD,2020,Q1,Adult
174716131,17471613,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,6-6-6 UNITS,,,U,,,,,,,INJECTION,,2020,Q1,Exposure during pregnancy,,2020,Q1,1,I,,20200213.0,20200228,20200228,EXP,,SD-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-238449,RANBAXY,"DEY M, SAHOO I, CHAWLA S, RAJPUT M. PREGNANCY WITH PRIOR CORONARY ARTERY DISEASE: SPECIFIC CONCERNS. MED-J-ARMED-FORCES-INDIA. 2020;75:109-111",35.0,YR,,F,Y,,,20200228.0,,HP,SD,SD,2020,Q1,Adult
174723571,17472357,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,U,U,,,,,,,,2020,Q1,Blood glucose fluctuation,,2020,Q1,1,I,20190724.0,20200214.0,20200228,20200228,EXP,DE-ADRED-04126-01,DE-NOVOPROD-712925,NOVO NORDISK,,75.0,YR,,F,Y,73.0,KG,20200228.0,,PH,DE,DE,2020,Q1,Elderly
174723571,17472357,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,U,U,,,,,,,,2020,Q1,Decreased appetite,,2020,Q1,1,I,20190724.0,20200214.0,20200228,20200228,EXP,DE-ADRED-04126-01,DE-NOVOPROD-712925,NOVO NORDISK,,75.0,YR,,F,Y,73.0,KG,20200228.0,,PH,DE,DE,2020,Q1,Elderly
174723571,17472357,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,U,U,,,,,,,,2020,Q1,Dizziness,,2020,Q1,1,I,20190724.0,20200214.0,20200228,20200228,EXP,DE-ADRED-04126-01,DE-NOVOPROD-712925,NOVO NORDISK,,75.0,YR,,F,Y,73.0,KG,20200228.0,,PH,DE,DE,2020,Q1,Elderly
174723571,17472357,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,U,U,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20190724.0,20200214.0,20200228,20200228,EXP,DE-ADRED-04126-01,DE-NOVOPROD-712925,NOVO NORDISK,,75.0,YR,,F,Y,73.0,KG,20200228.0,,PH,DE,DE,2020,Q1,Elderly
174723571,17472357,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,U,U,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20190724.0,20200214.0,20200228,20200228,EXP,DE-ADRED-04126-01,DE-NOVOPROD-712925,NOVO NORDISK,,75.0,YR,,F,Y,73.0,KG,20200228.0,,PH,DE,DE,2020,Q1,Elderly
174723571,17472357,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,U,U,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20190724.0,20200214.0,20200228,20200228,EXP,DE-ADRED-04126-01,DE-NOVOPROD-712925,NOVO NORDISK,,75.0,YR,,F,Y,73.0,KG,20200228.0,,PH,DE,DE,2020,Q1,Elderly
174723571,17472357,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, 4-4-3-0",,,U,U,,,,,,,,2020,Q1,Product administration error,,2020,Q1,1,I,20190724.0,20200214.0,20200228,20200228,EXP,DE-ADRED-04126-01,DE-NOVOPROD-712925,NOVO NORDISK,,75.0,YR,,F,Y,73.0,KG,20200228.0,,PH,DE,DE,2020,Q1,Elderly
174732201,17473220,15,SS,Insulin lispro,INSULIN LISPRO,1,Oral,UNKNOWN,,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,,20200218.0,20200228,20200228,EXP,,US-TORRENT-00009700,TORRENT,,61.0,YR,A,F,Y,,,20200228.0,,MD,US,US,2020,Q1,Adult
174732201,17473220,15,SS,Insulin lispro,INSULIN LISPRO,1,Oral,UNKNOWN,,,D,,,,,,,,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20200218.0,20200228,20200228,EXP,,US-TORRENT-00009700,TORRENT,,61.0,YR,A,F,Y,,,20200228.0,,MD,US,US,2020,Q1,Adult
174732791,17473279,1,SS,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,,20200218.0,20200228,20200228,EXP,,US-TORRENT-00010000,TORRENT,,37.0,YR,A,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Adult
174732791,17473279,1,SS,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,D,,,,,,,,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20200218.0,20200228,20200228,EXP,,US-TORRENT-00010000,TORRENT,,37.0,YR,A,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Adult
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pulmonary congestion,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal disorder,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Syncope,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174764411,17476441,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Altered state of consciousness,,2020,Q1,1,I,20200210.0,20200224.0,20200228,20200228,EXP,,US-PFIZER INC-2020083164,PFIZER,,11.0,YR,,F,Y,68.1,KG,20200228.0,,MD,US,US,2020,Q1,Child
174764411,17476441,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Seizure,,2020,Q1,1,I,20200210.0,20200224.0,20200228,20200228,EXP,,US-PFIZER INC-2020083164,PFIZER,,11.0,YR,,F,Y,68.1,KG,20200228.0,,MD,US,US,2020,Q1,Child
174801331,17480133,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,7.0,IU,UNKNOWN,TID,2020,Q1,Confusional state,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,7.0,IU,UNKNOWN,TID,2020,Q1,Fall,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,7.0,IU,UNKNOWN,TID,2020,Q1,Osteomyelitis,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,7.0,IU,UNKNOWN,TID,2020,Q1,Pneumonia,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,7.0,IU,UNKNOWN,TID,2020,Q1,Somnolence,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174819261,17481926,15,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Altered state of consciousness,,2020,Q1,1,I,20200210.0,20200220.0,20200302,20200302,EXP,,US-BAXTER-2020BAX004462,BAXTER,,11.0,YR,,F,Y,68.1,KG,20200302.0,,MD,US,US,2020,Q1,Child
174819261,17481926,15,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Seizure,,2020,Q1,1,I,20200210.0,20200220.0,20200302,20200302,EXP,,US-BAXTER-2020BAX004462,BAXTER,,11.0,YR,,F,Y,68.1,KG,20200302.0,,MD,US,US,2020,Q1,Child
174822061,17482206,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,22.0,IU,,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200217.0,20200302,20200302,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202002008484,ELI LILLY AND CO,,57.0,YR,,F,Y,95.4,KG,20200302.0,,CN,ES,ES,2020,Q1,Adult
174822061,17482206,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200217.0,20200302,20200302,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202002008484,ELI LILLY AND CO,,57.0,YR,,F,Y,95.4,KG,20200302.0,,CN,ES,ES,2020,Q1,Adult
174824171,17482417,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2020,Q1,Hypoglycaemic coma,,2020,Q1,1,I,20200213.0,20200219.0,20200302,20200302,PER,,US-ELI_LILLY_AND_COMPANY-US202002011230,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174824171,17482417,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2020,Q1,Joint instability,,2020,Q1,1,I,20200213.0,20200219.0,20200302,20200302,PER,,US-ELI_LILLY_AND_COMPANY-US202002011230,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174824171,17482417,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2020,Q1,Shock hypoglycaemic,,2020,Q1,1,I,20200213.0,20200219.0,20200302,20200302,PER,,US-ELI_LILLY_AND_COMPANY-US202002011230,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174824171,17482417,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C939454C,,20563.0,,,INJECTION,,2020,Q1,Hypoglycaemic coma,,2020,Q1,1,I,20200213.0,20200219.0,20200302,20200302,PER,,US-ELI_LILLY_AND_COMPANY-US202002011230,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174824171,17482417,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C939454C,,20563.0,,,INJECTION,,2020,Q1,Joint instability,,2020,Q1,1,I,20200213.0,20200219.0,20200302,20200302,PER,,US-ELI_LILLY_AND_COMPANY-US202002011230,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174824171,17482417,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C939454C,,20563.0,,,INJECTION,,2020,Q1,Shock hypoglycaemic,,2020,Q1,1,I,20200213.0,20200219.0,20200302,20200302,PER,,US-ELI_LILLY_AND_COMPANY-US202002011230,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Elderly
174826882,17482688,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Cardiac failure congestive,,2020,Q1,2,F,,20200319.0,20200302,20200326,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002009632AA,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200326.0,,MD,JP,JP,2020,Q1,Adult
174826882,17482688,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,,20200319.0,20200302,20200326,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002009632AA,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200326.0,,MD,JP,JP,2020,Q1,Adult
174827541,17482754,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,,20200224.0,20200302,20200302,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP002012,STRIDES,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, ET AL.. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT.. CLINICAL TOXICOLOGY. 2019;57(12):1220-1413",61.0,YR,,F,Y,,,20200302.0,,MD,US,US,2020,Q1,Adult
174921181,17492118,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Cardiac failure congestive,,2020,Q1,1,I,2017.0,20200225.0,20200304,20200304,EXP,,US-SA-2020SA053792,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Elderly
174921181,17492118,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Oedema,,2020,Q1,1,I,2017.0,20200225.0,20200304,20200304,EXP,,US-SA-2020SA053792,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Elderly
174921181,17492118,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Product dose omission,,2020,Q1,1,I,2017.0,20200225.0,20200304,20200304,EXP,,US-SA-2020SA053792,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Elderly
174921181,17492118,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Swelling,,2020,Q1,1,I,2017.0,20200225.0,20200304,20200304,EXP,,US-SA-2020SA053792,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Elderly
174929801,17492980,4,C,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20190520.0,20190604.0,20200304,20200304,EXP,,CN-GLAXOSMITHKLINE-2019-TSO02178-CN,GLAXOSMITHKLINE,,57.0,YR,,F,Y,55.0,KG,20200304.0,,MD,CN,CN,2020,Q1,Adult
175029552,17502955,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 IU, QD",,,Y,,,,,60.0,IU,,QD,2020,Q1,Drug interaction,,2020,Q1,2,F,20191128.0,20200324.0,20200305,20200330,EXP,IT-MINISAL02-596351,IT-SA-2020SA052788,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
175029552,17502955,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 IU, QD",,,Y,,,,,60.0,IU,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,20191128.0,20200324.0,20200305,20200330,EXP,IT-MINISAL02-596351,IT-SA-2020SA052788,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
175029552,17502955,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 IU, QD",,,Y,,,,,60.0,IU,,QD,2020,Q1,Loss of consciousness,,2020,Q1,2,F,20191128.0,20200324.0,20200305,20200330,EXP,IT-MINISAL02-596351,IT-SA-2020SA052788,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
175029552,17502955,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 IU, QD",,,Y,,,,,60.0,IU,,QD,2020,Q1,Seizure,,2020,Q1,2,F,20191128.0,20200324.0,20200305,20200330,EXP,IT-MINISAL02-596351,IT-SA-2020SA052788,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
175093061,17509306,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, QD",,,,,,,,24.0,IU,,QD,2020,Q1,Anaemia,,2020,Q1,1,I,20200104.0,20200226.0,20200306,20200306,EXP,GB-MHRA-MIDB-8EBE4951-0BDB-462A-B5E7-9126919135B5,GB-MYLANLABS-2020M1022950,MYLAN,,73.0,YR,,M,Y,,,20200306.0,,PH,GB,GB,2020,Q1,Elderly
175093061,17509306,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, QD",,,,,,,,24.0,IU,,QD,2020,Q1,Gastrointestinal haemorrhage,,2020,Q1,1,I,20200104.0,20200226.0,20200306,20200306,EXP,GB-MHRA-MIDB-8EBE4951-0BDB-462A-B5E7-9126919135B5,GB-MYLANLABS-2020M1022950,MYLAN,,73.0,YR,,M,Y,,,20200306.0,,PH,GB,GB,2020,Q1,Elderly
175185471,17518547,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,25 INTERNATIONAL UNIT,,,U,,,,,25.0,IU,,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,201807.0,20200225.0,20200310,20200310,EXP,,IT-AUROBINDO-AUR-APL-2020-010996,AUROBINDO,,63.0,YR,,M,Y,77.0,KG,20200310.0,,MD,IT,IT,2020,Q1,Adult
175185471,17518547,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,25 INTERNATIONAL UNIT,,,U,,,,,25.0,IU,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,201807.0,20200225.0,20200310,20200310,EXP,,IT-AUROBINDO-AUR-APL-2020-010996,AUROBINDO,,63.0,YR,,M,Y,77.0,KG,20200310.0,,MD,IT,IT,2020,Q1,Adult
175185471,17518547,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,16 INTERNATIONAL UNIT,,,U,,,,,16.0,IU,,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,201807.0,20200225.0,20200310,20200310,EXP,,IT-AUROBINDO-AUR-APL-2020-010996,AUROBINDO,,63.0,YR,,M,Y,77.0,KG,20200310.0,,MD,IT,IT,2020,Q1,Adult
175185471,17518547,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,16 INTERNATIONAL UNIT,,,U,,,,,16.0,IU,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,201807.0,20200225.0,20200310,20200310,EXP,,IT-AUROBINDO-AUR-APL-2020-010996,AUROBINDO,,63.0,YR,,M,Y,77.0,KG,20200310.0,,MD,IT,IT,2020,Q1,Adult
175189651,17518965,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,25 IU EACH MEAL,,,,,,,,,,,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,201807.0,20200227.0,20200309,20200309,EXP,,IT-BAUSCH-BL-2020-006503,BAUSCH AND LOMB,,63.0,YR,,M,Y,77.0,KG,20200309.0,,MD,IT,IT,2020,Q1,Adult
175189651,17518965,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,25 IU EACH MEAL,,,,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,201807.0,20200227.0,20200309,20200309,EXP,,IT-BAUSCH-BL-2020-006503,BAUSCH AND LOMB,,63.0,YR,,M,Y,77.0,KG,20200309.0,,MD,IT,IT,2020,Q1,Adult
175189651,17518965,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,16 IU EACH MEAL,,,,,,,,,,,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,201807.0,20200227.0,20200309,20200309,EXP,,IT-BAUSCH-BL-2020-006503,BAUSCH AND LOMB,,63.0,YR,,M,Y,77.0,KG,20200309.0,,MD,IT,IT,2020,Q1,Adult
175189651,17518965,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,16 IU EACH MEAL,,,,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,201807.0,20200227.0,20200309,20200309,EXP,,IT-BAUSCH-BL-2020-006503,BAUSCH AND LOMB,,63.0,YR,,M,Y,77.0,KG,20200309.0,,MD,IT,IT,2020,Q1,Adult
175203101,17520310,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2020,Q1,Adrenal adenoma,,2020,Q1,1,I,,20200226.0,20200309,20200309,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202002013329,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200309.0,,MD,IT,IT,2020,Q1,Elderly
175203101,17520310,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2020,Q1,Adrenal insufficiency,,2020,Q1,1,I,,20200226.0,20200309,20200309,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202002013329,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200309.0,,MD,IT,IT,2020,Q1,Elderly
175203101,17520310,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2020,Q1,Decreased appetite,,2020,Q1,1,I,,20200226.0,20200309,20200309,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202002013329,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200309.0,,MD,IT,IT,2020,Q1,Elderly
175203101,17520310,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200226.0,20200309,20200309,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202002013329,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200309.0,,MD,IT,IT,2020,Q1,Elderly
175217981,17521798,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U EACH + SCALE TREATMENT, TID (MORNING, NOON, EVENING)",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2020,Q1,Atrial fibrillation,,2020,Q1,1,I,20191220.0,20200305.0,20200310,20200310,EXP,,JP-SA-2020SA058550,SANOFI AVENTIS,,78.0,YR,E,M,Y,62.0,KG,20200310.0,,PH,JP,JP,2020,Q1,Elderly
175217981,17521798,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U EACH + SCALE TREATMENT, TID (MORNING, NOON, EVENING)",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2020,Q1,Hypokalaemia,,2020,Q1,1,I,20191220.0,20200305.0,20200310,20200310,EXP,,JP-SA-2020SA058550,SANOFI AVENTIS,,78.0,YR,E,M,Y,62.0,KG,20200310.0,,PH,JP,JP,2020,Q1,Elderly
175222372,17522237,45,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,6.0,DF,,TID,2020,Q1,Sepsis,,2020,Q1,2,F,20200115.0,20200316.0,20200310,20200327,EXP,,US-ABBVIE-20P-163-3242463-00,ABBVIE,,80.0,YR,,M,Y,48.0,KG,20200327.0,,MD,US,US,2020,Q1,Elderly
175282412,17528241,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,25 IU EACH MEAL,,,,,,,,,,,,2020,Q1,Blood glucose increased,,2020,Q1,2,F,201807.0,20200327.0,20200311,20200330,EXP,,IT-PFIZER INC-2020103460,PFIZER,,63.0,YR,,M,Y,77.0,KG,20200330.0,,MD,IT,IT,2020,Q1,Adult
175282412,17528241,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,25 IU EACH MEAL,,,,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,201807.0,20200327.0,20200311,20200330,EXP,,IT-PFIZER INC-2020103460,PFIZER,,63.0,YR,,M,Y,77.0,KG,20200330.0,,MD,IT,IT,2020,Q1,Adult
175282412,17528241,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,16 IU EACH MEAL,,,,,,,,,,,,2020,Q1,Blood glucose increased,,2020,Q1,2,F,201807.0,20200327.0,20200311,20200330,EXP,,IT-PFIZER INC-2020103460,PFIZER,,63.0,YR,,M,Y,77.0,KG,20200330.0,,MD,IT,IT,2020,Q1,Adult
175282412,17528241,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,16 IU EACH MEAL,,,,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,201807.0,20200327.0,20200311,20200330,EXP,,IT-PFIZER INC-2020103460,PFIZER,,63.0,YR,,M,Y,77.0,KG,20200330.0,,MD,IT,IT,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Drug ineffective,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Gait disturbance,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Hepatic enzyme increased,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Musculoskeletal stiffness,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Peripheral swelling,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Pharyngitis,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Poor venous access,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Pruritus,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Swelling,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Therapeutic response decreased,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Tremor,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175296331,17529633,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,,20200307.0,20200311,20200311,EXP,,CA-TEVA-2020-CA-1198783,TEVA,,62.0,YR,,M,Y,,,20200311.0,,HP,CA,CA,2020,Q1,Adult
175305061,17530506,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,20.0,IU,INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,20200205.0,20200304.0,20200312,20200312,PER,,US-ELI_LILLY_AND_COMPANY-US202003002618,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200312.0,,CN,US,US,2020,Q1,Adult
175305061,17530506,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,20.0,IU,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,1,I,20200205.0,20200304.0,20200312,20200312,PER,,US-ELI_LILLY_AND_COMPANY-US202003002618,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200312.0,,CN,US,US,2020,Q1,Adult
175305061,17530506,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,20.0,IU,INJECTION,,2020,Q1,Glycosylated haemoglobin abnormal,,2020,Q1,1,I,20200205.0,20200304.0,20200312,20200312,PER,,US-ELI_LILLY_AND_COMPANY-US202003002618,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200312.0,,CN,US,US,2020,Q1,Adult
175305061,17530506,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,20.0,IU,INJECTION,,2020,Q1,Hunger,,2020,Q1,1,I,20200205.0,20200304.0,20200312,20200312,PER,,US-ELI_LILLY_AND_COMPANY-US202003002618,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200312.0,,CN,US,US,2020,Q1,Adult
175305061,17530506,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,20.0,IU,INJECTION,,2020,Q1,Hypertension,,2020,Q1,1,I,20200205.0,20200304.0,20200312,20200312,PER,,US-ELI_LILLY_AND_COMPANY-US202003002618,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200312.0,,CN,US,US,2020,Q1,Adult
175305061,17530506,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,20.0,IU,INJECTION,,2020,Q1,Weight increased,,2020,Q1,1,I,20200205.0,20200304.0,20200312,20200312,PER,,US-ELI_LILLY_AND_COMPANY-US202003002618,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200312.0,,CN,US,US,2020,Q1,Adult
175311561,17531156,3,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"10 IU, 4X/DAY",,,U,,,,,10.0,IU,,QID,2020,Q1,Accidental exposure to product,,2020,Q1,1,I,20200207.0,20200310.0,20200311,20200311,EXP,,PT-PFIZER INC-2020105549,PFIZER,,51.0,YR,,F,Y,,,20200311.0,,CN,PT,PT,2020,Q1,Adult
175311561,17531156,3,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"10 IU, 4X/DAY",,,U,,,,,10.0,IU,,QID,2020,Q1,Blood pressure decreased,,2020,Q1,1,I,20200207.0,20200310.0,20200311,20200311,EXP,,PT-PFIZER INC-2020105549,PFIZER,,51.0,YR,,F,Y,,,20200311.0,,CN,PT,PT,2020,Q1,Adult
175311561,17531156,3,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"10 IU, 4X/DAY",,,U,,,,,10.0,IU,,QID,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,20200207.0,20200310.0,20200311,20200311,EXP,,PT-PFIZER INC-2020105549,PFIZER,,51.0,YR,,F,Y,,,20200311.0,,CN,PT,PT,2020,Q1,Adult
175311561,17531156,3,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"10 IU, 4X/DAY",,,U,,,,,10.0,IU,,QID,2020,Q1,Diabetic wound,,2020,Q1,1,I,20200207.0,20200310.0,20200311,20200311,EXP,,PT-PFIZER INC-2020105549,PFIZER,,51.0,YR,,F,Y,,,20200311.0,,CN,PT,PT,2020,Q1,Adult
175311561,17531156,3,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"10 IU, 4X/DAY",,,U,,,,,10.0,IU,,QID,2020,Q1,Foot deformity,,2020,Q1,1,I,20200207.0,20200310.0,20200311,20200311,EXP,,PT-PFIZER INC-2020105549,PFIZER,,51.0,YR,,F,Y,,,20200311.0,,CN,PT,PT,2020,Q1,Adult
175311561,17531156,3,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"10 IU, 4X/DAY",,,U,,,,,10.0,IU,,QID,2020,Q1,Foot fracture,,2020,Q1,1,I,20200207.0,20200310.0,20200311,20200311,EXP,,PT-PFIZER INC-2020105549,PFIZER,,51.0,YR,,F,Y,,,20200311.0,,CN,PT,PT,2020,Q1,Adult
175311561,17531156,3,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"10 IU, 4X/DAY",,,U,,,,,10.0,IU,,QID,2020,Q1,Product dose omission,,2020,Q1,1,I,20200207.0,20200310.0,20200311,20200311,EXP,,PT-PFIZER INC-2020105549,PFIZER,,51.0,YR,,F,Y,,,20200311.0,,CN,PT,PT,2020,Q1,Adult
175311561,17531156,3,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"10 IU, 4X/DAY",,,U,,,,,10.0,IU,,QID,2020,Q1,Rheumatoid arthritis,,2020,Q1,1,I,20200207.0,20200310.0,20200311,20200311,EXP,,PT-PFIZER INC-2020105549,PFIZER,,51.0,YR,,F,Y,,,20200311.0,,CN,PT,PT,2020,Q1,Adult
175311561,17531156,3,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"10 IU, 4X/DAY",,,U,,,,,10.0,IU,,QID,2020,Q1,Sepsis,,2020,Q1,1,I,20200207.0,20200310.0,20200311,20200311,EXP,,PT-PFIZER INC-2020105549,PFIZER,,51.0,YR,,F,Y,,,20200311.0,,CN,PT,PT,2020,Q1,Adult
175343591,17534359,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,1,I,,20200306.0,20200312,20200312,EXP,,DE-MYLANLABS-2020M1026455,MYLAN,,56.0,YR,,F,Y,,,20200312.0,,MD,DE,DE,2020,Q1,Adult
175343591,17534359,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 E/3ML, 4-4-4-0",,,,,,,,,,,,2020,Q1,Taste disorder,,2020,Q1,1,I,,20200306.0,20200312,20200312,EXP,,DE-MYLANLABS-2020M1026455,MYLAN,,56.0,YR,,F,Y,,,20200312.0,,MD,DE,DE,2020,Q1,Adult
175362371,17536237,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q1,Altered state of consciousness,,2020,Q1,1,I,20200210.0,20200228.0,20200313,20200313,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01201,HIKMA,,11.0,YR,,F,Y,68.0,KG,20200312.0,,HP,US,US,2020,Q1,Child
175362371,17536237,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q1,Cyanosis,,2020,Q1,1,I,20200210.0,20200228.0,20200313,20200313,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01201,HIKMA,,11.0,YR,,F,Y,68.0,KG,20200312.0,,HP,US,US,2020,Q1,Child
175362371,17536237,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q1,Drooling,,2020,Q1,1,I,20200210.0,20200228.0,20200313,20200313,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01201,HIKMA,,11.0,YR,,F,Y,68.0,KG,20200312.0,,HP,US,US,2020,Q1,Child
175362371,17536237,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q1,Irregular breathing,,2020,Q1,1,I,20200210.0,20200228.0,20200313,20200313,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01201,HIKMA,,11.0,YR,,F,Y,68.0,KG,20200312.0,,HP,US,US,2020,Q1,Child
175362371,17536237,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q1,Seizure,,2020,Q1,1,I,20200210.0,20200228.0,20200313,20200313,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01201,HIKMA,,11.0,YR,,F,Y,68.0,KG,20200312.0,,HP,US,US,2020,Q1,Child
175362371,17536237,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q1,Somnolence,,2020,Q1,1,I,20200210.0,20200228.0,20200313,20200313,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01201,HIKMA,,11.0,YR,,F,Y,68.0,KG,20200312.0,,HP,US,US,2020,Q1,Child
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Drug ineffective,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Gait disturbance,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Hepatic enzyme increased,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Musculoskeletal stiffness,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Peripheral swelling,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Pharyngitis,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Poor venous access,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Pruritus,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Swelling,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Therapeutic response decreased,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Tremor,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175438141,17543814,6,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,,20200310.0,20200316,20200316,EXP,,CA-TEVA-2020-CA-1202047,TEVA,,62.0,YR,,M,Y,,,20200316.0,,HP,CA,CA,2020,Q1,Adult
175443873,17544387,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-14 UNITS,,,,,,,,,,,TID,2020,Q1,Atrial fibrillation,,2020,Q1,3,F,20200301.0,20200313.0,20200316,20200324,EXP,,US-JNJFOC-20200307350,JOHNSON AND JOHNSON,,67.0,YR,,F,Y,94.43,KG,20200324.0,,MD,US,US,2020,Q1,Elderly
175443873,17544387,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-14 UNITS,,,,,,,,,,,TID,2020,Q1,Cerebrovascular accident,,2020,Q1,3,F,20200301.0,20200313.0,20200316,20200324,EXP,,US-JNJFOC-20200307350,JOHNSON AND JOHNSON,,67.0,YR,,F,Y,94.43,KG,20200324.0,,MD,US,US,2020,Q1,Elderly
175454843,17545484,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML INJECTION,,,U,,,,,,,INJECTION,,2020,Q1,Hypotension,,2020,Q1,3,F,20200101.0,20200317.0,20200316,20200330,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000017,VELOXIS PHARMACEUTICALS,,45.0,YR,,M,Y,115.3,KG,20200330.0,,HP,US,US,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Ascites,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Bilirubin conjugated increased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood albumin decreased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood alkaline phosphatase increased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood bilirubin increased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood sodium decreased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Cardiometabolic syndrome,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Cholestasis,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Faeces pale,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Gamma-glutamyltransferase increased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic cirrhosis,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic enzyme increased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic fibrosis,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatomegaly,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Muscle spasms,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Non-alcoholic steatohepatitis,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Platelet count decreased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Portal hypertension,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Pruritus,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Splenomegaly,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Varices oesophageal,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Weight decreased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Weight loss poor,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Ascites,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Bilirubin conjugated increased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood albumin decreased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood alkaline phosphatase increased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood bilirubin increased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood sodium decreased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Cardiometabolic syndrome,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Cholestasis,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Faeces pale,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Gamma-glutamyltransferase increased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic cirrhosis,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic enzyme increased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatic fibrosis,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hepatomegaly,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Muscle spasms,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Non-alcoholic steatohepatitis,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Platelet count decreased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Portal hypertension,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Pruritus,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Splenomegaly,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Varices oesophageal,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Weight decreased,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175496421,17549642,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Weight loss poor,,2020,Q1,1,I,,20200307.0,20200317,20200317,EXP,,DE-MYLANLABS-2020M1026989,MYLAN,"MICHEL, M.. A YOUNG PATIENT WITH TYPE 2 DIABETES ASSOCIATED NON-ALCOHOLIC STEATOHEPATITIS, LIVER CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA. ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2020;58(1):57-62",46.0,YR,,M,Y,107.0,KG,20200317.0,,HP,DE,DE,2020,Q1,Adult
175529381,17552938,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 20 MGUNITS DAILY,,,,,,,,,,,,2020,Q1,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q1,1,I,20190613.0,20200304.0,20200317,20200317,EXP,,US-VERTEX PHARMACEUTICALS-2020-006086,VERTEX,,20.0,YR,,F,Y,45.0,KG,20200317.0,,PH,US,US,2020,Q1,Youth
175529391,17552939,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"INJECT UPTO 20 UNITS, QD",,,,,,,,,,,,2020,Q1,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q1,1,I,20190126.0,20200304.0,20200317,20200317,EXP,,US-VERTEX PHARMACEUTICALS-2020-006084,VERTEX,,20.0,YR,,F,Y,45.0,KG,20200317.0,,HP,US,US,2020,Q1,Youth
175535251,17553525,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,UNK,,,,,,,,,,,,2020,Q1,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q1,1,I,20190714.0,20200304.0,20200317,20200317,EXP,,US-VERTEX PHARMACEUTICALS-2020-006087,VERTEX,,20.0,YR,,F,Y,45.0,KG,20200317.0,,HP,US,US,2020,Q1,Youth
175618671,17561867,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2020,Q1,Drug interaction,,2020,Q1,1,I,20200301.0,20200310.0,20200319,20200319,EXP,IT-MINISAL02-610154,IT-TEVA-2020-IT-1202394,TEVA,,61.0,YR,,M,Y,,,20200319.0,,MD,IT,IT,2020,Q1,Adult
175618671,17561867,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2020,Q1,Sopor,,2020,Q1,1,I,20200301.0,20200310.0,20200319,20200319,EXP,IT-MINISAL02-610154,IT-TEVA-2020-IT-1202394,TEVA,,61.0,YR,,M,Y,,,20200319.0,,MD,IT,IT,2020,Q1,Adult
175633362,17563336,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, PRN",,,,,,,,,,,,2020,Q1,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q1,2,F,20191029.0,20200323.0,20200319,20200326,EXP,,NL-VERTEX PHARMACEUTICALS-2019-010618,VERTEX,,52.0,YR,,F,Y,71.0,KG,20200326.0,,HP,NL,NL,2020,Q1,Adult
175633362,17563336,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, PRN",,,,,,,,,,,,2020,Q1,Pulmonary embolism,,2020,Q1,2,F,20191029.0,20200323.0,20200319,20200326,EXP,,NL-VERTEX PHARMACEUTICALS-2019-010618,VERTEX,,52.0,YR,,F,Y,71.0,KG,20200326.0,,HP,NL,NL,2020,Q1,Adult
175677792,17567779,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Hypokalaemia,,2020,Q1,2,F,20190228.0,20200327.0,20200320,20200330,EXP,,US-PFIZER INC-2019096689,PFIZER,,81.0,YR,,F,Y,64.85,KG,20200330.0,,HP,US,US,2020,Q1,Elderly
175677792,17567779,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Osteomyelitis,,2020,Q1,2,F,20190228.0,20200327.0,20200320,20200330,EXP,,US-PFIZER INC-2019096689,PFIZER,,81.0,YR,,F,Y,64.85,KG,20200330.0,,HP,US,US,2020,Q1,Elderly
175680011,17568001,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, TID, BREAKFAST-LUNCH-DINNER",,,U,,,,20563.0,,,,TID,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200122.0,20200320,20200320,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202003009126,ELI LILLY AND CO,,57.0,YR,,M,Y,97.0,KG,20200320.0,,CN,ES,ES,2020,Q1,Adult
175680341,17568034,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,U,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,1,I,20200301.0,20200312.0,20200320,20200320,EXP,IT-MINISAL02-610154,IT-PURDUE PHARMA-GBR-2020-0075748,PURDUE,,61.0,YR,,M,Y,,,20200319.0,,MD,IT,IT,2020,Q1,Adult
175680341,17568034,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,U,,,,,,,,2020,Q1,Sopor,,2020,Q1,1,I,20200301.0,20200312.0,20200320,20200320,EXP,IT-MINISAL02-610154,IT-PURDUE PHARMA-GBR-2020-0075748,PURDUE,,61.0,YR,,M,Y,,,20200319.0,,MD,IT,IT,2020,Q1,Adult
175753771,17575377,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,Y,U, C933643D,,,10.0,IU,INJECTION,,2020,Q1,Asthenia,,2020,Q1,1,I,20200310.0,20200312.0,20200324,20200324,EXP,,US-ELI_LILLY_AND_COMPANY-US202003006813,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200324.0,,CN,US,US,2020,Q1,Adult
175753771,17575377,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,Y,U, C933643D,,,10.0,IU,INJECTION,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20200310.0,20200312.0,20200324,20200324,EXP,,US-ELI_LILLY_AND_COMPANY-US202003006813,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200324.0,,CN,US,US,2020,Q1,Adult
175753771,17575377,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,Y,U, C933643D,,,10.0,IU,INJECTION,,2020,Q1,Malaise,,2020,Q1,1,I,20200310.0,20200312.0,20200324,20200324,EXP,,US-ELI_LILLY_AND_COMPANY-US202003006813,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200324.0,,CN,US,US,2020,Q1,Adult
175753771,17575377,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,Y,U, C938255F,,,10.0,IU,INJECTION,,2020,Q1,Asthenia,,2020,Q1,1,I,20200310.0,20200312.0,20200324,20200324,EXP,,US-ELI_LILLY_AND_COMPANY-US202003006813,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200324.0,,CN,US,US,2020,Q1,Adult
175753771,17575377,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,Y,U, C938255F,,,10.0,IU,INJECTION,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20200310.0,20200312.0,20200324,20200324,EXP,,US-ELI_LILLY_AND_COMPANY-US202003006813,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200324.0,,CN,US,US,2020,Q1,Adult
175753771,17575377,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,Y,U, C938255F,,,10.0,IU,INJECTION,,2020,Q1,Malaise,,2020,Q1,1,I,20200310.0,20200312.0,20200324,20200324,EXP,,US-ELI_LILLY_AND_COMPANY-US202003006813,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200324.0,,CN,US,US,2020,Q1,Adult
175762681,17576268,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",23510.0,IU,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Bradyphrenia,,2020,Q1,1,I,20200203.0,20200318.0,20200324,20200324,EXP,IT-MINISAL02-611155,IT-SA-2020SA069547,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200324.0,,MD,IT,IT,2020,Q1,Adult
175762681,17576268,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",23510.0,IU,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Drug interaction,,2020,Q1,1,I,20200203.0,20200318.0,20200324,20200324,EXP,IT-MINISAL02-611155,IT-SA-2020SA069547,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200324.0,,MD,IT,IT,2020,Q1,Adult
175762681,17576268,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",23510.0,IU,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20200203.0,20200318.0,20200324,20200324,EXP,IT-MINISAL02-611155,IT-SA-2020SA069547,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200324.0,,MD,IT,IT,2020,Q1,Adult
175762681,17576268,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",23510.0,IU,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hypokinesia,,2020,Q1,1,I,20200203.0,20200318.0,20200324,20200324,EXP,IT-MINISAL02-611155,IT-SA-2020SA069547,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200324.0,,MD,IT,IT,2020,Q1,Adult
175762681,17576268,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",23510.0,IU,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Malaise,,2020,Q1,1,I,20200203.0,20200318.0,20200324,20200324,EXP,IT-MINISAL02-611155,IT-SA-2020SA069547,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200324.0,,MD,IT,IT,2020,Q1,Adult
175762681,17576268,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",23510.0,IU,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Sopor,,2020,Q1,1,I,20200203.0,20200318.0,20200324,20200324,EXP,IT-MINISAL02-611155,IT-SA-2020SA069547,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200324.0,,MD,IT,IT,2020,Q1,Adult
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Asthma,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Blood count abnormal,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Chest discomfort,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Cough,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Diaphragmatic disorder,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Discomfort,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Hypoxia,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Left ventricular hypertrophy,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Obstructive airways disorder,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Oropharyngeal pain,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Pyrexia,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Therapeutic product effect incomplete,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Weight increased,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175768731,17576873,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q1,Wheezing,,2020,Q1,1,I,,20200319.0,20200324,20200324,EXP,,CA-PFIZER INC-2020121973,PFIZER,,83.0,YR,,M,Y,100.0,KG,20200324.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Asthma,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Blood count abnormal,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Chest discomfort,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Cough,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Diaphragmatic disorder,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Discomfort,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Hypoxia,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Left ventricular hypertrophy,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Obstructive airways disorder,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Oropharyngeal pain,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Pyrexia,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Therapeutic product effect incomplete,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Weight increased,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175836041,17583604,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q1,Wheezing,,2020,Q1,1,I,,20200319.0,20200326,20200326,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2020-1506,ORION,,83.0,YR,,M,Y,100.0,KG,20200326.0,,CN,CA,CA,2020,Q1,Elderly
175848681,17584868,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood insulin abnormal,,2020,Q1,1,I,201908.0,20200319.0,20200326,20200326,EXP,,PT-SA-2020SA072050,SANOFI AVENTIS,"ROS?RIO F.,  FORTUNATO F.,  BRANCO P., ADRAG?O T.. A CASE OF HYPOGLYCEMIA THAT DEFIES DIAGNOSTIC ALGORITHMS - THE IMPORTANCE OF DETAILS. REVISTA PORTUGUESA DE DIABETES. 2020;15(1):86-93",43.0,YR,A,F,Y,,,20200326.0,,HP,PT,PT,2020,Q1,Adult
175848681,17584868,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,201908.0,20200319.0,20200326,20200326,EXP,,PT-SA-2020SA072050,SANOFI AVENTIS,"ROS?RIO F.,  FORTUNATO F.,  BRANCO P., ADRAG?O T.. A CASE OF HYPOGLYCEMIA THAT DEFIES DIAGNOSTIC ALGORITHMS - THE IMPORTANCE OF DETAILS. REVISTA PORTUGUESA DE DIABETES. 2020;15(1):86-93",43.0,YR,A,F,Y,,,20200326.0,,HP,PT,PT,2020,Q1,Adult
175848681,17584868,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,1,I,201908.0,20200319.0,20200326,20200326,EXP,,PT-SA-2020SA072050,SANOFI AVENTIS,"ROS?RIO F.,  FORTUNATO F.,  BRANCO P., ADRAG?O T.. A CASE OF HYPOGLYCEMIA THAT DEFIES DIAGNOSTIC ALGORITHMS - THE IMPORTANCE OF DETAILS. REVISTA PORTUGUESA DE DIABETES. 2020;15(1):86-93",43.0,YR,A,F,Y,,,20200326.0,,HP,PT,PT,2020,Q1,Adult
175848681,17584868,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,201908.0,20200319.0,20200326,20200326,EXP,,PT-SA-2020SA072050,SANOFI AVENTIS,"ROS?RIO F.,  FORTUNATO F.,  BRANCO P., ADRAG?O T.. A CASE OF HYPOGLYCEMIA THAT DEFIES DIAGNOSTIC ALGORITHMS - THE IMPORTANCE OF DETAILS. REVISTA PORTUGUESA DE DIABETES. 2020;15(1):86-93",43.0,YR,A,F,Y,,,20200326.0,,HP,PT,PT,2020,Q1,Adult
175848681,17584868,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Insulin C-peptide abnormal,,2020,Q1,1,I,201908.0,20200319.0,20200326,20200326,EXP,,PT-SA-2020SA072050,SANOFI AVENTIS,"ROS?RIO F.,  FORTUNATO F.,  BRANCO P., ADRAG?O T.. A CASE OF HYPOGLYCEMIA THAT DEFIES DIAGNOSTIC ALGORITHMS - THE IMPORTANCE OF DETAILS. REVISTA PORTUGUESA DE DIABETES. 2020;15(1):86-93",43.0,YR,A,F,Y,,,20200326.0,,HP,PT,PT,2020,Q1,Adult
175848681,17584868,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,1,I,201908.0,20200319.0,20200326,20200326,EXP,,PT-SA-2020SA072050,SANOFI AVENTIS,"ROS?RIO F.,  FORTUNATO F.,  BRANCO P., ADRAG?O T.. A CASE OF HYPOGLYCEMIA THAT DEFIES DIAGNOSTIC ALGORITHMS - THE IMPORTANCE OF DETAILS. REVISTA PORTUGUESA DE DIABETES. 2020;15(1):86-93",43.0,YR,A,F,Y,,,20200326.0,,HP,PT,PT,2020,Q1,Adult
175860181,17586018,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q1,Fatigue,,2020,Q1,1,I,20200320.0,20200322.0,20200326,20200326,EXP,,EG-ELI_LILLY_AND_COMPANY-EG202003011196,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20200326.0,,CN,EG,EG,2020,Q1,Adult
175860181,17586018,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20200320.0,20200322.0,20200326,20200326,EXP,,EG-ELI_LILLY_AND_COMPANY-EG202003011196,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20200326.0,,CN,EG,EG,2020,Q1,Adult
175860181,17586018,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,20200320.0,20200322.0,20200326,20200326,EXP,,EG-ELI_LILLY_AND_COMPANY-EG202003011196,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20200326.0,,CN,EG,EG,2020,Q1,Adult
175860181,17586018,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q1,Wrong technique in product usage process,,2020,Q1,1,I,20200320.0,20200322.0,20200326,20200326,EXP,,EG-ELI_LILLY_AND_COMPANY-EG202003011196,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20200326.0,,CN,EG,EG,2020,Q1,Adult
175860201,17586020,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 DOSAGE FORM, DAILY",,,,,,,20563.0,24.0,DF,,QD,2020,Q1,Hyperhidrosis,,2020,Q1,1,I,20200205.0,20200316.0,20200326,20200326,EXP,IT-MINISAL02-611410,IT-ELI_LILLY_AND_COMPANY-IT202003007658,ELI LILLY AND CO,,30.0,YR,,M,Y,,,20200326.0,,MD,IT,IT,2020,Q1,Young Adult
175860201,17586020,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 DOSAGE FORM, DAILY",,,,,,,20563.0,24.0,DF,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20200205.0,20200316.0,20200326,20200326,EXP,IT-MINISAL02-611410,IT-ELI_LILLY_AND_COMPANY-IT202003007658,ELI LILLY AND CO,,30.0,YR,,M,Y,,,20200326.0,,MD,IT,IT,2020,Q1,Young Adult
175860201,17586020,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 DOSAGE FORM, DAILY",,,,,,,20563.0,24.0,DF,,QD,2020,Q1,Malaise,,2020,Q1,1,I,20200205.0,20200316.0,20200326,20200326,EXP,IT-MINISAL02-611410,IT-ELI_LILLY_AND_COMPANY-IT202003007658,ELI LILLY AND CO,,30.0,YR,,M,Y,,,20200326.0,,MD,IT,IT,2020,Q1,Young Adult
175860201,17586020,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 DOSAGE FORM, DAILY",,,,,,,20563.0,24.0,DF,,QD,2020,Q1,Medication error,,2020,Q1,1,I,20200205.0,20200316.0,20200326,20200326,EXP,IT-MINISAL02-611410,IT-ELI_LILLY_AND_COMPANY-IT202003007658,ELI LILLY AND CO,,30.0,YR,,M,Y,,,20200326.0,,MD,IT,IT,2020,Q1,Young Adult
175860201,17586020,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 DOSAGE FORM, DAILY",,,,,,,20563.0,24.0,DF,,QD,2020,Q1,Tremor,,2020,Q1,1,I,20200205.0,20200316.0,20200326,20200326,EXP,IT-MINISAL02-611410,IT-ELI_LILLY_AND_COMPANY-IT202003007658,ELI LILLY AND CO,,30.0,YR,,M,Y,,,20200326.0,,MD,IT,IT,2020,Q1,Young Adult
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Asthma,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Blood count abnormal,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Chest discomfort,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Cough,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Diaphragmatic disorder,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Discomfort,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Hypoxia,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Left ventricular hypertrophy,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Obstructive airways disorder,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Oropharyngeal pain,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Pyrexia,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Therapeutic product effect incomplete,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Weight increased,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
175884871,17588487,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q1,Wheezing,,2020,Q1,1,I,,20200320.0,20200327,20200327,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200327.0,,CN,CA,CA,2020,Q1,Elderly
176000431,17600043,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17 IU, QD (10-3-4)",,,U,U,,,,17.0,IU,,QD,2020,Q1,Foetal growth restriction,,2020,Q1,1,I,,20200316.0,20200330,20200330,EXP,,JP-NOVOPROD-720218,NOVO NORDISK,"KEIKO OSUGI, ET AL.. A CASE OF PREGNANT WOMAN WITH PREEXISTING TYPE 2 DIABETES AND SEVERE DIABETIC NEPHROPATHY HAVING SAFELY GIVEN BIRTH BY MULTIDISCIPLINARY THERAPY. J. JAPAN DIAB. SOC.. 2020;63(1):35-40",39.0,YR,,F,Y,65.8,KG,20200330.0,,MD,JP,JP,2020,Q1,Adult
176000431,17600043,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17 IU, QD (10-3-4)",,,U,U,,,,17.0,IU,,QD,2020,Q1,Maternal exposure during pregnancy,,2020,Q1,1,I,,20200316.0,20200330,20200330,EXP,,JP-NOVOPROD-720218,NOVO NORDISK,"KEIKO OSUGI, ET AL.. A CASE OF PREGNANT WOMAN WITH PREEXISTING TYPE 2 DIABETES AND SEVERE DIABETIC NEPHROPATHY HAVING SAFELY GIVEN BIRTH BY MULTIDISCIPLINARY THERAPY. J. JAPAN DIAB. SOC.. 2020;63(1):35-40",39.0,YR,,F,Y,65.8,KG,20200330.0,,MD,JP,JP,2020,Q1,Adult
176000431,17600043,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17 IU, QD (10-3-4)",,,U,U,,,,17.0,IU,,QD,2020,Q1,Premature delivery,,2020,Q1,1,I,,20200316.0,20200330,20200330,EXP,,JP-NOVOPROD-720218,NOVO NORDISK,"KEIKO OSUGI, ET AL.. A CASE OF PREGNANT WOMAN WITH PREEXISTING TYPE 2 DIABETES AND SEVERE DIABETIC NEPHROPATHY HAVING SAFELY GIVEN BIRTH BY MULTIDISCIPLINARY THERAPY. J. JAPAN DIAB. SOC.. 2020;63(1):35-40",39.0,YR,,F,Y,65.8,KG,20200330.0,,MD,JP,JP,2020,Q1,Adult
176003491,17600349,3,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",656.0,IU,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Drug interaction,,2020,Q1,1,I,20200210.0,20200326.0,20200330,20200330,EXP,IT-MINISAL02-612384,IT-SA-2020SA077382,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
176003491,17600349,3,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",656.0,IU,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20200210.0,20200326.0,20200330,20200330,EXP,IT-MINISAL02-612384,IT-SA-2020SA077382,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
176003491,17600349,3,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",656.0,IU,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Paraesthesia,,2020,Q1,1,I,20200210.0,20200326.0,20200330,20200330,EXP,IT-MINISAL02-612384,IT-SA-2020SA077382,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
176003491,17600349,3,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",656.0,IU,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Tachycardia,,2020,Q1,1,I,20200210.0,20200326.0,20200330,20200330,EXP,IT-MINISAL02-612384,IT-SA-2020SA077382,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
176003491,17600349,4,I,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE REDUCED,656.0,IU,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Drug interaction,,2020,Q1,1,I,20200210.0,20200326.0,20200330,20200330,EXP,IT-MINISAL02-612384,IT-SA-2020SA077382,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
176003491,17600349,4,I,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE REDUCED,656.0,IU,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20200210.0,20200326.0,20200330,20200330,EXP,IT-MINISAL02-612384,IT-SA-2020SA077382,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
176003491,17600349,4,I,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE REDUCED,656.0,IU,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Paraesthesia,,2020,Q1,1,I,20200210.0,20200326.0,20200330,20200330,EXP,IT-MINISAL02-612384,IT-SA-2020SA077382,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
176003491,17600349,4,I,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE REDUCED,656.0,IU,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Tachycardia,,2020,Q1,1,I,20200210.0,20200326.0,20200330,20200330,EXP,IT-MINISAL02-612384,IT-SA-2020SA077382,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
176003511,17600351,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Accident,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Biliary colic,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cholelithiasis,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Fatigue,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gait disturbance,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hepatic pain,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Accident,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Biliary colic,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cholelithiasis,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Fatigue,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gait disturbance,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hepatic pain,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",,,U,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Accident,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",,,U,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Biliary colic,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",,,U,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",,,U,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cholelithiasis,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",,,U,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Fatigue,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",,,U,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gait disturbance,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",,,U,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hepatic pain,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Accident,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Biliary colic,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cholelithiasis,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Fatigue,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gait disturbance,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",,,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hepatic pain,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176017551,17601755,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U,,,,8.0,IU,INJECTION,,2020,Q1,Blood glucose decreased,,2020,Q1,1,I,202002.0,20200313.0,20200331,20200331,PER,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200331.0,,CN,US,US,2020,Q1,Elderly
176017551,17601755,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U,,,,8.0,IU,INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,202002.0,20200313.0,20200331,20200331,PER,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200331.0,,CN,US,US,2020,Q1,Elderly
176017551,17601755,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U,,,,8.0,IU,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,1,I,202002.0,20200313.0,20200331,20200331,PER,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200331.0,,CN,US,US,2020,Q1,Elderly
176017551,17601755,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U,,,,8.0,IU,INJECTION,,2020,Q1,Wrong product administered,,2020,Q1,1,I,202002.0,20200313.0,20200331,20200331,PER,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200331.0,,CN,US,US,2020,Q1,Elderly
176017551,17601755,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U, C939454C,,,8.0,IU,INJECTION,,2020,Q1,Blood glucose decreased,,2020,Q1,1,I,202002.0,20200313.0,20200331,20200331,PER,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200331.0,,CN,US,US,2020,Q1,Elderly
176017551,17601755,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U, C939454C,,,8.0,IU,INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,202002.0,20200313.0,20200331,20200331,PER,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200331.0,,CN,US,US,2020,Q1,Elderly
176017551,17601755,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U, C939454C,,,8.0,IU,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,1,I,202002.0,20200313.0,20200331,20200331,PER,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200331.0,,CN,US,US,2020,Q1,Elderly
176017551,17601755,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U, C939454C,,,8.0,IU,INJECTION,,2020,Q1,Wrong product administered,,2020,Q1,1,I,202002.0,20200313.0,20200331,20200331,PER,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200331.0,,CN,US,US,2020,Q1,Elderly
176052011,17605201,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Death,,2020,Q1,1,I,20180507.0,20200327.0,20200331,20200331,EXP,,CA-GILEAD-2020-0457038,GILEAD,,58.0,YR,A,M,Y,67.2,KG,20200331.0,,HP,CA,CA,2020,Q1,Adult
176052011,17605201,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,20180507.0,20200327.0,20200331,20200331,EXP,,CA-GILEAD-2020-0457038,GILEAD,,58.0,YR,A,M,Y,67.2,KG,20200331.0,,HP,CA,CA,2020,Q1,Adult
109982195,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2020,Q2,Diabetic coma,,2020,Q2,5,F,20050414.0,20200415.0,20150408,20200423,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20200423.0,,HP,US,US,2020,Q2,Adult
109982195,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2020,Q2,Myocardial infarction,,2020,Q2,5,F,20050414.0,20200415.0,20150408,20200423,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20200423.0,,HP,US,US,2020,Q2,Adult
109982195,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2020,Q2,Off label use,,2020,Q2,5,F,20050414.0,20200415.0,20150408,20200423,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20200423.0,,HP,US,US,2020,Q2,Adult
109982195,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2020,Q2,Product use in unapproved indication,,2020,Q2,5,F,20050414.0,20200415.0,20150408,20200423,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20200423.0,,HP,US,US,2020,Q2,Adult
109982195,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2020,Q2,Steroid diabetes,,2020,Q2,5,F,20050414.0,20200415.0,20150408,20200423,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20200423.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Abdominal pain,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Ammonia increased,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Anaemia,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Atelectasis,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Back pain,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Blood bilirubin increased,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Blood lactate dehydrogenase increased,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Bronchial wall thickening,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Cellulitis,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Chest pain,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Chills,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Compression fracture,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Confusional state,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Crying,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Deep vein thrombosis,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Dermatitis,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Dizziness,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Dyspnoea exertional,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Encephalopathy,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Erythema,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Faeces discoloured,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Fluid overload,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Gastric disorder,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Gastric polyps,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Gastric ulcer,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Gastrointestinal erosion,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Gastrointestinal mucosal disorder,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Haematocrit decreased,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Haemoglobin decreased,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Haemolysis,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Haemorrhage,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Haptoglobin decreased,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Hepatic encephalopathy,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Hospitalisation,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Hypervolaemia,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Hypothyroidism,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Internal haemorrhage,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Jaundice acholuric,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Malnutrition,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Melaena,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Mental status changes,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Occult blood positive,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Oedema,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Oxygen consumption increased,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Oxygen therapy,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Peripheral venous disease,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Pneumonia escherichia,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Portal hypertensive gastropathy,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Post thrombotic syndrome,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Pulmonary oedema,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Respiratory distress,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Rhinitis,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Rhonchi,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Right ventricular failure,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Septic shock,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Skin ulcer,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Somnolence,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Surgery,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Swelling,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Toxic encephalopathy,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Transfusion,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Upper gastrointestinal haemorrhage,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Varices oesophageal,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
1159927528,11599275,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Wound infection pseudomonas,,2020,Q2,28,F,201412.0,20200605.0,20151006,20200616,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200616.0,,HP,US,US,2020,Q2,Adult
116002992,11600299,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D142268A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,201406.0,20200427.0,20150916,20200506,PER,,US-ELI_LILLY_AND_COMPANY-US201407001045,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20200506.0,,CN,US,US,2020,Q2,Child
116002992,11600299,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D142268A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood ketone body,,2020,Q2,2,F,201406.0,20200427.0,20150916,20200506,PER,,US-ELI_LILLY_AND_COMPANY-US201407001045,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20200506.0,,CN,US,US,2020,Q2,Child
116002992,11600299,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D142268A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,2,F,201406.0,20200427.0,20150916,20200506,PER,,US-ELI_LILLY_AND_COMPANY-US201407001045,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20200506.0,,CN,US,US,2020,Q2,Child
119195564,11919556,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q2,Cerebral haemorrhage,,2020,Q2,4,F,20140429.0,20200611.0,20160115,20200623,EXP,,US-JNJFOC-20160100992,JOHNSON AND JOHNSON,,51.0,YR,,F,Y,,,20200623.0,,CN,US,US,2020,Q2,Adult
119195564,11919556,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q2,Fall,,2020,Q2,4,F,20140429.0,20200611.0,20160115,20200623,EXP,,US-JNJFOC-20160100992,JOHNSON AND JOHNSON,,51.0,YR,,F,Y,,,20200623.0,,CN,US,US,2020,Q2,Adult
119195564,11919556,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,4,F,20140429.0,20200611.0,20160115,20200623,EXP,,US-JNJFOC-20160100992,JOHNSON AND JOHNSON,,51.0,YR,,F,Y,,,20200623.0,,CN,US,US,2020,Q2,Adult
119378512,11937851,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Depression,,2020,Q2,2,F,20120115.0,20200520.0,20160122,20200525,EXP,,US-ASTRAZENECA-2016SE04367,ASTRAZENECA,,24451.0,DY,,M,Y,,,20200525.0,,,US,US,2020,Q2,Elderly
119378512,11937851,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pancreatic carcinoma,,2020,Q2,2,F,20120115.0,20200520.0,20160122,20200525,EXP,,US-ASTRAZENECA-2016SE04367,ASTRAZENECA,,24451.0,DY,,M,Y,,,20200525.0,,,US,US,2020,Q2,Elderly
119378512,11937851,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Suicidal ideation,,2020,Q2,2,F,20120115.0,20200520.0,20160122,20200525,EXP,,US-ASTRAZENECA-2016SE04367,ASTRAZENECA,,24451.0,DY,,M,Y,,,20200525.0,,,US,US,2020,Q2,Elderly
122860882,12286088,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2020,Q2,Cachexia,,2020,Q2,2,F,20140422.0,20200527.0,20160420,20200608,EXP,,US-NOVOPROD-488031,NOVO NORDISK,,62.0,YR,,F,Y,84.4,KG,20200608.0,,LW,US,US,2020,Q2,Adult
122860882,12286088,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2020,Q2,Pancreatic carcinoma metastatic,,2020,Q2,2,F,20140422.0,20200527.0,20160420,20200608,EXP,,US-NOVOPROD-488031,NOVO NORDISK,,62.0,YR,,F,Y,84.4,KG,20200608.0,,LW,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Acute respiratory distress syndrome,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Acute respiratory failure,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Anaemia,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Antimitochondrial antibody,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Antinuclear antibody increased,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Apraxia,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Arrhythmia supraventricular,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Atrial fibrillation,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Atrial flutter,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Blood alkaline phosphatase increased,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Blood creatinine increased,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Blood urea increased,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Buttock injury,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Clostridium difficile infection,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Condition aggravated,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Congestive hepatopathy,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Cor pulmonale acute,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Cough,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Deep vein thrombosis,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Dehydration,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Diarrhoea,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Dizziness,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Double stranded DNA antibody,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Dysphonia,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Dyspnoea,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Extrapyramidal disorder,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Eye disorder,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Eye movement disorder,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Hepatic ischaemia,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Hypotension,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Hypoxia,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,International normalised ratio increased,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Ischaemic hepatitis,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Leukocytosis,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Liver function test increased,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Metabolic acidosis,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Metabolic encephalopathy,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Oral candidiasis,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Pneumonia,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Polyneuropathy,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Pulmonary hypertension,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Pyrexia,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Renal failure,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Renal tubular necrosis,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Respiratory distress,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Respiratory tract infection,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Right ventricular failure,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Sepsis,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Septic shock,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Skin disorder,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Tachycardia,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Tachypnoea,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Thrombocytopenia,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Transaminases increased,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Transfusion,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Urinary tract infection,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Urine output decreased,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1250646511,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2020,Q2,Vasculitis,,2020,Q2,11,F,20160529.0,20200505.0,20160628,20200519,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,,F,Y,,,20200519.0,,MD,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Blood pressure abnormal,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Cardiomegaly,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Chest pain,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Cough,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Electrolyte imbalance,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Fall,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Fatigue,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Fluid overload,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Generalised oedema,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Headache,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Hepatomegaly,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Ligament sprain,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Liver injury,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Localised oedema,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Loss of consciousness,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Memory impairment,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Muscle spasms,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Nausea,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Oedema,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Pulmonary arterial hypertension,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Pulmonary oedema,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Swelling,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Vaginal haemorrhage,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
1274994213,12749942,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Weight increased,,2020,Q2,13,F,20160912.0,20200522.0,20160915,20200604,EXP,,US-ACTELION-A-US2016-142215,ACTELION,,43.0,YR,,F,Y,106.12,KG,20200604.0,,HP,US,US,2020,Q2,Adult
131918664,13191866,24,C,Lispro Insulin,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Pneumonia,,2020,Q2,4,F,20161111.0,20200406.0,20170207,20200416,EXP,,JP-CELGENEUS-JPN-2016114371,CELGENE,,72.0,YR,,M,Y,,,20200416.0,,MD,JP,JP,2020,Q2,Elderly
131918664,13191866,24,C,Lispro Insulin,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Pulmonary radiation injury,,2020,Q2,4,F,20161111.0,20200406.0,20170207,20200416,EXP,,JP-CELGENEUS-JPN-2016114371,CELGENE,,72.0,YR,,M,Y,,,20200416.0,,MD,JP,JP,2020,Q2,Elderly
131918664,13191866,24,C,Lispro Insulin,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Radiation pneumonitis,,2020,Q2,4,F,20161111.0,20200406.0,20170207,20200416,EXP,,JP-CELGENEUS-JPN-2016114371,CELGENE,,72.0,YR,,M,Y,,,20200416.0,,MD,JP,JP,2020,Q2,Elderly
134266778,13426677,14,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Hypercalcaemia,,2020,Q2,8,F,20170329.0,20200406.0,20170411,20200414,EXP,,JP-CELGENEUS-JPN-20170401659,CELGENE,,68.0,YR,,M,Y,,,20200414.0,,MD,JP,JP,2020,Q2,Elderly
137567112,13756711,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,U,,,,,1.0,DF,,BID,2020,Q2,Caesarean section,,2020,Q2,2,F,,20170703.0,20170714,20200410,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-061904,BRISTOL MYERS SQUIBB,,25.0,YR,,F,Y,130.0,KG,20200410.0,,MD,US,US,2020,Q2,Young Adult
137567112,13756711,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,U,,,,,1.0,DF,,BID,2020,Q2,Diabetic ketoacidosis,,2020,Q2,2,F,,20170703.0,20170714,20200410,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-061904,BRISTOL MYERS SQUIBB,,25.0,YR,,F,Y,130.0,KG,20200410.0,,MD,US,US,2020,Q2,Young Adult
137567112,13756711,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,U,,,,,1.0,DF,,BID,2020,Q2,Gestational hypertension,,2020,Q2,2,F,,20170703.0,20170714,20200410,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-061904,BRISTOL MYERS SQUIBB,,25.0,YR,,F,Y,130.0,KG,20200410.0,,MD,US,US,2020,Q2,Young Adult
137567112,13756711,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,U,,,,,1.0,DF,,BID,2020,Q2,Intentional product use issue,,2020,Q2,2,F,,20170703.0,20170714,20200410,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-061904,BRISTOL MYERS SQUIBB,,25.0,YR,,F,Y,130.0,KG,20200410.0,,MD,US,US,2020,Q2,Young Adult
137567112,13756711,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,U,,,,,1.0,DF,,BID,2020,Q2,Maternal exposure before pregnancy,,2020,Q2,2,F,,20170703.0,20170714,20200410,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-061904,BRISTOL MYERS SQUIBB,,25.0,YR,,F,Y,130.0,KG,20200410.0,,MD,US,US,2020,Q2,Young Adult
137567112,13756711,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,U,,,,,1.0,DF,,BID,2020,Q2,Maternal exposure during pregnancy,,2020,Q2,2,F,,20170703.0,20170714,20200410,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-061904,BRISTOL MYERS SQUIBB,,25.0,YR,,F,Y,130.0,KG,20200410.0,,MD,US,US,2020,Q2,Young Adult
137567112,13756711,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,U,,,,,1.0,DF,,BID,2020,Q2,Pre-eclampsia,,2020,Q2,2,F,,20170703.0,20170714,20200410,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-061904,BRISTOL MYERS SQUIBB,,25.0,YR,,F,Y,130.0,KG,20200410.0,,MD,US,US,2020,Q2,Young Adult
137567112,13756711,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,U,,,,,1.0,DF,,BID,2020,Q2,Premature delivery,,2020,Q2,2,F,,20170703.0,20170714,20200410,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-061904,BRISTOL MYERS SQUIBB,,25.0,YR,,F,Y,130.0,KG,20200410.0,,MD,US,US,2020,Q2,Young Adult
137584333,13758433,13,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDONG SCALE)",,,,, C999324C,,,8.0,IU,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,3,F,20170613.0,20200528.0,20170717,20200603,PER,,US-ELI_LILLY_AND_COMPANY-US201706011831,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20200603.0,,CN,US,US,2020,Q2,Adult
137584333,13758433,13,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDONG SCALE)",,,,, C999324C,,,8.0,IU,INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,3,F,20170613.0,20200528.0,20170717,20200603,PER,,US-ELI_LILLY_AND_COMPANY-US201706011831,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20200603.0,,CN,US,US,2020,Q2,Adult
137584333,13758433,13,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDONG SCALE)",,,,, C999324C,,,8.0,IU,INJECTION,,2020,Q2,Product storage error,,2020,Q2,3,F,20170613.0,20200528.0,20170717,20200603,PER,,US-ELI_LILLY_AND_COMPANY-US201706011831,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20200603.0,,CN,US,US,2020,Q2,Adult
138427532,13842753,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pancreatic carcinoma,,2020,Q2,2,F,20121228.0,20200528.0,20170808,20200603,EXP,,US-ASTRAZENECA-2017SE78985,ASTRAZENECA,,18173.0,DY,,M,Y,99.8,KG,20200603.0,,,US,US,2020,Q2,Elderly
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Arthralgia,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Drug ineffective,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Gait disturbance,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Hepatic enzyme increased,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Musculoskeletal stiffness,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Peripheral swelling,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Pharyngitis,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Poor venous access,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Pruritus,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Swelling,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Therapeutic response decreased,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Tremor,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
139032259,13903225,9,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,D,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,9,F,,20200505.0,20170824,20200512,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20200512.0,,CN,CA,CA,2020,Q2,Adult
142018653,14201865,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,40 DF,,,U,,,,,40.0,DF,,,2020,Q2,Chest pain,,2020,Q2,3,F,20171005.0,20200421.0,20171117,20200427,EXP,GB-MHRA-ADR 24260280,GB-SA-2017SA196948,SANOFI AVENTIS,,30.0,YR,A,F,Y,,,20200427.0,,CN,GB,GB,2020,Q2,Young Adult
142018653,14201865,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,40 DF,,,U,,,,,40.0,DF,,,2020,Q2,Electrocardiogram T wave inversion,,2020,Q2,3,F,20171005.0,20200421.0,20171117,20200427,EXP,GB-MHRA-ADR 24260280,GB-SA-2017SA196948,SANOFI AVENTIS,,30.0,YR,A,F,Y,,,20200427.0,,CN,GB,GB,2020,Q2,Young Adult
143103442,14310344,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q2,Pancreatic neuroendocrine tumour,,2020,Q2,2,F,20150505.0,20200605.0,20171220,20200616,EXP,,US-NOVOPROD-577379,NOVO NORDISK,,49.0,YR,,M,Y,127.44,KG,20200617.0,,LW,US,US,2020,Q2,Adult
1455403312,14554033,26,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Diarrhoea,,2020,Q2,12,F,20180211.0,20200430.0,20180220,20200504,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20200504.0,,HP,CA,CA,2020,Q2,Elderly
1455403312,14554033,26,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Klebsiella infection,,2020,Q2,12,F,20180211.0,20200430.0,20180220,20200504,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20200504.0,,HP,CA,CA,2020,Q2,Elderly
1455403312,14554033,26,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Pneumonia,,2020,Q2,12,F,20180211.0,20200430.0,20180220,20200504,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20200504.0,,HP,CA,CA,2020,Q2,Elderly
1455403312,14554033,26,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Sepsis,,2020,Q2,12,F,20180211.0,20200430.0,20180220,20200504,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20200504.0,,HP,CA,CA,2020,Q2,Elderly
1455403312,14554033,26,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Septic shock,,2020,Q2,12,F,20180211.0,20200430.0,20180220,20200504,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20200504.0,,HP,CA,CA,2020,Q2,Elderly
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Asthenia,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Blood magnesium decreased,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Blood potassium increased,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Chest discomfort,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Dizziness,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Flank pain,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Fluid retention,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Headache,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Hypokalaemia,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Hypovolaemia,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Malaise,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Mental status changes,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Nausea,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Nephrolithiasis,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Oxygen saturation decreased,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Paraesthesia oral,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Presyncope,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Productive cough,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Pulmonary arterial hypertension,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Sinusitis,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Urinary tract infection,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,Viral infection,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
148071929,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2020,Q2,White blood cell count increased,,2020,Q2,9,F,20170105.0,20200423.0,20180425,20200507,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20200507.0,,HP,US,US,2020,Q2,Adult
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Acute kidney injury,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Adrenomegaly,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Blood pressure increased,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Chest pain,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Colitis,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Device related infection,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Dyspnoea,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Heparin-induced thrombocytopenia,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Hyperglycaemia,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Hypertensive crisis,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Klebsiella infection,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Malignant neoplasm progression,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Meningitis,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Metastases to meninges,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Pulmonary oedema,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Retinal detachment,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Tachycardia,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
1549343215,15493432,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q2,Urosepsis,,2020,Q2,15,F,20180419.0,20200608.0,20181012,20200615,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
157011552,15701155,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Medication error,,2020,Q2,2,F,20180827.0,20200427.0,20181207,20200429,EXP,,PHHY2018IT110706,NOVARTIS,,89.0,YR,,M,Y,,,20200429.0,,HP,IT,IT,2020,Q2,Elderly
157011552,15701155,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Sinus bradycardia,,2020,Q2,2,F,20180827.0,20200427.0,20181207,20200429,EXP,,PHHY2018IT110706,NOVARTIS,,89.0,YR,,M,Y,,,20200429.0,,HP,IT,IT,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Arthritis,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Blood pressure increased,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Brain natriuretic peptide abnormal,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Disease progression,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Fall,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Haemoglobin decreased,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Headache,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Pericardial effusion,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Pulmonary arterial hypertension,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Rib fracture,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Scratch,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Syncope,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Tachycardia,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
158146892,15814689,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cerebrovascular accident,,2020,Q2,2,F,20180613.0,20200514.0,20190111,20200521,EXP,,US-GILEAD-2018-0345555,GILEAD,,57.0,YR,A,M,Y,105.0,KG,20200521.0,,MD,US,US,2020,Q2,Adult
158146892,15814689,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Deep vein thrombosis,,2020,Q2,2,F,20180613.0,20200514.0,20190111,20200521,EXP,,US-GILEAD-2018-0345555,GILEAD,,57.0,YR,A,M,Y,105.0,KG,20200521.0,,MD,US,US,2020,Q2,Adult
159570436,15957043,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Infusion related reaction,,2020,Q2,6,F,20190129.0,20200520.0,20190213,20200526,EXP,,TR-ROCHE-2261674,ROCHE,,66.0,YR,,M,Y,71.0,KG,20200526.0,,MD,TR,TR,2020,Q2,Elderly
159570436,15957043,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Polyneuropathy,,2020,Q2,6,F,20190129.0,20200520.0,20190213,20200526,EXP,,TR-ROCHE-2261674,ROCHE,,66.0,YR,,M,Y,71.0,KG,20200526.0,,MD,TR,TR,2020,Q2,Elderly
159868784,15986878,45,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,4,F,20161207.0,20200505.0,20190220,20200513,EXP,,US-ASTRAZENECA-2018SF47921,ASTRAZENECA,,18303.0,DY,,M,Y,81.6,KG,20200513.0,,,US,US,2020,Q2,Elderly
159868784,15986878,45,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Chronic kidney disease,,2020,Q2,4,F,20161207.0,20200505.0,20190220,20200513,EXP,,US-ASTRAZENECA-2018SF47921,ASTRAZENECA,,18303.0,DY,,M,Y,81.6,KG,20200513.0,,,US,US,2020,Q2,Elderly
159868784,15986878,45,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,4,F,20161207.0,20200505.0,20190220,20200513,EXP,,US-ASTRAZENECA-2018SF47921,ASTRAZENECA,,18303.0,DY,,M,Y,81.6,KG,20200513.0,,,US,US,2020,Q2,Elderly
159868784,15986878,45,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal injury,,2020,Q2,4,F,20161207.0,20200505.0,20190220,20200513,EXP,,US-ASTRAZENECA-2018SF47921,ASTRAZENECA,,18303.0,DY,,M,Y,81.6,KG,20200513.0,,,US,US,2020,Q2,Elderly
159904853,15990485,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, BID (IN THE MORNING AND AT NIGHT)",,,,,,,20563.0,12.0,IU,,BID,2020,Q2,Diabetes mellitus,,2020,Q2,3,F,,20200515.0,20190221,20200527,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201902008422,ELI LILLY AND CO,,61.0,YR,,F,Y,80.0,KG,20200527.0,,CN,CN,CN,2020,Q2,Adult
159904853,15990485,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, BID (IN THE MORNING AND AT NIGHT)",,,,,,,20563.0,12.0,IU,,BID,2020,Q2,Oedema,,2020,Q2,3,F,,20200515.0,20190221,20200527,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201902008422,ELI LILLY AND CO,,61.0,YR,,F,Y,80.0,KG,20200527.0,,CN,CN,CN,2020,Q2,Adult
159904853,15990485,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, BID (IN THE MORNING AND AT NIGHT)",,,,,,,20563.0,12.0,IU,,BID,2020,Q2,Renal disorder,,2020,Q2,3,F,,20200515.0,20190221,20200527,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201902008422,ELI LILLY AND CO,,61.0,YR,,F,Y,80.0,KG,20200527.0,,CN,CN,CN,2020,Q2,Adult
159904853,15990485,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, BID (IN THE MORNING AND AT NIGHT)",,,,,,,20563.0,12.0,IU,,BID,2020,Q2,Swelling,,2020,Q2,3,F,,20200515.0,20190221,20200527,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201902008422,ELI LILLY AND CO,,61.0,YR,,F,Y,80.0,KG,20200527.0,,CN,CN,CN,2020,Q2,Adult
160129553,16012955,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,3,F,2011.0,20200403.0,20190227,20200406,EXP,,US-PFIZER INC-2019088083,PFIZER,,60.0,YR,,M,Y,,,20200406.0,,LW,US,US,2020,Q2,Adult
160129553,16012955,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Chronic kidney disease,,2020,Q2,3,F,2011.0,20200403.0,20190227,20200406,EXP,,US-PFIZER INC-2019088083,PFIZER,,60.0,YR,,M,Y,,,20200406.0,,LW,US,US,2020,Q2,Adult
160129553,16012955,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,End stage renal disease,,2020,Q2,3,F,2011.0,20200403.0,20190227,20200406,EXP,,US-PFIZER INC-2019088083,PFIZER,,60.0,YR,,M,Y,,,20200406.0,,LW,US,US,2020,Q2,Adult
160344644,16034464,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Dementia,,2020,Q2,4,F,,20200604.0,20190305,20200608,EXP,,US-PFIZER INC-2016521477,PFIZER,,81.0,YR,,F,Y,80.73,KG,20200608.0,,CN,US,US,2020,Q2,Elderly
160344644,16034464,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,4,F,,20200604.0,20190305,20200608,EXP,,US-PFIZER INC-2016521477,PFIZER,,81.0,YR,,F,Y,80.73,KG,20200608.0,,CN,US,US,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Arrhythmia,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Atrial fibrillation,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Bradycardia,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Dehydration,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Dizziness,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Haematocrit increased,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Haemoglobin increased,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Hypotension,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Hypovolaemia,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Left atrial dilatation,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Mucosal dryness,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Presyncope,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Pulmonary congestion,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Renal disorder,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Skin disorder,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Syncope,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Arrhythmia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Atrial fibrillation,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Bradycardia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Dehydration,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Dizziness,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Haematocrit increased,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Haemoglobin increased,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Heart rate irregular,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Hypovolaemia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Left atrial dilatation,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Mucosal dryness,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Presyncope,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Pulmonary congestion,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Renal disorder,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Skin disorder,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,D,,,,,,,,,2020,Q2,Syncope,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Abdominal pain,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Acute kidney injury,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Anaemia,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Back pain,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Candida infection,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Chondrocalcinosis pyrophosphate,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Chronic kidney disease,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Diarrhoea,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Dyspnoea,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Flank pain,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Hydronephrosis,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Hyperkalaemia,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Hypomagnesaemia,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Infection,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Melaena,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Nephrolithiasis,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Pyelonephritis,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Pyuria,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Sepsis,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Syncope,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Ureterolithiasis,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Urinary tract infection,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
1615902922,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2020,Q2,Vomiting,,2020,Q2,22,F,20190102.0,20200413.0,20190404,20200420,EXP,,PHHO2019US000774,NOVARTIS,,51.0,YR,,M,Y,95.8,KG,20200420.0,,HP,US,US,2020,Q2,Adult
161997668,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Cutaneous sarcoidosis,,2020,Q2,8,F,20190404.0,20200418.0,20190415,20200422,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200422.0,,HP,BR,BR,2020,Q2,Elderly
161997668,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Epiglottic oedema,,2020,Q2,8,F,20190404.0,20200418.0,20190415,20200422,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200422.0,,HP,BR,BR,2020,Q2,Elderly
161997668,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Sarcoidosis,,2020,Q2,8,F,20190404.0,20200418.0,20190415,20200422,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200422.0,,HP,BR,BR,2020,Q2,Elderly
162204833,16220483,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,3,F,20181116.0,20200413.0,20190421,20200420,PER,,US-JNJFOC-20190411774,JOHNSON AND JOHNSON,,77.0,YR,,M,Y,77.18,KG,20200420.0,,HP,US,US,2020,Q2,Elderly
162204833,16220483,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,3,F,20181116.0,20200413.0,20190421,20200420,PER,,US-JNJFOC-20190411774,JOHNSON AND JOHNSON,,77.0,YR,,M,Y,77.18,KG,20200420.0,,HP,US,US,2020,Q2,Elderly
162204833,16220483,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Increased tendency to bruise,,2020,Q2,3,F,20181116.0,20200413.0,20190421,20200420,PER,,US-JNJFOC-20190411774,JOHNSON AND JOHNSON,,77.0,YR,,M,Y,77.18,KG,20200420.0,,HP,US,US,2020,Q2,Elderly
162204833,16220483,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Off label use,,2020,Q2,3,F,20181116.0,20200413.0,20190421,20200420,PER,,US-JNJFOC-20190411774,JOHNSON AND JOHNSON,,77.0,YR,,M,Y,77.18,KG,20200420.0,,HP,US,US,2020,Q2,Elderly
162234072,16223407,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, SINGLE",,,,,,,,,,,,2020,Q2,Back pain,,2020,Q2,2,F,,20200520.0,20190422,20200521,EXP,,US-PFIZER INC-2019169167,PFIZER,,36.0,YR,,M,Y,101.2,KG,20200521.0,,HP,US,US,2020,Q2,Adult
162234072,16223407,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, SINGLE",,,,,,,,,,,,2020,Q2,Off label use,,2020,Q2,2,F,,20200520.0,20190422,20200521,EXP,,US-PFIZER INC-2019169167,PFIZER,,36.0,YR,,M,Y,101.2,KG,20200521.0,,HP,US,US,2020,Q2,Adult
162234072,16223407,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, SINGLE",,,,,,,,,,,,2020,Q2,Product prescribing issue,,2020,Q2,2,F,,20200520.0,20190422,20200521,EXP,,US-PFIZER INC-2019169167,PFIZER,,36.0,YR,,M,Y,101.2,KG,20200521.0,,HP,US,US,2020,Q2,Adult
162234072,16223407,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, SINGLE",,,,,,,,,,,,2020,Q2,Product use in unapproved indication,,2020,Q2,2,F,,20200520.0,20190422,20200521,EXP,,US-PFIZER INC-2019169167,PFIZER,,36.0,YR,,M,Y,101.2,KG,20200521.0,,HP,US,US,2020,Q2,Adult
163316552,16331655,17,C,Insulin Lispro Dci,,2,Oral,6 UNITS DAILY 3 TIMES BEFORE MEAL,,,,,,,,,,,,2020,Q2,Seizure,,2020,Q2,2,F,20181217.0,20190624.0,20190520,20200513,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011659,ACADIA PHARMACEUTICALS,,77.0,YR,,F,Y,68.0,KG,20200513.0,,HP,US,US,2020,Q2,Elderly
163316552,16331655,17,C,Insulin Lispro Dci,,2,Oral,6 UNITS DAILY 3 TIMES BEFORE MEAL,,,,,,,,,,,,2020,Q2,Urinary tract infection,,2020,Q2,2,F,20181217.0,20190624.0,20190520,20200513,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011659,ACADIA PHARMACEUTICALS,,77.0,YR,,F,Y,68.0,KG,20200513.0,,HP,US,US,2020,Q2,Elderly
163881484,16388148,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-10 UNITS,,,,,,,,,,,,2020,Q2,Bacteraemia,,2020,Q2,4,F,20180206.0,20200602.0,20190604,20200615,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,93.3,KG,20200615.0,,MD,US,US,2020,Q2,Elderly
163881484,16388148,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-10 UNITS,,,,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,4,F,20180206.0,20200602.0,20190604,20200615,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,93.3,KG,20200615.0,,MD,US,US,2020,Q2,Elderly
163881484,16388148,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-10 UNITS,,,,,,,,,,,,2020,Q2,Vascular device infection,,2020,Q2,4,F,20180206.0,20200602.0,20190604,20200615,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,93.3,KG,20200615.0,,MD,US,US,2020,Q2,Elderly
164320522,16432052,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Anhedonia,,2020,Q2,2,F,201802.0,20200320.0,20190614,20200415,EXP,,US-GILEAD-2019-0412940,GILEAD,,60.0,YR,A,M,Y,,,20200415.0,,LW,US,US,2020,Q2,Adult
164320522,16432052,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Anxiety,,2020,Q2,2,F,201802.0,20200320.0,20190614,20200415,EXP,,US-GILEAD-2019-0412940,GILEAD,,60.0,YR,A,M,Y,,,20200415.0,,LW,US,US,2020,Q2,Adult
164320522,16432052,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Chronic kidney disease,,2020,Q2,2,F,201802.0,20200320.0,20190614,20200415,EXP,,US-GILEAD-2019-0412940,GILEAD,,60.0,YR,A,M,Y,,,20200415.0,,LW,US,US,2020,Q2,Adult
164320522,16432052,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Economic problem,,2020,Q2,2,F,201802.0,20200320.0,20190614,20200415,EXP,,US-GILEAD-2019-0412940,GILEAD,,60.0,YR,A,M,Y,,,20200415.0,,LW,US,US,2020,Q2,Adult
164320522,16432052,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Emotional distress,,2020,Q2,2,F,201802.0,20200320.0,20190614,20200415,EXP,,US-GILEAD-2019-0412940,GILEAD,,60.0,YR,A,M,Y,,,20200415.0,,LW,US,US,2020,Q2,Adult
164320522,16432052,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,End stage renal disease,,2020,Q2,2,F,201802.0,20200320.0,20190614,20200415,EXP,,US-GILEAD-2019-0412940,GILEAD,,60.0,YR,A,M,Y,,,20200415.0,,LW,US,US,2020,Q2,Adult
164320522,16432052,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pain,,2020,Q2,2,F,201802.0,20200320.0,20190614,20200415,EXP,,US-GILEAD-2019-0412940,GILEAD,,60.0,YR,A,M,Y,,,20200415.0,,LW,US,US,2020,Q2,Adult
164320522,16432052,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,2,F,201802.0,20200320.0,20190614,20200415,EXP,,US-GILEAD-2019-0412940,GILEAD,,60.0,YR,A,M,Y,,,20200415.0,,LW,US,US,2020,Q2,Adult
167532692,16753269,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C999324C,,,,,INJECTION,,2020,Q2,Accidental underdose,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C999324C,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C999324C,,,,,INJECTION,,2020,Q2,Product dose omission,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C999324C,,,,,INJECTION,,2020,Q2,Accidental underdose,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C999324C,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C999324C,,,,,INJECTION,,2020,Q2,Product dose omission,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2020,Q2,Accidental underdose,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2020,Q2,Product dose omission,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2020,Q2,Accidental underdose,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2020,Q2,Product dose omission,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q2,Accidental underdose,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q2,Product dose omission,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q2,Accidental underdose,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q2,Product dose omission,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q2,Accidental underdose,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
167532692,16753269,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q2,Product dose omission,,2020,Q2,2,F,20200530.0,20200601.0,20190829,20200619,PER,,US-ELI_LILLY_AND_COMPANY-US201908012549,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200619.0,,PH,US,US,2020,Q2,Elderly
168225663,16822566,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (100 UNIT/ML; DIRECTED PER SLIDING SCALE, 4-0-10)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Depression,,2020,Q2,3,F,,20200403.0,20190918,20200408,PER,,US-PFIZER INC-2015330930,PFIZER,,45.0,YR,,F,Y,61.22,KG,20200408.0,,HP,US,US,2020,Q2,Adult
168225663,16822566,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, DAILY, (USE CARB RATIO 1:10 BREAKFAST 1:7 LUNCH AND DINNER PLUS SLIDING SCALE OF 1:50}150)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Depression,,2020,Q2,3,F,,20200403.0,20190918,20200408,PER,,US-PFIZER INC-2015330930,PFIZER,,45.0,YR,,F,Y,61.22,KG,20200408.0,,HP,US,US,2020,Q2,Adult
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Arthritis,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Blood pressure increased,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Brain natriuretic peptide abnormal,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Disease progression,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Fall,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Haemoglobin decreased,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Headache,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Pericardial effusion,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Pulmonary arterial hypertension,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Rib fracture,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Scratch,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Syncope,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Tachycardia,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169315998,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,8,F,201803.0,20200501.0,20191017,20200511,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200511.0,,CN,US,US,2020,Q2,Elderly
169315998,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q2,Bursitis infective,,2020,Q2,8,F,201803.0,20200501.0,20191017,20200511,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200511.0,,CN,US,US,2020,Q2,Elderly
169315998,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q2,Cardiac operation,,2020,Q2,8,F,201803.0,20200501.0,20191017,20200511,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200511.0,,CN,US,US,2020,Q2,Elderly
169315998,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q2,Coronary artery stenosis,,2020,Q2,8,F,201803.0,20200501.0,20191017,20200511,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200511.0,,CN,US,US,2020,Q2,Elderly
169315998,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q2,Haemarthrosis,,2020,Q2,8,F,201803.0,20200501.0,20191017,20200511,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200511.0,,CN,US,US,2020,Q2,Elderly
169315998,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q2,Haematoma,,2020,Q2,8,F,201803.0,20200501.0,20191017,20200511,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200511.0,,CN,US,US,2020,Q2,Elderly
169315998,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q2,Haemorrhage,,2020,Q2,8,F,201803.0,20200501.0,20191017,20200511,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200511.0,,CN,US,US,2020,Q2,Elderly
169315998,16931599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2020,Q2,Neuralgia,,2020,Q2,8,F,201803.0,20200501.0,20191017,20200511,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20200511.0,,CN,US,US,2020,Q2,Elderly
169356413,16935641,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNIT/ML, TID",,,,,,,,,,,,2020,Q2,Psychotic disorder,,2020,Q2,3,F,20190922.0,20200409.0,20191018,20200415,EXP,,US-VERTEX PHARMACEUTICALS-2019-009932,VERTEX,,40.0,YR,,M,Y,57.0,KG,20200415.0,,MD,US,US,2020,Q2,Adult
169363908,16936390,20,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,UNKNOWN,,2020,Q2,Blood glucose increased,,2020,Q2,8,F,201803.0,20200501.0,20191018,20200512,EXP,,US-JNJFOC-20191015451,JOHNSON AND JOHNSON,,77.0,YR,,F,Y,77.18,KG,20200512.0,,CN,US,US,2020,Q2,Elderly
169363908,16936390,20,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,UNKNOWN,,2020,Q2,Bursitis infective,,2020,Q2,8,F,201803.0,20200501.0,20191018,20200512,EXP,,US-JNJFOC-20191015451,JOHNSON AND JOHNSON,,77.0,YR,,F,Y,77.18,KG,20200512.0,,CN,US,US,2020,Q2,Elderly
169363908,16936390,20,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,UNKNOWN,,2020,Q2,Cardiac operation,,2020,Q2,8,F,201803.0,20200501.0,20191018,20200512,EXP,,US-JNJFOC-20191015451,JOHNSON AND JOHNSON,,77.0,YR,,F,Y,77.18,KG,20200512.0,,CN,US,US,2020,Q2,Elderly
169363908,16936390,20,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,UNKNOWN,,2020,Q2,Coronary artery occlusion,,2020,Q2,8,F,201803.0,20200501.0,20191018,20200512,EXP,,US-JNJFOC-20191015451,JOHNSON AND JOHNSON,,77.0,YR,,F,Y,77.18,KG,20200512.0,,CN,US,US,2020,Q2,Elderly
169363908,16936390,20,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,UNKNOWN,,2020,Q2,Haemarthrosis,,2020,Q2,8,F,201803.0,20200501.0,20191018,20200512,EXP,,US-JNJFOC-20191015451,JOHNSON AND JOHNSON,,77.0,YR,,F,Y,77.18,KG,20200512.0,,CN,US,US,2020,Q2,Elderly
169363908,16936390,20,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,UNKNOWN,,2020,Q2,Haematoma,,2020,Q2,8,F,201803.0,20200501.0,20191018,20200512,EXP,,US-JNJFOC-20191015451,JOHNSON AND JOHNSON,,77.0,YR,,F,Y,77.18,KG,20200512.0,,CN,US,US,2020,Q2,Elderly
169363908,16936390,20,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,UNKNOWN,,2020,Q2,Haemorrhage,,2020,Q2,8,F,201803.0,20200501.0,20191018,20200512,EXP,,US-JNJFOC-20191015451,JOHNSON AND JOHNSON,,77.0,YR,,F,Y,77.18,KG,20200512.0,,CN,US,US,2020,Q2,Elderly
169363908,16936390,20,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,UNKNOWN,,2020,Q2,Neuralgia,,2020,Q2,8,F,201803.0,20200501.0,20191018,20200512,EXP,,US-JNJFOC-20191015451,JOHNSON AND JOHNSON,,77.0,YR,,F,Y,77.18,KG,20200512.0,,CN,US,US,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Blood creatinine increased,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Cardiac arrest,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Cardio-respiratory arrest,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Diarrhoea,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Disorientation,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Extremity necrosis,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Gait disturbance,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Hypoglycaemia,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Hypotension,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Immunosuppressant drug level decreased,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Impaired healing,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Limb injury,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Localised infection,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Loss of consciousness,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Myocardial ischaemia,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Pain in extremity,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Pyrexia,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Renal disorder,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Seizure,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Sepsis,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Syncope,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
169687624,16968762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2020,Q2,Thyroid hormones increased,,2020,Q2,4,F,2019.0,20200605.0,20191029,20200617,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20200617.0,,CN,CO,CO,2020,Q2,Elderly
1696951023,16969510,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,12.0,DF,INJECTION,,2020,Q2,Heart injury,,2020,Q2,23,F,20191021.0,20200427.0,20191029,20200430,EXP,,CN-EISAI MEDICAL RESEARCH-EC-2019-064326,EISAI,,62.0,YR,A,M,Y,69.0,KG,20200430.0,,MD,CN,CN,2020,Q2,Adult
171208652,17120865,2,C,Insulin lispro,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2020,Q2,Drug ineffective,,2020,Q2,2,F,,20170519.0,20191206,20200528,PER,,US-UCBSA-2017020347,UCB,,45.0,YR,,M,Y,,,20200528.0,,HP,US,US,2020,Q2,Adult
171730313,17173031,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0.5-14 IU,,,,,,,,,,,,2020,Q2,Septic shock,,2020,Q2,3,F,20191210.0,20200513.0,20191218,20200520,EXP,,US-ABBVIE-19P-163-3191358-00,ABBVIE,,16.0,YR,,M,Y,70.0,KG,20200520.0,,MD,US,US,2020,Q2,Youth
172021393,17202139,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,3,F,20191214.0,20200430.0,20191226,20200504,EXP,,US-PFIZER INC-2019552689,PFIZER,,65.0,YR,,F,Y,,,20200504.0,,MD,US,US,2020,Q2,Elderly
172021393,17202139,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Hot flush,,2020,Q2,3,F,20191214.0,20200430.0,20191226,20200504,EXP,,US-PFIZER INC-2019552689,PFIZER,,65.0,YR,,F,Y,,,20200504.0,,MD,US,US,2020,Q2,Elderly
172021393,17202139,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,3,F,20191214.0,20200430.0,20191226,20200504,EXP,,US-PFIZER INC-2019552689,PFIZER,,65.0,YR,,F,Y,,,20200504.0,,MD,US,US,2020,Q2,Elderly
172021393,17202139,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Syncope,,2020,Q2,3,F,20191214.0,20200430.0,20191226,20200504,EXP,,US-PFIZER INC-2019552689,PFIZER,,65.0,YR,,F,Y,,,20200504.0,,MD,US,US,2020,Q2,Elderly
172021393,17202139,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,White blood cell count decreased,,2020,Q2,3,F,20191214.0,20200430.0,20191226,20200504,EXP,,US-PFIZER INC-2019552689,PFIZER,,65.0,YR,,F,Y,,,20200504.0,,MD,US,US,2020,Q2,Elderly
172388882,17238888,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q2,Injection site pain,,2020,Q2,2,F,,20200318.0,20200106,20200406,PER,,US-SA-2020SA001966,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200406.0,,CN,US,US,2020,Q2,Elderly
172575964,17257596,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Bone pain,,2020,Q2,4,F,202001.0,20200608.0,20200110,20200610,EXP,,US-PFIZER INC-2020010150,PFIZER,,58.0,YR,,F,Y,,,20200610.0,,CN,US,US,2020,Q2,Adult
172575964,17257596,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,4,F,202001.0,20200608.0,20200110,20200610,EXP,,US-PFIZER INC-2020010150,PFIZER,,58.0,YR,,F,Y,,,20200610.0,,CN,US,US,2020,Q2,Adult
172575964,17257596,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Haemorrhage,,2020,Q2,4,F,202001.0,20200608.0,20200110,20200610,EXP,,US-PFIZER INC-2020010150,PFIZER,,58.0,YR,,F,Y,,,20200610.0,,CN,US,US,2020,Q2,Adult
172575964,17257596,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Malaise,,2020,Q2,4,F,202001.0,20200608.0,20200110,20200610,EXP,,US-PFIZER INC-2020010150,PFIZER,,58.0,YR,,F,Y,,,20200610.0,,CN,US,US,2020,Q2,Adult
172575964,17257596,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Muscle spasms,,2020,Q2,4,F,202001.0,20200608.0,20200110,20200610,EXP,,US-PFIZER INC-2020010150,PFIZER,,58.0,YR,,F,Y,,,20200610.0,,CN,US,US,2020,Q2,Adult
172933824,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cholelithiasis,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Food intolerance,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Malaise,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Photophobia,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pituitary enlargement,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Vision blurred,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
173547762,17354776,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Gastric ulcer,,2020,Q2,2,F,20200120.0,20200407.0,20200131,20200414,EXP,,MX-BAYER-2020-016811,BAYER,,67.0,YR,E,M,Y,,,20200414.0,,CN,MX,MX,2020,Q2,Elderly
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Abdominal discomfort,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Anaemia,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Cough,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Diverticulum,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Dizziness,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Dyspnoea exertional,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Faeces discoloured,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Flushing,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Gastric ulcer haemorrhage,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Haematocrit decreased,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Haemoglobin decreased,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Nasopharyngitis,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Oxygen saturation decreased,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Pain,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Paraesthesia,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Paraesthesia oral,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Pulmonary arterial hypertension,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Tachycardia,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173551896,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Weight decreased,,2020,Q2,6,F,20191119.0,20200515.0,20200131,20200529,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200529.0,,HP,US,US,2020,Q2,Adult
173888422,17388842,3,SS,Lispro,INSULIN LISPRO,1,Unknown,"1-2 UNITS, OTHER (2-3 TIMES PER WEEK)",,,U,, UNK,,,,,,,2020,Q2,Blood glucose fluctuation,,2020,Q2,2,F,,20200416.0,20200207,20200422,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202002001132,ELI LILLY AND CO,FOVENYI J..EXTREME LONG DURATION OF TYPE 1 DIABETES MELLITUS.ORV HETIL 2020;161(5):193-197.DOI:10.1556/650.2020.31663,91.0,YR,,F,Y,,,20200422.0,,MD,HU,HU,2020,Q2,Elderly
173888422,17388842,3,SS,Lispro,INSULIN LISPRO,1,Unknown,"1-2 UNITS, OTHER (2-3 TIMES PER WEEK)",,,U,, UNK,,,,,,,2020,Q2,Dry age-related macular degeneration,,2020,Q2,2,F,,20200416.0,20200207,20200422,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202002001132,ELI LILLY AND CO,FOVENYI J..EXTREME LONG DURATION OF TYPE 1 DIABETES MELLITUS.ORV HETIL 2020;161(5):193-197.DOI:10.1556/650.2020.31663,91.0,YR,,F,Y,,,20200422.0,,MD,HU,HU,2020,Q2,Elderly
173888422,17388842,3,SS,Lispro,INSULIN LISPRO,1,Unknown,"1-2 UNITS, OTHER (2-3 TIMES PER WEEK)",,,U,, UNK,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,,20200416.0,20200207,20200422,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202002001132,ELI LILLY AND CO,FOVENYI J..EXTREME LONG DURATION OF TYPE 1 DIABETES MELLITUS.ORV HETIL 2020;161(5):193-197.DOI:10.1556/650.2020.31663,91.0,YR,,F,Y,,,20200422.0,,MD,HU,HU,2020,Q2,Elderly
173888422,17388842,3,SS,Lispro,INSULIN LISPRO,1,Unknown,"1-2 UNITS, OTHER (2-3 TIMES PER WEEK)",,,U,, UNK,,,,,,,2020,Q2,Myocardial infarction,,2020,Q2,2,F,,20200416.0,20200207,20200422,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202002001132,ELI LILLY AND CO,FOVENYI J..EXTREME LONG DURATION OF TYPE 1 DIABETES MELLITUS.ORV HETIL 2020;161(5):193-197.DOI:10.1556/650.2020.31663,91.0,YR,,F,Y,,,20200422.0,,MD,HU,HU,2020,Q2,Elderly
173888422,17388842,3,SS,Lispro,INSULIN LISPRO,1,Unknown,"1-2 UNITS, OTHER (2-3 TIMES PER WEEK)",,,U,, UNK,,,,,,,2020,Q2,Neuropathy peripheral,,2020,Q2,2,F,,20200416.0,20200207,20200422,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202002001132,ELI LILLY AND CO,FOVENYI J..EXTREME LONG DURATION OF TYPE 1 DIABETES MELLITUS.ORV HETIL 2020;161(5):193-197.DOI:10.1556/650.2020.31663,91.0,YR,,F,Y,,,20200422.0,,MD,HU,HU,2020,Q2,Elderly
173888422,17388842,3,SS,Lispro,INSULIN LISPRO,1,Unknown,"1-2 UNITS, OTHER (2-3 TIMES PER WEEK)",,,U,, UNK,,,,,,,2020,Q2,Overdose,,2020,Q2,2,F,,20200416.0,20200207,20200422,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202002001132,ELI LILLY AND CO,FOVENYI J..EXTREME LONG DURATION OF TYPE 1 DIABETES MELLITUS.ORV HETIL 2020;161(5):193-197.DOI:10.1556/650.2020.31663,91.0,YR,,F,Y,,,20200422.0,,MD,HU,HU,2020,Q2,Elderly
173888422,17388842,3,SS,Lispro,INSULIN LISPRO,1,Unknown,"1-2 UNITS, OTHER (2-3 TIMES PER WEEK)",,,U,, UNK,,,,,,,2020,Q2,Visual impairment,,2020,Q2,2,F,,20200416.0,20200207,20200422,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202002001132,ELI LILLY AND CO,FOVENYI J..EXTREME LONG DURATION OF TYPE 1 DIABETES MELLITUS.ORV HETIL 2020;161(5):193-197.DOI:10.1556/650.2020.31663,91.0,YR,,F,Y,,,20200422.0,,MD,HU,HU,2020,Q2,Elderly
173993842,17399384,4,C,LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Lung neoplasm malignant,,2020,Q2,2,F,,20200624.0,20200211,20200626,EXP,,US-BAUSCH-BL-2020-004260,BAUSCH AND LOMB,,76.0,YR,,M,Y,,,20200626.0,,HP,US,US,2020,Q2,Elderly
174044093,17404409,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute respiratory failure,,2020,Q2,3,F,20200120.0,20200407.0,20200211,20200421,EXP,,US-ACTELION-A-US2020-201561,ACTELION,,72.0,YR,,M,Y,78.91,KG,20200421.0,,HP,US,US,2020,Q2,Elderly
174044093,17404409,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Aortic aneurysm repair,,2020,Q2,3,F,20200120.0,20200407.0,20200211,20200421,EXP,,US-ACTELION-A-US2020-201561,ACTELION,,72.0,YR,,M,Y,78.91,KG,20200421.0,,HP,US,US,2020,Q2,Elderly
174044093,17404409,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,3,F,20200120.0,20200407.0,20200211,20200421,EXP,,US-ACTELION-A-US2020-201561,ACTELION,,72.0,YR,,M,Y,78.91,KG,20200421.0,,HP,US,US,2020,Q2,Elderly
174044093,17404409,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Pneumonia aspiration,,2020,Q2,3,F,20200120.0,20200407.0,20200211,20200421,EXP,,US-ACTELION-A-US2020-201561,ACTELION,,72.0,YR,,M,Y,78.91,KG,20200421.0,,HP,US,US,2020,Q2,Elderly
174044093,17404409,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Sternotomy,,2020,Q2,3,F,20200120.0,20200407.0,20200211,20200421,EXP,,US-ACTELION-A-US2020-201561,ACTELION,,72.0,YR,,M,Y,78.91,KG,20200421.0,,HP,US,US,2020,Q2,Elderly
174044093,17404409,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Tricuspid valve repair,,2020,Q2,3,F,20200120.0,20200407.0,20200211,20200421,EXP,,US-ACTELION-A-US2020-201561,ACTELION,,72.0,YR,,M,Y,78.91,KG,20200421.0,,HP,US,US,2020,Q2,Elderly
174112062,17411206,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U,,,,15.0,IU,INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U,,,,15.0,IU,INJECTION,QD,2020,Q2,Feeling abnormal,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U,,,,15.0,IU,INJECTION,QD,2020,Q2,Fingerprint loss,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U,,,,15.0,IU,INJECTION,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U,,,,15.0,IU,INJECTION,QD,2020,Q2,Injection site bruising,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U,,,,15.0,IU,INJECTION,QD,2020,Q2,Injection site mass,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U,,,,15.0,IU,INJECTION,QD,2020,Q2,Injection site pain,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U,,,,15.0,IU,INJECTION,QD,2020,Q2,Insomnia,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U,,,,15.0,IU,INJECTION,QD,2020,Q2,Musculoskeletal disorder,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U,,,,15.0,IU,INJECTION,QD,2020,Q2,Pain in extremity,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U,,,,15.0,IU,INJECTION,QD,2020,Q2,Product dispensing error,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U,,,,15.0,IU,INJECTION,QD,2020,Q2,Product storage error,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U, C938257C,,,15.0,IU,INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U, C938257C,,,15.0,IU,INJECTION,QD,2020,Q2,Feeling abnormal,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U, C938257C,,,15.0,IU,INJECTION,QD,2020,Q2,Fingerprint loss,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U, C938257C,,,15.0,IU,INJECTION,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U, C938257C,,,15.0,IU,INJECTION,QD,2020,Q2,Injection site bruising,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U, C938257C,,,15.0,IU,INJECTION,QD,2020,Q2,Injection site mass,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U, C938257C,,,15.0,IU,INJECTION,QD,2020,Q2,Injection site pain,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U, C938257C,,,15.0,IU,INJECTION,QD,2020,Q2,Insomnia,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U, C938257C,,,15.0,IU,INJECTION,QD,2020,Q2,Musculoskeletal disorder,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U, C938257C,,,15.0,IU,INJECTION,QD,2020,Q2,Pain in extremity,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U, C938257C,,,15.0,IU,INJECTION,QD,2020,Q2,Product dispensing error,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174112062,17411206,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (SLIDING SCALE)",,,U,U, C938257C,,,15.0,IU,INJECTION,QD,2020,Q2,Product storage error,,2020,Q2,2,F,20200402.0,20200403.0,20200212,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202002001422,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
174426613,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Anxiety,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Depression,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Dizziness,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Dry mouth,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Feeling abnormal,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Increased insulin requirement,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Paraesthesia,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Temperature intolerance,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Vertigo,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174524383,17452438,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNIT, QD",,,U,,,,,100.0,DF,,QD,2020,Q2,Transplant rejection,,2020,Q2,3,F,20200212.0,20200406.0,20200224,20200416,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000149,VELOXIS PHARMACEUTICALS,,70.0,YR,,F,Y,59.1,KG,20200416.0,,HP,US,US,2020,Q2,Elderly
174819262,17481926,16,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Altered state of consciousness,,2020,Q2,2,F,20200210.0,20200512.0,20200302,20200521,EXP,,US-BAXTER-2020BAX004462,BAXTER,,11.0,YR,,F,Y,68.1,KG,20200521.0,,MD,US,US,2020,Q2,Child
174819262,17481926,16,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Seizure,,2020,Q2,2,F,20200210.0,20200512.0,20200302,20200521,EXP,,US-BAXTER-2020BAX004462,BAXTER,,11.0,YR,,F,Y,68.1,KG,20200521.0,,MD,US,US,2020,Q2,Child
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Acute respiratory failure,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Anaemia,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Asthenia,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Death,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Dyspnoea,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Fall,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Fatigue,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Fibula fracture,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Haemorrhage urinary tract,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Hypercalcaemia,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Hypotension,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Neoplasm progression,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Pancytopenia,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Pneumonia,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Second primary malignancy,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Tibia fracture,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174827155,17482715,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, AS NEEDED (BEFORE MEALS AND AT BEDTIME, 1 UNIT OF INSULIN FOR EVERY 30 MG/ DL/140 MG/DL)(1-9 U)",,,,,,,,,,INJECTION,,2020,Q2,Waldenstrom's macroglobulinaemia,,2020,Q2,5,F,20200118.0,20200331.0,20200302,20200403,EXP,,US-PFIZER INC-2020089736,PFIZER,,73.0,YR,,F,Y,,,20200403.0,,HP,US,US,2020,Q2,Elderly
174911373,17491137,46,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, THRICE DAILY",,,,,,,,,,FORMULATION UNKNOWN,Q8H,2020,Q2,Cystitis,,2020,Q2,3,F,20190606.0,20200325.0,20200304,20200402,EXP,,US-ASTELLAS-2020US007301,ASTELLAS,,75.0,YR,,F,Y,,,20200402.0,,MD,US,US,2020,Q2,Elderly
174911373,17491137,46,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, THRICE DAILY",,,,,,,,,,FORMULATION UNKNOWN,Q8H,2020,Q2,Haematuria,,2020,Q2,3,F,20190606.0,20200325.0,20200304,20200402,EXP,,US-ASTELLAS-2020US007301,ASTELLAS,,75.0,YR,,F,Y,,,20200402.0,,MD,US,US,2020,Q2,Elderly
174911373,17491137,46,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, THRICE DAILY",,,,,,,,,,FORMULATION UNKNOWN,Q8H,2020,Q2,Thrombocytopenia,,2020,Q2,3,F,20190606.0,20200325.0,20200304,20200402,EXP,,US-ASTELLAS-2020US007301,ASTELLAS,,75.0,YR,,F,Y,,,20200402.0,,MD,US,US,2020,Q2,Elderly
175021572,17502157,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO PERSCRIPTION,,,,,,,,,,,,2020,Q2,Device related infection,,2020,Q2,2,F,2018.0,20200601.0,20200305,20200610,EXP,,ES-009507513-2003ESP001099,MERCK,,92.0,YR,,F,Y,50.0,KG,20200610.0,,MD,ES,ES,2020,Q2,Elderly
175021572,17502157,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO PERSCRIPTION,,,,,,,,,,,,2020,Q2,Infection,,2020,Q2,2,F,2018.0,20200601.0,20200305,20200610,EXP,,ES-009507513-2003ESP001099,MERCK,,92.0,YR,,F,Y,50.0,KG,20200610.0,,MD,ES,ES,2020,Q2,Elderly
175021572,17502157,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO PERSCRIPTION,,,,,,,,,,,,2020,Q2,Leg amputation,,2020,Q2,2,F,2018.0,20200601.0,20200305,20200610,EXP,,ES-009507513-2003ESP001099,MERCK,,92.0,YR,,F,Y,50.0,KG,20200610.0,,MD,ES,ES,2020,Q2,Elderly
175021572,17502157,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO PERSCRIPTION,,,,,,,,,,,,2020,Q2,Pneumonia aspiration,,2020,Q2,2,F,2018.0,20200601.0,20200305,20200610,EXP,,ES-009507513-2003ESP001099,MERCK,,92.0,YR,,F,Y,50.0,KG,20200610.0,,MD,ES,ES,2020,Q2,Elderly
175021572,17502157,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO PERSCRIPTION,,,,,,,,,,,,2020,Q2,Pseudomonal bacteraemia,,2020,Q2,2,F,2018.0,20200601.0,20200305,20200610,EXP,,ES-009507513-2003ESP001099,MERCK,,92.0,YR,,F,Y,50.0,KG,20200610.0,,MD,ES,ES,2020,Q2,Elderly
175149423,17514942,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,3,F,20200319.0,20200508.0,20200309,20200511,PER,,US-GILEAD-2020-0453945,GILEAD,,59.0,YR,A,F,Y,,,20200511.0,,CN,US,US,2020,Q2,Adult
175149423,17514942,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Myocardial infarction,,2020,Q2,3,F,20200319.0,20200508.0,20200309,20200511,PER,,US-GILEAD-2020-0453945,GILEAD,,59.0,YR,A,F,Y,,,20200511.0,,CN,US,US,2020,Q2,Adult
175149423,17514942,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Neuropathy peripheral,,2020,Q2,3,F,20200319.0,20200508.0,20200309,20200511,PER,,US-GILEAD-2020-0453945,GILEAD,,59.0,YR,A,F,Y,,,20200511.0,,CN,US,US,2020,Q2,Adult
175149423,17514942,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pain,,2020,Q2,3,F,20200319.0,20200508.0,20200309,20200511,PER,,US-GILEAD-2020-0453945,GILEAD,,59.0,YR,A,F,Y,,,20200511.0,,CN,US,US,2020,Q2,Adult
175217982,17521798,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U EACH + SCALE TREATMENT, TID (MORNING, NOON, EVENING)",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2020,Q2,Atrial fibrillation,,2020,Q2,2,F,20191220.0,20200407.0,20200310,20200413,EXP,,JP-SA-2020SA058550,SANOFI AVENTIS,,78.0,YR,E,M,Y,62.0,KG,20200413.0,,PH,JP,JP,2020,Q2,Elderly
175217982,17521798,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U EACH + SCALE TREATMENT, TID (MORNING, NOON, EVENING)",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2020,Q2,Hypokalaemia,,2020,Q2,2,F,20191220.0,20200407.0,20200310,20200413,EXP,,JP-SA-2020SA058550,SANOFI AVENTIS,,78.0,YR,E,M,Y,62.0,KG,20200413.0,,PH,JP,JP,2020,Q2,Elderly
175217982,17521798,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Atrial fibrillation,,2020,Q2,2,F,20191220.0,20200407.0,20200310,20200413,EXP,,JP-SA-2020SA058550,SANOFI AVENTIS,,78.0,YR,E,M,Y,62.0,KG,20200413.0,,PH,JP,JP,2020,Q2,Elderly
175217982,17521798,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hypokalaemia,,2020,Q2,2,F,20191220.0,20200407.0,20200310,20200413,EXP,,JP-SA-2020SA058550,SANOFI AVENTIS,,78.0,YR,E,M,Y,62.0,KG,20200413.0,,PH,JP,JP,2020,Q2,Elderly
175302582,17530258,3,C,LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,81.0,MG,,QD,2020,Q2,Blister,,2020,Q2,2,F,2019.0,20200324.0,20200312,20200401,EXP,,US-ASTRAZENECA-2020SE22116,ASTRAZENECA,,39.0,YR,,F,Y,124.7,KG,20200401.0,,CN,US,US,2020,Q2,Adult
175302582,17530258,3,C,LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,81.0,MG,,QD,2020,Q2,Chest pain,,2020,Q2,2,F,2019.0,20200324.0,20200312,20200401,EXP,,US-ASTRAZENECA-2020SE22116,ASTRAZENECA,,39.0,YR,,F,Y,124.7,KG,20200401.0,,CN,US,US,2020,Q2,Adult
175302582,17530258,3,C,LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,81.0,MG,,QD,2020,Q2,Dyspnoea,,2020,Q2,2,F,2019.0,20200324.0,20200312,20200401,EXP,,US-ASTRAZENECA-2020SE22116,ASTRAZENECA,,39.0,YR,,F,Y,124.7,KG,20200401.0,,CN,US,US,2020,Q2,Adult
175302582,17530258,3,C,LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,81.0,MG,,QD,2020,Q2,Exfoliative rash,,2020,Q2,2,F,2019.0,20200324.0,20200312,20200401,EXP,,US-ASTRAZENECA-2020SE22116,ASTRAZENECA,,39.0,YR,,F,Y,124.7,KG,20200401.0,,CN,US,US,2020,Q2,Adult
175302582,17530258,3,C,LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,81.0,MG,,QD,2020,Q2,Fatigue,,2020,Q2,2,F,2019.0,20200324.0,20200312,20200401,EXP,,US-ASTRAZENECA-2020SE22116,ASTRAZENECA,,39.0,YR,,F,Y,124.7,KG,20200401.0,,CN,US,US,2020,Q2,Adult
175302582,17530258,3,C,LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,81.0,MG,,QD,2020,Q2,Product use issue,,2020,Q2,2,F,2019.0,20200324.0,20200312,20200401,EXP,,US-ASTRAZENECA-2020SE22116,ASTRAZENECA,,39.0,YR,,F,Y,124.7,KG,20200401.0,,CN,US,US,2020,Q2,Adult
175443875,17544387,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-14 UNITS,,,,,,,,,,,TID,2020,Q2,Atrial fibrillation,,2020,Q2,5,F,20200229.0,20200513.0,20200316,20200527,EXP,,US-JNJFOC-20200307350,JOHNSON AND JOHNSON,,67.0,YR,,F,Y,94.43,KG,20200527.0,,MD,US,US,2020,Q2,Elderly
175443875,17544387,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-14 UNITS,,,,,,,,,,,TID,2020,Q2,Cerebrovascular accident,,2020,Q2,5,F,20200229.0,20200513.0,20200316,20200527,EXP,,US-JNJFOC-20200307350,JOHNSON AND JOHNSON,,67.0,YR,,F,Y,94.43,KG,20200527.0,,MD,US,US,2020,Q2,Elderly
175443875,17544387,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-14 UNITS,,,,,,,,,,,TID,2020,Q2,Encephalopathy,,2020,Q2,5,F,20200229.0,20200513.0,20200316,20200527,EXP,,US-JNJFOC-20200307350,JOHNSON AND JOHNSON,,67.0,YR,,F,Y,94.43,KG,20200527.0,,MD,US,US,2020,Q2,Elderly
175617683,17561768,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C999316C,,20563.0,,,INJECTION,,2020,Q2,Anxiety,,2020,Q2,3,F,20200310.0,20200325.0,20200319,20200423,PER,,US-ELI_LILLY_AND_COMPANY-US202003006556,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20200423.0,,CN,US,US,2020,Q2,Adult
175617683,17561768,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C999316C,,20563.0,,,INJECTION,,2020,Q2,Bipolar disorder,,2020,Q2,3,F,20200310.0,20200325.0,20200319,20200423,PER,,US-ELI_LILLY_AND_COMPANY-US202003006556,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20200423.0,,CN,US,US,2020,Q2,Adult
175617683,17561768,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C999316C,,20563.0,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,3,F,20200310.0,20200325.0,20200319,20200423,PER,,US-ELI_LILLY_AND_COMPANY-US202003006556,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20200423.0,,CN,US,US,2020,Q2,Adult
175617683,17561768,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C999316C,,20563.0,,,INJECTION,,2020,Q2,Fine motor skill dysfunction,,2020,Q2,3,F,20200310.0,20200325.0,20200319,20200423,PER,,US-ELI_LILLY_AND_COMPANY-US202003006556,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20200423.0,,CN,US,US,2020,Q2,Adult
175617683,17561768,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C999316C,,20563.0,,,INJECTION,,2020,Q2,Learning disability,,2020,Q2,3,F,20200310.0,20200325.0,20200319,20200423,PER,,US-ELI_LILLY_AND_COMPANY-US202003006556,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20200423.0,,CN,US,US,2020,Q2,Adult
175622452,17562245,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INJECT PER PUMP BEFORE MEALS AND BEDTIME AS NEEDED, INJECT UP TO 21 UNITS PER DAY",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Decreased insulin requirement,,2020,Q2,2,F,20200228.0,20200330.0,20200319,20200406,EXP,,US-AMERICAN REGENT INC-2020000658,AMERICAN REGENT,,7.0,YR,,M,Y,17.8,KG,20200406.0,,HP,US,US,2020,Q2,Child
175622452,17562245,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INJECT PER PUMP BEFORE MEALS AND BEDTIME AS NEEDED, INJECT UP TO 21 UNITS PER DAY",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,20200228.0,20200330.0,20200319,20200406,EXP,,US-AMERICAN REGENT INC-2020000658,AMERICAN REGENT,,7.0,YR,,M,Y,17.8,KG,20200406.0,,HP,US,US,2020,Q2,Child
175622452,17562245,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INJECT PER PUMP BEFORE MEALS AND BEDTIME AS NEEDED, INJECT UP TO 21 UNITS PER DAY",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Product use issue,,2020,Q2,2,F,20200228.0,20200330.0,20200319,20200406,EXP,,US-AMERICAN REGENT INC-2020000658,AMERICAN REGENT,,7.0,YR,,M,Y,17.8,KG,20200406.0,,HP,US,US,2020,Q2,Child
175633364,17563336,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, PRN",,,,,,,,,,,,2020,Q2,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q2,4,F,20191029.0,20200428.0,20200319,20200505,EXP,,NL-VERTEX PHARMACEUTICALS-2019-010618,VERTEX,,52.0,YR,,F,Y,71.0,KG,20200505.0,,HP,NL,NL,2020,Q2,Adult
175633364,17563336,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, PRN",,,,,,,,,,,,2020,Q2,Pulmonary embolism,,2020,Q2,4,F,20191029.0,20200428.0,20200319,20200505,EXP,,NL-VERTEX PHARMACEUTICALS-2019-010618,VERTEX,,52.0,YR,,F,Y,71.0,KG,20200505.0,,HP,NL,NL,2020,Q2,Adult
175753772,17575377,4,SS,INSULIN LISPRO LILLY (MIRIOPEN) (KWIKPEN),INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,Y,U, C933643D,,,10.0,IU,INJECTION,,2020,Q2,Asthenia,,2020,Q2,2,F,20200310.0,20200414.0,20200324,20200416,EXP,,US-ELI_LILLY_AND_COMPANY-US202003006813,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Adult
175753772,17575377,4,SS,INSULIN LISPRO LILLY (MIRIOPEN) (KWIKPEN),INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,Y,U, C933643D,,,10.0,IU,INJECTION,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,2,F,20200310.0,20200414.0,20200324,20200416,EXP,,US-ELI_LILLY_AND_COMPANY-US202003006813,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Adult
175753772,17575377,4,SS,INSULIN LISPRO LILLY (MIRIOPEN) (KWIKPEN),INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,Y,U, C933643D,,,10.0,IU,INJECTION,,2020,Q2,Malaise,,2020,Q2,2,F,20200310.0,20200414.0,20200324,20200416,EXP,,US-ELI_LILLY_AND_COMPANY-US202003006813,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Adult
175753772,17575377,5,SS,INSULIN LISPRO LILLY (MIRIOPEN) (KWIKPEN),INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,Y,U, C938255F,,,10.0,IU,INJECTION,,2020,Q2,Asthenia,,2020,Q2,2,F,20200310.0,20200414.0,20200324,20200416,EXP,,US-ELI_LILLY_AND_COMPANY-US202003006813,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Adult
175753772,17575377,5,SS,INSULIN LISPRO LILLY (MIRIOPEN) (KWIKPEN),INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,Y,U, C938255F,,,10.0,IU,INJECTION,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,2,F,20200310.0,20200414.0,20200324,20200416,EXP,,US-ELI_LILLY_AND_COMPANY-US202003006813,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Adult
175753772,17575377,5,SS,INSULIN LISPRO LILLY (MIRIOPEN) (KWIKPEN),INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,Y,U, C938255F,,,10.0,IU,INJECTION,,2020,Q2,Malaise,,2020,Q2,2,F,20200310.0,20200414.0,20200324,20200416,EXP,,US-ELI_LILLY_AND_COMPANY-US202003006813,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Adult
176082381,17608238,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100UNITS/ML SUBCUTANEOUS SOLUTION,,,,, UNKNOWN,,,1.0,DF,,QD,2020,Q2,Pneumonia,,2020,Q2,1,I,20200323.0,20200325.0,20200401,20200401,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-US-016591",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Asthma,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood count abnormal,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Chest discomfort,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Cough,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Diaphragmatic disorder,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Discomfort,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Dyspnoea,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Hypoxia,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Left ventricular hypertrophy,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Obstructive airways disorder,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Oedema peripheral,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Oropharyngeal pain,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Weight increased,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Wheezing,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Asthma,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Blood count abnormal,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Chest discomfort,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Cough,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Diaphragmatic disorder,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Discomfort,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Dyspnoea,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Hypoxia,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Left ventricular hypertrophy,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Obstructive airways disorder,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Oedema peripheral,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Oropharyngeal pain,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Weight increased,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176089541,17608954,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QOD",,,U,,,,,,,,QOD,2020,Q2,Wheezing,,2020,Q2,1,I,,20200318.0,20200401,20200401,EXP,,CA-SA-2020SA071509,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20200401.0,,CN,CA,CA,2020,Q2,Elderly
176124861,17612486,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),,,,,,,,,,,INJECTION,,2020,Q2,Asthenia,,2020,Q2,1,I,20170624.0,20200319.0,20200401,20200401,EXP,,IT-BAUSCH-BL-2020-008687,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20200401.0,,MD,IT,IT,2020,Q2,Elderly
176124861,17612486,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),,,,,,,,,,,INJECTION,,2020,Q2,Bradycardia,,2020,Q2,1,I,20170624.0,20200319.0,20200401,20200401,EXP,,IT-BAUSCH-BL-2020-008687,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20200401.0,,MD,IT,IT,2020,Q2,Elderly
176124861,17612486,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),,,,,,,,,,,INJECTION,,2020,Q2,Hypotension,,2020,Q2,1,I,20170624.0,20200319.0,20200401,20200401,EXP,,IT-BAUSCH-BL-2020-008687,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20200401.0,,MD,IT,IT,2020,Q2,Elderly
176126711,17612671,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,30-0-15,,,,, UNKNOWN,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,20200316.0,20200325.0,20200401,20200401,EXP,,MX-NOVOPROD-721199,NOVO NORDISK,,45.0,YR,,F,Y,,,20200401.0,,CN,MX,MX,2020,Q2,Adult
176126711,17612671,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,30-0-15,,,,, UNKNOWN,,,,,,,2020,Q2,Somnolence,,2020,Q2,1,I,20200316.0,20200325.0,20200401,20200401,EXP,,MX-NOVOPROD-721199,NOVO NORDISK,,45.0,YR,,F,Y,,,20200401.0,,CN,MX,MX,2020,Q2,Adult
176156671,17615667,9,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Mucosal inflammation,,2020,Q2,1,I,20200401.0,,20200401,20200401,DIR,,,FDA-CTU,,75.0,YR,,F,N,74.39,KG,20200401.0,N,,US,US,2020,Q2,Elderly
176170971,17617097,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q2,Contusion,,2020,Q2,1,I,,20200317.0,20200402,20200402,PER,,US-SA-2020SA081703,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200402.0,,CN,US,US,2020,Q2,Elderly
176232451,17623245,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",752.0,IU,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200216.0,20200401.0,20200403,20200403,EXP,IT-MINISAL02-612730,IT-SA-2020SA081417,SANOFI AVENTIS,,12.0,YR,T,F,Y,,,20200403.0,,MD,IT,IT,2020,Q2,Child
176232451,17623245,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",752.0,IU,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Sopor,,2020,Q2,1,I,20200216.0,20200401.0,20200403,20200403,EXP,IT-MINISAL02-612730,IT-SA-2020SA081417,SANOFI AVENTIS,,12.0,YR,T,F,Y,,,20200403.0,,MD,IT,IT,2020,Q2,Child
176243001,17624300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Dehydration,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Glycosuria,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Metabolic acidosis,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Oedema,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Peripheral swelling,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Polydipsia,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Product dose omission,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Treatment noncompliance,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Weight decreased,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Weight increased,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176244961,17624496,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"IN MORNING. 25/75 100UNITS/ML, 3ML",,,U,,,,,24.0,IU,,QD,2020,Q2,Orthostatic hypotension,,2020,Q2,1,I,20200220.0,20200402.0,20200403,20200403,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-028225,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,,,20200403.0,,PH,GB,GB,2020,Q2,Elderly
176244961,17624496,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"IN MORNING. 25/75 100UNITS/ML, 3ML",,,U,,,,,24.0,IU,,QD,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,1,I,20200220.0,20200402.0,20200403,20200403,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-028225,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,,,20200403.0,,PH,GB,GB,2020,Q2,Elderly
176266951,17626695,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Transplant rejection,,2020,Q2,1,I,20180319.0,20180416.0,20200405,20200405,EXP,,PHHO2018US005135,NOVARTIS,,65.0,YR,,M,Y,86.68,KG,20200405.0,,HP,US,US,2020,Q2,Elderly
176266951,17626695,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Wound infection,,2020,Q2,1,I,20180319.0,20180416.0,20200405,20200405,EXP,,PHHO2018US005135,NOVARTIS,,65.0,YR,,M,Y,86.68,KG,20200405.0,,HP,US,US,2020,Q2,Elderly
176294951,17629495,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING  SCALE)",,,,, C997208A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q2,Ketoacidosis,,2020,Q2,1,I,202001.0,20200326.0,20200406,20200406,EXP,,US-ELI_LILLY_AND_COMPANY-US202003012830,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
176294951,17629495,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING  SCALE)",,,,, C997208A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q2,Stress,,2020,Q2,1,I,202001.0,20200326.0,20200406,20200406,EXP,,US-ELI_LILLY_AND_COMPANY-US202003012830,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
176361731,17636173,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2020,Q2,Back pain,,2020,Q2,1,I,20200323.0,20200326.0,20200407,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003012795,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200407.0,,CN,US,US,2020,Q2,Adult
176361731,17636173,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2020,Q2,Blindness,,2020,Q2,1,I,20200323.0,20200326.0,20200407,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003012795,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200407.0,,CN,US,US,2020,Q2,Adult
176361731,17636173,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2020,Q2,Expired product administered,,2020,Q2,1,I,20200323.0,20200326.0,20200407,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003012795,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200407.0,,CN,US,US,2020,Q2,Adult
176361731,17636173,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,20200323.0,20200326.0,20200407,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003012795,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200407.0,,CN,US,US,2020,Q2,Adult
176361731,17636173,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2020,Q2,Myalgia,,2020,Q2,1,I,20200323.0,20200326.0,20200407,20200407,EXP,,US-ELI_LILLY_AND_COMPANY-US202003012795,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200407.0,,CN,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Abdominal discomfort,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Abdominal pain,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Asthenia,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Constipation,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Diarrhoea,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Dyspnoea,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Fatigue,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Hypotension,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Mediastinal mass,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Normocytic anaemia,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Osteoarthritis,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Palpitations,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Polyp,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Pure white cell aplasia,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Thymoma,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176364841,17636484,32,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, HS",,,U,,,,,,,,QD,2020,Q2,Vomiting,,2020,Q2,1,I,2019.0,20200324.0,20200407,20200407,EXP,,US-SA-2020SA081152,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
176394451,17639445,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,20200301.0,20200310.0,20200407,20200407,EXP,IT-MINISAL02-610154,IT-JNJFOC-20200315359,JOHNSON AND JOHNSON,,61.0,YR,,M,Y,,,20200407.0,,MD,IT,IT,2020,Q2,Adult
176394451,17639445,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Sopor,,2020,Q2,1,I,20200301.0,20200310.0,20200407,20200407,EXP,IT-MINISAL02-610154,IT-JNJFOC-20200315359,JOHNSON AND JOHNSON,,61.0,YR,,M,Y,,,20200407.0,,MD,IT,IT,2020,Q2,Adult
176396031,17639603,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Atrial fibrillation,,2020,Q2,1,I,20040214.0,20040305.0,20200407,20200407,EXP,,US-JNJFOC-20040301640,JOHNSON AND JOHNSON,,49.0,YR,,F,Y,63.56,KG,20200407.0,,MD,US,US,2020,Q2,Adult
176396031,17639603,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20040214.0,20040305.0,20200407,20200407,EXP,,US-JNJFOC-20040301640,JOHNSON AND JOHNSON,,49.0,YR,,F,Y,63.56,KG,20200407.0,,MD,US,US,2020,Q2,Adult
176396031,17639603,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,20040214.0,20040305.0,20200407,20200407,EXP,,US-JNJFOC-20040301640,JOHNSON AND JOHNSON,,49.0,YR,,F,Y,63.56,KG,20200407.0,,MD,US,US,2020,Q2,Adult
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Asthma,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood count abnormal,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Chest discomfort,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cough,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Diaphragmatic disorder,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Discomfort,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Left ventricular hypertrophy,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Obstructive airways disorder,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Oropharyngeal pain,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Weight increased,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176396231,17639623,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Wheezing,,2020,Q2,1,I,,20200327.0,20200407,20200407,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,,,20200407.0,,CN,JP,CA,2020,Q2,Elderly
176404181,17640418,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, QD, IN MORNING, (25/75 100UNITS/ML, 3ML)",,,,,,,,24.0,IU,SUSPENSION FOR INJECTION,QD,2020,Q2,Orthostatic hypotension,,2020,Q2,1,I,20200220.0,20200406.0,20200408,20200408,EXP,GB-MHRA-MIDB-853EB3A7-4D81-44CC-BDA2-E41235A70E2F,GB-009507513-2004GBR001868,MERCK,,73.0,YR,,M,Y,,,20200408.0,,PH,GB,GB,2020,Q2,Elderly
176404181,17640418,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, QD, IN MORNING, (25/75 100UNITS/ML, 3ML)",,,,,,,,24.0,IU,SUSPENSION FOR INJECTION,QD,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,1,I,20200220.0,20200406.0,20200408,20200408,EXP,GB-MHRA-MIDB-853EB3A7-4D81-44CC-BDA2-E41235A70E2F,GB-009507513-2004GBR001868,MERCK,,73.0,YR,,M,Y,,,20200408.0,,PH,GB,GB,2020,Q2,Elderly
176490982,17649098,8,C,INSULINE LISPRO,,2,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q2,Colitis,,2020,Q2,2,F,20200324.0,20200409.0,20200408,20200415,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-026124,BRISTOL MYERS SQUIBB,,72.0,YR,,F,Y,84.0,KG,20200415.0,,HP,CA,CA,2020,Q2,Elderly
176491181,17649118,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,,20200401.0,20200409,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202004000766,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
176491181,17649118,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,,,2020,Q2,Blood glucose fluctuation,,2020,Q2,1,I,,20200401.0,20200409,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202004000766,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
176491181,17649118,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,,,2020,Q2,Cerebrovascular accident,,2020,Q2,1,I,,20200401.0,20200409,20200409,EXP,,US-ELI_LILLY_AND_COMPANY-US202004000766,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20200409.0,,CN,US,US,2020,Q2,Elderly
176514301,17651430,10,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q2,Drug-induced liver injury,,2020,Q2,1,I,,20200330.0,20200409,20200409,EXP,,DE-TEVA-2020-DE-1219421,TEVA,"UEBERBERG B, FROMMBERGER U, MESSER T, ZWANZGER P, KUHN J, ANGHELESCU I, ET AL. DRUG-INDUCED LIVER INJURY (DILI) IN PATIENTS WITH DEPRESSION TREATED WITH ANTIDEPRESSANTS: A RETROSPECTIVE MULTICENTER STUDY. PHARMACOPSYCHIATRY 2020;53(2):60-64.",42.0,YR,,M,Y,,,20200409.0,,HP,DE,DE,2020,Q2,Adult
176559361,17655936,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"IN MORNING. 25/75 100UNITS/ML, 3ML",,,,, UNKNOWN,,,24.0,IU,SUSPENSION FOR INJECTION,,2020,Q2,Orthostatic hypotension,,2020,Q2,1,I,20200220.0,20200406.0,20200410,20200410,EXP,GB-MHRA-MIDB-853EB3A7-4D81-44CC-BDA2-E41235A70E2F,GB-TEVA-2020-GB-1221518,TEVA,,73.0,YR,,M,Y,,,20200410.0,,PH,GB,GB,2020,Q2,Elderly
176559361,17655936,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"IN MORNING. 25/75 100UNITS/ML, 3ML",,,,, UNKNOWN,,,24.0,IU,SUSPENSION FOR INJECTION,,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,1,I,20200220.0,20200406.0,20200410,20200410,EXP,GB-MHRA-MIDB-853EB3A7-4D81-44CC-BDA2-E41235A70E2F,GB-TEVA-2020-GB-1221518,TEVA,,73.0,YR,,M,Y,,,20200410.0,,PH,GB,GB,2020,Q2,Elderly
176576651,17657665,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Coma,,2020,Q2,1,I,20200315.0,20200409.0,20200411,20200411,EXP,FR-AFSSAPS-PO20200377,FR-SA-2020SA092645,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20200411.0,,MD,FR,FR,2020,Q2,Adult
176576651,17657665,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200315.0,20200409.0,20200411,20200411,EXP,FR-AFSSAPS-PO20200377,FR-SA-2020SA092645,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20200411.0,,MD,FR,FR,2020,Q2,Adult
176585862,17658586,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,2,F,,20200410.0,20200412,20200414,PER,,US-SA-2020SA093554,SANOFI AVENTIS,,10.0,DY,N,,Y,2.7,KG,20200414.0,,PH,US,US,2020,Q2,Child
176585862,17658586,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2020,Q2,Product use issue,,2020,Q2,2,F,,20200410.0,20200412,20200414,PER,,US-SA-2020SA093554,SANOFI AVENTIS,,10.0,DY,N,,Y,2.7,KG,20200414.0,,PH,US,US,2020,Q2,Child
176593353,17659335,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, ACHC",,,U,,,,,,,,,2020,Q2,Haemorrhage intracranial,,2020,Q2,3,F,20200401.0,20200520.0,20200413,20200526,EXP,,US-SA-2020SA092989,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20200526.0,,MD,US,US,2020,Q2,Elderly
176593353,17659335,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, ACHC",,,U,,,,,,,,,2020,Q2,Infusion related reaction,,2020,Q2,3,F,20200401.0,20200520.0,20200413,20200526,EXP,,US-SA-2020SA092989,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20200526.0,,MD,US,US,2020,Q2,Elderly
176593613,17659361,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"VARYING IU, Q6H, AS NEEDED",,,U,,,,,,,,,2020,Q2,Acute respiratory failure,,2020,Q2,3,F,20200326.0,20200507.0,20200413,20200518,EXP,,US-SA-2020SA091169,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20200518.0,,MD,US,US,2020,Q2,Elderly
176593613,17659361,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"VARYING IU, Q6H, AS NEEDED",,,U,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,3,F,20200326.0,20200507.0,20200413,20200518,EXP,,US-SA-2020SA091169,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20200518.0,,MD,US,US,2020,Q2,Elderly
176593613,17659361,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"VARYING IU, Q6H, AS NEEDED",,,U,,,,,,,,,2020,Q2,Atrial fibrillation,,2020,Q2,3,F,20200326.0,20200507.0,20200413,20200518,EXP,,US-SA-2020SA091169,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20200518.0,,MD,US,US,2020,Q2,Elderly
176593613,17659361,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"VARYING IU, Q6H, AS NEEDED",,,U,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,3,F,20200326.0,20200507.0,20200413,20200518,EXP,,US-SA-2020SA091169,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20200518.0,,MD,US,US,2020,Q2,Elderly
176615381,17661538,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Increased bronchial secretion,,2020,Q2,1,I,202002.0,20200226.0,20200413,20200413,PER,,US-VERTEX PHARMACEUTICALS-2020-004767,VERTEX,,20.0,YR,,M,Y,,,20200413.0,,PH,US,US,2020,Q2,Youth
176615381,17661538,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Nasopharyngitis,,2020,Q2,1,I,202002.0,20200226.0,20200413,20200413,PER,,US-VERTEX PHARMACEUTICALS-2020-004767,VERTEX,,20.0,YR,,M,Y,,,20200413.0,,PH,US,US,2020,Q2,Youth
176615381,17661538,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Productive cough,,2020,Q2,1,I,202002.0,20200226.0,20200413,20200413,PER,,US-VERTEX PHARMACEUTICALS-2020-004767,VERTEX,,20.0,YR,,M,Y,,,20200413.0,,PH,US,US,2020,Q2,Youth
176615381,17661538,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Scrotal inflammation,,2020,Q2,1,I,202002.0,20200226.0,20200413,20200413,PER,,US-VERTEX PHARMACEUTICALS-2020-004767,VERTEX,,20.0,YR,,M,Y,,,20200413.0,,PH,US,US,2020,Q2,Youth
176615381,17661538,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Scrotal oedema,,2020,Q2,1,I,202002.0,20200226.0,20200413,20200413,PER,,US-VERTEX PHARMACEUTICALS-2020-004767,VERTEX,,20.0,YR,,M,Y,,,20200413.0,,PH,US,US,2020,Q2,Youth
176615381,17661538,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Testicular disorder,,2020,Q2,1,I,202002.0,20200226.0,20200413,20200413,PER,,US-VERTEX PHARMACEUTICALS-2020-004767,VERTEX,,20.0,YR,,M,Y,,,20200413.0,,PH,US,US,2020,Q2,Youth
176629122,17662912,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2020,Q2,Dehydration,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2020,Q2,Glycosuria,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2020,Q2,Metabolic acidosis,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2020,Q2,Oedema,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2020,Q2,Peripheral swelling,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2020,Q2,Polydipsia,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2020,Q2,Product dose omission,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2020,Q2,Treatment noncompliance,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2020,Q2,Weight decreased,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2020,Q2,Weight increased,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176639392,17663939,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,U,,,20563.0,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200326.0,20200410.0,20200414,20200421,PER,,US-ELI_LILLY_AND_COMPANY-US202004004002,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Adult
176639392,17663939,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,U,,,20563.0,,,INJECTION,,2020,Q2,Incorrect product administration duration,,2020,Q2,2,F,20200326.0,20200410.0,20200414,20200421,PER,,US-ELI_LILLY_AND_COMPANY-US202004004002,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Adult
176639392,17663939,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,U,,,20563.0,,,INJECTION,,2020,Q2,Stress,,2020,Q2,2,F,20200326.0,20200410.0,20200414,20200421,PER,,US-ELI_LILLY_AND_COMPANY-US202004004002,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Adult
176639392,17663939,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,U, C812956E,,20563.0,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200326.0,20200410.0,20200414,20200421,PER,,US-ELI_LILLY_AND_COMPANY-US202004004002,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Adult
176639392,17663939,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,U, C812956E,,20563.0,,,INJECTION,,2020,Q2,Incorrect product administration duration,,2020,Q2,2,F,20200326.0,20200410.0,20200414,20200421,PER,,US-ELI_LILLY_AND_COMPANY-US202004004002,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Adult
176639392,17663939,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,U, C812956E,,20563.0,,,INJECTION,,2020,Q2,Stress,,2020,Q2,2,F,20200326.0,20200410.0,20200414,20200421,PER,,US-ELI_LILLY_AND_COMPANY-US202004004002,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Adult
176640161,17664016,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 IU / ML, ACCORDING TO PLAN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Dizziness,,2020,Q2,1,I,,20200410.0,20200414,20200414,EXP,,DE-SA-2020SA095697,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20200414.0,,MD,DE,DE,2020,Q2,Elderly
176640161,17664016,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 IU / ML, ACCORDING TO PLAN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Fall,,2020,Q2,1,I,,20200410.0,20200414,20200414,EXP,,DE-SA-2020SA095697,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20200414.0,,MD,DE,DE,2020,Q2,Elderly
176640161,17664016,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 IU / ML, ACCORDING TO PLAN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200410.0,20200414,20200414,EXP,,DE-SA-2020SA095697,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20200414.0,,MD,DE,DE,2020,Q2,Elderly
176640161,17664016,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 IU / ML, ACCORDING TO PLAN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Headache,,2020,Q2,1,I,,20200410.0,20200414,20200414,EXP,,DE-SA-2020SA095697,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20200414.0,,MD,DE,DE,2020,Q2,Elderly
176640161,17664016,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 IU / ML, ACCORDING TO PLAN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hyperhidrosis,,2020,Q2,1,I,,20200410.0,20200414,20200414,EXP,,DE-SA-2020SA095697,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20200414.0,,MD,DE,DE,2020,Q2,Elderly
176640161,17664016,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 IU / ML, ACCORDING TO PLAN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200410.0,20200414,20200414,EXP,,DE-SA-2020SA095697,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20200414.0,,MD,DE,DE,2020,Q2,Elderly
176641221,17664122,2,SS,INSULINA LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200123.0,20200410.0,20200414,20200414,EXP,,IT-EMD SERONO-9157257,EMD SERONO INC,,74.0,YR,,M,Y,,,20200414.0,,MD,IT,IT,2020,Q2,Elderly
176641221,17664122,3,SS,INSULINA LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE REDUCED,,,,,,,,,,INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200123.0,20200410.0,20200414,20200414,EXP,,IT-EMD SERONO-9157257,EMD SERONO INC,,74.0,YR,,M,Y,,,20200414.0,,MD,IT,IT,2020,Q2,Elderly
176644691,17664469,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"16 U, DAILY",,,,,,,,,,,,2020,Q2,Bone marrow failure,,2020,Q2,1,I,,20200331.0,20200414,20200414,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-243933,RANBAXY,"OHARA N, KOBAYASHI M, IKEDA Y, HOSHI T, MORITA S, KANEFUJI T, ET AL.. NON-INSULIN-DEPENDENT DIABETES MELLITUS INDUCED BY IMMUNE CHECKPOINT INHIBITOR THERAPY IN AN INSULINOMA-ASSOCIATED ANTIGEN-2 AUTOANTIBODY-POSITIVE PATIENT WITH ADVANCED GASTRIC CANCER. INTERN MED. 2020;59(4):551-556",70.0,YR,,M,Y,,,20200414.0,,MD,JP,JP,2020,Q2,Elderly
176644691,17664469,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"16 U, DAILY",,,,,,,,,,,,2020,Q2,Decreased appetite,,2020,Q2,1,I,,20200331.0,20200414,20200414,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-243933,RANBAXY,"OHARA N, KOBAYASHI M, IKEDA Y, HOSHI T, MORITA S, KANEFUJI T, ET AL.. NON-INSULIN-DEPENDENT DIABETES MELLITUS INDUCED BY IMMUNE CHECKPOINT INHIBITOR THERAPY IN AN INSULINOMA-ASSOCIATED ANTIGEN-2 AUTOANTIBODY-POSITIVE PATIENT WITH ADVANCED GASTRIC CANCER. INTERN MED. 2020;59(4):551-556",70.0,YR,,M,Y,,,20200414.0,,MD,JP,JP,2020,Q2,Elderly
176644691,17664469,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"16 U, DAILY",,,,,,,,,,,,2020,Q2,Disease progression,,2020,Q2,1,I,,20200331.0,20200414,20200414,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-243933,RANBAXY,"OHARA N, KOBAYASHI M, IKEDA Y, HOSHI T, MORITA S, KANEFUJI T, ET AL.. NON-INSULIN-DEPENDENT DIABETES MELLITUS INDUCED BY IMMUNE CHECKPOINT INHIBITOR THERAPY IN AN INSULINOMA-ASSOCIATED ANTIGEN-2 AUTOANTIBODY-POSITIVE PATIENT WITH ADVANCED GASTRIC CANCER. INTERN MED. 2020;59(4):551-556",70.0,YR,,M,Y,,,20200414.0,,MD,JP,JP,2020,Q2,Elderly
176644691,17664469,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"16 U, DAILY",,,,,,,,,,,,2020,Q2,Lymphadenopathy,,2020,Q2,1,I,,20200331.0,20200414,20200414,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-243933,RANBAXY,"OHARA N, KOBAYASHI M, IKEDA Y, HOSHI T, MORITA S, KANEFUJI T, ET AL.. NON-INSULIN-DEPENDENT DIABETES MELLITUS INDUCED BY IMMUNE CHECKPOINT INHIBITOR THERAPY IN AN INSULINOMA-ASSOCIATED ANTIGEN-2 AUTOANTIBODY-POSITIVE PATIENT WITH ADVANCED GASTRIC CANCER. INTERN MED. 2020;59(4):551-556",70.0,YR,,M,Y,,,20200414.0,,MD,JP,JP,2020,Q2,Elderly
176644691,17664469,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"16 U, DAILY",,,,,,,,,,,,2020,Q2,Weight decreased,,2020,Q2,1,I,,20200331.0,20200414,20200414,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-243933,RANBAXY,"OHARA N, KOBAYASHI M, IKEDA Y, HOSHI T, MORITA S, KANEFUJI T, ET AL.. NON-INSULIN-DEPENDENT DIABETES MELLITUS INDUCED BY IMMUNE CHECKPOINT INHIBITOR THERAPY IN AN INSULINOMA-ASSOCIATED ANTIGEN-2 AUTOANTIBODY-POSITIVE PATIENT WITH ADVANCED GASTRIC CANCER. INTERN MED. 2020;59(4):551-556",70.0,YR,,M,Y,,,20200414.0,,MD,JP,JP,2020,Q2,Elderly
176647221,17664722,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT IN MORNING. 25/75 100UNITS/ML, 3ML",,,,,,,,24.0,IU,INJECTION,,2020,Q2,Orthostatic hypotension,,2020,Q2,1,I,20200220.0,20200402.0,20200414,20200414,EXP,GB-MHRA-ADR 24486860,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-000440,EMCURE,,73.0,YR,,M,Y,,,20200414.0,,PH,GB,GB,2020,Q2,Elderly
176647221,17664722,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT IN MORNING. 25/75 100UNITS/ML, 3ML",,,,,,,,24.0,IU,INJECTION,,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,1,I,20200220.0,20200402.0,20200414,20200414,EXP,GB-MHRA-ADR 24486860,GB-EMCURE PHARMACEUTICALS LTD-2020-EPL-000440,EMCURE,,73.0,YR,,M,Y,,,20200414.0,,PH,GB,GB,2020,Q2,Elderly
176681102,17668110,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q2,Blood glucose decreased,,2020,Q2,2,F,202002.0,20200413.0,20200414,20200422,EXP,,US-ELI_LILLY_AND_COMPANY-US202004002102,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200422.0,,CN,US,US,2020,Q2,Adult
176681102,17668110,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q2,Drug ineffective,,2020,Q2,2,F,202002.0,20200413.0,20200414,20200422,EXP,,US-ELI_LILLY_AND_COMPANY-US202004002102,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200422.0,,CN,US,US,2020,Q2,Adult
176681102,17668110,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,202002.0,20200413.0,20200414,20200422,EXP,,US-ELI_LILLY_AND_COMPANY-US202004002102,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200422.0,,CN,US,US,2020,Q2,Adult
176681102,17668110,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q2,Hyperhidrosis,,2020,Q2,2,F,202002.0,20200413.0,20200414,20200422,EXP,,US-ELI_LILLY_AND_COMPANY-US202004002102,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200422.0,,CN,US,US,2020,Q2,Adult
176681102,17668110,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2020,Q2,Mobility decreased,,2020,Q2,2,F,202002.0,20200413.0,20200414,20200422,EXP,,US-ELI_LILLY_AND_COMPANY-US202004002102,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200422.0,,CN,US,US,2020,Q2,Adult
176687231,17668723,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, ONCE A DAY (IN MORNING. 25/75 100UNITS/ML, 3ML)",,,U,,,,,24.0,IU,SUSPENSION FOR INJECTION,QD,2020,Q2,Orthostatic hypotension,,2020,Q2,1,I,20200220.0,20200406.0,20200415,20200415,EXP,,GB-AUROBINDO-AUR-APL-2020-017923,AUROBINDO,,73.0,YR,,M,Y,,,20200415.0,,PH,GB,GB,2020,Q2,Elderly
176687231,17668723,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, ONCE A DAY (IN MORNING. 25/75 100UNITS/ML, 3ML)",,,U,,,,,24.0,IU,SUSPENSION FOR INJECTION,QD,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,1,I,20200220.0,20200406.0,20200415,20200415,EXP,,GB-AUROBINDO-AUR-APL-2020-017923,AUROBINDO,,73.0,YR,,M,Y,,,20200415.0,,PH,GB,GB,2020,Q2,Elderly
176735861,17673586,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subdermal,"26 IU, QD",2626.0,IU,Y,,,,209196.0,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Drug interaction,,2020,Q2,1,I,20200309.0,20200414.0,20200415,20200415,EXP,IT-MINISAL02-614139,IT-SA-2020SA097155,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200415.0,,MD,IT,IT,2020,Q2,Adult
176735861,17673586,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subdermal,"26 IU, QD",2626.0,IU,Y,,,,209196.0,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200309.0,20200414.0,20200415,20200415,EXP,IT-MINISAL02-614139,IT-SA-2020SA097155,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200415.0,,MD,IT,IT,2020,Q2,Adult
176735861,17673586,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subdermal,"26 IU, QD",2626.0,IU,Y,,,,209196.0,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Loss of consciousness,,2020,Q2,1,I,20200309.0,20200414.0,20200415,20200415,EXP,IT-MINISAL02-614139,IT-SA-2020SA097155,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200415.0,,MD,IT,IT,2020,Q2,Adult
176735861,17673586,4,I,INSULIN LISPRO,INSULIN LISPRO,1,Subdermal,UNK,2626.0,IU,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Drug interaction,,2020,Q2,1,I,20200309.0,20200414.0,20200415,20200415,EXP,IT-MINISAL02-614139,IT-SA-2020SA097155,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200415.0,,MD,IT,IT,2020,Q2,Adult
176735861,17673586,4,I,INSULIN LISPRO,INSULIN LISPRO,1,Subdermal,UNK,2626.0,IU,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200309.0,20200414.0,20200415,20200415,EXP,IT-MINISAL02-614139,IT-SA-2020SA097155,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200415.0,,MD,IT,IT,2020,Q2,Adult
176735861,17673586,4,I,INSULIN LISPRO,INSULIN LISPRO,1,Subdermal,UNK,2626.0,IU,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Loss of consciousness,,2020,Q2,1,I,20200309.0,20200414.0,20200415,20200415,EXP,IT-MINISAL02-614139,IT-SA-2020SA097155,SANOFI AVENTIS,,49.0,YR,A,M,Y,,,20200415.0,,MD,IT,IT,2020,Q2,Adult
176763692,17676369,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"32 INTERNATIONAL UNIT, ONCE A DAY, (8 AT BREAKFAST, 10 FOR LUNCH, 14 FOR DINNER)",,,U,U,,,,32.0,IU,,QD,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,,20200420.0,20200416,20200429,EXP,,IT-AUROBINDO-AUR-APL-2020-018717,AUROBINDO,,55.0,YR,,M,Y,,,20200429.0,,MD,IT,IT,2020,Q2,Adult
176763692,17676369,5,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY, (10 BREAKFAST + 14 LUNCH + 18 DINNER IU)",,,U,U,,,,42.0,IU,,QD,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,,20200420.0,20200416,20200429,EXP,,IT-AUROBINDO-AUR-APL-2020-018717,AUROBINDO,,55.0,YR,,M,Y,,,20200429.0,,MD,IT,IT,2020,Q2,Adult
176774311,17677431,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,1,I,20180929.0,20200413.0,20200416,20200416,EXP,,US-PFIZER INC-2020153767,PFIZER,,67.0,YR,,M,Y,92.8,KG,20200416.0,,MD,US,US,2020,Q2,Elderly
176774311,17677431,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Urinary retention,,2020,Q2,1,I,20180929.0,20200413.0,20200416,20200416,EXP,,US-PFIZER INC-2020153767,PFIZER,,67.0,YR,,M,Y,92.8,KG,20200416.0,,MD,US,US,2020,Q2,Elderly
176791181,17679118,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, IN MORNING. 25/75 100UNITS/ML, 3ML",,,,,,,,,,SUSPENSION FOR INJECTION,,2020,Q2,Orthostatic hypotension,Orthostatic hypotension,2020,Q2,1,I,20200220.0,20200406.0,20200417,20200417,EXP,GB-MHRA-MIDB-853EB3A7-4D81-44CC-BDA2-E41235A70E2F,GB-ALVOGEN-2020-ALVOGEN-108145,ALVOGEN,,73.0,YR,,M,Y,,,20200417.0,,CN,GB,GB,2020,Q2,Elderly
176791181,17679118,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, IN MORNING. 25/75 100UNITS/ML, 3ML",,,,,,,,,,SUSPENSION FOR INJECTION,,2020,Q2,Subarachnoid haemorrhage,Subarachnoid haemorrhage,2020,Q2,1,I,20200220.0,20200406.0,20200417,20200417,EXP,GB-MHRA-MIDB-853EB3A7-4D81-44CC-BDA2-E41235A70E2F,GB-ALVOGEN-2020-ALVOGEN-108145,ALVOGEN,,73.0,YR,,M,Y,,,20200417.0,,CN,GB,GB,2020,Q2,Elderly
176815911,17681591,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(8 AT BREAKFAST, 10 FOR LUNCH, 14 FOR DINNER)",,,U,,,,,32.0,IU,,QD,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,,20200409.0,20200417,20200417,EXP,,IT-BAUSCH-BL-2020-011038,BAUSCH AND LOMB,,55.0,YR,,M,Y,,,20200417.0,,MD,IT,IT,2020,Q2,Adult
176815911,17681591,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(10 BREAKFAST PLUS 14 LUNCH PLUS 18 DINNER IU),,,U,,,,,42.0,IU,,QD,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,,20200409.0,20200417,20200417,EXP,,IT-BAUSCH-BL-2020-011038,BAUSCH AND LOMB,,55.0,YR,,M,Y,,,20200417.0,,MD,IT,IT,2020,Q2,Adult
176838951,17683895,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU, TID (BEFORE MEAL)",,,U,,,,,6.0,IU,,Q8H,2020,Q2,Epilepsy,,2020,Q2,1,I,,20200415.0,20200420,20200420,EXP,,RU-SA-2020SA099903,SANOFI AVENTIS,,50.0,YR,A,M,Y,,,20200420.0,,MD,RU,RU,2020,Q2,Adult
176838951,17683895,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU, TID (BEFORE MEAL)",,,U,,,,,6.0,IU,,Q8H,2020,Q2,Fatigue,,2020,Q2,1,I,,20200415.0,20200420,20200420,EXP,,RU-SA-2020SA099903,SANOFI AVENTIS,,50.0,YR,A,M,Y,,,20200420.0,,MD,RU,RU,2020,Q2,Adult
176838951,17683895,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU, TID (BEFORE MEAL)",,,U,,,,,6.0,IU,,Q8H,2020,Q2,Headache,,2020,Q2,1,I,,20200415.0,20200420,20200420,EXP,,RU-SA-2020SA099903,SANOFI AVENTIS,,50.0,YR,A,M,Y,,,20200420.0,,MD,RU,RU,2020,Q2,Adult
176838951,17683895,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU, TID (BEFORE MEAL)",,,U,,,,,6.0,IU,,Q8H,2020,Q2,Hypoaesthesia,,2020,Q2,1,I,,20200415.0,20200420,20200420,EXP,,RU-SA-2020SA099903,SANOFI AVENTIS,,50.0,YR,A,M,Y,,,20200420.0,,MD,RU,RU,2020,Q2,Adult
176842071,17684207,3,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, QD",14760.0,IU,Y,,,,,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Drug interaction,,2020,Q2,1,I,20200125.0,20200227.0,20200420,20200420,EXP,IT-MINISAL02-606767,IT-SA-2020SA052948,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200420.0,,MD,IT,IT,2020,Q2,Elderly
176842071,17684207,3,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, QD",14760.0,IU,Y,,,,,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200125.0,20200227.0,20200420,20200420,EXP,IT-MINISAL02-606767,IT-SA-2020SA052948,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200420.0,,MD,IT,IT,2020,Q2,Elderly
176844181,17684418,2,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q2,Localised oedema,Localised oedema,2020,Q2,1,I,,20200413.0,20200420,20200420,EXP,,CN-NEOPHARMA INC-000326,NEOPHARMA,,76.0,YR,E,F,Y,,,20200420.0,,HP,CN,CN,2020,Q2,Elderly
176844181,17684418,2,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q2,Oedema,Oedema,2020,Q2,1,I,,20200413.0,20200420,20200420,EXP,,CN-NEOPHARMA INC-000326,NEOPHARMA,,76.0,YR,E,F,Y,,,20200420.0,,HP,CN,CN,2020,Q2,Elderly
176844181,17684418,2,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q2,Pleural effusion,Pleural effusion,2020,Q2,1,I,,20200413.0,20200420,20200420,EXP,,CN-NEOPHARMA INC-000326,NEOPHARMA,,76.0,YR,E,F,Y,,,20200420.0,,HP,CN,CN,2020,Q2,Elderly
176844181,17684418,2,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q2,Weight increased,Weight increased,2020,Q2,1,I,,20200413.0,20200420,20200420,EXP,,CN-NEOPHARMA INC-000326,NEOPHARMA,,76.0,YR,E,F,Y,,,20200420.0,,HP,CN,CN,2020,Q2,Elderly
176847171,17684717,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 UNIT WITH BREAKFAST,",,,,,,,,,,INJECTION,QD,2020,Q2,Febrile neutropenia,,2020,Q2,1,I,20200311.0,20200408.0,20200420,20200420,EXP,,US-FRESENIUS KABI-FK202003865,FRESENIUS KABI,,68.0,YR,,M,Y,71.1,KG,20200420.0,,MD,US,US,2020,Q2,Elderly
176847171,17684717,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 UNIT WITH BREAKFAST,",,,,,,,,,,INJECTION,QD,2020,Q2,Neurotoxicity,,2020,Q2,1,I,20200311.0,20200408.0,20200420,20200420,EXP,,US-FRESENIUS KABI-FK202003865,FRESENIUS KABI,,68.0,YR,,M,Y,71.1,KG,20200420.0,,MD,US,US,2020,Q2,Elderly
176847171,17684717,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0-10 UNIT,,,,,,,,,,INJECTION,TID,2020,Q2,Febrile neutropenia,,2020,Q2,1,I,20200311.0,20200408.0,20200420,20200420,EXP,,US-FRESENIUS KABI-FK202003865,FRESENIUS KABI,,68.0,YR,,M,Y,71.1,KG,20200420.0,,MD,US,US,2020,Q2,Elderly
176847171,17684717,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0-10 UNIT,,,,,,,,,,INJECTION,TID,2020,Q2,Neurotoxicity,,2020,Q2,1,I,20200311.0,20200408.0,20200420,20200420,EXP,,US-FRESENIUS KABI-FK202003865,FRESENIUS KABI,,68.0,YR,,M,Y,71.1,KG,20200420.0,,MD,US,US,2020,Q2,Elderly
176847171,17684717,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10-20 UNIT WITH LUNCH,,,,,,,,,,INJECTION,,2020,Q2,Febrile neutropenia,,2020,Q2,1,I,20200311.0,20200408.0,20200420,20200420,EXP,,US-FRESENIUS KABI-FK202003865,FRESENIUS KABI,,68.0,YR,,M,Y,71.1,KG,20200420.0,,MD,US,US,2020,Q2,Elderly
176847171,17684717,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10-20 UNIT WITH LUNCH,,,,,,,,,,INJECTION,,2020,Q2,Neurotoxicity,,2020,Q2,1,I,20200311.0,20200408.0,20200420,20200420,EXP,,US-FRESENIUS KABI-FK202003865,FRESENIUS KABI,,68.0,YR,,M,Y,71.1,KG,20200420.0,,MD,US,US,2020,Q2,Elderly
176851221,17685122,1,PS,insulin lispro,INSULIN LISPRO,1,Subcutaneous,?          QUANTITY:1 INJECTION(S);?,,,Y,Y, C999324C,20210930,,,,SUSPENSION FOR INJECTION,QD,2020,Q2,Dizziness,,2020,Q2,1,I,20200413.0,,20200420,20200420,DIR,,,FDA-CTU,,65.0,YR,,F,N,52.65,KG,20200420.0,N,CN,US,US,2020,Q2,Elderly
176851221,17685122,1,PS,insulin lispro,INSULIN LISPRO,1,Subcutaneous,?          QUANTITY:1 INJECTION(S);?,,,Y,Y, C999324C,20210930,,,,SUSPENSION FOR INJECTION,QD,2020,Q2,Peripheral swelling,,2020,Q2,1,I,20200413.0,,20200420,20200420,DIR,,,FDA-CTU,,65.0,YR,,F,N,52.65,KG,20200420.0,N,CN,US,US,2020,Q2,Elderly
176851221,17685122,1,PS,insulin lispro,INSULIN LISPRO,1,Subcutaneous,?          QUANTITY:1 INJECTION(S);?,,,Y,Y, C999324C,20210930,,,,SUSPENSION FOR INJECTION,QD,2020,Q2,Tachycardia,,2020,Q2,1,I,20200413.0,,20200420,20200420,DIR,,,FDA-CTU,,65.0,YR,,F,N,52.65,KG,20200420.0,N,CN,US,US,2020,Q2,Elderly
176851221,17685122,1,PS,insulin lispro,INSULIN LISPRO,1,Subcutaneous,?          QUANTITY:1 INJECTION(S);?,,,Y,Y, C999324C,20210930,,,,SUSPENSION FOR INJECTION,QD,2020,Q2,Tremor,,2020,Q2,1,I,20200413.0,,20200420,20200420,DIR,,,FDA-CTU,,65.0,YR,,F,N,52.65,KG,20200420.0,N,CN,US,US,2020,Q2,Elderly
176851221,17685122,1,PS,insulin lispro,INSULIN LISPRO,1,Subcutaneous,?          QUANTITY:1 INJECTION(S);?,,,Y,Y, C999324C,20210930,,,,SUSPENSION FOR INJECTION,QD,2020,Q2,Visual impairment,,2020,Q2,1,I,20200413.0,,20200420,20200420,DIR,,,FDA-CTU,,65.0,YR,,F,N,52.65,KG,20200420.0,N,CN,US,US,2020,Q2,Elderly
176858851,17685885,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,UNK,,2020,Q2,Oedema,,2020,Q2,1,I,,20200414.0,20200420,20200420,EXP,,CN-TAKEDA-2020TJP007983,TAKEDA,"XUE J, LIU W, SHI F, ZHENG J, MA J.. PLEURAL EFFUSION DUE TO USE OF PIOGLITAZONE: A CASE REPORT.. METABOLIC SYNDROME AND RELATED DISORDERS.. 2020;18(3):168-171",76.0,YR,,F,Y,,,20200420.0,,MD,CN,CN,2020,Q2,Elderly
176858851,17685885,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,UNK,,2020,Q2,Pleural effusion,,2020,Q2,1,I,,20200414.0,20200420,20200420,EXP,,CN-TAKEDA-2020TJP007983,TAKEDA,"XUE J, LIU W, SHI F, ZHENG J, MA J.. PLEURAL EFFUSION DUE TO USE OF PIOGLITAZONE: A CASE REPORT.. METABOLIC SYNDROME AND RELATED DISORDERS.. 2020;18(3):168-171",76.0,YR,,F,Y,,,20200420.0,,MD,CN,CN,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Asthma,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Blood count abnormal,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Chest discomfort,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Diaphragmatic disorder,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Discomfort,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Dyspnoea,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Hypoxia,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Left ventricular hypertrophy,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Obstructive airways disorder,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Oedema peripheral,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Oropharyngeal pain,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176891471,17689147,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, BID",,,,,,,,,,,BID,2020,Q2,Weight increased,,2020,Q2,1,I,,20200411.0,20200421,20200421,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202004004242,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20200421.0,,CN,CA,CA,2020,Q2,Elderly
176903351,17690335,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"600 IE, 4-6-8-0",,,,,,,,,,,,2020,Q2,Spinal pain,,2020,Q2,1,I,20190926.0,20200412.0,20200421,20200421,EXP,,DE-BAUSCH-BL-2020-011367,BAUSCH AND LOMB,,80.0,YR,,F,Y,,,20200421.0,,MD,DE,DE,2020,Q2,Elderly
176906231,17690623,10,C,Insulin lispro,INSULIN LISPRO,1,,"600 IE, 4-6-8-0",,,,, UNKNOWN,,,,,,,2020,Q2,Spinal pain,,2020,Q2,1,I,20190926.0,20200414.0,20200421,20200421,EXP,,DE-TEVA-2020-DE-1226014,TEVA,,80.0,YR,,F,Y,,,20200422.0,,MD,DE,DE,2020,Q2,Elderly
176924521,17692452,13,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hospice care,,2020,Q2,1,I,20200421.0,,20200421,20200421,DIR,,,FDA-CTU,,76.0,YR,,M,N,72.9,KG,20200421.0,N,MD,US,US,2020,Q2,Elderly
176977062,17697706,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, TID (8-12 UNITS WITH BREAKFAST, LUNCH, AND DINNER)",,,U,U, D142268A,,,12.0,IU,SOLUTION FOR INJECTION,TID,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200412.0,20200421.0,20200423,20200427,PER,,US-ELI_LILLY_AND_COMPANY-US202004008482,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20200427.0,,CN,US,US,2020,Q2,Elderly
176977062,17697706,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, TID (8-12 UNITS WITH BREAKFAST, LUNCH, AND DINNER)",,,U,U, D142268A,,,12.0,IU,SOLUTION FOR INJECTION,TID,2020,Q2,Drug ineffective,,2020,Q2,2,F,20200412.0,20200421.0,20200423,20200427,PER,,US-ELI_LILLY_AND_COMPANY-US202004008482,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20200427.0,,CN,US,US,2020,Q2,Elderly
176977062,17697706,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, TID (8-12 UNITS WITH BREAKFAST, LUNCH, AND DINNER)",,,U,U, D142268A,,,12.0,IU,SOLUTION FOR INJECTION,TID,2020,Q2,Wrong product administered,,2020,Q2,2,F,20200412.0,20200421.0,20200423,20200427,PER,,US-ELI_LILLY_AND_COMPANY-US202004008482,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20200427.0,,CN,US,US,2020,Q2,Elderly
176977062,17697706,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"24 U, TID",,,U,U, D142268A,,,24.0,IU,SOLUTION FOR INJECTION,TID,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200412.0,20200421.0,20200423,20200427,PER,,US-ELI_LILLY_AND_COMPANY-US202004008482,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20200427.0,,CN,US,US,2020,Q2,Elderly
176977062,17697706,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"24 U, TID",,,U,U, D142268A,,,24.0,IU,SOLUTION FOR INJECTION,TID,2020,Q2,Drug ineffective,,2020,Q2,2,F,20200412.0,20200421.0,20200423,20200427,PER,,US-ELI_LILLY_AND_COMPANY-US202004008482,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20200427.0,,CN,US,US,2020,Q2,Elderly
176977062,17697706,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"24 U, TID",,,U,U, D142268A,,,24.0,IU,SOLUTION FOR INJECTION,TID,2020,Q2,Wrong product administered,,2020,Q2,2,F,20200412.0,20200421.0,20200423,20200427,PER,,US-ELI_LILLY_AND_COMPANY-US202004008482,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20200427.0,,CN,US,US,2020,Q2,Elderly
176977062,17697706,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C997208A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200412.0,20200421.0,20200423,20200427,PER,,US-ELI_LILLY_AND_COMPANY-US202004008482,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20200427.0,,CN,US,US,2020,Q2,Elderly
176977062,17697706,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C997208A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,2,F,20200412.0,20200421.0,20200423,20200427,PER,,US-ELI_LILLY_AND_COMPANY-US202004008482,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20200427.0,,CN,US,US,2020,Q2,Elderly
176977062,17697706,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C997208A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Wrong product administered,,2020,Q2,2,F,20200412.0,20200421.0,20200423,20200427,PER,,US-ELI_LILLY_AND_COMPANY-US202004008482,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20200427.0,,CN,US,US,2020,Q2,Elderly
176992103,17699210,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Abdominal discomfort,,2020,Q2,3,F,202002.0,20200611.0,20200423,20200617,PER,,US-VERTEX PHARMACEUTICALS-2020-009097,VERTEX,,30.0,YR,,F,Y,,,20200617.0,,MD,US,US,2020,Q2,Young Adult
176992103,17699210,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,3,F,202002.0,20200611.0,20200423,20200617,PER,,US-VERTEX PHARMACEUTICALS-2020-009097,VERTEX,,30.0,YR,,F,Y,,,20200617.0,,MD,US,US,2020,Q2,Young Adult
177002131,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q2,Aphonia,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q2,Dizziness,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q2,Drug ineffective,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q2,Frequent bowel movements,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q2,Insomnia,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q2,Insulin resistance,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q2,Aphonia,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q2,Dizziness,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q2,Drug ineffective,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q2,Frequent bowel movements,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q2,Insomnia,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q2,Insulin resistance,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177058061,17705806,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, 1X/DAY (IN MORNING. 25/75 100UNITS/ML, 3ML)",,,,, UNKNOWN,,,24.0,IU,SUSPENSION FOR INJECTION,QD,2020,Q2,Orthostatic hypotension,,2020,Q2,1,I,20200220.0,20200422.0,20200424,20200424,EXP,GB-MHRA-MIDB-853EB3A7-4D81-44CC-BDA2-E41235A70E2F,GB-PFIZER INC-2020162778,PFIZER,,73.0,YR,,M,Y,,,20200424.0,,PH,GB,GB,2020,Q2,Elderly
177058061,17705806,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, 1X/DAY (IN MORNING. 25/75 100UNITS/ML, 3ML)",,,,, UNKNOWN,,,24.0,IU,SUSPENSION FOR INJECTION,QD,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,1,I,20200220.0,20200422.0,20200424,20200424,EXP,GB-MHRA-MIDB-853EB3A7-4D81-44CC-BDA2-E41235A70E2F,GB-PFIZER INC-2020162778,PFIZER,,73.0,YR,,M,Y,,,20200424.0,,PH,GB,GB,2020,Q2,Elderly
177071842,17707184,2,I,Insulin Lispro,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,2,F,,20200424.0,20200424,20200503,EXP,,CN-ACCORD-179562,ACCORD,"XUE J, LIU W, SHI F, ZHENG J, MA J. PLEURAL EFFUSION DUE TO USE OF PIOGLITAZONE: A CASE REPORT. METAB SYNDR RELAT DISORD. 2020 APR;18(3):168-171.",76.0,YR,,F,Y,,,20200504.0,,MD,CN,CN,2020,Q2,Elderly
177071842,17707184,2,I,Insulin Lispro,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q2,Generalised oedema,,2020,Q2,2,F,,20200424.0,20200424,20200503,EXP,,CN-ACCORD-179562,ACCORD,"XUE J, LIU W, SHI F, ZHENG J, MA J. PLEURAL EFFUSION DUE TO USE OF PIOGLITAZONE: A CASE REPORT. METAB SYNDR RELAT DISORD. 2020 APR;18(3):168-171.",76.0,YR,,F,Y,,,20200504.0,,MD,CN,CN,2020,Q2,Elderly
177071842,17707184,2,I,Insulin Lispro,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,2,F,,20200424.0,20200424,20200503,EXP,,CN-ACCORD-179562,ACCORD,"XUE J, LIU W, SHI F, ZHENG J, MA J. PLEURAL EFFUSION DUE TO USE OF PIOGLITAZONE: A CASE REPORT. METAB SYNDR RELAT DISORD. 2020 APR;18(3):168-171.",76.0,YR,,F,Y,,,20200504.0,,MD,CN,CN,2020,Q2,Elderly
177083981,17708398,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,DOSE DEPENDS ON BLOOD GLUCOSE,,,U,U,,,,,,,,2020,Q2,Cough,,2020,Q2,1,I,20190608.0,20190613.0,20200426,20200426,EXP,,PHHY2019BR140214,NOVARTIS,,66.0,YR,,F,Y,,,20200426.0,,CN,BR,BR,2020,Q2,Elderly
177083981,17708398,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,DOSE DEPENDS ON BLOOD GLUCOSE,,,U,U,,,,,,,,2020,Q2,Decreased immune responsiveness,,2020,Q2,1,I,20190608.0,20190613.0,20200426,20200426,EXP,,PHHY2019BR140214,NOVARTIS,,66.0,YR,,F,Y,,,20200426.0,,CN,BR,BR,2020,Q2,Elderly
177083981,17708398,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,DOSE DEPENDS ON BLOOD GLUCOSE,,,U,U,,,,,,,,2020,Q2,Diabetes mellitus,,2020,Q2,1,I,20190608.0,20190613.0,20200426,20200426,EXP,,PHHY2019BR140214,NOVARTIS,,66.0,YR,,F,Y,,,20200426.0,,CN,BR,BR,2020,Q2,Elderly
177083981,17708398,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,DOSE DEPENDS ON BLOOD GLUCOSE,,,U,U,,,,,,,,2020,Q2,Epistaxis,,2020,Q2,1,I,20190608.0,20190613.0,20200426,20200426,EXP,,PHHY2019BR140214,NOVARTIS,,66.0,YR,,F,Y,,,20200426.0,,CN,BR,BR,2020,Q2,Elderly
177083981,17708398,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,DOSE DEPENDS ON BLOOD GLUCOSE,,,U,U,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,20190608.0,20190613.0,20200426,20200426,EXP,,PHHY2019BR140214,NOVARTIS,,66.0,YR,,F,Y,,,20200426.0,,CN,BR,BR,2020,Q2,Elderly
177083981,17708398,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,DOSE DEPENDS ON BLOOD GLUCOSE,,,U,U,,,,,,,,2020,Q2,Fatigue,,2020,Q2,1,I,20190608.0,20190613.0,20200426,20200426,EXP,,PHHY2019BR140214,NOVARTIS,,66.0,YR,,F,Y,,,20200426.0,,CN,BR,BR,2020,Q2,Elderly
177083981,17708398,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,DOSE DEPENDS ON BLOOD GLUCOSE,,,U,U,,,,,,,,2020,Q2,Hypertension,,2020,Q2,1,I,20190608.0,20190613.0,20200426,20200426,EXP,,PHHY2019BR140214,NOVARTIS,,66.0,YR,,F,Y,,,20200426.0,,CN,BR,BR,2020,Q2,Elderly
177083981,17708398,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,DOSE DEPENDS ON BLOOD GLUCOSE,,,U,U,,,,,,,,2020,Q2,Influenza,,2020,Q2,1,I,20190608.0,20190613.0,20200426,20200426,EXP,,PHHY2019BR140214,NOVARTIS,,66.0,YR,,F,Y,,,20200426.0,,CN,BR,BR,2020,Q2,Elderly
177083981,17708398,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,DOSE DEPENDS ON BLOOD GLUCOSE,,,U,U,,,,,,,,2020,Q2,Pain,,2020,Q2,1,I,20190608.0,20190613.0,20200426,20200426,EXP,,PHHY2019BR140214,NOVARTIS,,66.0,YR,,F,Y,,,20200426.0,,CN,BR,BR,2020,Q2,Elderly
177083981,17708398,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,DOSE DEPENDS ON BLOOD GLUCOSE,,,U,U,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,1,I,20190608.0,20190613.0,20200426,20200426,EXP,,PHHY2019BR140214,NOVARTIS,,66.0,YR,,F,Y,,,20200426.0,,CN,BR,BR,2020,Q2,Elderly
177097956,17709795,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,12 UNIT,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,6,F,20200414.0,20200612.0,20200427,20200629,EXP,,US-ROCHE-2587420,ROCHE,,61.0,YR,,M,Y,68.0,KG,20200629.0,,MD,US,US,2020,Q2,Adult
177097956,17709795,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,12 UNIT,,,,,,,,,,,,2020,Q2,Staphylococcal infection,,2020,Q2,6,F,20200414.0,20200612.0,20200427,20200629,EXP,,US-ROCHE-2587420,ROCHE,,61.0,YR,,M,Y,68.0,KG,20200629.0,,MD,US,US,2020,Q2,Adult
177102461,17710246,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26 IU,,,U,,,,,26.0,IU,,,2020,Q2,Cough,,2020,Q2,1,I,,20200421.0,20200427,20200427,PER,,US-SA-2020SA106705,SANOFI AVENTIS,,32.0,YR,A,F,Y,,,20200427.0,,CN,US,US,2020,Q2,Young Adult
177102461,17710246,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26 IU,,,U,,,,,26.0,IU,,,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,1,I,,20200421.0,20200427,20200427,PER,,US-SA-2020SA106705,SANOFI AVENTIS,,32.0,YR,A,F,Y,,,20200427.0,,CN,US,US,2020,Q2,Young Adult
177102461,17710246,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26 IU,,,U,,,,,26.0,IU,,,2020,Q2,Localised infection,,2020,Q2,1,I,,20200421.0,20200427,20200427,PER,,US-SA-2020SA106705,SANOFI AVENTIS,,32.0,YR,A,F,Y,,,20200427.0,,CN,US,US,2020,Q2,Young Adult
177102461,17710246,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26 IU,,,U,,,,,26.0,IU,,,2020,Q2,Medical device discomfort,,2020,Q2,1,I,,20200421.0,20200427,20200427,PER,,US-SA-2020SA106705,SANOFI AVENTIS,,32.0,YR,A,F,Y,,,20200427.0,,CN,US,US,2020,Q2,Young Adult
177113742,17711374,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (LAST YEAR),,,,,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,2,F,,20200424.0,20200427,20200506,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2020-01754,LUPIN,,76.0,YR,,F,Y,,,20200506.0,,MD,CN,CN,2020,Q2,Elderly
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Acidosis,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Acute respiratory distress syndrome,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Acute respiratory failure,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Alkalosis hypochloraemic,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Anaemia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Asthenia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Bandaemia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Blood urea increased,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Bronchial haemorrhage,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Bronchitis chronic,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Concomitant disease aggravated,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Constipation,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Cough,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Cystic fibrosis,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Diarrhoea,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Dysphagia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Dyspnoea,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Fungal disease carrier,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Gastroenteritis norovirus,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Gastrointestinal disorder,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Generalised oedema,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Glucose tolerance impaired,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Glucose tolerance test,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Granulocytosis,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Haematuria,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Haemoptysis,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Hypercapnia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Hypernatraemia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Hypertension,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Hypertriglyceridaemia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Hypervolaemia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Hypokalaemia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Ill-defined disorder,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Infective exacerbation of bronchiectasis,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Insomnia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Intensive care unit acquired weakness,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Iron deficiency,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Leukocytosis,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Metabolic acidosis,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Muscle atrophy,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Paresis,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Pneumonia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Pulmonary congestion,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Pyrexia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Sepsis,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Stenotrophomonas test positive,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Tachycardia,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Thrombocytosis,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177152211,17715221,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,, UNK,,,18.0,DF,,,2020,Q2,Weight decreased,,2020,Q2,1,I,20160303.0,20171128.0,20200427,20200427,PER,,US-002147023-PHHY2017US177182,MYLAN,,37.0,YR,,M,Y,68.44,KG,20200427.0,,MD,US,US,2020,Q2,Adult
177172603,17717260,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,3,F,,20200503.0,20200428,20200511,PER,,US-SA-2020SA109456,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200511.0,,CN,US,US,2020,Q2,Elderly
177172603,17717260,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Therapeutic response decreased,,2020,Q2,3,F,,20200503.0,20200428,20200511,PER,,US-SA-2020SA109456,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200511.0,,CN,US,US,2020,Q2,Elderly
177172603,17717260,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Wrong product administered,,2020,Q2,3,F,,20200503.0,20200428,20200511,PER,,US-SA-2020SA109456,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200511.0,,CN,US,US,2020,Q2,Elderly
177180081,17718008,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"IN MORNING. 25/75 100UNITS/ML, 3ML",,,,,,,,24.0,IU,SUSPENSION FOR INJECTION,,2020,Q2,Orthostatic hypotension,,2020,Q2,1,I,20200220.0,20200417.0,20200428,20200428,EXP,GB-MHRA-ADR 24486860,GB-ACCORD-179421,ACCORD,,73.0,YR,,M,Y,,,20200428.0,,PH,GB,GB,2020,Q2,Elderly
177180081,17718008,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"IN MORNING. 25/75 100UNITS/ML, 3ML",,,,,,,,24.0,IU,SUSPENSION FOR INJECTION,,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,1,I,20200220.0,20200417.0,20200428,20200428,EXP,GB-MHRA-ADR 24486860,GB-ACCORD-179421,ACCORD,,73.0,YR,,M,Y,,,20200428.0,,PH,GB,GB,2020,Q2,Elderly
177215031,17721503,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, TID",,,U,U,,,20563.0,6.0,IU,INJECTION,TID,2020,Q2,Asthenia,,2020,Q2,1,I,20200330.0,20200331.0,20200429,20200429,PER,,US-ELI_LILLY_AND_COMPANY-US202004000743,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20200429.0,,CN,US,US,2020,Q2,Elderly
177215031,17721503,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, TID",,,U,U,,,20563.0,6.0,IU,INJECTION,TID,2020,Q2,Blood glucose increased,,2020,Q2,1,I,20200330.0,20200331.0,20200429,20200429,PER,,US-ELI_LILLY_AND_COMPANY-US202004000743,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20200429.0,,CN,US,US,2020,Q2,Elderly
177215031,17721503,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, TID",,,U,U,,,20563.0,6.0,IU,INJECTION,TID,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,20200330.0,20200331.0,20200429,20200429,PER,,US-ELI_LILLY_AND_COMPANY-US202004000743,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20200429.0,,CN,US,US,2020,Q2,Elderly
177215031,17721503,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, TID",,,U,U,,,20563.0,6.0,IU,INJECTION,TID,2020,Q2,Incorrect dose administered,,2020,Q2,1,I,20200330.0,20200331.0,20200429,20200429,PER,,US-ELI_LILLY_AND_COMPANY-US202004000743,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20200429.0,,CN,US,US,2020,Q2,Elderly
177215031,17721503,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, TID",,,U,U, C999324C,,20563.0,6.0,IU,INJECTION,TID,2020,Q2,Asthenia,,2020,Q2,1,I,20200330.0,20200331.0,20200429,20200429,PER,,US-ELI_LILLY_AND_COMPANY-US202004000743,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20200429.0,,CN,US,US,2020,Q2,Elderly
177215031,17721503,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, TID",,,U,U, C999324C,,20563.0,6.0,IU,INJECTION,TID,2020,Q2,Blood glucose increased,,2020,Q2,1,I,20200330.0,20200331.0,20200429,20200429,PER,,US-ELI_LILLY_AND_COMPANY-US202004000743,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20200429.0,,CN,US,US,2020,Q2,Elderly
177215031,17721503,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, TID",,,U,U, C999324C,,20563.0,6.0,IU,INJECTION,TID,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,20200330.0,20200331.0,20200429,20200429,PER,,US-ELI_LILLY_AND_COMPANY-US202004000743,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20200429.0,,CN,US,US,2020,Q2,Elderly
177215031,17721503,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, TID",,,U,U, C999324C,,20563.0,6.0,IU,INJECTION,TID,2020,Q2,Incorrect dose administered,,2020,Q2,1,I,20200330.0,20200331.0,20200429,20200429,PER,,US-ELI_LILLY_AND_COMPANY-US202004000743,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20200429.0,,CN,US,US,2020,Q2,Elderly
177227051,17722705,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Amyloidosis,,2020,Q2,1,I,,20200423.0,20200429,20200429,EXP,,US-SA-2020SA106039,SANOFI AVENTIS,"SAMLASKA C.; REBER S.; MURRY T.. INSULIN-DERIVED AMYLOIDOSIS: THE INSULIN BALL, AMYLOIDOMA. JAAD CASE REPORTS. 2020;6(4):351-353",51.0,YR,A,M,Y,,,20200429.0,,HP,US,US,2020,Q2,Adult
177256041,17725604,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"IN MORNING. 25/75 100UNITS/ML, 3ML",,,,,,,,24.0,IU,SUSPENSION FOR INJECTION,QD,2020,Q2,Orthostatic hypotension,,2020,Q2,1,I,20200220.0,20200427.0,20200429,20200429,EXP,GB-MHRA-MIDB-853EB3A7-4D81-44CC-BDA2-E41235A70E2F,GB-MYLANLABS-2020M1042293,MYLAN,,73.0,YR,,M,Y,,,20200429.0,,PH,GB,GB,2020,Q2,Elderly
177256041,17725604,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"IN MORNING. 25/75 100UNITS/ML, 3ML",,,,,,,,24.0,IU,SUSPENSION FOR INJECTION,QD,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,1,I,20200220.0,20200427.0,20200429,20200429,EXP,GB-MHRA-MIDB-853EB3A7-4D81-44CC-BDA2-E41235A70E2F,GB-MYLANLABS-2020M1042293,MYLAN,,73.0,YR,,M,Y,,,20200429.0,,PH,GB,GB,2020,Q2,Elderly
177283281,17728328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Anaemia,,2020,Q2,1,I,20200326.0,20200421.0,20200430,20200430,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177283281,17728328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Blood glucose fluctuation,,2020,Q2,1,I,20200326.0,20200421.0,20200430,20200430,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177283281,17728328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Blood potassium increased,,2020,Q2,1,I,20200326.0,20200421.0,20200430,20200430,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177283281,17728328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Blood sodium decreased,,2020,Q2,1,I,20200326.0,20200421.0,20200430,20200430,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177283281,17728328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200326.0,20200421.0,20200430,20200430,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177283281,17728328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Infection,,2020,Q2,1,I,20200326.0,20200421.0,20200430,20200430,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177283281,17728328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Inflammation,,2020,Q2,1,I,20200326.0,20200421.0,20200430,20200430,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177283281,17728328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Oropharyngeal pain,,2020,Q2,1,I,20200326.0,20200421.0,20200430,20200430,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177283281,17728328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Platelet count decreased,,2020,Q2,1,I,20200326.0,20200421.0,20200430,20200430,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177283281,17728328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Secondary immunodeficiency,,2020,Q2,1,I,20200326.0,20200421.0,20200430,20200430,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Abdominal pain,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Abscess,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Adrenal insufficiency,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Ascites,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Asthenia,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Blood alkaline phosphatase increased,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Blood bilirubin increased,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Blood potassium decreased,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Blood pressure diastolic abnormal,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Blood pressure increased,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Congestive hepatopathy,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Depression,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Diverticulitis,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Endometrial disorder,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Enterococcus test positive,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Fibrosis,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Gamma-glutamyltransferase increased,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Gastrointestinal disorder,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Generalised oedema,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Heart rate increased,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Herpes zoster,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Hypersensitivity,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Increased appetite,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Influenza,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Infusion related reaction,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Injection site extravasation,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Intensive care unit acquired weakness,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Intervertebral disc protrusion,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Joint effusion,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Joint swelling,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Micturition disorder,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Myelopathy,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Myopathy,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Nasopharyngitis,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Nerve compression,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Neuropathy peripheral,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Neutropenia,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Osteoarthritis,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Pancytopenia,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Peripheral sensorimotor neuropathy,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Peritonitis,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Pseudomonal bacteraemia,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Rheumatoid arthritis,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Septic shock,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Therapeutic response decreased,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Weight decreased,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177324131,17732413,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Weight increased,,2020,Q2,1,I,,20200420.0,20200501,20200501,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20200501.0,,HP,CA,CA,2020,Q2,Adult
177359321,17735932,2,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,1,I,,20200427.0,20200501,20200501,EXP,,"CN-BRECKENRIDGE PHARMACEUTICAL, INC.-2083422",BRECKENRIDGE,"^PLEURAL EFFUSION DUE TO USE OF PIOGLITAZONE: A CASE REPORT^ BY JINHUI XUE, MD; WEI LIU, MD, PHD; FANGHONG SHI, MPHARM; JUN ZHENG, MD, MM; AND JING MA, MD, PHD",76.0,YR,,F,Y,,,20200501.0,,HP,US,CN,2020,Q2,Elderly
177408601,17740860,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q2,Oedema,,2020,Q2,1,I,,20200427.0,20200504,20200504,EXP,,CN-PRINSTON PHARMACEUTICAL INC.-2020PRN00144,PRINSTON PHARMACEUTICAL,"XUE J, LIU W, SHI F, ZHENG J, MA J. PLEURAL EFFUSION DUE TO USE OF PIOGLITAZONE: A CASE REPORT. METAB SYNDR RELAT DISORD. 2020;18(3):168-171",76.0,YR,,F,Y,,,20200504.0,,MD,CN,CN,2020,Q2,Elderly
177408601,17740860,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,1,I,,20200427.0,20200504,20200504,EXP,,CN-PRINSTON PHARMACEUTICAL INC.-2020PRN00144,PRINSTON PHARMACEUTICAL,"XUE J, LIU W, SHI F, ZHENG J, MA J. PLEURAL EFFUSION DUE TO USE OF PIOGLITAZONE: A CASE REPORT. METAB SYNDR RELAT DISORD. 2020;18(3):168-171",76.0,YR,,F,Y,,,20200504.0,,MD,CN,CN,2020,Q2,Elderly
177441511,17744151,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY",10.0,IU,Y,, D093732A,,20563.0,10.0,IU,,QD,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,20200416.0,20200429.0,20200505,20200505,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202004012296,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200505.0,,CN,CN,CN,2020,Q2,Elderly
177441511,17744151,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY",10.0,IU,Y,, D093732A,,20563.0,10.0,IU,,QD,2020,Q2,Blood glucose increased,,2020,Q2,1,I,20200416.0,20200429.0,20200505,20200505,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202004012296,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200505.0,,CN,CN,CN,2020,Q2,Elderly
177441511,17744151,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY",10.0,IU,Y,, D093732A,,20563.0,10.0,IU,,QD,2020,Q2,Dizziness,,2020,Q2,1,I,20200416.0,20200429.0,20200505,20200505,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202004012296,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200505.0,,CN,CN,CN,2020,Q2,Elderly
177441511,17744151,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY",10.0,IU,Y,, D093732A,,20563.0,10.0,IU,,QD,2020,Q2,Fatigue,,2020,Q2,1,I,20200416.0,20200429.0,20200505,20200505,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202004012296,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200505.0,,CN,CN,CN,2020,Q2,Elderly
177443721,17744372,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Adverse drug reaction,,2020,Q2,1,I,20181130.0,20200428.0,20200504,20200504,PER,,US-AMGEN-USACT2020070889,AMGEN,,65.0,YR,E,M,Y,,,20200504.0,,MD,US,US,2020,Q2,Elderly
177463981,17746398,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,202004.0,20200501.0,20200505,20200505,PER,,US-ELI_LILLY_AND_COMPANY-US202005000329,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
177463981,17746398,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q2,Feeling abnormal,,2020,Q2,1,I,202004.0,20200501.0,20200505,20200505,PER,,US-ELI_LILLY_AND_COMPANY-US202005000329,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
177463981,17746398,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q2,Malaise,,2020,Q2,1,I,202004.0,20200501.0,20200505,20200505,PER,,US-ELI_LILLY_AND_COMPANY-US202005000329,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
177463981,17746398,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q2,Nervousness,,2020,Q2,1,I,202004.0,20200501.0,20200505,20200505,PER,,US-ELI_LILLY_AND_COMPANY-US202005000329,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
177463981,17746398,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q2,Wrong product administered,,2020,Q2,1,I,202004.0,20200501.0,20200505,20200505,PER,,US-ELI_LILLY_AND_COMPANY-US202005000329,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
177463981,17746398,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C999324C,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,202004.0,20200501.0,20200505,20200505,PER,,US-ELI_LILLY_AND_COMPANY-US202005000329,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
177463981,17746398,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C999324C,,,,,INJECTION,,2020,Q2,Feeling abnormal,,2020,Q2,1,I,202004.0,20200501.0,20200505,20200505,PER,,US-ELI_LILLY_AND_COMPANY-US202005000329,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
177463981,17746398,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C999324C,,,,,INJECTION,,2020,Q2,Malaise,,2020,Q2,1,I,202004.0,20200501.0,20200505,20200505,PER,,US-ELI_LILLY_AND_COMPANY-US202005000329,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
177463981,17746398,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C999324C,,,,,INJECTION,,2020,Q2,Nervousness,,2020,Q2,1,I,202004.0,20200501.0,20200505,20200505,PER,,US-ELI_LILLY_AND_COMPANY-US202005000329,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
177463981,17746398,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C999324C,,,,,INJECTION,,2020,Q2,Wrong product administered,,2020,Q2,1,I,202004.0,20200501.0,20200505,20200505,PER,,US-ELI_LILLY_AND_COMPANY-US202005000329,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
177481761,17748176,2,SS,Lispro,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,UNKNOWN,,2020,Q2,Accidental overdose,,2020,Q2,1,I,20200427.0,20200427.0,20200506,20200506,EXP,,CA-BIOGEN-2020BI00869271,BIOGEN,,58.0,YR,,F,Y,,,20200505.0,,HP,CA,CA,2020,Q2,Adult
177481761,17748176,2,SS,Lispro,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,UNKNOWN,,2020,Q2,Diabetes mellitus,,2020,Q2,1,I,20200427.0,20200427.0,20200506,20200506,EXP,,CA-BIOGEN-2020BI00869271,BIOGEN,,58.0,YR,,F,Y,,,20200505.0,,HP,CA,CA,2020,Q2,Adult
177481761,17748176,2,SS,Lispro,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,UNKNOWN,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200427.0,20200427.0,20200506,20200506,EXP,,CA-BIOGEN-2020BI00869271,BIOGEN,,58.0,YR,,F,Y,,,20200505.0,,HP,CA,CA,2020,Q2,Adult
177505101,17750510,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"26 INTERNATIONAL UNIT, TOTAL (AS REPORTED)",,,Y,,,,20563.0,26.0,IU,,,2020,Q2,Asthenia,,2020,Q2,1,I,20191202.0,20200427.0,20200506,20200506,EXP,IT-MINISAL02-616362,IT-ELI_LILLY_AND_COMPANY-IT202004011153,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20200506.0,,MD,IT,IT,2020,Q2,Adult
177505101,17750510,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"26 INTERNATIONAL UNIT, TOTAL (AS REPORTED)",,,Y,,,,20563.0,26.0,IU,,,2020,Q2,Hyperhidrosis,,2020,Q2,1,I,20191202.0,20200427.0,20200506,20200506,EXP,IT-MINISAL02-616362,IT-ELI_LILLY_AND_COMPANY-IT202004011153,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20200506.0,,MD,IT,IT,2020,Q2,Adult
177505101,17750510,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"26 INTERNATIONAL UNIT, TOTAL (AS REPORTED)",,,Y,,,,20563.0,26.0,IU,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20191202.0,20200427.0,20200506,20200506,EXP,IT-MINISAL02-616362,IT-ELI_LILLY_AND_COMPANY-IT202004011153,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20200506.0,,MD,IT,IT,2020,Q2,Adult
177505101,17750510,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"26 INTERNATIONAL UNIT, TOTAL (AS REPORTED)",,,Y,,,,20563.0,26.0,IU,,,2020,Q2,Wrong product administered,,2020,Q2,1,I,20191202.0,20200427.0,20200506,20200506,EXP,IT-MINISAL02-616362,IT-ELI_LILLY_AND_COMPANY-IT202004011153,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20200506.0,,MD,IT,IT,2020,Q2,Adult
177509551,17750955,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,CONTINUOUS SUBCUTANEOUS INFUSION PUMP AT 22 TO 24 UNITS DAILY (0.39-0.42 UNITS/KG/D) DIVIDED APPROXI,,,,,,,,,,INFUSION,,2020,Q2,Circulatory collapse,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,CONTINUOUS SUBCUTANEOUS INFUSION PUMP AT 22 TO 24 UNITS DAILY (0.39-0.42 UNITS/KG/D) DIVIDED APPROXI,,,,,,,,,,INFUSION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,CONTINUOUS SUBCUTANEOUS INFUSION PUMP AT 22 TO 24 UNITS DAILY (0.39-0.42 UNITS/KG/D) DIVIDED APPROXI,,,,,,,,,,INFUSION,,2020,Q2,Hypotension,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,CONTINUOUS SUBCUTANEOUS INFUSION PUMP AT 22 TO 24 UNITS DAILY (0.39-0.42 UNITS/KG/D) DIVIDED APPROXI,,,,,,,,,,INFUSION,,2020,Q2,Sinus bradycardia,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,CONTINUOUS SUBCUTANEOUS INFUSION PUMP AT 22 TO 24 UNITS DAILY (0.39-0.42 UNITS/KG/D) DIVIDED APPROXI,,,,,,,,,,INFUSION,,2020,Q2,Unresponsive to stimuli,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, 1X/DAYBASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Circulatory collapse,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, 1X/DAYBASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, 1X/DAYBASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Hypotension,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, 1X/DAYBASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Sinus bradycardia,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, 1X/DAYBASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Unresponsive to stimuli,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 U, 1X/DAY BASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Circulatory collapse,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 U, 1X/DAY BASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 U, 1X/DAY BASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Hypotension,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 U, 1X/DAY BASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Sinus bradycardia,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177509551,17750955,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 U, 1X/DAY BASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Unresponsive to stimuli,,2020,Q2,1,I,,20200427.0,20200506,20200506,EXP,,CA-PRINSTON PHARMACEUTICAL INC.-2020PRN00146,PRINSTON PHARMACEUTICAL,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT.. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200506.0,,PH,CA,CA,2020,Q2,Adult
177551461,17755146,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 E/3ML, 4-4-4-0",,,U,,,,,,,,,2020,Q2,Paraesthesia,,2020,Q2,1,I,,20200506.0,20200507,20200507,EXP,,NVSC2020DE123162,NOVARTIS,,56.0,YR,,F,Y,,,20200507.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q2,Adult
177551461,17755146,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 E/3ML, 4-4-4-0",,,U,,,,,,,,,2020,Q2,Taste disorder,,2020,Q2,1,I,,20200506.0,20200507,20200507,EXP,,NVSC2020DE123162,NOVARTIS,,56.0,YR,,F,Y,,,20200507.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q2,Adult
177567031,17756703,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,20130725.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02148,HIKMA,,33.0,YR,,M,Y,72.0,KG,20200504.0,,MD,US,US,2020,Q2,Young Adult
177567031,17756703,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Intra-abdominal haematoma,,2020,Q2,1,I,20130725.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02148,HIKMA,,33.0,YR,,M,Y,72.0,KG,20200504.0,,MD,US,US,2020,Q2,Young Adult
177567031,17756703,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Transplant rejection,,2020,Q2,1,I,20130725.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02148,HIKMA,,33.0,YR,,M,Y,72.0,KG,20200504.0,,MD,US,US,2020,Q2,Young Adult
177568641,17756864,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Bronchopulmonary aspergillosis,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Febrile neutropenia,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Fungal infection,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Pneumonia,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Sepsis,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Syncope,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Tachycardia,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Upper respiratory tract infection,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,White blood cell count decreased,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177597802,17759780,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULN INJECTION,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Confusional state,,2020,Q2,2,F,201905.0,20200430.0,20200508,20200514,EXP,,US-SA-2020SA115791,SANOFI AVENTIS,ROBBINS D.J.; TAYLOR N.E.; NARAYANAN D.; HESS A.S.; ROSE W.N.. THERAPEUTIC PLASMA EXCHANGE FOR EXOGENOUS INSULIN ANTIBODY SYNDROME IN COMBINED VARIABLE IMMUNODEFICIENCY: A CASE REPORT. JOURNAL OF CLINICAL APHERESIS. 2020;35(2):128-130,32.0,YR,A,M,Y,,,20200514.0,,HP,US,US,2020,Q2,Young Adult
177597802,17759780,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULN INJECTION,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,201905.0,20200430.0,20200508,20200514,EXP,,US-SA-2020SA115791,SANOFI AVENTIS,ROBBINS D.J.; TAYLOR N.E.; NARAYANAN D.; HESS A.S.; ROSE W.N.. THERAPEUTIC PLASMA EXCHANGE FOR EXOGENOUS INSULIN ANTIBODY SYNDROME IN COMBINED VARIABLE IMMUNODEFICIENCY: A CASE REPORT. JOURNAL OF CLINICAL APHERESIS. 2020;35(2):128-130,32.0,YR,A,M,Y,,,20200514.0,,HP,US,US,2020,Q2,Young Adult
177597802,17759780,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULN INJECTION,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Immunodeficiency common variable,,2020,Q2,2,F,201905.0,20200430.0,20200508,20200514,EXP,,US-SA-2020SA115791,SANOFI AVENTIS,ROBBINS D.J.; TAYLOR N.E.; NARAYANAN D.; HESS A.S.; ROSE W.N.. THERAPEUTIC PLASMA EXCHANGE FOR EXOGENOUS INSULIN ANTIBODY SYNDROME IN COMBINED VARIABLE IMMUNODEFICIENCY: A CASE REPORT. JOURNAL OF CLINICAL APHERESIS. 2020;35(2):128-130,32.0,YR,A,M,Y,,,20200514.0,,HP,US,US,2020,Q2,Young Adult
177597802,17759780,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULN INJECTION,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Insulin autoimmune syndrome,,2020,Q2,2,F,201905.0,20200430.0,20200508,20200514,EXP,,US-SA-2020SA115791,SANOFI AVENTIS,ROBBINS D.J.; TAYLOR N.E.; NARAYANAN D.; HESS A.S.; ROSE W.N.. THERAPEUTIC PLASMA EXCHANGE FOR EXOGENOUS INSULIN ANTIBODY SYNDROME IN COMBINED VARIABLE IMMUNODEFICIENCY: A CASE REPORT. JOURNAL OF CLINICAL APHERESIS. 2020;35(2):128-130,32.0,YR,A,M,Y,,,20200514.0,,HP,US,US,2020,Q2,Young Adult
177597802,17759780,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULN INJECTION,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Loss of consciousness,,2020,Q2,2,F,201905.0,20200430.0,20200508,20200514,EXP,,US-SA-2020SA115791,SANOFI AVENTIS,ROBBINS D.J.; TAYLOR N.E.; NARAYANAN D.; HESS A.S.; ROSE W.N.. THERAPEUTIC PLASMA EXCHANGE FOR EXOGENOUS INSULIN ANTIBODY SYNDROME IN COMBINED VARIABLE IMMUNODEFICIENCY: A CASE REPORT. JOURNAL OF CLINICAL APHERESIS. 2020;35(2):128-130,32.0,YR,A,M,Y,,,20200514.0,,HP,US,US,2020,Q2,Young Adult
177597802,17759780,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULN INJECTION,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2020,Q2,Visual impairment,,2020,Q2,2,F,201905.0,20200430.0,20200508,20200514,EXP,,US-SA-2020SA115791,SANOFI AVENTIS,ROBBINS D.J.; TAYLOR N.E.; NARAYANAN D.; HESS A.S.; ROSE W.N.. THERAPEUTIC PLASMA EXCHANGE FOR EXOGENOUS INSULIN ANTIBODY SYNDROME IN COMBINED VARIABLE IMMUNODEFICIENCY: A CASE REPORT. JOURNAL OF CLINICAL APHERESIS. 2020;35(2):128-130,32.0,YR,A,M,Y,,,20200514.0,,HP,US,US,2020,Q2,Young Adult
177614362,17761436,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,QACHS,,,,,,,,,,,,2020,Q2,Obliterative bronchiolitis,,2020,Q2,2,F,20200320.0,20200520.0,20200508,20200528,EXP,,US-VERTEX PHARMACEUTICALS-2020-010044,VERTEX,,29.0,YR,,M,Y,53.0,KG,20200528.0,,PH,US,US,2020,Q2,Young Adult
177614362,17761436,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,QACHS,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,2,F,20200320.0,20200520.0,20200508,20200528,EXP,,US-VERTEX PHARMACEUTICALS-2020-010044,VERTEX,,29.0,YR,,M,Y,53.0,KG,20200528.0,,PH,US,US,2020,Q2,Young Adult
177614362,17761436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,0.67 UNITS/ HR (INFUSION),,,,,,,,,,,,2020,Q2,Obliterative bronchiolitis,,2020,Q2,2,F,20200320.0,20200520.0,20200508,20200528,EXP,,US-VERTEX PHARMACEUTICALS-2020-010044,VERTEX,,29.0,YR,,M,Y,53.0,KG,20200528.0,,PH,US,US,2020,Q2,Young Adult
177614362,17761436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,0.67 UNITS/ HR (INFUSION),,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,2,F,20200320.0,20200520.0,20200508,20200528,EXP,,US-VERTEX PHARMACEUTICALS-2020-010044,VERTEX,,29.0,YR,,M,Y,53.0,KG,20200528.0,,PH,US,US,2020,Q2,Young Adult
177620691,17762069,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,CONTINUOUS SUBCUTANEOUS INFUSION PUMP AT 22 TO 24 UNITS DAILY (0.39-0.42 UNITS/KG/D) DIVIDED APPROXI,,,,,,,,,,INFUSION,,2020,Q2,Circulatory collapse,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,CONTINUOUS SUBCUTANEOUS INFUSION PUMP AT 22 TO 24 UNITS DAILY (0.39-0.42 UNITS/KG/D) DIVIDED APPROXI,,,,,,,,,,INFUSION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,CONTINUOUS SUBCUTANEOUS INFUSION PUMP AT 22 TO 24 UNITS DAILY (0.39-0.42 UNITS/KG/D) DIVIDED APPROXI,,,,,,,,,,INFUSION,,2020,Q2,Hypotension,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,CONTINUOUS SUBCUTANEOUS INFUSION PUMP AT 22 TO 24 UNITS DAILY (0.39-0.42 UNITS/KG/D) DIVIDED APPROXI,,,,,,,,,,INFUSION,,2020,Q2,Sinus bradycardia,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,CONTINUOUS SUBCUTANEOUS INFUSION PUMP AT 22 TO 24 UNITS DAILY (0.39-0.42 UNITS/KG/D) DIVIDED APPROXI,,,,,,,,,,INFUSION,,2020,Q2,Unresponsive to stimuli,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, 1X/DAYBASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Circulatory collapse,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, 1X/DAYBASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, 1X/DAYBASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Hypotension,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, 1X/DAYBASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Sinus bradycardia,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, 1X/DAYBASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Unresponsive to stimuli,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 U, 1X/DAY BASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Circulatory collapse,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 U, 1X/DAY BASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 U, 1X/DAY BASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Hypotension,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 U, 1X/DAY BASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Sinus bradycardia,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177620691,17762069,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 U, 1X/DAY BASAL DOSE",,,,,,,,,,INFUSION,QD,2020,Q2,Unresponsive to stimuli,,2020,Q2,1,I,,20200427.0,20200508,20200508,EXP,,CA-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00156,JUBILANT,BARRY AR. SEVERE HYPOGLYCEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS RECENTLY STARTED ON SACUBITRIL/VALSARTAN: A CASE REPORT. CJC OPEN. 2020,55.0,YR,,F,Y,57.0,KG,20200508.0,,PH,CA,CA,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Ascites,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Bilirubin conjugated increased,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood albumin decreased,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood alkaline phosphatase increased,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood bilirubin increased,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood sodium decreased,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Cholestasis,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Dyspnoea,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Faeces pale,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Fatigue,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Gamma-glutamyltransferase increased,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hepatic cirrhosis,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hepatic enzyme increased,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hepatic fibrosis,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hepatomegaly,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Metabolic syndrome,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Muscle spasms,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Non-alcoholic steatohepatitis,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Platelet count decreased,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Portal hypertension,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Pruritus,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Splenomegaly,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Varices oesophageal,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Weight decreased,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177626641,17762664,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,CHANGE IN INSULIN DOSING,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Weight loss poor,,2020,Q2,1,I,,20200506.0,20200508,20200508,EXP,,NVSC2020DE124880,NOVARTIS,,46.0,YR,,M,Y,107.0,KG,20200508.0,,HP,DE,DE,2020,Q2,Adult
177672021,17767202,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q2,Oedema,,2020,Q2,1,I,,20200427.0,20200511,20200511,EXP,,CN-PURACAP PHARMACEUTICAL LLC-2020EPC00161,PURACAP,"XUE J, LIU W, SHI F, ZHENG J, MA J. PLEURAL EFFUSION DUE TO USE OF PIOGLITAZONE: A CASE REPORT. METAB SYNDR RELAT DISORD. 2020;18(3):168-171",76.0,YR,,F,Y,,,20200511.0,,MD,CN,CN,2020,Q2,Elderly
177672021,17767202,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,1,I,,20200427.0,20200511,20200511,EXP,,CN-PURACAP PHARMACEUTICAL LLC-2020EPC00161,PURACAP,"XUE J, LIU W, SHI F, ZHENG J, MA J. PLEURAL EFFUSION DUE TO USE OF PIOGLITAZONE: A CASE REPORT. METAB SYNDR RELAT DISORD. 2020;18(3):168-171",76.0,YR,,F,Y,,,20200511.0,,MD,CN,CN,2020,Q2,Elderly
177684891,17768489,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"10 U, UNKNOWN",,,,, C938255F,,20563.0,10.0,IU,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,20200502.0,20200505.0,20200511,20200511,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200511.0,,CN,US,US,2020,Q2,Elderly
177684891,17768489,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"10 U, UNKNOWN",,,,, C938255F,,20563.0,10.0,IU,INJECTION,,2020,Q2,Wrong product administered,,2020,Q2,1,I,20200502.0,20200505.0,20200511,20200511,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200511.0,,CN,US,US,2020,Q2,Elderly
177684891,17768489,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"12 U, UNKNOWN",,,,, C938255F,,20563.0,12.0,IU,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,20200502.0,20200505.0,20200511,20200511,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200511.0,,CN,US,US,2020,Q2,Elderly
177684891,17768489,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"12 U, UNKNOWN",,,,, C938255F,,20563.0,12.0,IU,INJECTION,,2020,Q2,Wrong product administered,,2020,Q2,1,I,20200502.0,20200505.0,20200511,20200511,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200511.0,,CN,US,US,2020,Q2,Elderly
177684891,17768489,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"30 U, UNKNOWN",,,,, C938255F,,20563.0,30.0,IU,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,20200502.0,20200505.0,20200511,20200511,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200511.0,,CN,US,US,2020,Q2,Elderly
177684891,17768489,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"30 U, UNKNOWN",,,,, C938255F,,20563.0,30.0,IU,INJECTION,,2020,Q2,Wrong product administered,,2020,Q2,1,I,20200502.0,20200505.0,20200511,20200511,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200511.0,,CN,US,US,2020,Q2,Elderly
177713931,17771393,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"26 INTERNATIONAL UNIT, DAILY",2392.0,IU,Y,,,,20563.0,26.0,IU,,QD,2020,Q2,Confusional state,,2020,Q2,1,I,20200401.0,20200501.0,20200512,20200512,EXP,IT-MINISAL02-616675,IT-ELI_LILLY_AND_COMPANY-IT202005000526,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20200512.0,,MD,IT,IT,2020,Q2,Elderly
177713931,17771393,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"26 INTERNATIONAL UNIT, DAILY",2392.0,IU,Y,,,,20563.0,26.0,IU,,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200401.0,20200501.0,20200512,20200512,EXP,IT-MINISAL02-616675,IT-ELI_LILLY_AND_COMPANY-IT202005000526,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20200512.0,,MD,IT,IT,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Abdominal distension,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Abdominal pain,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Abdominal wall haematoma,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Anaemia,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Anaemia of chronic disease,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Atelectasis,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Atrial fibrillation,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Back pain,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Blood albumin decreased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Blood alkaline phosphatase,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Blood calcium decreased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Blood chloride increased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Blood iron decreased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Blood loss anaemia,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Blood osmolarity increased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Blood potassium decreased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Blood urea increased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Brain natriuretic peptide increased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Cardiac failure acute,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Cardiac failure congestive,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Chronic kidney disease,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Chronic obstructive pulmonary disease,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Clostridium difficile colitis,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Clostridium difficile infection,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Culture urine positive,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Cyanosis,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Death,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Diabetes mellitus,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Dialysis,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Dyspnoea at rest,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Dyspnoea exertional,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,End stage renal disease,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Escherichia urinary tract infection,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Fluid overload,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Haematochezia,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Haematocrit increased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Haemoglobin decreased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Haemorrhage,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Herpes zoster,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Hyperparathyroidism,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Hypocalcaemia,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Hypokalaemia,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Hypophagia,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Hypovolaemia,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Influenza,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Left ventricular failure,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Metabolic acidosis,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Oropharyngeal pain,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Orthopnoea,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Oxygen saturation decreased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Packed red blood cell transfusion,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Pain,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Pain in jaw,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Pharyngitis streptococcal,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Red blood cell count decreased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Serum ferritin increased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Shock haemorrhagic,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Staphylococcal infection,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Staphylococcal sepsis,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Syncope,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Therapy non-responder,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Thyroxine free increased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Transferrin saturation decreased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Vertigo,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,Weight increased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177730712,17773071,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,,,2020,Q2,White blood cell count increased,,2020,Q2,2,F,201810.0,20200521.0,20200512,20200604,EXP,,US-ACTELION-A-NJ2018-180688,ACTELION,,85.0,YR,,F,Y,62.13,KG,20200604.0,,HP,US,US,2020,Q2,Elderly
177748481,17774848,15,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200511.0,,20200512,20200512,DIR,,,FDA-CTU,,69.0,YR,,F,N,79.4,KG,20200512.0,Y,PH,US,US,2020,Q2,Elderly
177748481,17774848,15,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200511.0,,20200512,20200512,DIR,,,FDA-CTU,,69.0,YR,,F,N,79.4,KG,20200512.0,Y,PH,US,US,2020,Q2,Elderly
177748481,17774848,15,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Oliguria,,2020,Q2,1,I,20200511.0,,20200512,20200512,DIR,,,FDA-CTU,,69.0,YR,,F,N,79.4,KG,20200512.0,Y,PH,US,US,2020,Q2,Elderly
177748501,17774850,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200511.0,,20200512,20200512,DIR,,,FDA-CTU,,61.0,YR,,M,N,83.0,KG,20200512.0,N,PH,US,US,2020,Q2,Adult
177748501,17774850,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,COVID-19 pneumonia,,2020,Q2,1,I,20200511.0,,20200512,20200512,DIR,,,FDA-CTU,,61.0,YR,,M,N,83.0,KG,20200512.0,N,PH,US,US,2020,Q2,Adult
177748501,17774850,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Haemodynamic instability,,2020,Q2,1,I,20200511.0,,20200512,20200512,DIR,,,FDA-CTU,,61.0,YR,,M,N,83.0,KG,20200512.0,N,PH,US,US,2020,Q2,Adult
177748501,17774850,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,20200511.0,,20200512,20200512,DIR,,,FDA-CTU,,61.0,YR,,M,N,83.0,KG,20200512.0,N,PH,US,US,2020,Q2,Adult
177748501,17774850,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal tubular necrosis,,2020,Q2,1,I,20200511.0,,20200512,20200512,DIR,,,FDA-CTU,,61.0,YR,,M,N,83.0,KG,20200512.0,N,PH,US,US,2020,Q2,Adult
177748501,17774850,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200511.0,,20200512,20200512,DIR,,,FDA-CTU,,61.0,YR,,M,N,83.0,KG,20200512.0,N,PH,US,US,2020,Q2,Adult
177748501,17774850,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Weight decreased,,2020,Q2,1,I,20200511.0,,20200512,20200512,DIR,,,FDA-CTU,,61.0,YR,,M,N,83.0,KG,20200512.0,N,PH,US,US,2020,Q2,Adult
177786662,17778666,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2020,Q2,Bile duct stone,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2020,Q2,Cholangitis,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2020,Q2,Cholecystitis acute,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2020,Q2,Enterococcus test positive,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2020,Q2,Hyperbilirubinaemia,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2020,Q2,Hyponatraemia,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2020,Q2,Liver function test increased,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2020,Q2,Vascular device infection,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177794311,17779431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,,,2020,Q2,Dizziness,,2020,Q2,1,I,20200420.0,20200507.0,20200513,20200513,PER,PT-INFARMED-F202004-768,PT-EISAI MEDICAL RESEARCH-EC-2020-074319,EISAI,,68.0,YR,E,F,Y,65.0,KG,20200513.0,,HP,PT,PT,2020,Q2,Elderly
177794311,17779431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,1,I,20200420.0,20200507.0,20200513,20200513,PER,PT-INFARMED-F202004-768,PT-EISAI MEDICAL RESEARCH-EC-2020-074319,EISAI,,68.0,YR,E,F,Y,65.0,KG,20200513.0,,HP,PT,PT,2020,Q2,Elderly
177794311,17779431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,1,I,20200420.0,20200507.0,20200513,20200513,PER,PT-INFARMED-F202004-768,PT-EISAI MEDICAL RESEARCH-EC-2020-074319,EISAI,,68.0,YR,E,F,Y,65.0,KG,20200513.0,,HP,PT,PT,2020,Q2,Elderly
177794311,17779431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,20200420.0,20200507.0,20200513,20200513,PER,PT-INFARMED-F202004-768,PT-EISAI MEDICAL RESEARCH-EC-2020-074319,EISAI,,68.0,YR,E,F,Y,65.0,KG,20200513.0,,HP,PT,PT,2020,Q2,Elderly
177794311,17779431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,,,2020,Q2,Pain,,2020,Q2,1,I,20200420.0,20200507.0,20200513,20200513,PER,PT-INFARMED-F202004-768,PT-EISAI MEDICAL RESEARCH-EC-2020-074319,EISAI,,68.0,YR,E,F,Y,65.0,KG,20200513.0,,HP,PT,PT,2020,Q2,Elderly
177794311,17779431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,20200420.0,20200507.0,20200513,20200513,PER,PT-INFARMED-F202004-768,PT-EISAI MEDICAL RESEARCH-EC-2020-074319,EISAI,,68.0,YR,E,F,Y,65.0,KG,20200513.0,,HP,PT,PT,2020,Q2,Elderly
177847711,17784771,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"5 U, DAILY",,,U,U,,,20563.0,5.0,IU,INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200506.0,20200513,20200513,PER,,US-ELI_LILLY_AND_COMPANY-US202005002834,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20200513.0,,CN,US,US,2020,Q2,Adult
177847711,17784771,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200506.0,20200513,20200513,PER,,US-ELI_LILLY_AND_COMPANY-US202005002834,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20200513.0,,CN,US,US,2020,Q2,Adult
177911321,17791132,18,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cardio-respiratory arrest,,2020,Q2,1,I,20200514.0,,20200514,20200514,DIR,,,FDA-CTU,,61.0,YR,,M,N,78.5,KG,20200514.0,N,PH,US,US,2020,Q2,Adult
177911321,17791132,18,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Clinical trial participant,,2020,Q2,1,I,20200514.0,,20200514,20200514,DIR,,,FDA-CTU,,61.0,YR,,M,N,78.5,KG,20200514.0,N,PH,US,US,2020,Q2,Adult
177911321,17791132,18,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Product use in unapproved indication,,2020,Q2,1,I,20200514.0,,20200514,20200514,DIR,,,FDA-CTU,,61.0,YR,,M,N,78.5,KG,20200514.0,N,PH,US,US,2020,Q2,Adult
177967362,17796736,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-15 UNIT, Q4H",,,U,,,,,,,,Q4H,2020,Q2,Alanine aminotransferase increased,,2020,Q2,2,F,20200421.0,20200517.0,20200518,20200525,EXP,,US-SA-2020SA118594,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200525.0,,MD,US,US,2020,Q2,Adult
177967362,17796736,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-15 UNIT, Q4H",,,U,,,,,,,,Q4H,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,2,F,20200421.0,20200517.0,20200518,20200525,EXP,,US-SA-2020SA118594,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200525.0,,MD,US,US,2020,Q2,Adult
177967362,17796736,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-15 UNIT, Q4H",,,U,,,,,,,,Q4H,2020,Q2,Klebsiella infection,,2020,Q2,2,F,20200421.0,20200517.0,20200518,20200525,EXP,,US-SA-2020SA118594,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200525.0,,MD,US,US,2020,Q2,Adult
177967381,17796738,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,INJECTION,TID,2020,Q2,Fatigue,,2020,Q2,1,I,20200513.0,20200513.0,20200518,20200518,PER,,US-ELI_LILLY_AND_COMPANY-US202005005501,ELI LILLY AND CO,,31.0,YR,,M,Y,,,20200518.0,,CN,US,US,2020,Q2,Young Adult
177967381,17796738,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,INJECTION,TID,2020,Q2,Malaise,,2020,Q2,1,I,20200513.0,20200513.0,20200518,20200518,PER,,US-ELI_LILLY_AND_COMPANY-US202005005501,ELI LILLY AND CO,,31.0,YR,,M,Y,,,20200518.0,,CN,US,US,2020,Q2,Young Adult
177967381,17796738,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,INJECTION,TID,2020,Q2,Thirst,,2020,Q2,1,I,20200513.0,20200513.0,20200518,20200518,PER,,US-ELI_LILLY_AND_COMPANY-US202005005501,ELI LILLY AND CO,,31.0,YR,,M,Y,,,20200518.0,,CN,US,US,2020,Q2,Young Adult
177967951,17796795,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU,QD",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Diabetic retinopathy,,2020,Q2,1,I,201204.0,20120607.0,20200518,20200518,EXP,,MX-SANOFI-AVENTIS-2012SA040987,SANOFI AVENTIS,,51.0,YR,A,M,Y,74.0,KG,20200518.0,,CN,MX,MX,2020,Q2,Adult
177967951,17796795,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU,QD",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Eye disorder,,2020,Q2,1,I,201204.0,20120607.0,20200518,20200518,EXP,,MX-SANOFI-AVENTIS-2012SA040987,SANOFI AVENTIS,,51.0,YR,A,M,Y,74.0,KG,20200518.0,,CN,MX,MX,2020,Q2,Adult
177967951,17796795,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU,QD",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,201204.0,20120607.0,20200518,20200518,EXP,,MX-SANOFI-AVENTIS-2012SA040987,SANOFI AVENTIS,,51.0,YR,A,M,Y,74.0,KG,20200518.0,,CN,MX,MX,2020,Q2,Adult
177967951,17796795,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU,QD",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Vision blurred,,2020,Q2,1,I,201204.0,20120607.0,20200518,20200518,EXP,,MX-SANOFI-AVENTIS-2012SA040987,SANOFI AVENTIS,,51.0,YR,A,M,Y,74.0,KG,20200518.0,,CN,MX,MX,2020,Q2,Adult
177972921,17797292,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200511.0,,20200517,20200517,DIR,,,FDA-CTU,,70.0,YR,,M,N,145.0,KG,20200517.0,Y,PH,US,US,2020,Q2,Elderly
177972921,17797292,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Protein total increased,,2020,Q2,1,I,20200511.0,,20200517,20200517,DIR,,,FDA-CTU,,70.0,YR,,M,N,145.0,KG,20200517.0,Y,PH,US,US,2020,Q2,Elderly
177972921,17797292,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal tubular necrosis,,2020,Q2,1,I,20200511.0,,20200517,20200517,DIR,,,FDA-CTU,,70.0,YR,,M,N,145.0,KG,20200517.0,Y,PH,US,US,2020,Q2,Elderly
177972921,17797292,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,1,I,20200511.0,,20200517,20200517,DIR,,,FDA-CTU,,70.0,YR,,M,N,145.0,KG,20200517.0,Y,PH,US,US,2020,Q2,Elderly
177987441,17798744,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Product substitution issue,,2020,Q2,1,I,20200518.0,,20200518,20200518,DIR,,,FDA-CTU,,61.0,YR,,M,N,76.5,KG,20200518.0,N,CN,US,US,2020,Q2,Adult
177987441,17798744,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Rash,,2020,Q2,1,I,20200518.0,,20200518,20200518,DIR,,,FDA-CTU,,61.0,YR,,M,N,76.5,KG,20200518.0,N,CN,US,US,2020,Q2,Adult
178018091,17801809,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200518.0,,20200518,20200518,DIR,,,FDA-CTU,,72.0,YR,,M,N,69.4,KG,20200518.0,N,PH,US,US,2020,Q2,Elderly
178018151,17801815,17,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,1,I,20200515.0,,20200518,20200518,DIR,,,FDA-CTU,,67.0,YR,,F,N,72.6,KG,20200518.0,Y,PH,US,US,2020,Q2,Elderly
178018151,17801815,17,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Swelling,,2020,Q2,1,I,20200515.0,,20200518,20200518,DIR,,,FDA-CTU,,67.0,YR,,F,N,72.6,KG,20200518.0,Y,PH,US,US,2020,Q2,Elderly
178018151,17801815,17,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Throat irritation,,2020,Q2,1,I,20200515.0,,20200518,20200518,DIR,,,FDA-CTU,,67.0,YR,,F,N,72.6,KG,20200518.0,Y,PH,US,US,2020,Q2,Elderly
178026381,17802638,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Bacteraemia,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,60.0,YR,,F,N,90.0,KG,20200519.0,N,PH,US,US,2020,Q2,Adult
178026381,17802638,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,COVID-19,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,60.0,YR,,F,N,90.0,KG,20200519.0,N,PH,US,US,2020,Q2,Adult
178026381,17802638,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cardiac arrest,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,60.0,YR,,F,N,90.0,KG,20200519.0,N,PH,US,US,2020,Q2,Adult
178026381,17802638,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Disease complication,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,60.0,YR,,F,N,90.0,KG,20200519.0,N,PH,US,US,2020,Q2,Adult
178026381,17802638,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pneumonia pseudomonal,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,60.0,YR,,F,N,90.0,KG,20200519.0,N,PH,US,US,2020,Q2,Adult
178026381,17802638,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,60.0,YR,,F,N,90.0,KG,20200519.0,N,PH,US,US,2020,Q2,Adult
178029521,17802952,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pulseless electrical activity,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,53.0,YR,,M,N,68.0,KG,20200519.0,Y,MD,US,US,2020,Q2,Adult
178037752,17803775,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Abscess drainage,,2020,Q2,2,F,20190417.0,20200528.0,20200519,20200605,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200605.0,,HP,SE,SE,2020,Q2,Elderly
178037752,17803775,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Appendicitis,,2020,Q2,2,F,20190417.0,20200528.0,20200519,20200605,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200605.0,,HP,SE,SE,2020,Q2,Elderly
178037752,17803775,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Gastric polyps,,2020,Q2,2,F,20190417.0,20200528.0,20200519,20200605,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200605.0,,HP,SE,SE,2020,Q2,Elderly
178037752,17803775,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Iron deficiency anaemia,,2020,Q2,2,F,20190417.0,20200528.0,20200519,20200605,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200605.0,,HP,SE,SE,2020,Q2,Elderly
178037752,17803775,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Weight increased,,2020,Q2,2,F,20190417.0,20200528.0,20200519,20200605,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200605.0,,HP,SE,SE,2020,Q2,Elderly
178042971,17804297,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 UNIT, QD",,,,,,,,,,,QD,2020,Q2,Invasive breast carcinoma,,2020,Q2,1,I,20200428.0,20200513.0,20200519,20200519,PER,,US-AMGEN-USACT2020078712,AMGEN,,74.0,YR,E,F,Y,102.95,KG,20200519.0,,MD,US,US,2020,Q2,Elderly
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Arthralgia,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Drug ineffective,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Gait disturbance,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Hepatic enzyme increased,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Musculoskeletal stiffness,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Peripheral swelling,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Pharyngitis,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Poor venous access,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Pruritus,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Swelling,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Therapeutic response decreased,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Tremor,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178048081,17804808,6,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,,20200511.0,20200520,20200520,EXP,,CA-ROCHE-2598886,ROCHE,,62.0,YR,,M,Y,,,20200520.0,,HP,CA,CA,2020,Q2,Adult
178067361,17806736,14,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Arrhythmia,,2020,Q2,1,I,20200516.0,,20200519,20200519,DIR,,,FDA-CTU,,54.0,YR,,M,N,,,20200519.0,Y,PH,US,US,2020,Q2,Adult
178067361,17806736,14,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Clinical trial participant,,2020,Q2,1,I,20200516.0,,20200519,20200519,DIR,,,FDA-CTU,,54.0,YR,,M,N,,,20200519.0,Y,PH,US,US,2020,Q2,Adult
178067361,17806736,14,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Product use in unapproved indication,,2020,Q2,1,I,20200516.0,,20200519,20200519,DIR,,,FDA-CTU,,54.0,YR,,M,N,,,20200519.0,Y,PH,US,US,2020,Q2,Adult
178067361,17806736,14,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pulseless electrical activity,,2020,Q2,1,I,20200516.0,,20200519,20200519,DIR,,,FDA-CTU,,54.0,YR,,M,N,,,20200519.0,Y,PH,US,US,2020,Q2,Adult
178067361,17806736,14,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Tachycardia,,2020,Q2,1,I,20200516.0,,20200519,20200519,DIR,,,FDA-CTU,,54.0,YR,,M,N,,,20200519.0,Y,PH,US,US,2020,Q2,Adult
178067901,17806790,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood alkaline phosphatase increased,,2020,Q2,1,I,20200519.0,,20200519,20200519,DIR,,,FDA-CTU,,49.0,YR,,F,N,87.8,KG,20200519.0,Y,PH,US,US,2020,Q2,Adult
178067901,17806790,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood pressure decreased,,2020,Q2,1,I,20200519.0,,20200519,20200519,DIR,,,FDA-CTU,,49.0,YR,,F,N,87.8,KG,20200519.0,Y,PH,US,US,2020,Q2,Adult
178067901,17806790,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Body temperature increased,,2020,Q2,1,I,20200519.0,,20200519,20200519,DIR,,,FDA-CTU,,49.0,YR,,F,N,87.8,KG,20200519.0,Y,PH,US,US,2020,Q2,Adult
178100563,17810056,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,3,F,20200511.0,20200529.0,20200520,20200616,EXP,,US-GILEAD-2020-0467380,GILEAD,,69.0,YR,E,F,Y,79.4,KG,20200616.0,,PH,US,US,2020,Q2,Elderly
178100563,17810056,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,3,F,20200511.0,20200529.0,20200520,20200616,EXP,,US-GILEAD-2020-0467380,GILEAD,,69.0,YR,E,F,Y,79.4,KG,20200616.0,,PH,US,US,2020,Q2,Elderly
178100563,17810056,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Death,,2020,Q2,3,F,20200511.0,20200529.0,20200520,20200616,EXP,,US-GILEAD-2020-0467380,GILEAD,,69.0,YR,E,F,Y,79.4,KG,20200616.0,,PH,US,US,2020,Q2,Elderly
178100563,17810056,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Oliguria,,2020,Q2,3,F,20200511.0,20200529.0,20200520,20200616,EXP,,US-GILEAD-2020-0467380,GILEAD,,69.0,YR,E,F,Y,79.4,KG,20200616.0,,PH,US,US,2020,Q2,Elderly
178109791,17810979,2,SS,Insulin Lispro,INSULIN LISPRO,1,,UNKNOWN,,,,U,,,,,,,,2020,Q2,Generalised oedema,,2020,Q2,1,I,,20200518.0,20200521,20200521,EXP,,CN-CELLTRION-2020-CN-000130,CELLTRION,"XUE J, LIU W, SHI F, ZHENG J, MA J. .PLEURAL EFFUSION DUE TO USE OF PIOGLITAZONE: A CASE REPORT.2020;18(3):168-171. .METABOLIC SYNDROME AND RELATED DISORDERS.2020;18(3):168-171.",76.0,YR,,F,Y,80.0,KG,20200521.0,,HP,CN,CN,2020,Q2,Elderly
178109791,17810979,2,SS,Insulin Lispro,INSULIN LISPRO,1,,UNKNOWN,,,,U,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,1,I,,20200518.0,20200521,20200521,EXP,,CN-CELLTRION-2020-CN-000130,CELLTRION,"XUE J, LIU W, SHI F, ZHENG J, MA J. .PLEURAL EFFUSION DUE TO USE OF PIOGLITAZONE: A CASE REPORT.2020;18(3):168-171. .METABOLIC SYNDROME AND RELATED DISORDERS.2020;18(3):168-171.",76.0,YR,,F,Y,80.0,KG,20200521.0,,HP,CN,CN,2020,Q2,Elderly
178110121,17811012,17,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200518.0,,20200520,20200520,DIR,,,FDA-CTU,,35.0,YR,,M,N,272.7,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178110121,17811012,17,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200518.0,,20200520,20200520,DIR,,,FDA-CTU,,35.0,YR,,M,N,272.7,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178110121,17811012,17,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200518.0,,20200520,20200520,DIR,,,FDA-CTU,,35.0,YR,,M,N,272.7,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178110201,17811020,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200519.0,,20200520,20200520,DIR,,,FDA-CTU,,72.0,YR,,M,N,69.0,KG,20200520.0,N,PH,US,US,2020,Q2,Elderly
178110561,17811056,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Platelet count decreased,,2020,Q2,1,I,20200517.0,,20200520,20200520,DIR,,,FDA-CTU,,71.0,YR,,M,N,107.0,KG,20200520.0,Y,PH,AF,AF,2020,Q2,Elderly
178120722,17812072,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200519.0,20200519.0,20200521,20200601,PER,,US-ELI_LILLY_AND_COMPANY-US202005007692,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20200601.0,,CN,US,US,2020,Q2,Adult
178120722,17812072,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q2,Product dose omission,,2020,Q2,2,F,20200519.0,20200519.0,20200521,20200601,PER,,US-ELI_LILLY_AND_COMPANY-US202005007692,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20200601.0,,CN,US,US,2020,Q2,Adult
178125591,17812559,14,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hyperhidrosis,,2020,Q2,1,I,20200515.0,,20200521,20200521,DIR,,,FDA-CTU,,64.0,YR,,M,N,125.55,KG,20200521.0,N,PH,US,US,2020,Q2,Adult
178125591,17812559,14,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,20200515.0,,20200521,20200521,DIR,,,FDA-CTU,,64.0,YR,,M,N,125.55,KG,20200521.0,N,PH,US,US,2020,Q2,Adult
178125591,17812559,14,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,20200515.0,,20200521,20200521,DIR,,,FDA-CTU,,64.0,YR,,M,N,125.55,KG,20200521.0,N,PH,US,US,2020,Q2,Adult
178134871,17813487,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 U, UNKNOWN",,,,,,,,4.0,IU,,,2020,Q2,Neoplasm malignant,,2020,Q2,1,I,201905.0,20200518.0,20200521,20200521,EXP,,US-ELI_LILLY_AND_COMPANY-US202005006561,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Elderly
178159061,17815906,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acidosis,,2020,Q2,1,I,20200511.0,,20200522,20200522,DIR,,,FDA-CTU,,69.0,YR,,F,N,,,20200520.0,N,,US,US,2020,Q2,Elderly
178159061,17815906,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Disseminated intravascular coagulation,,2020,Q2,1,I,20200511.0,,20200522,20200522,DIR,,,FDA-CTU,,69.0,YR,,F,N,,,20200520.0,N,,US,US,2020,Q2,Elderly
178159061,17815906,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20200511.0,,20200522,20200522,DIR,,,FDA-CTU,,69.0,YR,,F,N,,,20200520.0,N,,US,US,2020,Q2,Elderly
178159061,17815906,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Paralysis,,2020,Q2,1,I,20200511.0,,20200522,20200522,DIR,,,FDA-CTU,,69.0,YR,,F,N,,,20200520.0,N,,US,US,2020,Q2,Elderly
178159061,17815906,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,1,I,20200511.0,,20200522,20200522,DIR,,,FDA-CTU,,69.0,YR,,F,N,,,20200520.0,N,,US,US,2020,Q2,Elderly
178159061,17815906,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Shock,,2020,Q2,1,I,20200511.0,,20200522,20200522,DIR,,,FDA-CTU,,69.0,YR,,F,N,,,20200520.0,N,,US,US,2020,Q2,Elderly
178185392,17818539,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Bradycardia,,2020,Q2,2,F,20200519.0,20200605.0,20200522,20200610,EXP,,US-GILEAD-2020-0468282,GILEAD,,53.0,YR,A,M,Y,68.0,KG,20200610.0,,PH,US,US,2020,Q2,Adult
178185392,17818539,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Pulseless electrical activity,,2020,Q2,2,F,20200519.0,20200605.0,20200522,20200610,EXP,,US-GILEAD-2020-0468282,GILEAD,,53.0,YR,A,M,Y,68.0,KG,20200610.0,,PH,US,US,2020,Q2,Adult
178207351,17820735,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,32 IU,,,D,,,,,32.0,IU,,,2020,Q2,Cerebral haemorrhage,,2020,Q2,1,I,20191021.0,20200113.0,20200525,20200525,EXP,IT-MINISAL02-583429,NVSC2020IT007740,NOVARTIS,,67.0,YR,,M,Y,,,20200525.0,,HP,IT,IT,2020,Q2,Elderly
178207351,17820735,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,32 IU,,,D,,,,,32.0,IU,,,2020,Q2,Loss of consciousness,,2020,Q2,1,I,20191021.0,20200113.0,20200525,20200525,EXP,IT-MINISAL02-583429,NVSC2020IT007740,NOVARTIS,,67.0,YR,,M,Y,,,20200525.0,,HP,IT,IT,2020,Q2,Elderly
178207351,17820735,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,32 IU,,,D,,,,,32.0,IU,,,2020,Q2,Neurological symptom,,2020,Q2,1,I,20191021.0,20200113.0,20200525,20200525,EXP,IT-MINISAL02-583429,NVSC2020IT007740,NOVARTIS,,67.0,YR,,M,Y,,,20200525.0,,HP,IT,IT,2020,Q2,Elderly
178207351,17820735,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,32 IU,,,D,,,,,32.0,IU,,,2020,Q2,Respiratory arrest,,2020,Q2,1,I,20191021.0,20200113.0,20200525,20200525,EXP,IT-MINISAL02-583429,NVSC2020IT007740,NOVARTIS,,67.0,YR,,M,Y,,,20200525.0,,HP,IT,IT,2020,Q2,Elderly
178230781,17823078,6,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200522.0,,20200524,20200524,DIR,,,FDA-CTU,,68.0,YR,,M,N,99.5,KG,20200524.0,N,PH,US,US,2020,Q2,Elderly
178230781,17823078,6,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Haemodialysis,,2020,Q2,1,I,20200522.0,,20200524,20200524,DIR,,,FDA-CTU,,68.0,YR,,M,N,99.5,KG,20200524.0,N,PH,US,US,2020,Q2,Elderly
178230981,17823098,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatine increased,,2020,Q2,1,I,20200520.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178230981,17823098,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Dialysis,,2020,Q2,1,I,20200520.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178230981,17823098,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,1,I,20200520.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178230981,17823098,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,1,I,20200520.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178230981,17823098,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hepatic failure,,2020,Q2,1,I,20200520.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178230981,17823098,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,20200520.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178230981,17823098,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypovolaemic shock,,2020,Q2,1,I,20200520.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178230981,17823098,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Metabolic acidosis,,2020,Q2,1,I,20200520.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178230981,17823098,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,1,I,20200520.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178230981,17823098,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Shock haemorrhagic,,2020,Q2,1,I,20200520.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178231031,17823103,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200519.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178231031,17823103,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatine increased,,2020,Q2,1,I,20200519.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178231031,17823103,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Dialysis,,2020,Q2,1,I,20200519.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178231031,17823103,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,1,I,20200519.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178231031,17823103,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,1,I,20200519.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178231031,17823103,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hepatic failure,,2020,Q2,1,I,20200519.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178231031,17823103,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypovolaemic shock,,2020,Q2,1,I,20200519.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178231031,17823103,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Liver function test increased,,2020,Q2,1,I,20200519.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178231031,17823103,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Shock haemorrhagic,,2020,Q2,1,I,20200519.0,,20200523,20200523,DIR,,,FDA-CTU,,66.0,YR,,M,N,135.62,KG,20200523.0,N,HP,US,US,2020,Q2,Elderly
178231251,17823125,4,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Blood lactic acid decreased,,2020,Q2,1,I,20200516.0,,20200524,20200524,DIR,,,FDA-CTU,,71.0,YR,,M,N,95.3,KG,20200524.0,N,PH,US,US,2020,Q2,Elderly
178231251,17823125,4,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Renal injury,,2020,Q2,1,I,20200516.0,,20200524,20200524,DIR,,,FDA-CTU,,71.0,YR,,M,N,95.3,KG,20200524.0,N,PH,US,US,2020,Q2,Elderly
178231251,17823125,4,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Respiratory rate increased,,2020,Q2,1,I,20200516.0,,20200524,20200524,DIR,,,FDA-CTU,,71.0,YR,,M,N,95.3,KG,20200524.0,N,PH,US,US,2020,Q2,Elderly
178231251,17823125,4,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Septic shock,,2020,Q2,1,I,20200516.0,,20200524,20200524,DIR,,,FDA-CTU,,71.0,YR,,M,N,95.3,KG,20200524.0,N,PH,US,US,2020,Q2,Elderly
178231251,17823125,4,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Tachypnoea,,2020,Q2,1,I,20200516.0,,20200524,20200524,DIR,,,FDA-CTU,,71.0,YR,,M,N,95.3,KG,20200524.0,N,PH,US,US,2020,Q2,Elderly
178231251,17823125,4,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Urinary casts,,2020,Q2,1,I,20200516.0,,20200524,20200524,DIR,,,FDA-CTU,,71.0,YR,,M,N,95.3,KG,20200524.0,N,PH,US,US,2020,Q2,Elderly
178231811,17823181,7,C,INSULIN LISPRO SUBCUTANEOUS,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypopnoea,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,75.0,YR,,F,N,82.6,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231811,17823181,7,C,INSULIN LISPRO SUBCUTANEOUS,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Infusion related reaction,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,75.0,YR,,F,N,82.6,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231811,17823181,7,C,INSULIN LISPRO SUBCUTANEOUS,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Rash,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,75.0,YR,,F,N,82.6,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231811,17823181,7,C,INSULIN LISPRO SUBCUTANEOUS,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Rash pruritic,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,75.0,YR,,F,N,82.6,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231811,17823181,7,C,INSULIN LISPRO SUBCUTANEOUS,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Respiratory distress,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,75.0,YR,,F,N,82.6,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231811,17823181,7,C,INSULIN LISPRO SUBCUTANEOUS,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Wheezing,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,75.0,YR,,F,N,82.6,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231881,17823188,10,C,INSULIN LISPRO SUBCUTANEOUS,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,60.0,YR,,F,N,143.0,KG,20200525.0,N,PH,US,US,2020,Q2,Adult
178231881,17823188,10,C,INSULIN LISPRO SUBCUTANEOUS,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,60.0,YR,,F,N,143.0,KG,20200525.0,N,PH,US,US,2020,Q2,Adult
178231951,17823195,3,C,Insulin lispro + insulin glargine,,2,,,,,,,,,,,,,,2020,Q2,Anxiety,,2020,Q2,1,I,20200524.0,,20200525,20200525,DIR,,,FDA-CTU,,68.0,YR,,F,N,76.0,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231951,17823195,3,C,Insulin lispro + insulin glargine,,2,,,,,,,,,,,,,,2020,Q2,Encephalopathy,,2020,Q2,1,I,20200524.0,,20200525,20200525,DIR,,,FDA-CTU,,68.0,YR,,F,N,76.0,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231951,17823195,3,C,Insulin lispro + insulin glargine,,2,,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20200524.0,,20200525,20200525,DIR,,,FDA-CTU,,68.0,YR,,F,N,76.0,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231951,17823195,3,C,Insulin lispro + insulin glargine,,2,,,,,,,,,,,,,,2020,Q2,Respiratory distress,,2020,Q2,1,I,20200524.0,,20200525,20200525,DIR,,,FDA-CTU,,68.0,YR,,F,N,76.0,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231951,17823195,3,C,Insulin lispro + insulin glargine,,2,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200524.0,,20200525,20200525,DIR,,,FDA-CTU,,68.0,YR,,F,N,76.0,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231951,17823195,3,C,Insulin lispro + insulin glargine,,2,,,,,,,,,,,,,,2020,Q2,Unresponsive to stimuli,,2020,Q2,1,I,20200524.0,,20200525,20200525,DIR,,,FDA-CTU,,68.0,YR,,F,N,76.0,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178232201,17823220,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acidosis,,2020,Q2,1,I,20200514.0,,20200522,20200522,DIR,,,FDA-CTU,,60.0,YR,,M,N,103.0,KG,20200522.0,Y,PH,US,US,2020,Q2,Adult
178232201,17823220,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200514.0,,20200522,20200522,DIR,,,FDA-CTU,,60.0,YR,,M,N,103.0,KG,20200522.0,Y,PH,US,US,2020,Q2,Adult
178238611,17823861,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute respiratory failure,,2020,Q2,1,I,20200404.0,,20200522,20200522,DIR,,,FDA-CTU,,74.0,YR,,M,N,,,20200522.0,Y,PH,US,US,2020,Q2,Elderly
178238611,17823861,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,1,I,20200404.0,,20200522,20200522,DIR,,,FDA-CTU,,74.0,YR,,M,N,,,20200522.0,Y,PH,US,US,2020,Q2,Elderly
178238611,17823861,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,1,I,20200404.0,,20200522,20200522,DIR,,,FDA-CTU,,74.0,YR,,M,N,,,20200522.0,Y,PH,US,US,2020,Q2,Elderly
178239941,17823994,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"9 INTERNATIONAL UNIT, PRN",,,Y,,,,20563.0,9.0,IU,,,2020,Q2,Extra dose administered,,2020,Q2,1,I,20200414.0,20200513.0,20200526,20200526,EXP,IT-MINISAL02-618371,IT-ELI_LILLY_AND_COMPANY-IT202005005271,ELI LILLY AND CO,,12.0,YR,,F,Y,,,20200526.0,,MD,IT,IT,2020,Q2,Child
178239941,17823994,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"9 INTERNATIONAL UNIT, PRN",,,Y,,,,20563.0,9.0,IU,,,2020,Q2,Hyperinsulinaemic hypoglycaemia,,2020,Q2,1,I,20200414.0,20200513.0,20200526,20200526,EXP,IT-MINISAL02-618371,IT-ELI_LILLY_AND_COMPANY-IT202005005271,ELI LILLY AND CO,,12.0,YR,,F,Y,,,20200526.0,,MD,IT,IT,2020,Q2,Child
178239971,17823997,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,,20200509.0,20200526,20200526,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202005003141,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200526.0,,CN,CN,CN,2020,Q2,Adult
178239971,17823997,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200509.0,20200526,20200526,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202005003141,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200526.0,,CN,CN,CN,2020,Q2,Adult
178239971,17823997,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q2,Eye disorder,,2020,Q2,1,I,,20200509.0,20200526,20200526,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202005003141,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200526.0,,CN,CN,CN,2020,Q2,Adult
178239971,17823997,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,,20200509.0,20200526,20200526,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202005003141,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200526.0,,CN,CN,CN,2020,Q2,Adult
178240601,17824060,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cardio-respiratory arrest,,2020,Q2,1,I,20200525.0,,20200526,20200526,DIR,,,FDA-CTU,,76.0,YR,,F,N,102.0,KG,20200526.0,N,PH,US,US,2020,Q2,Elderly
178240861,17824086,6,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200522.0,,20200526,20200526,DIR,,,FDA-CTU,,69.0,YR,,M,N,65.0,KG,20200526.0,Y,PH,US,US,2020,Q2,Elderly
178249501,17824950,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200524.0,,20200526,20200526,DIR,,,FDA-CTU,,46.0,YR,,F,N,63.7,KG,20200526.0,Y,PH,US,US,2020,Q2,Adult
178249701,17824970,8,C,insulin lispro SQ sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200525.0,,20200526,20200526,DIR,,,FDA-CTU,,56.0,YR,,M,N,99.0,KG,20200526.0,N,PH,US,US,2020,Q2,Adult
178262671,17826267,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,3X SLIDING SCALE A DAY BEFORE MEALS AND HS,,,U,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200417.0,20200420.0,20200526,20200526,EXP,,US-SA-2020SA111342,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200526.0,,MD,US,US,2020,Q2,Elderly
178265301,17826530,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Death,,2020,Q2,1,I,20200526.0,20200526.0,20200527,20200527,EXP,,US-ABBVIE-20P-163-3419171-00,ABBVIE,,89.0,YR,,M,Y,,,20200527.0,,CN,US,US,2020,Q2,Elderly
178265722,17826572,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal tubular necrosis,,2020,Q2,2,F,20200511.0,20200611.0,20200526,20200617,EXP,,US-GILEAD-2020-0467950,GILEAD,,70.0,YR,E,M,Y,145.0,KG,20200617.0,,PH,US,US,2020,Q2,Elderly
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Arthralgia,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Bronchitis,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Death,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Dementia,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Drug ineffective,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Ear infection,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Gait disturbance,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Hepatic enzyme increased,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Hepatic steatosis,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Joint swelling,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Liver disorder,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Liver injury,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Loss of personal independence in daily activities,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Musculoskeletal stiffness,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Nasopharyngitis,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Noninfective encephalitis,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Peripheral swelling,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Pharyngitis,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Poor venous access,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Pruritus,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Rheumatoid arthritis,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Seizure,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Swelling,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Therapeutic product effect decreased,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Therapeutic response decreased,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Tremor,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178280951,17828095,6,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-ROCHE-2605112,ROCHE,,62.0,YR,,F,Y,,,20200527.0,,HP,CA,CA,2020,Q2,Adult
178300261,17830026,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Hospitalisation,,2020,Q2,1,I,20200514.0,20200521.0,20200527,20200527,EXP,,US-BAYER-2020-092730,BAYER,,50.0,YR,A,F,Y,,,20200527.0,,HP,US,US,2020,Q2,Adult
178300261,17830026,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Off label use,,2020,Q2,1,I,20200514.0,20200521.0,20200527,20200527,EXP,,US-BAYER-2020-092730,BAYER,,50.0,YR,A,F,Y,,,20200527.0,,HP,US,US,2020,Q2,Adult
178300261,17830026,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Product use in unapproved indication,,2020,Q2,1,I,20200514.0,20200521.0,20200527,20200527,EXP,,US-BAYER-2020-092730,BAYER,,50.0,YR,A,F,Y,,,20200527.0,,HP,US,US,2020,Q2,Adult
178333381,17833338,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TOTAL (1 3-ML PEN AT 100 UNITS/ML)",,,D,,,,,300.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TOTAL (1 3-ML PEN AT 100 UNITS/ML)",,,D,,,,,300.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Depressed level of consciousness,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TOTAL (1 3-ML PEN AT 100 UNITS/ML)",,,D,,,,,300.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypophagia,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TOTAL (1 3-ML PEN AT 100 UNITS/ML)",,,D,,,,,300.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Intentional overdose,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TOTAL (1 3-ML PEN AT 100 UNITS/ML)",,,D,,,,,300.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Nausea,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Depressed level of consciousness,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hypophagia,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Intentional overdose,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Nausea,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178334331,17833433,14,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200519.0,,20200527,20200527,DIR,,,FDA-CTU,,57.0,YR,,M,N,73.0,KG,20200527.0,Y,PH,US,US,2020,Q2,Adult
178334331,17833433,14,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200519.0,,20200527,20200527,DIR,,,FDA-CTU,,57.0,YR,,M,N,73.0,KG,20200527.0,Y,PH,US,US,2020,Q2,Adult
178334381,17833438,12,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypokalaemia,,2020,Q2,1,I,20200526.0,,20200527,20200527,DIR,,,FDA-CTU,,43.0,YR,,M,N,157.0,KG,20200527.0,N,PH,US,US,2020,Q2,Adult
178334891,17833489,9,C,"Insulin ( lispro, regular)",,2,,,,,,,,,,,,,,2020,Q2,Acute hepatic failure,,2020,Q2,1,I,20200524.0,,20200527,20200527,DIR,,,FDA-CTU,,83.0,YR,,F,N,79.3,KG,20200527.0,Y,PH,US,US,2020,Q2,Elderly
178334891,17833489,9,C,"Insulin ( lispro, regular)",,2,,,,,,,,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,1,I,20200524.0,,20200527,20200527,DIR,,,FDA-CTU,,83.0,YR,,F,N,79.3,KG,20200527.0,Y,PH,US,US,2020,Q2,Elderly
178334891,17833489,9,C,"Insulin ( lispro, regular)",,2,,,,,,,,,,,,,,2020,Q2,Malaise,,2020,Q2,1,I,20200524.0,,20200527,20200527,DIR,,,FDA-CTU,,83.0,YR,,F,N,79.3,KG,20200527.0,Y,PH,US,US,2020,Q2,Elderly
178334891,17833489,9,C,"Insulin ( lispro, regular)",,2,,,,,,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,1,I,20200524.0,,20200527,20200527,DIR,,,FDA-CTU,,83.0,YR,,F,N,79.3,KG,20200527.0,Y,PH,US,US,2020,Q2,Elderly
178335101,17833510,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200526.0,,20200527,20200527,DIR,,,FDA-CTU,,50.0,YR,,M,N,116.0,KG,20200527.0,N,PH,US,US,2020,Q2,Adult
178336471,17833647,4,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Chills,,2020,Q2,1,I,20200526.0,,20200527,20200527,DIR,,,FDA-CTU,,42.0,YR,,M,N,72.2,KG,20200527.0,Y,PH,US,US,2020,Q2,Adult
178336471,17833647,4,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Tremor,,2020,Q2,1,I,20200526.0,,20200527,20200527,DIR,,,FDA-CTU,,42.0,YR,,M,N,72.2,KG,20200527.0,Y,PH,US,US,2020,Q2,Adult
178345971,17834597,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Bradycardia,,2020,Q2,1,I,20200521.0,,20200528,20200528,DIR,,,FDA-CTU,,38.0,YR,,F,N,71.7,KG,20200528.0,Y,PH,US,US,2020,Q2,Adult
178345971,17834597,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,20200521.0,,20200528,20200528,DIR,,,FDA-CTU,,38.0,YR,,F,N,71.7,KG,20200528.0,Y,PH,US,US,2020,Q2,Adult
178345971,17834597,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,20200521.0,,20200528,20200528,DIR,,,FDA-CTU,,38.0,YR,,F,N,71.7,KG,20200528.0,Y,PH,US,US,2020,Q2,Adult
178345971,17834597,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Inflammatory marker increased,,2020,Q2,1,I,20200521.0,,20200528,20200528,DIR,,,FDA-CTU,,38.0,YR,,F,N,71.7,KG,20200528.0,Y,PH,US,US,2020,Q2,Adult
178345971,17834597,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Ventricular fibrillation,,2020,Q2,1,I,20200521.0,,20200528,20200528,DIR,,,FDA-CTU,,38.0,YR,,F,N,71.7,KG,20200528.0,Y,PH,US,US,2020,Q2,Adult
178346031,17834603,6,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200516.0,,20200528,20200528,DIR,,,FDA-CTU,,51.0,YR,,M,N,122.5,KG,20200528.0,N,PH,US,US,2020,Q2,Adult
178346031,17834603,6,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200516.0,,20200528,20200528,DIR,,,FDA-CTU,,51.0,YR,,M,N,122.5,KG,20200528.0,N,PH,US,US,2020,Q2,Adult
178346031,17834603,6,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood pressure decreased,,2020,Q2,1,I,20200516.0,,20200528,20200528,DIR,,,FDA-CTU,,51.0,YR,,M,N,122.5,KG,20200528.0,N,PH,US,US,2020,Q2,Adult
178346031,17834603,6,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood urea increased,,2020,Q2,1,I,20200516.0,,20200528,20200528,DIR,,,FDA-CTU,,51.0,YR,,M,N,122.5,KG,20200528.0,N,PH,US,US,2020,Q2,Adult
178349461,17834946,17,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200527.0,,20200528,20200528,DIR,,,FDA-CTU,,65.0,YR,,M,N,71.0,KG,20200528.0,N,PH,US,US,2020,Q2,Elderly
178349461,17834946,17,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal tubular necrosis,,2020,Q2,1,I,20200527.0,,20200528,20200528,DIR,,,FDA-CTU,,65.0,YR,,M,N,71.0,KG,20200528.0,N,PH,US,US,2020,Q2,Elderly
178358763,17835876,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Alanine aminotransferase abnormal,,2020,Q2,3,F,20200519.0,20200627.0,20200528,20200630,EXP,,US-GILEAD-2020-0468482,GILEAD,,49.0,YR,A,F,Y,87.8,KG,20200630.0,,PH,US,US,2020,Q2,Adult
178358763,17835876,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Blood alkaline phosphatase increased,,2020,Q2,3,F,20200519.0,20200627.0,20200528,20200630,EXP,,US-GILEAD-2020-0468482,GILEAD,,49.0,YR,A,F,Y,87.8,KG,20200630.0,,PH,US,US,2020,Q2,Adult
178358763,17835876,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,3,F,20200519.0,20200627.0,20200528,20200630,EXP,,US-GILEAD-2020-0468482,GILEAD,,49.0,YR,A,F,Y,87.8,KG,20200630.0,,PH,US,US,2020,Q2,Adult
178358822,17835882,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,2,F,20200515.0,20200623.0,20200528,20200626,EXP,,US-GILEAD-2020-0468290,GILEAD,,67.0,YR,E,F,Y,72.6,KG,20200626.0,,PH,US,US,2020,Q2,Elderly
178358822,17835882,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Swelling,,2020,Q2,2,F,20200515.0,20200623.0,20200528,20200626,EXP,,US-GILEAD-2020-0468290,GILEAD,,67.0,YR,E,F,Y,72.6,KG,20200626.0,,PH,US,US,2020,Q2,Elderly
178358822,17835882,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Throat irritation,,2020,Q2,2,F,20200515.0,20200623.0,20200528,20200626,EXP,,US-GILEAD-2020-0468290,GILEAD,,67.0,YR,E,F,Y,72.6,KG,20200626.0,,PH,US,US,2020,Q2,Elderly
178377982,17837798,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Death,,2020,Q2,2,F,20200525.0,20200611.0,20200528,20200616,EXP,,US-GILEAD-2020-0468927,GILEAD,,76.0,YR,E,F,Y,102.0,KG,20200616.0,,PH,US,US,2020,Q2,Elderly
178389551,17838955,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200527.0,,20200528,20200528,DIR,,,FDA-CTU,,63.0,YR,,M,N,88.1,KG,20200528.0,N,PH,US,US,2020,Q2,Adult
178389551,17838955,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Ischaemic hepatitis,,2020,Q2,1,I,20200527.0,,20200528,20200528,DIR,,,FDA-CTU,,63.0,YR,,M,N,88.1,KG,20200528.0,N,PH,US,US,2020,Q2,Adult
178389551,17838955,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Transaminases increased,,2020,Q2,1,I,20200527.0,,20200528,20200528,DIR,,,FDA-CTU,,63.0,YR,,M,N,88.1,KG,20200528.0,N,PH,US,US,2020,Q2,Adult
178397901,17839790,15,C,"Insulin (glargine, lispro and regular)",,2,,,,,,,,,,,,,,2020,Q2,Dialysis,,2020,Q2,1,I,20200524.0,,20200529,20200529,DIR,,,FDA-CTU,,81.0,YR,,F,N,88.6,KG,20200529.0,Y,PH,US,US,2020,Q2,Elderly
178397901,17839790,15,C,"Insulin (glargine, lispro and regular)",,2,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,1,I,20200524.0,,20200529,20200529,DIR,,,FDA-CTU,,81.0,YR,,F,N,88.6,KG,20200529.0,Y,PH,US,US,2020,Q2,Elderly
178397901,17839790,15,C,"Insulin (glargine, lispro and regular)",,2,,,,,,,,,,,,,,2020,Q2,Tachypnoea,,2020,Q2,1,I,20200524.0,,20200529,20200529,DIR,,,FDA-CTU,,81.0,YR,,F,N,88.6,KG,20200529.0,Y,PH,US,US,2020,Q2,Elderly
178400871,17840087,10,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Disease progression,,2020,Q2,1,I,20200525.0,,20200529,20200529,DIR,,,FDA-CTU,,73.0,YR,,M,N,77.0,KG,20200528.0,Y,MD,US,US,2020,Q2,Elderly
178400871,17840087,10,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20200525.0,,20200529,20200529,DIR,,,FDA-CTU,,73.0,YR,,M,N,77.0,KG,20200528.0,Y,MD,US,US,2020,Q2,Elderly
178400871,17840087,10,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200525.0,,20200529,20200529,DIR,,,FDA-CTU,,73.0,YR,,M,N,77.0,KG,20200528.0,Y,MD,US,US,2020,Q2,Elderly
178400871,17840087,10,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Severe acute respiratory syndrome,,2020,Q2,1,I,20200525.0,,20200529,20200529,DIR,,,FDA-CTU,,73.0,YR,,M,N,77.0,KG,20200528.0,Y,MD,US,US,2020,Q2,Elderly
178414381,17841438,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 ML OF SINGLE DOSE, DAILY",,,Y,, D093732,,20563.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Blister,,2020,Q2,1,I,20200421.0,20200517.0,20200529,20200529,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202005006879,ELI LILLY AND CO,,57.0,YR,,F,Y,56.0,KG,20200529.0,,HP,CN,CN,2020,Q2,Adult
178414381,17841438,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 ML OF SINGLE DOSE, DAILY",,,Y,, D093732,,20563.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Discomfort,,2020,Q2,1,I,20200421.0,20200517.0,20200529,20200529,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202005006879,ELI LILLY AND CO,,57.0,YR,,F,Y,56.0,KG,20200529.0,,HP,CN,CN,2020,Q2,Adult
178414381,17841438,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 ML OF SINGLE DOSE, DAILY",,,Y,, D093732,,20563.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Pruritus,,2020,Q2,1,I,20200421.0,20200517.0,20200529,20200529,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202005006879,ELI LILLY AND CO,,57.0,YR,,F,Y,56.0,KG,20200529.0,,HP,CN,CN,2020,Q2,Adult
178414381,17841438,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 ML OF SINGLE DOSE, DAILY",,,Y,, D093732,,20563.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Rash erythematous,,2020,Q2,1,I,20200421.0,20200517.0,20200529,20200529,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202005006879,ELI LILLY AND CO,,57.0,YR,,F,Y,56.0,KG,20200529.0,,HP,CN,CN,2020,Q2,Adult
178417562,17841756,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute respiratory failure,,2020,Q2,2,F,20200524.0,20200611.0,20200529,20200616,EXP,,US-GILEAD-2020-0468849,GILEAD,,68.0,YR,E,F,Y,76.0,KG,20200616.0,,PH,US,US,2020,Q2,Elderly
178417562,17841756,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,COVID-19,,2020,Q2,2,F,20200524.0,20200611.0,20200529,20200616,EXP,,US-GILEAD-2020-0468849,GILEAD,,68.0,YR,E,F,Y,76.0,KG,20200616.0,,PH,US,US,2020,Q2,Elderly
178429991,17842999,12,C,INSULINE LISPRO,,2,Subcutaneous,NON RENSEIGN?E,,,U,,,,,,,,,2020,Q2,Cerebrovascular accident,,2020,Q2,1,I,20180603.0,20200518.0,20200530,20200530,EXP,FR-AFSSAPS-LM20200178,NVSC2020FR137053,NOVARTIS,,63.0,YR,,F,Y,48.0,KG,20200530.0,,PH,FR,FR,2020,Q2,Adult
178429991,17842999,12,C,INSULINE LISPRO,,2,Subcutaneous,NON RENSEIGN?E,,,U,,,,,,,,,2020,Q2,Neutropenia,,2020,Q2,1,I,20180603.0,20200518.0,20200530,20200530,EXP,FR-AFSSAPS-LM20200178,NVSC2020FR137053,NOVARTIS,,63.0,YR,,F,Y,48.0,KG,20200530.0,,PH,FR,FR,2020,Q2,Adult
178450071,17845007,16,C,insulin lispro per sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200529.0,,20200529,20200529,DIR,,,FDA-CTU,,75.0,YR,,F,N,96.0,KG,20200529.0,Y,PH,US,US,2020,Q2,Elderly
178450651,17845065,10,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acidosis,,2020,Q2,1,I,20200528.0,,20200529,20200529,DIR,,,FDA-CTU,,59.0,YR,,M,N,73.0,KG,20200529.0,Y,CN,US,US,2020,Q2,Adult
178450651,17845065,10,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200528.0,,20200529,20200529,DIR,,,FDA-CTU,,59.0,YR,,M,N,73.0,KG,20200529.0,Y,CN,US,US,2020,Q2,Adult
178450651,17845065,10,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200528.0,,20200529,20200529,DIR,,,FDA-CTU,,59.0,YR,,M,N,73.0,KG,20200529.0,Y,CN,US,US,2020,Q2,Adult
178450651,17845065,10,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood pressure systolic decreased,,2020,Q2,1,I,20200528.0,,20200529,20200529,DIR,,,FDA-CTU,,59.0,YR,,M,N,73.0,KG,20200529.0,Y,CN,US,US,2020,Q2,Adult
178450651,17845065,10,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Bronchitis,,2020,Q2,1,I,20200528.0,,20200529,20200529,DIR,,,FDA-CTU,,59.0,YR,,M,N,73.0,KG,20200529.0,Y,CN,US,US,2020,Q2,Adult
178450651,17845065,10,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,20200528.0,,20200529,20200529,DIR,,,FDA-CTU,,59.0,YR,,M,N,73.0,KG,20200529.0,Y,CN,US,US,2020,Q2,Adult
178450651,17845065,10,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Multiple organ dysfunction syndrome,,2020,Q2,1,I,20200528.0,,20200529,20200529,DIR,,,FDA-CTU,,59.0,YR,,M,N,73.0,KG,20200529.0,Y,CN,US,US,2020,Q2,Adult
178450651,17845065,10,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Oliguria,,2020,Q2,1,I,20200528.0,,20200529,20200529,DIR,,,FDA-CTU,,59.0,YR,,M,N,73.0,KG,20200529.0,Y,CN,US,US,2020,Q2,Adult
178450651,17845065,10,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,1,I,20200528.0,,20200529,20200529,DIR,,,FDA-CTU,,59.0,YR,,M,N,73.0,KG,20200529.0,Y,CN,US,US,2020,Q2,Adult
178450651,17845065,10,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200528.0,,20200529,20200529,DIR,,,FDA-CTU,,59.0,YR,,M,N,73.0,KG,20200529.0,Y,CN,US,US,2020,Q2,Adult
178450651,17845065,10,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200528.0,,20200529,20200529,DIR,,,FDA-CTU,,59.0,YR,,M,N,73.0,KG,20200529.0,Y,CN,US,US,2020,Q2,Adult
178450651,17845065,10,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,1,I,20200528.0,,20200529,20200529,DIR,,,FDA-CTU,,59.0,YR,,M,N,73.0,KG,20200529.0,Y,CN,US,US,2020,Q2,Adult
178462101,17846210,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY(12-15)",,,,,,,20563.0,15.0,IU,INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,1,I,20200505.0,20200505.0,20200601,20200601,PER,,US-ELI_LILLY_AND_COMPANY-US202005002128,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20200601.0,,CN,US,US,2020,Q2,Elderly
178462101,17846210,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY(12-15)",,,,,,,20563.0,15.0,IU,INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,1,I,20200505.0,20200505.0,20200601,20200601,PER,,US-ELI_LILLY_AND_COMPANY-US202005002128,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20200601.0,,CN,US,US,2020,Q2,Elderly
178462101,17846210,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY(12-15)",,,,, C938255F,,20563.0,15.0,IU,INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,1,I,20200505.0,20200505.0,20200601,20200601,PER,,US-ELI_LILLY_AND_COMPANY-US202005002128,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20200601.0,,CN,US,US,2020,Q2,Elderly
178462101,17846210,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY(12-15)",,,,, C938255F,,20563.0,15.0,IU,INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,1,I,20200505.0,20200505.0,20200601,20200601,PER,,US-ELI_LILLY_AND_COMPANY-US202005002128,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20200601.0,,CN,US,US,2020,Q2,Elderly
178480391,17848039,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Death,,2020,Q2,1,I,20200524.0,20200527.0,20200601,20200601,EXP,,US-GILEAD-2020-0469173,GILEAD,,82.0,YR,E,F,Y,79.3,KG,20200601.0,,PH,US,US,2020,Q2,Elderly
178480432,17848043,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Respiratory arrest,,2020,Q2,2,F,20200527.0,20200615.0,20200601,20200618,EXP,,US-GILEAD-2020-0469167,GILEAD,,61.0,YR,A,F,Y,140.6,KG,20200618.0,,PH,US,US,2020,Q2,Adult
178480442,17848044,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,2,F,20200523.0,20200610.0,20200601,20200615,EXP,,US-GILEAD-2020-0469503,GILEAD,,45.0,YR,A,M,Y,145.0,KG,20200615.0,,PH,US,US,2020,Q2,Adult
178480442,17848044,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cardiac arrest,,2020,Q2,2,F,20200523.0,20200610.0,20200601,20200615,EXP,,US-GILEAD-2020-0469503,GILEAD,,45.0,YR,A,M,Y,145.0,KG,20200615.0,,PH,US,US,2020,Q2,Adult
178480442,17848044,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,2,F,20200523.0,20200610.0,20200601,20200615,EXP,,US-GILEAD-2020-0469503,GILEAD,,45.0,YR,A,M,Y,145.0,KG,20200615.0,,PH,US,US,2020,Q2,Adult
178480442,17848044,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Liver function test increased,,2020,Q2,2,F,20200523.0,20200610.0,20200601,20200615,EXP,,US-GILEAD-2020-0469503,GILEAD,,45.0,YR,A,M,Y,145.0,KG,20200615.0,,PH,US,US,2020,Q2,Adult
178480442,17848044,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,2,F,20200523.0,20200610.0,20200601,20200615,EXP,,US-GILEAD-2020-0469503,GILEAD,,45.0,YR,A,M,Y,145.0,KG,20200615.0,,PH,US,US,2020,Q2,Adult
178480771,17848077,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Platelet count increased,,2020,Q2,1,I,20200516.0,20200520.0,20200601,20200601,EXP,,US-GILEAD-2020-0468738,GILEAD,,71.0,YR,E,M,Y,107.0,KG,20200601.0,,PH,US,US,2020,Q2,Elderly
178492091,17849209,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200531.0,,20200601,20200601,DIR,,,FDA-CTU,,80.0,YR,,M,N,83.5,KG,20200601.0,N,MD,US,US,2020,Q2,Elderly
178492091,17849209,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200531.0,,20200601,20200601,DIR,,,FDA-CTU,,80.0,YR,,M,N,83.5,KG,20200601.0,N,MD,US,US,2020,Q2,Elderly
178492091,17849209,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200531.0,,20200601,20200601,DIR,,,FDA-CTU,,80.0,YR,,M,N,83.5,KG,20200601.0,N,MD,US,US,2020,Q2,Elderly
178492091,17849209,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood culture positive,,2020,Q2,1,I,20200531.0,,20200601,20200601,DIR,,,FDA-CTU,,80.0,YR,,M,N,83.5,KG,20200601.0,N,MD,US,US,2020,Q2,Elderly
178492091,17849209,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,International normalised ratio increased,,2020,Q2,1,I,20200531.0,,20200601,20200601,DIR,,,FDA-CTU,,80.0,YR,,M,N,83.5,KG,20200601.0,N,MD,US,US,2020,Q2,Elderly
178492091,17849209,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Staphylococcal infection,,2020,Q2,1,I,20200531.0,,20200601,20200601,DIR,,,FDA-CTU,,80.0,YR,,M,N,83.5,KG,20200601.0,N,MD,US,US,2020,Q2,Elderly
178492141,17849214,13,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Liver function test increased,,2020,Q2,1,I,20200528.0,,20200601,20200601,DIR,,,FDA-CTU,,63.0,YR,,F,N,155.9,KG,20200601.0,Y,HP,US,US,2020,Q2,Adult
178493681,17849368,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200527.0,,20200601,20200601,DIR,,,FDA-CTU,,70.0,YR,,M,N,101.7,KG,20200601.0,Y,HP,US,US,2020,Q2,Elderly
178493681,17849368,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Haemodialysis,,2020,Q2,1,I,20200527.0,,20200601,20200601,DIR,,,FDA-CTU,,70.0,YR,,M,N,101.7,KG,20200601.0,Y,HP,US,US,2020,Q2,Elderly
178493681,17849368,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,1,I,20200527.0,,20200601,20200601,DIR,,,FDA-CTU,,70.0,YR,,M,N,101.7,KG,20200601.0,Y,HP,US,US,2020,Q2,Elderly
178493681,17849368,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Therapy cessation,,2020,Q2,1,I,20200527.0,,20200601,20200601,DIR,,,FDA-CTU,,70.0,YR,,M,N,101.7,KG,20200601.0,Y,HP,US,US,2020,Q2,Elderly
178498451,17849845,11,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200601.0,,20200602,20200602,DIR,,,FDA-CTU,,23.0,YR,,M,N,53.6,KG,20200602.0,Y,PH,US,US,2020,Q2,Youth
178501721,17850172,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute respiratory failure,,2020,Q2,1,I,202004.0,20200522.0,20200602,20200602,EXP,,US-BAYER-2020-097878,BAYER,,74.0,YR,E,M,Y,,,20200602.0,,CN,US,US,2020,Q2,Elderly
178501721,17850172,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,1,I,202004.0,20200522.0,20200602,20200602,EXP,,US-BAYER-2020-097878,BAYER,,74.0,YR,E,M,Y,,,20200602.0,,CN,US,US,2020,Q2,Elderly
178501721,17850172,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,1,I,202004.0,20200522.0,20200602,20200602,EXP,,US-BAYER-2020-097878,BAYER,,74.0,YR,E,M,Y,,,20200602.0,,CN,US,US,2020,Q2,Elderly
178501721,17850172,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,1,I,202004.0,20200522.0,20200602,20200602,EXP,,US-BAYER-2020-097878,BAYER,,74.0,YR,E,M,Y,,,20200602.0,,CN,US,US,2020,Q2,Elderly
178508171,17850817,7,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,1,I,20200529.0,,20200602,20200602,DIR,,,FDA-CTU,,71.0,YR,,M,N,98.6,KG,20200602.0,N,PH,US,US,2020,Q2,Elderly
178545661,17854566,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cholecystitis,,2020,Q2,1,I,20200531.0,,20200602,20200602,DIR,,,FDA-CTU,,76.0,YR,,M,N,80.8,KG,20200602.0,Y,HP,US,US,2020,Q2,Elderly
178545661,17854566,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cholelithiasis,,2020,Q2,1,I,20200531.0,,20200602,20200602,DIR,,,FDA-CTU,,76.0,YR,,M,N,80.8,KG,20200602.0,Y,HP,US,US,2020,Q2,Elderly
178545661,17854566,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Chronic kidney disease,,2020,Q2,1,I,20200531.0,,20200602,20200602,DIR,,,FDA-CTU,,76.0,YR,,M,N,80.8,KG,20200602.0,Y,HP,US,US,2020,Q2,Elderly
178545661,17854566,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,20200531.0,,20200602,20200602,DIR,,,FDA-CTU,,76.0,YR,,M,N,80.8,KG,20200602.0,Y,HP,US,US,2020,Q2,Elderly
178545661,17854566,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hepatic enzyme increased,,2020,Q2,1,I,20200531.0,,20200602,20200602,DIR,,,FDA-CTU,,76.0,YR,,M,N,80.8,KG,20200602.0,Y,HP,US,US,2020,Q2,Elderly
178545661,17854566,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,1,I,20200531.0,,20200602,20200602,DIR,,,FDA-CTU,,76.0,YR,,M,N,80.8,KG,20200602.0,Y,HP,US,US,2020,Q2,Elderly
178546821,17854682,5,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Rhabdomyolysis,,2020,Q2,1,I,20200521.0,,20200602,20200602,DIR,,,FDA-CTU,,52.0,YR,,M,N,111.0,KG,20200602.0,N,PH,US,US,2020,Q2,Adult
178567531,17856753,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,202005.0,20200529.0,20200603,20200603,EXP,,US-GILEAD-2020-0469662,GILEAD,,59.0,YR,A,M,Y,73.0,KG,20200603.0,,CN,US,US,2020,Q2,Adult
178567531,17856753,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Bronchitis,,2020,Q2,1,I,202005.0,20200529.0,20200603,20200603,EXP,,US-GILEAD-2020-0469662,GILEAD,,59.0,YR,A,M,Y,73.0,KG,20200603.0,,CN,US,US,2020,Q2,Adult
178567531,17856753,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,202005.0,20200529.0,20200603,20200603,EXP,,US-GILEAD-2020-0469662,GILEAD,,59.0,YR,A,M,Y,73.0,KG,20200603.0,,CN,US,US,2020,Q2,Adult
178567531,17856753,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Multiple organ dysfunction syndrome,,2020,Q2,1,I,202005.0,20200529.0,20200603,20200603,EXP,,US-GILEAD-2020-0469662,GILEAD,,59.0,YR,A,M,Y,73.0,KG,20200603.0,,CN,US,US,2020,Q2,Adult
178567531,17856753,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Oliguria,,2020,Q2,1,I,202005.0,20200529.0,20200603,20200603,EXP,,US-GILEAD-2020-0469662,GILEAD,,59.0,YR,A,M,Y,73.0,KG,20200603.0,,CN,US,US,2020,Q2,Adult
178567531,17856753,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,1,I,202005.0,20200529.0,20200603,20200603,EXP,,US-GILEAD-2020-0469662,GILEAD,,59.0,YR,A,M,Y,73.0,KG,20200603.0,,CN,US,US,2020,Q2,Adult
178567531,17856753,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,202005.0,20200529.0,20200603,20200603,EXP,,US-GILEAD-2020-0469662,GILEAD,,59.0,YR,A,M,Y,73.0,KG,20200603.0,,CN,US,US,2020,Q2,Adult
178567531,17856753,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,202005.0,20200529.0,20200603,20200603,EXP,,US-GILEAD-2020-0469662,GILEAD,,59.0,YR,A,M,Y,73.0,KG,20200603.0,,CN,US,US,2020,Q2,Adult
178567531,17856753,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,1,I,202005.0,20200529.0,20200603,20200603,EXP,,US-GILEAD-2020-0469662,GILEAD,,59.0,YR,A,M,Y,73.0,KG,20200603.0,,CN,US,US,2020,Q2,Adult
178571031,17857103,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200514.0,20200522.0,20200603,20200603,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,103.0,KG,20200603.0,,PH,US,US,2020,Q2,Adult
178571411,17857141,9,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,COVID-19,,2020,Q2,1,I,20200525.0,20200529.0,20200603,20200603,EXP,,US-GILEAD-2020-0469657,GILEAD,,73.0,YR,E,M,Y,77.0,KG,20200603.0,,MD,US,US,2020,Q2,Elderly
178571411,17857141,9,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20200525.0,20200529.0,20200603,20200603,EXP,,US-GILEAD-2020-0469657,GILEAD,,73.0,YR,E,M,Y,77.0,KG,20200603.0,,MD,US,US,2020,Q2,Elderly
178571411,17857141,9,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200525.0,20200529.0,20200603,20200603,EXP,,US-GILEAD-2020-0469657,GILEAD,,73.0,YR,E,M,Y,77.0,KG,20200603.0,,MD,US,US,2020,Q2,Elderly
178587471,17858747,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,20200601.0,,20200603,20200603,DIR,,,FDA-CTU,,51.0,YR,,F,N,72.0,KG,20200603.0,Y,HP,US,US,2020,Q2,Adult
178587471,17858747,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Liver function test increased,,2020,Q2,1,I,20200601.0,,20200603,20200603,DIR,,,FDA-CTU,,51.0,YR,,F,N,72.0,KG,20200603.0,Y,HP,US,US,2020,Q2,Adult
178593831,17859383,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Disease progression,,2020,Q2,1,I,,,20200603,20200603,DIR,,,FDA-CTU,,50.0,YR,,F,N,90.0,KG,20200603.0,N,MD,US,US,2020,Q2,Adult
178600791,17860079,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200526.0,,20200604,20200604,DIR,,,FDA-CTU,,27.0,YR,,F,N,176.3,KG,20200604.0,Y,PH,US,US,2020,Q2,Young Adult
178600791,17860079,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200526.0,,20200604,20200604,DIR,,,FDA-CTU,,27.0,YR,,F,N,176.3,KG,20200604.0,Y,PH,US,US,2020,Q2,Young Adult
178600791,17860079,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Haemodialysis,,2020,Q2,1,I,20200526.0,,20200604,20200604,DIR,,,FDA-CTU,,27.0,YR,,F,N,176.3,KG,20200604.0,Y,PH,US,US,2020,Q2,Young Adult
178614451,17861445,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"WITH MEALS, SLIDING SCALE, TAPERED DOWN",,,,,,,,12.0,IU,,,2020,Q2,Cellulitis,,2020,Q2,1,I,20200515.0,20200521.0,20200604,20200604,EXP,,US-ROCHE-2607417,ROCHE,,78.0,YR,,M,Y,72.0,KG,20200604.0,,MD,US,US,2020,Q2,Elderly
178614451,17861445,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"WITH MEALS, SLIDING SCALE, TAPERED DOWN",,,,,,,,12.0,IU,,,2020,Q2,Deep vein thrombosis,,2020,Q2,1,I,20200515.0,20200521.0,20200604,20200604,EXP,,US-ROCHE-2607417,ROCHE,,78.0,YR,,M,Y,72.0,KG,20200604.0,,MD,US,US,2020,Q2,Elderly
178614451,17861445,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"WITH MEALS, SLIDING SCALE, TAPERED DOWN",,,,,,,,12.0,IU,,,2020,Q2,Intentional product use issue,,2020,Q2,1,I,20200515.0,20200521.0,20200604,20200604,EXP,,US-ROCHE-2607417,ROCHE,,78.0,YR,,M,Y,72.0,KG,20200604.0,,MD,US,US,2020,Q2,Elderly
178614451,17861445,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"WITH MEALS, SLIDING SCALE, TAPERED DOWN",,,,,,,,12.0,IU,,,2020,Q2,Off label use,,2020,Q2,1,I,20200515.0,20200521.0,20200604,20200604,EXP,,US-ROCHE-2607417,ROCHE,,78.0,YR,,M,Y,72.0,KG,20200604.0,,MD,US,US,2020,Q2,Elderly
178614451,17861445,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"WITH MEALS, SLIDING SCALE, TAPERED DOWN",,,,,,,,12.0,IU,,,2020,Q2,Peripheral swelling,,2020,Q2,1,I,20200515.0,20200521.0,20200604,20200604,EXP,,US-ROCHE-2607417,ROCHE,,78.0,YR,,M,Y,72.0,KG,20200604.0,,MD,US,US,2020,Q2,Elderly
178619071,17861907,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute hepatic failure,,2020,Q2,1,I,20200518.0,20200530.0,20200604,20200604,EXP,,US-GILEAD-2020-0469837,GILEAD,,66.0,YR,E,M,Y,,,20200604.0,,HP,US,US,2020,Q2,Elderly
178619071,17861907,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200518.0,20200530.0,20200604,20200604,EXP,,US-GILEAD-2020-0469837,GILEAD,,66.0,YR,E,M,Y,,,20200604.0,,HP,US,US,2020,Q2,Elderly
178619071,17861907,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200518.0,20200530.0,20200604,20200604,EXP,,US-GILEAD-2020-0469837,GILEAD,,66.0,YR,E,M,Y,,,20200604.0,,HP,US,US,2020,Q2,Elderly
178619071,17861907,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Cardiovascular disorder,,2020,Q2,1,I,20200518.0,20200530.0,20200604,20200604,EXP,,US-GILEAD-2020-0469837,GILEAD,,66.0,YR,E,M,Y,,,20200604.0,,HP,US,US,2020,Q2,Elderly
178619071,17861907,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,1,I,20200518.0,20200530.0,20200604,20200604,EXP,,US-GILEAD-2020-0469837,GILEAD,,66.0,YR,E,M,Y,,,20200604.0,,HP,US,US,2020,Q2,Elderly
178619071,17861907,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,1,I,20200518.0,20200530.0,20200604,20200604,EXP,,US-GILEAD-2020-0469837,GILEAD,,66.0,YR,E,M,Y,,,20200604.0,,HP,US,US,2020,Q2,Elderly
178619071,17861907,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,20200518.0,20200530.0,20200604,20200604,EXP,,US-GILEAD-2020-0469837,GILEAD,,66.0,YR,E,M,Y,,,20200604.0,,HP,US,US,2020,Q2,Elderly
178619071,17861907,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Hypovolaemic shock,,2020,Q2,1,I,20200518.0,20200530.0,20200604,20200604,EXP,,US-GILEAD-2020-0469837,GILEAD,,66.0,YR,E,M,Y,,,20200604.0,,HP,US,US,2020,Q2,Elderly
178619071,17861907,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Metabolic acidosis,,2020,Q2,1,I,20200518.0,20200530.0,20200604,20200604,EXP,,US-GILEAD-2020-0469837,GILEAD,,66.0,YR,E,M,Y,,,20200604.0,,HP,US,US,2020,Q2,Elderly
178619071,17861907,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Shock haemorrhagic,,2020,Q2,1,I,20200518.0,20200530.0,20200604,20200604,EXP,,US-GILEAD-2020-0469837,GILEAD,,66.0,YR,E,M,Y,,,20200604.0,,HP,US,US,2020,Q2,Elderly
178631821,17863182,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200524.0,20200526.0,20200604,20200604,EXP,,US-GILEAD-2020-0469222,GILEAD,,46.0,YR,A,F,Y,63.7,KG,20200604.0,,PH,US,US,2020,Q2,Adult
178633231,17863323,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"31 INTERNATIONAL UNIT ( 1.6 UNITS KG DAY), DAILY",,,,,,,20563.0,31.0,IU,,QD,2020,Q2,Oedema,,2020,Q2,1,I,,20200525.0,20200604,20200604,EXP,,TR-ELI_LILLY_AND_COMPANY-TR202005010465,ELI LILLY AND CO,"H.Y.KOSTEK, N.KOROGLU, F.O.COMLEK, E.DILEK, F.TUTUNCULER.INSULIN-INDUCED OEDEMA: A RARE COMPLICATION IN A PATIENT WITH NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2020;VOL. 16:N1.DOI:DOI: 10.22141/2224-0721.16.1.2020.199132",9.0,YR,,M,Y,36.0,KG,20200604.0,,MD,TR,TR,2020,Q2,Child
178633231,17863323,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"31 INTERNATIONAL UNIT ( 1.6 UNITS KG DAY), DAILY",,,,,,,20563.0,31.0,IU,,QD,2020,Q2,Precocious puberty,,2020,Q2,1,I,,20200525.0,20200604,20200604,EXP,,TR-ELI_LILLY_AND_COMPANY-TR202005010465,ELI LILLY AND CO,"H.Y.KOSTEK, N.KOROGLU, F.O.COMLEK, E.DILEK, F.TUTUNCULER.INSULIN-INDUCED OEDEMA: A RARE COMPLICATION IN A PATIENT WITH NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2020;VOL. 16:N1.DOI:DOI: 10.22141/2224-0721.16.1.2020.199132",9.0,YR,,M,Y,36.0,KG,20200604.0,,MD,TR,TR,2020,Q2,Child
178633231,17863323,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"31 INTERNATIONAL UNIT ( 1.6 UNITS KG DAY), DAILY",,,,,,,20563.0,31.0,IU,,QD,2020,Q2,Weight increased,,2020,Q2,1,I,,20200525.0,20200604,20200604,EXP,,TR-ELI_LILLY_AND_COMPANY-TR202005010465,ELI LILLY AND CO,"H.Y.KOSTEK, N.KOROGLU, F.O.COMLEK, E.DILEK, F.TUTUNCULER.INSULIN-INDUCED OEDEMA: A RARE COMPLICATION IN A PATIENT WITH NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2020;VOL. 16:N1.DOI:DOI: 10.22141/2224-0721.16.1.2020.199132",9.0,YR,,M,Y,36.0,KG,20200604.0,,MD,TR,TR,2020,Q2,Child
178633231,17863323,2,SS,Insulin  Lispro,INSULIN LISPRO,1,,"2.2  UNITS KG DAY, UNKNOWN",,,,,,,20563.0,2.2,IU,,,2020,Q2,Oedema,,2020,Q2,1,I,,20200525.0,20200604,20200604,EXP,,TR-ELI_LILLY_AND_COMPANY-TR202005010465,ELI LILLY AND CO,"H.Y.KOSTEK, N.KOROGLU, F.O.COMLEK, E.DILEK, F.TUTUNCULER.INSULIN-INDUCED OEDEMA: A RARE COMPLICATION IN A PATIENT WITH NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2020;VOL. 16:N1.DOI:DOI: 10.22141/2224-0721.16.1.2020.199132",9.0,YR,,M,Y,36.0,KG,20200604.0,,MD,TR,TR,2020,Q2,Child
178633231,17863323,2,SS,Insulin  Lispro,INSULIN LISPRO,1,,"2.2  UNITS KG DAY, UNKNOWN",,,,,,,20563.0,2.2,IU,,,2020,Q2,Precocious puberty,,2020,Q2,1,I,,20200525.0,20200604,20200604,EXP,,TR-ELI_LILLY_AND_COMPANY-TR202005010465,ELI LILLY AND CO,"H.Y.KOSTEK, N.KOROGLU, F.O.COMLEK, E.DILEK, F.TUTUNCULER.INSULIN-INDUCED OEDEMA: A RARE COMPLICATION IN A PATIENT WITH NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2020;VOL. 16:N1.DOI:DOI: 10.22141/2224-0721.16.1.2020.199132",9.0,YR,,M,Y,36.0,KG,20200604.0,,MD,TR,TR,2020,Q2,Child
178633231,17863323,2,SS,Insulin  Lispro,INSULIN LISPRO,1,,"2.2  UNITS KG DAY, UNKNOWN",,,,,,,20563.0,2.2,IU,,,2020,Q2,Weight increased,,2020,Q2,1,I,,20200525.0,20200604,20200604,EXP,,TR-ELI_LILLY_AND_COMPANY-TR202005010465,ELI LILLY AND CO,"H.Y.KOSTEK, N.KOROGLU, F.O.COMLEK, E.DILEK, F.TUTUNCULER.INSULIN-INDUCED OEDEMA: A RARE COMPLICATION IN A PATIENT WITH NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2020;VOL. 16:N1.DOI:DOI: 10.22141/2224-0721.16.1.2020.199132",9.0,YR,,M,Y,36.0,KG,20200604.0,,MD,TR,TR,2020,Q2,Child
178634131,17863413,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE MEALS,,,U,, UNKNOWN,,,5.0,IU,,Q8H,2020,Q2,Feeling abnormal,,2020,Q2,1,I,,20200601.0,20200605,20200605,PER,,US-DRREDDYS-USA/USA/20/0123649,DR REDDYS,"PATEL K, STUMMER L, PATEL K. STIFF-PERSON SYNDROME IN A PATIENT WITH COMORBID BIPOLAR AND PANIC DISORDERS: A CASE REPORT AND LITERATURE REVIEW. MENT HEALTH CLIN. 2020;10(3):95-99. DOI: 10.9740/MHC.2020.05.095.",58.0,YR,A,F,Y,,,20200605.0,,PH,US,US,2020,Q2,Adult
178634131,17863413,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE MEALS,,,U,, UNKNOWN,,,5.0,IU,,Q8H,2020,Q2,Sedation,,2020,Q2,1,I,,20200601.0,20200605,20200605,PER,,US-DRREDDYS-USA/USA/20/0123649,DR REDDYS,"PATEL K, STUMMER L, PATEL K. STIFF-PERSON SYNDROME IN A PATIENT WITH COMORBID BIPOLAR AND PANIC DISORDERS: A CASE REPORT AND LITERATURE REVIEW. MENT HEALTH CLIN. 2020;10(3):95-99. DOI: 10.9740/MHC.2020.05.095.",58.0,YR,A,F,Y,,,20200605.0,,PH,US,US,2020,Q2,Adult
178654731,17865473,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200601.0,,20200605,20200605,DIR,,,FDA-CTU,,4.0,WK,,M,N,78.3,KG,20200605.0,Y,PH,US,US,2020,Q2,Child
178654731,17865473,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Bilirubin conjugated abnormal,,2020,Q2,1,I,20200601.0,,20200605,20200605,DIR,,,FDA-CTU,,4.0,WK,,M,N,78.3,KG,20200605.0,Y,PH,US,US,2020,Q2,Child
178669361,17866936,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Chills,,2020,Q2,1,I,20200526.0,20200527.0,20200605,20200605,EXP,,US-GILEAD-2020-0469248,GILEAD,,41.0,YR,A,M,Y,72.2,KG,20200605.0,,PH,US,US,2020,Q2,Adult
178669361,17866936,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Tremor,,2020,Q2,1,I,20200526.0,20200527.0,20200605,20200605,EXP,,US-GILEAD-2020-0469248,GILEAD,,41.0,YR,A,M,Y,72.2,KG,20200605.0,,PH,US,US,2020,Q2,Adult
178679741,17867974,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"IN MORNING. 25/75 100UNITS/ML, 3ML",,,U,,,,,,,,,2020,Q2,Orthostatic hypotension,,2020,Q2,1,I,20200220.0,20200603.0,20200605,20200605,EXP,GB-MHRA-MIDB-853EB3A7-4D81-44CC-BDA2-E41235A70E2F,NVSC2020GB156235,NOVARTIS,,73.0,YR,,M,Y,,,20200605.0,,HP,GB,GB,2020,Q2,Elderly
178679741,17867974,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"IN MORNING. 25/75 100UNITS/ML, 3ML",,,U,,,,,,,,,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,1,I,20200220.0,20200603.0,20200605,20200605,EXP,GB-MHRA-MIDB-853EB3A7-4D81-44CC-BDA2-E41235A70E2F,NVSC2020GB156235,NOVARTIS,,73.0,YR,,M,Y,,,20200605.0,,HP,GB,GB,2020,Q2,Elderly
178681921,17868192,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Transaminases increased,,2020,Q2,1,I,20200519.0,20200527.0,20200605,20200605,EXP,,US-GILEAD-2020-0469449,GILEAD,,57.0,YR,A,M,Y,73.0,KG,20200605.0,,PH,US,US,2020,Q2,Adult
178686851,17868685,14,C,insulin lispro--sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200601.0,,20200605,20200605,DIR,,,FDA-CTU,,62.0,YR,,M,N,95.6,KG,20200605.0,Y,PH,US,US,2020,Q2,Adult
178686851,17868685,14,C,insulin lispro--sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Shock,,2020,Q2,1,I,20200601.0,,20200605,20200605,DIR,,,FDA-CTU,,62.0,YR,,M,N,95.6,KG,20200605.0,Y,PH,US,US,2020,Q2,Adult
178686971,17868697,11,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cardiac arrest,,2020,Q2,1,I,20200601.0,,20200605,20200605,DIR,,,FDA-CTU,,56.0,YR,,M,N,86.0,KG,20200605.0,N,PH,US,US,2020,Q2,Adult
178696541,17869654,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2020,Q2,Blood glucose abnormal,,2020,Q2,1,I,,20200603.0,20200608,20200608,PER,,US-ELI_LILLY_AND_COMPANY-US202006002612,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200608.0,,HP,US,US,2020,Q2,Elderly
178707771,17870777,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,300 UNITS,,,U,U,,,,,,,,2020,Q2,Intentional overdose,,2020,Q2,1,I,,20200605.0,20200608,20200608,EXP,,NVSC2020AU157797,NOVARTIS,"ENDALL R, MCCALLUM R, BURGESS J. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS.. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1-6",45.0,YR,,F,Y,,,20200608.0,,HP,AU,AU,2020,Q2,Adult
178707771,17870777,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,300 UNITS,,,U,U,,,,,,,,2020,Q2,Suicide attempt,,2020,Q2,1,I,,20200605.0,20200608,20200608,EXP,,NVSC2020AU157797,NOVARTIS,"ENDALL R, MCCALLUM R, BURGESS J. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS.. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1-6",45.0,YR,,F,Y,,,20200608.0,,HP,AU,AU,2020,Q2,Adult
178722441,17872244,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hepatic enzyme increased,,2020,Q2,1,I,20200607.0,,20200608,20200608,DIR,,,FDA-CTU,,74.0,YR,,M,N,100.8,KG,20200608.0,N,PH,US,US,2020,Q2,Elderly
178739101,17873910,11,C,Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Hypertension,,2020,Q2,1,I,20200418.0,20200603.0,20200609,20200609,PER,,US-CELGENEUS-USA-20200601259,CELGENE,,58.0,YR,,F,Y,113.5,KG,20200609.0,,PH,US,US,2020,Q2,Adult
178739101,17873910,11,C,Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Meningitis,,2020,Q2,1,I,20200418.0,20200603.0,20200609,20200609,PER,,US-CELGENEUS-USA-20200601259,CELGENE,,58.0,YR,,F,Y,113.5,KG,20200609.0,,PH,US,US,2020,Q2,Adult
178759782,17875978,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Arterial occlusive disease,,2020,Q2,2,F,202004.0,20200602.0,20200609,20200611,EXP,,US-ELI_LILLY_AND_COMPANY-US202006000206,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200611.0,,CN,US,US,2020,Q2,Elderly
178759782,17875978,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Urticaria,,2020,Q2,2,F,202004.0,20200602.0,20200609,20200611,EXP,,US-ELI_LILLY_AND_COMPANY-US202006000206,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200611.0,,CN,US,US,2020,Q2,Elderly
178759782,17875978,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Wrong technique in product usage process,,2020,Q2,2,F,202004.0,20200602.0,20200609,20200611,EXP,,US-ELI_LILLY_AND_COMPANY-US202006000206,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200611.0,,CN,US,US,2020,Q2,Elderly
178759782,17875978,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D142268A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Arterial occlusive disease,,2020,Q2,2,F,202004.0,20200602.0,20200609,20200611,EXP,,US-ELI_LILLY_AND_COMPANY-US202006000206,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200611.0,,CN,US,US,2020,Q2,Elderly
178759782,17875978,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D142268A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Urticaria,,2020,Q2,2,F,202004.0,20200602.0,20200609,20200611,EXP,,US-ELI_LILLY_AND_COMPANY-US202006000206,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200611.0,,CN,US,US,2020,Q2,Elderly
178759782,17875978,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D142268A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Wrong technique in product usage process,,2020,Q2,2,F,202004.0,20200602.0,20200609,20200611,EXP,,US-ELI_LILLY_AND_COMPANY-US202006000206,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200611.0,,CN,US,US,2020,Q2,Elderly
178760851,17876085,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypertensive urgency,,2020,Q2,1,I,20200527.0,,20200609,20200609,DIR,,,FDA-CTU,,42.0,YR,,M,N,91.0,KG,20200609.0,N,PH,US,US,2020,Q2,Adult
178760851,17876085,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200527.0,,20200609,20200609,DIR,,,FDA-CTU,,42.0,YR,,M,N,91.0,KG,20200609.0,N,PH,US,US,2020,Q2,Adult
178773621,17877362,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Loss of consciousness,,2020,Q2,1,I,20191110.0,20200608.0,20200609,20200609,EXP,IT-MINISAL02-621341,IT-MYLANLABS-2020M1055512,MYLAN,,87.0,YR,,M,Y,,,20200609.0,,MD,IT,IT,2020,Q2,Elderly
178785361,17878536,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"200 U, DAILY",,,,, D166927A,,,200.0,IU,INJECTION,QD,2020,Q2,Aspiration,,2020,Q2,1,I,202001.0,20200604.0,20200610,20200610,PER,,US-ELI_LILLY_AND_COMPANY-US202006002432,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200610.0,,CN,US,US,2020,Q2,Adult
178785361,17878536,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"200 U, DAILY",,,,, D166927A,,,200.0,IU,INJECTION,QD,2020,Q2,Diabetic coma,,2020,Q2,1,I,202001.0,20200604.0,20200610,20200610,PER,,US-ELI_LILLY_AND_COMPANY-US202006002432,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200610.0,,CN,US,US,2020,Q2,Adult
178785361,17878536,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"200 U, DAILY",,,,, D166927A,,,200.0,IU,INJECTION,QD,2020,Q2,Hypophagia,,2020,Q2,1,I,202001.0,20200604.0,20200610,20200610,PER,,US-ELI_LILLY_AND_COMPANY-US202006002432,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200610.0,,CN,US,US,2020,Q2,Adult
178785361,17878536,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"200 U, DAILY",,,,, D166927A,,,200.0,IU,INJECTION,QD,2020,Q2,Nightmare,,2020,Q2,1,I,202001.0,20200604.0,20200610,20200610,PER,,US-ELI_LILLY_AND_COMPANY-US202006002432,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200610.0,,CN,US,US,2020,Q2,Adult
178785361,17878536,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"200 U, DAILY",,,,, D166927A,,,200.0,IU,INJECTION,QD,2020,Q2,Speech disorder,,2020,Q2,1,I,202001.0,20200604.0,20200610,20200610,PER,,US-ELI_LILLY_AND_COMPANY-US202006002432,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200610.0,,CN,US,US,2020,Q2,Adult
178785361,17878536,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"200 U, DAILY",,,,, D166927A,,,200.0,IU,INJECTION,QD,2020,Q2,Type 1 diabetes mellitus,,2020,Q2,1,I,202001.0,20200604.0,20200610,20200610,PER,,US-ELI_LILLY_AND_COMPANY-US202006002432,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20200610.0,,CN,US,US,2020,Q2,Adult
178812571,17881257,13,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200524.0,,20200610,20200610,DIR,,,FDA-CTU,,73.0,YR,,M,N,99.4,KG,20200610.0,N,PH,US,US,2020,Q2,Elderly
178812571,17881257,13,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200524.0,,20200610,20200610,DIR,,,FDA-CTU,,73.0,YR,,M,N,99.4,KG,20200610.0,N,PH,US,US,2020,Q2,Elderly
178812571,17881257,13,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal tubular injury,,2020,Q2,1,I,20200524.0,,20200610,20200610,DIR,,,FDA-CTU,,73.0,YR,,M,N,99.4,KG,20200610.0,N,PH,US,US,2020,Q2,Elderly
178819481,17881948,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, 12-10-16-0",,,,,,,,,,,,2020,Q2,Blood bilirubin increased,,2020,Q2,1,I,,20200604.0,20200610,20200610,EXP,,DE-EISAI MEDICAL RESEARCH-EC-2020-075521,EISAI,,71.0,YR,E,M,Y,92.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
178819481,17881948,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, 12-10-16-0",,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200604.0,20200610,20200610,EXP,,DE-EISAI MEDICAL RESEARCH-EC-2020-075521,EISAI,,71.0,YR,E,M,Y,92.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
178819481,17881948,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, 12-10-16-0",,,,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,1,I,,20200604.0,20200610,20200610,EXP,,DE-EISAI MEDICAL RESEARCH-EC-2020-075521,EISAI,,71.0,YR,E,M,Y,92.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
178819481,17881948,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, 12-10-16-0",,,,,,,,,,,,2020,Q2,Gait disturbance,,2020,Q2,1,I,,20200604.0,20200610,20200610,EXP,,DE-EISAI MEDICAL RESEARCH-EC-2020-075521,EISAI,,71.0,YR,E,M,Y,92.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
178819481,17881948,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, 12-10-16-0",,,,,,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200604.0,20200610,20200610,EXP,,DE-EISAI MEDICAL RESEARCH-EC-2020-075521,EISAI,,71.0,YR,E,M,Y,92.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
178819481,17881948,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, 12-10-16-0",,,,,,,,,,,,2020,Q2,Incontinence,,2020,Q2,1,I,,20200604.0,20200610,20200610,EXP,,DE-EISAI MEDICAL RESEARCH-EC-2020-075521,EISAI,,71.0,YR,E,M,Y,92.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
178822901,17882290,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase abnormal,,2020,Q2,1,I,20200601.0,20200602.0,20200610,20200610,EXP,,US-GILEAD-2020-0470081,GILEAD,,23.0,YR,A,M,Y,53.6,KG,20200610.0,,PH,US,US,2020,Q2,Youth
178822901,17882290,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200601.0,20200602.0,20200610,20200610,EXP,,US-GILEAD-2020-0470081,GILEAD,,23.0,YR,A,M,Y,53.6,KG,20200610.0,,PH,US,US,2020,Q2,Youth
178845922,17884592,19,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Appendicitis,,2020,Q2,2,F,20200603.0,20200611.0,20200611,20200615,EXP,,NVSC2020US157141,NOVARTIS,,43.0,YR,,M,Y,74.9,KG,20200615.0,,HP,US,US,2020,Q2,Adult
178847182,17884718,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, 1 PEN OF 3ML AT 100 UNITS/ML (300 UNITS); CONTINUOUS SC INFUSION VIA A INSULIN PUMP",,,D,,,,,1.0,DF,INJECTION,,2020,Q2,Depressed level of consciousness,,2020,Q2,2,F,,20200604.0,20200611,20200619,EXP,,AU-MYLANLABS-2020M1056108,MYLAN,,45.0,YR,,F,Y,,,20200619.0,,HP,AU,AU,2020,Q2,Adult
178847182,17884718,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, 1 PEN OF 3ML AT 100 UNITS/ML (300 UNITS); CONTINUOUS SC INFUSION VIA A INSULIN PUMP",,,D,,,,,1.0,DF,INJECTION,,2020,Q2,Intentional overdose,,2020,Q2,2,F,,20200604.0,20200611,20200619,EXP,,AU-MYLANLABS-2020M1056108,MYLAN,,45.0,YR,,F,Y,,,20200619.0,,HP,AU,AU,2020,Q2,Adult
178847182,17884718,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, 1 PEN OF 3ML AT 100 UNITS/ML (300 UNITS); CONTINUOUS SC INFUSION VIA A INSULIN PUMP",,,D,,,,,1.0,DF,INJECTION,,2020,Q2,Suicide attempt,,2020,Q2,2,F,,20200604.0,20200611,20200619,EXP,,AU-MYLANLABS-2020M1056108,MYLAN,,45.0,YR,,F,Y,,,20200619.0,,HP,AU,AU,2020,Q2,Adult
178850061,17885006,5,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200522.0,,20200611,20200611,DIR,,,FDA-CTU,,66.0,YR,,M,N,79.6,KG,20200611.0,N,PH,US,US,2020,Q2,Elderly
178850061,17885006,5,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Azotaemia,,2020,Q2,1,I,20200522.0,,20200611,20200611,DIR,,,FDA-CTU,,66.0,YR,,M,N,79.6,KG,20200611.0,N,PH,US,US,2020,Q2,Elderly
178850061,17885006,5,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Fluid overload,,2020,Q2,1,I,20200522.0,,20200611,20200611,DIR,,,FDA-CTU,,66.0,YR,,M,N,79.6,KG,20200611.0,N,PH,US,US,2020,Q2,Elderly
178850061,17885006,5,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Inflammation,,2020,Q2,1,I,20200522.0,,20200611,20200611,DIR,,,FDA-CTU,,66.0,YR,,M,N,79.6,KG,20200611.0,N,PH,US,US,2020,Q2,Elderly
178862431,17886243,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200526.0,20200604.0,20200611,20200611,EXP,,US-GILEAD-2020-0470876,GILEAD,,27.0,YR,A,F,Y,176.3,KG,20200611.0,,PH,US,US,2020,Q2,Young Adult
178862431,17886243,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200526.0,20200604.0,20200611,20200611,EXP,,US-GILEAD-2020-0470876,GILEAD,,27.0,YR,A,F,Y,176.3,KG,20200611.0,,PH,US,US,2020,Q2,Young Adult
178868341,17886834,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20200531.0,20200602.0,20200611,20200611,EXP,,US-ROCHE-2615271,ROCHE,,71.0,YR,,F,Y,47.3,KG,20200611.0,,HP,US,US,2020,Q2,Elderly
178876381,17887638,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Product use issue,,2020,Q2,1,I,20200527.0,20200528.0,20200611,20200611,EXP,,US-GILEAD-2020-0469605,GILEAD,,43.0,YR,A,M,Y,72.0,KG,20200611.0,,MD,US,US,2020,Q2,Adult
178882731,17888273,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200605.0,,20200611,20200611,DIR,,,FDA-CTU,,54.0,YR,,M,N,164.0,KG,20200611.0,Y,PH,US,US,2020,Q2,Adult
178882731,17888273,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood bilirubin increased,,2020,Q2,1,I,20200605.0,,20200611,20200611,DIR,,,FDA-CTU,,54.0,YR,,M,N,164.0,KG,20200611.0,Y,PH,US,US,2020,Q2,Adult
178882731,17888273,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Disseminated intravascular coagulation,,2020,Q2,1,I,20200605.0,,20200611,20200611,DIR,,,FDA-CTU,,54.0,YR,,M,N,164.0,KG,20200611.0,Y,PH,US,US,2020,Q2,Adult
178882731,17888273,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Shock,,2020,Q2,1,I,20200605.0,,20200611,20200611,DIR,,,FDA-CTU,,54.0,YR,,M,N,164.0,KG,20200611.0,Y,PH,US,US,2020,Q2,Adult
178895851,17889585,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Angioedema,,2020,Q2,1,I,20200610.0,,20200612,20200612,DIR,,,FDA-CTU,,33.0,YR,,F,N,136.3,KG,20200612.0,Y,PH,US,US,2020,Q2,Young Adult
178895851,17889585,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,1,I,20200610.0,,20200612,20200612,DIR,,,FDA-CTU,,33.0,YR,,F,N,136.3,KG,20200612.0,Y,PH,US,US,2020,Q2,Young Adult
178895851,17889585,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Ear pruritus,,2020,Q2,1,I,20200610.0,,20200612,20200612,DIR,,,FDA-CTU,,33.0,YR,,F,N,136.3,KG,20200612.0,Y,PH,US,US,2020,Q2,Young Adult
178895851,17889585,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Eye irritation,,2020,Q2,1,I,20200610.0,,20200612,20200612,DIR,,,FDA-CTU,,33.0,YR,,F,N,136.3,KG,20200612.0,Y,PH,US,US,2020,Q2,Young Adult
178895851,17889585,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Eye pruritus,,2020,Q2,1,I,20200610.0,,20200612,20200612,DIR,,,FDA-CTU,,33.0,YR,,F,N,136.3,KG,20200612.0,Y,PH,US,US,2020,Q2,Young Adult
178895851,17889585,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Throat irritation,,2020,Q2,1,I,20200610.0,,20200612,20200612,DIR,,,FDA-CTU,,33.0,YR,,F,N,136.3,KG,20200612.0,Y,PH,US,US,2020,Q2,Young Adult
178926041,17892604,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200601.0,20200605.0,20200612,20200612,EXP,,US-GILEAD-2020-0470948,GILEAD,,62.0,YR,A,M,Y,95.6,KG,20200612.0,,PH,US,US,2020,Q2,Adult
178926041,17892604,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200601.0,20200605.0,20200612,20200612,EXP,,US-GILEAD-2020-0470948,GILEAD,,62.0,YR,A,M,Y,95.6,KG,20200612.0,,PH,US,US,2020,Q2,Adult
178926041,17892604,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Shock,,2020,Q2,1,I,20200601.0,20200605.0,20200612,20200612,EXP,,US-GILEAD-2020-0470948,GILEAD,,62.0,YR,A,M,Y,95.6,KG,20200612.0,,PH,US,US,2020,Q2,Adult
178926261,17892626,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Product administration error,,2020,Q2,1,I,20200529.0,20200602.0,20200612,20200612,EXP,,US-GILEAD-2020-0470372,GILEAD,,71.0,YR,E,M,Y,98.5,KG,20200612.0,,PH,US,US,2020,Q2,Elderly
178947281,17894728,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hepatotoxicity,,2020,Q2,1,I,20200608.0,,20200612,20200612,DIR,,,FDA-CTU,,46.0,YR,,F,N,82.6,KG,20200612.0,N,,US,US,2020,Q2,Adult
178947281,17894728,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,20200608.0,,20200612,20200612,DIR,,,FDA-CTU,,46.0,YR,,F,N,82.6,KG,20200612.0,N,,US,US,2020,Q2,Adult
178947281,17894728,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Platelet count decreased,,2020,Q2,1,I,20200608.0,,20200612,20200612,DIR,,,FDA-CTU,,46.0,YR,,F,N,82.6,KG,20200612.0,N,,US,US,2020,Q2,Adult
178947281,17894728,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,1,I,20200608.0,,20200612,20200612,DIR,,,FDA-CTU,,46.0,YR,,F,N,82.6,KG,20200612.0,N,,US,US,2020,Q2,Adult
178947281,17894728,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200608.0,,20200612,20200612,DIR,,,FDA-CTU,,46.0,YR,,F,N,82.6,KG,20200612.0,N,,US,US,2020,Q2,Adult
178947281,17894728,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Septic shock,,2020,Q2,1,I,20200608.0,,20200612,20200612,DIR,,,FDA-CTU,,46.0,YR,,F,N,82.6,KG,20200612.0,N,,US,US,2020,Q2,Adult
178955711,17895571,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Febrile neutropenia,,2020,Q2,1,I,20200528.0,20200605.0,20200615,20200615,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20200615.0,,HP,US,US,2020,Q2,Elderly
178955711,17895571,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Neutrophil count decreased,,2020,Q2,1,I,20200528.0,20200605.0,20200615,20200615,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20200615.0,,HP,US,US,2020,Q2,Elderly
178955711,17895571,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,Pancytopenia,,2020,Q2,1,I,20200528.0,20200605.0,20200615,20200615,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20200615.0,,HP,US,US,2020,Q2,Elderly
178955711,17895571,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q2,White blood cell count decreased,,2020,Q2,1,I,20200528.0,20200605.0,20200615,20200615,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20200615.0,,HP,US,US,2020,Q2,Elderly
178957342,17895734,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"SLIDIG SCALE, Q4H",,,,,,,,,,,,2020,Q2,Cardio-respiratory arrest,,2020,Q2,2,F,20200609.0,20200615.0,20200615,20200626,EXP,,"US-KARYOPHARM THERAPEUTICS, INC.-2020KPT000647",KARYOPHARM THERAPEUTICS,,47.0,YR,,F,Y,73.0,KG,20200626.0,,HP,US,US,2020,Q2,Adult
178966503,17896650,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,3,F,20200607.0,20200619.0,20200615,20200623,EXP,,US-GILEAD-2020-0472197,GILEAD,,63.0,YR,A,M,Y,75.8,KG,20200623.0,,PH,US,US,2020,Q2,Adult
178966503,17896650,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute myocardial infarction,,2020,Q2,3,F,20200607.0,20200619.0,20200615,20200623,EXP,,US-GILEAD-2020-0472197,GILEAD,,63.0,YR,A,M,Y,75.8,KG,20200623.0,,PH,US,US,2020,Q2,Adult
178966503,17896650,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute respiratory distress syndrome,,2020,Q2,3,F,20200607.0,20200619.0,20200615,20200623,EXP,,US-GILEAD-2020-0472197,GILEAD,,63.0,YR,A,M,Y,75.8,KG,20200623.0,,PH,US,US,2020,Q2,Adult
178966503,17896650,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute respiratory failure,,2020,Q2,3,F,20200607.0,20200619.0,20200615,20200623,EXP,,US-GILEAD-2020-0472197,GILEAD,,63.0,YR,A,M,Y,75.8,KG,20200623.0,,PH,US,US,2020,Q2,Adult
178966503,17896650,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Arrhythmia,,2020,Q2,3,F,20200607.0,20200619.0,20200615,20200623,EXP,,US-GILEAD-2020-0472197,GILEAD,,63.0,YR,A,M,Y,75.8,KG,20200623.0,,PH,US,US,2020,Q2,Adult
178966503,17896650,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Cardiomyopathy,,2020,Q2,3,F,20200607.0,20200619.0,20200615,20200623,EXP,,US-GILEAD-2020-0472197,GILEAD,,63.0,YR,A,M,Y,75.8,KG,20200623.0,,PH,US,US,2020,Q2,Adult
178966503,17896650,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Death,,2020,Q2,3,F,20200607.0,20200619.0,20200615,20200623,EXP,,US-GILEAD-2020-0472197,GILEAD,,63.0,YR,A,M,Y,75.8,KG,20200623.0,,PH,US,US,2020,Q2,Adult
178966503,17896650,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Ischaemic hepatitis,,2020,Q2,3,F,20200607.0,20200619.0,20200615,20200623,EXP,,US-GILEAD-2020-0472197,GILEAD,,63.0,YR,A,M,Y,75.8,KG,20200623.0,,PH,US,US,2020,Q2,Adult
178966503,17896650,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Respiratory distress,,2020,Q2,3,F,20200607.0,20200619.0,20200615,20200623,EXP,,US-GILEAD-2020-0472197,GILEAD,,63.0,YR,A,M,Y,75.8,KG,20200623.0,,PH,US,US,2020,Q2,Adult
178994041,17899404,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,1,I,20200612.0,,20200615,20200615,DIR,,,FDA-CTU,,78.0,YR,,F,N,79.0,KG,20200615.0,N,PH,US,US,2020,Q2,Elderly
178994041,17899404,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Therapy cessation,,2020,Q2,1,I,20200612.0,,20200615,20200615,DIR,,,FDA-CTU,,78.0,YR,,F,N,79.0,KG,20200615.0,N,PH,US,US,2020,Q2,Elderly
178994161,17899416,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200612.0,,20200615,20200615,DIR,,,FDA-CTU,,62.0,YR,,M,N,135.9,KG,20200615.0,Y,HP,US,US,2020,Q2,Adult
178994161,17899416,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Bilirubin conjugated decreased,,2020,Q2,1,I,20200612.0,,20200615,20200615,DIR,,,FDA-CTU,,62.0,YR,,M,N,135.9,KG,20200615.0,Y,HP,US,US,2020,Q2,Adult
178994161,17899416,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,20200612.0,,20200615,20200615,DIR,,,FDA-CTU,,62.0,YR,,M,N,135.9,KG,20200615.0,Y,HP,US,US,2020,Q2,Adult
178994161,17899416,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,1,I,20200612.0,,20200615,20200615,DIR,,,FDA-CTU,,62.0,YR,,M,N,135.9,KG,20200615.0,Y,HP,US,US,2020,Q2,Adult
178994161,17899416,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,1,I,20200612.0,,20200615,20200615,DIR,,,FDA-CTU,,62.0,YR,,M,N,135.9,KG,20200615.0,Y,HP,US,US,2020,Q2,Adult
178994161,17899416,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Transaminases increased,,2020,Q2,1,I,20200612.0,,20200615,20200615,DIR,,,FDA-CTU,,62.0,YR,,M,N,135.9,KG,20200615.0,Y,HP,US,US,2020,Q2,Adult
178994291,17899429,7,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,1,I,20200612.0,,20200615,20200615,DIR,,,FDA-CTU,,60.0,YR,,F,N,86.5,KG,20200615.0,N,PH,US,US,2020,Q2,Adult
178994291,17899429,7,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200612.0,,20200615,20200615,DIR,,,FDA-CTU,,60.0,YR,,F,N,86.5,KG,20200615.0,N,PH,US,US,2020,Q2,Adult
178994351,17899435,11,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,1,I,20200613.0,,20200615,20200615,DIR,,,FDA-CTU,,78.0,YR,,F,N,76.2,KG,20200615.0,Y,HP,US,US,2020,Q2,Elderly
178996711,17899671,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"9-15 U, TID",,,,,,,20563.0,15.0,IU,INJECTION,TID,2020,Q2,Adrenal gland cancer,,2020,Q2,1,I,20200227.0,20200604.0,20200616,20200616,EXP,,US-ELI_LILLY_AND_COMPANY-US202006002543,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20200616.0,,CN,US,US,2020,Q2,Elderly
178996711,17899671,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"9-15 U, TID",,,,,,,20563.0,15.0,IU,INJECTION,TID,2020,Q2,Pneumonia,,2020,Q2,1,I,20200227.0,20200604.0,20200616,20200616,EXP,,US-ELI_LILLY_AND_COMPANY-US202006002543,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20200616.0,,CN,US,US,2020,Q2,Elderly
178996711,17899671,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"9-15 U, TID",,,,,,,20563.0,15.0,IU,INJECTION,TID,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200227.0,20200604.0,20200616,20200616,EXP,,US-ELI_LILLY_AND_COMPANY-US202006002543,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20200616.0,,CN,US,US,2020,Q2,Elderly
178996711,17899671,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"9-15 U, TID",,,,, C933643D,,20563.0,15.0,IU,INJECTION,TID,2020,Q2,Adrenal gland cancer,,2020,Q2,1,I,20200227.0,20200604.0,20200616,20200616,EXP,,US-ELI_LILLY_AND_COMPANY-US202006002543,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20200616.0,,CN,US,US,2020,Q2,Elderly
178996711,17899671,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"9-15 U, TID",,,,, C933643D,,20563.0,15.0,IU,INJECTION,TID,2020,Q2,Pneumonia,,2020,Q2,1,I,20200227.0,20200604.0,20200616,20200616,EXP,,US-ELI_LILLY_AND_COMPANY-US202006002543,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20200616.0,,CN,US,US,2020,Q2,Elderly
178996711,17899671,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"9-15 U, TID",,,,, C933643D,,20563.0,15.0,IU,INJECTION,TID,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200227.0,20200604.0,20200616,20200616,EXP,,US-ELI_LILLY_AND_COMPANY-US202006002543,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20200616.0,,CN,US,US,2020,Q2,Elderly
179002121,17900212,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2020,Q2,Loss of consciousness,,2020,Q2,1,I,20191110.0,20200608.0,20200616,20200616,EXP,IT-MINISAL02-621341,IT-TEVA-2020-IT-1247927,TEVA,,87.0,YR,,M,Y,,,20200616.0,,MD,IT,IT,2020,Q2,Elderly
179004811,17900481,23,C,insulin lispro pen,,2,,,,,,,,,,,,,,2020,Q2,Abdominal distension,,2020,Q2,1,I,20200528.0,,20200615,20200615,DIR,,,FDA-CTU,,85.0,YR,,M,N,85.5,KG,20200615.0,Y,CN,US,US,2020,Q2,Elderly
179004811,17900481,23,C,insulin lispro pen,,2,,,,,,,,,,,,,,2020,Q2,Abdominal infection,,2020,Q2,1,I,20200528.0,,20200615,20200615,DIR,,,FDA-CTU,,85.0,YR,,M,N,85.5,KG,20200615.0,Y,CN,US,US,2020,Q2,Elderly
179004811,17900481,23,C,insulin lispro pen,,2,,,,,,,,,,,,,,2020,Q2,Gastric fluid analysis abnormal,,2020,Q2,1,I,20200528.0,,20200615,20200615,DIR,,,FDA-CTU,,85.0,YR,,M,N,85.5,KG,20200615.0,Y,CN,US,US,2020,Q2,Elderly
179004811,17900481,23,C,insulin lispro pen,,2,,,,,,,,,,,,,,2020,Q2,Gastrointestinal obstruction,,2020,Q2,1,I,20200528.0,,20200615,20200615,DIR,,,FDA-CTU,,85.0,YR,,M,N,85.5,KG,20200615.0,Y,CN,US,US,2020,Q2,Elderly
179004811,17900481,23,C,insulin lispro pen,,2,,,,,,,,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,20200528.0,,20200615,20200615,DIR,,,FDA-CTU,,85.0,YR,,M,N,85.5,KG,20200615.0,Y,CN,US,US,2020,Q2,Elderly
179005021,17900502,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200611.0,,20200615,20200615,DIR,,,FDA-CTU,,74.0,YR,,F,N,97.5,KG,20200615.0,Y,PH,US,US,2020,Q2,Elderly
179005021,17900502,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,1,I,20200611.0,,20200615,20200615,DIR,,,FDA-CTU,,74.0,YR,,F,N,97.5,KG,20200615.0,Y,PH,US,US,2020,Q2,Elderly
179033321,17903332,4,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,300 UNITS (1 3ML PEN AT 100 UNITS/ML),,,U,,,,,,,,,2020,Q2,Depressed level of consciousness,,2020,Q2,1,I,,20200604.0,20200617,20200617,EXP,,AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-250235,RANBAXY,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179033321,17903332,4,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,300 UNITS (1 3ML PEN AT 100 UNITS/ML),,,U,,,,,,,,,2020,Q2,Overdose,,2020,Q2,1,I,,20200604.0,20200617,20200617,EXP,,AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-250235,RANBAXY,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179033321,17903332,4,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,300 UNITS (1 3ML PEN AT 100 UNITS/ML),,,U,,,,,,,,,2020,Q2,Suicide attempt,,2020,Q2,1,I,,20200604.0,20200617,20200617,EXP,,AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-250235,RANBAXY,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179038411,17903841,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 UNITS (1 PEN OF 3ML OF 100 UNITS/ML),,,,,,,,,,,,2020,Q2,Depressed level of consciousness,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,AU-STRIDES ARCOLAB LIMITED-2020SP007039,STRIDES,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179038411,17903841,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 UNITS (1 PEN OF 3ML OF 100 UNITS/ML),,,,,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,AU-STRIDES ARCOLAB LIMITED-2020SP007039,STRIDES,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179038411,17903841,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 UNITS (1 PEN OF 3ML OF 100 UNITS/ML),,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,AU-STRIDES ARCOLAB LIMITED-2020SP007039,STRIDES,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179038411,17903841,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 UNITS (1 PEN OF 3ML OF 100 UNITS/ML),,,,,,,,,,,,2020,Q2,Suicidal ideation,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,AU-STRIDES ARCOLAB LIMITED-2020SP007039,STRIDES,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179038411,17903841,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (INSULIN LISPRO, VIA A MEDTRONIC INSULIN PUMP DEVICE)",,,,,,,,,,,,2020,Q2,Depressed level of consciousness,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,AU-STRIDES ARCOLAB LIMITED-2020SP007039,STRIDES,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179038411,17903841,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (INSULIN LISPRO, VIA A MEDTRONIC INSULIN PUMP DEVICE)",,,,,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,AU-STRIDES ARCOLAB LIMITED-2020SP007039,STRIDES,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179038411,17903841,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (INSULIN LISPRO, VIA A MEDTRONIC INSULIN PUMP DEVICE)",,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,AU-STRIDES ARCOLAB LIMITED-2020SP007039,STRIDES,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179038411,17903841,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (INSULIN LISPRO, VIA A MEDTRONIC INSULIN PUMP DEVICE)",,,,,,,,,,,,2020,Q2,Suicidal ideation,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,AU-STRIDES ARCOLAB LIMITED-2020SP007039,STRIDES,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179055081,17905508,7,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200616.0,,20200616,20200616,DIR,,,FDA-CTU,,45.0,YR,,M,N,168.2,KG,20200616.0,N,PH,US,US,2020,Q2,Adult
179071871,17907187,7,C,Lispro Insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200608.0,,20200617,20200617,DIR,,,FDA-CTU,,77.0,YR,,F,N,80.0,KG,20200617.0,N,MD,US,US,2020,Q2,Elderly
179077681,17907768,8,C,lispro insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200608.0,,20200617,20200617,DIR,,,FDA-CTU,,77.0,YR,,F,N,36.29,KG,20200617.0,N,MD,US,US,2020,Q2,Elderly
179098471,17909847,2,SS,INSULINA LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200123.0,20200615.0,20200617,20200617,EXP,IT-MINISAL02-606915,NVSC2020IT168554,NOVARTIS,,74.0,YR,,M,Y,,,20200617.0,,HP,IT,IT,2020,Q2,Elderly
179108931,17910893,9,C,insulin lispro SQ per protocol,,2,,,,,,,,,,,,,,2020,Q2,Haemodialysis,,2020,Q2,1,I,20200612.0,,20200617,20200617,DIR,,,FDA-CTU,,67.0,YR,,M,N,106.4,KG,20200617.0,N,PH,US,US,2020,Q2,Elderly
179108931,17910893,9,C,insulin lispro SQ per protocol,,2,,,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,20200612.0,,20200617,20200617,DIR,,,FDA-CTU,,67.0,YR,,M,N,106.4,KG,20200617.0,N,PH,US,US,2020,Q2,Elderly
179108931,17910893,9,C,insulin lispro SQ per protocol,,2,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200612.0,,20200617,20200617,DIR,,,FDA-CTU,,67.0,YR,,M,N,106.4,KG,20200617.0,N,PH,US,US,2020,Q2,Elderly
179108931,17910893,9,C,insulin lispro SQ per protocol,,2,,,,,,,,,,,,,,2020,Q2,Septic shock,,2020,Q2,1,I,20200612.0,,20200617,20200617,DIR,,,FDA-CTU,,67.0,YR,,M,N,106.4,KG,20200617.0,N,PH,US,US,2020,Q2,Elderly
179115261,17911526,8,C,Lispro Insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200608.0,,20200617,20200617,DIR,,,FDA-CTU,,77.0,YR,,F,N,80.0,KG,20200617.0,Y,MD,US,US,2020,Q2,Elderly
179115261,17911526,8,C,Lispro Insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200608.0,,20200617,20200617,DIR,,,FDA-CTU,,77.0,YR,,F,N,80.0,KG,20200617.0,Y,MD,US,US,2020,Q2,Elderly
179140631,17914063,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"MORNNG 6 UNIT, NOON 8 UNIT, EVENING 8 UNIT",,,,,,,,,,,,2020,Q2,Gastrooesophageal cancer,,2020,Q2,1,I,,20200616.0,20200618,20200618,EXP,,JP-GILEAD-2020-0472835,GILEAD,,7.0,DEC,E,M,Y,73.4,KG,20200618.0,,PH,JP,JP,2020,Q2,Child
179146992,17914699,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Abdominal distension,,2020,Q2,2,F,20200528.0,20200629.0,20200618,20200630,EXP,,US-GILEAD-2020-0473311,GILEAD,,85.0,YR,E,M,Y,190.0,KG,20200630.0,,CN,US,US,2020,Q2,Elderly
179146992,17914699,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Bile output increased,,2020,Q2,2,F,20200528.0,20200629.0,20200618,20200630,EXP,,US-GILEAD-2020-0473311,GILEAD,,85.0,YR,E,M,Y,190.0,KG,20200630.0,,CN,US,US,2020,Q2,Elderly
179146992,17914699,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Death,,2020,Q2,2,F,20200528.0,20200629.0,20200618,20200630,EXP,,US-GILEAD-2020-0473311,GILEAD,,85.0,YR,E,M,Y,190.0,KG,20200630.0,,CN,US,US,2020,Q2,Elderly
179147262,17914726,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,2,F,202006.0,20200611.0,20200618,20200624,EXP,,US-GILEAD-2020-0473031,GILEAD,,54.0,YR,A,M,Y,164.0,KG,20200624.0,,PH,US,US,2020,Q2,Adult
179147262,17914726,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,2,F,202006.0,20200611.0,20200618,20200624,EXP,,US-GILEAD-2020-0473031,GILEAD,,54.0,YR,A,M,Y,164.0,KG,20200624.0,,PH,US,US,2020,Q2,Adult
179147262,17914726,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood bilirubin increased,,2020,Q2,2,F,202006.0,20200611.0,20200618,20200624,EXP,,US-GILEAD-2020-0473031,GILEAD,,54.0,YR,A,M,Y,164.0,KG,20200624.0,,PH,US,US,2020,Q2,Adult
179147262,17914726,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Disseminated intravascular coagulation,,2020,Q2,2,F,202006.0,20200611.0,20200618,20200624,EXP,,US-GILEAD-2020-0473031,GILEAD,,54.0,YR,A,M,Y,164.0,KG,20200624.0,,PH,US,US,2020,Q2,Adult
179147262,17914726,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Shock,,2020,Q2,2,F,202006.0,20200611.0,20200618,20200624,EXP,,US-GILEAD-2020-0473031,GILEAD,,54.0,YR,A,M,Y,164.0,KG,20200624.0,,PH,US,US,2020,Q2,Adult
179147721,17914772,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Angioedema,,2020,Q2,1,I,20200610.0,20200612.0,20200618,20200618,EXP,,US-GILEAD-2020-0473016,GILEAD,,33.0,YR,A,F,Y,136.3,KG,20200618.0,,PH,US,US,2020,Q2,Young Adult
179147721,17914772,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Eye irritation,,2020,Q2,1,I,20200610.0,20200612.0,20200618,20200618,EXP,,US-GILEAD-2020-0473016,GILEAD,,33.0,YR,A,F,Y,136.3,KG,20200618.0,,PH,US,US,2020,Q2,Young Adult
179147721,17914772,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Pruritus,,2020,Q2,1,I,20200610.0,20200612.0,20200618,20200618,EXP,,US-GILEAD-2020-0473016,GILEAD,,33.0,YR,A,F,Y,136.3,KG,20200618.0,,PH,US,US,2020,Q2,Young Adult
179152741,17915274,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, NACH PLAN",,,,,,,,100.0,IU,,,2020,Q2,Anal abscess,,2020,Q2,1,I,,20200612.0,20200619,20200619,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-029706",BOEHRINGER INGELHEIM,,55.0,YR,,F,Y,,,20200619.0,,MD,DE,DE,2020,Q2,Adult
179152741,17915274,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, NACH PLAN",,,,,,,,100.0,IU,,,2020,Q2,Inflammation,,2020,Q2,1,I,,20200612.0,20200619,20200619,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-029706",BOEHRINGER INGELHEIM,,55.0,YR,,F,Y,,,20200619.0,,MD,DE,DE,2020,Q2,Adult
179152741,17915274,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, NACH PLAN",,,,,,,,100.0,IU,,,2020,Q2,Localised infection,,2020,Q2,1,I,,20200612.0,20200619,20200619,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-029706",BOEHRINGER INGELHEIM,,55.0,YR,,F,Y,,,20200619.0,,MD,DE,DE,2020,Q2,Adult
179152741,17915274,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, NACH PLAN",,,,,,,,100.0,IU,,,2020,Q2,Proctalgia,,2020,Q2,1,I,,20200612.0,20200619,20200619,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-029706",BOEHRINGER INGELHEIM,,55.0,YR,,F,Y,,,20200619.0,,MD,DE,DE,2020,Q2,Adult
179152741,17915274,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, NACH PLAN",,,,,,,,100.0,IU,,,2020,Q2,Product prescribing error,,2020,Q2,1,I,,20200612.0,20200619,20200619,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-029706",BOEHRINGER INGELHEIM,,55.0,YR,,F,Y,,,20200619.0,,MD,DE,DE,2020,Q2,Adult
179152741,17915274,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE, NACH PLAN",,,,,,,,100.0,IU,,,2020,Q2,Swelling,,2020,Q2,1,I,,20200612.0,20200619,20200619,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-029706",BOEHRINGER INGELHEIM,,55.0,YR,,F,Y,,,20200619.0,,MD,DE,DE,2020,Q2,Adult
179166331,17916633,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Transaminases increased,,2020,Q2,1,I,20200617.0,,20200619,20200619,DIR,,,FDA-CTU,,54.0,YR,,F,N,78.4,KG,20200619.0,Y,PH,US,US,2020,Q2,Adult
179170851,17917085,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200612.0,20200615.0,20200619,20200619,EXP,,US-GILEAD-2020-0473734,GILEAD,,62.0,YR,A,M,Y,135.9,KG,20200619.0,,HP,US,US,2020,Q2,Adult
179170851,17917085,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Bilirubin conjugated increased,,2020,Q2,1,I,20200612.0,20200615.0,20200619,20200619,EXP,,US-GILEAD-2020-0473734,GILEAD,,62.0,YR,A,M,Y,135.9,KG,20200619.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Abdominal pain,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Adverse event,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Ammonia increased,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Back pain,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood bilirubin increased,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood lactate dehydrogenase increased,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cellulitis,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Compression fracture,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Dermatitis,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastric polyps,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastric ulcer,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastrointestinal erosion,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastrointestinal mucosal disorder,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hepatic encephalopathy,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypervolaemia,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypothyroidism,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Internal haemorrhage,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Peripheral venous disease,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pneumonia escherichia,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Portal hypertension,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Portal hypertensive gastropathy,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Post thrombotic syndrome,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pulmonary oedema,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Respiratory distress,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Right ventricular failure,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Septic shock,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Skin ulcer,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Surgery,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Toxic encephalopathy,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Varices oesophageal,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179186302,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Wound infection pseudomonas,,2020,Q2,2,F,20150717.0,20200611.0,20200619,20200625,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,43.0,YR,,F,Y,63.56,KG,20200625.0,,HP,US,US,2020,Q2,Adult
179191961,17919196,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 600 IE, 4-6-8-0",,,U,,,,,,,,,2020,Q2,Spinal pain,,2020,Q2,1,I,20190926.0,20200615.0,20200619,20200619,EXP,,NVSC2020DE171144,NOVARTIS,,80.0,YR,,F,Y,,,20200619.0,,HP,DE,DE,2020,Q2,Elderly
179221351,17922135,7,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Death,,2020,Q2,1,I,20200621.0,,20200621,20200621,DIR,,,FDA-CTU,,76.0,YR,,M,N,95.0,KG,20200621.0,Y,PH,US,US,2020,Q2,Elderly
179231141,17923114,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200608.0,20200617.0,20200622,20200622,EXP,,US-GILEAD-2020-0473800,GILEAD,,76.0,YR,E,F,Y,80.0,KG,20200622.0,,MD,US,US,2020,Q2,Elderly
179231141,17923114,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200608.0,20200617.0,20200622,20200622,EXP,,US-GILEAD-2020-0473800,GILEAD,,76.0,YR,E,F,Y,80.0,KG,20200622.0,,MD,US,US,2020,Q2,Elderly
179248921,17924892,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Transaminases increased,,2020,Q2,1,I,20200617.0,20200619.0,20200622,20200622,EXP,,US-GILEAD-2020-0474386,GILEAD,,54.0,YR,A,F,Y,78.4,KG,20200622.0,,PH,US,US,2020,Q2,Adult
179252262,17925226,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,2,F,20200611.0,20200623.0,20200622,20200625,EXP,,US-GILEAD-2020-0473427,GILEAD,,74.0,YR,E,F,Y,102.0,KG,20200625.0,,PH,US,US,2020,Q2,Elderly
179252262,17925226,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Death,,2020,Q2,2,F,20200611.0,20200623.0,20200622,20200625,EXP,,US-GILEAD-2020-0473427,GILEAD,,74.0,YR,E,F,Y,102.0,KG,20200625.0,,PH,US,US,2020,Q2,Elderly
179252262,17925226,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,2,F,20200611.0,20200623.0,20200622,20200625,EXP,,US-GILEAD-2020-0473427,GILEAD,,74.0,YR,E,F,Y,102.0,KG,20200625.0,,PH,US,US,2020,Q2,Elderly
179261971,17926197,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,,,,,,,,,,2020,Q2,Anaemia,,2020,Q2,1,I,20181002.0,20190205.0,20200622,20200622,EXP,,US-ACTELION-A-NJ2019-186025,ACTELION,,66.0,YR,,M,Y,,,20200622.0,,MD,US,US,2020,Q2,Elderly
179261971,17926197,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,,,,,,,,,,2020,Q2,Chronic left ventricular failure,,2020,Q2,1,I,20181002.0,20190205.0,20200622,20200622,EXP,,US-ACTELION-A-NJ2019-186025,ACTELION,,66.0,YR,,M,Y,,,20200622.0,,MD,US,US,2020,Q2,Elderly
179261971,17926197,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,,,,,,,,,,2020,Q2,Fluid overload,,2020,Q2,1,I,20181002.0,20190205.0,20200622,20200622,EXP,,US-ACTELION-A-NJ2019-186025,ACTELION,,66.0,YR,,M,Y,,,20200622.0,,MD,US,US,2020,Q2,Elderly
179261971,17926197,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,,,,,,,,,,2020,Q2,Haemoglobin decreased,,2020,Q2,1,I,20181002.0,20190205.0,20200622,20200622,EXP,,US-ACTELION-A-NJ2019-186025,ACTELION,,66.0,YR,,M,Y,,,20200622.0,,MD,US,US,2020,Q2,Elderly
179261971,17926197,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,,,,,,,,,,2020,Q2,International normalised ratio increased,,2020,Q2,1,I,20181002.0,20190205.0,20200622,20200622,EXP,,US-ACTELION-A-NJ2019-186025,ACTELION,,66.0,YR,,M,Y,,,20200622.0,,MD,US,US,2020,Q2,Elderly
179261971,17926197,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,,,,,,,,,,2020,Q2,Pulmonary arterial hypertension,,2020,Q2,1,I,20181002.0,20190205.0,20200622,20200622,EXP,,US-ACTELION-A-NJ2019-186025,ACTELION,,66.0,YR,,M,Y,,,20200622.0,,MD,US,US,2020,Q2,Elderly
179307651,17930765,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Death,,2020,Q2,1,I,20200621.0,20200621.0,20200623,20200623,EXP,,US-GILEAD-2020-0474819,GILEAD,,76.0,YR,E,M,Y,95.0,KG,20200623.0,,PH,US,US,2020,Q2,Elderly
179328141,17932814,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q2,Cytokine release syndrome,,2020,Q2,1,I,20200511.0,20200512.0,20200623,20200623,PER,,US-GILEAD-2020-0467478,GILEAD,,67.0,YR,E,M,Y,100.8,KG,20200623.0,,HP,US,US,2020,Q2,Elderly
179343301,17934330,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hospice care,,2020,Q2,1,I,20200621.0,,20200623,20200623,DIR,,,FDA-CTU,,73.0,YR,,F,N,92.2,KG,20200623.0,N,PH,US,US,2020,Q2,Elderly
179343401,17934340,17,C,Insulin lispro sliding scale 5x/day,,2,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200615.0,,20200623,20200623,DIR,,,FDA-CTU,,74.0,YR,,F,N,100.2,KG,20200623.0,N,PH,US,US,2020,Q2,Elderly
179343401,17934340,17,C,Insulin lispro sliding scale 5x/day,,2,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200615.0,,20200623,20200623,DIR,,,FDA-CTU,,74.0,YR,,F,N,100.2,KG,20200623.0,N,PH,US,US,2020,Q2,Elderly
179343401,17934340,17,C,Insulin lispro sliding scale 5x/day,,2,,,,,,,,,,,,,,2020,Q2,Blood bilirubin increased,,2020,Q2,1,I,20200615.0,,20200623,20200623,DIR,,,FDA-CTU,,74.0,YR,,F,N,100.2,KG,20200623.0,N,PH,US,US,2020,Q2,Elderly
179343401,17934340,17,C,Insulin lispro sliding scale 5x/day,,2,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200615.0,,20200623,20200623,DIR,,,FDA-CTU,,74.0,YR,,F,N,100.2,KG,20200623.0,N,PH,US,US,2020,Q2,Elderly
179343401,17934340,17,C,Insulin lispro sliding scale 5x/day,,2,,,,,,,,,,,,,,2020,Q2,Device occlusion,,2020,Q2,1,I,20200615.0,,20200623,20200623,DIR,,,FDA-CTU,,74.0,YR,,F,N,100.2,KG,20200623.0,N,PH,US,US,2020,Q2,Elderly
179343401,17934340,17,C,Insulin lispro sliding scale 5x/day,,2,,,,,,,,,,,,,,2020,Q2,Face oedema,,2020,Q2,1,I,20200615.0,,20200623,20200623,DIR,,,FDA-CTU,,74.0,YR,,F,N,100.2,KG,20200623.0,N,PH,US,US,2020,Q2,Elderly
179343401,17934340,17,C,Insulin lispro sliding scale 5x/day,,2,,,,,,,,,,,,,,2020,Q2,Haemodialysis,,2020,Q2,1,I,20200615.0,,20200623,20200623,DIR,,,FDA-CTU,,74.0,YR,,F,N,100.2,KG,20200623.0,N,PH,US,US,2020,Q2,Elderly
179343401,17934340,17,C,Insulin lispro sliding scale 5x/day,,2,,,,,,,,,,,,,,2020,Q2,International normalised ratio increased,,2020,Q2,1,I,20200615.0,,20200623,20200623,DIR,,,FDA-CTU,,74.0,YR,,F,N,100.2,KG,20200623.0,N,PH,US,US,2020,Q2,Elderly
179343401,17934340,17,C,Insulin lispro sliding scale 5x/day,,2,,,,,,,,,,,,,,2020,Q2,Oxygen saturation abnormal,,2020,Q2,1,I,20200615.0,,20200623,20200623,DIR,,,FDA-CTU,,74.0,YR,,F,N,100.2,KG,20200623.0,N,PH,US,US,2020,Q2,Elderly
179343401,17934340,17,C,Insulin lispro sliding scale 5x/day,,2,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200615.0,,20200623,20200623,DIR,,,FDA-CTU,,74.0,YR,,F,N,100.2,KG,20200623.0,N,PH,US,US,2020,Q2,Elderly
179343401,17934340,17,C,Insulin lispro sliding scale 5x/day,,2,,,,,,,,,,,,,,2020,Q2,Therapy interrupted,,2020,Q2,1,I,20200615.0,,20200623,20200623,DIR,,,FDA-CTU,,74.0,YR,,F,N,100.2,KG,20200623.0,N,PH,US,US,2020,Q2,Elderly
179343911,17934391,6,C,lispro insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200610.0,,20200623,20200623,DIR,,,FDA-CTU,,56.0,YR,,M,N,105.5,KG,20200623.0,N,PH,US,US,2020,Q2,Adult
179343911,17934391,6,C,lispro insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatine increased,,2020,Q2,1,I,20200610.0,,20200623,20200623,DIR,,,FDA-CTU,,56.0,YR,,M,N,105.5,KG,20200623.0,N,PH,US,US,2020,Q2,Adult
179343911,17934391,6,C,lispro insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,1,I,20200610.0,,20200623,20200623,DIR,,,FDA-CTU,,56.0,YR,,M,N,105.5,KG,20200623.0,N,PH,US,US,2020,Q2,Adult
179343911,17934391,6,C,lispro insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,1,I,20200610.0,,20200623,20200623,DIR,,,FDA-CTU,,56.0,YR,,M,N,105.5,KG,20200623.0,N,PH,US,US,2020,Q2,Adult
179343911,17934391,6,C,lispro insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,SARS-CoV-2 test positive,,2020,Q2,1,I,20200610.0,,20200623,20200623,DIR,,,FDA-CTU,,56.0,YR,,M,N,105.5,KG,20200623.0,N,PH,US,US,2020,Q2,Adult
179343911,17934391,6,C,lispro insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Septic shock,,2020,Q2,1,I,20200610.0,,20200623,20200623,DIR,,,FDA-CTU,,56.0,YR,,M,N,105.5,KG,20200623.0,N,PH,US,US,2020,Q2,Adult
179360151,17936015,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"18 DF, DAILY",,,,,,,,18.0,DF,,,2020,Q2,Irritability,,2020,Q2,1,I,,20200618.0,20200624,20200624,EXP,,JP-PFIZER INC-2020239707,PFIZER,"IZUCHI, T.. A CASE OF AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 3 WITH CONCOMITANT AUTOIMMUNE CEREBELLAR ATAXIA POSITIVE FOR ANTI-GLUTAMICACID DECARBOXYLASE ANTIBODY AND ANTI-GLIADIN ANTIBODY. J.JAPAN DIAB. SOC.. 2020;63:331-338",42.0,YR,,F,Y,46.3,KG,20200624.0,,MD,JP,JP,2020,Q2,Adult
179362621,17936262,6,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200619.0,,20200624,20200624,DIR,,,FDA-CTU,,64.0,YR,,M,N,78.3,KG,20200624.0,N,PH,US,US,2020,Q2,Adult
179362621,17936262,6,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200619.0,,20200624,20200624,DIR,,,FDA-CTU,,64.0,YR,,M,N,78.3,KG,20200624.0,N,PH,US,US,2020,Q2,Adult
179362621,17936262,6,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate increased,,2020,Q2,1,I,20200619.0,,20200624,20200624,DIR,,,FDA-CTU,,64.0,YR,,M,N,78.3,KG,20200624.0,N,PH,US,US,2020,Q2,Adult
179362621,17936262,6,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Haemodialysis,,2020,Q2,1,I,20200619.0,,20200624,20200624,DIR,,,FDA-CTU,,64.0,YR,,M,N,78.3,KG,20200624.0,N,PH,US,US,2020,Q2,Adult
179362621,17936262,6,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200619.0,,20200624,20200624,DIR,,,FDA-CTU,,64.0,YR,,M,N,78.3,KG,20200624.0,N,PH,US,US,2020,Q2,Adult
179385781,17938578,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(),,,,,,,,,,,,2020,Q2,Loss of consciousness,,2020,Q2,1,I,20191110.0,20200610.0,20200625,20200625,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-251462,RANBAXY,,87.0,YR,,M,Y,,,20200625.0,,HP,NL,IT,2020,Q2,Elderly
179393592,17939359,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 INTERNATIONAL UNIT, DAILY",43700.0,IU,Y,,,,20563.0,19.0,IU,,QD,2020,Q2,Aphasia,,2020,Q2,2,F,20200521.0,20200618.0,20200624,20200630,EXP,IT-MINISAL02-622816,IT-ELI_LILLY_AND_COMPANY-IT202006006857,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200630.0,,MD,IT,IT,2020,Q2,Elderly
179393592,17939359,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 INTERNATIONAL UNIT, DAILY",43700.0,IU,Y,,,,20563.0,19.0,IU,,QD,2020,Q2,Drug interaction,,2020,Q2,2,F,20200521.0,20200618.0,20200624,20200630,EXP,IT-MINISAL02-622816,IT-ELI_LILLY_AND_COMPANY-IT202006006857,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200630.0,,MD,IT,IT,2020,Q2,Elderly
179393592,17939359,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 INTERNATIONAL UNIT, DAILY",43700.0,IU,Y,,,,20563.0,19.0,IU,,QD,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,20200521.0,20200618.0,20200624,20200630,EXP,IT-MINISAL02-622816,IT-ELI_LILLY_AND_COMPANY-IT202006006857,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200630.0,,MD,IT,IT,2020,Q2,Elderly
179393592,17939359,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 INTERNATIONAL UNIT, DAILY",43700.0,IU,Y,,,,20563.0,19.0,IU,,QD,2020,Q2,Loss of consciousness,,2020,Q2,2,F,20200521.0,20200618.0,20200624,20200630,EXP,IT-MINISAL02-622816,IT-ELI_LILLY_AND_COMPANY-IT202006006857,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200630.0,,MD,IT,IT,2020,Q2,Elderly
179393592,17939359,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 INTERNATIONAL UNIT, DAILY",43700.0,IU,Y,,,,20563.0,19.0,IU,,QD,2020,Q2,Sopor,,2020,Q2,2,F,20200521.0,20200618.0,20200624,20200630,EXP,IT-MINISAL02-622816,IT-ELI_LILLY_AND_COMPANY-IT202006006857,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200630.0,,MD,IT,IT,2020,Q2,Elderly
179393592,17939359,2,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 INTERNATIONAL UNIT, DAILY",43700.0,IU,Y,,,,20563.0,19.0,IU,,QD,2020,Q2,Aphasia,,2020,Q2,2,F,20200521.0,20200618.0,20200624,20200630,EXP,IT-MINISAL02-622816,IT-ELI_LILLY_AND_COMPANY-IT202006006857,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200630.0,,MD,IT,IT,2020,Q2,Elderly
179393592,17939359,2,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 INTERNATIONAL UNIT, DAILY",43700.0,IU,Y,,,,20563.0,19.0,IU,,QD,2020,Q2,Drug interaction,,2020,Q2,2,F,20200521.0,20200618.0,20200624,20200630,EXP,IT-MINISAL02-622816,IT-ELI_LILLY_AND_COMPANY-IT202006006857,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200630.0,,MD,IT,IT,2020,Q2,Elderly
179393592,17939359,2,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 INTERNATIONAL UNIT, DAILY",43700.0,IU,Y,,,,20563.0,19.0,IU,,QD,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,20200521.0,20200618.0,20200624,20200630,EXP,IT-MINISAL02-622816,IT-ELI_LILLY_AND_COMPANY-IT202006006857,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200630.0,,MD,IT,IT,2020,Q2,Elderly
179393592,17939359,2,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 INTERNATIONAL UNIT, DAILY",43700.0,IU,Y,,,,20563.0,19.0,IU,,QD,2020,Q2,Loss of consciousness,,2020,Q2,2,F,20200521.0,20200618.0,20200624,20200630,EXP,IT-MINISAL02-622816,IT-ELI_LILLY_AND_COMPANY-IT202006006857,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200630.0,,MD,IT,IT,2020,Q2,Elderly
179393592,17939359,2,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 INTERNATIONAL UNIT, DAILY",43700.0,IU,Y,,,,20563.0,19.0,IU,,QD,2020,Q2,Sopor,,2020,Q2,2,F,20200521.0,20200618.0,20200624,20200630,EXP,IT-MINISAL02-622816,IT-ELI_LILLY_AND_COMPANY-IT202006006857,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200630.0,,MD,IT,IT,2020,Q2,Elderly
179409541,17940954,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200530.0,,20200624,20200624,DIR,,,FDA-CTU,,81.0,YR,,M,N,81.5,KG,20200624.0,Y,PH,US,US,2020,Q2,Elderly
179409541,17940954,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200530.0,,20200624,20200624,DIR,,,FDA-CTU,,81.0,YR,,M,N,81.5,KG,20200624.0,Y,PH,US,US,2020,Q2,Elderly
179409981,17940998,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cardiac arrest,,2020,Q2,1,I,20200622.0,,20200624,20200624,DIR,,,FDA-CTU,,36.0,YR,,M,N,82.2,KG,20200624.0,N,MD,US,US,2020,Q2,Adult
179409981,17940998,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20200622.0,,20200624,20200624,DIR,,,FDA-CTU,,36.0,YR,,M,N,82.2,KG,20200624.0,N,MD,US,US,2020,Q2,Adult
179409981,17940998,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Respiratory acidosis,,2020,Q2,1,I,20200622.0,,20200624,20200624,DIR,,,FDA-CTU,,36.0,YR,,M,N,82.2,KG,20200624.0,N,MD,US,US,2020,Q2,Adult
179410971,17941097,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q2,Acute respiratory distress syndrome,,2020,Q2,1,I,20200616.0,,20200624,20200624,DIR,,,FDA-CTU,,69.0,YR,,M,N,110.5,KG,20200624.0,Y,PH,US,US,2020,Q2,Elderly
179410971,17941097,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q2,COVID-19,,2020,Q2,1,I,20200616.0,,20200624,20200624,DIR,,,FDA-CTU,,69.0,YR,,M,N,110.5,KG,20200624.0,Y,PH,US,US,2020,Q2,Elderly
179410971,17941097,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q2,Fibrin D dimer increased,,2020,Q2,1,I,20200616.0,,20200624,20200624,DIR,,,FDA-CTU,,69.0,YR,,M,N,110.5,KG,20200624.0,Y,PH,US,US,2020,Q2,Elderly
179410971,17941097,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q2,Hypercalcaemia,,2020,Q2,1,I,20200616.0,,20200624,20200624,DIR,,,FDA-CTU,,69.0,YR,,M,N,110.5,KG,20200624.0,Y,PH,US,US,2020,Q2,Elderly
179410971,17941097,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20200616.0,,20200624,20200624,DIR,,,FDA-CTU,,69.0,YR,,M,N,110.5,KG,20200624.0,Y,PH,US,US,2020,Q2,Elderly
179410971,17941097,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q2,Leukocytosis,,2020,Q2,1,I,20200616.0,,20200624,20200624,DIR,,,FDA-CTU,,69.0,YR,,M,N,110.5,KG,20200624.0,Y,PH,US,US,2020,Q2,Elderly
179410971,17941097,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,1,I,20200616.0,,20200624,20200624,DIR,,,FDA-CTU,,69.0,YR,,M,N,110.5,KG,20200624.0,Y,PH,US,US,2020,Q2,Elderly
179410971,17941097,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,1,I,20200616.0,,20200624,20200624,DIR,,,FDA-CTU,,69.0,YR,,M,N,110.5,KG,20200624.0,Y,PH,US,US,2020,Q2,Elderly
179410971,17941097,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q2,Tachycardia,,2020,Q2,1,I,20200616.0,,20200624,20200624,DIR,,,FDA-CTU,,69.0,YR,,M,N,110.5,KG,20200624.0,Y,PH,US,US,2020,Q2,Elderly
179410971,17941097,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q2,Tachypnoea,,2020,Q2,1,I,20200616.0,,20200624,20200624,DIR,,,FDA-CTU,,69.0,YR,,M,N,110.5,KG,20200624.0,Y,PH,US,US,2020,Q2,Elderly
179411561,17941156,14,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q2,Acute respiratory failure,,2020,Q2,1,I,20200608.0,,20200624,20200624,DIR,,,FDA-CTU,,60.0,YR,,M,N,62.5,KG,20200624.0,N,PH,US,US,2020,Q2,Adult
179411561,17941156,14,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200608.0,,20200624,20200624,DIR,,,FDA-CTU,,60.0,YR,,M,N,62.5,KG,20200624.0,N,PH,US,US,2020,Q2,Adult
179411561,17941156,14,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20200608.0,,20200624,20200624,DIR,,,FDA-CTU,,60.0,YR,,M,N,62.5,KG,20200624.0,N,PH,US,US,2020,Q2,Adult
179411561,17941156,14,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q2,Oxygen saturation decreased,,2020,Q2,1,I,20200608.0,,20200624,20200624,DIR,,,FDA-CTU,,60.0,YR,,M,N,62.5,KG,20200624.0,N,PH,US,US,2020,Q2,Adult
179411561,17941156,14,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,1,I,20200608.0,,20200624,20200624,DIR,,,FDA-CTU,,60.0,YR,,M,N,62.5,KG,20200624.0,N,PH,US,US,2020,Q2,Adult
179411561,17941156,14,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q2,SARS-CoV-2 test positive,,2020,Q2,1,I,20200608.0,,20200624,20200624,DIR,,,FDA-CTU,,60.0,YR,,M,N,62.5,KG,20200624.0,N,PH,US,US,2020,Q2,Adult
179412561,17941256,15,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,20200621.0,,20200624,20200624,DIR,,,FDA-CTU,,61.0,YR,,M,N,106.4,KG,20200624.0,Y,PH,US,US,2020,Q2,Adult
179412561,17941256,15,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q2,Oxygen saturation decreased,,2020,Q2,1,I,20200621.0,,20200624,20200624,DIR,,,FDA-CTU,,61.0,YR,,M,N,106.4,KG,20200624.0,Y,PH,US,US,2020,Q2,Adult
179412561,17941256,15,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q2,Pulse absent,,2020,Q2,1,I,20200621.0,,20200624,20200624,DIR,,,FDA-CTU,,61.0,YR,,M,N,106.4,KG,20200624.0,Y,PH,US,US,2020,Q2,Adult
179424401,17942440,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2020,Q2,Anaemia,,2020,Q2,1,I,,20200620.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424401,17942440,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2020,Q2,Electrolyte imbalance,,2020,Q2,1,I,,20200620.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424401,17942440,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,,20200620.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424401,17942440,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2020,Q2,Labelled drug-drug interaction medication error,,2020,Q2,1,I,,20200620.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424401,17942440,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2020,Q2,Product monitoring error,,2020,Q2,1,I,,20200620.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424401,17942440,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,,20200620.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179449601,17944960,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY",,,,,,,20563.0,10.0,IU,INJECTION,QD,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,20200616.0,20200622.0,20200626,20200626,PER,,US-ELI_LILLY_AND_COMPANY-US202006009688,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200626.0,,CN,US,US,2020,Q2,Elderly
179449601,17944960,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY",,,,,,,20563.0,10.0,IU,INJECTION,QD,2020,Q2,Diabetic coma,,2020,Q2,1,I,20200616.0,20200622.0,20200626,20200626,PER,,US-ELI_LILLY_AND_COMPANY-US202006009688,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200626.0,,CN,US,US,2020,Q2,Elderly
179449601,17944960,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY",,,,,,,20563.0,10.0,IU,INJECTION,QD,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,20200616.0,20200622.0,20200626,20200626,PER,,US-ELI_LILLY_AND_COMPANY-US202006009688,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200626.0,,CN,US,US,2020,Q2,Elderly
179449601,17944960,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY",,,,,,,20563.0,10.0,IU,INJECTION,QD,2020,Q2,Diabetic coma,,2020,Q2,1,I,20200616.0,20200622.0,20200626,20200626,PER,,US-ELI_LILLY_AND_COMPANY-US202006009688,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200626.0,,CN,US,US,2020,Q2,Elderly
179449601,17944960,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY",,,,, D137576C,,20563.0,10.0,IU,INJECTION,QD,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,20200616.0,20200622.0,20200626,20200626,PER,,US-ELI_LILLY_AND_COMPANY-US202006009688,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200626.0,,CN,US,US,2020,Q2,Elderly
179449601,17944960,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY",,,,, D137576C,,20563.0,10.0,IU,INJECTION,QD,2020,Q2,Diabetic coma,,2020,Q2,1,I,20200616.0,20200622.0,20200626,20200626,PER,,US-ELI_LILLY_AND_COMPANY-US202006009688,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200626.0,,CN,US,US,2020,Q2,Elderly
179449601,17944960,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY",,,,, D137576C,,20563.0,10.0,IU,INJECTION,QD,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,20200616.0,20200622.0,20200626,20200626,PER,,US-ELI_LILLY_AND_COMPANY-US202006009688,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200626.0,,CN,US,US,2020,Q2,Elderly
179449601,17944960,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY",,,,, D137576C,,20563.0,10.0,IU,INJECTION,QD,2020,Q2,Diabetic coma,,2020,Q2,1,I,20200616.0,20200622.0,20200626,20200626,PER,,US-ELI_LILLY_AND_COMPANY-US202006009688,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200626.0,,CN,US,US,2020,Q2,Elderly
179471361,17947136,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Neutrophil count decreased,,2020,Q2,1,I,20200623.0,,20200625,20200625,DIR,,,FDA-CTU,,85.0,YR,,F,N,61.7,KG,20200625.0,N,PH,US,US,2020,Q2,Elderly
179471361,17947136,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Platelet count decreased,,2020,Q2,1,I,20200623.0,,20200625,20200625,DIR,,,FDA-CTU,,85.0,YR,,F,N,61.7,KG,20200625.0,N,PH,US,US,2020,Q2,Elderly
179471361,17947136,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,White blood cell count decreased,,2020,Q2,1,I,20200623.0,,20200625,20200625,DIR,,,FDA-CTU,,85.0,YR,,F,N,61.7,KG,20200625.0,N,PH,US,US,2020,Q2,Elderly
179483071,17948307,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12 IU UTD,,,,,,,,12.0,IU,,,2020,Q2,Pancreatitis,,2020,Q2,1,I,20191226.0,20200303.0,20200625,20200625,PER,,US-NOVOPROD-716741,NOVO NORDISK,,74.0,YR,,F,Y,89.52,KG,20200625.0,,MD,US,US,2020,Q2,Elderly
179491821,17949182,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Extra dose administered,,2020,Q2,1,I,20200625.0,,20200626,20200626,DIR,,,FDA-CTU,,37.0,YR,,F,N,90.3,KG,20200626.0,N,PH,US,US,2020,Q2,Adult
179521051,17952105,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Death,,2020,Q2,1,I,20200621.0,20200624.0,20200626,20200626,EXP,,US-GILEAD-2020-0475740,GILEAD,,61.0,YR,A,M,Y,106.4,KG,20200626.0,,PH,US,US,2020,Q2,Adult
179526101,17952610,14,C,INSULIN LISPRO DCI,,2,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200608.0,20200624.0,20200626,20200626,EXP,,US-GILEAD-2020-0476284,GILEAD,,60.0,YR,A,M,Y,62.5,KG,20200626.0,,PH,US,US,2020,Q2,Adult
179526241,17952624,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood bilirubin increased,,2020,Q2,1,I,20200616.0,20200624.0,20200626,20200626,EXP,,US-GILEAD-2020-0476289,GILEAD,,69.0,YR,E,M,Y,110.5,KG,20200626.0,,PH,US,US,2020,Q2,Elderly
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Abdominal pain,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Adverse event,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Ammonia increased,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Back pain,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood bilirubin increased,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Blood lactate dehydrogenase increased,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Cellulitis,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Compression fracture,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Dermatitis,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastric polyps,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastric ulcer,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastrointestinal erosion,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastrointestinal mucosal disorder,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hepatic encephalopathy,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypervolaemia,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Hypothyroidism,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Internal haemorrhage,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Peripheral venous disease,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pneumonia escherichia,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Portal hypertension,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Portal hypertensive gastropathy,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Post thrombotic syndrome,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Pulmonary oedema,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Respiratory distress,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Right ventricular failure,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Septic shock,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Skin ulcer,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Surgery,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Toxic encephalopathy,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Varices oesophageal,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179562491,17956249,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q2,Wound infection pseudomonas,,2020,Q2,1,I,20150717.0,20200611.0,20200629,20200629,EXP,,US-BAYER-2020-119479,BAYER,,48.0,YR,A,F,Y,63.56,KG,20200629.0,,HP,US,US,2020,Q2,Adult
179572561,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q2,Gangrene,,2020,Q2,1,I,20191217.0,20200624.0,20200629,20200629,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200629.0,,HP,DE,DE,2020,Q2,Adult
179572561,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q2,Hypernatraemia,,2020,Q2,1,I,20191217.0,20200624.0,20200629,20200629,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200629.0,,HP,DE,DE,2020,Q2,Adult
179572561,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q2,Infection,,2020,Q2,1,I,20191217.0,20200624.0,20200629,20200629,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200629.0,,HP,DE,DE,2020,Q2,Adult
179572561,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q2,Lymphangiosis carcinomatosa,,2020,Q2,1,I,20191217.0,20200624.0,20200629,20200629,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200629.0,,HP,DE,DE,2020,Q2,Adult
179572561,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q2,Pain,,2020,Q2,1,I,20191217.0,20200624.0,20200629,20200629,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200629.0,,HP,DE,DE,2020,Q2,Adult
179572561,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,1,I,20191217.0,20200624.0,20200629,20200629,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200629.0,,HP,DE,DE,2020,Q2,Adult
179572561,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q2,Pneumothorax,,2020,Q2,1,I,20191217.0,20200624.0,20200629,20200629,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200629.0,,HP,DE,DE,2020,Q2,Adult
179572561,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q2,Rash,,2020,Q2,1,I,20191217.0,20200624.0,20200629,20200629,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200629.0,,HP,DE,DE,2020,Q2,Adult
179572561,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q2,Rash erythematous,,2020,Q2,1,I,20191217.0,20200624.0,20200629,20200629,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200629.0,,HP,DE,DE,2020,Q2,Adult
179572561,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q2,Rash vesicular,,2020,Q2,1,I,20191217.0,20200624.0,20200629,20200629,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200629.0,,HP,DE,DE,2020,Q2,Adult
179572561,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q2,Superinfection,,2020,Q2,1,I,20191217.0,20200624.0,20200629,20200629,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200629.0,,HP,DE,DE,2020,Q2,Adult
179592891,17959289,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q2,Blood glucose abnormal,,2020,Q2,1,I,202004.0,20200623.0,20200629,20200629,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20200629.0,,CN,US,US,2020,Q2,Elderly
179592891,17959289,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q2,Device leakage,,2020,Q2,1,I,202004.0,20200623.0,20200629,20200629,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20200629.0,,CN,US,US,2020,Q2,Elderly
179592891,17959289,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q2,Injection site mass,,2020,Q2,1,I,202004.0,20200623.0,20200629,20200629,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20200629.0,,CN,US,US,2020,Q2,Elderly
179592891,17959289,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q2,Injection site urticaria,,2020,Q2,1,I,202004.0,20200623.0,20200629,20200629,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20200629.0,,CN,US,US,2020,Q2,Elderly
179592891,17959289,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q2,Wrong technique in device usage process,,2020,Q2,1,I,202004.0,20200623.0,20200629,20200629,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20200629.0,,CN,US,US,2020,Q2,Elderly
179611191,17961119,11,C,insulin lispro sliding scale subQ q4h,,2,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,1,I,20200629.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,F,N,70.0,KG,20200629.0,N,PH,US,US,2020,Q2,Elderly
179611191,17961119,11,C,insulin lispro sliding scale subQ q4h,,2,,,,,,,,,,,,,,2020,Q2,Hepatic enzyme increased,,2020,Q2,1,I,20200629.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,F,N,70.0,KG,20200629.0,N,PH,US,US,2020,Q2,Elderly
179611191,17961119,11,C,insulin lispro sliding scale subQ q4h,,2,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200629.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,F,N,70.0,KG,20200629.0,N,PH,US,US,2020,Q2,Elderly
179611191,17961119,11,C,insulin lispro sliding scale subQ q4h,,2,,,,,,,,,,,,,,2020,Q2,Therapy cessation,,2020,Q2,1,I,20200629.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,F,N,70.0,KG,20200629.0,N,PH,US,US,2020,Q2,Elderly
179651021,17965102,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,D,,,,,42.0,IU,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200620.0,20200630,20200630,EXP,,CZ-HETERO-HET2020CZ00682,HETERO,"VODICKA M, SLANAR O, PISAR M, SALEK T. ROSUVASTATIN-INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CES. SLOV. FARM. 2020;69:100-102",74.0,YR,,M,Y,,,20200701.0,,HP,CZ,CZ,2020,Q2,Elderly
179651021,17965102,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,D,,,,,42.0,IU,,,2020,Q2,Medication error,,2020,Q2,1,I,,20200620.0,20200630,20200630,EXP,,CZ-HETERO-HET2020CZ00682,HETERO,"VODICKA M, SLANAR O, PISAR M, SALEK T. ROSUVASTATIN-INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CES. SLOV. FARM. 2020;69:100-102",74.0,YR,,M,Y,,,20200701.0,,HP,CZ,CZ,2020,Q2,Elderly
179651021,17965102,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,D,,,,,42.0,IU,,,2020,Q2,Rhabdomyolysis,,2020,Q2,1,I,,20200620.0,20200630,20200630,EXP,,CZ-HETERO-HET2020CZ00682,HETERO,"VODICKA M, SLANAR O, PISAR M, SALEK T. ROSUVASTATIN-INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CES. SLOV. FARM. 2020;69:100-102",74.0,YR,,M,Y,,,20200701.0,,HP,CZ,CZ,2020,Q2,Elderly
105094686,10509468,90,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, BID",,,U,U,,,,6.0,DF,,BID,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,90,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, BID",,,U,U,,,,6.0,DF,,BID,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,90,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, BID",,,U,U,,,,6.0,DF,,BID,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,91,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, BID",,,U,U,,,,6.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,91,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, BID",,,U,U,,,,6.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,91,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, BID",,,U,U,,,,6.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,92,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, QD",,,U,U,,,,10.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,92,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, QD",,,U,U,,,,10.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,92,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, QD",,,U,U,,,,10.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,93,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 U, QD",,,U,U,,,,8.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,93,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 U, QD",,,U,U,,,,8.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,93,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 U, QD",,,U,U,,,,8.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,94,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,94,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,94,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,95,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,95,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,95,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,96,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,96,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,96,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,97,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,97,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,97,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,98,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,98,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,98,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,99,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,99,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,99,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,100,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, BID",,,U,U,,,,6.0,DF,,BID,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,100,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, BID",,,U,U,,,,6.0,DF,,BID,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,100,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, BID",,,U,U,,,,6.0,DF,,BID,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,101,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,101,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,101,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,102,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,102,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,102,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,103,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, BID",,,U,U,,,,4.0,DF,,BID,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,103,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, BID",,,U,U,,,,4.0,DF,,BID,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,103,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, BID",,,U,U,,,,4.0,DF,,BID,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,104,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,104,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,104,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,105,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,105,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,105,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,106,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,106,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,106,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,107,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, BID",,,U,U,,,,4.0,DF,,BID,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,107,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, BID",,,U,U,,,,4.0,DF,,BID,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,107,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, BID",,,U,U,,,,4.0,DF,,BID,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,108,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,108,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,108,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,109,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Cerebrospinal fluid leakage,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,109,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Diabetes mellitus,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
105094686,10509468,109,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 U, QD",,,U,U,,,,4.0,DF,,QD,2020,Q3,Meningitis,,2020,Q3,6,F,20140418.0,20150304.0,20141009,20150311,EXP,,PHHO2014KR007286,NOVARTIS,,51.0,YR,,F,Y,57.0,KG,20150311.0,,HP,KR,KR,2020,Q3,Adult
115422946,11542294,5,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,G,,BID,2020,Q3,Encephalopathy,,2020,Q3,6,F,,20200629.0,20150923,20200707,EXP,,CA-BAUSCH-BL-2015-021717,BAUSCH AND LOMB,"VIVAS L, GOLD W, MANDELL D, WU P. AN 82?YEAR?OLD MAN WITH ATAXIA AND DYSARTHRIA. CMAJ. 2016?188(17?18):1251?1254. DOI:10.1503/CMAJ.150573",82.0,YR,,M,Y,,,20200707.0,,MD,CA,CA,2020,Q3,Elderly
115422946,11542294,5,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,G,,BID,2020,Q3,Fall,,2020,Q3,6,F,,20200629.0,20150923,20200707,EXP,,CA-BAUSCH-BL-2015-021717,BAUSCH AND LOMB,"VIVAS L, GOLD W, MANDELL D, WU P. AN 82?YEAR?OLD MAN WITH ATAXIA AND DYSARTHRIA. CMAJ. 2016?188(17?18):1251?1254. DOI:10.1503/CMAJ.150573",82.0,YR,,M,Y,,,20200707.0,,MD,CA,CA,2020,Q3,Elderly
115422946,11542294,5,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,G,,BID,2020,Q3,Nervous system disorder,,2020,Q3,6,F,,20200629.0,20150923,20200707,EXP,,CA-BAUSCH-BL-2015-021717,BAUSCH AND LOMB,"VIVAS L, GOLD W, MANDELL D, WU P. AN 82?YEAR?OLD MAN WITH ATAXIA AND DYSARTHRIA. CMAJ. 2016?188(17?18):1251?1254. DOI:10.1503/CMAJ.150573",82.0,YR,,M,Y,,,20200707.0,,MD,CA,CA,2020,Q3,Elderly
115941143,11594114,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q3,Acute respiratory failure,,2020,Q3,3,F,20140318.0,20200816.0,20151005,20200827,EXP,,US-JNJFOC-20150927555,JOHNSON AND JOHNSON,,68.0,YR,E,M,Y,,,20200827.0,,CN,US,US,2020,Q3,Elderly
115941143,11594114,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q3,Bladder perforation,,2020,Q3,3,F,20140318.0,20200816.0,20151005,20200827,EXP,,US-JNJFOC-20150927555,JOHNSON AND JOHNSON,,68.0,YR,E,M,Y,,,20200827.0,,CN,US,US,2020,Q3,Elderly
115941143,11594114,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q3,Haematuria,,2020,Q3,3,F,20140318.0,20200816.0,20151005,20200827,EXP,,US-JNJFOC-20150927555,JOHNSON AND JOHNSON,,68.0,YR,E,M,Y,,,20200827.0,,CN,US,US,2020,Q3,Elderly
115941143,11594114,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q3,Renal haemorrhage,,2020,Q3,3,F,20140318.0,20200816.0,20151005,20200827,EXP,,US-JNJFOC-20150927555,JOHNSON AND JOHNSON,,68.0,YR,E,M,Y,,,20200827.0,,CN,US,US,2020,Q3,Elderly
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Ammonia increased,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Anaemia,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Atelectasis,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Back pain,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Blood bilirubin increased,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Blood lactate dehydrogenase increased,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Bronchial wall thickening,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Cellulitis,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Chest pain,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Chills,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Compression fracture,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Crying,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Deep vein thrombosis,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dermatitis,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dizziness,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dysphagia,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dyspnoea exertional,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Encephalopathy,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Erythema,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Faeces discoloured,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Fatigue,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Fluid overload,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Gastric disorder,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Gastric polyps,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Gastric ulcer,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Gastrointestinal erosion,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Gastrointestinal mucosal disorder,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Gastrooesophageal reflux disease,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Haematocrit decreased,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Haemoglobin decreased,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Haemolysis,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Haemoptysis,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Haemorrhage,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Haptoglobin decreased,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Headache,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hepatic encephalopathy,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hospitalisation,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypervolaemia,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypothyroidism,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Internal haemorrhage,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Jaundice acholuric,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Malnutrition,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Melaena,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Mental status changes,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Occult blood positive,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Oedema,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Oxygen consumption increased,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Oxygen therapy,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pain in extremity,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Peripheral venous disease,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pneumonia escherichia,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Portal hypertensive gastropathy,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Post thrombotic syndrome,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pulmonary oedema,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Renal failure,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Respiratory distress,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Respiratory failure,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Rhinitis,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Rhonchi,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Right ventricular failure,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Skin ulcer,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Somnolence,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Surgery,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Swelling,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Toxic encephalopathy,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Transfusion,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Upper gastrointestinal haemorrhage,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Varices oesophageal,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
1159927530,11599275,52,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Wound infection pseudomonas,,2020,Q3,30,F,201412.0,20200817.0,20151006,20200824,EXP,,US-ACTELION-A-NJ2015-124867,ACTELION,,42.0,YR,,F,Y,65.31,KG,20200824.0,,HP,US,US,2020,Q3,Adult
136026922,13602692,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"U100, SLIDING SCALE",,,,,,,,,,,,2020,Q3,Dermatitis bullous,,2020,Q3,2,F,20161128.0,20180108.0,20170601,20180116,EXP,,US-ASTRAZENECA-2017SE01987,ASTRAZENECA,,64.0,YR,,M,Y,61.0,KG,20180116.0,,MD,US,US,2020,Q3,Adult
136026922,13602692,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"U100, SLIDING SCALE",,,,,,,,,,,,2020,Q3,Hyperglycaemia,,2020,Q3,2,F,20161128.0,20180108.0,20170601,20180116,EXP,,US-ASTRAZENECA-2017SE01987,ASTRAZENECA,,64.0,YR,,M,Y,61.0,KG,20180116.0,,MD,US,US,2020,Q3,Adult
136026922,13602692,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"U100, SLIDING SCALE",,,,,,,,,,,,2020,Q3,Hypophosphataemia,,2020,Q3,2,F,20161128.0,20180108.0,20170601,20180116,EXP,,US-ASTRAZENECA-2017SE01987,ASTRAZENECA,,64.0,YR,,M,Y,61.0,KG,20180116.0,,MD,US,US,2020,Q3,Adult
136026922,13602692,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"U100, SLIDING SCALE",,,,,,,,,,,,2020,Q3,Lichenoid keratosis,,2020,Q3,2,F,20161128.0,20180108.0,20170601,20180116,EXP,,US-ASTRAZENECA-2017SE01987,ASTRAZENECA,,64.0,YR,,M,Y,61.0,KG,20180116.0,,MD,US,US,2020,Q3,Adult
136026922,13602692,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"U100, SLIDING SCALE",,,,,,,,,,,,2020,Q3,Oedema,,2020,Q3,2,F,20161128.0,20180108.0,20170601,20180116,EXP,,US-ASTRAZENECA-2017SE01987,ASTRAZENECA,,64.0,YR,,M,Y,61.0,KG,20180116.0,,MD,US,US,2020,Q3,Adult
136026922,13602692,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"U100, SLIDING SCALE",,,,,,,,,,,,2020,Q3,Pruritus,,2020,Q3,2,F,20161128.0,20180108.0,20170601,20180116,EXP,,US-ASTRAZENECA-2017SE01987,ASTRAZENECA,,64.0,YR,,M,Y,61.0,KG,20180116.0,,MD,US,US,2020,Q3,Adult
136026922,13602692,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"U100, SLIDING SCALE",,,,,,,,,,,,2020,Q3,Skin disorder,,2020,Q3,2,F,20161128.0,20180108.0,20170601,20180116,EXP,,US-ASTRAZENECA-2017SE01987,ASTRAZENECA,,64.0,YR,,M,Y,61.0,KG,20180116.0,,MD,US,US,2020,Q3,Adult
136243011,13624301,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12.000 IU TID,,,,,,,,,,,,2020,Q3,Hepatic function abnormal,,2020,Q3,1,I,20161021.0,20161021.0,20170608,20170608,EXP,,JP-ASTRAZENECA-2016SF11826,ASTRAZENECA,,22070.0,DY,,M,Y,,,20170608.0,,MD,JP,JP,2020,Q3,Elderly
137584335,13758433,46,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDONG SCALE)",,,,, C999324C,,,8.0,IU,INJECTION,,2020,Q3,Blood glucose decreased,,2020,Q3,5,F,20170613.0,20200825.0,20170717,20200901,PER,,US-ELI_LILLY_AND_COMPANY-US201706011831,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20200901.0,,CN,US,US,2020,Q3,Adult
137584335,13758433,46,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDONG SCALE)",,,,, C999324C,,,8.0,IU,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,5,F,20170613.0,20200825.0,20170717,20200901,PER,,US-ELI_LILLY_AND_COMPANY-US201706011831,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20200901.0,,CN,US,US,2020,Q3,Adult
137584335,13758433,46,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDONG SCALE)",,,,, C999324C,,,8.0,IU,INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,5,F,20170613.0,20200825.0,20170717,20200901,PER,,US-ELI_LILLY_AND_COMPANY-US201706011831,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20200901.0,,CN,US,US,2020,Q3,Adult
137584335,13758433,46,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDONG SCALE)",,,,, C999324C,,,8.0,IU,INJECTION,,2020,Q3,Product storage error,,2020,Q3,5,F,20170613.0,20200825.0,20170717,20200901,PER,,US-ELI_LILLY_AND_COMPANY-US201706011831,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20200901.0,,CN,US,US,2020,Q3,Adult
137584335,13758433,47,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDONG SCALE)",,,,, C999324C,,,8.0,IU,INJECTION,,2020,Q3,Blood glucose decreased,,2020,Q3,5,F,20170613.0,20200825.0,20170717,20200901,PER,,US-ELI_LILLY_AND_COMPANY-US201706011831,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20200901.0,,CN,US,US,2020,Q3,Adult
137584335,13758433,47,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDONG SCALE)",,,,, C999324C,,,8.0,IU,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,5,F,20170613.0,20200825.0,20170717,20200901,PER,,US-ELI_LILLY_AND_COMPANY-US201706011831,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20200901.0,,CN,US,US,2020,Q3,Adult
137584335,13758433,47,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDONG SCALE)",,,,, C999324C,,,8.0,IU,INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,5,F,20170613.0,20200825.0,20170717,20200901,PER,,US-ELI_LILLY_AND_COMPANY-US201706011831,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20200901.0,,CN,US,US,2020,Q3,Adult
137584335,13758433,47,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDONG SCALE)",,,,, C999324C,,,8.0,IU,INJECTION,,2020,Q3,Product storage error,,2020,Q3,5,F,20170613.0,20200825.0,20170717,20200901,PER,,US-ELI_LILLY_AND_COMPANY-US201706011831,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20200901.0,,CN,US,US,2020,Q3,Adult
140172036,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,,,,,2020,Q3,Balance disorder,,2020,Q3,6,F,20170919.0,20200807.0,20170927,20200812,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20200812.0,,MD,US,US,2020,Q3,Elderly
140172036,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,,,,,2020,Q3,Bundle branch block right,,2020,Q3,6,F,20170919.0,20200807.0,20170927,20200812,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20200812.0,,MD,US,US,2020,Q3,Elderly
140172036,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,,,,,2020,Q3,Demyelination,,2020,Q3,6,F,20170919.0,20200807.0,20170927,20200812,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20200812.0,,MD,US,US,2020,Q3,Elderly
140172036,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,,,,,2020,Q3,Loss of consciousness,,2020,Q3,6,F,20170919.0,20200807.0,20170927,20200812,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20200812.0,,MD,US,US,2020,Q3,Elderly
140172036,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,,,,,2020,Q3,Lymphocyte count decreased,,2020,Q3,6,F,20170919.0,20200807.0,20170927,20200812,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20200812.0,,MD,US,US,2020,Q3,Elderly
140172036,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,,,,,2020,Q3,Malignant melanoma in situ,,2020,Q3,6,F,20170919.0,20200807.0,20170927,20200812,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20200812.0,,MD,US,US,2020,Q3,Elderly
140172036,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,,,,,2020,Q3,Syncope,,2020,Q3,6,F,20170919.0,20200807.0,20170927,20200812,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20200812.0,,MD,US,US,2020,Q3,Elderly
140172036,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,,,,,2020,Q3,White blood cell count decreased,,2020,Q3,6,F,20170919.0,20200807.0,20170927,20200812,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20200812.0,,MD,US,US,2020,Q3,Elderly
141648672,14164867,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,AS REQUIRED,,,,,,,,,,INJECTION,,2020,Q3,Gastric haemorrhage,,2020,Q3,2,F,20171104.0,20171212.0,20171107,20171220,EXP,,JP-ASTRAZENECA-2017SF12405,ASTRAZENECA,,25674.0,DY,,M,Y,,,20171220.0,,MD,JP,JP,2020,Q3,Elderly
141648672,14164867,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,AS REQUIRED,,,,,,,,,,INJECTION,,2020,Q3,Urethritis,,2020,Q3,2,F,20171104.0,20171212.0,20171107,20171220,EXP,,JP-ASTRAZENECA-2017SF12405,ASTRAZENECA,,25674.0,DY,,M,Y,,,20171220.0,,MD,JP,JP,2020,Q3,Elderly
147579493,14757949,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Cardiac failure,,2020,Q3,3,F,20131122.0,20200818.0,20180413,20200826,EXP,,US-ASTRAZENECA-2018SE44562,ASTRAZENECA,,23551.0,DY,,M,Y,111.8,KG,20200826.0,,,US,US,2020,Q3,Elderly
147579493,14757949,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Cardiac failure congestive,,2020,Q3,3,F,20131122.0,20200818.0,20180413,20200826,EXP,,US-ASTRAZENECA-2018SE44562,ASTRAZENECA,,23551.0,DY,,M,Y,111.8,KG,20200826.0,,,US,US,2020,Q3,Elderly
147579493,14757949,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Cardiovascular disorder,,2020,Q3,3,F,20131122.0,20200818.0,20180413,20200826,EXP,,US-ASTRAZENECA-2018SE44562,ASTRAZENECA,,23551.0,DY,,M,Y,111.8,KG,20200826.0,,,US,US,2020,Q3,Elderly
147579493,14757949,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Chronic left ventricular failure,,2020,Q3,3,F,20131122.0,20200818.0,20180413,20200826,EXP,,US-ASTRAZENECA-2018SE44562,ASTRAZENECA,,23551.0,DY,,M,Y,111.8,KG,20200826.0,,,US,US,2020,Q3,Elderly
147579493,14757949,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Myocardial infarction,,2020,Q3,3,F,20131122.0,20200818.0,20180413,20200826,EXP,,US-ASTRAZENECA-2018SE44562,ASTRAZENECA,,23551.0,DY,,M,Y,111.8,KG,20200826.0,,,US,US,2020,Q3,Elderly
148442205,14844220,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24?24?26 I.U. DAILY,,,D,,,,,1.0,DF,,TID,2020,Q3,Stevens-Johnson syndrome,,2020,Q3,5,F,20041111.0,20180906.0,20180503,20180919,EXP,,DE-BAUSCH-DSA_31515_2008,BAUSCH AND LOMB,,71.0,YR,,F,Y,,,20180919.0,,MD,DE,DE,2020,Q3,Elderly
148442205,14844220,22,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2020,Q3,Stevens-Johnson syndrome,,2020,Q3,5,F,20041111.0,20180906.0,20180503,20180919,EXP,,DE-BAUSCH-DSA_31515_2008,BAUSCH AND LOMB,,71.0,YR,,F,Y,,,20180919.0,,MD,DE,DE,2020,Q3,Elderly
148641284,14864128,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blister,,2020,Q3,4,F,20041104.0,20180906.0,20180508,20180914,EXP,DE-BFARM-08008921,DE-SA-200810558DE,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20180914.0,,CN,DE,DE,2020,Q3,Elderly
148641284,14864128,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Conjunctivitis,,2020,Q3,4,F,20041104.0,20180906.0,20180508,20180914,EXP,DE-BFARM-08008921,DE-SA-200810558DE,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20180914.0,,CN,DE,DE,2020,Q3,Elderly
148641284,14864128,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Lip erosion,,2020,Q3,4,F,20041104.0,20180906.0,20180508,20180914,EXP,DE-BFARM-08008921,DE-SA-200810558DE,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20180914.0,,CN,DE,DE,2020,Q3,Elderly
148641284,14864128,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Mouth ulceration,,2020,Q3,4,F,20041104.0,20180906.0,20180508,20180914,EXP,DE-BFARM-08008921,DE-SA-200810558DE,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20180914.0,,CN,DE,DE,2020,Q3,Elderly
148641284,14864128,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Nikolsky's sign,,2020,Q3,4,F,20041104.0,20180906.0,20180508,20180914,EXP,DE-BFARM-08008921,DE-SA-200810558DE,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20180914.0,,CN,DE,DE,2020,Q3,Elderly
148641284,14864128,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Ocular hyperaemia,,2020,Q3,4,F,20041104.0,20180906.0,20180508,20180914,EXP,DE-BFARM-08008921,DE-SA-200810558DE,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20180914.0,,CN,DE,DE,2020,Q3,Elderly
148641284,14864128,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Oral disorder,,2020,Q3,4,F,20041104.0,20180906.0,20180508,20180914,EXP,DE-BFARM-08008921,DE-SA-200810558DE,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20180914.0,,CN,DE,DE,2020,Q3,Elderly
148641284,14864128,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pruritus,,2020,Q3,4,F,20041104.0,20180906.0,20180508,20180914,EXP,DE-BFARM-08008921,DE-SA-200810558DE,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20180914.0,,CN,DE,DE,2020,Q3,Elderly
148641284,14864128,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Purpura,,2020,Q3,4,F,20041104.0,20180906.0,20180508,20180914,EXP,DE-BFARM-08008921,DE-SA-200810558DE,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20180914.0,,CN,DE,DE,2020,Q3,Elderly
148641284,14864128,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Skin reaction,,2020,Q3,4,F,20041104.0,20180906.0,20180508,20180914,EXP,DE-BFARM-08008921,DE-SA-200810558DE,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20180914.0,,CN,DE,DE,2020,Q3,Elderly
148641284,14864128,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Stevens-Johnson syndrome,,2020,Q3,4,F,20041104.0,20180906.0,20180508,20180914,EXP,DE-BFARM-08008921,DE-SA-200810558DE,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20180914.0,,CN,DE,DE,2020,Q3,Elderly
148641284,14864128,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Swollen tongue,,2020,Q3,4,F,20041104.0,20180906.0,20180508,20180914,EXP,DE-BFARM-08008921,DE-SA-200810558DE,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20180914.0,,CN,DE,DE,2020,Q3,Elderly
1489664942,14896649,60,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2020,Q3,Foetal disorder,,2020,Q3,42,F,20170804.0,20190905.0,20180515,20190918,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190918.0,,HP,FR,FR,2020,Q3,Child
1489664942,14896649,60,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2020,Q3,Low birth weight baby,,2020,Q3,42,F,20170804.0,20190905.0,20180515,20190918,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190918.0,,HP,FR,FR,2020,Q3,Child
1489664942,14896649,60,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2020,Q3,Maternal exposure during pregnancy,,2020,Q3,42,F,20170804.0,20190905.0,20180515,20190918,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190918.0,,HP,FR,FR,2020,Q3,Child
1489664942,14896649,60,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2020,Q3,Neutropenia neonatal,,2020,Q3,42,F,20170804.0,20190905.0,20180515,20190918,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190918.0,,HP,FR,FR,2020,Q3,Child
1489664942,14896649,60,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2020,Q3,Premature baby,,2020,Q3,42,F,20170804.0,20190905.0,20180515,20190918,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190918.0,,HP,FR,FR,2020,Q3,Child
1489664942,14896649,61,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2020,Q3,Foetal disorder,,2020,Q3,42,F,20170804.0,20190905.0,20180515,20190918,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190918.0,,HP,FR,FR,2020,Q3,Child
1489664942,14896649,61,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2020,Q3,Low birth weight baby,,2020,Q3,42,F,20170804.0,20190905.0,20180515,20190918,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190918.0,,HP,FR,FR,2020,Q3,Child
1489664942,14896649,61,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2020,Q3,Maternal exposure during pregnancy,,2020,Q3,42,F,20170804.0,20190905.0,20180515,20190918,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190918.0,,HP,FR,FR,2020,Q3,Child
1489664942,14896649,61,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2020,Q3,Neutropenia neonatal,,2020,Q3,42,F,20170804.0,20190905.0,20180515,20190918,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190918.0,,HP,FR,FR,2020,Q3,Child
1489664942,14896649,61,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2020,Q3,Premature baby,,2020,Q3,42,F,20170804.0,20190905.0,20180515,20190918,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190918.0,,HP,FR,FR,2020,Q3,Child
1508376210,15083762,39,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,21 UG/M2 DAILY;,,,U,,,,,21.0,UG/M**2,,QD,2020,Q3,Foetal disorder,,2020,Q3,10,F,20170914.0,20190227.0,20180628,20190820,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190820.0,,HP,FR,FR,2020,Q3,Child
1508376210,15083762,39,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,21 UG/M2 DAILY;,,,U,,,,,21.0,UG/M**2,,QD,2020,Q3,Foetal exposure during pregnancy,,2020,Q3,10,F,20170914.0,20190227.0,20180628,20190820,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190820.0,,HP,FR,FR,2020,Q3,Child
1508376210,15083762,39,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,21 UG/M2 DAILY;,,,U,,,,,21.0,UG/M**2,,QD,2020,Q3,Low birth weight baby,,2020,Q3,10,F,20170914.0,20190227.0,20180628,20190820,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190820.0,,HP,FR,FR,2020,Q3,Child
1508376210,15083762,39,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,21 UG/M2 DAILY;,,,U,,,,,21.0,UG/M**2,,QD,2020,Q3,Neutropenia neonatal,,2020,Q3,10,F,20170914.0,20190227.0,20180628,20190820,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190820.0,,HP,FR,FR,2020,Q3,Child
1508376210,15083762,39,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,21 UG/M2 DAILY;,,,U,,,,,21.0,UG/M**2,,QD,2020,Q3,Premature baby,,2020,Q3,10,F,20170914.0,20190227.0,20180628,20190820,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190820.0,,HP,FR,FR,2020,Q3,Child
1508376210,15083762,40,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 UG/M2 DAILY;,,,U,,,,,7.0,UG/M**2,,QD,2020,Q3,Foetal disorder,,2020,Q3,10,F,20170914.0,20190227.0,20180628,20190820,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190820.0,,HP,FR,FR,2020,Q3,Child
1508376210,15083762,40,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 UG/M2 DAILY;,,,U,,,,,7.0,UG/M**2,,QD,2020,Q3,Foetal exposure during pregnancy,,2020,Q3,10,F,20170914.0,20190227.0,20180628,20190820,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190820.0,,HP,FR,FR,2020,Q3,Child
1508376210,15083762,40,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 UG/M2 DAILY;,,,U,,,,,7.0,UG/M**2,,QD,2020,Q3,Low birth weight baby,,2020,Q3,10,F,20170914.0,20190227.0,20180628,20190820,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190820.0,,HP,FR,FR,2020,Q3,Child
1508376210,15083762,40,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 UG/M2 DAILY;,,,U,,,,,7.0,UG/M**2,,QD,2020,Q3,Neutropenia neonatal,,2020,Q3,10,F,20170914.0,20190227.0,20180628,20190820,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190820.0,,HP,FR,FR,2020,Q3,Child
1508376210,15083762,40,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 UG/M2 DAILY;,,,U,,,,,7.0,UG/M**2,,QD,2020,Q3,Premature baby,,2020,Q3,10,F,20170914.0,20190227.0,20180628,20190820,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190820.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,55,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,7.0,UG/M**2,,QD,2020,Q3,Foetal disorder,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,55,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,7.0,UG/M**2,,QD,2020,Q3,Foetal exposure during pregnancy,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,55,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,7.0,UG/M**2,,QD,2020,Q3,Low birth weight baby,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,55,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,7.0,UG/M**2,,QD,2020,Q3,Neutropenia neonatal,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,55,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,7.0,UG/M**2,,QD,2020,Q3,Premature baby,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,56,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,21.0,UG/M**2,,QD,2020,Q3,Foetal disorder,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,56,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,21.0,UG/M**2,,QD,2020,Q3,Foetal exposure during pregnancy,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,56,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,21.0,UG/M**2,,QD,2020,Q3,Low birth weight baby,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,56,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,21.0,UG/M**2,,QD,2020,Q3,Neutropenia neonatal,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,56,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,21.0,UG/M**2,,QD,2020,Q3,Premature baby,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,21.0,UG/M**2,,QD,2020,Q3,Foetal disorder,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,21.0,UG/M**2,,QD,2020,Q3,Foetal exposure during pregnancy,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,21.0,UG/M**2,,QD,2020,Q3,Low birth weight baby,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,21.0,UG/M**2,,QD,2020,Q3,Neutropenia neonatal,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,, UNK,,,21.0,UG/M**2,,QD,2020,Q3,Premature baby,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Acute kidney injury,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Adrenomegaly,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Chest pain,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Colitis,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Device related infection,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Heparin-induced thrombocytopenia,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Hyperglycaemia,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Hypertensive crisis,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Klebsiella infection,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Malignant neoplasm progression,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Meningitis,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Metastases to meninges,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Pulmonary oedema,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Retinal detachment,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Tachycardia,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
1549343217,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2020,Q3,Urosepsis,,2020,Q3,17,F,20180419.0,20200818.0,20181012,20200824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20200824.0,,HP,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Acute kidney injury,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Adrenomegaly,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Chest pain,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Colitis,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Device related infection,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Heparin-induced thrombocytopenia,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Hyperglycaemia,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Hypertensive crisis,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Klebsiella infection,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Malignant neoplasm progression,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Meningitis,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Metastases to meninges,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Pulmonary oedema,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Retinal detachment,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Retinopathy,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Tachycardia,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
156620016,15662001,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,D,,,,,300.0,DF,INJECTION,,2020,Q3,Urosepsis,,2020,Q3,6,F,20180419.0,20200717.0,20181127,20200720,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20200721.0,,PH,DE,DE,2020,Q3,Elderly
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Blood creatine phosphokinase increased,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Bronchitis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Bronchopulmonary aspergillosis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Cerumen impaction,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Chronic graft versus host disease,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Constipation,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Dermal cyst,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Duodenal ulcer,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Encephalitis viral,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Febrile neutropenia,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Hepatic enzyme increased,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Insomnia,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Neutropenia,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Papule,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Patella fracture,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Pulmonary artery thrombosis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Renal failure,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Sepsis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Stasis dermatitis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Substance-induced psychotic disorder,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,195,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Transplantation complication,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Blood creatine phosphokinase increased,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Bronchitis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Bronchopulmonary aspergillosis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Cerumen impaction,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Chronic graft versus host disease,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Constipation,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Dermal cyst,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Duodenal ulcer,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Encephalitis viral,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Febrile neutropenia,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Hepatic enzyme increased,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Insomnia,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Neutropenia,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Papule,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Patella fracture,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Pulmonary artery thrombosis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Renal failure,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Sepsis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Stasis dermatitis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Substance-induced psychotic disorder,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,196,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Transplantation complication,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
160438003,16043800,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Chronic kidney disease,,2020,Q3,3,F,2006.0,20200727.0,20190306,20200731,EXP,,US-ASTRAZENECA-2019SE35954,ASTRAZENECA,,68.0,YR,,F,Y,108.9,KG,20200731.0,,,US,US,2020,Q3,Elderly
160438003,16043800,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,3,F,2006.0,20200727.0,20190306,20200731,EXP,,US-ASTRAZENECA-2019SE35954,ASTRAZENECA,,68.0,YR,,F,Y,108.9,KG,20200731.0,,,US,US,2020,Q3,Elderly
160438003,16043800,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,End stage renal disease,,2020,Q3,3,F,2006.0,20200727.0,20190306,20200731,EXP,,US-ASTRAZENECA-2019SE35954,ASTRAZENECA,,68.0,YR,,F,Y,108.9,KG,20200731.0,,,US,US,2020,Q3,Elderly
160564473,16056447,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2020,Q3,Pyrexia,,2020,Q3,3,F,20190301.0,20190325.0,20190311,20190327,EXP,,US-ROCHE-2276777,ROCHE,,80.0,YR,,F,Y,56.2,KG,20190327.0,,MD,US,US,2020,Q3,Elderly
161172074,16117207,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q3,Drug hypersensitivity,,2020,Q3,4,F,20190317.0,20200817.0,20190326,20200827,PER,,US-ELI_LILLY_AND_COMPANY-US201903010619,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20200827.0,,CN,US,US,2020,Q3,Elderly
161172074,16117207,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q3,Incorrect dose administered,,2020,Q3,4,F,20190317.0,20200817.0,20190326,20200827,PER,,US-ELI_LILLY_AND_COMPANY-US201903010619,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20200827.0,,CN,US,US,2020,Q3,Elderly
161172074,16117207,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q3,Product storage error,,2020,Q3,4,F,20190317.0,20200817.0,20190326,20200827,PER,,US-ELI_LILLY_AND_COMPANY-US201903010619,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20200827.0,,CN,US,US,2020,Q3,Elderly
161172074,16117207,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q3,Wrong patient received product,,2020,Q3,4,F,20190317.0,20200817.0,20190326,20200827,PER,,US-ELI_LILLY_AND_COMPANY-US201903010619,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20200827.0,,CN,US,US,2020,Q3,Elderly
161607624,16160762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,0?5 UNITS AND MILD CORRECTIVE SCALE,,,,,,,,,,,,2020,Q3,Pneumonia aspiration,,2020,Q3,4,F,20190323.0,20200825.0,20190405,20200828,EXP,,US-ROCHE-2292788,ROCHE,,68.0,YR,,M,Y,82.17,KG,20200828.0,,MD,US,US,2020,Q3,Elderly
161607624,16160762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,0?5 UNITS AND MILD CORRECTIVE SCALE,,,,,,,,,,,,2020,Q3,Pneumonia cytomegaloviral,,2020,Q3,4,F,20190323.0,20200825.0,20190405,20200828,EXP,,US-ROCHE-2292788,ROCHE,,68.0,YR,,M,Y,82.17,KG,20200828.0,,MD,US,US,2020,Q3,Elderly
161607624,16160762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,0?5 UNITS AND MILD CORRECTIVE SCALE,,,,,,,,,,,,2020,Q3,Pneumonia pseudomonal,,2020,Q3,4,F,20190323.0,20200825.0,20190405,20200828,EXP,,US-ROCHE-2292788,ROCHE,,68.0,YR,,M,Y,82.17,KG,20200828.0,,MD,US,US,2020,Q3,Elderly
161607624,16160762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,0?5 UNITS AND MILD CORRECTIVE SCALE,,,,,,,,,,,,2020,Q3,Respiratory tract infection,,2020,Q3,4,F,20190323.0,20200825.0,20190405,20200828,EXP,,US-ROCHE-2292788,ROCHE,,68.0,YR,,M,Y,82.17,KG,20200828.0,,MD,US,US,2020,Q3,Elderly
161997669,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Cutaneous sarcoidosis,,2020,Q3,9,F,20190404.0,20200921.0,20190415,20200928,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200928.0,,HP,BR,BR,2020,Q3,Elderly
161997669,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Epiglottic oedema,,2020,Q3,9,F,20190404.0,20200921.0,20190415,20200928,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200928.0,,HP,BR,BR,2020,Q3,Elderly
161997669,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Sarcoidosis,,2020,Q3,9,F,20190404.0,20200921.0,20190415,20200928,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200928.0,,HP,BR,BR,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Acute kidney injury,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Adrenomegaly,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Chest pain,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Colitis,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Device related infection,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Heparin-induced thrombocytopenia,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Hyperglycaemia,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Hypertensive crisis,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Klebsiella infection,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Malignant neoplasm progression,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Meningitis,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Metastases to meninges,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Pulmonary oedema,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Retinal detachment,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Retinopathy,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Tachycardia,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162405147,16240514,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2020,Q3,Urosepsis,,2020,Q3,7,F,20180419.0,20200720.0,20190425,20200724,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20200724.0,,PH,DE,DE,2020,Q3,Elderly
162543568,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Arrhythmia,,2020,Q3,8,F,20190415.0,20200715.0,20190430,20200720,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200720.0,,MD,JP,JP,2020,Q3,Adult
162543568,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Ascites,,2020,Q3,8,F,20190415.0,20200715.0,20190430,20200720,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200720.0,,MD,JP,JP,2020,Q3,Adult
162543568,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Cardio-respiratory arrest,,2020,Q3,8,F,20190415.0,20200715.0,20190430,20200720,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200720.0,,MD,JP,JP,2020,Q3,Adult
162543568,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,8,F,20190415.0,20200715.0,20190430,20200720,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200720.0,,MD,JP,JP,2020,Q3,Adult
162543568,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Fall,,2020,Q3,8,F,20190415.0,20200715.0,20190430,20200720,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200720.0,,MD,JP,JP,2020,Q3,Adult
162543568,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Oedema,,2020,Q3,8,F,20190415.0,20200715.0,20190430,20200720,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200720.0,,MD,JP,JP,2020,Q3,Adult
162543568,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pulmonary arterial hypertension,,2020,Q3,8,F,20190415.0,20200715.0,20190430,20200720,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200720.0,,MD,JP,JP,2020,Q3,Adult
162543568,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pulmonary arterial pressure increased,,2020,Q3,8,F,20190415.0,20200715.0,20190430,20200720,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20200720.0,,MD,JP,JP,2020,Q3,Adult
167079114,16707911,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2020,Q3,Cytokine release syndrome,,2020,Q3,4,F,20190723.0,20200921.0,20190815,20200922,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20200922.0,,MD,US,US,2020,Q3,Elderly
167079114,16707911,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,4,F,20190723.0,20200921.0,20190815,20200922,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20200922.0,,MD,US,US,2020,Q3,Elderly
167079114,16707911,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,4,F,20190723.0,20200921.0,20190815,20200922,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20200922.0,,MD,US,US,2020,Q3,Elderly
167079114,16707911,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,4,F,20190723.0,20200921.0,20190815,20200922,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20200922.0,,MD,US,US,2020,Q3,Elderly
167079114,16707911,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,4,F,20190723.0,20200921.0,20190815,20200922,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20200922.0,,MD,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Abdominal discomfort,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Acute sinusitis,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Arthralgia,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Arthropathy,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Back pain,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Blood alkaline phosphatase increased,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Blood calcium increased,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Blood glucose increased,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Blood parathyroid hormone increased,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Bone pain,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Constipation,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Crying,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Decreased appetite,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Depression,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dyspnoea exertional,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Ear discomfort,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Ear infection,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Emotional disorder,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Fall,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Fatigue,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Gait disturbance,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Gastrooesophageal reflux disease,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Headache,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypoacusis,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypomagnesaemia,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypothyroidism,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Influenza,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Influenza A virus test positive,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Intervertebral disc protrusion,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Malaise,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Muscular weakness,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Nasopharyngitis,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Neck pain,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Oxygen consumption increased,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pain,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pain in extremity,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pain in jaw,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Peripheral swelling,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pruritus,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Seizure,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Sinusitis,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Swelling,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Tachycardia,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Unevaluable event,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Urinary incontinence,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Weight decreased,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
1671749024,16717490,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,24,F,201906.0,20200709.0,20190819,20200723,EXP,,US-ACTELION-A-NJ2019-192312,ACTELION,,72.0,YR,,F,Y,62.59,KG,20200723.0,,PH,US,US,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Asthma,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Blood count abnormal,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Chest discomfort,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Cough,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Diaphragmatic disorder,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Discomfort,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Dyspnoea,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Hypoxia,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Left ventricular hypertrophy,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Obstructive airways disorder,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Oedema peripheral,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Oropharyngeal pain,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Pyrexia,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Weight increased,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169116752,16911675,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,U,,,,,,,,BID,2020,Q3,Wheezing,,2020,Q3,2,F,,20200703.0,20191013,20200713,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20200714.0,,CN,CA,CA,2020,Q3,Elderly
169222132,16922213,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0?18U,,,,,,,,,,,QID,2020,Q3,Diabetic ketoacidosis,,2020,Q3,2,F,,20200730.0,20191015,20200807,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-106991",BOEHRINGER INGELHEIM,"MAYES C, SEXE J, TOFTS P. EUGLYCEMIC DIABETIC KETOACIDOSIS IN A LUNG CANCER PATIENT USING EMPAGLIFLOZIN. CASE REPORTS IN CRITICAL CARE. 2020?.",58.0,YR,,M,Y,,,20200807.0,,HP,US,US,2020,Q3,Adult
169222132,16922213,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0?18U,,,,,,,,,,,QID,2020,Q3,Hypovolaemic shock,,2020,Q3,2,F,,20200730.0,20191015,20200807,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-106991",BOEHRINGER INGELHEIM,"MAYES C, SEXE J, TOFTS P. EUGLYCEMIC DIABETIC KETOACIDOSIS IN A LUNG CANCER PATIENT USING EMPAGLIFLOZIN. CASE REPORTS IN CRITICAL CARE. 2020?.",58.0,YR,,M,Y,,,20200807.0,,HP,US,US,2020,Q3,Adult
169222132,16922213,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0?18U,,,,,,,,,,,QID,2020,Q3,Pancytopenia,,2020,Q3,2,F,,20200730.0,20191015,20200807,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-106991",BOEHRINGER INGELHEIM,"MAYES C, SEXE J, TOFTS P. EUGLYCEMIC DIABETIC KETOACIDOSIS IN A LUNG CANCER PATIENT USING EMPAGLIFLOZIN. CASE REPORTS IN CRITICAL CARE. 2020?.",58.0,YR,,M,Y,,,20200807.0,,HP,US,US,2020,Q3,Adult
169222132,16922213,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0?18U,,,,,,,,,,,QID,2020,Q3,Staphylococcal infection,,2020,Q3,2,F,,20200730.0,20191015,20200807,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-106991",BOEHRINGER INGELHEIM,"MAYES C, SEXE J, TOFTS P. EUGLYCEMIC DIABETIC KETOACIDOSIS IN A LUNG CANCER PATIENT USING EMPAGLIFLOZIN. CASE REPORTS IN CRITICAL CARE. 2020?.",58.0,YR,,M,Y,,,20200807.0,,HP,US,US,2020,Q3,Adult
169324972,16932497,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Leukopenia,,2020,Q3,2,F,20190723.0,20200917.0,20191017,20200921,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20200921.0,,MD,PL,PL,2020,Q3,Adult
169324972,16932497,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,2,F,20190723.0,20200917.0,20191017,20200921,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20200921.0,,MD,PL,PL,2020,Q3,Adult
169385035,16938503,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,5,F,20190903.0,20200814.0,20191019,20200817,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200817.0,,HP,US,US,2020,Q3,Adult
169385035,16938503,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,5,F,20190903.0,20200814.0,20191019,20200817,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200817.0,,HP,US,US,2020,Q3,Adult
169385035,16938503,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,5,F,20190903.0,20200814.0,20191019,20200817,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200817.0,,HP,US,US,2020,Q3,Adult
169385035,16938503,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,5,F,20190903.0,20200814.0,20191019,20200817,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200817.0,,HP,US,US,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Abdominal pain,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Abscess,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Adrenal insufficiency,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Alanine aminotransferase increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Ascites,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Asthenia,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Blood alkaline phosphatase increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Blood bilirubin increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Blood potassium decreased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Blood pressure diastolic abnormal,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Blood pressure increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Congestive hepatopathy,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Depression,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Diverticulitis,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Endometrial disorder,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Enterococcus test positive,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Fibrosis,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Gamma-glutamyltransferase increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Gastrointestinal disorder,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Generalised oedema,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Heart rate increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Herpes zoster,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Hypersensitivity,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Hypoglycaemia,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Hypotension,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Increased appetite,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Influenza,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Infusion related reaction,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Injection site extravasation,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Intensive care unit acquired weakness,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Intervertebral disc protrusion,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Joint effusion,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Joint swelling,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Micturition disorder,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Myelopathy,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Myopathy,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Nasopharyngitis,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Nausea,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Nerve compression,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Neuropathy peripheral,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Neutropenia,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Osteoarthritis,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Pancytopenia,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Peripheral sensorimotor neuropathy,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Peritonitis,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Pneumonia,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Pseudomonal bacteraemia,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Rheumatoid arthritis,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Septic shock,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Therapeutic response decreased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Vomiting,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Weight decreased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2020,Q3,Weight increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Abscess,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Adrenal insufficiency,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Ascites,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Blood alkaline phosphatase increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Blood bilirubin increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Blood potassium decreased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Blood pressure diastolic abnormal,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Blood pressure increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Congestive hepatopathy,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Depression,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Diverticulitis,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Endometrial disorder,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Enterococcus test positive,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Fibrosis,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Gamma-glutamyltransferase increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Gastrointestinal disorder,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Generalised oedema,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Heart rate increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Herpes zoster,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Hypersensitivity,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Increased appetite,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Influenza,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Infusion related reaction,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Injection site extravasation,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Intensive care unit acquired weakness,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Intervertebral disc protrusion,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Joint effusion,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Joint swelling,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Micturition disorder,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Myelopathy,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Myopathy,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Nasopharyngitis,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Nerve compression,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Neuropathy peripheral,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Osteoarthritis,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Pancytopenia,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Peripheral sensorimotor neuropathy,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Peritonitis,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Pseudomonal bacteraemia,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Rheumatoid arthritis,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Therapeutic response decreased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Weight decreased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
170382833,17038283,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,3,F,,20200707.0,20191115,20200717,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20200717.0,,HP,CA,CA,2020,Q3,Adult
173477812,17347781,34,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,.6 IU (INTERNATIONAL UNIT),,,,,,,,0.6,IU,UNKNOWN,TID,2020,Q3,Hypoxia,,2020,Q3,2,F,20200101.0,20200821.0,20200130,20200831,PER,,US-CELGENEUS-USA-20200109441,CELGENE,,73.0,YR,,F,Y,100.0,KG,20200831.0,,MD,US,US,2020,Q3,Elderly
173477812,17347781,34,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,.6 IU (INTERNATIONAL UNIT),,,,,,,,0.6,IU,UNKNOWN,TID,2020,Q3,Influenza,,2020,Q3,2,F,20200101.0,20200821.0,20200130,20200831,PER,,US-CELGENEUS-USA-20200109441,CELGENE,,73.0,YR,,F,Y,100.0,KG,20200831.0,,MD,US,US,2020,Q3,Elderly
173477812,17347781,34,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,.6 IU (INTERNATIONAL UNIT),,,,,,,,0.6,IU,UNKNOWN,TID,2020,Q3,Pneumonia,,2020,Q3,2,F,20200101.0,20200821.0,20200130,20200831,PER,,US-CELGENEUS-USA-20200109441,CELGENE,,73.0,YR,,F,Y,100.0,KG,20200831.0,,MD,US,US,2020,Q3,Elderly
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Abdominal discomfort,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Anaemia,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Diverticulum,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dizziness,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dyspnoea exertional,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Faeces discoloured,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Flushing,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Gastric ulcer haemorrhage,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Haematocrit decreased,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Haemoglobin decreased,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Headache,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Myalgia,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Nasopharyngitis,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Oxygen saturation decreased,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pain,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Paraesthesia,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Paraesthesia oral,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pulmonary arterial hypertension,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Tachycardia,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
173551897,17355189,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Weight decreased,,2020,Q3,7,F,20191119.0,20200724.0,20200131,20200806,EXP,,US-ACTELION-A-NJ2019-199090,ACTELION,,59.0,YR,,F,Y,99.32,KG,20200806.0,,HP,US,US,2020,Q3,Adult
174008455,17400845,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2020,Q3,Ear haemorrhage,,2020,Q3,5,F,2020.0,20200727.0,20200211,20200803,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20200803.0,,HP,US,US,2020,Q3,Elderly
174008455,17400845,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2020,Q3,Off label use,,2020,Q3,5,F,2020.0,20200727.0,20200211,20200803,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20200803.0,,HP,US,US,2020,Q3,Elderly
174064013,17406401,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2020,Q3,Injury associated with device,,2020,Q3,3,F,20200220.0,20200812.0,20200212,20200818,PER,,US-ELI_LILLY_AND_COMPANY-US202002004755,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20200818.0,,CN,US,US,2020,Q3,Elderly
174064013,17406401,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2020,Q3,Tremor,,2020,Q3,3,F,20200220.0,20200812.0,20200212,20200818,PER,,US-ELI_LILLY_AND_COMPANY-US202002004755,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20200818.0,,CN,US,US,2020,Q3,Elderly
174064013,17406401,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2020,Q3,Visual impairment,,2020,Q3,3,F,20200220.0,20200812.0,20200212,20200818,PER,,US-ELI_LILLY_AND_COMPANY-US202002004755,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20200818.0,,CN,US,US,2020,Q3,Elderly
174689233,17468923,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID WITH MEALS",,,,,,,,,,,TID,2020,Q3,Condition aggravated,,2020,Q3,3,F,20180716.0,20200701.0,20200227,20200713,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200713.0,,HP,US,US,2020,Q3,Adult
174689233,17468923,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID WITH MEALS",,,,,,,,,,,TID,2020,Q3,Diabetes mellitus,,2020,Q3,3,F,20180716.0,20200701.0,20200227,20200713,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200713.0,,HP,US,US,2020,Q3,Adult
174689233,17468923,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID WITH MEALS",,,,,,,,,,,TID,2020,Q3,Drug ineffective for unapproved indication,,2020,Q3,3,F,20180716.0,20200701.0,20200227,20200713,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200713.0,,HP,US,US,2020,Q3,Adult
174689233,17468923,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID WITH MEALS",,,,,,,,,,,TID,2020,Q3,Hypertriglyceridaemia,,2020,Q3,3,F,20180716.0,20200701.0,20200227,20200713,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200713.0,,HP,US,US,2020,Q3,Adult
174689233,17468923,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID WITH MEALS",,,,,,,,,,,TID,2020,Q3,Insulin resistance,,2020,Q3,3,F,20180716.0,20200701.0,20200227,20200713,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200713.0,,HP,US,US,2020,Q3,Adult
174689233,17468923,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID WITH MEALS",,,,,,,,,,,TID,2020,Q3,Off label use,,2020,Q3,3,F,20180716.0,20200701.0,20200227,20200713,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200713.0,,HP,US,US,2020,Q3,Adult
174689233,17468923,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"85 IU, BID",,,,,,,,85.0,IU,,BID,2020,Q3,Condition aggravated,,2020,Q3,3,F,20180716.0,20200701.0,20200227,20200713,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200713.0,,HP,US,US,2020,Q3,Adult
174689233,17468923,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"85 IU, BID",,,,,,,,85.0,IU,,BID,2020,Q3,Diabetes mellitus,,2020,Q3,3,F,20180716.0,20200701.0,20200227,20200713,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200713.0,,HP,US,US,2020,Q3,Adult
174689233,17468923,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"85 IU, BID",,,,,,,,85.0,IU,,BID,2020,Q3,Drug ineffective for unapproved indication,,2020,Q3,3,F,20180716.0,20200701.0,20200227,20200713,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200713.0,,HP,US,US,2020,Q3,Adult
174689233,17468923,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"85 IU, BID",,,,,,,,85.0,IU,,BID,2020,Q3,Hypertriglyceridaemia,,2020,Q3,3,F,20180716.0,20200701.0,20200227,20200713,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200713.0,,HP,US,US,2020,Q3,Adult
174689233,17468923,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"85 IU, BID",,,,,,,,85.0,IU,,BID,2020,Q3,Insulin resistance,,2020,Q3,3,F,20180716.0,20200701.0,20200227,20200713,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200713.0,,HP,US,US,2020,Q3,Adult
174689233,17468923,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"85 IU, BID",,,,,,,,85.0,IU,,BID,2020,Q3,Off label use,,2020,Q3,3,F,20180716.0,20200701.0,20200227,20200713,EXP,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004561",AEGERION,,54.0,YR,,M,Y,,,20200713.0,,HP,US,US,2020,Q3,Adult
175032581,17503258,18,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200228.0,20200305,20200305,EXP,,CA-CELGENEUS-CAN-20200210711,CELGENE,,72.0,YR,,F,Y,,,20200305.0,,HP,CA,CA,2020,Q3,Elderly
175032581,17503258,18,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200228.0,20200305,20200305,EXP,,CA-CELGENEUS-CAN-20200210711,CELGENE,,72.0,YR,,F,Y,,,20200305.0,,HP,CA,CA,2020,Q3,Elderly
175032581,17503258,18,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200228.0,20200305,20200305,EXP,,CA-CELGENEUS-CAN-20200210711,CELGENE,,72.0,YR,,F,Y,,,20200305.0,,HP,CA,CA,2020,Q3,Elderly
175032581,17503258,18,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Small intestinal obstruction,,2020,Q3,1,I,,20200228.0,20200305,20200305,EXP,,CA-CELGENEUS-CAN-20200210711,CELGENE,,72.0,YR,,F,Y,,,20200305.0,,HP,CA,CA,2020,Q3,Elderly
175032581,17503258,18,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Urinary tract obstruction,,2020,Q3,1,I,,20200228.0,20200305,20200305,EXP,,CA-CELGENEUS-CAN-20200210711,CELGENE,,72.0,YR,,F,Y,,,20200305.0,,HP,CA,CA,2020,Q3,Elderly
176017552,17601755,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U,,,20563.0,8.0,IU,INJECTION,,2020,Q3,Blood glucose decreased,,2020,Q3,2,F,202002.0,20200708.0,20200331,20200720,EXP,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200720.0,,CN,US,US,2020,Q3,Elderly
176017552,17601755,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U,,,20563.0,8.0,IU,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,202002.0,20200708.0,20200331,20200720,EXP,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200720.0,,CN,US,US,2020,Q3,Elderly
176017552,17601755,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U,,,20563.0,8.0,IU,INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,2,F,202002.0,20200708.0,20200331,20200720,EXP,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200720.0,,CN,US,US,2020,Q3,Elderly
176017552,17601755,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U,,,20563.0,8.0,IU,INJECTION,,2020,Q3,Primary biliary cholangitis,,2020,Q3,2,F,202002.0,20200708.0,20200331,20200720,EXP,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200720.0,,CN,US,US,2020,Q3,Elderly
176017552,17601755,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U,,,20563.0,8.0,IU,INJECTION,,2020,Q3,Wrong product administered,,2020,Q3,2,F,202002.0,20200708.0,20200331,20200720,EXP,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200720.0,,CN,US,US,2020,Q3,Elderly
176017552,17601755,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U, C939454C,,20563.0,8.0,IU,INJECTION,,2020,Q3,Blood glucose decreased,,2020,Q3,2,F,202002.0,20200708.0,20200331,20200720,EXP,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200720.0,,CN,US,US,2020,Q3,Elderly
176017552,17601755,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U, C939454C,,20563.0,8.0,IU,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,202002.0,20200708.0,20200331,20200720,EXP,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200720.0,,CN,US,US,2020,Q3,Elderly
176017552,17601755,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U, C939454C,,20563.0,8.0,IU,INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,2,F,202002.0,20200708.0,20200331,20200720,EXP,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200720.0,,CN,US,US,2020,Q3,Elderly
176017552,17601755,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U, C939454C,,20563.0,8.0,IU,INJECTION,,2020,Q3,Primary biliary cholangitis,,2020,Q3,2,F,202002.0,20200708.0,20200331,20200720,EXP,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200720.0,,CN,US,US,2020,Q3,Elderly
176017552,17601755,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN",,,Y,U, C939454C,,20563.0,8.0,IU,INJECTION,,2020,Q3,Wrong product administered,,2020,Q3,2,F,202002.0,20200708.0,20200331,20200720,EXP,,US-ELI_LILLY_AND_COMPANY-US202003007422,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200720.0,,CN,US,US,2020,Q3,Elderly
176318203,17631820,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, TID MEALS; DAILY BEDTIME",,,,,,,,8.0,IU,,TID,2020,Q3,Death,,2020,Q3,3,F,20200319.0,20200702.0,20200406,20200710,EXP,,US-GILEAD-2020-0455596,GILEAD,,64.0,YR,,M,Y,75.28,KG,20200710.0,,HP,US,US,2020,Q3,Adult
176327844,17632784,9,C,"INSULIN LISPRO, HUMAN",,2,,UNK,,,,,,,,,,,,2020,Q3,Alopecia,,2020,Q3,4,F,20170301.0,20200710.0,20200406,20200713,PER,,US-PFIZER INC-2020142094,PFIZER,,63.0,YR,,F,Y,,,20200713.0,,LW,US,US,2020,Q3,Adult
176327844,17632784,9,C,"INSULIN LISPRO, HUMAN",,2,,UNK,,,,,,,,,,,,2020,Q3,Hair colour changes,,2020,Q3,4,F,20170301.0,20200710.0,20200406,20200713,PER,,US-PFIZER INC-2020142094,PFIZER,,63.0,YR,,F,Y,,,20200713.0,,LW,US,US,2020,Q3,Adult
176327844,17632784,9,C,"INSULIN LISPRO, HUMAN",,2,,UNK,,,,,,,,,,,,2020,Q3,Hair disorder,,2020,Q3,4,F,20170301.0,20200710.0,20200406,20200713,PER,,US-PFIZER INC-2020142094,PFIZER,,63.0,YR,,F,Y,,,20200713.0,,LW,US,US,2020,Q3,Adult
176327844,17632784,9,C,"INSULIN LISPRO, HUMAN",,2,,UNK,,,,,,,,,,,,2020,Q3,Hair texture abnormal,,2020,Q3,4,F,20170301.0,20200710.0,20200406,20200713,PER,,US-PFIZER INC-2020142094,PFIZER,,63.0,YR,,F,Y,,,20200713.0,,LW,US,US,2020,Q3,Adult
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Asthma,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Blood count abnormal,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Chest discomfort,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Cough,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Diaphragmatic disorder,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Discomfort,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Dyspnoea,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Hypoxia,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Left ventricular hypertrophy,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Obstructive airways disorder,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Oedema peripheral,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Oropharyngeal pain,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Pyrexia,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Weight increased,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176396232,17639623,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 2X/DAY",,,,,,,,,,,BID,2020,Q3,Wheezing,,2020,Q3,2,F,,20200812.0,20200407,20200825,EXP,,CA-COVIS PHARMA B.V.-2020COV00143,COVIS,,83.0,YR,,M,Y,100.0,KG,20200824.0,,CN,CA,CA,2020,Q3,Elderly
176843902,17684390,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID (1?8 UNITS)",,,,,,,,,,,TID,2020,Q3,Metastases to spine,,2020,Q3,2,F,201605.0,20200730.0,20200420,20200810,EXP,,US-MYLANLABS-2020M1038563,MYLAN,,76.0,YR,,M,Y,,,20200810.0,,CN,US,US,2020,Q3,Elderly
176843902,17684390,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID (1?8 UNITS)",,,,,,,,,,,TID,2020,Q3,Renal cancer metastatic,,2020,Q3,2,F,201605.0,20200730.0,20200420,20200810,EXP,,US-MYLANLABS-2020M1038563,MYLAN,,76.0,YR,,M,Y,,,20200810.0,,CN,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Alanine aminotransferase increased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Aortic valve incompetence,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Asthenia,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Cardiac index decreased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Decreased appetite,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Dysarthria,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Fall,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Femur fracture,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Haematoma,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Haemoglobin decreased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Hypersomnia,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Hypotension,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Klebsiella test positive,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Lethargy,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Liver function test increased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Muscle strain,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Pain in extremity,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Peripheral swelling,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Renal disorder,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Retroperitoneal haemorrhage,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Skin laceration,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Therapy non-responder,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Urinary retention,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Urinary tract infection,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Urosepsis,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,Weight decreased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,,,,TID,2020,Q3,White blood cell count increased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177002132,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q3,Aphonia,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q3,Blood glucose decreased,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q3,Blood glucose increased,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q3,Dizziness,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q3,Drug ineffective,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q3,Frequent bowel movements,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q3,Gastrooesophageal reflux disease,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q3,Insomnia,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2020,Q3,Insulin resistance,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q3,Aphonia,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q3,Blood glucose decreased,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q3,Dizziness,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q3,Drug ineffective,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q3,Frequent bowel movements,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q3,Gastrooesophageal reflux disease,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q3,Insomnia,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2020,Q3,Insulin resistance,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177262063,17726206,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Aphasia,,2020,Q3,3,F,20200421.0,20200508.0,20200429,20200512,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033677,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,58.1,KG,20200512.0,,HP,US,US,2020,Q3,Adult
177262063,17726206,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Death,,2020,Q3,3,F,20200421.0,20200508.0,20200429,20200512,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033677,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,58.1,KG,20200512.0,,HP,US,US,2020,Q3,Adult
177262063,17726206,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,3,F,20200421.0,20200508.0,20200429,20200512,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033677,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,58.1,KG,20200512.0,,HP,US,US,2020,Q3,Adult
177262063,17726206,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Failure to thrive,,2020,Q3,3,F,20200421.0,20200508.0,20200429,20200512,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033677,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,58.1,KG,20200512.0,,HP,US,US,2020,Q3,Adult
177262063,17726206,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Small intestinal obstruction,,2020,Q3,3,F,20200421.0,20200508.0,20200429,20200512,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033677,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,58.1,KG,20200512.0,,HP,US,US,2020,Q3,Adult
178037753,17803775,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Abscess drainage,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178037753,17803775,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Appendicitis,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178037753,17803775,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178037753,17803775,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Gastric polyps,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178037753,17803775,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178037753,17803775,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Iron deficiency anaemia,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178037753,17803775,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,3,F,20190417.0,20200804.0,20200519,20200813,EXP,,SE-ACTELION-A-CH2019-191286,ACTELION,,73.0,YR,,M,Y,103.0,KG,20200813.0,,MD,SE,SE,2020,Q3,Elderly
178571032,17857103,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?10 UNITS PRN,,,,,,,,,,,,2020,Q3,Acidosis,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?10 UNITS PRN,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?10 UNITS PRN,,,,,,,,,,,,2020,Q3,COVID-19,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?10 UNITS PRN,,,,,,,,,,,,2020,Q3,Hypokalaemia,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?10 UNITS PRN,,,,,,,,,,,,2020,Q3,Hypomagnesaemia,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?10 UNITS PRN,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?10 UNITS PRN,,,,,,,,,,,,2020,Q3,Paralysis,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acidosis,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,COVID-19,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hypokalaemia,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hypomagnesaemia,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Paralysis,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178634132,17863413,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE MEALS,,,U,, UNKNOWN,,,5.0,IU,,Q8H,2020,Q3,Feeling abnormal,,2020,Q3,2,F,,20200901.0,20200605,20200915,PER,,US-DRREDDYS-USA/USA/20/0123649,DR REDDYS,"PATEL K, STUMMER L, PATEL K. STIFF?PERSON SYNDROME IN A PATIENT WITH COMORBID BIPOLAR AND PANIC DISORDERS: A CASE REPORT AND LITERATURE REVIEW. MENT HEALTH CLIN. 2020?10(3):95?99. DOI: 10.9740/MHC.2020.05.095.",58.0,YR,A,F,Y,,,20200915.0,,PH,US,US,2020,Q3,Adult
178634132,17863413,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE MEALS,,,U,, UNKNOWN,,,5.0,IU,,Q8H,2020,Q3,Sedation,,2020,Q3,2,F,,20200901.0,20200605,20200915,PER,,US-DRREDDYS-USA/USA/20/0123649,DR REDDYS,"PATEL K, STUMMER L, PATEL K. STIFF?PERSON SYNDROME IN A PATIENT WITH COMORBID BIPOLAR AND PANIC DISORDERS: A CASE REPORT AND LITERATURE REVIEW. MENT HEALTH CLIN. 2020?10(3):95?99. DOI: 10.9740/MHC.2020.05.095.",58.0,YR,A,F,Y,,,20200915.0,,PH,US,US,2020,Q3,Adult
178679982,17867998,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,2,F,20200522.0,20200707.0,20200605,20200710,EXP,,US-GILEAD-2020-0469207,GILEAD,,69.0,YR,E,M,Y,65.0,KG,20200710.0,,PH,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Anaemia,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Dizziness,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Dyspnoea,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Fluid overload,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Haematocrit decreased,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Haemoglobin decreased,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Hypotension,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Incorrect dose administered,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Internal haemorrhage,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Mineral supplementation,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Muscle spasms,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Pain in extremity,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Red blood cell count decreased,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID BEFORE MEALS",,,,,,,,,,,TID,2020,Q3,Transfusion,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178782652,17878265,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,20200514.0,20200715.0,20200609,20200717,EXP,,US-GILEAD-2020-0470883,GILEAD,,70.0,YR,E,M,Y,95.5,KG,20200717.0,,PH,US,US,2020,Q3,Elderly
178782652,17878265,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,COVID-19 pneumonia,,2020,Q3,2,F,20200514.0,20200715.0,20200609,20200717,EXP,,US-GILEAD-2020-0470883,GILEAD,,70.0,YR,E,M,Y,95.5,KG,20200717.0,,PH,US,US,2020,Q3,Elderly
178782652,17878265,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Respiratory failure,,2020,Q3,2,F,20200514.0,20200715.0,20200609,20200717,EXP,,US-GILEAD-2020-0470883,GILEAD,,70.0,YR,E,M,Y,95.5,KG,20200717.0,,PH,US,US,2020,Q3,Elderly
178812264,17881226,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,4,F,20200527.0,20200728.0,20200610,20200731,EXP,,US-GILEAD-2020-0470048,GILEAD,,69.0,YR,E,M,Y,,,20200731.0,,HP,US,US,2020,Q3,Elderly
178826672,17882667,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,2,F,20200528.0,20200629.0,20200610,20200702,EXP,,US-GILEAD-2020-0470043,GILEAD,,63.0,YR,A,F,Y,155.9,KG,20200702.0,,HP,US,US,2020,Q3,Adult
178876323,17887632,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Drug-induced liver injury,,2020,Q3,3,F,20200601.0,20200629.0,20200611,20200702,EXP,,US-GILEAD-2020-0470690,GILEAD,,50.0,YR,A,F,Y,72.0,KG,20200702.0,,HP,US,US,2020,Q3,Adult
178876323,17887632,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Ischaemic hepatitis,,2020,Q3,3,F,20200601.0,20200629.0,20200611,20200702,EXP,,US-GILEAD-2020-0470690,GILEAD,,50.0,YR,A,F,Y,72.0,KG,20200702.0,,HP,US,US,2020,Q3,Adult
178876323,17887632,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,3,F,20200601.0,20200629.0,20200611,20200702,EXP,,US-GILEAD-2020-0470690,GILEAD,,50.0,YR,A,F,Y,72.0,KG,20200702.0,,HP,US,US,2020,Q3,Adult
178876323,17887632,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Shock,,2020,Q3,3,F,20200601.0,20200629.0,20200611,20200702,EXP,,US-GILEAD-2020-0470690,GILEAD,,50.0,YR,A,F,Y,72.0,KG,20200702.0,,HP,US,US,2020,Q3,Adult
178876323,17887632,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Supraventricular tachycardia,,2020,Q3,3,F,20200601.0,20200629.0,20200611,20200702,EXP,,US-GILEAD-2020-0470690,GILEAD,,50.0,YR,A,F,Y,72.0,KG,20200702.0,,HP,US,US,2020,Q3,Adult
178877284,17887728,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,4,F,20200530.0,20200627.0,20200612,20200710,EXP,,US-GILEAD-2020-0469658,GILEAD,,63.0,YR,A,M,Y,86.2,KG,20200710.0,,MD,US,US,2020,Q3,Adult
178914143,17891414,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 U, DAILY (BEFORE DINNER)",,,Y,, C938257C,,,6.0,IU,INJECTION,QD,2020,Q3,Arthropathy,,2020,Q3,3,F,202005.0,20200922.0,20200612,20200924,PER,,US-ELI_LILLY_AND_COMPANY-US202006004846,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20200924.0,,CN,US,US,2020,Q3,Elderly
178914143,17891414,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 U, DAILY (BEFORE DINNER)",,,Y,, C938257C,,,6.0,IU,INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,3,F,202005.0,20200922.0,20200612,20200924,PER,,US-ELI_LILLY_AND_COMPANY-US202006004846,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20200924.0,,CN,US,US,2020,Q3,Elderly
178914143,17891414,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 U, DAILY (BEFORE DINNER)",,,Y,, C938257C,,,6.0,IU,INJECTION,QD,2020,Q3,Hypoacusis,,2020,Q3,3,F,202005.0,20200922.0,20200612,20200924,PER,,US-ELI_LILLY_AND_COMPANY-US202006004846,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20200924.0,,CN,US,US,2020,Q3,Elderly
178914143,17891414,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 U, DAILY (BEFORE DINNER)",,,Y,, C938257C,,,6.0,IU,INJECTION,QD,2020,Q3,Skin disorder,,2020,Q3,3,F,202005.0,20200922.0,20200612,20200924,PER,,US-ELI_LILLY_AND_COMPANY-US202006004846,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20200924.0,,CN,US,US,2020,Q3,Elderly
178925972,17892597,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,20200531.0,20200630.0,20200612,20200702,EXP,,US-GILEAD-2020-0470641,GILEAD,,75.0,YR,E,M,Y,80.8,KG,20200702.0,,HP,US,US,2020,Q3,Elderly
178925972,17892597,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,2,F,20200531.0,20200630.0,20200612,20200702,EXP,,US-GILEAD-2020-0470641,GILEAD,,75.0,YR,E,M,Y,80.8,KG,20200702.0,,HP,US,US,2020,Q3,Elderly
178957343,17895734,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"SLIDIG SCALE, Q4H",,,,,,,,,,,,2020,Q3,Long QT syndrome,,2020,Q3,3,F,20200608.0,20200709.0,20200615,20200721,EXP,,"US-KARYOPHARM THERAPEUTICS, INC.-2020KPT000647",KARYOPHARM THERAPEUTICS,,47.0,YR,,M,Y,73.0,KG,20200721.0,,CN,US,US,2020,Q3,Adult
179095913,17909591,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Chest discomfort,,2020,Q3,3,F,20200606.0,20200619.0,20200617,20200702,EXP,,US-ACTELION-A-NJ2020-206098,ACTELION,,64.0,YR,,M,Y,,,20200702.0,,HP,US,US,2020,Q3,Adult
179095913,17909591,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Chest pain,,2020,Q3,3,F,20200606.0,20200619.0,20200617,20200702,EXP,,US-ACTELION-A-NJ2020-206098,ACTELION,,64.0,YR,,M,Y,,,20200702.0,,HP,US,US,2020,Q3,Adult
179095913,17909591,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Feeling abnormal,,2020,Q3,3,F,20200606.0,20200619.0,20200617,20200702,EXP,,US-ACTELION-A-NJ2020-206098,ACTELION,,64.0,YR,,M,Y,,,20200702.0,,HP,US,US,2020,Q3,Adult
179095913,17909591,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hospitalisation,,2020,Q3,3,F,20200606.0,20200619.0,20200617,20200702,EXP,,US-ACTELION-A-NJ2020-206098,ACTELION,,64.0,YR,,M,Y,,,20200702.0,,HP,US,US,2020,Q3,Adult
179095913,17909591,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Swelling face,,2020,Q3,3,F,20200606.0,20200619.0,20200617,20200702,EXP,,US-ACTELION-A-NJ2020-206098,ACTELION,,64.0,YR,,M,Y,,,20200702.0,,HP,US,US,2020,Q3,Adult
179095913,17909591,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Tremor,,2020,Q3,3,F,20200606.0,20200619.0,20200617,20200702,EXP,,US-ACTELION-A-NJ2020-206098,ACTELION,,64.0,YR,,M,Y,,,20200702.0,,HP,US,US,2020,Q3,Adult
179095913,17909591,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Vision blurred,,2020,Q3,3,F,20200606.0,20200619.0,20200617,20200702,EXP,,US-ACTELION-A-NJ2020-206098,ACTELION,,64.0,YR,,M,Y,,,20200702.0,,HP,US,US,2020,Q3,Adult
179101252,17910125,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,2,F,20200608.0,20200701.0,20200617,20200707,EXP,,US-GILEAD-2020-0473143,GILEAD,,46.0,YR,A,F,Y,82.59,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179101252,17910125,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,2,F,20200608.0,20200701.0,20200617,20200707,EXP,,US-GILEAD-2020-0473143,GILEAD,,46.0,YR,A,F,Y,82.59,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179101252,17910125,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hepatotoxicity,,2020,Q3,2,F,20200608.0,20200701.0,20200617,20200707,EXP,,US-GILEAD-2020-0473143,GILEAD,,46.0,YR,A,F,Y,82.59,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179101252,17910125,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,2,F,20200608.0,20200701.0,20200617,20200707,EXP,,US-GILEAD-2020-0473143,GILEAD,,46.0,YR,A,F,Y,82.59,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179101252,17910125,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Infection,,2020,Q3,2,F,20200608.0,20200701.0,20200617,20200707,EXP,,US-GILEAD-2020-0473143,GILEAD,,46.0,YR,A,F,Y,82.59,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179101252,17910125,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Ischaemic hepatitis,,2020,Q3,2,F,20200608.0,20200701.0,20200617,20200707,EXP,,US-GILEAD-2020-0473143,GILEAD,,46.0,YR,A,F,Y,82.59,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179101252,17910125,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,2,F,20200608.0,20200701.0,20200617,20200707,EXP,,US-GILEAD-2020-0473143,GILEAD,,46.0,YR,A,F,Y,82.59,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179101252,17910125,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Platelet count decreased,,2020,Q3,2,F,20200608.0,20200701.0,20200617,20200707,EXP,,US-GILEAD-2020-0473143,GILEAD,,46.0,YR,A,F,Y,82.59,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179101252,17910125,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,2,F,20200608.0,20200701.0,20200617,20200707,EXP,,US-GILEAD-2020-0473143,GILEAD,,46.0,YR,A,F,Y,82.59,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179101252,17910125,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,2,F,20200608.0,20200701.0,20200617,20200707,EXP,,US-GILEAD-2020-0473143,GILEAD,,46.0,YR,A,F,Y,82.59,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179101252,17910125,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,2,F,20200608.0,20200701.0,20200617,20200707,EXP,,US-GILEAD-2020-0473143,GILEAD,,46.0,YR,A,F,Y,82.59,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179162968,17916296,20,C,LISPRO,INSULIN LISPRO,1,,DOSE: 2 UNIT,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,8,F,20200528.0,20200908.0,20200619,20200910,EXP,,US-ROCHE-2614732,ROCHE,,68.0,YR,,M,Y,69.6,KG,20200910.0,,MD,US,US,2020,Q3,Elderly
179162968,17916296,20,C,LISPRO,INSULIN LISPRO,1,,DOSE: 2 UNIT,,,,,,,,,,,,2020,Q3,COVID-19 pneumonia,,2020,Q3,8,F,20200528.0,20200908.0,20200619,20200910,EXP,,US-ROCHE-2614732,ROCHE,,68.0,YR,,M,Y,69.6,KG,20200910.0,,MD,US,US,2020,Q3,Elderly
179162968,17916296,20,C,LISPRO,INSULIN LISPRO,1,,DOSE: 2 UNIT,,,,,,,,,,,,2020,Q3,Enterobacter pneumonia,,2020,Q3,8,F,20200528.0,20200908.0,20200619,20200910,EXP,,US-ROCHE-2614732,ROCHE,,68.0,YR,,M,Y,69.6,KG,20200910.0,,MD,US,US,2020,Q3,Elderly
179162968,17916296,20,C,LISPRO,INSULIN LISPRO,1,,DOSE: 2 UNIT,,,,,,,,,,,,2020,Q3,Lower gastrointestinal haemorrhage,,2020,Q3,8,F,20200528.0,20200908.0,20200619,20200910,EXP,,US-ROCHE-2614732,ROCHE,,68.0,YR,,M,Y,69.6,KG,20200910.0,,MD,US,US,2020,Q3,Elderly
179162968,17916296,20,C,LISPRO,INSULIN LISPRO,1,,DOSE: 2 UNIT,,,,,,,,,,,,2020,Q3,Melaena,,2020,Q3,8,F,20200528.0,20200908.0,20200619,20200910,EXP,,US-ROCHE-2614732,ROCHE,,68.0,YR,,M,Y,69.6,KG,20200910.0,,MD,US,US,2020,Q3,Elderly
179162968,17916296,20,C,LISPRO,INSULIN LISPRO,1,,DOSE: 2 UNIT,,,,,,,,,,,,2020,Q3,Pneumonia bacterial,,2020,Q3,8,F,20200528.0,20200908.0,20200619,20200910,EXP,,US-ROCHE-2614732,ROCHE,,68.0,YR,,M,Y,69.6,KG,20200910.0,,MD,US,US,2020,Q3,Elderly
179162968,17916296,20,C,LISPRO,INSULIN LISPRO,1,,DOSE: 2 UNIT,,,,,,,,,,,,2020,Q3,Streptococcal bacteraemia,,2020,Q3,8,F,20200528.0,20200908.0,20200619,20200910,EXP,,US-ROCHE-2614732,ROCHE,,68.0,YR,,M,Y,69.6,KG,20200910.0,,MD,US,US,2020,Q3,Elderly
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Adverse event,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Ammonia increased,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Back pain,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Blood bilirubin increased,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Blood lactate dehydrogenase increased,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Cellulitis,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Compression fracture,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Dermatitis,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Dysphagia,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Gastric polyps,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Gastric ulcer,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Gastrointestinal erosion,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Gastrointestinal mucosal disorder,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Gastrooesophageal reflux disease,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Haemorrhage,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hepatic encephalopathy,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hypervolaemia,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hypothyroidism,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Internal haemorrhage,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Peripheral venous disease,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pneumonia escherichia,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Portal hypertension,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Portal hypertensive gastropathy,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Post thrombotic syndrome,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pulmonary oedema,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Respiratory distress,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Right ventricular failure,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Skin ulcer,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Surgery,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Toxic encephalopathy,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Varices oesophageal,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179186304,17918630,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Wound infection pseudomonas,,2020,Q3,4,F,20150717.0,20200817.0,20200619,20200831,EXP,,US-JNJFOC-20200618467,JOHNSON AND JOHNSON,,48.0,YR,A,F,Y,63.56,KG,20200831.0,,HP,US,US,2020,Q3,Adult
179197772,17919777,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?8,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,2,F,20200602.0,20200916.0,20200619,20200921,EXP,,US-GILEAD-2020-0473916,GILEAD,,48.0,YR,A,M,Y,113.38,KG,20200921.0,,PH,US,US,2020,Q3,Adult
179256532,17925653,12,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,0?20 UNITS,,,,,,,,,,UNKNOWN,TID,2020,Q3,Colitis,,2020,Q3,2,F,20200610.0,20200629.0,20200622,20200701,EXP,,US-CELGENEUS-USA-20200603401,CELGENE,,76.0,YR,,M,Y,88.6,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179266562,17926656,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,, UNKNOWN,,,300.0,IU,,TID,2020,Q3,Anaemia,,2020,Q3,2,F,,20200701.0,20200623,20200709,PER,,DE-DRREDDYS-GER/GER/20/0124238,DR REDDYS,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,PH,DE,DE,2020,Q3,Elderly
179266562,17926656,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,, UNKNOWN,,,300.0,IU,,TID,2020,Q3,Electrolyte imbalance,,2020,Q3,2,F,,20200701.0,20200623,20200709,PER,,DE-DRREDDYS-GER/GER/20/0124238,DR REDDYS,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,PH,DE,DE,2020,Q3,Elderly
179266562,17926656,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,, UNKNOWN,,,300.0,IU,,TID,2020,Q3,Hyperkalaemia,,2020,Q3,2,F,,20200701.0,20200623,20200709,PER,,DE-DRREDDYS-GER/GER/20/0124238,DR REDDYS,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,PH,DE,DE,2020,Q3,Elderly
179266562,17926656,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,, UNKNOWN,,,300.0,IU,,TID,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,2,F,,20200701.0,20200623,20200709,PER,,DE-DRREDDYS-GER/GER/20/0124238,DR REDDYS,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,PH,DE,DE,2020,Q3,Elderly
179266562,17926656,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,, UNKNOWN,,,300.0,IU,,TID,2020,Q3,Product monitoring error,,2020,Q3,2,F,,20200701.0,20200623,20200709,PER,,DE-DRREDDYS-GER/GER/20/0124238,DR REDDYS,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,PH,DE,DE,2020,Q3,Elderly
179266562,17926656,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,, UNKNOWN,,,300.0,IU,,TID,2020,Q3,Renal impairment,,2020,Q3,2,F,,20200701.0,20200623,20200709,PER,,DE-DRREDDYS-GER/GER/20/0124238,DR REDDYS,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,PH,DE,DE,2020,Q3,Elderly
179374352,17937435,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (THREE TIMES A DAY)",,,,, D143863A,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,2005.0,20200619.0,20200624,20200701,EXP,,US-ELI_LILLY_AND_COMPANY-US202006008828,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200701.0,,CN,US,US,2020,Q3,Elderly
179374352,17937435,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (THREE TIMES A DAY)",,,,, D143863A,,20563.0,,,INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,2,F,2005.0,20200619.0,20200624,20200701,EXP,,US-ELI_LILLY_AND_COMPANY-US202006008828,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200701.0,,CN,US,US,2020,Q3,Elderly
179374352,17937435,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (THREE TIMES A DAY)",,,,, D143863A,,20563.0,,,INJECTION,,2020,Q3,Hypophagia,,2020,Q3,2,F,2005.0,20200619.0,20200624,20200701,EXP,,US-ELI_LILLY_AND_COMPANY-US202006008828,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200701.0,,CN,US,US,2020,Q3,Elderly
179374352,17937435,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (THREE TIMES A DAY)",,,,, D143863A,,20563.0,,,INJECTION,,2020,Q3,Retinal disorder,,2020,Q3,2,F,2005.0,20200619.0,20200624,20200701,EXP,,US-ELI_LILLY_AND_COMPANY-US202006008828,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200701.0,,CN,US,US,2020,Q3,Elderly
179374352,17937435,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (THREE TIMES A DAY)",,,,, D143863A,,20563.0,,,INJECTION,,2020,Q3,Stress,,2020,Q3,2,F,2005.0,20200619.0,20200624,20200701,EXP,,US-ELI_LILLY_AND_COMPANY-US202006008828,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200701.0,,CN,US,US,2020,Q3,Elderly
179374352,17937435,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (THREE TIMES A DAY)",,,,, D143863A,,20563.0,,,INJECTION,,2020,Q3,Visual impairment,,2020,Q3,2,F,2005.0,20200619.0,20200624,20200701,EXP,,US-ELI_LILLY_AND_COMPANY-US202006008828,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200701.0,,CN,US,US,2020,Q3,Elderly
179374352,17937435,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (THREE TIMES A DAY)",,,,,,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,2005.0,20200619.0,20200624,20200701,EXP,,US-ELI_LILLY_AND_COMPANY-US202006008828,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200701.0,,CN,US,US,2020,Q3,Elderly
179374352,17937435,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (THREE TIMES A DAY)",,,,,,,20563.0,,,INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,2,F,2005.0,20200619.0,20200624,20200701,EXP,,US-ELI_LILLY_AND_COMPANY-US202006008828,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200701.0,,CN,US,US,2020,Q3,Elderly
179374352,17937435,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (THREE TIMES A DAY)",,,,,,,20563.0,,,INJECTION,,2020,Q3,Hypophagia,,2020,Q3,2,F,2005.0,20200619.0,20200624,20200701,EXP,,US-ELI_LILLY_AND_COMPANY-US202006008828,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200701.0,,CN,US,US,2020,Q3,Elderly
179374352,17937435,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (THREE TIMES A DAY)",,,,,,,20563.0,,,INJECTION,,2020,Q3,Retinal disorder,,2020,Q3,2,F,2005.0,20200619.0,20200624,20200701,EXP,,US-ELI_LILLY_AND_COMPANY-US202006008828,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200701.0,,CN,US,US,2020,Q3,Elderly
179374352,17937435,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (THREE TIMES A DAY)",,,,,,,20563.0,,,INJECTION,,2020,Q3,Stress,,2020,Q3,2,F,2005.0,20200619.0,20200624,20200701,EXP,,US-ELI_LILLY_AND_COMPANY-US202006008828,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200701.0,,CN,US,US,2020,Q3,Elderly
179374352,17937435,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (THREE TIMES A DAY)",,,,,,,20563.0,,,INJECTION,,2020,Q3,Visual impairment,,2020,Q3,2,F,2005.0,20200619.0,20200624,20200701,EXP,,US-ELI_LILLY_AND_COMPANY-US202006008828,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20200701.0,,CN,US,US,2020,Q3,Elderly
179386182,17938618,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, 3 TIMES A DAY (8?8?8?0)",,,U,,,,,300.0,IU,,TID,2020,Q3,Anaemia,,2020,Q3,2,F,,20200629.0,20200625,20200706,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179386182,17938618,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, 3 TIMES A DAY (8?8?8?0)",,,U,,,,,300.0,IU,,TID,2020,Q3,Electrolyte imbalance,,2020,Q3,2,F,,20200629.0,20200625,20200706,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179386182,17938618,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, 3 TIMES A DAY (8?8?8?0)",,,U,,,,,300.0,IU,,TID,2020,Q3,Hyperkalaemia,,2020,Q3,2,F,,20200629.0,20200625,20200706,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179386182,17938618,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, 3 TIMES A DAY (8?8?8?0)",,,U,,,,,300.0,IU,,TID,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,2,F,,20200629.0,20200625,20200706,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179386182,17938618,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, 3 TIMES A DAY (8?8?8?0)",,,U,,,,,300.0,IU,,TID,2020,Q3,Product monitoring error,,2020,Q3,2,F,,20200629.0,20200625,20200706,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179386182,17938618,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, 3 TIMES A DAY (8?8?8?0)",,,U,,,,,300.0,IU,,TID,2020,Q3,Renal impairment,,2020,Q3,2,F,,20200629.0,20200625,20200706,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179400342,17940034,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Glomerular filtration rate decreased,,2020,Q3,2,F,20200614.0,20200710.0,20200624,20200715,EXP,,US-GILEAD-2020-0473153,GILEAD,,78.0,YR,E,F,Y,76.2,KG,20200715.0,,HP,US,US,2020,Q3,Elderly
179424402,17942440,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2020,Q3,Anaemia,,2020,Q3,2,F,,20200707.0,20200624,20200715,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200715.0,,PH,DE,DE,2020,Q3,Elderly
179424402,17942440,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,2,F,,20200707.0,20200624,20200715,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200715.0,,PH,DE,DE,2020,Q3,Elderly
179424402,17942440,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2020,Q3,Hyperkalaemia,,2020,Q3,2,F,,20200707.0,20200624,20200715,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200715.0,,PH,DE,DE,2020,Q3,Elderly
179424402,17942440,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,2,F,,20200707.0,20200624,20200715,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200715.0,,PH,DE,DE,2020,Q3,Elderly
179424402,17942440,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2020,Q3,Product monitoring error,,2020,Q3,2,F,,20200707.0,20200624,20200715,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200715.0,,PH,DE,DE,2020,Q3,Elderly
179424402,17942440,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,2,F,,20200707.0,20200624,20200715,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200715.0,,PH,DE,DE,2020,Q3,Elderly
179425635,17942563,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Anaemia,,2020,Q3,5,F,,20200715.0,20200625,20200717,EXP,,DE-PFIZER INC-2020243867,PFIZER,,70.0,YR,,M,Y,78.0,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
179425635,17942563,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Electrolyte imbalance,,2020,Q3,5,F,,20200715.0,20200625,20200717,EXP,,DE-PFIZER INC-2020243867,PFIZER,,70.0,YR,,M,Y,78.0,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
179425635,17942563,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Hyperkalaemia,,2020,Q3,5,F,,20200715.0,20200625,20200717,EXP,,DE-PFIZER INC-2020243867,PFIZER,,70.0,YR,,M,Y,78.0,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
179425635,17942563,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,5,F,,20200715.0,20200625,20200717,EXP,,DE-PFIZER INC-2020243867,PFIZER,,70.0,YR,,M,Y,78.0,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
179425635,17942563,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Product monitoring error,,2020,Q3,5,F,,20200715.0,20200625,20200717,EXP,,DE-PFIZER INC-2020243867,PFIZER,,70.0,YR,,M,Y,78.0,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
179425635,17942563,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Renal impairment,,2020,Q3,5,F,,20200715.0,20200625,20200717,EXP,,DE-PFIZER INC-2020243867,PFIZER,,70.0,YR,,M,Y,78.0,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
179529062,17952906,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Anaemia,,2020,Q3,2,F,,20200701.0,20200627,20200709,EXP,DE-BFARM-20006678,DE-ACCORD-186635,ACCORD,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Elderly
179529062,17952906,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Electrolyte imbalance,,2020,Q3,2,F,,20200701.0,20200627,20200709,EXP,DE-BFARM-20006678,DE-ACCORD-186635,ACCORD,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Elderly
179529062,17952906,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Hyperkalaemia,,2020,Q3,2,F,,20200701.0,20200627,20200709,EXP,DE-BFARM-20006678,DE-ACCORD-186635,ACCORD,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Elderly
179529062,17952906,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,2,F,,20200701.0,20200627,20200709,EXP,DE-BFARM-20006678,DE-ACCORD-186635,ACCORD,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Elderly
179529062,17952906,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Product monitoring error,,2020,Q3,2,F,,20200701.0,20200627,20200709,EXP,DE-BFARM-20006678,DE-ACCORD-186635,ACCORD,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Elderly
179529062,17952906,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Renal impairment,,2020,Q3,2,F,,20200701.0,20200627,20200709,EXP,DE-BFARM-20006678,DE-ACCORD-186635,ACCORD,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Elderly
179570003,17957000,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,U,,,,,300.0,IU,,,2020,Q3,Anaemia,,2020,Q3,3,F,,20200706.0,20200629,20200714,EXP,DE-ADRED-04543-01,DE-TORRENT-00017882,TORRENT,,70.0,YR,E,M,Y,78.0,KG,20200714.0,,HP,DE,DE,2020,Q3,Elderly
179570003,17957000,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,U,,,,,300.0,IU,,,2020,Q3,Electrolyte imbalance,,2020,Q3,3,F,,20200706.0,20200629,20200714,EXP,DE-ADRED-04543-01,DE-TORRENT-00017882,TORRENT,,70.0,YR,E,M,Y,78.0,KG,20200714.0,,HP,DE,DE,2020,Q3,Elderly
179570003,17957000,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,U,,,,,300.0,IU,,,2020,Q3,Hyperkalaemia,,2020,Q3,3,F,,20200706.0,20200629,20200714,EXP,DE-ADRED-04543-01,DE-TORRENT-00017882,TORRENT,,70.0,YR,E,M,Y,78.0,KG,20200714.0,,HP,DE,DE,2020,Q3,Elderly
179570003,17957000,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,U,,,,,300.0,IU,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,3,F,,20200706.0,20200629,20200714,EXP,DE-ADRED-04543-01,DE-TORRENT-00017882,TORRENT,,70.0,YR,E,M,Y,78.0,KG,20200714.0,,HP,DE,DE,2020,Q3,Elderly
179570003,17957000,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,U,,,,,300.0,IU,,,2020,Q3,Product monitoring error,,2020,Q3,3,F,,20200706.0,20200629,20200714,EXP,DE-ADRED-04543-01,DE-TORRENT-00017882,TORRENT,,70.0,YR,E,M,Y,78.0,KG,20200714.0,,HP,DE,DE,2020,Q3,Elderly
179570003,17957000,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,U,,,,,300.0,IU,,,2020,Q3,Renal impairment,,2020,Q3,3,F,,20200706.0,20200629,20200714,EXP,DE-ADRED-04543-01,DE-TORRENT-00017882,TORRENT,,70.0,YR,E,M,Y,78.0,KG,20200714.0,,HP,DE,DE,2020,Q3,Elderly
179572563,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Gangrene,,2020,Q3,3,F,20191217.0,20200813.0,20200629,20200814,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200814.0,,HP,DE,DE,2020,Q3,Adult
179572563,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Hypernatraemia,,2020,Q3,3,F,20191217.0,20200813.0,20200629,20200814,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200814.0,,HP,DE,DE,2020,Q3,Adult
179572563,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Infection,,2020,Q3,3,F,20191217.0,20200813.0,20200629,20200814,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200814.0,,HP,DE,DE,2020,Q3,Adult
179572563,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Neoplasm progression,,2020,Q3,3,F,20191217.0,20200813.0,20200629,20200814,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200814.0,,HP,DE,DE,2020,Q3,Adult
179572563,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Pain,,2020,Q3,3,F,20191217.0,20200813.0,20200629,20200814,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200814.0,,HP,DE,DE,2020,Q3,Adult
179572563,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Pleural effusion,,2020,Q3,3,F,20191217.0,20200813.0,20200629,20200814,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200814.0,,HP,DE,DE,2020,Q3,Adult
179572563,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Pneumothorax,,2020,Q3,3,F,20191217.0,20200813.0,20200629,20200814,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200814.0,,HP,DE,DE,2020,Q3,Adult
179572563,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Rash,,2020,Q3,3,F,20191217.0,20200813.0,20200629,20200814,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200814.0,,HP,DE,DE,2020,Q3,Adult
179572563,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Rash erythematous,,2020,Q3,3,F,20191217.0,20200813.0,20200629,20200814,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200814.0,,HP,DE,DE,2020,Q3,Adult
179572563,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Rash vesicular,,2020,Q3,3,F,20191217.0,20200813.0,20200629,20200814,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200814.0,,HP,DE,DE,2020,Q3,Adult
179572563,17957256,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Superinfection,,2020,Q3,3,F,20191217.0,20200813.0,20200629,20200814,EXP,,DE-PFIZER INC-2020244576,PFIZER,,56.0,YR,,F,Y,82.0,KG,20200814.0,,HP,DE,DE,2020,Q3,Adult
179654404,17965440,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Anaemia,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179654404,17965440,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Electrolyte imbalance,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179654404,17965440,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Hyperkalaemia,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179654404,17965440,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Intentional product misuse,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179654404,17965440,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179654404,17965440,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Product monitoring error,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179654404,17965440,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 8?8?8?0",,,,,,,,300.0,IU,,,2020,Q3,Renal impairment,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Acute hepatic failure,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Ascites,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Asthenia,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Cerebral haemorrhage,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Chronic hepatitis B,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Diabetes mellitus,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Emphysema,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Enterococcal infection,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Hepatic cirrhosis,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Liver disorder,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Oedema,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Peritonitis bacterial,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Pleural effusion,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Streptococcal infection,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Thrombocytopenia,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Varices oesophageal,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Acute hepatic failure,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Ascites,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Asthenia,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Cerebral haemorrhage,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Chronic hepatitis B,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Diabetes mellitus,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Emphysema,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Enterococcal infection,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Hepatic cirrhosis,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Liver disorder,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Oedema,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Peritonitis bacterial,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Pleural effusion,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Streptococcal infection,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Thrombocytopenia,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,TID,2020,Q3,Varices oesophageal,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179681121,17968112,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200627.0,,20200701,20200701,DIR,,,FDA-CTU,,46.0,YR,,M,N,64.9,KG,20200701.0,N,PH,US,US,2020,Q3,Adult
179681121,17968112,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Transaminases increased,,2020,Q3,1,I,20200627.0,,20200701,20200701,DIR,,,FDA-CTU,,46.0,YR,,M,N,64.9,KG,20200701.0,N,PH,US,US,2020,Q3,Adult
179698332,17969833,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Acute myocardial infarction,,2020,Q3,2,F,202006.0,20200824.0,20200701,20200826,EXP,,US-GILEAD-2020-0477758,GILEAD,,85.0,YR,E,F,Y,84.0,KG,20200826.0,,PH,US,US,2020,Q3,Elderly
179698332,17969833,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,2,F,202006.0,20200824.0,20200701,20200826,EXP,,US-GILEAD-2020-0477758,GILEAD,,85.0,YR,E,F,Y,84.0,KG,20200826.0,,PH,US,US,2020,Q3,Elderly
179698332,17969833,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,2,F,202006.0,20200824.0,20200701,20200826,EXP,,US-GILEAD-2020-0477758,GILEAD,,85.0,YR,E,F,Y,84.0,KG,20200826.0,,PH,US,US,2020,Q3,Elderly
179698332,17969833,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,2,F,202006.0,20200824.0,20200701,20200826,EXP,,US-GILEAD-2020-0477758,GILEAD,,85.0,YR,E,F,Y,84.0,KG,20200826.0,,PH,US,US,2020,Q3,Elderly
179698332,17969833,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,2,F,202006.0,20200824.0,20200701,20200826,EXP,,US-GILEAD-2020-0477758,GILEAD,,85.0,YR,E,F,Y,84.0,KG,20200826.0,,PH,US,US,2020,Q3,Elderly
179760571,17976057,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,,,,,,,,,2020,Q3,Anaemia,,2020,Q3,1,I,,20200621.0,20200703,20200703,EXP,,DE-TEVA-2020-DE-1791828,TEVA,,70.0,YR,,M,Y,78.0,KG,20200703.0,,PH,DE,DE,2020,Q3,Elderly
179760571,17976057,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200621.0,20200703,20200703,EXP,,DE-TEVA-2020-DE-1791828,TEVA,,70.0,YR,,M,Y,78.0,KG,20200703.0,,PH,DE,DE,2020,Q3,Elderly
179760571,17976057,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,,,,,,,,,2020,Q3,Hyperkalaemia,,2020,Q3,1,I,,20200621.0,20200703,20200703,EXP,,DE-TEVA-2020-DE-1791828,TEVA,,70.0,YR,,M,Y,78.0,KG,20200703.0,,PH,DE,DE,2020,Q3,Elderly
179760571,17976057,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,,,,,,,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,1,I,,20200621.0,20200703,20200703,EXP,,DE-TEVA-2020-DE-1791828,TEVA,,70.0,YR,,M,Y,78.0,KG,20200703.0,,PH,DE,DE,2020,Q3,Elderly
179760571,17976057,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,,,,,,,,,2020,Q3,Product monitoring error,,2020,Q3,1,I,,20200621.0,20200703,20200703,EXP,,DE-TEVA-2020-DE-1791828,TEVA,,70.0,YR,,M,Y,78.0,KG,20200703.0,,PH,DE,DE,2020,Q3,Elderly
179760571,17976057,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,1,I,,20200621.0,20200703,20200703,EXP,,DE-TEVA-2020-DE-1791828,TEVA,,70.0,YR,,M,Y,78.0,KG,20200703.0,,PH,DE,DE,2020,Q3,Elderly
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Acute lymphocytic leukaemia,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Areflexia,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Blood albumin decreased,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Blood bicarbonate decreased,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Blood fibrinogen decreased,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Brain herniation,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Brain stem syndrome,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Cardiac arrest,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Glomerular filtration rate decreased,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Haematocrit decreased,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Haemoglobin decreased,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Haemolysis,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Haptoglobin decreased,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Multiple organ dysfunction syndrome,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Oxygen saturation increased,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Platelet count decreased,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Prothrombin time prolonged,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Pupil fixed,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Red blood cell count decreased,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Red cell distribution width increased,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Septic shock,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179790264,17979026,44,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD (5 UNIT)",,,D,,,,,,,INJECTION,QD,2020,Q3,Urinary sediment present,,2020,Q3,4,F,20200605.0,20200915.0,20200703,20200916,EXP,,NVSC2020US187205,NOVARTIS,,21.0,YR,,M,Y,91.0,KG,20200916.0,,HP,US,US,2020,Q3,Youth
179803801,17980380,5,C,Insulina lispro Sanofi,,2,Unknown,3000 KILO?INTERNATIONAL UNIT,,,U,,,,,3000.0,KIU,,,2020,Q3,Dehydration,,2020,Q3,1,I,20200519.0,20200625.0,20200703,20200703,EXP,,IT-AUROBINDO-AUR-APL-2020-031857,AUROBINDO,,87.0,YR,,F,Y,,,20200704.0,,MD,IT,IT,2020,Q3,Elderly
179803801,17980380,5,C,Insulina lispro Sanofi,,2,Unknown,3000 KILO?INTERNATIONAL UNIT,,,U,,,,,3000.0,KIU,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,20200519.0,20200625.0,20200703,20200703,EXP,,IT-AUROBINDO-AUR-APL-2020-031857,AUROBINDO,,87.0,YR,,F,Y,,,20200704.0,,MD,IT,IT,2020,Q3,Elderly
179816902,17981690,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0 ()",,,U,,,,,,,,,2020,Q3,Anaemia,,2020,Q3,2,F,,20200706.0,20200706,20200720,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252126,RANBAXY,,70.0,YR,,M,Y,78.0,KG,20200720.0,,HP,NL,DE,2020,Q3,Elderly
179816902,17981690,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0 ()",,,U,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,2,F,,20200706.0,20200706,20200720,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252126,RANBAXY,,70.0,YR,,M,Y,78.0,KG,20200720.0,,HP,NL,DE,2020,Q3,Elderly
179816902,17981690,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0 ()",,,U,,,,,,,,,2020,Q3,Hyperkalaemia,,2020,Q3,2,F,,20200706.0,20200706,20200720,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252126,RANBAXY,,70.0,YR,,M,Y,78.0,KG,20200720.0,,HP,NL,DE,2020,Q3,Elderly
179816902,17981690,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0 ()",,,U,,,,,,,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,2,F,,20200706.0,20200706,20200720,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252126,RANBAXY,,70.0,YR,,M,Y,78.0,KG,20200720.0,,HP,NL,DE,2020,Q3,Elderly
179816902,17981690,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0 ()",,,U,,,,,,,,,2020,Q3,Product monitoring error,,2020,Q3,2,F,,20200706.0,20200706,20200720,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252126,RANBAXY,,70.0,YR,,M,Y,78.0,KG,20200720.0,,HP,NL,DE,2020,Q3,Elderly
179816902,17981690,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0 ()",,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,2,F,,20200706.0,20200706,20200720,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252126,RANBAXY,,70.0,YR,,M,Y,78.0,KG,20200720.0,,HP,NL,DE,2020,Q3,Elderly
179821941,17982194,3,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200703.0,,20200703,20200703,DIR,,,FDA-CTU,,46.0,YR,,M,N,90.9,KG,20200703.0,N,PH,US,US,2020,Q3,Adult
179822001,17982200,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200702.0,,20200703,20200703,DIR,,,FDA-CTU,,55.0,YR,,M,N,85.9,KG,20200703.0,N,PH,US,US,2020,Q3,Adult
179822751,17982275,6,C,insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,20200702.0,,20200703,20200703,DIR,,,FDA-CTU,,49.0,YR,,M,N,112.0,KG,20200703.0,N,PH,US,US,2020,Q3,Adult
179822751,17982275,6,C,insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,20200702.0,,20200703,20200703,DIR,,,FDA-CTU,,49.0,YR,,M,N,112.0,KG,20200703.0,N,PH,US,US,2020,Q3,Adult
179870011,17987001,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,202004.0,20200429.0,20200707,20200707,PER,,US-AMGEN-USA-20200409620,AMGEN,,56.0,YR,A,F,Y,,,20200707.0,,CN,US,US,2020,Q3,Adult
179881631,17988163,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Disease progression,,2020,Q3,1,I,20200706.0,,20200706,20200706,DIR,,,FDA-CTU,,56.0,YR,,F,N,94.8,KG,20200706.0,N,MD,US,US,2020,Q3,Adult
179890121,17989012,5,C,Insulin lispro 4 units,,2,,,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,20200702.0,,20200707,20200707,DIR,,,FDA-CTU,,53.0,YR,,M,N,85.5,KG,20200707.0,N,PH,US,US,2020,Q3,Adult
179890121,17989012,5,C,Insulin lispro 4 units,,2,,,,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,20200702.0,,20200707,20200707,DIR,,,FDA-CTU,,53.0,YR,,M,N,85.5,KG,20200707.0,N,PH,US,US,2020,Q3,Adult
179895961,17989596,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200627.0,20200702.0,20200707,20200707,EXP,,US-GILEAD-2020-0479362,GILEAD,,46.0,YR,A,M,Y,64.9,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179922132,17992213,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,2,F,20200701.0,20200724.0,20200707,20200728,EXP,,US-GILEAD-2020-0479521,GILEAD,,50.0,YR,A,M,Y,88.8,KG,20200728.0,,PH,US,US,2020,Q3,Adult
179938081,17993808,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200703.0,,20200707,20200707,DIR,,,FDA-CTU,,46.0,YR,,M,N,159.8,KG,20200707.0,N,HP,US,US,2020,Q3,Adult
179943381,17994338,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Amnesia,,2020,Q3,1,I,201903.0,20190307.0,20200708,20200708,EXP,,US-BAUSCH-BL-2019-007572,BAUSCH AND LOMB,,63.0,YR,,M,Y,,,20200708.0,,CN,US,US,2020,Q3,Adult
179943381,17994338,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,1,I,201903.0,20190307.0,20200708,20200708,EXP,,US-BAUSCH-BL-2019-007572,BAUSCH AND LOMB,,63.0,YR,,M,Y,,,20200708.0,,CN,US,US,2020,Q3,Adult
179943381,17994338,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,201903.0,20190307.0,20200708,20200708,EXP,,US-BAUSCH-BL-2019-007572,BAUSCH AND LOMB,,63.0,YR,,M,Y,,,20200708.0,,CN,US,US,2020,Q3,Adult
179943381,17994338,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hospitalisation,,2020,Q3,1,I,201903.0,20190307.0,20200708,20200708,EXP,,US-BAUSCH-BL-2019-007572,BAUSCH AND LOMB,,63.0,YR,,M,Y,,,20200708.0,,CN,US,US,2020,Q3,Adult
179943381,17994338,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Therapy interrupted,,2020,Q3,1,I,201903.0,20190307.0,20200708,20200708,EXP,,US-BAUSCH-BL-2019-007572,BAUSCH AND LOMB,,63.0,YR,,M,Y,,,20200708.0,,CN,US,US,2020,Q3,Adult
179958471,17995847,3,C,INSULINA LISPRO SANOFI,,2,,3000 KU,,,,, UNKNOWN,,,3000.0,KIU,,,2020,Q3,Dehydration,,2020,Q3,1,I,20200519.0,20200630.0,20200708,20200708,EXP,IT-MINISAL02-624277,IT-TEVA-2020-IT-1797970,TEVA,,87.0,YR,,F,Y,,,20200708.0,,MD,IT,IT,2020,Q3,Elderly
179958471,17995847,3,C,INSULINA LISPRO SANOFI,,2,,3000 KU,,,,, UNKNOWN,,,3000.0,KIU,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,20200519.0,20200630.0,20200708,20200708,EXP,IT-MINISAL02-624277,IT-TEVA-2020-IT-1797970,TEVA,,87.0,YR,,F,Y,,,20200708.0,,MD,IT,IT,2020,Q3,Elderly
179984062,17998406,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,20200622.0,20200706.0,20200709,20200714,PER,,US-ELI_LILLY_AND_COMPANY-US202007002295,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200714.0,,CN,US,US,2020,Q3,Elderly
179993661,17999366,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Loss of consciousness,,2020,Q3,1,I,20191110.0,20200701.0,20200709,20200709,EXP,IT-MINISAL02-621341,NVSC2020IT186374,NOVARTIS,,87.0,YR,,M,Y,,,20200709.0,,HP,IT,IT,2020,Q3,Elderly
180020381,18002038,3,C,INSULINA LISPRO,INSULIN LISPRO,1,,3000 KILO?INTERNATIONAL UNIT,,,,,,,,3000.0,KIU,,,2020,Q3,Dehydration,,2020,Q3,1,I,20200519.0,20200629.0,20200709,20200709,EXP,IT-MINISAL02-624277,IT-MYLANLABS-2020M1061219,MYLAN,,87.0,YR,,F,Y,,,20200709.0,,MD,IT,IT,2020,Q3,Elderly
180020381,18002038,3,C,INSULINA LISPRO,INSULIN LISPRO,1,,3000 KILO?INTERNATIONAL UNIT,,,,,,,,3000.0,KIU,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,20200519.0,20200629.0,20200709,20200709,EXP,IT-MINISAL02-624277,IT-MYLANLABS-2020M1061219,MYLAN,,87.0,YR,,F,Y,,,20200709.0,,MD,IT,IT,2020,Q3,Elderly
180025371,18002537,7,SS,Insulin lispro,INSULIN LISPRO,1,Parenteral,,,,D,,,,,,,,,2020,Q3,Completed suicide,,2020,Q3,1,I,,20200630.0,20200710,20200710,EXP,,US-AUROBINDO-AUR-APL-2020-032476,AUROBINDO,,37.0,YR,,M,Y,,,20200710.0,,HP,US,US,2020,Q3,Adult
180025371,18002537,8,SS,Insulin lispro,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2020,Q3,Completed suicide,,2020,Q3,1,I,,20200630.0,20200710,20200710,EXP,,US-AUROBINDO-AUR-APL-2020-032476,AUROBINDO,,37.0,YR,,M,Y,,,20200710.0,,HP,US,US,2020,Q3,Adult
180049071,18004907,6,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,20200707.0,,20200709,20200709,DIR,,,FDA-CTU,,56.0,YR,,M,N,81.0,KG,20200709.0,N,PH,US,US,2020,Q3,Adult
180049071,18004907,6,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,20200707.0,,20200709,20200709,DIR,,,FDA-CTU,,56.0,YR,,M,N,81.0,KG,20200709.0,N,PH,US,US,2020,Q3,Adult
180054491,18005449,20,SS,Insulin lispro,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2020,Q3,Completed suicide,,2020,Q3,1,I,,20200630.0,20200710,20200710,EXP,,US-AUROBINDO-AUR-APL-2020-032632,AUROBINDO,,61.0,YR,,F,Y,,,20200710.0,,HP,US,US,2020,Q3,Adult
180062501,18006250,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200709.0,,20200710,20200710,DIR,,,FDA-CTU,,79.0,YR,,F,N,64.2,KG,20200710.0,N,PH,US,US,2020,Q3,Elderly
180126632,18012663,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"32 DOSAGE FORM, QD",14080.0,DF,Y,U,,,,32.0,DF,INJECTION,QD,2020,Q3,Hyperhidrosis,,2020,Q3,2,F,20200512.0,20200707.0,20200713,20200720,EXP,IT-MINISAL02-625563,IT-MYLANLABS-2020M1063253,MYLAN,,87.0,YR,,F,Y,,,20200720.0,,MD,IT,IT,2020,Q3,Elderly
180126632,18012663,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"32 DOSAGE FORM, QD",14080.0,DF,Y,U,,,,32.0,DF,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,20200512.0,20200707.0,20200713,20200720,EXP,IT-MINISAL02-625563,IT-MYLANLABS-2020M1063253,MYLAN,,87.0,YR,,F,Y,,,20200720.0,,MD,IT,IT,2020,Q3,Elderly
180126632,18012663,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"32 DOSAGE FORM, QD",14080.0,DF,Y,U,,,,32.0,DF,INJECTION,QD,2020,Q3,Malaise,,2020,Q3,2,F,20200512.0,20200707.0,20200713,20200720,EXP,IT-MINISAL02-625563,IT-MYLANLABS-2020M1063253,MYLAN,,87.0,YR,,F,Y,,,20200720.0,,MD,IT,IT,2020,Q3,Elderly
180193661,18019366,8,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20200705.0,,20200714,20200714,DIR,,,FDA-CTU,,41.0,YR,,M,N,218.6,KG,20200714.0,N,PH,US,US,2020,Q3,Adult
180193661,18019366,8,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Therapy interrupted,,2020,Q3,1,I,20200705.0,,20200714,20200714,DIR,,,FDA-CTU,,41.0,YR,,M,N,218.6,KG,20200714.0,N,PH,US,US,2020,Q3,Adult
180242631,18024263,14,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20200630.0,,20200714,20200714,DIR,,,FDA-CTU,,54.0,YR,,M,N,104.3,KG,20200714.0,Y,PH,US,US,2020,Q3,Adult
180242631,18024263,14,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,1,I,20200630.0,,20200714,20200714,DIR,,,FDA-CTU,,54.0,YR,,M,N,104.3,KG,20200714.0,Y,PH,US,US,2020,Q3,Adult
180242631,18024263,14,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,1,I,20200630.0,,20200714,20200714,DIR,,,FDA-CTU,,54.0,YR,,M,N,104.3,KG,20200714.0,Y,PH,US,US,2020,Q3,Adult
180242631,18024263,14,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q3,Inflammatory marker increased,,2020,Q3,1,I,20200630.0,,20200714,20200714,DIR,,,FDA-CTU,,54.0,YR,,M,N,104.3,KG,20200714.0,Y,PH,US,US,2020,Q3,Adult
180242631,18024263,14,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q3,International normalised ratio increased,,2020,Q3,1,I,20200630.0,,20200714,20200714,DIR,,,FDA-CTU,,54.0,YR,,M,N,104.3,KG,20200714.0,Y,PH,US,US,2020,Q3,Adult
180242631,18024263,14,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q3,Oxygen saturation decreased,,2020,Q3,1,I,20200630.0,,20200714,20200714,DIR,,,FDA-CTU,,54.0,YR,,M,N,104.3,KG,20200714.0,Y,PH,US,US,2020,Q3,Adult
180242701,18024270,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,20200705.0,,20200714,20200714,DIR,,,FDA-CTU,,55.0,YR,,M,N,104.3,KG,20200714.0,N,PH,US,US,2020,Q3,Adult
180242701,18024270,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20200705.0,,20200714,20200714,DIR,,,FDA-CTU,,55.0,YR,,M,N,104.3,KG,20200714.0,N,PH,US,US,2020,Q3,Adult
180242701,18024270,13,C,insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q3,International normalised ratio increased,,2020,Q3,1,I,20200705.0,,20200714,20200714,DIR,,,FDA-CTU,,55.0,YR,,M,N,104.3,KG,20200714.0,N,PH,US,US,2020,Q3,Adult
180244761,18024476,1,PS,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,,20200714,20200714,DIR,,,FDA-CTU,,64.0,YR,,M,N,78.3,KG,20200714.0,N,HP,US,US,2020,Q3,Adult
180244761,18024476,1,PS,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,,20200714,20200714,DIR,,,FDA-CTU,,64.0,YR,,M,N,78.3,KG,20200714.0,N,HP,US,US,2020,Q3,Adult
180244761,18024476,1,PS,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Nasal congestion,,2020,Q3,1,I,,,20200714,20200714,DIR,,,FDA-CTU,,64.0,YR,,M,N,78.3,KG,20200714.0,N,HP,US,US,2020,Q3,Adult
180247421,18024742,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute pulmonary oedema,,2020,Q3,1,I,20200714.0,,20200715,20200715,DIR,,,FDA-CTU,,58.0,YR,,M,N,,,20200715.0,N,PH,US,US,2020,Q3,Adult
180247421,18024742,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Agitation,,2020,Q3,1,I,20200714.0,,20200715,20200715,DIR,,,FDA-CTU,,58.0,YR,,M,N,,,20200715.0,N,PH,US,US,2020,Q3,Adult
180247421,18024742,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,20200714.0,,20200715,20200715,DIR,,,FDA-CTU,,58.0,YR,,M,N,,,20200715.0,N,PH,US,US,2020,Q3,Adult
180247421,18024742,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Lung infiltration,,2020,Q3,1,I,20200714.0,,20200715,20200715,DIR,,,FDA-CTU,,58.0,YR,,M,N,,,20200715.0,N,PH,US,US,2020,Q3,Adult
180247421,18024742,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Obstructive airways disorder,,2020,Q3,1,I,20200714.0,,20200715,20200715,DIR,,,FDA-CTU,,58.0,YR,,M,N,,,20200715.0,N,PH,US,US,2020,Q3,Adult
180247421,18024742,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pulse absent,,2020,Q3,1,I,20200714.0,,20200715,20200715,DIR,,,FDA-CTU,,58.0,YR,,M,N,,,20200715.0,N,PH,US,US,2020,Q3,Adult
180247421,18024742,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Rales,,2020,Q3,1,I,20200714.0,,20200715,20200715,DIR,,,FDA-CTU,,58.0,YR,,M,N,,,20200715.0,N,PH,US,US,2020,Q3,Adult
180247421,18024742,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Respiratory failure,,2020,Q3,1,I,20200714.0,,20200715,20200715,DIR,,,FDA-CTU,,58.0,YR,,M,N,,,20200715.0,N,PH,US,US,2020,Q3,Adult
180247421,18024742,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Respiratory rate decreased,,2020,Q3,1,I,20200714.0,,20200715,20200715,DIR,,,FDA-CTU,,58.0,YR,,M,N,,,20200715.0,N,PH,US,US,2020,Q3,Adult
180247871,18024787,8,C,insulin lispro sliding scale 4x/d,,2,,,,,,,,,,,,,,2020,Q3,International normalised ratio increased,,2020,Q3,1,I,20200706.0,,20200715,20200715,DIR,,,FDA-CTU,,51.0,YR,,F,N,94.2,KG,20200715.0,N,PH,US,US,2020,Q3,Adult
180258401,18025840,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,,14080.0,DF,Y,,,,20563.0,32.0,DF,,QD,2020,Q3,Hyperhidrosis,,2020,Q3,1,I,20200512.0,20200703.0,20200715,20200715,EXP,IT-MINISAL02-625563,IT-ELI_LILLY_AND_COMPANY-IT202007001911,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20200715.0,,MD,IT,IT,2020,Q3,Elderly
180258401,18025840,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,,14080.0,DF,Y,,,,20563.0,32.0,DF,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200512.0,20200703.0,20200715,20200715,EXP,IT-MINISAL02-625563,IT-ELI_LILLY_AND_COMPANY-IT202007001911,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20200715.0,,MD,IT,IT,2020,Q3,Elderly
180258401,18025840,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,,14080.0,DF,Y,,,,20563.0,32.0,DF,,QD,2020,Q3,Malaise,,2020,Q3,1,I,20200512.0,20200703.0,20200715,20200715,EXP,IT-MINISAL02-625563,IT-ELI_LILLY_AND_COMPANY-IT202007001911,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20200715.0,,MD,IT,IT,2020,Q3,Elderly
180296311,18029631,8,C,lispro insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Bradycardia,,2020,Q3,1,I,20200714.0,,20200715,20200715,DIR,,,FDA-CTU,,62.0,YR,,M,N,91.2,KG,20200715.0,N,PH,US,US,2020,Q3,Adult
180310471,18031047,3,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,, C999324C,,,,,INJECTION,,2020,Q3,Rectal cancer,,2020,Q3,1,I,201910.0,20200707.0,20200716,20200716,EXP,,US-ELI_LILLY_AND_COMPANY-US202007002872,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200716.0,,CN,US,US,2020,Q3,Elderly
180332391,18033239,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,20200705.0,20200714.0,20200716,20200716,EXP,,US-GILEAD-2020-0483276,GILEAD,,55.0,YR,A,M,Y,104.3,KG,20200716.0,,PH,US,US,2020,Q3,Adult
180332391,18033239,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20200705.0,20200714.0,20200716,20200716,EXP,,US-GILEAD-2020-0483276,GILEAD,,55.0,YR,A,M,Y,104.3,KG,20200716.0,,PH,US,US,2020,Q3,Adult
180352471,18035247,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D166927A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,202007.0,20200714.0,20200717,20200717,PER,,US-ELI_LILLY_AND_COMPANY-US202007006300,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200717.0,,CN,US,US,2020,Q3,Elderly
180361761,18036176,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,COVID-19 pneumonia,,2020,Q3,1,I,20200715.0,,20200717,20200717,DIR,,,FDA-CTU,,44.0,YR,,M,N,100.5,KG,20200717.0,Y,HP,US,US,2020,Q3,Adult
180361761,18036176,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Oxygen saturation decreased,,2020,Q3,1,I,20200715.0,,20200717,20200717,DIR,,,FDA-CTU,,44.0,YR,,M,N,100.5,KG,20200717.0,Y,HP,US,US,2020,Q3,Adult
180361761,18036176,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Platelet count increased,,2020,Q3,1,I,20200715.0,,20200717,20200717,DIR,,,FDA-CTU,,44.0,YR,,M,N,100.5,KG,20200717.0,Y,HP,US,US,2020,Q3,Adult
180361761,18036176,9,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,SARS-CoV-2 test positive,,2020,Q3,1,I,20200715.0,,20200717,20200717,DIR,,,FDA-CTU,,44.0,YR,,M,N,100.5,KG,20200717.0,Y,HP,US,US,2020,Q3,Adult
180379881,18037988,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,1,I,20200630.0,20200714.0,20200717,20200717,EXP,,US-GILEAD-2020-0483702,GILEAD,,54.0,YR,A,M,Y,104.3,KG,20200717.0,,PH,US,US,2020,Q3,Adult
180379881,18037988,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,1,I,20200630.0,20200714.0,20200717,20200717,EXP,,US-GILEAD-2020-0483702,GILEAD,,54.0,YR,A,M,Y,104.3,KG,20200717.0,,PH,US,US,2020,Q3,Adult
180397241,18039724,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,28.0,IU,,,2020,Q3,Anaemia,,2020,Q3,1,I,20200422.0,20200710.0,20200718,20200718,EXP,IT-MINISAL02-626397,IT-ACCORD-191052,ACCORD,,84.0,YR,,F,Y,64.0,KG,20200718.0,,PH,IT,IT,2020,Q3,Elderly
180397241,18039724,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,28.0,IU,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,20200422.0,20200710.0,20200718,20200718,EXP,IT-MINISAL02-626397,IT-ACCORD-191052,ACCORD,,84.0,YR,,F,Y,64.0,KG,20200718.0,,PH,IT,IT,2020,Q3,Elderly
180401411,18040141,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200713.0,20200717,20200717,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200717.0,,CN,US,US,2020,Q3,Elderly
180401411,18040141,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Dialysis,,2020,Q3,1,I,,20200713.0,20200717,20200717,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200717.0,,CN,US,US,2020,Q3,Elderly
180401411,18040141,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Disturbance in attention,,2020,Q3,1,I,,20200713.0,20200717,20200717,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200717.0,,CN,US,US,2020,Q3,Elderly
180401411,18040141,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Inability to afford medication,,2020,Q3,1,I,,20200713.0,20200717,20200717,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200717.0,,CN,US,US,2020,Q3,Elderly
180401411,18040141,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Liver dialysis,,2020,Q3,1,I,,20200713.0,20200717,20200717,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200717.0,,CN,US,US,2020,Q3,Elderly
180401534,18040153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Acute myocardial infarction,,2020,Q3,4,F,202007.0,20200820.0,20200717,20200821,EXP,,US-GILEAD-2020-0483271,GILEAD,,90.0,YR,E,M,Y,95.0,KG,20200821.0,,PH,US,US,2020,Q3,Elderly
180401534,18040153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Bradycardia,,2020,Q3,4,F,202007.0,20200820.0,20200717,20200821,EXP,,US-GILEAD-2020-0483271,GILEAD,,90.0,YR,E,M,Y,95.0,KG,20200821.0,,PH,US,US,2020,Q3,Elderly
180401534,18040153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Respiratory failure,,2020,Q3,4,F,202007.0,20200820.0,20200717,20200821,EXP,,US-GILEAD-2020-0483271,GILEAD,,90.0,YR,E,M,Y,95.0,KG,20200821.0,,PH,US,US,2020,Q3,Elderly
180407271,18040727,3,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,3000 KIU,,,U,,,,,3000.0,KIU,,,2020,Q3,Dehydration,,2020,Q3,1,I,20200519.0,20200714.0,20200717,20200717,EXP,IT-MINISAL02-624277,NVSC2020IT198253,NOVARTIS,,87.0,YR,,F,Y,,,20200718.0,,HP,IT,IT,2020,Q3,Elderly
180407271,18040727,3,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,3000 KIU,,,U,,,,,3000.0,KIU,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,20200519.0,20200714.0,20200717,20200717,EXP,IT-MINISAL02-624277,NVSC2020IT198253,NOVARTIS,,87.0,YR,,F,Y,,,20200718.0,,HP,IT,IT,2020,Q3,Elderly
180415282,18041528,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood uric acid increased,,2020,Q3,2,F,,20200813.0,20200720,20200824,EXP,,FR-BAUSCH-BL-2020-020519,BAUSCH AND LOMB,,77.0,YR,,F,Y,,,20200824.0,,PH,FR,FR,2020,Q3,Elderly
180415282,18041528,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypercalcaemia,,2020,Q3,2,F,,20200813.0,20200720,20200824,EXP,,FR-BAUSCH-BL-2020-020519,BAUSCH AND LOMB,,77.0,YR,,F,Y,,,20200824.0,,PH,FR,FR,2020,Q3,Elderly
180427111,18042711,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Glomerular filtration rate decreased,,2020,Q3,1,I,20200716.0,,20200717,20200717,DIR,,,FDA-CTU,,82.0,YR,,M,N,101.0,KG,20200717.0,N,PH,US,US,2020,Q3,Elderly
180427601,18042760,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200713.0,,20200717,20200717,DIR,,,FDA-CTU,,62.0,YR,,M,N,50.3,KG,20200717.0,Y,PH,US,US,2020,Q3,Adult
180440531,18044053,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200626.0,,20200718,20200718,DIR,,,FDA-CTU,,58.0,YR,,M,N,105.5,KG,20200716.0,N,MD,US,US,2020,Q3,Adult
180440531,18044053,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Sinus tachycardia,,2020,Q3,1,I,20200626.0,,20200718,20200718,DIR,,,FDA-CTU,,58.0,YR,,M,N,105.5,KG,20200716.0,N,MD,US,US,2020,Q3,Adult
180443001,18044300,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,COVID-19 pneumonia,,2020,Q3,1,I,20200717.0,,20200720,20200720,DIR,,,FDA-CTU,,69.0,YR,,M,N,96.6,KG,20200720.0,N,PH,US,US,2020,Q3,Elderly
180443001,18044300,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Metabolic acidosis,,2020,Q3,1,I,20200717.0,,20200720,20200720,DIR,,,FDA-CTU,,69.0,YR,,M,N,96.6,KG,20200720.0,N,PH,US,US,2020,Q3,Elderly
180443001,18044300,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pulseless electrical activity,,2020,Q3,1,I,20200717.0,,20200720,20200720,DIR,,,FDA-CTU,,69.0,YR,,M,N,96.6,KG,20200720.0,N,PH,US,US,2020,Q3,Elderly
180443001,18044300,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Respiratory failure,,2020,Q3,1,I,20200717.0,,20200720,20200720,DIR,,,FDA-CTU,,69.0,YR,,M,N,96.6,KG,20200720.0,N,PH,US,US,2020,Q3,Elderly
180443001,18044300,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,1,I,20200717.0,,20200720,20200720,DIR,,,FDA-CTU,,69.0,YR,,M,N,96.6,KG,20200720.0,N,PH,US,US,2020,Q3,Elderly
180462201,18046220,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D049598F,,,,,INJECTION,,2020,Q3,Cerebral disorder,,2020,Q3,1,I,20200716.0,20200716.0,20200721,20200721,PER,,US-ELI_LILLY_AND_COMPANY-US202007007446,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20200721.0,,CN,US,US,2020,Q3,Elderly
180493231,18049323,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hospice care,,2020,Q3,1,I,20200721.0,,20200721,20200721,DIR,,,FDA-CTU,,81.0,YR,,F,N,64.0,KG,20200721.0,N,,US,US,2020,Q3,Elderly
180497951,18049795,15,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200714.0,,20200721,20200721,DIR,,,FDA-CTU,,52.0,YR,,M,N,102.8,KG,20200721.0,Y,HP,US,US,2020,Q3,Adult
180506354,18050635,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,, ASKED BUT UNKNOWN,,,,,,,2020,Q3,Hypercalcaemia,,2020,Q3,4,F,20200706.0,20200903.0,20200721,20200908,EXP,,FR-ROCHE-2644810,ROCHE,,77.0,YR,,F,Y,,,20200908.0,,PH,FR,FR,2020,Q3,Elderly
180506354,18050635,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,, ASKED BUT UNKNOWN,,,,,,,2020,Q3,Hyperuricaemia,,2020,Q3,4,F,20200706.0,20200903.0,20200721,20200908,EXP,,FR-ROCHE-2644810,ROCHE,,77.0,YR,,F,Y,,,20200908.0,,PH,FR,FR,2020,Q3,Elderly
180519893,18051989,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2020,Q3,Blood uric acid increased,,2020,Q3,3,F,,20200828.0,20200721,20200903,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202007006247,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200903.0,,PH,FR,FR,2020,Q3,Elderly
180519893,18051989,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2020,Q3,Hypercalcaemia,,2020,Q3,3,F,,20200828.0,20200721,20200903,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202007006247,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200903.0,,PH,FR,FR,2020,Q3,Elderly
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Aortic aneurysm,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Arthralgia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Arthritis,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Diabetes mellitus,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Hypertension,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Impaired healing,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Injection site pain,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Liver disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Metabolic syndrome,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral swelling,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral venous disease,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Sensorimotor disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 UNK, U/ML, 26?28?22U",,,Y,,,,,,,INJECTION,,2020,Q3,Weight increased,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Aortic aneurysm,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Arthralgia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Arthritis,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Diabetes mellitus,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Hypertension,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Impaired healing,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Injection site pain,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Liver disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Metabolic syndrome,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral swelling,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral venous disease,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Sensorimotor disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?18",,,Y,,,,,,,INJECTION,,2020,Q3,Weight increased,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Aortic aneurysm,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Arthralgia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Arthritis,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Diabetes mellitus,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Hypertension,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Impaired healing,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Injection site pain,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Liver disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Metabolic syndrome,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral swelling,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral venous disease,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Sensorimotor disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, 30?32?30",,,Y,,,,,,,INJECTION,,2020,Q3,Weight increased,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Aortic aneurysm,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Arthralgia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Arthritis,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Diabetes mellitus,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Hypertension,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Impaired healing,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Injection site pain,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Liver disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Metabolic syndrome,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral swelling,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral venous disease,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Sensorimotor disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Weight increased,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Aortic aneurysm,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Arthralgia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Arthritis,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Diabetes mellitus,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Hypertension,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Impaired healing,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Injection site pain,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Liver disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Metabolic syndrome,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral swelling,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral venous disease,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Sensorimotor disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,RE INTRODUCED WITH THE DOSE OF 100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Weight increased,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Aortic aneurysm,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Arthralgia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Arthritis,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Diabetes mellitus,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Hypertension,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Impaired healing,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Injection site pain,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Liver disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Metabolic syndrome,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral swelling,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral venous disease,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Sensorimotor disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML,,,Y,,,,,,,INJECTION,,2020,Q3,Weight increased,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Aortic aneurysm,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Arthralgia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Arthritis,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Diabetes mellitus,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Hypertension,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Impaired healing,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Injection site pain,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Liver disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Metabolic syndrome,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral swelling,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Peripheral venous disease,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Sensorimotor disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"MODIFIED TO 30?32?30 U,",,,Y,,,,,,,INJECTION,,2020,Q3,Weight increased,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180591451,18059145,4,C,insulin glargine + lispro,,2,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase decreased,,2020,Q3,1,I,20200722.0,,20200723,20200723,DIR,,,FDA-CTU,,63.0,YR,,M,N,101.7,KG,20200723.0,N,PH,US,US,2020,Q3,Adult
180591451,18059145,4,C,insulin glargine + lispro,,2,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase decreased,,2020,Q3,1,I,20200722.0,,20200723,20200723,DIR,,,FDA-CTU,,63.0,YR,,M,N,101.7,KG,20200723.0,N,PH,US,US,2020,Q3,Adult
180591451,18059145,4,C,insulin glargine + lispro,,2,,,,,,,,,,,,,,2020,Q3,Hepatotoxicity,,2020,Q3,1,I,20200722.0,,20200723,20200723,DIR,,,FDA-CTU,,63.0,YR,,M,N,101.7,KG,20200723.0,N,PH,US,US,2020,Q3,Adult
180605331,18060533,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,28 IU,,,,, UNKNOWN,,,28.0,IU,,,2020,Q3,Anaemia,,2020,Q3,1,I,20200422.0,20200715.0,20200723,20200723,EXP,IT-MINISAL02-626397,IT-TEVA-2020-IT-1803950,TEVA,,84.0,YR,,F,Y,64.0,KG,20200723.0,,PH,IT,IT,2020,Q3,Elderly
180605331,18060533,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,28 IU,,,,, UNKNOWN,,,28.0,IU,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,20200422.0,20200715.0,20200723,20200723,EXP,IT-MINISAL02-626397,IT-TEVA-2020-IT-1803950,TEVA,,84.0,YR,,F,Y,64.0,KG,20200723.0,,PH,IT,IT,2020,Q3,Elderly
180615581,18061558,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200713.0,20200717.0,20200723,20200723,EXP,,US-GILEAD-2020-0484363,GILEAD,,62.0,YR,A,M,Y,50.3,KG,20200723.0,,PH,US,US,2020,Q3,Adult
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Acute kidney injury,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Asthenia,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Constipation,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Contraindicated product administered,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Dehydration,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Drug clearance decreased,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Drug interaction,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Duplicate therapy error,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Fatigue,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,International normalised ratio increased,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Medication error,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Mobility decreased,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Myalgia,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Oedema peripheral,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Overdose,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Product administration error,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Product name confusion,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Rhabdomyolysis,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Toxicity to various agents,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Urinary incontinence,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180658241,18065824,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Infusion site erythema,,2020,Q3,1,I,20200723.0,,20200724,20200724,DIR,,,FDA-CTU,,78.0,YR,,F,N,80.3,KG,20200724.0,Y,PH,US,US,2020,Q3,Elderly
180658241,18065824,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Infusion site extravasation,,2020,Q3,1,I,20200723.0,,20200724,20200724,DIR,,,FDA-CTU,,78.0,YR,,F,N,80.3,KG,20200724.0,Y,PH,US,US,2020,Q3,Elderly
180658241,18065824,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Infusion site swelling,,2020,Q3,1,I,20200723.0,,20200724,20200724,DIR,,,FDA-CTU,,78.0,YR,,F,N,80.3,KG,20200724.0,Y,PH,US,US,2020,Q3,Elderly
180662901,18066290,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200722.0,,20200724,20200724,DIR,,,FDA-CTU,,66.0,YR,,F,N,92.0,KG,20200724.0,N,PH,US,US,2020,Q3,Elderly
180663051,18066305,8,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Anxiety,,2020,Q3,1,I,20200724.0,,20200724,20200724,DIR,,,FDA-CTU,,69.0,YR,,M,N,84.5,KG,20200724.0,N,PH,US,US,2020,Q3,Elderly
180663051,18066305,8,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Throat tightness,,2020,Q3,1,I,20200724.0,,20200724,20200724,DIR,,,FDA-CTU,,69.0,YR,,M,N,84.5,KG,20200724.0,N,PH,US,US,2020,Q3,Elderly
180669894,18066989,25,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1?6 UNITS/0.01 ML, QID",,,,,,,,,,INJECTION,QID,2020,Q3,Blood potassium increased,,2020,Q3,4,F,20200714.0,20200817.0,20200724,20200822,EXP,,US-UNITED THERAPEUTICS-UNT-2020-010957,UNITED THERAPEUTICS,,69.0,YR,,F,Y,85.26,KG,20200822.0,,CN,US,US,2020,Q3,Elderly
180675651,18067565,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"30 U, DAILY (DIVIDED BY 3 TIMES)",,,,,,,,30.0,IU,INJECTION,QD,2020,Q3,Blood glucose decreased,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"30 U, DAILY (DIVIDED BY 3 TIMES)",,,,,,,,30.0,IU,INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"30 U, DAILY (DIVIDED BY 3 TIMES)",,,,,,,,30.0,IU,INJECTION,QD,2020,Q3,Diarrhoea,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"30 U, DAILY (DIVIDED BY 3 TIMES)",,,,,,,,30.0,IU,INJECTION,QD,2020,Q3,Drug ineffective,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"30 U, DAILY (DIVIDED BY 3 TIMES)",,,,,,,,30.0,IU,INJECTION,QD,2020,Q3,Nausea,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"30 U, DAILY (DIVIDED BY 3 TIMES)",,,,,,,,30.0,IU,INJECTION,QD,2020,Q3,Presyncope,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"30 U, DAILY (DIVIDED BY 3 TIMES)",,,,,,,,30.0,IU,INJECTION,QD,2020,Q3,Pyrexia,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"30 U, DAILY (DIVIDED BY 3 TIMES)",,,,,,,,30.0,IU,INJECTION,QD,2020,Q3,SARS-CoV-2 test negative,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"30 U, DAILY (DIVIDED BY 3 TIMES)",,,,,,,,30.0,IU,INJECTION,QD,2020,Q3,Sinusitis,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"30 U, DAILY (DIVIDED BY 3 TIMES)",,,,,,,,30.0,IU,INJECTION,QD,2020,Q3,Weight increased,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"18 U, TID (12?18 UNITS TID)",,,,, D137578A,,,18.0,IU,INJECTION,TID,2020,Q3,Blood glucose decreased,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"18 U, TID (12?18 UNITS TID)",,,,, D137578A,,,18.0,IU,INJECTION,TID,2020,Q3,Blood glucose increased,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"18 U, TID (12?18 UNITS TID)",,,,, D137578A,,,18.0,IU,INJECTION,TID,2020,Q3,Diarrhoea,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"18 U, TID (12?18 UNITS TID)",,,,, D137578A,,,18.0,IU,INJECTION,TID,2020,Q3,Drug ineffective,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"18 U, TID (12?18 UNITS TID)",,,,, D137578A,,,18.0,IU,INJECTION,TID,2020,Q3,Nausea,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"18 U, TID (12?18 UNITS TID)",,,,, D137578A,,,18.0,IU,INJECTION,TID,2020,Q3,Presyncope,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"18 U, TID (12?18 UNITS TID)",,,,, D137578A,,,18.0,IU,INJECTION,TID,2020,Q3,Pyrexia,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"18 U, TID (12?18 UNITS TID)",,,,, D137578A,,,18.0,IU,INJECTION,TID,2020,Q3,SARS-CoV-2 test negative,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"18 U, TID (12?18 UNITS TID)",,,,, D137578A,,,18.0,IU,INJECTION,TID,2020,Q3,Sinusitis,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180675651,18067565,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"18 U, TID (12?18 UNITS TID)",,,,, D137578A,,,18.0,IU,INJECTION,TID,2020,Q3,Weight increased,,2020,Q3,1,I,2020.0,20200714.0,20200724,20200724,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006681,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20200724.0,,CN,US,US,2020,Q3,Adult
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Asthma,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Blood count abnormal,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Chest discomfort,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Cough,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Diaphragmatic disorder,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Discomfort,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Hypoxia,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Left ventricular hypertrophy,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Obstructive airways disorder,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Weight increased,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180682311,18068231,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Wheezing,,2020,Q3,1,I,,20200717.0,20200724,20200724,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-036513",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200724.0,,MD,CA,CA,2020,Q3,Elderly
180693201,18069320,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood uric acid increased,,2020,Q3,1,I,,20200717.0,20200725,20200725,EXP,,NVSC2020FR202907,NOVARTIS,,77.0,YR,,F,Y,,,20200725.0,,HP,COUNTRY NOT SPECIFIED,FR,2020,Q3,Elderly
180693201,18069320,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypercalcaemia,,2020,Q3,1,I,,20200717.0,20200725,20200725,EXP,,NVSC2020FR202907,NOVARTIS,,77.0,YR,,F,Y,,,20200725.0,,HP,COUNTRY NOT SPECIFIED,FR,2020,Q3,Elderly
180713892,18071389,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Asthenia,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Drug interaction,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Duplicate therapy error,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Immobile,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,International normalised ratio increased,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Medication error,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Myalgia,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Rhabdomyolysis,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Urinary incontinence,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180728421,18072842,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,1,I,20200726.0,,20200727,20200727,DIR,,,FDA-CTU,,77.0,YR,,F,N,70.0,KG,20200727.0,N,PH,US,US,2020,Q3,Elderly
180773922,18077392,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,2,F,20200711.0,20200813.0,20200727,20200814,EXP,,US-GILEAD-2020-0485708,GILEAD,,73.0,YR,E,M,Y,91.5,KG,20200814.0,,PH,US,US,2020,Q3,Elderly
180776271,18077627,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D088599D,,20563.0,,,INJECTION,,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,20200712.0,20200715.0,20200727,20200727,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006678,ELI LILLY AND CO,,24.0,YR,,M,Y,,,20200727.0,,CN,US,US,2020,Q3,Young Adult
180776271,18077627,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D088599D,,20563.0,,,INJECTION,,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,20200712.0,20200715.0,20200727,20200727,EXP,,US-ELI_LILLY_AND_COMPANY-US202007006678,ELI LILLY AND CO,,24.0,YR,,M,Y,,,20200727.0,,CN,US,US,2020,Q3,Young Adult
180777083,18077708,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,18 UNITS ? 20 UNITS,,,D,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,3,F,201610.0,20200811.0,20200727,20200825,EXP,,"PL-ARBOR PHARMACEUTICALS, LLC-PL-2020ARB000579",ARBOR,,66.0,YR,,M,Y,,,20200825.0,,HP,PL,PL,2020,Q3,Elderly
180777083,18077708,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,18 UNITS ? 20 UNITS,,,D,,,,,,,,,2020,Q3,Cardiac disorder,,2020,Q3,3,F,201610.0,20200811.0,20200727,20200825,EXP,,"PL-ARBOR PHARMACEUTICALS, LLC-PL-2020ARB000579",ARBOR,,66.0,YR,,M,Y,,,20200825.0,,HP,PL,PL,2020,Q3,Elderly
180777083,18077708,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,18 UNITS ? 20 UNITS,,,D,,,,,,,,,2020,Q3,Cough,,2020,Q3,3,F,201610.0,20200811.0,20200727,20200825,EXP,,"PL-ARBOR PHARMACEUTICALS, LLC-PL-2020ARB000579",ARBOR,,66.0,YR,,M,Y,,,20200825.0,,HP,PL,PL,2020,Q3,Elderly
180777083,18077708,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,18 UNITS ? 20 UNITS,,,D,,,,,,,,,2020,Q3,Decreased appetite,,2020,Q3,3,F,201610.0,20200811.0,20200727,20200825,EXP,,"PL-ARBOR PHARMACEUTICALS, LLC-PL-2020ARB000579",ARBOR,,66.0,YR,,M,Y,,,20200825.0,,HP,PL,PL,2020,Q3,Elderly
180777083,18077708,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,18 UNITS ? 20 UNITS,,,D,,,,,,,,,2020,Q3,Lacrimation increased,,2020,Q3,3,F,201610.0,20200811.0,20200727,20200825,EXP,,"PL-ARBOR PHARMACEUTICALS, LLC-PL-2020ARB000579",ARBOR,,66.0,YR,,M,Y,,,20200825.0,,HP,PL,PL,2020,Q3,Elderly
180777083,18077708,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,18 UNITS ? 20 UNITS,,,D,,,,,,,,,2020,Q3,Off label use,,2020,Q3,3,F,201610.0,20200811.0,20200727,20200825,EXP,,"PL-ARBOR PHARMACEUTICALS, LLC-PL-2020ARB000579",ARBOR,,66.0,YR,,M,Y,,,20200825.0,,HP,PL,PL,2020,Q3,Elderly
180777083,18077708,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,18 UNITS ? 20 UNITS,,,D,,,,,,,,,2020,Q3,Pain in extremity,,2020,Q3,3,F,201610.0,20200811.0,20200727,20200825,EXP,,"PL-ARBOR PHARMACEUTICALS, LLC-PL-2020ARB000579",ARBOR,,66.0,YR,,M,Y,,,20200825.0,,HP,PL,PL,2020,Q3,Elderly
180777083,18077708,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,18 UNITS ? 20 UNITS,,,D,,,,,,,,,2020,Q3,Taste disorder,,2020,Q3,3,F,201610.0,20200811.0,20200727,20200825,EXP,,"PL-ARBOR PHARMACEUTICALS, LLC-PL-2020ARB000579",ARBOR,,66.0,YR,,M,Y,,,20200825.0,,HP,PL,PL,2020,Q3,Elderly
180789984,18078998,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?18 UNITS,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,4,F,20200714.0,20200818.0,20200728,20200827,EXP,,US-GILEAD-2020-0485015,GILEAD,,51.0,YR,A,M,Y,102.8,KG,20200827.0,,HP,US,US,2020,Q3,Adult
180801861,18080186,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,18?18?18 UNITS?200 U/ML?THERAPY START DATE: JUN 2018,,,Y,,,,,,,,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,18?18?18 UNITS?200 U/ML?THERAPY START DATE: JUN 2018,,,Y,,,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,18?18?18 UNITS?200 U/ML?THERAPY START DATE: JUN 2018,,,Y,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180802072,18080207,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood uric acid increased,,2020,Q3,2,F,20200706.0,20200902.0,20200728,20200910,EXP,,FR-EMD SERONO-E2B_90079050,EMD SERONO INC,,77.0,YR,E,F,Y,,,20200910.0,,PH,FR,FR,2020,Q3,Elderly
180802072,18080207,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypercalcaemia,,2020,Q3,2,F,20200706.0,20200902.0,20200728,20200910,EXP,,FR-EMD SERONO-E2B_90079050,EMD SERONO INC,,77.0,YR,E,F,Y,,,20200910.0,,PH,FR,FR,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Acute kidney injury,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Alanine aminotransferase increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Asthenia,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Bedridden,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Blood creatine phosphokinase increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Blood creatinine increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Blood urea increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Constipation,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Contraindicated product administered,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Dehydration,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Drug clearance decreased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Drug interaction,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Fatigue,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Immobile,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Incorrect dose administered,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,International normalised ratio increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Medication error,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Mobility decreased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Myalgia,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Myoglobin blood increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Oedema peripheral,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Overdose,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Polyuria,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Product administration error,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Product name confusion,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Rhabdomyolysis,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Toxicity to various agents,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Transaminases increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q3,Urinary incontinence,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180842112,18084211,42,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,2,F,20200710.0,20200913.0,20200728,20200915,EXP,,US-GILEAD-2020-0486110,GILEAD,,46.0,YR,A,M,Y,138.01,KG,20200915.0,,PH,US,US,2020,Q3,Adult
180855832,18085583,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,PER SCALE,,,,,,,,,,,Q6H,2020,Q3,Aortic dissection,,2020,Q3,2,F,20200718.0,20200828.0,20200729,20200831,EXP,,US-GILEAD-2020-0486599,GILEAD,,67.0,YR,E,M,Y,129.0,KG,20200831.0,,MD,US,US,2020,Q3,Elderly
180855832,18085583,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,PER SCALE,,,,,,,,,,,Q6H,2020,Q3,Death,,2020,Q3,2,F,20200718.0,20200828.0,20200729,20200831,EXP,,US-GILEAD-2020-0486599,GILEAD,,67.0,YR,E,M,Y,129.0,KG,20200831.0,,MD,US,US,2020,Q3,Elderly
180855832,18085583,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,PER SCALE,,,,,,,,,,,Q6H,2020,Q3,Depressed level of consciousness,,2020,Q3,2,F,20200718.0,20200828.0,20200729,20200831,EXP,,US-GILEAD-2020-0486599,GILEAD,,67.0,YR,E,M,Y,129.0,KG,20200831.0,,MD,US,US,2020,Q3,Elderly
180855832,18085583,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,PER SCALE,,,,,,,,,,,Q6H,2020,Q3,Hypertension,,2020,Q3,2,F,20200718.0,20200828.0,20200729,20200831,EXP,,US-GILEAD-2020-0486599,GILEAD,,67.0,YR,E,M,Y,129.0,KG,20200831.0,,MD,US,US,2020,Q3,Elderly
180855832,18085583,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,PER SCALE,,,,,,,,,,,Q6H,2020,Q3,Hypoxia,,2020,Q3,2,F,20200718.0,20200828.0,20200729,20200831,EXP,,US-GILEAD-2020-0486599,GILEAD,,67.0,YR,E,M,Y,129.0,KG,20200831.0,,MD,US,US,2020,Q3,Elderly
180855832,18085583,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,PER SCALE,,,,,,,,,,,Q6H,2020,Q3,Tachycardia,,2020,Q3,2,F,20200718.0,20200828.0,20200729,20200831,EXP,,US-GILEAD-2020-0486599,GILEAD,,67.0,YR,E,M,Y,129.0,KG,20200831.0,,MD,US,US,2020,Q3,Elderly
180857761,18085776,8,C,Insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Bradycardia,,2020,Q3,1,I,20200727.0,,20200728,20200728,DIR,,,FDA-CTU,,78.0,YR,,M,N,82.0,KG,20200728.0,Y,PH,US,US,2020,Q3,Elderly
180857761,18085776,8,C,Insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,1,I,20200727.0,,20200728,20200728,DIR,,,FDA-CTU,,78.0,YR,,M,N,82.0,KG,20200728.0,Y,PH,US,US,2020,Q3,Elderly
180857761,18085776,8,C,Insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Cardio-respiratory arrest,,2020,Q3,1,I,20200727.0,,20200728,20200728,DIR,,,FDA-CTU,,78.0,YR,,M,N,82.0,KG,20200728.0,Y,PH,US,US,2020,Q3,Elderly
180857761,18085776,8,C,Insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,20200727.0,,20200728,20200728,DIR,,,FDA-CTU,,78.0,YR,,M,N,82.0,KG,20200728.0,Y,PH,US,US,2020,Q3,Elderly
180857761,18085776,8,C,Insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,1,I,20200727.0,,20200728,20200728,DIR,,,FDA-CTU,,78.0,YR,,M,N,82.0,KG,20200728.0,Y,PH,US,US,2020,Q3,Elderly
180857761,18085776,8,C,Insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Unresponsive to stimuli,,2020,Q3,1,I,20200727.0,,20200728,20200728,DIR,,,FDA-CTU,,78.0,YR,,M,N,82.0,KG,20200728.0,Y,PH,US,US,2020,Q3,Elderly
180859601,18085960,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20200710.0,,20200729,20200729,DIR,,,FDA-CTU,,80.0,YR,,M,N,74.4,KG,20200729.0,N,PH,US,US,2020,Q3,Elderly
180859601,18085960,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Blood pressure decreased,,2020,Q3,1,I,20200710.0,,20200729,20200729,DIR,,,FDA-CTU,,80.0,YR,,M,N,74.4,KG,20200729.0,N,PH,US,US,2020,Q3,Elderly
180859601,18085960,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Disseminated intravascular coagulation,,2020,Q3,1,I,20200710.0,,20200729,20200729,DIR,,,FDA-CTU,,80.0,YR,,M,N,74.4,KG,20200729.0,N,PH,US,US,2020,Q3,Elderly
180859601,18085960,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Therapy non-responder,,2020,Q3,1,I,20200710.0,,20200729,20200729,DIR,,,FDA-CTU,,80.0,YR,,M,N,74.4,KG,20200729.0,N,PH,US,US,2020,Q3,Elderly
180877773,18087777,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18 UNITS ? 20 UNITS,,,,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,3,F,201610.0,20200811.0,20200729,20200824,EXP,,"PL-VERITY PHARMACEUTICALS, INC.-2020VTY00145",VERITY PHARMACEUTICALS,,66.0,YR,,M,Y,,,20200824.0,,CN,COUNTRY NOT SPECIFIED,PL,2020,Q3,Elderly
180877773,18087777,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18 UNITS ? 20 UNITS,,,,,,,,,,,,2020,Q3,Cardiac disorder,,2020,Q3,3,F,201610.0,20200811.0,20200729,20200824,EXP,,"PL-VERITY PHARMACEUTICALS, INC.-2020VTY00145",VERITY PHARMACEUTICALS,,66.0,YR,,M,Y,,,20200824.0,,CN,COUNTRY NOT SPECIFIED,PL,2020,Q3,Elderly
180877773,18087777,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18 UNITS ? 20 UNITS,,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,3,F,201610.0,20200811.0,20200729,20200824,EXP,,"PL-VERITY PHARMACEUTICALS, INC.-2020VTY00145",VERITY PHARMACEUTICALS,,66.0,YR,,M,Y,,,20200824.0,,CN,COUNTRY NOT SPECIFIED,PL,2020,Q3,Elderly
180877773,18087777,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18 UNITS ? 20 UNITS,,,,,,,,,,,,2020,Q3,Decreased appetite,,2020,Q3,3,F,201610.0,20200811.0,20200729,20200824,EXP,,"PL-VERITY PHARMACEUTICALS, INC.-2020VTY00145",VERITY PHARMACEUTICALS,,66.0,YR,,M,Y,,,20200824.0,,CN,COUNTRY NOT SPECIFIED,PL,2020,Q3,Elderly
180877773,18087777,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18 UNITS ? 20 UNITS,,,,,,,,,,,,2020,Q3,Lacrimation increased,,2020,Q3,3,F,201610.0,20200811.0,20200729,20200824,EXP,,"PL-VERITY PHARMACEUTICALS, INC.-2020VTY00145",VERITY PHARMACEUTICALS,,66.0,YR,,M,Y,,,20200824.0,,CN,COUNTRY NOT SPECIFIED,PL,2020,Q3,Elderly
180877773,18087777,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18 UNITS ? 20 UNITS,,,,,,,,,,,,2020,Q3,Off label use,,2020,Q3,3,F,201610.0,20200811.0,20200729,20200824,EXP,,"PL-VERITY PHARMACEUTICALS, INC.-2020VTY00145",VERITY PHARMACEUTICALS,,66.0,YR,,M,Y,,,20200824.0,,CN,COUNTRY NOT SPECIFIED,PL,2020,Q3,Elderly
180877773,18087777,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18 UNITS ? 20 UNITS,,,,,,,,,,,,2020,Q3,Pain in extremity,,2020,Q3,3,F,201610.0,20200811.0,20200729,20200824,EXP,,"PL-VERITY PHARMACEUTICALS, INC.-2020VTY00145",VERITY PHARMACEUTICALS,,66.0,YR,,M,Y,,,20200824.0,,CN,COUNTRY NOT SPECIFIED,PL,2020,Q3,Elderly
180877773,18087777,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18 UNITS ? 20 UNITS,,,,,,,,,,,,2020,Q3,Taste disorder,,2020,Q3,3,F,201610.0,20200811.0,20200729,20200824,EXP,,"PL-VERITY PHARMACEUTICALS, INC.-2020VTY00145",VERITY PHARMACEUTICALS,,66.0,YR,,M,Y,,,20200824.0,,CN,COUNTRY NOT SPECIFIED,PL,2020,Q3,Elderly
180885471,18088547,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Acute kidney injury,,2020,Q3,1,I,,20200727.0,20200729,20200729,EXP,,NVSC2020CZ211240,NOVARTIS,"VODICKA M, SLANAF O, PISAR M, SALEK T. ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CESKA A SLOVENSKA FARMACIE. 2020?69(2):100?2",74.0,YR,,M,Y,,,20200729.0,,HP,CZ,CZ,2020,Q3,Elderly
180885471,18088547,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Contraindicated product administered,,2020,Q3,1,I,,20200727.0,20200729,20200729,EXP,,NVSC2020CZ211240,NOVARTIS,"VODICKA M, SLANAF O, PISAR M, SALEK T. ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CESKA A SLOVENSKA FARMACIE. 2020?69(2):100?2",74.0,YR,,M,Y,,,20200729.0,,HP,CZ,CZ,2020,Q3,Elderly
180885471,18088547,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Medication error,,2020,Q3,1,I,,20200727.0,20200729,20200729,EXP,,NVSC2020CZ211240,NOVARTIS,"VODICKA M, SLANAF O, PISAR M, SALEK T. ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CESKA A SLOVENSKA FARMACIE. 2020?69(2):100?2",74.0,YR,,M,Y,,,20200729.0,,HP,CZ,CZ,2020,Q3,Elderly
180885471,18088547,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Polyuria,,2020,Q3,1,I,,20200727.0,20200729,20200729,EXP,,NVSC2020CZ211240,NOVARTIS,"VODICKA M, SLANAF O, PISAR M, SALEK T. ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CESKA A SLOVENSKA FARMACIE. 2020?69(2):100?2",74.0,YR,,M,Y,,,20200729.0,,HP,CZ,CZ,2020,Q3,Elderly
180885471,18088547,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Rhabdomyolysis,,2020,Q3,1,I,,20200727.0,20200729,20200729,EXP,,NVSC2020CZ211240,NOVARTIS,"VODICKA M, SLANAF O, PISAR M, SALEK T. ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CESKA A SLOVENSKA FARMACIE. 2020?69(2):100?2",74.0,YR,,M,Y,,,20200729.0,,HP,CZ,CZ,2020,Q3,Elderly
180890883,18089088,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BEFORE MEALS 3X DAY,,,,,,,,12.0,,,Q8H,2020,Q3,Fournier's gangrene,,2020,Q3,3,F,20170618.0,20200921.0,20200730,20200925,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-038617",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,,,20200925.0,,MD,US,US,2020,Q3,Adult
180890883,18089088,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BEFORE MEALS 3X DAY,,,,,,,,12.0,,,Q8H,2020,Q3,Sepsis,,2020,Q3,3,F,20170618.0,20200921.0,20200730,20200925,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-038617",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,,,20200925.0,,MD,US,US,2020,Q3,Adult
180890883,18089088,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BEFORE MEALS 3X DAY,,,,,,,,12.0,,,Q8H,2020,Q3,Tachycardia,,2020,Q3,3,F,20170618.0,20200921.0,20200730,20200925,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-038617",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,,,20200925.0,,MD,US,US,2020,Q3,Adult
180890901,18089090,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, TID",,,,,,,,10.0,IU,INJECTION,,2020,Q3,Blindness,,2020,Q3,1,I,,20190613.0,20200730,20200730,PER,,US-STRIDES ARCOLAB LIMITED-2019SP005104,STRIDES,,61.0,YR,,F,Y,,,20200730.0,,HP,US,US,2020,Q3,Adult
180890901,18089090,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, TID",,,,,,,,10.0,IU,INJECTION,,2020,Q3,Central nervous system lymphoma,,2020,Q3,1,I,,20190613.0,20200730,20200730,PER,,US-STRIDES ARCOLAB LIMITED-2019SP005104,STRIDES,,61.0,YR,,F,Y,,,20200730.0,,HP,US,US,2020,Q3,Adult
180890901,18089090,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, TID",,,,,,,,10.0,IU,INJECTION,,2020,Q3,Cognitive disorder,,2020,Q3,1,I,,20190613.0,20200730,20200730,PER,,US-STRIDES ARCOLAB LIMITED-2019SP005104,STRIDES,,61.0,YR,,F,Y,,,20200730.0,,HP,US,US,2020,Q3,Adult
180890901,18089090,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, TID",,,,,,,,10.0,IU,INJECTION,,2020,Q3,Epstein-Barr virus infection,,2020,Q3,1,I,,20190613.0,20200730,20200730,PER,,US-STRIDES ARCOLAB LIMITED-2019SP005104,STRIDES,,61.0,YR,,F,Y,,,20200730.0,,HP,US,US,2020,Q3,Adult
180890901,18089090,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, TID",,,,,,,,10.0,IU,INJECTION,,2020,Q3,Headache,,2020,Q3,1,I,,20190613.0,20200730,20200730,PER,,US-STRIDES ARCOLAB LIMITED-2019SP005104,STRIDES,,61.0,YR,,F,Y,,,20200730.0,,HP,US,US,2020,Q3,Adult
180890901,18089090,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, TID",,,,,,,,10.0,IU,INJECTION,,2020,Q3,Pleocytosis,,2020,Q3,1,I,,20190613.0,20200730,20200730,PER,,US-STRIDES ARCOLAB LIMITED-2019SP005104,STRIDES,,61.0,YR,,F,Y,,,20200730.0,,HP,US,US,2020,Q3,Adult
180890901,18089090,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, TID",,,,,,,,10.0,IU,INJECTION,,2020,Q3,Post transplant lymphoproliferative disorder,,2020,Q3,1,I,,20190613.0,20200730,20200730,PER,,US-STRIDES ARCOLAB LIMITED-2019SP005104,STRIDES,,61.0,YR,,F,Y,,,20200730.0,,HP,US,US,2020,Q3,Adult
180903351,18090335,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,U, D137576C,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200702.0,20200702.0,20200730,20200730,PER,,US-ELI_LILLY_AND_COMPANY-US202007001651,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200730.0,,CN,US,US,2020,Q3,Elderly
180903351,18090335,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,U, D137576C,,20563.0,,,INJECTION,,2020,Q3,Product storage error,,2020,Q3,1,I,20200702.0,20200702.0,20200730,20200730,PER,,US-ELI_LILLY_AND_COMPANY-US202007001651,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20200730.0,,CN,US,US,2020,Q3,Elderly
180964512,18096451,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood uric acid increased,,2020,Q3,2,F,,20200901.0,20200731,20200912,EXP,,FR-APOTEX-2020AP014801,APOTEX,,77.0,YR,,F,Y,,,20200912.0,,CN,GB,FR,2020,Q3,Elderly
180964512,18096451,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypercalcaemia,,2020,Q3,2,F,,20200901.0,20200731,20200912,EXP,,FR-APOTEX-2020AP014801,APOTEX,,77.0,YR,,F,Y,,,20200912.0,,CN,GB,FR,2020,Q3,Elderly
180966812,18096681,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, THERAPY START DATE AND END DATE: ASKU",,,U,," ASKU,ASKED BUT UNKNOWN",,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood uric acid increased,,2020,Q3,2,F,,20200909.0,20200731,20200918,EXP,,FR-TEVA-2020-FR-1806789,TEVA,,77.0,YR,E,F,Y,,,20200918.0,,PH,FR,FR,2020,Q3,Elderly
180966812,18096681,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, THERAPY START DATE AND END DATE: ASKU",,,U,," ASKU,ASKED BUT UNKNOWN",,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypercalcaemia,,2020,Q3,2,F,,20200909.0,20200731,20200918,EXP,,FR-TEVA-2020-FR-1806789,TEVA,,77.0,YR,E,F,Y,,,20200918.0,,PH,FR,FR,2020,Q3,Elderly
180971781,18097178,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200726.0,20200727.0,20200730,20200730,PER,,US-ELI_LILLY_AND_COMPANY-US202007012595,ELI LILLY AND CO,,45.0,YR,,M,Y,,,20200730.0,,CN,US,US,2020,Q3,Adult
181006902,18100690,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?2 UNITS,,,,,,,,,,,,2020,Q3,Allergic oedema,,2020,Q3,2,F,20200719.0,20200728.0,20200731,20200915,EXP,,US-GILEAD-2020-0487549,GILEAD,,89.0,YR,E,F,Y,75.01,KG,20200915.0,,HP,US,US,2020,Q3,Elderly
181006902,18100690,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?2 UNITS,,,,,,,,,,,,2020,Q3,Hypersensitivity,,2020,Q3,2,F,20200719.0,20200728.0,20200731,20200915,EXP,,US-GILEAD-2020-0487549,GILEAD,,89.0,YR,E,F,Y,75.01,KG,20200915.0,,HP,US,US,2020,Q3,Elderly
181006902,18100690,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?2 UNITS,,,,,,,,,,,,2020,Q3,Urticaria,,2020,Q3,2,F,20200719.0,20200728.0,20200731,20200915,EXP,,US-GILEAD-2020-0487549,GILEAD,,89.0,YR,E,F,Y,75.01,KG,20200915.0,,HP,US,US,2020,Q3,Elderly
181008382,18100838,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Fournier's gangrene,,2020,Q3,2,F,20180611.0,20200803.0,20200731,20200811,EXP,,US-ASTRAZENECA-2020SE93122,ASTRAZENECA,,18633.0,DY,,M,Y,,,20200811.0,,,US,US,2020,Q3,Elderly
181008382,18100838,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Scrotal abscess,,2020,Q3,2,F,20180611.0,20200803.0,20200731,20200811,EXP,,US-ASTRAZENECA-2020SE93122,ASTRAZENECA,,18633.0,DY,,M,Y,,,20200811.0,,,US,US,2020,Q3,Elderly
181008382,18100838,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,2,F,20180611.0,20200803.0,20200731,20200811,EXP,,US-ASTRAZENECA-2020SE93122,ASTRAZENECA,,18633.0,DY,,M,Y,,,20200811.0,,,US,US,2020,Q3,Elderly
181008382,18100838,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Urinary tract infection,,2020,Q3,2,F,20180611.0,20200803.0,20200731,20200811,EXP,,US-ASTRAZENECA-2020SE93122,ASTRAZENECA,,18633.0,DY,,M,Y,,,20200811.0,,,US,US,2020,Q3,Elderly
181030491,18103049,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20200727.0,,20200731,20200731,DIR,,,FDA-CTU,,75.0,YR,,M,N,100.0,KG,20200731.0,N,PH,US,US,2020,Q3,Elderly
181037201,18103720,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,, UNK,,,,,,,2020,Q3,Heparin-induced thrombocytopenia,,2020,Q3,1,I,,20200729.0,20200803,20200803,EXP,,CZ-FRESENIUS KABI-FK202007837,FRESENIUS KABI,POLAK P. HEPARIN?INDUCED THROMBOCYTOPENIA: A CASE REPORT AND LITERATURE REVIEW.,62.0,YR,,F,Y,,,20200803.0,,,COUNTRY NOT SPECIFIED,CZ,2020,Q3,Adult
181037201,18103720,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,, UNK,,,,,,,2020,Q3,Incision site impaired healing,,2020,Q3,1,I,,20200729.0,20200803,20200803,EXP,,CZ-FRESENIUS KABI-FK202007837,FRESENIUS KABI,POLAK P. HEPARIN?INDUCED THROMBOCYTOPENIA: A CASE REPORT AND LITERATURE REVIEW.,62.0,YR,,F,Y,,,20200803.0,,,COUNTRY NOT SPECIFIED,CZ,2020,Q3,Adult
181037201,18103720,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,, UNK,,,,,,,2020,Q3,Off label use,,2020,Q3,1,I,,20200729.0,20200803,20200803,EXP,,CZ-FRESENIUS KABI-FK202007837,FRESENIUS KABI,POLAK P. HEPARIN?INDUCED THROMBOCYTOPENIA: A CASE REPORT AND LITERATURE REVIEW.,62.0,YR,,F,Y,,,20200803.0,,,COUNTRY NOT SPECIFIED,CZ,2020,Q3,Adult
181053371,18105337,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Coma scale abnormal,,2020,Q3,1,I,,20200728.0,20200803,20200803,EXP,,CA-TEVA-2020-CA-1808719,TEVA,,75.0,YR,E,M,Y,,,20200803.0,,CN,CA,CA,2020,Q3,Elderly
181053371,18105337,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,,20200728.0,20200803,20200803,EXP,,CA-TEVA-2020-CA-1808719,TEVA,,75.0,YR,E,M,Y,,,20200803.0,,CN,CA,CA,2020,Q3,Elderly
181053371,18105337,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Subdural haematoma,,2020,Q3,1,I,,20200728.0,20200803,20200803,EXP,,CA-TEVA-2020-CA-1808719,TEVA,,75.0,YR,E,M,Y,,,20200803.0,,CN,CA,CA,2020,Q3,Elderly
181053371,18105337,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Unresponsive to stimuli,,2020,Q3,1,I,,20200728.0,20200803,20200803,EXP,,CA-TEVA-2020-CA-1808719,TEVA,,75.0,YR,E,M,Y,,,20200803.0,,CN,CA,CA,2020,Q3,Elderly
181084471,18108447,7,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Death,,2020,Q3,1,I,20200721.0,20200729.0,20200804,20200804,EXP,,US-CELGENEUS-USA-20200800055,CELGENE,,58.0,YR,,M,Y,,,20200804.0,,MD,US,US,2020,Q3,Adult
181099161,18109916,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,, ASKU,,,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200714.0,20200727.0,20200804,20200804,EXP,,US-ELI_LILLY_AND_COMPANY-US202007012214,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20200804.0,,CN,US,US,2020,Q3,Adult
181099161,18109916,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,, ASKU,,,,,INJECTION,,2020,Q3,Ketoacidosis,,2020,Q3,1,I,20200714.0,20200727.0,20200804,20200804,EXP,,US-ELI_LILLY_AND_COMPANY-US202007012214,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20200804.0,,CN,US,US,2020,Q3,Adult
181107741,18110774,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,20200727.0,20200804.0,20200804,20200804,EXP,IT-MINISAL02-629016,IT-TAKEDA-2020TEU006967,TAKEDA,,55.0,YR,,F,Y,80.0,KG,20200804.0,,MD,IT,IT,2020,Q3,Adult
181130591,18113059,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2020,Q3,Blood glucose decreased,,2020,Q3,1,I,20200202.0,20200706.0,20200805,20200805,PER,,US-ELI_LILLY_AND_COMPANY-US202007002716,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200805.0,,CN,US,US,2020,Q3,Elderly
181130591,18113059,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2020,Q3,Incorrect dose administered,,2020,Q3,1,I,20200202.0,20200706.0,20200805,20200805,PER,,US-ELI_LILLY_AND_COMPANY-US202007002716,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200805.0,,CN,US,US,2020,Q3,Elderly
181178591,18117859,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20200731.0,,20200805,20200805,DIR,,,FDA-CTU,,71.0,YR,,M,N,117.4,KG,20200805.0,N,CN,US,US,2020,Q3,Elderly
181180152,18118015,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Arthralgia,,2020,Q3,2,F,20200728.0,20200803.0,20200806,20200810,PER,,US-ELI_LILLY_AND_COMPANY-US202008000904,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200810.0,,CN,US,US,2020,Q3,Elderly
181180152,18118015,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,20200728.0,20200803.0,20200806,20200810,PER,,US-ELI_LILLY_AND_COMPANY-US202008000904,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200810.0,,CN,US,US,2020,Q3,Elderly
181180152,18118015,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Gait disturbance,,2020,Q3,2,F,20200728.0,20200803.0,20200806,20200810,PER,,US-ELI_LILLY_AND_COMPANY-US202008000904,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200810.0,,CN,US,US,2020,Q3,Elderly
181180152,18118015,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Mobility decreased,,2020,Q3,2,F,20200728.0,20200803.0,20200806,20200810,PER,,US-ELI_LILLY_AND_COMPANY-US202008000904,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200810.0,,CN,US,US,2020,Q3,Elderly
181180651,18118065,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Electrocardiogram QT prolonged,,2020,Q3,1,I,,20200804.0,20200806,20200806,EXP,,NVSC2020US217087,NOVARTIS,"KAZI DS, MARTIN LM, LITMANOVICH D, PINTO DS, CLERKIN KJ, ZIMETBAUM PJ ET AL.. CASE 18?2020: A 73?YEAR?OLD MAN WITH HYPOXEMIC RESPIRATORY FAILURE. NEW ENGLAND JOURNAL OF MEDICINE. 2020?382(24):2354?64",73.0,YR,,M,Y,,,20200806.0,,HP,US,US,2020,Q3,Elderly
181180651,18118065,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Product use in unapproved indication,,2020,Q3,1,I,,20200804.0,20200806,20200806,EXP,,NVSC2020US217087,NOVARTIS,"KAZI DS, MARTIN LM, LITMANOVICH D, PINTO DS, CLERKIN KJ, ZIMETBAUM PJ ET AL.. CASE 18?2020: A 73?YEAR?OLD MAN WITH HYPOXEMIC RESPIRATORY FAILURE. NEW ENGLAND JOURNAL OF MEDICINE. 2020?382(24):2354?64",73.0,YR,,M,Y,,,20200806.0,,HP,US,US,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Asthma,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Blood count abnormal,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Chest discomfort,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Diaphragmatic disorder,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Discomfort,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Left ventricular hypertrophy,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Obstructive airways disorder,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181198191,18119819,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Wheezing,,2020,Q3,1,I,,20200727.0,20200806,20200806,EXP,,CA-COVIS PHARMA B.V.-2020COV00319,COVIS,,83.0,YR,,M,Y,,,20200806.0,,CN,CA,CA,2020,Q3,Elderly
181221006,18122100,35,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,QID,2020,Q3,Bacteraemia,,2020,Q3,6,F,20200706.0,20200921.0,20200806,20200924,EXP,,US-ROCHE-2649233,ROCHE,,68.0,YR,,M,Y,154.0,KG,20200925.0,,MD,US,US,2020,Q3,Elderly
181221006,18122100,35,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,QID,2020,Q3,Device related infection,,2020,Q3,6,F,20200706.0,20200921.0,20200806,20200924,EXP,,US-ROCHE-2649233,ROCHE,,68.0,YR,,M,Y,154.0,KG,20200925.0,,MD,US,US,2020,Q3,Elderly
181221006,18122100,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Bacteraemia,,2020,Q3,6,F,20200706.0,20200921.0,20200806,20200924,EXP,,US-ROCHE-2649233,ROCHE,,68.0,YR,,M,Y,154.0,KG,20200925.0,,MD,US,US,2020,Q3,Elderly
181221006,18122100,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Device related infection,,2020,Q3,6,F,20200706.0,20200921.0,20200806,20200924,EXP,,US-ROCHE-2649233,ROCHE,,68.0,YR,,M,Y,154.0,KG,20200925.0,,MD,US,US,2020,Q3,Elderly
181236541,18123654,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, TID",,,,,,,,25.0,IU,,TID,2020,Q3,Tooth infection,,2020,Q3,1,I,202002.0,20200403.0,20200807,20200807,PER,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004802",AEGERION,,20.0,YR,,F,Y,41.1,KG,20200807.0,,HP,US,US,2020,Q3,Youth
181236541,18123654,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, TID",,,,,,,,25.0,IU,,TID,2020,Q3,Tooth infection,,2020,Q3,1,I,202002.0,20200403.0,20200807,20200807,PER,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004802",AEGERION,,20.0,YR,,F,Y,41.1,KG,20200807.0,,HP,US,US,2020,Q3,Youth
181245962,18124596,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"SS, SUBCUTANEOUS, TIO BEFORE MEALS, INJECT 30 UNITS",,,,,,,,,,,,2020,Q3,Fournier's gangrene,,2020,Q3,2,F,20181117.0,20200921.0,20200807,20200925,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-040672",BOEHRINGER INGELHEIM,,60.0,YR,A,M,Y,185.0,KG,20200925.0,,CN,US,US,2020,Q3,Adult
181245962,18124596,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"SS, SUBCUTANEOUS, TIO BEFORE MEALS, INJECT 30 UNITS",,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,2,F,20181117.0,20200921.0,20200807,20200925,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-040672",BOEHRINGER INGELHEIM,,60.0,YR,A,M,Y,185.0,KG,20200925.0,,CN,US,US,2020,Q3,Adult
181267471,18126747,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID (26?28?22 IU/DAILY)",,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,1,I,,20200801.0,20200809,20200809,EXP,,CZ-AUROBINDO-AUR-APL-2020-038054,AUROBINDO,HIMMELOVA K. EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE.. KAZUSITIKY V DIABETOLOGII. 2020?2:33?36,62.0,YR,,M,Y,,,20200810.0,,MD,CZ,CZ,2020,Q3,Adult
181267471,18126747,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID (26?28?22 IU/DAILY)",,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,1,I,,20200801.0,20200809,20200809,EXP,,CZ-AUROBINDO-AUR-APL-2020-038054,AUROBINDO,HIMMELOVA K. EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE.. KAZUSITIKY V DIABETOLOGII. 2020?2:33?36,62.0,YR,,M,Y,,,20200810.0,,MD,CZ,CZ,2020,Q3,Adult
181267471,18126747,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID (26?28?22 IU/DAILY)",,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200801.0,20200809,20200809,EXP,,CZ-AUROBINDO-AUR-APL-2020-038054,AUROBINDO,HIMMELOVA K. EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE.. KAZUSITIKY V DIABETOLOGII. 2020?2:33?36,62.0,YR,,M,Y,,,20200810.0,,MD,CZ,CZ,2020,Q3,Adult
181282251,18128225,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200804.0,,20200807,20200807,DIR,,,FDA-CTU,,33.0,YR,,F,N,79.4,KG,20200807.0,Y,PH,US,US,2020,Q3,Young Adult
181282251,18128225,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20200804.0,,20200807,20200807,DIR,,,FDA-CTU,,33.0,YR,,F,N,79.4,KG,20200807.0,Y,PH,US,US,2020,Q3,Young Adult
181282251,18128225,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,COVID-19 pneumonia,,2020,Q3,1,I,20200804.0,,20200807,20200807,DIR,,,FDA-CTU,,33.0,YR,,F,N,79.4,KG,20200807.0,Y,PH,US,US,2020,Q3,Young Adult
181282251,18128225,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Diabetes mellitus,,2020,Q3,1,I,20200804.0,,20200807,20200807,DIR,,,FDA-CTU,,33.0,YR,,F,N,79.4,KG,20200807.0,Y,PH,US,US,2020,Q3,Young Adult
181282251,18128225,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Inflammatory marker increased,,2020,Q3,1,I,20200804.0,,20200807,20200807,DIR,,,FDA-CTU,,33.0,YR,,F,N,79.4,KG,20200807.0,Y,PH,US,US,2020,Q3,Young Adult
181282251,18128225,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,SARS-CoV-2 test positive,,2020,Q3,1,I,20200804.0,,20200807,20200807,DIR,,,FDA-CTU,,33.0,YR,,F,N,79.4,KG,20200807.0,Y,PH,US,US,2020,Q3,Young Adult
181283361,18128336,15,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hepatic function abnormal,,2020,Q3,1,I,20200805.0,,20200807,20200807,DIR,,,FDA-CTU,,70.0,YR,,M,N,103.7,KG,20200807.0,N,PH,US,US,2020,Q3,Elderly
181283561,18128356,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200804.0,,20200809,20200809,DIR,,,FDA-CTU,,66.0,YR,,F,N,148.8,KG,20200809.0,N,PH,US,US,2020,Q3,Elderly
181301321,18130132,17,C,Insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200728.0,,20200810,20200810,DIR,,,FDA-CTU,,79.0,YR,,M,N,93.9,KG,20200810.0,Y,PH,US,US,2020,Q3,Elderly
181301321,18130132,17,C,Insulin lispro sliding scale 4x/day,,2,,,,,,,,,,,,,,2020,Q3,Haemodialysis,,2020,Q3,1,I,20200728.0,,20200810,20200810,DIR,,,FDA-CTU,,79.0,YR,,M,N,93.9,KG,20200810.0,Y,PH,US,US,2020,Q3,Elderly
181301331,18130133,8,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Respiratory failure,,2020,Q3,1,I,20200809.0,,20200810,20200810,DIR,,,FDA-CTU,,72.0,YR,,F,N,82.4,KG,20200810.0,N,,US,US,2020,Q3,Elderly
181301441,18130144,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Depressed level of consciousness,,2020,Q3,1,I,20200809.0,,20200810,20200810,DIR,,,FDA-CTU,,87.0,YR,,F,N,65.3,KG,20200810.0,N,,US,US,2020,Q3,Elderly
181301441,18130144,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,1,I,20200809.0,,20200810,20200810,DIR,,,FDA-CTU,,87.0,YR,,F,N,65.3,KG,20200810.0,N,,US,US,2020,Q3,Elderly
181301441,18130144,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Oxygen saturation decreased,,2020,Q3,1,I,20200809.0,,20200810,20200810,DIR,,,FDA-CTU,,87.0,YR,,F,N,65.3,KG,20200810.0,N,,US,US,2020,Q3,Elderly
181301441,18130144,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Somnolence,,2020,Q3,1,I,20200809.0,,20200810,20200810,DIR,,,FDA-CTU,,87.0,YR,,F,N,65.3,KG,20200810.0,N,,US,US,2020,Q3,Elderly
181315892,18131589,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,16 U,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,2,F,20200728.0,20200807.0,20200810,20200817,EXP,,US-ROCHE-2654392,ROCHE,,43.0,YR,,M,Y,78.5,KG,20200817.0,,MD,US,US,2020,Q3,Adult
181315892,18131589,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,16 U,,,,,,,,,,,,2020,Q3,Quadriplegia,,2020,Q3,2,F,20200728.0,20200807.0,20200810,20200817,EXP,,US-ROCHE-2654392,ROCHE,,43.0,YR,,M,Y,78.5,KG,20200817.0,,MD,US,US,2020,Q3,Adult
181315892,18131589,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,16 U,,,,,,,,,,,,2020,Q3,Shock haemorrhagic,,2020,Q3,2,F,20200728.0,20200807.0,20200810,20200817,EXP,,US-ROCHE-2654392,ROCHE,,43.0,YR,,M,Y,78.5,KG,20200817.0,,MD,US,US,2020,Q3,Adult
181329761,18132976,12,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,US-AUROBINDO-AUR-APL-2020-038513,AUROBINDO,,46.0,YR,,M,Y,,,20200811.0,,HP,US,US,2020,Q3,Adult
181329761,18132976,12,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,US-AUROBINDO-AUR-APL-2020-038513,AUROBINDO,,46.0,YR,,M,Y,,,20200811.0,,HP,US,US,2020,Q3,Adult
181329761,18132976,12,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Off label use,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,US-AUROBINDO-AUR-APL-2020-038513,AUROBINDO,,46.0,YR,,M,Y,,,20200811.0,,HP,US,US,2020,Q3,Adult
181336812,18133681,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,PUMP,,,,, UNKNOWN,,,,,,,2020,Q3,Acute lymphocytic leukaemia recurrent,,2020,Q3,2,F,,20200814.0,20200811,20200820,EXP,,US-DRREDDYS-USA/USA/20/0125867,DR REDDYS,"LUNDHOLM M, CHARNOGURSKY G. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 JUL?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200820.0,,HP,US,US,2020,Q3,Elderly
181336812,18133681,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,PUMP,,,,, UNKNOWN,,,,,,,2020,Q3,Drug resistance,,2020,Q3,2,F,,20200814.0,20200811,20200820,EXP,,US-DRREDDYS-USA/USA/20/0125867,DR REDDYS,"LUNDHOLM M, CHARNOGURSKY G. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 JUL?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200820.0,,HP,US,US,2020,Q3,Elderly
181336812,18133681,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,PUMP,,,,, UNKNOWN,,,,,,,2020,Q3,Hyperglycaemia,,2020,Q3,2,F,,20200814.0,20200811,20200820,EXP,,US-DRREDDYS-USA/USA/20/0125867,DR REDDYS,"LUNDHOLM M, CHARNOGURSKY G. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 JUL?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200820.0,,HP,US,US,2020,Q3,Elderly
181341071,18134107,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,2020.0,20200731.0,20200811,20200811,EXP,,US-MYLANLABS-2020M1070397,MYLAN,"KAZI DS, MARTIN LM, LITMANOVICH D, PINTO DS, CLERKIN KJ, ZIMETBAUM PJ, ET AL. CASE 18?2020: A 73?YEAR?OLD MAN WITH HYPOXEMIC RESPIRATORY FAILURE AND CARDIAC DYSFUNCTION. N?ENGL?J?MED 2020?382(24):2354?2364.",73.0,YR,,M,Y,,,20200811.0,,MD,US,US,2020,Q3,Elderly
181341071,18134107,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2020,Q3,Electrocardiogram QT prolonged,,2020,Q3,1,I,2020.0,20200731.0,20200811,20200811,EXP,,US-MYLANLABS-2020M1070397,MYLAN,"KAZI DS, MARTIN LM, LITMANOVICH D, PINTO DS, CLERKIN KJ, ZIMETBAUM PJ, ET AL. CASE 18?2020: A 73?YEAR?OLD MAN WITH HYPOXEMIC RESPIRATORY FAILURE AND CARDIAC DYSFUNCTION. N?ENGL?J?MED 2020?382(24):2354?2364.",73.0,YR,,M,Y,,,20200811.0,,MD,US,US,2020,Q3,Elderly
181341071,18134107,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,1,I,2020.0,20200731.0,20200811,20200811,EXP,,US-MYLANLABS-2020M1070397,MYLAN,"KAZI DS, MARTIN LM, LITMANOVICH D, PINTO DS, CLERKIN KJ, ZIMETBAUM PJ, ET AL. CASE 18?2020: A 73?YEAR?OLD MAN WITH HYPOXEMIC RESPIRATORY FAILURE AND CARDIAC DYSFUNCTION. N?ENGL?J?MED 2020?382(24):2354?2364.",73.0,YR,,M,Y,,,20200811.0,,MD,US,US,2020,Q3,Elderly
181341071,18134107,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2020,Q3,Off label use,,2020,Q3,1,I,2020.0,20200731.0,20200811,20200811,EXP,,US-MYLANLABS-2020M1070397,MYLAN,"KAZI DS, MARTIN LM, LITMANOVICH D, PINTO DS, CLERKIN KJ, ZIMETBAUM PJ, ET AL. CASE 18?2020: A 73?YEAR?OLD MAN WITH HYPOXEMIC RESPIRATORY FAILURE AND CARDIAC DYSFUNCTION. N?ENGL?J?MED 2020?382(24):2354?2364.",73.0,YR,,M,Y,,,20200811.0,,MD,US,US,2020,Q3,Elderly
181364681,18136468,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Blood creatine phosphokinase increased,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Blood urea increased,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Incorrect dose administered,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,International normalised ratio increased,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Medication error,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Myoglobin blood increased,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Rhabdomyolysis,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q3,Transaminases increased,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181369071,18136907,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,,,2020,Q3,Abdominal distension,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008002320,ELI LILLY AND CO,,64.0,YR,,F,Y,120.0,KG,20200811.0,,PH,DE,DE,2020,Q3,Adult
181369071,18136907,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,,,2020,Q3,Anuria,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008002320,ELI LILLY AND CO,,64.0,YR,,F,Y,120.0,KG,20200811.0,,PH,DE,DE,2020,Q3,Adult
181369071,18136907,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,,,2020,Q3,Constipation,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008002320,ELI LILLY AND CO,,64.0,YR,,F,Y,120.0,KG,20200811.0,,PH,DE,DE,2020,Q3,Adult
181369071,18136907,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008002320,ELI LILLY AND CO,,64.0,YR,,F,Y,120.0,KG,20200811.0,,PH,DE,DE,2020,Q3,Adult
181369071,18136907,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,,,2020,Q3,Fatigue,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008002320,ELI LILLY AND CO,,64.0,YR,,F,Y,120.0,KG,20200811.0,,PH,DE,DE,2020,Q3,Adult
181369071,18136907,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008002320,ELI LILLY AND CO,,64.0,YR,,F,Y,120.0,KG,20200811.0,,PH,DE,DE,2020,Q3,Adult
181369071,18136907,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,,,2020,Q3,Product administration error,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008002320,ELI LILLY AND CO,,64.0,YR,,F,Y,120.0,KG,20200811.0,,PH,DE,DE,2020,Q3,Adult
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Asthma,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Blood count abnormal,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Chest discomfort,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Cough,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Diaphragmatic disorder,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Discomfort,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Hypoxia,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Left ventricular hypertrophy,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Obstructive airways disorder,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Weight increased,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181369891,18136989,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Wheezing,,2020,Q3,1,I,,20200803.0,20200811,20200811,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200811.0,,CN,CA,CA,2020,Q3,Elderly
181371671,18137167,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT (BY VALUE),,,,, UNKNOWN,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200807.0,20200812,20200812,EXP,,DE-DRREDDYS-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181371671,18137167,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT (BY VALUE),,,,, UNKNOWN,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200807.0,20200812,20200812,EXP,,DE-DRREDDYS-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181371671,18137167,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT (BY VALUE),,,,, UNKNOWN,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200807.0,20200812,20200812,EXP,,DE-DRREDDYS-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181371671,18137167,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT (BY VALUE),,,,, UNKNOWN,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200807.0,20200812,20200812,EXP,,DE-DRREDDYS-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181380611,18138061,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, (BY VALUE)",,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200806.0,20200812,20200812,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181380611,18138061,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, (BY VALUE)",,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200806.0,20200812,20200812,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181380611,18138061,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, (BY VALUE)",,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200806.0,20200812,20200812,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181380611,18138061,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, (BY VALUE)",,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200806.0,20200812,20200812,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181392052,18139205,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Cholestasis,,2020,Q3,2,F,,20200810.0,20200812,20200817,EXP,,US-PFIZER INC-2020302617,PFIZER,"BEECHAR, V.. NON?TYPEABLE HAEMOPHILUS INFLUENZAE AND PURPURA FULMINANS. BMJ CASE REPORTS. 2020?13 (7):10.1136/BCR?2020?234880",53.0,YR,,M,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
181392052,18139205,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hepatitis,,2020,Q3,2,F,,20200810.0,20200812,20200817,EXP,,US-PFIZER INC-2020302617,PFIZER,"BEECHAR, V.. NON?TYPEABLE HAEMOPHILUS INFLUENZAE AND PURPURA FULMINANS. BMJ CASE REPORTS. 2020?13 (7):10.1136/BCR?2020?234880",53.0,YR,,M,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
181404261,18140426,3,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Chills,,2020,Q3,1,I,20200803.0,,20200812,20200812,DIR,,,FDA-CTU,,58.0,YR,,M,N,106.5,KG,20200812.0,Y,PH,US,US,2020,Q3,Adult
181404261,18140426,3,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,20200803.0,,20200812,20200812,DIR,,,FDA-CTU,,58.0,YR,,M,N,106.5,KG,20200812.0,Y,PH,US,US,2020,Q3,Adult
181404261,18140426,3,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Rash,,2020,Q3,1,I,20200803.0,,20200812,20200812,DIR,,,FDA-CTU,,58.0,YR,,M,N,106.5,KG,20200812.0,Y,PH,US,US,2020,Q3,Adult
181404261,18140426,3,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Wheezing,,2020,Q3,1,I,20200803.0,,20200812,20200812,DIR,,,FDA-CTU,,58.0,YR,,M,N,106.5,KG,20200812.0,Y,PH,US,US,2020,Q3,Adult
181417031,18141703,4,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,20200629.0,20200810.0,20200812,20200812,EXP,IT-MINISAL02-630053,NVSC2020IT222728,NOVARTIS,,38.0,YR,,M,Y,,,20200812.0,,HP,IT,IT,2020,Q3,Adult
181419111,18141911,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE WITH MEALS)",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,202001.0,20200803.0,20200812,20200812,EXP,,US-ELI_LILLY_AND_COMPANY-US202008001719,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200812.0,,CN,US,US,2020,Q3,Elderly
181419111,18141911,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE WITH MEALS)",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Glaucoma,,2020,Q3,1,I,202001.0,20200803.0,20200812,20200812,EXP,,US-ELI_LILLY_AND_COMPANY-US202008001719,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200812.0,,CN,US,US,2020,Q3,Elderly
181419111,18141911,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE WITH MEALS)",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Road traffic accident,,2020,Q3,1,I,202001.0,20200803.0,20200812,20200812,EXP,,US-ELI_LILLY_AND_COMPANY-US202008001719,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200812.0,,CN,US,US,2020,Q3,Elderly
181419111,18141911,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE WITH MEALS)",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,202001.0,20200803.0,20200812,20200812,EXP,,US-ELI_LILLY_AND_COMPANY-US202008001719,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200812.0,,CN,US,US,2020,Q3,Elderly
181419111,18141911,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE WITH MEALS)",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Glaucoma,,2020,Q3,1,I,202001.0,20200803.0,20200812,20200812,EXP,,US-ELI_LILLY_AND_COMPANY-US202008001719,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200812.0,,CN,US,US,2020,Q3,Elderly
181419111,18141911,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE WITH MEALS)",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Road traffic accident,,2020,Q3,1,I,202001.0,20200803.0,20200812,20200812,EXP,,US-ELI_LILLY_AND_COMPANY-US202008001719,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200812.0,,CN,US,US,2020,Q3,Elderly
181419111,18141911,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK, PRN (SLIDING SCALE WITH MEALS)",,,U,, D049598F,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,202001.0,20200803.0,20200812,20200812,EXP,,US-ELI_LILLY_AND_COMPANY-US202008001719,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200812.0,,CN,US,US,2020,Q3,Elderly
181419111,18141911,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK, PRN (SLIDING SCALE WITH MEALS)",,,U,, D049598F,,20563.0,,,INJECTION,,2020,Q3,Glaucoma,,2020,Q3,1,I,202001.0,20200803.0,20200812,20200812,EXP,,US-ELI_LILLY_AND_COMPANY-US202008001719,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200812.0,,CN,US,US,2020,Q3,Elderly
181419111,18141911,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK, PRN (SLIDING SCALE WITH MEALS)",,,U,, D049598F,,20563.0,,,INJECTION,,2020,Q3,Road traffic accident,,2020,Q3,1,I,202001.0,20200803.0,20200812,20200812,EXP,,US-ELI_LILLY_AND_COMPANY-US202008001719,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200812.0,,CN,US,US,2020,Q3,Elderly
181419111,18141911,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK, PRN (SLIDING SCALE WITH MEALS)",,,U,, D049598F,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,202001.0,20200803.0,20200812,20200812,EXP,,US-ELI_LILLY_AND_COMPANY-US202008001719,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200812.0,,CN,US,US,2020,Q3,Elderly
181419111,18141911,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK, PRN (SLIDING SCALE WITH MEALS)",,,U,, D049598F,,20563.0,,,INJECTION,,2020,Q3,Glaucoma,,2020,Q3,1,I,202001.0,20200803.0,20200812,20200812,EXP,,US-ELI_LILLY_AND_COMPANY-US202008001719,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200812.0,,CN,US,US,2020,Q3,Elderly
181419111,18141911,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK, PRN (SLIDING SCALE WITH MEALS)",,,U,, D049598F,,20563.0,,,INJECTION,,2020,Q3,Road traffic accident,,2020,Q3,1,I,202001.0,20200803.0,20200812,20200812,EXP,,US-ELI_LILLY_AND_COMPANY-US202008001719,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200812.0,,CN,US,US,2020,Q3,Elderly
181419131,18141913,1,PS,Lispro,INSULIN LISPRO,1,Oral,"300 INTERNATIONAL UNIT, PRN",,,U,,,,20563.0,300.0,IU,,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200731.0,20200812,20200812,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008000328,ELI LILLY AND CO,,78.0,YR,,M,Y,70.0,KG,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181419131,18141913,1,PS,Lispro,INSULIN LISPRO,1,Oral,"300 INTERNATIONAL UNIT, PRN",,,U,,,,20563.0,300.0,IU,,,2020,Q3,Constipation,,2020,Q3,1,I,,20200731.0,20200812,20200812,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008000328,ELI LILLY AND CO,,78.0,YR,,M,Y,70.0,KG,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181419131,18141913,1,PS,Lispro,INSULIN LISPRO,1,Oral,"300 INTERNATIONAL UNIT, PRN",,,U,,,,20563.0,300.0,IU,,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200731.0,20200812,20200812,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008000328,ELI LILLY AND CO,,78.0,YR,,M,Y,70.0,KG,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181419131,18141913,1,PS,Lispro,INSULIN LISPRO,1,Oral,"300 INTERNATIONAL UNIT, PRN",,,U,,,,20563.0,300.0,IU,,,2020,Q3,Flatulence,,2020,Q3,1,I,,20200731.0,20200812,20200812,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008000328,ELI LILLY AND CO,,78.0,YR,,M,Y,70.0,KG,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181419131,18141913,1,PS,Lispro,INSULIN LISPRO,1,Oral,"300 INTERNATIONAL UNIT, PRN",,,U,,,,20563.0,300.0,IU,,,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,,20200731.0,20200812,20200812,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008000328,ELI LILLY AND CO,,78.0,YR,,M,Y,70.0,KG,20200812.0,,PH,DE,DE,2020,Q3,Elderly
181423831,18142383,2,C,Insulin lispro,INSULIN LISPRO,1,Unknown,20 INTERNATIONAL UNIT (0?0?1?0),,,,,,,,20.0,IU,,,2020,Q3,Acute respiratory failure,,2020,Q3,1,I,,20200806.0,20200813,20200813,EXP,,DE-AUROBINDO-AUR-APL-2020-038767,AUROBINDO,,71.0,YR,,M,Y,,,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181423831,18142383,2,C,Insulin lispro,INSULIN LISPRO,1,Unknown,20 INTERNATIONAL UNIT (0?0?1?0),,,,,,,,20.0,IU,,,2020,Q3,Angina pectoris,,2020,Q3,1,I,,20200806.0,20200813,20200813,EXP,,DE-AUROBINDO-AUR-APL-2020-038767,AUROBINDO,,71.0,YR,,M,Y,,,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181423831,18142383,2,C,Insulin lispro,INSULIN LISPRO,1,Unknown,20 INTERNATIONAL UNIT (0?0?1?0),,,,,,,,20.0,IU,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200806.0,20200813,20200813,EXP,,DE-AUROBINDO-AUR-APL-2020-038767,AUROBINDO,,71.0,YR,,M,Y,,,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181423831,18142383,2,C,Insulin lispro,INSULIN LISPRO,1,Unknown,20 INTERNATIONAL UNIT (0?0?1?0),,,,,,,,20.0,IU,,,2020,Q3,Fatigue,,2020,Q3,1,I,,20200806.0,20200813,20200813,EXP,,DE-AUROBINDO-AUR-APL-2020-038767,AUROBINDO,,71.0,YR,,M,Y,,,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181423831,18142383,2,C,Insulin lispro,INSULIN LISPRO,1,Unknown,20 INTERNATIONAL UNIT (0?0?1?0),,,,,,,,20.0,IU,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200806.0,20200813,20200813,EXP,,DE-AUROBINDO-AUR-APL-2020-038767,AUROBINDO,,71.0,YR,,M,Y,,,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181423831,18142383,2,C,Insulin lispro,INSULIN LISPRO,1,Unknown,20 INTERNATIONAL UNIT (0?0?1?0),,,,,,,,20.0,IU,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200806.0,20200813,20200813,EXP,,DE-AUROBINDO-AUR-APL-2020-038767,AUROBINDO,,71.0,YR,,M,Y,,,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181425401,18142540,4,C,Insulina lispro Sanofi,,2,Unknown,UNK,,,,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,20200629.0,20200807.0,20200813,20200813,EXP,,IT-AUROBINDO-AUR-APL-2020-038909,AUROBINDO,,38.0,YR,,M,Y,,,20200813.0,,MD,IT,IT,2020,Q3,Adult
181426661,18142666,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, Q8H (26?28?22 IU/DAILY)",,,Y,,,,,,,SOLUTION FOR INJECTION,Q8H,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,1,I,,20200805.0,20200812,20200812,EXP,,CZ-MYLANLABS-2020M1070229,MYLAN,HIMMELOVA K. EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE. KAZUSITIKY V DIABETOLOGII. 2020?2:33?36,62.0,YR,,M,Y,,,20200812.0,,MD,CZ,CZ,2020,Q3,Adult
181426661,18142666,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, Q8H (26?28?22 IU/DAILY)",,,Y,,,,,,,SOLUTION FOR INJECTION,Q8H,2020,Q3,Injection site pain,,2020,Q3,1,I,,20200805.0,20200812,20200812,EXP,,CZ-MYLANLABS-2020M1070229,MYLAN,HIMMELOVA K. EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE. KAZUSITIKY V DIABETOLOGII. 2020?2:33?36,62.0,YR,,M,Y,,,20200812.0,,MD,CZ,CZ,2020,Q3,Adult
181426661,18142666,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, Q8H (26?28?22 IU/DAILY)",,,Y,,,,,,,SOLUTION FOR INJECTION,Q8H,2020,Q3,Weight increased,,2020,Q3,1,I,,20200805.0,20200812,20200812,EXP,,CZ-MYLANLABS-2020M1070229,MYLAN,HIMMELOVA K. EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE. KAZUSITIKY V DIABETOLOGII. 2020?2:33?36,62.0,YR,,M,Y,,,20200812.0,,MD,CZ,CZ,2020,Q3,Adult
181432882,18143288,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,2,F,20200804.0,20200904.0,20200812,20200908,EXP,,US-GILEAD-2020-0489707,GILEAD,,33.0,YR,A,F,Y,79.4,KG,20200908.0,,PH,US,US,2020,Q3,Young Adult
181433771,18143377,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"22 UNIT, TID",,,,,,,,,,,TID,2020,Q3,Drug resistance,,2020,Q3,1,I,,20200731.0,20200813,20200813,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04472,LUPIN,,65.0,YR,,M,Y,,,20200813.0,,HP,US,US,2020,Q3,Elderly
181433771,18143377,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"10 UNIT, TID",,,,,,,,,,,TID,2020,Q3,Drug resistance,,2020,Q3,1,I,,20200731.0,20200813,20200813,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04472,LUPIN,,65.0,YR,,M,Y,,,20200813.0,,HP,US,US,2020,Q3,Elderly
181433771,18143377,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"30 UNIT, TID",,,,,,,,,,,TID,2020,Q3,Drug resistance,,2020,Q3,1,I,,20200731.0,20200813,20200813,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04472,LUPIN,,65.0,YR,,M,Y,,,20200813.0,,HP,US,US,2020,Q3,Elderly
181448211,18144821,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Oral candidiasis,,2020,Q3,1,I,20200809.0,,20200813,20200813,DIR,,,FDA-CTU,,36.0,YR,,,N,98.7,KG,20200813.0,N,PH,US,US,2020,Q3,Adult
181458001,18145800,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"22 INTERNATIONAL UNIT, THREE TIMES DAILY",,,,,,,,22.0,IU,,TID,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,US-MYLANLABS-2020M1070717,MYLAN,"LUNDHOLM MD, CHARNOGURSKY GA. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLIN?CASE?REP 2020?8(7):1238?1240.",65.0,YR,,M,Y,,,20200813.0,,HP,US,US,2020,Q3,Elderly
181458001,18145800,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,REDUCED TO 10 UNITS THREE TIMES DAILY,,,,,,,,,,,TID,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,US-MYLANLABS-2020M1070717,MYLAN,"LUNDHOLM MD, CHARNOGURSKY GA. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLIN?CASE?REP 2020?8(7):1238?1240.",65.0,YR,,M,Y,,,20200813.0,,HP,US,US,2020,Q3,Elderly
181458001,18145800,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,INCREASED TO 30 UNITS THREE TIMES DAILY,,,,,,,,,,,TID,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,US-MYLANLABS-2020M1070717,MYLAN,"LUNDHOLM MD, CHARNOGURSKY GA. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLIN?CASE?REP 2020?8(7):1238?1240.",65.0,YR,,M,Y,,,20200813.0,,HP,US,US,2020,Q3,Elderly
181469981,18146998,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"SLIDING SCALE, QID",,,,,,,,,,,Q6H,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200728.0,20200810.0,20200813,20200813,EXP,,US-GILEAD-2020-0489892,GILEAD,,78.0,YR,E,M,Y,93.9,KG,20200813.0,,PH,US,US,2020,Q3,Elderly
181471201,18147120,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"10 U, PRN",,,U,,,,20563.0,10.0,IU,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,202006.0,20200716.0,20200813,20200813,PER,,US-ELI_LILLY_AND_COMPANY-US202007007450,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20200813.0,,CN,US,US,2020,Q3,Adult
181471201,18147120,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"10 U, PRN",,,U,,,,20563.0,10.0,IU,INJECTION,,2020,Q3,Incorrect dose administered,,2020,Q3,1,I,202006.0,20200716.0,20200813,20200813,PER,,US-ELI_LILLY_AND_COMPANY-US202007007450,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20200813.0,,CN,US,US,2020,Q3,Adult
181471201,18147120,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"10 U, PRN",,,U,,,,20563.0,10.0,IU,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,202006.0,20200716.0,20200813,20200813,PER,,US-ELI_LILLY_AND_COMPANY-US202007007450,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20200813.0,,CN,US,US,2020,Q3,Adult
181471201,18147120,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"10 U, PRN",,,U,,,,20563.0,10.0,IU,INJECTION,,2020,Q3,Incorrect dose administered,,2020,Q3,1,I,202006.0,20200716.0,20200813,20200813,PER,,US-ELI_LILLY_AND_COMPANY-US202007007450,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20200813.0,,CN,US,US,2020,Q3,Adult
181471201,18147120,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"10 U, PRN",,,U,, D137576C,,20563.0,10.0,IU,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,202006.0,20200716.0,20200813,20200813,PER,,US-ELI_LILLY_AND_COMPANY-US202007007450,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20200813.0,,CN,US,US,2020,Q3,Adult
181471201,18147120,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"10 U, PRN",,,U,, D137576C,,20563.0,10.0,IU,INJECTION,,2020,Q3,Incorrect dose administered,,2020,Q3,1,I,202006.0,20200716.0,20200813,20200813,PER,,US-ELI_LILLY_AND_COMPANY-US202007007450,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20200813.0,,CN,US,US,2020,Q3,Adult
181471201,18147120,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"10 U, PRN",,,U,, D137576C,,20563.0,10.0,IU,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,202006.0,20200716.0,20200813,20200813,PER,,US-ELI_LILLY_AND_COMPANY-US202007007450,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20200813.0,,CN,US,US,2020,Q3,Adult
181471201,18147120,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"10 U, PRN",,,U,, D137576C,,20563.0,10.0,IU,INJECTION,,2020,Q3,Incorrect dose administered,,2020,Q3,1,I,202006.0,20200716.0,20200813,20200813,PER,,US-ELI_LILLY_AND_COMPANY-US202007007450,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20200813.0,,CN,US,US,2020,Q3,Adult
181483251,18148325,3,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"120 INTERNATIONAL UNIT, QD",,,Y,,,,,120.0,IU,,,2020,Q3,Acute myocardial infarction,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,3,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"120 INTERNATIONAL UNIT, QD",,,Y,,,,,120.0,IU,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,3,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"120 INTERNATIONAL UNIT, QD",,,Y,,,,,120.0,IU,,,2020,Q3,Pancytopenia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,4,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"20 INTERNATIONAL UNIT, TID",,,Y,,,,,20.0,IU,,TID,2020,Q3,Acute myocardial infarction,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,4,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"20 INTERNATIONAL UNIT, TID",,,Y,,,,,20.0,IU,,TID,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,4,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"20 INTERNATIONAL UNIT, TID",,,Y,,,,,20.0,IU,,TID,2020,Q3,Pancytopenia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,5,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,10 INTERNATIONAL UNIT,,,Y,,,,,10.0,IU,,TID,2020,Q3,Acute myocardial infarction,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,5,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,10 INTERNATIONAL UNIT,,,Y,,,,,10.0,IU,,TID,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,5,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,10 INTERNATIONAL UNIT,,,Y,,,,,10.0,IU,,TID,2020,Q3,Pancytopenia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,6,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"30 INTERNATIONAL UNIT, TID",,,Y,,,,,30.0,IU,,TID,2020,Q3,Acute myocardial infarction,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,6,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"30 INTERNATIONAL UNIT, TID",,,Y,,,,,30.0,IU,,TID,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,6,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"30 INTERNATIONAL UNIT, TID",,,Y,,,,,30.0,IU,,TID,2020,Q3,Pancytopenia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181500541,18150054,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 U, PRN",,,U,, D182600E,,,8.0,IU,INJECTION,,2020,Q3,Cerebrovascular accident,,2020,Q3,1,I,20200426.0,20200803.0,20200814,20200814,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005244,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20200814.0,,CN,US,US,2020,Q3,Elderly
181509641,18150964,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200806.0,20200814,20200814,EXP,DE-BFARM-20008561,DE-ACCORD-195398,ACCORD,,83.0,YR,E,M,Y,,,20200814.0,,PH,DE,DE,2020,Q3,Elderly
181509641,18150964,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200806.0,20200814,20200814,EXP,DE-BFARM-20008561,DE-ACCORD-195398,ACCORD,,83.0,YR,E,M,Y,,,20200814.0,,PH,DE,DE,2020,Q3,Elderly
181509641,18150964,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200806.0,20200814,20200814,EXP,DE-BFARM-20008561,DE-ACCORD-195398,ACCORD,,83.0,YR,E,M,Y,,,20200814.0,,PH,DE,DE,2020,Q3,Elderly
181509641,18150964,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200806.0,20200814,20200814,EXP,DE-BFARM-20008561,DE-ACCORD-195398,ACCORD,,83.0,YR,E,M,Y,,,20200814.0,,PH,DE,DE,2020,Q3,Elderly
181516051,18151605,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"26?28?22 IU/DAILY, TID",,,Y,,,,20563.0,,,SOLUTION FOR INJECTION,TID,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,1,I,,20200803.0,20200814,20200814,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ202008000544,ELI LILLY AND CO,HIMMELOVA K.EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE..KAZUSITIKY V DIABETOLOGII. 2020?2:33?36.DOI:UNK,62.0,YR,,M,Y,,,20200814.0,,MD,CZ,CZ,2020,Q3,Adult
181516051,18151605,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"26?28?22 IU/DAILY, TID",,,Y,,,,20563.0,,,SOLUTION FOR INJECTION,TID,2020,Q3,Injection site pain,,2020,Q3,1,I,,20200803.0,20200814,20200814,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ202008000544,ELI LILLY AND CO,HIMMELOVA K.EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE..KAZUSITIKY V DIABETOLOGII. 2020?2:33?36.DOI:UNK,62.0,YR,,M,Y,,,20200814.0,,MD,CZ,CZ,2020,Q3,Adult
181516051,18151605,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"26?28?22 IU/DAILY, TID",,,Y,,,,20563.0,,,SOLUTION FOR INJECTION,TID,2020,Q3,Weight increased,,2020,Q3,1,I,,20200803.0,20200814,20200814,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ202008000544,ELI LILLY AND CO,HIMMELOVA K.EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE..KAZUSITIKY V DIABETOLOGII. 2020?2:33?36.DOI:UNK,62.0,YR,,M,Y,,,20200814.0,,MD,CZ,CZ,2020,Q3,Adult
181529192,18152919,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,20200729.0,20200923.0,20200814,20200924,EXP,,US-GILEAD-2020-0490146,GILEAD,,87.0,YR,E,F,Y,82.0,KG,20200924.0,,PH,US,US,2020,Q3,Elderly
181556771,18155677,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Fungal sepsis,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hydroureter,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Nephrotic syndrome,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pyelonephritis,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Urinary tract infection,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Urinary tract obstruction,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181561931,18156193,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH WERT,,,U,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200810.0,20200817,20200817,EXP,DE-ADRED-05240-01,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20200817.0,,HP,DE,DE,2020,Q3,Elderly
181561931,18156193,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH WERT,,,U,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200810.0,20200817,20200817,EXP,DE-ADRED-05240-01,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20200817.0,,HP,DE,DE,2020,Q3,Elderly
181561931,18156193,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH WERT,,,U,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200810.0,20200817,20200817,EXP,DE-ADRED-05240-01,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20200817.0,,HP,DE,DE,2020,Q3,Elderly
181561931,18156193,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH WERT,,,U,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200810.0,20200817,20200817,EXP,DE-ADRED-05240-01,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20200817.0,,HP,DE,DE,2020,Q3,Elderly
181563111,18156311,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200805.0,20200817,20200817,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK049056,GLENMARK,"FINEGAN A, MABROUK U, NELSON LA.. GABAPENTIN?INDUCED BILATERAL LOWER EXTREMITY EDEMA IN A PATIENT WITH PERVASIVE DEVELOPMENTAL DISORDER AND SCHIZOAFFECTIVE DISORDER.. MENT HEALTH CLIN.. 2020?10 (4):250?253",46.0,YR,,M,Y,,,20200817.0,,PH,US,US,2020,Q3,Adult
181563111,18156311,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200805.0,20200817,20200817,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK049056,GLENMARK,"FINEGAN A, MABROUK U, NELSON LA.. GABAPENTIN?INDUCED BILATERAL LOWER EXTREMITY EDEMA IN A PATIENT WITH PERVASIVE DEVELOPMENTAL DISORDER AND SCHIZOAFFECTIVE DISORDER.. MENT HEALTH CLIN.. 2020?10 (4):250?253",46.0,YR,,M,Y,,,20200817.0,,PH,US,US,2020,Q3,Adult
181563111,18156311,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Off label use,,2020,Q3,1,I,,20200805.0,20200817,20200817,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK049056,GLENMARK,"FINEGAN A, MABROUK U, NELSON LA.. GABAPENTIN?INDUCED BILATERAL LOWER EXTREMITY EDEMA IN A PATIENT WITH PERVASIVE DEVELOPMENTAL DISORDER AND SCHIZOAFFECTIVE DISORDER.. MENT HEALTH CLIN.. 2020?10 (4):250?253",46.0,YR,,M,Y,,,20200817.0,,PH,US,US,2020,Q3,Adult
181570421,18157042,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,, D049598F,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200811.0,20200811.0,20200817,20200817,PER,,US-ELI_LILLY_AND_COMPANY-US202008004905,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20200817.0,,PH,US,US,2020,Q3,Elderly
181580941,18158094,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH SCHEMA,,,U,,,,,,,,,2020,Q3,Angina pectoris,,2020,Q3,1,I,,20200810.0,20200817,20200817,EXP,,NVSC2020DE223225,NOVARTIS,,84.0,YR,,F,Y,76.0,KG,20200817.0,,HP,DE,DE,2020,Q3,Elderly
181580941,18158094,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH SCHEMA,,,U,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200810.0,20200817,20200817,EXP,,NVSC2020DE223225,NOVARTIS,,84.0,YR,,F,Y,76.0,KG,20200817.0,,HP,DE,DE,2020,Q3,Elderly
181580941,18158094,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH SCHEMA,,,U,,,,,,,,,2020,Q3,Flank pain,,2020,Q3,1,I,,20200810.0,20200817,20200817,EXP,,NVSC2020DE223225,NOVARTIS,,84.0,YR,,F,Y,76.0,KG,20200817.0,,HP,DE,DE,2020,Q3,Elderly
181580941,18158094,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH SCHEMA,,,U,,,,,,,,,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,,20200810.0,20200817,20200817,EXP,,NVSC2020DE223225,NOVARTIS,,84.0,YR,,F,Y,76.0,KG,20200817.0,,HP,DE,DE,2020,Q3,Elderly
181580941,18158094,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH SCHEMA,,,U,,,,,,,,,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200810.0,20200817,20200817,EXP,,NVSC2020DE223225,NOVARTIS,,84.0,YR,,F,Y,76.0,KG,20200817.0,,HP,DE,DE,2020,Q3,Elderly
181580941,18158094,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH SCHEMA,,,U,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200810.0,20200817,20200817,EXP,,NVSC2020DE223225,NOVARTIS,,84.0,YR,,F,Y,76.0,KG,20200817.0,,HP,DE,DE,2020,Q3,Elderly
181585853,18158585,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEDTIME,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,3,F,20200715.0,20200828.0,20200817,20200902,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20200902.0,,MD,US,US,2020,Q3,Adult
181585853,18158585,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEDTIME,,,,,,,,,,,,2020,Q3,Cardio-respiratory arrest,,2020,Q3,3,F,20200715.0,20200828.0,20200817,20200902,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20200902.0,,MD,US,US,2020,Q3,Adult
181585853,18158585,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEDTIME,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,3,F,20200715.0,20200828.0,20200817,20200902,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20200902.0,,MD,US,US,2020,Q3,Adult
181585853,18158585,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,3,F,20200715.0,20200828.0,20200817,20200902,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20200902.0,,MD,US,US,2020,Q3,Adult
181585853,18158585,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Cardio-respiratory arrest,,2020,Q3,3,F,20200715.0,20200828.0,20200817,20200902,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20200902.0,,MD,US,US,2020,Q3,Adult
181585853,18158585,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,3,F,20200715.0,20200828.0,20200817,20200902,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20200902.0,,MD,US,US,2020,Q3,Adult
181585853,18158585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,3,F,20200715.0,20200828.0,20200817,20200902,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20200902.0,,MD,US,US,2020,Q3,Adult
181585853,18158585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Cardio-respiratory arrest,,2020,Q3,3,F,20200715.0,20200828.0,20200817,20200902,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20200902.0,,MD,US,US,2020,Q3,Adult
181585853,18158585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,3,F,20200715.0,20200828.0,20200817,20200902,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20200902.0,,MD,US,US,2020,Q3,Adult
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Asthma,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Blood count abnormal,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Chest discomfort,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Diaphragmatic disorder,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Discomfort,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Hypoxia,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Left ventricular hypertrophy,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Obstructive airways disorder,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181591961,18159196,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Weight increased,,2020,Q3,1,I,,20200811.0,20200818,20200818,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-041640",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200818.0,,CN,CA,CA,2020,Q3,Elderly
181594101,18159410,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200805.0,20200818,20200818,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04754,LUPIN,,46.0,YR,,M,Y,,,20200818.0,,MD,US,US,2020,Q3,Adult
181594101,18159410,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200805.0,20200818,20200818,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04754,LUPIN,,46.0,YR,,M,Y,,,20200818.0,,MD,US,US,2020,Q3,Adult
181594101,18159410,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Off label use,,2020,Q3,1,I,,20200805.0,20200818,20200818,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04754,LUPIN,,46.0,YR,,M,Y,,,20200818.0,,MD,US,US,2020,Q3,Adult
181658321,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH WERT,,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181658321,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH WERT,,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181658321,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH WERT,,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181658321,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH WERT,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181658792,18165879,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,2,F,2020.0,20200821.0,20200819,20200827,EXP,,US-TEVA-2020-US-1815202,TEVA,"KAZI DS, MARTIN LM, LITMANOVICH D, PINTO DS, CLERKIN KJ, ZIMETBAUM PJ, ET AL. CASE 18?2020: A 73?YEAR?OLD MAN WITH HYPOXEMIC RESPIRATORY FAILURE AND CARDIAC DYSFUNCTION. N?ENGL?J?MED 2020?382(24):2354?2364.",73.0,YR,E,M,Y,,,20200827.0,,MD,US,US,2020,Q3,Elderly
181658792,18165879,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2020,Q3,Electrocardiogram QT prolonged,,2020,Q3,2,F,2020.0,20200821.0,20200819,20200827,EXP,,US-TEVA-2020-US-1815202,TEVA,"KAZI DS, MARTIN LM, LITMANOVICH D, PINTO DS, CLERKIN KJ, ZIMETBAUM PJ, ET AL. CASE 18?2020: A 73?YEAR?OLD MAN WITH HYPOXEMIC RESPIRATORY FAILURE AND CARDIAC DYSFUNCTION. N?ENGL?J?MED 2020?382(24):2354?2364.",73.0,YR,E,M,Y,,,20200827.0,,MD,US,US,2020,Q3,Elderly
181658792,18165879,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,2,F,2020.0,20200821.0,20200819,20200827,EXP,,US-TEVA-2020-US-1815202,TEVA,"KAZI DS, MARTIN LM, LITMANOVICH D, PINTO DS, CLERKIN KJ, ZIMETBAUM PJ, ET AL. CASE 18?2020: A 73?YEAR?OLD MAN WITH HYPOXEMIC RESPIRATORY FAILURE AND CARDIAC DYSFUNCTION. N?ENGL?J?MED 2020?382(24):2354?2364.",73.0,YR,E,M,Y,,,20200827.0,,MD,US,US,2020,Q3,Elderly
181658792,18165879,19,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2020,Q3,Off label use,,2020,Q3,2,F,2020.0,20200821.0,20200819,20200827,EXP,,US-TEVA-2020-US-1815202,TEVA,"KAZI DS, MARTIN LM, LITMANOVICH D, PINTO DS, CLERKIN KJ, ZIMETBAUM PJ, ET AL. CASE 18?2020: A 73?YEAR?OLD MAN WITH HYPOXEMIC RESPIRATORY FAILURE AND CARDIAC DYSFUNCTION. N?ENGL?J?MED 2020?382(24):2354?2364.",73.0,YR,E,M,Y,,,20200827.0,,MD,US,US,2020,Q3,Elderly
181659272,18165927,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Cholestasis,,2020,Q3,2,F,,20200817.0,20200819,20200826,EXP,,US-AUROBINDO-AUR-APL-2020-039143,AUROBINDO,,53.0,YR,,M,Y,,,20200826.0,,HP,US,US,2020,Q3,Adult
181659272,18165927,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Hepatic enzyme increased,,2020,Q3,2,F,,20200817.0,20200819,20200826,EXP,,US-AUROBINDO-AUR-APL-2020-039143,AUROBINDO,,53.0,YR,,M,Y,,,20200826.0,,HP,US,US,2020,Q3,Adult
181659272,18165927,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Hepatitis,,2020,Q3,2,F,,20200817.0,20200819,20200826,EXP,,US-AUROBINDO-AUR-APL-2020-039143,AUROBINDO,,53.0,YR,,M,Y,,,20200826.0,,HP,US,US,2020,Q3,Adult
181659272,18165927,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Liver injury,,2020,Q3,2,F,,20200817.0,20200819,20200826,EXP,,US-AUROBINDO-AUR-APL-2020-039143,AUROBINDO,,53.0,YR,,M,Y,,,20200826.0,,HP,US,US,2020,Q3,Adult
181664001,18166400,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, (1 IE, BEDARF, INSULINPEN)",,,U,,,,,1.0,IU,,,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, (1 IE, BEDARF, INSULINPEN)",,,U,,,,,1.0,IU,,,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, (1 IE, BEDARF, INSULINPEN)",,,U,,,,,1.0,IU,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, (1 IE, BEDARF, INSULINPEN)",,,U,,,,,1.0,IU,,,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, (1 IE, BEDARF, INSULINPEN)",,,U,,,,,1.0,IU,,,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, (1 IE, BEDARF, INSULINPEN)",,,U,,,,,1.0,IU,,,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, (1 IE, BEDARF, INSULINPEN)",,,U,,,,,1.0,IU,,,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181664001,18166400,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, (1 IE, BEDARF, INSULINPEN)",,,U,,,,,1.0,IU,,,2020,Q3,Pain,,2020,Q3,1,I,20191213.0,20200810.0,20200819,20200819,EXP,,DE-AUROBINDO-AUR-APL-2020-039276,AUROBINDO,,61.0,YR,,F,Y,94.0,KG,20200819.0,,PH,DE,DE,2020,Q3,Adult
181673991,18167399,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20200816.0,,20200818,20200818,DIR,,,FDA-CTU,,70.0,YR,,F,N,113.1,KG,20200818.0,N,PH,US,US,2020,Q3,Elderly
181676301,18167630,1,PS,"LIPROLOG 50% LISPRO, 50% NPL",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (26?0?26?0, AMPOULES)",,,U,,,,20563.0,,,,,2020,Q3,Dizziness,,2020,Q3,1,I,,20200812.0,20200818,20200818,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008005099,ELI LILLY AND CO,,83.0,YR,,F,Y,80.0,KG,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181676301,18167630,1,PS,"LIPROLOG 50% LISPRO, 50% NPL",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (26?0?26?0, AMPOULES)",,,U,,,,20563.0,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200812.0,20200818,20200818,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008005099,ELI LILLY AND CO,,83.0,YR,,F,Y,80.0,KG,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181676301,18167630,1,PS,"LIPROLOG 50% LISPRO, 50% NPL",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (26?0?26?0, AMPOULES)",,,U,,,,20563.0,,,,,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,,20200812.0,20200818,20200818,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008005099,ELI LILLY AND CO,,83.0,YR,,F,Y,80.0,KG,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181676301,18167630,1,PS,"LIPROLOG 50% LISPRO, 50% NPL",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (26?0?26?0, AMPOULES)",,,U,,,,20563.0,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200812.0,20200818,20200818,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008005099,ELI LILLY AND CO,,83.0,YR,,F,Y,80.0,KG,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181676301,18167630,1,PS,"LIPROLOG 50% LISPRO, 50% NPL",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (26?0?26?0, AMPOULES)",,,U,,,,20563.0,,,,,2020,Q3,Somnolence,,2020,Q3,1,I,,20200812.0,20200818,20200818,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008005099,ELI LILLY AND CO,,83.0,YR,,F,Y,80.0,KG,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181678981,18167898,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,1,I,,20190912.0,20200818,20200818,EXP,,US-OTSUKA-2019_032357,OTSUKA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC GERIATRICS. 2020?20(1):179",68.0,YR,,M,Y,,,20200818.0,,HP,US,US,2020,Q3,Elderly
181697901,18169790,2,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Chills,,2020,Q3,1,I,20200803.0,20200806.0,20200819,20200819,EXP,,US-ACCORD-194905,ACCORD,,58.0,YR,A,M,Y,108.1,KG,20200819.0,,PH,US,US,2020,Q3,Adult
181697901,18169790,2,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,20200803.0,20200806.0,20200819,20200819,EXP,,US-ACCORD-194905,ACCORD,,58.0,YR,A,M,Y,108.1,KG,20200819.0,,PH,US,US,2020,Q3,Adult
181697901,18169790,2,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Rash,,2020,Q3,1,I,20200803.0,20200806.0,20200819,20200819,EXP,,US-ACCORD-194905,ACCORD,,58.0,YR,A,M,Y,108.1,KG,20200819.0,,PH,US,US,2020,Q3,Adult
181697901,18169790,2,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Wheezing,,2020,Q3,1,I,20200803.0,20200806.0,20200819,20200819,EXP,,US-ACCORD-194905,ACCORD,,58.0,YR,A,M,Y,108.1,KG,20200819.0,,PH,US,US,2020,Q3,Adult
181702991,18170299,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 IU, QD (INSULIN HUMALOG 50, 20 IE, 0?0?1?0)",,,,,,,,20.0,IU,,QD,2020,Q3,Acute respiratory failure,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071310,MYLAN,,71.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181702991,18170299,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 IU, QD (INSULIN HUMALOG 50, 20 IE, 0?0?1?0)",,,,,,,,20.0,IU,,QD,2020,Q3,Angina pectoris,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071310,MYLAN,,71.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181702991,18170299,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 IU, QD (INSULIN HUMALOG 50, 20 IE, 0?0?1?0)",,,,,,,,20.0,IU,,QD,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071310,MYLAN,,71.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181702991,18170299,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 IU, QD (INSULIN HUMALOG 50, 20 IE, 0?0?1?0)",,,,,,,,20.0,IU,,QD,2020,Q3,Fatigue,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071310,MYLAN,,71.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181702991,18170299,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 IU, QD (INSULIN HUMALOG 50, 20 IE, 0?0?1?0)",,,,,,,,20.0,IU,,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071310,MYLAN,,71.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181702991,18170299,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 IU, QD (INSULIN HUMALOG 50, 20 IE, 0?0?1?0)",,,,,,,,20.0,IU,,QD,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071310,MYLAN,,71.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181702991,18170299,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 IU, QD (INSULIN HUMALOG 25, 15 IE, 1?0?0?0)",,,,,,,,15.0,IU,,QD,2020,Q3,Acute respiratory failure,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071310,MYLAN,,71.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181702991,18170299,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 IU, QD (INSULIN HUMALOG 25, 15 IE, 1?0?0?0)",,,,,,,,15.0,IU,,QD,2020,Q3,Angina pectoris,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071310,MYLAN,,71.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181702991,18170299,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 IU, QD (INSULIN HUMALOG 25, 15 IE, 1?0?0?0)",,,,,,,,15.0,IU,,QD,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071310,MYLAN,,71.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181702991,18170299,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 IU, QD (INSULIN HUMALOG 25, 15 IE, 1?0?0?0)",,,,,,,,15.0,IU,,QD,2020,Q3,Fatigue,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071310,MYLAN,,71.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181702991,18170299,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 IU, QD (INSULIN HUMALOG 25, 15 IE, 1?0?0?0)",,,,,,,,15.0,IU,,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071310,MYLAN,,71.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181702991,18170299,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 IU, QD (INSULIN HUMALOG 25, 15 IE, 1?0?0?0)",,,,,,,,15.0,IU,,QD,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071310,MYLAN,,71.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181720841,18172084,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,, UNKNOWN,,,1.0,IU,,,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,, UNKNOWN,,,1.0,IU,,,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,, UNKNOWN,,,1.0,IU,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,, UNKNOWN,,,1.0,IU,,,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,, UNKNOWN,,,1.0,IU,,,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,, UNKNOWN,,,1.0,IU,,,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,, UNKNOWN,,,1.0,IU,,,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181720841,18172084,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,, UNKNOWN,,,1.0,IU,,,2020,Q3,Pain,,2020,Q3,1,I,20191213.0,20200811.0,20200820,20200820,EXP,,DE-DRREDDYS-GER/GER/20/0126020,DR REDDYS,,61.0,YR,A,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181722311,18172231,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,CA-ROCHE-2659490,ROCHE,,58.0,YR,,M,Y,98.0,KG,20200820.0,,PH,CA,CA,2020,Q3,Adult
181722311,18172231,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,CA-ROCHE-2659490,ROCHE,,58.0,YR,,M,Y,98.0,KG,20200820.0,,PH,CA,CA,2020,Q3,Adult
181722311,18172231,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,CA-ROCHE-2659490,ROCHE,,58.0,YR,,M,Y,98.0,KG,20200820.0,,PH,CA,CA,2020,Q3,Adult
181722311,18172231,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Malaise,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,CA-ROCHE-2659490,ROCHE,,58.0,YR,,M,Y,98.0,KG,20200820.0,,PH,CA,CA,2020,Q3,Adult
181722311,18172231,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,CA-ROCHE-2659490,ROCHE,,58.0,YR,,M,Y,98.0,KG,20200820.0,,PH,CA,CA,2020,Q3,Adult
181722311,18172231,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200813.0,20200820,20200820,EXP,,CA-ROCHE-2659490,ROCHE,,58.0,YR,,M,Y,98.0,KG,20200820.0,,PH,CA,CA,2020,Q3,Adult
181732421,18173242,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,4?5 TO A MAXIMUM OF 10 UNITS,,,Y,Y, D110092A,,20563.0,,,INJECTION,,2020,Q3,Eczema,,2020,Q3,1,I,202007.0,20200807.0,20200819,20200819,EXP,DE-AMK-243589,DE-ELI_LILLY_AND_COMPANY-DE202008003562,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Adult
181732421,18173242,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,4?5 TO A MAXIMUM OF 10 UNITS,,,Y,Y, D110092A,,20563.0,,,INJECTION,,2020,Q3,Erythema,,2020,Q3,1,I,202007.0,20200807.0,20200819,20200819,EXP,DE-AMK-243589,DE-ELI_LILLY_AND_COMPANY-DE202008003562,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Adult
181732421,18173242,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,4?5 TO A MAXIMUM OF 10 UNITS,,,Y,Y, D110092A,,20563.0,,,INJECTION,,2020,Q3,Product impurity,,2020,Q3,1,I,202007.0,20200807.0,20200819,20200819,EXP,DE-AMK-243589,DE-ELI_LILLY_AND_COMPANY-DE202008003562,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Adult
181732421,18173242,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,4?5 TO A MAXIMUM OF 10 UNITS,,,Y,Y, D110092A,,20563.0,,,INJECTION,,2020,Q3,Pustule,,2020,Q3,1,I,202007.0,20200807.0,20200819,20200819,EXP,DE-AMK-243589,DE-ELI_LILLY_AND_COMPANY-DE202008003562,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Adult
181732421,18173242,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,4?5 TO A MAXIMUM OF 10 UNITS,,,Y,Y, D110092A,,20563.0,,,INJECTION,,2020,Q3,Skin swelling,,2020,Q3,1,I,202007.0,20200807.0,20200819,20200819,EXP,DE-AMK-243589,DE-ELI_LILLY_AND_COMPANY-DE202008003562,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Adult
181732421,18173242,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,4?5 TO A MAXIMUM OF 10 UNITS,,,Y,Y, D110092A,,20563.0,,,INJECTION,,2020,Q3,Tenderness,,2020,Q3,1,I,202007.0,20200807.0,20200819,20200819,EXP,DE-AMK-243589,DE-ELI_LILLY_AND_COMPANY-DE202008003562,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20200819.0,,PH,DE,DE,2020,Q3,Adult
181752451,18175245,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Atrioventricular block second degree,,2020,Q3,1,I,20200817.0,,20200820,20200820,DIR,,,FDA-CTU,,70.0,YR,,M,N,87.4,KG,20200820.0,N,PH,US,US,2020,Q3,Elderly
181752451,18175245,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Bradycardia,,2020,Q3,1,I,20200817.0,,20200820,20200820,DIR,,,FDA-CTU,,70.0,YR,,M,N,87.4,KG,20200820.0,N,PH,US,US,2020,Q3,Elderly
181752451,18175245,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Bundle branch block left,,2020,Q3,1,I,20200817.0,,20200820,20200820,DIR,,,FDA-CTU,,70.0,YR,,M,N,87.4,KG,20200820.0,N,PH,US,US,2020,Q3,Elderly
181759661,18175966,4,C,INSULIN LISPRO SANOFI,,2,,UNK,,,,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,20200629.0,20200811.0,20200820,20200820,EXP,IT-MINISAL02-630053,IT-MYLANLABS-2020M1071336,MYLAN,,38.0,YR,,M,Y,,,20200820.0,,MD,IT,IT,2020,Q3,Adult
181762631,18176263,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED; INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED; INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED; INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED; INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED; INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED; INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED; INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181762631,18176263,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED; INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Pain in extremity,,2020,Q3,1,I,20191213.0,20200818.0,20200820,20200820,EXP,DE-ADRED-04622-01,DE-PFIZER INC-2020320266,PFIZER,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,,,,,1.0,IU,,,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,,,,,1.0,IU,,,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,,,,,1.0,IU,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,,,,,1.0,IU,,,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,,,,,1.0,IU,,,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,,,,,1.0,IU,,,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,,,,,1.0,IU,,,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181780481,18178048,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,,,,,,1.0,IU,,,2020,Q3,Pain,,2020,Q3,1,I,20191213.0,20200812.0,20200820,20200820,EXP,,DE-MYLANLABS-2020M1071798,MYLAN,,61.0,YR,,F,Y,94.0,KG,20200820.0,,PH,DE,DE,2020,Q3,Adult
181784391,18178439,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Febrile neutropenia,,2020,Q3,1,I,20180520.0,20200812.0,20200820,20200820,EXP,,US-TEVA-2020-US-1817145,TEVA,,51.0,YR,A,F,Y,71.0,KG,20200820.0,,MD,US,US,2020,Q3,Adult
181784391,18178439,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,1,I,20180520.0,20200812.0,20200820,20200820,EXP,,US-TEVA-2020-US-1817145,TEVA,,51.0,YR,A,F,Y,71.0,KG,20200820.0,,MD,US,US,2020,Q3,Adult
181790222,18179022,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Chest pain,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Dyspepsia,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Dyspnoea exertional,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Haematuria,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Inflammation,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Localised infection,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Musculoskeletal pain,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181790222,18179022,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pain,,2020,Q3,2,F,20191213.0,20200823.0,20200821,20200902,EXP,,DE-TEVA-2020-DE-1817342,TEVA,,61.0,YR,A,F,Y,94.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Adult
181794211,18179421,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200813.0,20200821,20200821,EXP,,DE-TEVA-2020-DE-1816027,TEVA,,83.0,YR,E,M,Y,,,20200821.0,,PH,DE,DE,2020,Q3,Elderly
181794211,18179421,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200813.0,20200821,20200821,EXP,,DE-TEVA-2020-DE-1816027,TEVA,,83.0,YR,E,M,Y,,,20200821.0,,PH,DE,DE,2020,Q3,Elderly
181794211,18179421,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200813.0,20200821,20200821,EXP,,DE-TEVA-2020-DE-1816027,TEVA,,83.0,YR,E,M,Y,,,20200821.0,,PH,DE,DE,2020,Q3,Elderly
181794211,18179421,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200813.0,20200821,20200821,EXP,,DE-TEVA-2020-DE-1816027,TEVA,,83.0,YR,E,M,Y,,,20200821.0,,PH,DE,DE,2020,Q3,Elderly
181798761,18179876,4,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,120.0,IU,,,2020,Q3,Acute myeloid leukaemia,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,4,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,120.0,IU,,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,4,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,120.0,IU,,,2020,Q3,Drug resistance,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,4,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,120.0,IU,,,2020,Q3,Leukaemia recurrent,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,4,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,120.0,IU,,,2020,Q3,Philadelphia chromosome positive,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,22.0,IU,,TID,2020,Q3,Acute myeloid leukaemia,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,22.0,IU,,TID,2020,Q3,Blood glucose increased,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,22.0,IU,,TID,2020,Q3,Drug resistance,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,22.0,IU,,TID,2020,Q3,Leukaemia recurrent,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,22.0,IU,,TID,2020,Q3,Philadelphia chromosome positive,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181804592,18180459,9,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,2,F,,20200824.0,20200821,20200901,EXP,,DE-PFIZER INC-2020324169,PFIZER,,87.0,YR,,F,Y,60.0,KG,20200901.0,,MD,DE,DE,2020,Q3,Elderly
181804592,18180459,9,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,,,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,2,F,,20200824.0,20200821,20200901,EXP,,DE-PFIZER INC-2020324169,PFIZER,,87.0,YR,,F,Y,60.0,KG,20200901.0,,MD,DE,DE,2020,Q3,Elderly
181807611,18180761,1,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20200821.0,,PH,DE,DE,2020,Q3,Elderly
181807611,18180761,1,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20200821.0,,PH,DE,DE,2020,Q3,Elderly
181807611,18180761,1,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20200821.0,,PH,DE,DE,2020,Q3,Elderly
181807611,18180761,1,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20200821.0,,PH,DE,DE,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Acute respiratory failure,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dizziness,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Haemoglobin decreased,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Headache,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypoaesthesia,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Mental status changes,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Muscular weakness,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Oxygen saturation decreased,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Paraesthesia,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pulmonary hypertension,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Transfusion,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181829891,18182989,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Urinary retention,,2020,Q3,1,I,2020.0,20200330.0,20200821,20200821,EXP,,US-ACTELION-A-NJ2020-203897,ACTELION,,65.0,YR,,F,Y,,,20200821.0,,CN,US,US,2020,Q3,Elderly
181830541,18183054,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,U,,,,,1.0,IU,,,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,U,,,,,1.0,IU,,,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,U,,,,,1.0,IU,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,U,,,,,1.0,IU,,,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,U,,,,,1.0,IU,,,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,U,,,,,1.0,IU,,,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,U,,,,,1.0,IU,,,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181830541,18183054,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, INSULINPEN",,,U,,,,,1.0,IU,,,2020,Q3,Pain,,2020,Q3,1,I,20191213.0,20200810.0,20200821,20200821,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008003911,ELI LILLY AND CO,,61.0,YR,,F,Y,94.0,KG,20200821.0,,PH,DE,DE,2020,Q3,Adult
181832132,18183213,45,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,20200817.0,20200913.0,20200821,20200916,EXP,,US-GILEAD-2020-0491560,GILEAD,,71.0,YR,E,F,Y,90.0,KG,20200915.0,,PH,US,US,2020,Q3,Elderly
181838261,18183826,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, AS NECESSARY",,,U,,,,,1.0,IU,,,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, AS NECESSARY",,,U,,,,,1.0,IU,,,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, AS NECESSARY",,,U,,,,,1.0,IU,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, AS NECESSARY",,,U,,,,,1.0,IU,,,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, AS NECESSARY",,,U,,,,,1.0,IU,,,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, AS NECESSARY",,,U,,,,,1.0,IU,,,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, AS NECESSARY",,,U,,,,,1.0,IU,,,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181838261,18183826,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, AS NECESSARY",,,U,,,,,1.0,IU,,,2020,Q3,Pain,,2020,Q3,1,I,20191213.0,20200813.0,20200823,20200823,EXP,DE-ADRED-04622-01,DE-TORRENT-00018211,TORRENT,,61.0,YR,A,F,Y,94.0,KG,20200823.0,,PH,DE,DE,2020,Q3,Adult
181852641,18185264,15,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20200818.0,,20200821,20200821,DIR,,,FDA-CTU,,78.0,YR,,M,N,78.8,KG,20200821.0,N,PH,US,US,2020,Q3,Elderly
181873451,18187345,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Blood pressure increased,,2020,Q3,1,I,20200515.0,,20200824,20200824,DIR,,,FDA-CTU,,68.0,YR,,F,N,77.9,KG,20200824.0,N,PH,US,US,2020,Q3,Elderly
181873451,18187345,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Heart rate increased,,2020,Q3,1,I,20200515.0,,20200824,20200824,DIR,,,FDA-CTU,,68.0,YR,,F,N,77.9,KG,20200824.0,N,PH,US,US,2020,Q3,Elderly
181873451,18187345,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Intraventricular haemorrhage,,2020,Q3,1,I,20200515.0,,20200824,20200824,DIR,,,FDA-CTU,,68.0,YR,,F,N,77.9,KG,20200824.0,N,PH,US,US,2020,Q3,Elderly
181876951,18187695,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Anxiety,,2020,Q3,1,I,202002.0,20200812.0,20200824,20200824,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005136,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200824.0,,CN,US,US,2020,Q3,Adult
181876951,18187695,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Cardiac failure congestive,,2020,Q3,1,I,202002.0,20200812.0,20200824,20200824,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005136,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200824.0,,CN,US,US,2020,Q3,Adult
181876951,18187695,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Cataract,,2020,Q3,1,I,202002.0,20200812.0,20200824,20200824,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005136,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200824.0,,CN,US,US,2020,Q3,Adult
181876951,18187695,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,202002.0,20200812.0,20200824,20200824,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005136,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200824.0,,CN,US,US,2020,Q3,Adult
181876951,18187695,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetic neuropathy,,2020,Q3,1,I,202002.0,20200812.0,20200824,20200824,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005136,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200824.0,,CN,US,US,2020,Q3,Adult
181876951,18187695,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Dizziness,,2020,Q3,1,I,202002.0,20200812.0,20200824,20200824,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005136,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200824.0,,CN,US,US,2020,Q3,Adult
181876951,18187695,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Fall,,2020,Q3,1,I,202002.0,20200812.0,20200824,20200824,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005136,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200824.0,,CN,US,US,2020,Q3,Adult
181876951,18187695,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,1,I,202002.0,20200812.0,20200824,20200824,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005136,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200824.0,,CN,US,US,2020,Q3,Adult
181876951,18187695,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Joint injury,,2020,Q3,1,I,202002.0,20200812.0,20200824,20200824,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005136,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200824.0,,CN,US,US,2020,Q3,Adult
181876951,18187695,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Renal failure,,2020,Q3,1,I,202002.0,20200812.0,20200824,20200824,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005136,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200824.0,,CN,US,US,2020,Q3,Adult
181876951,18187695,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Retinopathy,,2020,Q3,1,I,202002.0,20200812.0,20200824,20200824,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005136,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200824.0,,CN,US,US,2020,Q3,Adult
181876951,18187695,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Skin ulcer,,2020,Q3,1,I,202002.0,20200812.0,20200824,20200824,EXP,,US-ELI_LILLY_AND_COMPANY-US202008005136,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20200824.0,,CN,US,US,2020,Q3,Adult
181897861,18189786,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, D137576E,,20563.0,,,INJECTION,,2020,Q3,Blood glucose fluctuation,,2020,Q3,1,I,202001.0,20200727.0,20200825,20200825,PER,,US-ELI_LILLY_AND_COMPANY-US202007011408,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20200825.0,,CN,US,US,2020,Q3,Elderly
181901602,18190160,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D204245A,,,,,INJECTION,,2020,Q3,Blood glucose decreased,,2020,Q3,2,F,20200817.0,20200820.0,20200824,20200901,EXP,,US-ELI_LILLY_AND_COMPANY-US202008007394,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200901.0,,CN,US,US,2020,Q3,Elderly
181901602,18190160,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D204245A,,,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,20200817.0,20200820.0,20200824,20200901,EXP,,US-ELI_LILLY_AND_COMPANY-US202008007394,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200901.0,,CN,US,US,2020,Q3,Elderly
181901602,18190160,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D204245A,,,,,INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,2,F,20200817.0,20200820.0,20200824,20200901,EXP,,US-ELI_LILLY_AND_COMPANY-US202008007394,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200901.0,,CN,US,US,2020,Q3,Elderly
181901602,18190160,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D204245A,,,,,INJECTION,,2020,Q3,Uterine leiomyoma,,2020,Q3,2,F,20200817.0,20200820.0,20200824,20200901,EXP,,US-ELI_LILLY_AND_COMPANY-US202008007394,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200901.0,,CN,US,US,2020,Q3,Elderly
181901602,18190160,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D204245A,,,,,INJECTION,,2020,Q3,Visual impairment,,2020,Q3,2,F,20200817.0,20200820.0,20200824,20200901,EXP,,US-ELI_LILLY_AND_COMPANY-US202008007394,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200901.0,,CN,US,US,2020,Q3,Elderly
181949691,18194969,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,20563.0,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,20200316.0,20200625.0,20200825,20200825,EXP,IT-MINISAL02-624342,IT-ELI_LILLY_AND_COMPANY-IT202006011771,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20200825.0,,MD,IT,IT,2020,Q3,Elderly
181949691,18194969,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,20563.0,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200316.0,20200625.0,20200825,20200825,EXP,IT-MINISAL02-624342,IT-ELI_LILLY_AND_COMPANY-IT202006011771,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20200825.0,,MD,IT,IT,2020,Q3,Elderly
181957341,18195734,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,SLIDING SCALE FOUR TIMES  PRN,,,U,, D166927A,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200823.0,20200824.0,20200826,20200826,PER,,US-ELI_LILLY_AND_COMPANY-US202008009916,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20200826.0,,CN,US,US,2020,Q3,Elderly
181990751,18199075,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,,20200817.0,20200826,20200826,EXP,,CA-FRESENIUS KABI-FK202008537,FRESENIUS KABI,,58.0,YR,,M,Y,98.0,KG,20200826.0,,HP,CA,CA,2020,Q3,Adult
181990751,18199075,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200817.0,20200826,20200826,EXP,,CA-FRESENIUS KABI-FK202008537,FRESENIUS KABI,,58.0,YR,,M,Y,98.0,KG,20200826.0,,HP,CA,CA,2020,Q3,Adult
181990751,18199075,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200817.0,20200826,20200826,EXP,,CA-FRESENIUS KABI-FK202008537,FRESENIUS KABI,,58.0,YR,,M,Y,98.0,KG,20200826.0,,HP,CA,CA,2020,Q3,Adult
181990751,18199075,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Malaise,,2020,Q3,1,I,,20200817.0,20200826,20200826,EXP,,CA-FRESENIUS KABI-FK202008537,FRESENIUS KABI,,58.0,YR,,M,Y,98.0,KG,20200826.0,,HP,CA,CA,2020,Q3,Adult
181990751,18199075,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,,20200817.0,20200826,20200826,EXP,,CA-FRESENIUS KABI-FK202008537,FRESENIUS KABI,,58.0,YR,,M,Y,98.0,KG,20200826.0,,HP,CA,CA,2020,Q3,Adult
181990751,18199075,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200817.0,20200826,20200826,EXP,,CA-FRESENIUS KABI-FK202008537,FRESENIUS KABI,,58.0,YR,,M,Y,98.0,KG,20200826.0,,HP,CA,CA,2020,Q3,Adult
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Asthma,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Blood count abnormal,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Chest discomfort,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Diaphragmatic disorder,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Discomfort,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Hypoxia,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Left ventricular hypertrophy,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Obstructive airways disorder,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
181994611,18199461,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, 1X/DAY",,,,,,,,2.0,DF,,QD,2020,Q3,Weight increased,,2020,Q3,1,I,,20200813.0,20200826,20200826,EXP,,CA-COVIS PHARMA B.V.-2020COV00400,COVIS,,83.0,YR,,M,Y,100.0,KG,20200825.0,,CN,CA,CA,2020,Q3,Elderly
182003541,18200354,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"RAPID?ACTING INSULIN, AT MIDDAY",,,N,,,,20563.0,,,,QD,2020,Q3,Chest pain,,2020,Q3,1,I,,20200814.0,20200826,20200826,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202008006443,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200826.0,,CN,FR,FR,2020,Q3,Adult
182003541,18200354,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"RAPID?ACTING INSULIN, AT MIDDAY",,,N,,,,20563.0,,,,QD,2020,Q3,Heart rate increased,,2020,Q3,1,I,,20200814.0,20200826,20200826,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202008006443,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200826.0,,CN,FR,FR,2020,Q3,Adult
182003541,18200354,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"RAPID?ACTING INSULIN, AT MIDDAY",,,N,,,,20563.0,,,,QD,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,,20200814.0,20200826,20200826,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202008006443,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200826.0,,CN,FR,FR,2020,Q3,Adult
182003541,18200354,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"RAPID?ACTING INSULIN, AT MIDDAY",,,N,,,,20563.0,,,,QD,2020,Q3,Hypertensive crisis,,2020,Q3,1,I,,20200814.0,20200826,20200826,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202008006443,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200826.0,,CN,FR,FR,2020,Q3,Adult
182003541,18200354,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"RAPID?ACTING INSULIN, AT MIDDAY",,,N,,,,20563.0,,,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200814.0,20200826,20200826,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202008006443,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200826.0,,CN,FR,FR,2020,Q3,Adult
182003541,18200354,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"RAPID?ACTING INSULIN, AT MIDDAY",,,N,,,,20563.0,,,,QD,2020,Q3,Palpitations,,2020,Q3,1,I,,20200814.0,20200826,20200826,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202008006443,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200826.0,,CN,FR,FR,2020,Q3,Adult
182003541,18200354,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"RAPID?ACTING INSULIN, AT MIDDAY",,,N,,,,20563.0,,,,QD,2020,Q3,Weight decreased,,2020,Q3,1,I,,20200814.0,20200826,20200826,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202008006443,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20200826.0,,CN,FR,FR,2020,Q3,Adult
182004911,18200491,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200824.0,20200826,20200826,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20200826.0,,PH,DE,DE,2020,Q3,Elderly
182004911,18200491,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200824.0,20200826,20200826,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20200826.0,,PH,DE,DE,2020,Q3,Elderly
182004911,18200491,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200824.0,20200826,20200826,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20200826.0,,PH,DE,DE,2020,Q3,Elderly
182004911,18200491,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200824.0,20200826,20200826,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20200826.0,,PH,DE,DE,2020,Q3,Elderly
182008752,18200875,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,,,2020,Q3,Acute respiratory failure,,2020,Q3,2,F,20200825.0,20200903.0,20200826,20200908,EXP,,US-GILEAD-2020-0492145,GILEAD,,79.0,YR,E,F,Y,36.01,KG,20200908.0,,PH,US,US,2020,Q3,Elderly
182008752,18200875,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,,,2020,Q3,COVID-19,,2020,Q3,2,F,20200825.0,20200903.0,20200826,20200908,EXP,,US-GILEAD-2020-0492145,GILEAD,,79.0,YR,E,F,Y,36.01,KG,20200908.0,,PH,US,US,2020,Q3,Elderly
182008752,18200875,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,,,2020,Q3,Cardio-respiratory arrest,,2020,Q3,2,F,20200825.0,20200903.0,20200826,20200908,EXP,,US-GILEAD-2020-0492145,GILEAD,,79.0,YR,E,F,Y,36.01,KG,20200908.0,,PH,US,US,2020,Q3,Elderly
182008752,18200875,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,2,F,20200825.0,20200903.0,20200826,20200908,EXP,,US-GILEAD-2020-0492145,GILEAD,,79.0,YR,E,F,Y,36.01,KG,20200908.0,,PH,US,US,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Asthma,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Blood count abnormal,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Chest discomfort,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Cough,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Diaphragmatic disorder,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Discomfort,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Hypoxia,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Left ventricular hypertrophy,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Obstructive airways disorder,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Weight increased,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182011861,18201186,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO TIMES A DAY,,,,,,,,,,,BID,2020,Q3,Wheezing,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043985",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200826.0,,CN,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Asthma,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Blood count abnormal,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Chest discomfort,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Diaphragmatic disorder,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Discomfort,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Hypoxia,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Left ventricular hypertrophy,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Obstructive airways disorder,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182012011,18201201,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,2.0,DF,,QD,2020,Q3,Weight increased,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-043981",BOEHRINGER INGELHEIM,,83.0,YR,,M,Y,100.0,KG,20200827.0,,HP,CA,CA,2020,Q3,Elderly
182024031,18202403,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase decreased,,2020,Q3,1,I,20200824.0,,20200827,20200827,DIR,,,FDA-CTU,,69.0,YR,,F,N,81.0,KG,20200826.0,N,MD,US,US,2020,Q3,Elderly
182024031,18202403,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,1,I,20200824.0,,20200827,20200827,DIR,,,FDA-CTU,,69.0,YR,,F,N,81.0,KG,20200826.0,N,MD,US,US,2020,Q3,Elderly
182024031,18202403,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,20200824.0,,20200827,20200827,DIR,,,FDA-CTU,,69.0,YR,,F,N,81.0,KG,20200826.0,N,MD,US,US,2020,Q3,Elderly
182030022,18203002,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Angiopathy,,2020,Q3,2,F,20190509.0,20200825.0,20200827,20200909,EXP,,"US-AMICUS THERAPEUTICS, INC.-AMI_1023",AMICUS THERAPEUTICS,,62.0,YR,,M,Y,113.38,KG,20200909.0,,CN,US,US,2020,Q3,Adult
182030022,18203002,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Chest discomfort,,2020,Q3,2,F,20190509.0,20200825.0,20200827,20200909,EXP,,"US-AMICUS THERAPEUTICS, INC.-AMI_1023",AMICUS THERAPEUTICS,,62.0,YR,,M,Y,113.38,KG,20200909.0,,CN,US,US,2020,Q3,Adult
182030022,18203002,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,2,F,20190509.0,20200825.0,20200827,20200909,EXP,,"US-AMICUS THERAPEUTICS, INC.-AMI_1023",AMICUS THERAPEUTICS,,62.0,YR,,M,Y,113.38,KG,20200909.0,,CN,US,US,2020,Q3,Adult
182030022,18203002,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Off label use,,2020,Q3,2,F,20190509.0,20200825.0,20200827,20200909,EXP,,"US-AMICUS THERAPEUTICS, INC.-AMI_1023",AMICUS THERAPEUTICS,,62.0,YR,,M,Y,113.38,KG,20200909.0,,CN,US,US,2020,Q3,Adult
182030022,18203002,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Pain,,2020,Q3,2,F,20190509.0,20200825.0,20200827,20200909,EXP,,"US-AMICUS THERAPEUTICS, INC.-AMI_1023",AMICUS THERAPEUTICS,,62.0,YR,,M,Y,113.38,KG,20200909.0,,CN,US,US,2020,Q3,Adult
182030022,18203002,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Volume blood decreased,,2020,Q3,2,F,20190509.0,20200825.0,20200827,20200909,EXP,,"US-AMICUS THERAPEUTICS, INC.-AMI_1023",AMICUS THERAPEUTICS,,62.0,YR,,M,Y,113.38,KG,20200909.0,,CN,US,US,2020,Q3,Adult
182033071,18203307,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"300 IU, BY VALUE",,,U,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200824.0,20200827,20200827,EXP,,DE-009507513-2008DEU011901,MERCK,,78.0,YR,,M,Y,70.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182033071,18203307,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"300 IU, BY VALUE",,,U,,,,,,,,,2020,Q3,Constipation,,2020,Q3,1,I,,20200824.0,20200827,20200827,EXP,,DE-009507513-2008DEU011901,MERCK,,78.0,YR,,M,Y,70.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182033071,18203307,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"300 IU, BY VALUE",,,U,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200824.0,20200827,20200827,EXP,,DE-009507513-2008DEU011901,MERCK,,78.0,YR,,M,Y,70.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182033071,18203307,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"300 IU, BY VALUE",,,U,,,,,,,,,2020,Q3,Flatulence,,2020,Q3,1,I,,20200824.0,20200827,20200827,EXP,,DE-009507513-2008DEU011901,MERCK,,78.0,YR,,M,Y,70.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182033071,18203307,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"300 IU, BY VALUE",,,U,,,,,,,,,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,,20200824.0,20200827,20200827,EXP,,DE-009507513-2008DEU011901,MERCK,,78.0,YR,,M,Y,70.0,KG,20200827.0,,PH,DE,DE,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Asthma,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Blood count abnormal,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Chest discomfort,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Diaphragmatic disorder,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Discomfort,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Hypoxia,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Left ventricular hypertrophy,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Obstructive airways disorder,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182054501,18205450,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Weight increased,,2020,Q3,1,I,,20200820.0,20200828,20200828,EXP,,CA-TEVA-2020-CA-1818966,TEVA,,83.0,YR,E,M,Y,100.0,KG,20200828.0,,CN,CA,CA,2020,Q3,Elderly
182090392,18209039,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,INJECTION,,2020,Q3,Sopor,,2020,Q3,2,F,20200701.0,20200902.0,20200828,20200908,EXP,IT-MINISAL02-631316,IT-MYLANLABS-2020M1074851,MYLAN,,85.0,YR,,M,Y,,,20200908.0,,HP,IT,IT,2020,Q3,Elderly
182098791,18209879,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Sopor,,2020,Q3,1,I,20200701.0,20200821.0,20200829,20200829,EXP,,IT-AUROBINDO-AUR-APL-2020-045278,AUROBINDO,,85.0,YR,,M,Y,,,20200829.0,,MD,IT,IT,2020,Q3,Elderly
182104391,18210439,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Chest pain,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Dyspepsia,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Haematuria,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Inflammation,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Localised infection,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182104391,18210439,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, INSULIN PEN",,,,,,,,1.0,IU,,,2020,Q3,Pain,,2020,Q3,1,I,20191213.0,20200819.0,20200829,20200829,EXP,,DE-MICRO LABS LIMITED-ML2020-02473,MICRO LABS,,61.0,YR,,F,Y,94.0,KG,20200829.0,,PH,DE,DE,2020,Q3,Adult
182122541,18212254,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, C942028D,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200824.0,20200827.0,20200831,20200831,PER,,US-ELI_LILLY_AND_COMPANY-US202008011768,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20200831.0,,CN,US,US,2020,Q3,Elderly
182122541,18212254,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, C942028D,,20563.0,,,INJECTION,,2020,Q3,Incorrect dose administered,,2020,Q3,1,I,20200824.0,20200827.0,20200831,20200831,PER,,US-ELI_LILLY_AND_COMPANY-US202008011768,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20200831.0,,CN,US,US,2020,Q3,Elderly
182122541,18212254,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, C942028D,,20563.0,,,INJECTION,,2020,Q3,Incorrect product administration duration,,2020,Q3,1,I,20200824.0,20200827.0,20200831,20200831,PER,,US-ELI_LILLY_AND_COMPANY-US202008011768,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20200831.0,,CN,US,US,2020,Q3,Elderly
182122541,18212254,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, C942028D,,20563.0,,,INJECTION,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,20200824.0,20200827.0,20200831,20200831,PER,,US-ELI_LILLY_AND_COMPANY-US202008011768,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20200831.0,,CN,US,US,2020,Q3,Elderly
182122541,18212254,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, C942028D,,20563.0,,,INJECTION,,2020,Q3,Product storage error,,2020,Q3,1,I,20200824.0,20200827.0,20200831,20200831,PER,,US-ELI_LILLY_AND_COMPANY-US202008011768,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20200831.0,,CN,US,US,2020,Q3,Elderly
182128511,18212851,7,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200813.0,20200831,20200831,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-065966,BRISTOL MYERS SQUIBB,,87.0,YR,,F,Y,60.0,KG,20200831.0,,MD,DE,DE,2020,Q3,Elderly
182128511,18212851,7,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,,,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,,20200813.0,20200831,20200831,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-065966,BRISTOL MYERS SQUIBB,,87.0,YR,,F,Y,60.0,KG,20200831.0,,MD,DE,DE,2020,Q3,Elderly
182157842,18215784,5,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Sopor,,2020,Q3,2,F,20200701.0,20200824.0,20200831,20200901,EXP,IT-MINISAL02-631316,IT-ACCORD-197935,ACCORD,,85.0,YR,,M,Y,,,20200901.0,,MD,IT,IT,2020,Q3,Elderly
182174881,18217488,11,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,U,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200824.0,20200901,20200901,EXP,,NVSC2020DE235288,NOVARTIS,,87.0,YR,,F,Y,60.0,KG,20200901.0,,HP,DE,DE,2020,Q3,Elderly
182174881,18217488,11,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,U,,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,,20200824.0,20200901,20200901,EXP,,NVSC2020DE235288,NOVARTIS,,87.0,YR,,F,Y,60.0,KG,20200901.0,,HP,DE,DE,2020,Q3,Elderly
182176731,18217673,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200816.0,20200820.0,20200901,20200901,EXP,,US-ELI_LILLY_AND_COMPANY-US202008008581,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20200901.0,,CN,US,US,2020,Q3,Elderly
182176731,18217673,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q3,Dementia,,2020,Q3,1,I,20200816.0,20200820.0,20200901,20200901,EXP,,US-ELI_LILLY_AND_COMPANY-US202008008581,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20200901.0,,CN,US,US,2020,Q3,Elderly
182176731,18217673,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q3,Shock hypoglycaemic,,2020,Q3,1,I,20200816.0,20200820.0,20200901,20200901,EXP,,US-ELI_LILLY_AND_COMPANY-US202008008581,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20200901.0,,CN,US,US,2020,Q3,Elderly
182201711,18220171,13,I,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, BEFORE FOOD",,,U,U,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200824.0,20200902,20200902,EXP,,DE-AUROBINDO-AUR-APL-2020-045481,AUROBINDO,,87.0,YR,,F,Y,60.0,KG,20200902.0,,MD,DE,DE,2020,Q3,Elderly
182201711,18220171,13,I,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, BEFORE FOOD",,,U,U,,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,,20200824.0,20200902,20200902,EXP,,DE-AUROBINDO-AUR-APL-2020-045481,AUROBINDO,,87.0,YR,,F,Y,60.0,KG,20200902.0,,MD,DE,DE,2020,Q3,Elderly
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Abdominal discomfort,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Abdominal distension,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Abdominal pain upper,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Anaemia,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Cellulitis,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Constipation,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Decreased appetite,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Diarrhoea,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Dizziness,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Dyspnoea exertional,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Fatigue,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Gastric ulcer,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Haemorrhoids,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Headache,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Helicobacter infection,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Hepatomegaly,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Nausea,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Palpitations,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Portal hypertensive gastropathy,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Pyuria,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Transaminases increased,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Varices oesophageal,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182213043,18221304,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2020,Q3,Vomiting,,2020,Q3,3,F,2020.0,20200917.0,20200902,20200926,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,85.71,KG,20200926.0,,HP,US,US,2020,Q3,Adult
182240531,18224053,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, BEFORE FOOD",,,U,,,,20563.0,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200824.0,20200902,20200902,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008009965,ELI LILLY AND CO,,87.0,YR,,F,Y,60.0,KG,20200902.0,,MD,DE,DE,2020,Q3,Elderly
182240531,18224053,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, BEFORE FOOD",,,U,,,,20563.0,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,,20200824.0,20200902,20200902,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008009965,ELI LILLY AND CO,,87.0,YR,,F,Y,60.0,KG,20200902.0,,MD,DE,DE,2020,Q3,Elderly
182266961,18226696,11,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Economic problem,,2020,Q3,1,I,20200901.0,,20200902,20200902,DIR,,,FDA-CTU,,71.0,YR,,F,N,,,20200902.0,Y,PH,US,US,2020,Q3,Elderly
182266961,18226696,11,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Therapy cessation,,2020,Q3,1,I,20200901.0,,20200902,20200902,DIR,,,FDA-CTU,,71.0,YR,,F,N,,,20200902.0,Y,PH,US,US,2020,Q3,Elderly
182287411,18228741,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,1,I,201008.0,20200826.0,20200903,20200903,EXP,,SK-MYLANLABS-2020M1075162,MYLAN,BRECKOVA A.. TREATMENT WITH THE NEW MODIFIED INSULIN GLARGINE (SEMGLEE) IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: CASE REPORT.. DIABETES AND OBESITY.. 2020?20(39):61?62,43.0,YR,,M,Y,,,20200903.0,,MD,SK,SK,2020,Q3,Adult
182287411,18228741,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,201008.0,20200826.0,20200903,20200903,EXP,,SK-MYLANLABS-2020M1075162,MYLAN,BRECKOVA A.. TREATMENT WITH THE NEW MODIFIED INSULIN GLARGINE (SEMGLEE) IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: CASE REPORT.. DIABETES AND OBESITY.. 2020?20(39):61?62,43.0,YR,,M,Y,,,20200903.0,,MD,SK,SK,2020,Q3,Adult
182287411,18228741,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, TID (8?8?8?IU)",,,,,,,,8.0,IU,SOLUTION FOR INJECTION,Q8H,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,1,I,201008.0,20200826.0,20200903,20200903,EXP,,SK-MYLANLABS-2020M1075162,MYLAN,BRECKOVA A.. TREATMENT WITH THE NEW MODIFIED INSULIN GLARGINE (SEMGLEE) IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: CASE REPORT.. DIABETES AND OBESITY.. 2020?20(39):61?62,43.0,YR,,M,Y,,,20200903.0,,MD,SK,SK,2020,Q3,Adult
182287411,18228741,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, TID (8?8?8?IU)",,,,,,,,8.0,IU,SOLUTION FOR INJECTION,Q8H,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,201008.0,20200826.0,20200903,20200903,EXP,,SK-MYLANLABS-2020M1075162,MYLAN,BRECKOVA A.. TREATMENT WITH THE NEW MODIFIED INSULIN GLARGINE (SEMGLEE) IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: CASE REPORT.. DIABETES AND OBESITY.. 2020?20(39):61?62,43.0,YR,,M,Y,,,20200903.0,,MD,SK,SK,2020,Q3,Adult
182322801,18232280,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Hypertension,,2020,Q3,1,I,20191009.0,20191024.0,20200904,20200904,EXP,,US-AMERICAN REGENT INC-2019002332,AMERICAN REGENT,,82.0,YR,,M,Y,,,20200904.0,,CN,US,US,2020,Q3,Elderly
182328261,18232826,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hepatic encephalopathy,,2020,Q3,1,I,20200816.0,,20200903,20200903,DIR,,,FDA-CTU,,66.0,YR,,M,N,,,20200903.0,Y,PH,US,US,2020,Q3,Elderly
182328261,18232826,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Mental status changes,,2020,Q3,1,I,20200816.0,,20200903,20200903,DIR,,,FDA-CTU,,66.0,YR,,M,N,,,20200903.0,Y,PH,US,US,2020,Q3,Elderly
182333472,18233347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Atrial fibrillation,,2020,Q3,2,F,,20200914.0,20200904,20200922,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20200922.0,,PH,CA,CA,2020,Q3,Adult
182333472,18233347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,2,F,,20200914.0,20200904,20200922,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20200922.0,,PH,CA,CA,2020,Q3,Adult
182333472,18233347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,2,F,,20200914.0,20200904,20200922,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20200922.0,,PH,CA,CA,2020,Q3,Adult
182333472,18233347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Malaise,,2020,Q3,2,F,,20200914.0,20200904,20200922,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20200922.0,,PH,CA,CA,2020,Q3,Adult
182333472,18233347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Product dose omission issue,,2020,Q3,2,F,,20200914.0,20200904,20200922,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20200922.0,,PH,CA,CA,2020,Q3,Adult
182333472,18233347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,2,F,,20200914.0,20200904,20200922,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20200922.0,,PH,CA,CA,2020,Q3,Adult
182350931,18235093,19,I,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200827.0,20200905,20200905,EXP,DE-EMA-DD-20200825-AGRAHARI_P-162903,DE-ACCORD-199016,ACCORD,,87.0,YR,E,F,Y,60.0,KG,20200905.0,,MD,DE,DE,2020,Q3,Elderly
182350931,18235093,19,I,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,,,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,,20200827.0,20200905,20200905,EXP,DE-EMA-DD-20200825-AGRAHARI_P-162903,DE-ACCORD-199016,ACCORD,,87.0,YR,E,F,Y,60.0,KG,20200905.0,,MD,DE,DE,2020,Q3,Elderly
182356052,18235605,3,SS,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,Unknown,,5610.0,KIU,U,,,,,30.0,KIU,,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,20200706.0,20200827.0,20200905,20200907,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-260112,RANBAXY,,69.0,YR,,F,Y,,,20200907.0,,HP,NL,IT,2020,Q3,Elderly
182375843,18237584,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE: SEE INSTRUCTIONS. INJECT UNDER THE SKIN 4?6 UNITS BEFORE BREAKFAST AND DINNER,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,3,F,20200831.0,20200910.0,20200907,20200922,EXP,,US-PFIZER INC-2020339572,PFIZER,,67.0,YR,,F,Y,47.4,KG,20200922.0,,HP,US,US,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Asthma,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Blood count abnormal,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Chest discomfort,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Cough,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Diaphragmatic disorder,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Discomfort,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Dyspnoea,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Hypoxia,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Left ventricular hypertrophy,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Obstructive airways disorder,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Oedema peripheral,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Oropharyngeal pain,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Pyrexia,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Weight increased,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182376112,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,,,,BID,2020,Q3,Wheezing,,2020,Q3,2,F,,20200908.0,20200907,20200916,EXP,E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20200916.0,,CN,CA,CA,2020,Q3,Elderly
182405201,18240520,20,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (BEFORE FOOD),,,U,, UNKNOWN,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200826.0,20200908,20200908,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-05369,LUPIN,,87.0,YR,,F,Y,60.0,KG,20200908.0,,CN,NL,DE,2020,Q3,Elderly
182405201,18240520,20,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (BEFORE FOOD),,,U,, UNKNOWN,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,,20200826.0,20200908,20200908,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-05369,LUPIN,,87.0,YR,,F,Y,60.0,KG,20200908.0,,CN,NL,DE,2020,Q3,Elderly
182414171,18241417,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D182601C,,20563.0,10.0,IU,INJECTION,BID,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200831.0,20200903.0,20200908,20200908,PER,,US-ELI_LILLY_AND_COMPANY-US202009002197,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20200908.0,,CN,US,US,2020,Q3,Elderly
182418621,18241862,8,C,insulin lispro 35 units,,2,,,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,1,I,20200820.0,,20200908,20200908,DIR,,,FDA-CTU,,55.0,YR,,M,N,110.8,KG,20200908.0,N,PH,US,US,2020,Q3,Adult
182418621,18241862,8,C,insulin lispro 35 units,,2,,,,,,,,,,,,,,2020,Q3,Pulmonary embolism,,2020,Q3,1,I,20200820.0,,20200908,20200908,DIR,,,FDA-CTU,,55.0,YR,,M,N,110.8,KG,20200908.0,N,PH,US,US,2020,Q3,Adult
182418621,18241862,8,C,insulin lispro 35 units,,2,,,,,,,,,,,,,,2020,Q3,Tachycardia,,2020,Q3,1,I,20200820.0,,20200908,20200908,DIR,,,FDA-CTU,,55.0,YR,,M,N,110.8,KG,20200908.0,N,PH,US,US,2020,Q3,Adult
182421231,18242123,3,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200902.0,,20200908,20200908,DIR,,,FDA-CTU,,79.0,YR,,M,N,77.2,KG,20200908.0,Y,HP,US,US,2020,Q3,Elderly
182426431,18242643,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hyperhidrosis,,2020,Q3,1,I,20200515.0,20200904.0,20200908,20200908,EXP,,US-GILEAD-2020-0493990,GILEAD,,64.0,YR,A,M,Y,125.55,KG,20200908.0,,PH,US,US,2020,Q3,Adult
182426431,18242643,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,1,I,20200515.0,20200904.0,20200908,20200908,EXP,,US-GILEAD-2020-0493990,GILEAD,,64.0,YR,A,M,Y,125.55,KG,20200908.0,,PH,US,US,2020,Q3,Adult
182426431,18242643,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,20200515.0,20200904.0,20200908,20200908,EXP,,US-GILEAD-2020-0493990,GILEAD,,64.0,YR,A,M,Y,125.55,KG,20200908.0,,PH,US,US,2020,Q3,Adult
182436371,18243637,20,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200901.0,20200908,20200908,EXP,,DE-009507513-2009DEU000442,MERCK,,87.0,YR,,F,Y,60.0,KG,20200908.0,,MD,DE,DE,2020,Q3,Elderly
182436371,18243637,20,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,,,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,,20200901.0,20200908,20200908,EXP,,DE-009507513-2009DEU000442,MERCK,,87.0,YR,,F,Y,60.0,KG,20200908.0,,MD,DE,DE,2020,Q3,Elderly
182444321,18244432,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2?12 UNITS,,,,,,,,,,,TID,2020,Q3,Pulmonary hypertension,,2020,Q3,1,I,,20200824.0,20200908,20200908,EXP,,US-JNJFOC-A-NJ2020-208807,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20200908.0,,HP,US,US,2020,Q3,Elderly
182444321,18244432,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2?12 UNITS,,,,,,,,,,,TID,2020,Q3,Respiratory failure,,2020,Q3,1,I,,20200824.0,20200908,20200908,EXP,,US-JNJFOC-A-NJ2020-208807,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20200908.0,,HP,US,US,2020,Q3,Elderly
182449261,18244926,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q3,Feeling hot,,2020,Q3,1,I,20200813.0,20200813.0,20200909,20200909,PER,,US-ELI_LILLY_AND_COMPANY-US202008006099,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200909.0,,CN,US,US,2020,Q3,Elderly
182449261,18244926,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q3,Glycosylated haemoglobin abnormal,,2020,Q3,1,I,20200813.0,20200813.0,20200909,20200909,PER,,US-ELI_LILLY_AND_COMPANY-US202008006099,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200909.0,,CN,US,US,2020,Q3,Elderly
182449261,18244926,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q3,Hyperhidrosis,,2020,Q3,1,I,20200813.0,20200813.0,20200909,20200909,PER,,US-ELI_LILLY_AND_COMPANY-US202008006099,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200909.0,,CN,US,US,2020,Q3,Elderly
182449261,18244926,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,20200813.0,20200813.0,20200909,20200909,PER,,US-ELI_LILLY_AND_COMPANY-US202008006099,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200909.0,,CN,US,US,2020,Q3,Elderly
182449261,18244926,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2020,Q3,Feeling hot,,2020,Q3,1,I,20200813.0,20200813.0,20200909,20200909,PER,,US-ELI_LILLY_AND_COMPANY-US202008006099,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200909.0,,CN,US,US,2020,Q3,Elderly
182449261,18244926,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2020,Q3,Glycosylated haemoglobin abnormal,,2020,Q3,1,I,20200813.0,20200813.0,20200909,20200909,PER,,US-ELI_LILLY_AND_COMPANY-US202008006099,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200909.0,,CN,US,US,2020,Q3,Elderly
182449261,18244926,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2020,Q3,Hyperhidrosis,,2020,Q3,1,I,20200813.0,20200813.0,20200909,20200909,PER,,US-ELI_LILLY_AND_COMPANY-US202008006099,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200909.0,,CN,US,US,2020,Q3,Elderly
182449261,18244926,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,20200813.0,20200813.0,20200909,20200909,PER,,US-ELI_LILLY_AND_COMPANY-US202008006099,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20200909.0,,CN,US,US,2020,Q3,Elderly
182460411,18246041,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2020,Q3,Sopor,,2020,Q3,1,I,20200701.0,20200901.0,20200909,20200909,EXP,IT-MINISAL02-631316,IT-TEVA-2020-IT-1824531,TEVA,,5.0,MON,I,M,Y,,,20200909.0,,MD,IT,IT,2020,Q3,Child
182473393,18247339,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2020,Q3,Enteritis,,2020,Q3,3,F,20200831.0,20200914.0,20200909,20200923,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20200923.0,,HP,US,US,2020,Q3,Adult
182473393,18247339,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2020,Q3,Hospitalisation,,2020,Q3,3,F,20200831.0,20200914.0,20200909,20200923,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20200923.0,,HP,US,US,2020,Q3,Adult
182473393,18247339,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2020,Q3,Malaise,,2020,Q3,3,F,20200831.0,20200914.0,20200909,20200923,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20200923.0,,HP,US,US,2020,Q3,Adult
182473393,18247339,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2020,Q3,Speech disorder,,2020,Q3,3,F,20200831.0,20200914.0,20200909,20200923,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20200923.0,,HP,US,US,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Abscess,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Adrenal insufficiency,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Ascites,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Blood alkaline phosphatase increased,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Blood bilirubin increased,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Blood potassium decreased,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Blood pressure diastolic abnormal,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Blood pressure increased,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Congestive hepatopathy,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Depression,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Diverticulitis,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Endometrial disorder,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Enterococcus test positive,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Fibrosis,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Gamma-glutamyltransferase increased,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Gastrointestinal disorder,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Generalised oedema,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Heart rate increased,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Herpes zoster,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Hypersensitivity,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Increased appetite,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Influenza,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Infusion related reaction,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Injection site extravasation,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Intensive care unit acquired weakness,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Intervertebral disc protrusion,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Joint effusion,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Joint swelling,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Micturition disorder,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Myelopathy,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Myopathy,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Nasopharyngitis,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Nerve compression,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Neuropathy peripheral,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Osteoarthritis,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Pancytopenia,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Peripheral sensorimotor neuropathy,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Peritonitis,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Pseudomonal bacteraemia,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Rheumatoid arthritis,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Therapeutic response decreased,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Weight decreased,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182478711,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200831.0,20200909,20200909,EXP,,CA-ASTRAZENECA-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20200909.0,,HP,CA,CA,2020,Q3,Adult
182498321,18249832,19,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD (),,,U,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200828.0,20200910,20200910,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-260628,RANBAXY,,87.0,YR,,F,Y,60.0,KG,20200910.0,,HP,NL,DE,2020,Q3,Elderly
182498321,18249832,19,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD (),,,U,,,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,,20200828.0,20200910,20200910,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-260628,RANBAXY,,87.0,YR,,F,Y,60.0,KG,20200910.0,,HP,NL,DE,2020,Q3,Elderly
182513221,18251322,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200904.0,20200904.0,20200910,20200910,PER,,US-ELI_LILLY_AND_COMPANY-US202009003749,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20200910.0,,CN,US,US,2020,Q3,Elderly
182513221,18251322,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,20200904.0,20200904.0,20200910,20200910,PER,,US-ELI_LILLY_AND_COMPANY-US202009003749,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20200910.0,,CN,US,US,2020,Q3,Elderly
182525811,18252581,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Bradycardia,,2020,Q3,1,I,20200710.0,,20200910,20200910,DIR,,,FDA-CTU,,67.0,YR,,F,N,120.2,KG,20200910.0,N,PH,US,US,2020,Q3,Elderly
182537761,18253776,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,20200808.0,20200810.0,20200910,20200910,EXP,,US-GILEAD-2020-0490003,GILEAD,,71.0,YR,E,M,Y,26.62,KG,20200910.0,,HP,US,US,2020,Q3,Elderly
182537761,18253776,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Cytokine release syndrome,,2020,Q3,1,I,20200808.0,20200810.0,20200910,20200910,EXP,,US-GILEAD-2020-0490003,GILEAD,,71.0,YR,E,M,Y,26.62,KG,20200910.0,,HP,US,US,2020,Q3,Elderly
182537761,18253776,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,1,I,20200808.0,20200810.0,20200910,20200910,EXP,,US-GILEAD-2020-0490003,GILEAD,,71.0,YR,E,M,Y,26.62,KG,20200910.0,,HP,US,US,2020,Q3,Elderly
182537761,18253776,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,1,I,20200808.0,20200810.0,20200910,20200910,EXP,,US-GILEAD-2020-0490003,GILEAD,,71.0,YR,E,M,Y,26.62,KG,20200910.0,,HP,US,US,2020,Q3,Elderly
182537761,18253776,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,20200808.0,20200810.0,20200910,20200910,EXP,,US-GILEAD-2020-0490003,GILEAD,,71.0,YR,E,M,Y,26.62,KG,20200910.0,,HP,US,US,2020,Q3,Elderly
182541301,18254130,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,,, D182601C,,20563.0,10.0,IU,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200831.0,20200903.0,20200910,20200910,PER,,US-ELI_LILLY_AND_COMPANY-US202009003211,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20200910.0,,CN,US,US,2020,Q3,Elderly
182541301,18254130,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,,, D182601C,,20563.0,10.0,IU,INJECTION,,2020,Q3,Product storage error,,2020,Q3,1,I,20200831.0,20200903.0,20200910,20200910,PER,,US-ELI_LILLY_AND_COMPANY-US202009003211,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20200910.0,,CN,US,US,2020,Q3,Elderly
182542211,18254221,11,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(BEFORE FOOD),,,U,U,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200904.0,20200910,20200910,EXP,,DE-MYLANLABS-2020M1077644,MYLAN,,87.0,YR,,F,Y,60.0,KG,20200910.0,,MD,DE,DE,2020,Q3,Elderly
182542211,18254221,11,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(BEFORE FOOD),,,U,U,,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,,20200904.0,20200910,20200910,EXP,,DE-MYLANLABS-2020M1077644,MYLAN,,87.0,YR,,F,Y,60.0,KG,20200910.0,,MD,DE,DE,2020,Q3,Elderly
182591281,18259128,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Bradycardia,,2020,Q3,1,I,20200710.0,20200910.0,20200911,20200911,EXP,,US-GILEAD-2020-0494609,GILEAD,,67.0,YR,E,F,Y,120.2,KG,20200911.0,,PH,US,US,2020,Q3,Elderly
182594462,18259446,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,2,F,20200908.0,20200924.0,20200911,20200925,EXP,,US-GILEAD-2020-0494634,GILEAD,,69.0,YR,E,M,Y,107.0,KG,20200925.0,,PH,US,US,2020,Q3,Elderly
182594462,18259446,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,2,F,20200908.0,20200924.0,20200911,20200925,EXP,,US-GILEAD-2020-0494634,GILEAD,,69.0,YR,E,M,Y,107.0,KG,20200925.0,,PH,US,US,2020,Q3,Elderly
182598811,18259881,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Asthenia,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598811,18259881,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598811,18259881,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598811,18259881,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598811,18259881,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Fall,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598811,18259881,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598811,18259881,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Hypovolaemia,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598831,18259883,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182598831,18259883,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182598831,18259883,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182598831,18259883,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182598831,18259883,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182598831,18259883,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182598831,18259883,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Hypovolaemia,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182611731,18261173,33,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU (1IU, CO)",,,U,U, UNKNOWN,,,1.0,IU,,,2020,Q3,Toxic epidermal necrolysis,,2020,Q3,1,I,20200809.0,20200911.0,20200914,20200914,EXP,,NVSC2020FR249758,NOVARTIS,,75.0,YR,,M,Y,,,20200914.0,,HP,FR,FR,2020,Q3,Elderly
182613681,18261368,20,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,U, UNKNOWN,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200903.0,20200914,20200914,PER,,DE-DRREDDYS-GER/GER/20/0126671,DR REDDYS,,87.0,YR,E,F,Y,60.0,KG,20200914.0,,MD,DE,DE,2020,Q3,Elderly
182613681,18261368,20,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,U, UNKNOWN,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,,20200903.0,20200914,20200914,PER,,DE-DRREDDYS-GER/GER/20/0126671,DR REDDYS,,87.0,YR,E,F,Y,60.0,KG,20200914.0,,MD,DE,DE,2020,Q3,Elderly
182618001,18261800,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200814.0,20200817.0,20200914,20200914,PER,,US-ELI_LILLY_AND_COMPANY-US202008006966,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200914.0,,CN,US,US,2020,Q3,Elderly
182618001,18261800,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2020,Q3,Hyperhidrosis,,2020,Q3,1,I,20200814.0,20200817.0,20200914,20200914,PER,,US-ELI_LILLY_AND_COMPANY-US202008006966,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200914.0,,CN,US,US,2020,Q3,Elderly
182618001,18261800,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2020,Q3,Product storage error,,2020,Q3,1,I,20200814.0,20200817.0,20200914,20200914,PER,,US-ELI_LILLY_AND_COMPANY-US202008006966,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200914.0,,CN,US,US,2020,Q3,Elderly
182618001,18261800,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2020,Q3,Stress,,2020,Q3,1,I,20200814.0,20200817.0,20200914,20200914,PER,,US-ELI_LILLY_AND_COMPANY-US202008006966,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20200914.0,,CN,US,US,2020,Q3,Elderly
182640161,18264016,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (PEN),,,U,,,,,,,,,2020,Q3,Haematochezia,,2020,Q3,1,I,,20200910.0,20200914,20200914,EXP,,NVSC2020DE249091,NOVARTIS,,72.0,YR,,F,Y,,,20200914.0,,HP,DE,DE,2020,Q3,Elderly
182640161,18264016,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (PEN),,,U,,,,,,,,,2020,Q3,Swelling,,2020,Q3,1,I,,20200910.0,20200914,20200914,EXP,,NVSC2020DE249091,NOVARTIS,,72.0,YR,,F,Y,,,20200914.0,,HP,DE,DE,2020,Q3,Elderly
182650591,18265059,1,PS,Insulin Lispro,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 INTERNATIONAL UNIT, UNKNOWN",,,U,, ASKED BUT UNKNOWN,,20563.0,1.0,IU,,,2020,Q3,Toxic epidermal necrolysis,,2020,Q3,1,I,20200809.0,20200909.0,20200914,20200914,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202009004654,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200914.0,,MD,FR,FR,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Asthma,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Blood count abnormal,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Chest discomfort,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Diaphragmatic disorder,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Discomfort,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Hypoxia,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Left ventricular hypertrophy,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Obstructive airways disorder,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182656761,18265676,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2020,Q3,Weight increased,,2020,Q3,1,I,,20200907.0,20200915,20200915,EXP,,CA-BAUSCH-BL-2020-025890,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20200915.0,,CN,CA,CA,2020,Q3,Elderly
182672411,18267241,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200819.0,,20200915,20200915,DIR,,,FDA-CTU,,71.0,YR,,F,N,44.9,KG,20200915.0,Y,PH,US,US,2020,Q3,Elderly
182672411,18267241,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,1,I,20200819.0,,20200915,20200915,DIR,,,FDA-CTU,,71.0,YR,,F,N,44.9,KG,20200915.0,Y,PH,US,US,2020,Q3,Elderly
182672411,18267241,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Therapy interrupted,,2020,Q3,1,I,20200819.0,,20200915,20200915,DIR,,,FDA-CTU,,71.0,YR,,F,N,44.9,KG,20200915.0,Y,PH,US,US,2020,Q3,Elderly
182685061,18268506,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"30 U, UNKNOWN",,,,,,,20563.0,30.0,IU,INJECTION,,2020,Q3,Macular degeneration,,2020,Q3,1,I,202002.0,20200902.0,20200915,20200915,EXP,,US-ELI_LILLY_AND_COMPANY-US202009001908,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200915.0,,CN,US,US,2020,Q3,Elderly
182685061,18268506,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"30 U, UNKNOWN",,,,,,,20563.0,30.0,IU,INJECTION,,2020,Q3,Retinal detachment,,2020,Q3,1,I,202002.0,20200902.0,20200915,20200915,EXP,,US-ELI_LILLY_AND_COMPANY-US202009001908,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200915.0,,CN,US,US,2020,Q3,Elderly
182685061,18268506,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"30 U, UNKNOWN",,,,, D153476H,,20563.0,30.0,IU,INJECTION,,2020,Q3,Macular degeneration,,2020,Q3,1,I,202002.0,20200902.0,20200915,20200915,EXP,,US-ELI_LILLY_AND_COMPANY-US202009001908,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200915.0,,CN,US,US,2020,Q3,Elderly
182685061,18268506,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"30 U, UNKNOWN",,,,, D153476H,,20563.0,30.0,IU,INJECTION,,2020,Q3,Retinal detachment,,2020,Q3,1,I,202002.0,20200902.0,20200915,20200915,EXP,,US-ELI_LILLY_AND_COMPANY-US202009001908,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20200915.0,,CN,US,US,2020,Q3,Elderly
182698651,18269865,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200816.0,20200818.0,20200915,20200915,PER,,US-ELI_LILLY_AND_COMPANY-US202008007309,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200915.0,,CN,US,US,2020,Q3,Elderly
182698651,18269865,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2020,Q3,Injury associated with device,,2020,Q3,1,I,20200816.0,20200818.0,20200915,20200915,PER,,US-ELI_LILLY_AND_COMPANY-US202008007309,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200915.0,,CN,US,US,2020,Q3,Elderly
182698651,18269865,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,20200816.0,20200818.0,20200915,20200915,PER,,US-ELI_LILLY_AND_COMPANY-US202008007309,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200915.0,,CN,US,US,2020,Q3,Elderly
182698651,18269865,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D153476H,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200816.0,20200818.0,20200915,20200915,PER,,US-ELI_LILLY_AND_COMPANY-US202008007309,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200915.0,,CN,US,US,2020,Q3,Elderly
182698651,18269865,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D153476H,,20563.0,,,INJECTION,,2020,Q3,Injury associated with device,,2020,Q3,1,I,20200816.0,20200818.0,20200915,20200915,PER,,US-ELI_LILLY_AND_COMPANY-US202008007309,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200915.0,,CN,US,US,2020,Q3,Elderly
182698651,18269865,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D153476H,,20563.0,,,INJECTION,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,20200816.0,20200818.0,20200915,20200915,PER,,US-ELI_LILLY_AND_COMPANY-US202008007309,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20200915.0,,CN,US,US,2020,Q3,Elderly
182702481,18270248,29,SS,Insulin lispro,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 INTERNATIONAL UNIT (CO),,,U,U,,,,1.0,IU,,,2020,Q3,Toxic epidermal necrolysis,,2020,Q3,1,I,20200809.0,20200909.0,20200916,20200916,EXP,,FR-AUROBINDO-AUR-APL-2020-047708,AUROBINDO,,75.0,YR,,M,Y,,,20200916.0,,MD,FR,FR,2020,Q3,Elderly
182730281,18273028,13,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Transaminases increased,,2020,Q3,1,I,20200913.0,,20200916,20200916,DIR,,,FDA-CTU,,84.0,YR,,M,N,104.4,KG,20200916.0,N,PH,US,US,2020,Q3,Elderly
182737781,18273778,21,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,, UNKNOWN,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200907.0,20200916,20200916,EXP,,DE-TEVA-2020-DE-1826702,TEVA,,87.0,YR,E,F,Y,60.0,KG,20200916.0,,MD,DE,DE,2020,Q3,Elderly
182737781,18273778,21,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD,,,U,, UNKNOWN,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,,20200907.0,20200916,20200916,EXP,,DE-TEVA-2020-DE-1826702,TEVA,,87.0,YR,E,F,Y,60.0,KG,20200916.0,,MD,DE,DE,2020,Q3,Elderly
182768431,18276843,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,,,,20563.0,5.0,IU,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,,,,20563.0,5.0,IU,INJECTION,,2020,Q3,Disturbance in attention,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,,,,20563.0,5.0,IU,INJECTION,,2020,Q3,Dizziness,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,,,,20563.0,5.0,IU,INJECTION,,2020,Q3,Drug hypersensitivity,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,,,,20563.0,5.0,IU,INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,,,,20563.0,5.0,IU,INJECTION,,2020,Q3,Ocular rosacea,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,,,,20563.0,5.0,IU,INJECTION,,2020,Q3,Reading disorder,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,, D207627A,,20563.0,5.0,IU,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,, D207627A,,20563.0,5.0,IU,INJECTION,,2020,Q3,Disturbance in attention,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,, D207627A,,20563.0,5.0,IU,INJECTION,,2020,Q3,Dizziness,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,, D207627A,,20563.0,5.0,IU,INJECTION,,2020,Q3,Drug hypersensitivity,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,, D207627A,,20563.0,5.0,IU,INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,, D207627A,,20563.0,5.0,IU,INJECTION,,2020,Q3,Ocular rosacea,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182768431,18276843,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1?5 U, PRN",,,Y,, D207627A,,20563.0,5.0,IU,INJECTION,,2020,Q3,Reading disorder,,2020,Q3,1,I,202004.0,20200908.0,20200917,20200917,EXP,,US-ELI_LILLY_AND_COMPANY-US202009003645,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20200917.0,,CN,US,US,2020,Q3,Adult
182790821,18279082,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Anaemia,,2020,Q3,1,I,,20200910.0,20200917,20200917,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-074641,BRISTOL MYERS SQUIBB,,84.0,YR,,F,Y,,,20200917.0,,MD,DE,DE,2020,Q3,Elderly
182811621,18281162,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811621,18281162,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811621,18281162,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811621,18281162,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811621,18281162,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811621,18281162,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811621,18281162,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Hypovolaemia,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182831322,18283132,34,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU (1IU, CO)",,,U,,,,,1.0,IU,,,2020,Q3,Toxic epidermal necrolysis,,2020,Q3,2,F,20200809.0,20200914.0,20200918,20200921,EXP,,FR-PFIZER INC-2020358219,PFIZER,,75.0,YR,,M,Y,,,20200921.0,,MD,FR,FR,2020,Q3,Elderly
182846331,18284633,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,CA-ASTRAZENECA-2020SF16518,ASTRAZENECA,,72.0,YR,,F,Y,,,20200918.0,,HP,CA,CA,2020,Q3,Elderly
182846331,18284633,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,CA-ASTRAZENECA-2020SF16518,ASTRAZENECA,,72.0,YR,,F,Y,,,20200918.0,,HP,CA,CA,2020,Q3,Elderly
182846331,18284633,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,CA-ASTRAZENECA-2020SF16518,ASTRAZENECA,,72.0,YR,,F,Y,,,20200918.0,,HP,CA,CA,2020,Q3,Elderly
182846331,18284633,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Small intestinal obstruction,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,CA-ASTRAZENECA-2020SF16518,ASTRAZENECA,,72.0,YR,,F,Y,,,20200918.0,,HP,CA,CA,2020,Q3,Elderly
182846331,18284633,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Urinary tract obstruction,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,CA-ASTRAZENECA-2020SF16518,ASTRAZENECA,,72.0,YR,,F,Y,,,20200918.0,,HP,CA,CA,2020,Q3,Elderly
182848161,18284816,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200831.0,20200914.0,20200919,20200919,PER,,US-AMGEN-USASP2020149787,AMGEN,,67.0,YR,E,F,Y,47.4,KG,20200918.0,,HP,US,US,2020,Q3,Elderly
182848161,18284816,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Atelectasis,,2020,Q3,1,I,20200831.0,20200914.0,20200919,20200919,PER,,US-AMGEN-USASP2020149787,AMGEN,,67.0,YR,E,F,Y,47.4,KG,20200918.0,,HP,US,US,2020,Q3,Elderly
182848161,18284816,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,20200831.0,20200914.0,20200919,20200919,PER,,US-AMGEN-USASP2020149787,AMGEN,,67.0,YR,E,F,Y,47.4,KG,20200918.0,,HP,US,US,2020,Q3,Elderly
182848161,18284816,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Distributive shock,,2020,Q3,1,I,20200831.0,20200914.0,20200919,20200919,PER,,US-AMGEN-USASP2020149787,AMGEN,,67.0,YR,E,F,Y,47.4,KG,20200918.0,,HP,US,US,2020,Q3,Elderly
182848161,18284816,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pleural effusion,,2020,Q3,1,I,20200831.0,20200914.0,20200919,20200919,PER,,US-AMGEN-USASP2020149787,AMGEN,,67.0,YR,E,F,Y,47.4,KG,20200918.0,,HP,US,US,2020,Q3,Elderly
182848161,18284816,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,1,I,20200831.0,20200914.0,20200919,20200919,PER,,US-AMGEN-USASP2020149787,AMGEN,,67.0,YR,E,F,Y,47.4,KG,20200918.0,,HP,US,US,2020,Q3,Elderly
182856221,18285622,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Ammonia increased,,2020,Q3,1,I,20200703.0,20200723.0,20200918,20200918,EXP,,US-JNJFOC-A-US2020-207767,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20200918.0,,HP,US,US,2020,Q3,Elderly
182856221,18285622,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hepatic encephalopathy,,2020,Q3,1,I,20200703.0,20200723.0,20200918,20200918,EXP,,US-JNJFOC-A-US2020-207767,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20200918.0,,HP,US,US,2020,Q3,Elderly
182856221,18285622,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Mental disorder,,2020,Q3,1,I,20200703.0,20200723.0,20200918,20200918,EXP,,US-JNJFOC-A-US2020-207767,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20200918.0,,HP,US,US,2020,Q3,Elderly
182863461,18286346,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,201912.0,20200914.0,20200920,20200920,PER,,US-ELI_LILLY_AND_COMPANY-US202009007102,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200920.0,,CN,US,US,2020,Q3,Elderly
182863461,18286346,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Injection site bruising,,2020,Q3,1,I,201912.0,20200914.0,20200920,20200920,PER,,US-ELI_LILLY_AND_COMPANY-US202009007102,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200920.0,,CN,US,US,2020,Q3,Elderly
182863461,18286346,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Injection site haemorrhage,,2020,Q3,1,I,201912.0,20200914.0,20200920,20200920,PER,,US-ELI_LILLY_AND_COMPANY-US202009007102,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200920.0,,CN,US,US,2020,Q3,Elderly
182863461,18286346,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Injection site pain,,2020,Q3,1,I,201912.0,20200914.0,20200920,20200920,PER,,US-ELI_LILLY_AND_COMPANY-US202009007102,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200920.0,,CN,US,US,2020,Q3,Elderly
182863461,18286346,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Mobility decreased,,2020,Q3,1,I,201912.0,20200914.0,20200920,20200920,PER,,US-ELI_LILLY_AND_COMPANY-US202009007102,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200920.0,,CN,US,US,2020,Q3,Elderly
182863461,18286346,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2020,Q3,Nerve compression,,2020,Q3,1,I,201912.0,20200914.0,20200920,20200920,PER,,US-ELI_LILLY_AND_COMPANY-US202009007102,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20200920.0,,CN,US,US,2020,Q3,Elderly
182865241,18286524,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),CO,,,U,,,,,1.0,IU,,,2020,Q3,Toxic epidermal necrolysis,,2020,Q3,1,I,20200809.0,20200911.0,20200920,20200920,EXP,,FR-BAUSCH-BL-2020-026348,BAUSCH AND LOMB,,75.0,YR,,M,Y,,,20200920.0,,MD,FR,FR,2020,Q3,Elderly
182885771,18288577,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, TID",,,U,, ASKU,,20563.0,15.0,IU,,TID,2020,Q3,Fatigue,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, TID",,,U,, ASKU,,20563.0,15.0,IU,,TID,2020,Q3,Injection site dermatitis,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, TID",,,U,, ASKU,,20563.0,15.0,IU,,TID,2020,Q3,Injection site erythema,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, TID",,,U,, ASKU,,20563.0,15.0,IU,,TID,2020,Q3,Injection site pain,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, TID",,,U,, ASKU,,20563.0,15.0,IU,,TID,2020,Q3,Injection site pruritus,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, TID",,,U,, ASKU,,20563.0,15.0,IU,,TID,2020,Q3,Injection site swelling,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, TID",,,U,, ASKU,,20563.0,15.0,IU,,TID,2020,Q3,Ketoacidosis,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, TID",,,U,, ASKU,,20563.0,15.0,IU,,TID,2020,Q3,Skin lesion,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,2,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,,,,20563.0,,,,,2020,Q3,Fatigue,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,2,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,,,,20563.0,,,,,2020,Q3,Injection site dermatitis,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,2,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,,,,20563.0,,,,,2020,Q3,Injection site erythema,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,2,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,,,,20563.0,,,,,2020,Q3,Injection site pain,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,2,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,,,,20563.0,,,,,2020,Q3,Injection site pruritus,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,2,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,,,,20563.0,,,,,2020,Q3,Injection site swelling,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,2,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,,,,20563.0,,,,,2020,Q3,Ketoacidosis,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182885771,18288577,2,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,,,,20563.0,,,,,2020,Q3,Skin lesion,,2020,Q3,1,I,202008.0,20200909.0,20200921,20200921,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003697,ELI LILLY AND CO,,61.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182888531,18288853,6,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200920.0,,20200921,20200921,DIR,,,FDA-CTU,,76.0,YR,,M,N,82.0,KG,20200921.0,N,PH,US,US,2020,Q3,Elderly
182888531,18288853,6,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,1,I,20200920.0,,20200921,20200921,DIR,,,FDA-CTU,,76.0,YR,,M,N,82.0,KG,20200921.0,N,PH,US,US,2020,Q3,Elderly
182888531,18288853,6,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Hepatotoxicity,,2020,Q3,1,I,20200920.0,,20200921,20200921,DIR,,,FDA-CTU,,76.0,YR,,M,N,82.0,KG,20200921.0,N,PH,US,US,2020,Q3,Elderly
182888531,18288853,6,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Therapy cessation,,2020,Q3,1,I,20200920.0,,20200921,20200921,DIR,,,FDA-CTU,,76.0,YR,,M,N,82.0,KG,20200921.0,N,PH,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Acute respiratory failure,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dizziness,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Haemoglobin decreased,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Headache,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypoaesthesia,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Malaise,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Mental status changes,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Muscular weakness,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Oxygen saturation decreased,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Paraesthesia,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Pulmonary hypertension,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Transfusion,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182912511,18291251,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q3,Urinary retention,,2020,Q3,1,I,2020.0,20200330.0,20200921,20200921,EXP,,US-JNJFOC-A-NJ2020-203897,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Elderly
182916791,18291679,11,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,1,I,20200831.0,20200914.0,20200922,20200922,EXP,,US-BAXTER-2020BAX019200,BAXTER,,67.0,YR,,F,Y,47.4,KG,20200922.0,,MD,US,US,2020,Q3,Elderly
182917611,18291761,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, TID",90.0,IU,D,,,,,15.0,IU,,TID,2020,Q3,Dermatitis allergic,,2020,Q3,1,I,20200811.0,20200909.0,20200921,20200921,EXP,,CN-NOVOPROD-753854,NOVO NORDISK,,62.0,YR,,F,Y,59.0,KG,20200921.0,,HP,CN,CN,2020,Q3,Adult
182928471,18292847,15,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Anaemia,,2020,Q3,1,I,20200916.0,,20200921,20200921,DIR,,,FDA-CTU,,47.0,YR,,F,N,85.08,KG,20200921.0,N,PH,US,US,2020,Q3,Adult
182928471,18292847,15,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Blood lactate dehydrogenase increased,,2020,Q3,1,I,20200916.0,,20200921,20200921,DIR,,,FDA-CTU,,47.0,YR,,F,N,85.08,KG,20200921.0,N,PH,US,US,2020,Q3,Adult
182928471,18292847,15,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Haptoglobin decreased,,2020,Q3,1,I,20200916.0,,20200921,20200921,DIR,,,FDA-CTU,,47.0,YR,,F,N,85.08,KG,20200921.0,N,PH,US,US,2020,Q3,Adult
182928471,18292847,15,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q3,Reticulocyte count increased,,2020,Q3,1,I,20200916.0,,20200921,20200921,DIR,,,FDA-CTU,,47.0,YR,,F,N,85.08,KG,20200921.0,N,PH,US,US,2020,Q3,Adult
182929161,18292916,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,U,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200914.0,20200922,20200922,EXP,DE-ADRED-05185-01,NVSC2020DE251706,NOVARTIS,,61.0,YR,,F,Y,58.0,KG,20200922.0,,HP,DE,DE,2020,Q3,Adult
182929161,18292916,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,U,,,,,,,,,2020,Q3,Feeling hot,,2020,Q3,1,I,,20200914.0,20200922,20200922,EXP,DE-ADRED-05185-01,NVSC2020DE251706,NOVARTIS,,61.0,YR,,F,Y,58.0,KG,20200922.0,,HP,DE,DE,2020,Q3,Adult
182929161,18292916,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,U,,,,,,,,,2020,Q3,Inflammation,,2020,Q3,1,I,,20200914.0,20200922,20200922,EXP,DE-ADRED-05185-01,NVSC2020DE251706,NOVARTIS,,61.0,YR,,F,Y,58.0,KG,20200922.0,,HP,DE,DE,2020,Q3,Adult
182929161,18292916,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,U,,,,,,,,,2020,Q3,Localised infection,,2020,Q3,1,I,,20200914.0,20200922,20200922,EXP,DE-ADRED-05185-01,NVSC2020DE251706,NOVARTIS,,61.0,YR,,F,Y,58.0,KG,20200922.0,,HP,DE,DE,2020,Q3,Adult
182929161,18292916,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,U,,,,,,,,,2020,Q3,Skin ulcer,,2020,Q3,1,I,,20200914.0,20200922,20200922,EXP,DE-ADRED-05185-01,NVSC2020DE251706,NOVARTIS,,61.0,YR,,F,Y,58.0,KG,20200922.0,,HP,DE,DE,2020,Q3,Adult
182952881,18295288,30,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,U,, UNK,,,1.0,IU,UNKNOWN,,2020,Q3,Toxic epidermal necrolysis,,2020,Q3,1,I,20200809.0,20200915.0,20200922,20200922,EXP,,FR-FRESENIUS KABI-FK202009537,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200922.0,,HP,NL,FR,2020,Q3,Elderly
183057541,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200917.0,20200923,20200923,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183057541,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,,,,,,,,,2020,Q3,Dizziness,,2020,Q3,1,I,,20200917.0,20200923,20200923,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183057541,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200917.0,20200923,20200923,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183057541,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200917.0,20200923,20200923,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183057541,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,,20200917.0,20200923,20200923,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183057541,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,,,,,,,,,2020,Q3,Thirst,,2020,Q3,1,I,,20200917.0,20200923,20200923,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183061352,18306135,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Nephropathy,,2020,Q3,2,F,20200914.0,20200925.0,20200924,20200930,EXP,,NVSC2020RU252695,NOVARTIS,,30.0,YR,,M,Y,69.0,KG,20200930.0,,MD,RU,RU,2020,Q3,Young Adult
183064011,18306401,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,42.0,IU,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,42.0,IU,,,2020,Q3,Bedridden,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,42.0,IU,,,2020,Q3,Constipation,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,42.0,IU,,,2020,Q3,Contraindicated product administered,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,42.0,IU,,,2020,Q3,Drug clearance decreased,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,42.0,IU,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,42.0,IU,,,2020,Q3,International normalised ratio increased,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,42.0,IU,,,2020,Q3,Overdose,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,42.0,IU,,,2020,Q3,Product administration error,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,42.0,IU,,,2020,Q3,Product name confusion,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,42.0,IU,,,2020,Q3,Rhabdomyolysis,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,42.0,IU,,,2020,Q3,Toxicity to various agents,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183080511,18308051,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,1,I,20200831.0,20200914.0,20200924,20200924,EXP,,US-ENDO PHARMACEUTICALS INC-2020-006195,ENDO,,67.0,YR,,F,Y,47.39,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183100891,18310089,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,,, UNKNOWN,,,300.0,IU,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200917.0,20200925,20200925,PER,,DE-DRREDDYS-GER/GER/20/0127072,DR REDDYS,,61.0,YR,A,F,Y,58.0,KG,20200925.0,,MD,DE,DE,2020,Q3,Adult
183100891,18310089,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,,, UNKNOWN,,,300.0,IU,,,2020,Q3,Feeling hot,,2020,Q3,1,I,,20200917.0,20200925,20200925,PER,,DE-DRREDDYS-GER/GER/20/0127072,DR REDDYS,,61.0,YR,A,F,Y,58.0,KG,20200925.0,,MD,DE,DE,2020,Q3,Adult
183100891,18310089,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,,, UNKNOWN,,,300.0,IU,,,2020,Q3,Inflammation,,2020,Q3,1,I,,20200917.0,20200925,20200925,PER,,DE-DRREDDYS-GER/GER/20/0127072,DR REDDYS,,61.0,YR,A,F,Y,58.0,KG,20200925.0,,MD,DE,DE,2020,Q3,Adult
183100891,18310089,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,,, UNKNOWN,,,300.0,IU,,,2020,Q3,Localised infection,,2020,Q3,1,I,,20200917.0,20200925,20200925,PER,,DE-DRREDDYS-GER/GER/20/0127072,DR REDDYS,,61.0,YR,A,F,Y,58.0,KG,20200925.0,,MD,DE,DE,2020,Q3,Adult
183100891,18310089,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,,, UNKNOWN,,,300.0,IU,,,2020,Q3,Skin ulcer,,2020,Q3,1,I,,20200917.0,20200925,20200925,PER,,DE-DRREDDYS-GER/GER/20/0127072,DR REDDYS,,61.0,YR,A,F,Y,58.0,KG,20200925.0,,MD,DE,DE,2020,Q3,Adult
183112641,18311264,29,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1IU, CO",,,U,U, ASKED BUT UNKNOWN,,,1.0,IU,UNKNOWN,,2020,Q3,Toxic epidermal necrolysis,,2020,Q3,1,I,20200809.0,20200911.0,20200925,20200925,EXP,,FR-JNJFOC-20200939670,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,,,20200925.0,,MD,FR,FR,2020,Q3,Elderly
183118971,18311897,15,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,UNSPECIFIED,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,,20200919.0,20200925,20200925,EXP,000914081,CA-ACCORD-202269,ACCORD,,58.0,YR,,M,Y,98.0,KG,20200925.0,,PH,CA,CA,2020,Q3,Adult
183118971,18311897,15,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,UNSPECIFIED,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200919.0,20200925,20200925,EXP,000914081,CA-ACCORD-202269,ACCORD,,58.0,YR,,M,Y,98.0,KG,20200925.0,,PH,CA,CA,2020,Q3,Adult
183118971,18311897,15,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,UNSPECIFIED,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200919.0,20200925,20200925,EXP,000914081,CA-ACCORD-202269,ACCORD,,58.0,YR,,M,Y,98.0,KG,20200925.0,,PH,CA,CA,2020,Q3,Adult
183118971,18311897,15,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,UNSPECIFIED,,2020,Q3,Malaise,,2020,Q3,1,I,,20200919.0,20200925,20200925,EXP,000914081,CA-ACCORD-202269,ACCORD,,58.0,YR,,M,Y,98.0,KG,20200925.0,,PH,CA,CA,2020,Q3,Adult
183118971,18311897,15,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,UNSPECIFIED,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,,20200919.0,20200925,20200925,EXP,000914081,CA-ACCORD-202269,ACCORD,,58.0,YR,,M,Y,98.0,KG,20200925.0,,PH,CA,CA,2020,Q3,Adult
183118971,18311897,15,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,UNSPECIFIED,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200919.0,20200925,20200925,EXP,000914081,CA-ACCORD-202269,ACCORD,,58.0,YR,,M,Y,98.0,KG,20200925.0,,PH,CA,CA,2020,Q3,Adult
183129201,18312920,15,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,1,I,20200925.0,,20200925,20200925,DIR,,,FDA-CTU,,87.0,YR,,M,N,80.3,KG,20200925.0,N,PH,US,US,2020,Q3,Elderly
183129231,18312923,15,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200921.0,,20200925,20200925,DIR,,,FDA-CTU,,60.0,YR,,F,N,99.9,KG,20200925.0,N,CN,US,US,2020,Q3,Adult
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Aortic valve incompetence,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Asthenia,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Cardiac index decreased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Decreased appetite,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Dysarthria,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Fall,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Femur fracture,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Haematoma,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Haemoglobin decreased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Hypersomnia,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Hypotension,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Klebsiella test positive,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Lethargy,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Liver function test abnormal,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Liver function test increased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Muscle strain,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Pain in extremity,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Peripheral swelling,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Renal disorder,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Retroperitoneal haemorrhage,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Skin laceration,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Therapy non-responder,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Urinary retention,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Urinary tract infection,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Urosepsis,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,Weight decreased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"200 U/ML, TID",,,,,,,,200.0,IU,,TID,2020,Q3,White blood cell count increased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183162801,18316280,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 UNK,,,,,,,,,,,,2020,Q3,Depressive symptom,,2020,Q3,1,I,,20200603.0,20200927,20200927,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-02670,LUPIN,,68.0,YR,,M,Y,,,20200927.0,,HP,US,US,2020,Q3,Elderly
183162801,18316280,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 UNK,,,,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200603.0,20200927,20200927,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-02670,LUPIN,,68.0,YR,,M,Y,,,20200927.0,,HP,US,US,2020,Q3,Elderly
183162801,18316280,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 UNK,,,,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,1,I,,20200603.0,20200927,20200927,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-02670,LUPIN,,68.0,YR,,M,Y,,,20200927.0,,HP,US,US,2020,Q3,Elderly
183162801,18316280,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 UNK,,,,,,,,,,,,2020,Q3,Suicidal ideation,,2020,Q3,1,I,,20200603.0,20200927,20200927,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-02670,LUPIN,,68.0,YR,,M,Y,,,20200927.0,,HP,US,US,2020,Q3,Elderly
183182421,18318242,15,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,,,20200925,20200925,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,,N,MD,US,US,2020,Q3,Elderly
183182421,18318242,15,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,1,I,,,20200925,20200925,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,,N,MD,US,US,2020,Q3,Elderly
183182421,18318242,15,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Blood alkaline phosphatase increased,,2020,Q3,1,I,,,20200925,20200925,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,,N,MD,US,US,2020,Q3,Elderly
183182421,18318242,15,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Blood bilirubin increased,,2020,Q3,1,I,,,20200925,20200925,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,,N,MD,US,US,2020,Q3,Elderly
183182421,18318242,15,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,,,20200925,20200925,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,,N,MD,US,US,2020,Q3,Elderly
183182421,18318242,15,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Blood potassium increased,,2020,Q3,1,I,,,20200925,20200925,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,,N,MD,US,US,2020,Q3,Elderly
183182421,18318242,15,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,International normalised ratio increased,,2020,Q3,1,I,,,20200925,20200925,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,,N,MD,US,US,2020,Q3,Elderly
183182421,18318242,15,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Metabolic encephalopathy,,2020,Q3,1,I,,,20200925,20200925,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,,N,MD,US,US,2020,Q3,Elderly
183182421,18318242,15,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,1,I,,,20200925,20200925,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,,N,MD,US,US,2020,Q3,Elderly
183203451,18320345,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (),,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood uric acid increased,,2020,Q3,1,I,,20200901.0,20200929,20200929,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-260544,RANBAXY,,77.0,YR,,F,Y,,,20200929.0,,HP,NL,FR,2020,Q3,Elderly
183203451,18320345,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (),,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypercalcaemia,,2020,Q3,1,I,,20200901.0,20200929,20200929,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-260544,RANBAXY,,77.0,YR,,F,Y,,,20200929.0,,HP,NL,FR,2020,Q3,Elderly
183205201,18320520,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,,, D204245A,,20563.0,10.0,IU,INJECTION,,2020,Q3,Food poisoning,,2020,Q3,1,I,20200922.0,20200922.0,20200929,20200929,PER,,US-ELI_LILLY_AND_COMPANY-US202009012514,ELI LILLY AND CO,,97.0,YR,,F,Y,,,20200929.0,,CN,US,US,2020,Q3,Elderly
183205201,18320520,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,,, D204245A,,20563.0,10.0,IU,INJECTION,,2020,Q3,Nausea,,2020,Q3,1,I,20200922.0,20200922.0,20200929,20200929,PER,,US-ELI_LILLY_AND_COMPANY-US202009012514,ELI LILLY AND CO,,97.0,YR,,F,Y,,,20200929.0,,CN,US,US,2020,Q3,Elderly
183212881,18321288,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN,SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,1,I,,20200917.0,20200928,20200928,EXP,,DE-TEVA-2020-DE-1831264,TEVA,,89.0,YR,E,F,Y,,,20200928.0,,MD,DE,DE,2020,Q3,Elderly
183212881,18321288,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN,SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200917.0,20200928,20200928,EXP,,DE-TEVA-2020-DE-1831264,TEVA,,89.0,YR,E,F,Y,,,20200928.0,,MD,DE,DE,2020,Q3,Elderly
183212881,18321288,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN,SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200917.0,20200928,20200928,EXP,,DE-TEVA-2020-DE-1831264,TEVA,,89.0,YR,E,F,Y,,,20200928.0,,MD,DE,DE,2020,Q3,Elderly
183212881,18321288,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN,SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200917.0,20200928,20200928,EXP,,DE-TEVA-2020-DE-1831264,TEVA,,89.0,YR,E,F,Y,,,20200928.0,,MD,DE,DE,2020,Q3,Elderly
183212881,18321288,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN,SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,,20200917.0,20200928,20200928,EXP,,DE-TEVA-2020-DE-1831264,TEVA,,89.0,YR,E,F,Y,,,20200928.0,,MD,DE,DE,2020,Q3,Elderly
183212881,18321288,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN,SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200917.0,20200928,20200928,EXP,,DE-TEVA-2020-DE-1831264,TEVA,,89.0,YR,E,F,Y,,,20200928.0,,MD,DE,DE,2020,Q3,Elderly
183212881,18321288,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN,SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2020,Q3,Hypovolaemia,,2020,Q3,1,I,,20200917.0,20200928,20200928,EXP,,DE-TEVA-2020-DE-1831264,TEVA,,89.0,YR,E,F,Y,,,20200928.0,,MD,DE,DE,2020,Q3,Elderly
183240921,18324092,13,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200927.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183240921,18324092,13,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Hypoperfusion,,2020,Q3,1,I,20200927.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183240921,18324092,13,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Hypovolaemia,,2020,Q3,1,I,20200927.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183240921,18324092,13,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Large intestine perforation,,2020,Q3,1,I,20200927.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183240991,18324099,12,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Acute respiratory failure,,2020,Q3,1,I,20200926.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,N,PH,US,US,2020,Q3,Elderly
183240991,18324099,12,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Colectomy,,2020,Q3,1,I,20200926.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,N,PH,US,US,2020,Q3,Elderly
183240991,18324099,12,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Ileostomy,,2020,Q3,1,I,20200926.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,N,PH,US,US,2020,Q3,Elderly
183240991,18324099,12,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Large intestine perforation,,2020,Q3,1,I,20200926.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,N,PH,US,US,2020,Q3,Elderly
183240991,18324099,12,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,1,I,20200926.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,N,PH,US,US,2020,Q3,Elderly
183240991,18324099,12,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,1,I,20200926.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,N,PH,US,US,2020,Q3,Elderly
183243811,18324381,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Cerebrovascular accident,,2020,Q3,1,I,20200820.0,20200821.0,20200929,20200929,EXP,,NVSC2020US232957,NOVARTIS,,61.0,YR,,M,Y,82.0,KG,20200929.0,,HP,US,US,2020,Q3,Adult
183243831,18324383,6,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20200920.0,,20200929,20200929,DIR,,,FDA-CTU,,55.0,YR,,M,N,81.0,KG,20200929.0,N,,US,US,2020,Q3,Adult
183247171,18324717,34,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,D,, UNK,,,1.0,IU,UNKNOWN,,2020,Q3,Toxic epidermal necrolysis,,2020,Q3,1,I,20200809.0,20200831.0,20200929,20200929,EXP,,FR-FRESENIUS KABI-FK202008998,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200929.0,,HP,NL,FR,2020,Q3,Elderly
183249331,18324933,3,SS,LISPRO PEN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Device difficult to use,,2020,Q3,1,I,20200929.0,,20200929,20200929,DIR,,,FDA-CTU,,29.0,YR,,F,N,126.0,KG,20200929.0,N,PH,US,US,2020,Q3,Young Adult
183249331,18324933,3,SS,LISPRO PEN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Needle issue,,2020,Q3,1,I,20200929.0,,20200929,20200929,DIR,,,FDA-CTU,,29.0,YR,,F,N,126.0,KG,20200929.0,N,PH,US,US,2020,Q3,Young Adult
183249331,18324933,3,SS,LISPRO PEN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q3,Product quality issue,,2020,Q3,1,I,20200929.0,,20200929,20200929,DIR,,,FDA-CTU,,29.0,YR,,F,N,126.0,KG,20200929.0,N,PH,US,US,2020,Q3,Young Adult
183251351,18325135,47,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 INTERNATIONAL UNIT 1IU, CO",,,U,U,,,,1.0,IU,INJECTION,,2020,Q3,Toxic epidermal necrolysis,,2020,Q3,1,I,20200809.0,20200921.0,20200929,20200929,EXP,,FR-MYLANLABS-2020M1081401,MYLAN,,75.0,YR,,M,Y,,,20200929.0,,MD,FR,FR,2020,Q3,Elderly
183270341,18327034,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Drug ineffective for unapproved indication,,2020,Q3,1,I,2020.0,20200805.0,20200930,20200930,PER,,US-STRIDES ARCOLAB LIMITED-2020SP009138,STRIDES,"KAZI DS, MARTIN LM, LITMANOVICH D, PINTO DS, CLERKIN KJ, ZIMETBAUM PJ, ET AL.. CASE 18?2020: A 73?YEAR?OLD MAN WITH HYPOXEMIC RESPIRATORY FAILURE AND CARDIAC DYSFUNCTION. NEW ENGLAND JOURNAL OF MEDICINE. 2020?382(24):2354?2364",73.0,YR,,M,Y,,,20200930.0,,MD,US,US,2020,Q3,Elderly
183277451,18327745,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Angina pectoris,,2020,Q3,1,I,,20200923.0,20200930,20200930,EXP,,DE-AUROBINDO-AUR-APL-2020-049765,AUROBINDO,,43.0,YR,,F,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Adult
183277451,18327745,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200923.0,20200930,20200930,EXP,,DE-AUROBINDO-AUR-APL-2020-049765,AUROBINDO,,43.0,YR,,F,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Adult
183277451,18327745,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200923.0,20200930,20200930,EXP,,DE-AUROBINDO-AUR-APL-2020-049765,AUROBINDO,,43.0,YR,,F,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Adult
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Band neutrophil count increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood bilirubin increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood calcium decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood glucose decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood magnesium increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood sodium increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood urea increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Bradycardia,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Carbon dioxide decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Cardiac disorder,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Dialysis,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Glomerular filtration rate,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Haematocrit decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Haemodialysis,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Haemoglobin decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Hypochromasia,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Hypokalaemia,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Lymphocyte count decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Macrocytosis,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Mean cell volume decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Mean platelet volume decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Metabolic acidosis,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Metamyelocyte count increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Monocyte count decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Neutrophil count increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Neutrophil toxic granulation present,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Platelet count decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Pupil fixed,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Red blood cell count decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Respiratory failure,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Unresponsive to stimuli,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183304371,18330437,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,,,,,,300.0,IU,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081860,MYLAN,,61.0,YR,,F,Y,58.0,KG,20200930.0,,MD,DE,DE,2020,Q3,Adult
183304371,18330437,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,,,,,,300.0,IU,,,2020,Q3,Feeling hot,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081860,MYLAN,,61.0,YR,,F,Y,58.0,KG,20200930.0,,MD,DE,DE,2020,Q3,Adult
183304371,18330437,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,,,,,,300.0,IU,,,2020,Q3,Inflammation,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081860,MYLAN,,61.0,YR,,F,Y,58.0,KG,20200930.0,,MD,DE,DE,2020,Q3,Adult
183304371,18330437,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,,,,,,300.0,IU,,,2020,Q3,Localised infection,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081860,MYLAN,,61.0,YR,,F,Y,58.0,KG,20200930.0,,MD,DE,DE,2020,Q3,Adult
183304371,18330437,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, NACH SCHEMA, AMPULLEN",,,,,,,,300.0,IU,,,2020,Q3,Skin ulcer,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081860,MYLAN,,61.0,YR,,F,Y,58.0,KG,20200930.0,,MD,DE,DE,2020,Q3,Adult
65814262,6581426,22,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1,,,,2020,Q3,Blister,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,22,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1,,,,2020,Q3,Conjunctivitis,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,22,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1,,,,2020,Q3,Lip erosion,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,22,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1,,,,2020,Q3,Nikolsky's sign,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,22,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1,,,,2020,Q3,Ocular hyperaemia,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,22,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1,,,,2020,Q3,Pruritus,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,22,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1,,,,2020,Q3,Purpura,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,22,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1,,,,2020,Q3,Stevens-Johnson syndrome,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,22,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1,,,,2020,Q3,Swollen tongue,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
89569661,8956966,10,C,INSULIN HUMAN LISPRO,,2,Unknown,,,,,,,,,,,,,2020,Q3,Brain oedema,,2020,Q3,1,I,20120817.0,20121203.0,20121210,20121210,EXP,,US-ROCHE-1104023,ROCHE,,42.0,YR,,M,Y,99.7,KG,20121210.0,,MD,US,US,2020,Q3,Adult
89569661,8956966,10,C,INSULIN HUMAN LISPRO,,2,Unknown,,,,,,,,,,,,,2020,Q3,Upper gastrointestinal haemorrhage,,2020,Q3,1,I,20120817.0,20121203.0,20121210,20121210,EXP,,US-ROCHE-1104023,ROCHE,,42.0,YR,,M,Y,99.7,KG,20121210.0,,MD,US,US,2020,Q3,Adult
113412694,11341269,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q4,Anticoagulant therapy,,2020,Q4,4,F,20130713.0,20201110.0,20150805,20201113,EXP,,US-JNJFOC-20150712724,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,,,20201113.0,,CN,US,US,2020,Q4,Elderly
113412694,11341269,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q4,Epistaxis,,2020,Q4,4,F,20130713.0,20201110.0,20150805,20201113,EXP,,US-JNJFOC-20150712724,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,,,20201113.0,,CN,US,US,2020,Q4,Elderly
141278382,14127838,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Decreased appetite,,2020,Q4,2,F,,20200119.0,20171026,20201021,PER,,US-APOTEX-2016AP016125,APOTEX,,58.0,YR,,M,Y,,,20201021.0,,PH,US,US,2020,Q4,Adult
141278382,14127838,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Dysgeusia,,2020,Q4,2,F,,20200119.0,20171026,20201021,PER,,US-APOTEX-2016AP016125,APOTEX,,58.0,YR,,M,Y,,,20201021.0,,PH,US,US,2020,Q4,Adult
141278382,14127838,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Parosmia,,2020,Q4,2,F,,20200119.0,20171026,20201021,PER,,US-APOTEX-2016AP016125,APOTEX,,58.0,YR,,M,Y,,,20201021.0,,PH,US,US,2020,Q4,Adult
149557823,14955782,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D204245A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,3,F,20180515.0,20201130.0,20180531,20201207,PER,,US-ELI_LILLY_AND_COMPANY-US201805013999,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20201207.0,,CN,US,US,2020,Q4,Elderly
149557823,14955782,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D204245A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Drug ineffective,,2020,Q4,3,F,20180515.0,20201130.0,20180531,20201207,PER,,US-ELI_LILLY_AND_COMPANY-US201805013999,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20201207.0,,CN,US,US,2020,Q4,Elderly
149557823,14955782,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D204245A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Incorrect product administration duration,,2020,Q4,3,F,20180515.0,20201130.0,20180531,20201207,PER,,US-ELI_LILLY_AND_COMPANY-US201805013999,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20201207.0,,CN,US,US,2020,Q4,Elderly
149557823,14955782,10,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D204245A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,3,F,20180515.0,20201130.0,20180531,20201207,PER,,US-ELI_LILLY_AND_COMPANY-US201805013999,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20201207.0,,CN,US,US,2020,Q4,Elderly
149557823,14955782,10,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D204245A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Drug ineffective,,2020,Q4,3,F,20180515.0,20201130.0,20180531,20201207,PER,,US-ELI_LILLY_AND_COMPANY-US201805013999,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20201207.0,,CN,US,US,2020,Q4,Elderly
149557823,14955782,10,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D204245A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Incorrect product administration duration,,2020,Q4,3,F,20180515.0,20201130.0,20180531,20201207,PER,,US-ELI_LILLY_AND_COMPANY-US201805013999,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20201207.0,,CN,US,US,2020,Q4,Elderly
156175002,15617500,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,,,,,36.0,IU,INJECTION,QD,2020,Q4,Aphasia,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,,,,,36.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,,,,,36.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,,,,,36.0,IU,INJECTION,QD,2020,Q4,Muscle spasticity,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,,,,,36.0,IU,INJECTION,QD,2020,Q4,Aphasia,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,,,,,36.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,,,,,36.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,,,,,36.0,IU,INJECTION,QD,2020,Q4,Muscle spasticity,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,,,,,14.0,IU,INJECTION,QD,2020,Q4,Aphasia,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,,,,,14.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,,,,,14.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,,,,,14.0,IU,INJECTION,QD,2020,Q4,Muscle spasticity,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,,,,,14.0,IU,INJECTION,QD,2020,Q4,Aphasia,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,,,,,14.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,,,,,14.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,,,,,14.0,IU,INJECTION,QD,2020,Q4,Muscle spasticity,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,,,,,18.0,IU,INJECTION,QD,2020,Q4,Aphasia,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,,,,,18.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,,,,,18.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,,,,,18.0,IU,INJECTION,QD,2020,Q4,Muscle spasticity,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,,,,,18.0,IU,INJECTION,QD,2020,Q4,Aphasia,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,,,,,18.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,,,,,18.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,,,,,18.0,IU,INJECTION,QD,2020,Q4,Muscle spasticity,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,, D214632C,,,36.0,IU,INJECTION,QD,2020,Q4,Aphasia,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,, D214632C,,,36.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,, D214632C,,,36.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,, D214632C,,,36.0,IU,INJECTION,QD,2020,Q4,Muscle spasticity,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,, D214632C,,,36.0,IU,INJECTION,QD,2020,Q4,Aphasia,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,, D214632C,,,36.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,, D214632C,,,36.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"36 U, EACH MORNING",,,U,, D214632C,,,36.0,IU,INJECTION,QD,2020,Q4,Muscle spasticity,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,, D214632C,,,14.0,IU,INJECTION,QD,2020,Q4,Aphasia,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,, D214632C,,,14.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,, D214632C,,,14.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,, D214632C,,,14.0,IU,INJECTION,QD,2020,Q4,Muscle spasticity,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,, D214632C,,,14.0,IU,INJECTION,QD,2020,Q4,Aphasia,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,, D214632C,,,14.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,, D214632C,,,14.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,, D214632C,,,14.0,IU,INJECTION,QD,2020,Q4,Muscle spasticity,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,, D214632C,,,18.0,IU,INJECTION,QD,2020,Q4,Aphasia,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,, D214632C,,,18.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,, D214632C,,,18.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,, D214632C,,,18.0,IU,INJECTION,QD,2020,Q4,Muscle spasticity,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,, D214632C,,,18.0,IU,INJECTION,QD,2020,Q4,Aphasia,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,, D214632C,,,18.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,, D214632C,,,18.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
156175002,15617500,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,U,, D214632C,,,18.0,IU,INJECTION,QD,2020,Q4,Muscle spasticity,,2020,Q4,2,F,20161219.0,20201005.0,20181114,20201012,EXP,,US-ELI_LILLY_AND_COMPANY-US201811003012,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Abdominal pain,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Abscess,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Adrenal insufficiency,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Alanine aminotransferase increased,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Ascites,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Asthenia,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Blood alkaline phosphatase increased,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Blood bilirubin increased,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Blood potassium decreased,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Blood pressure diastolic abnormal,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Blood pressure increased,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Congestive hepatopathy,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Depression,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Diverticulitis,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Endometrial disorder,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Enterococcus test positive,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Fibrosis,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Gamma-glutamyltransferase increased,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Gastrointestinal disorder,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Generalised oedema,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Heart rate increased,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Herpes zoster,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Hypersensitivity,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Hypoglycaemia,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Hypotension,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Increased appetite,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Influenza,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Infusion related reaction,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Injection site extravasation,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Intensive care unit acquired weakness,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Intervertebral disc protrusion,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Joint effusion,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Joint swelling,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Micturition disorder,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Myelopathy,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Myopathy,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Nasopharyngitis,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Nausea,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Nerve compression,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Neuropathy peripheral,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Neutropenia,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Osteoarthritis,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Pancytopenia,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Peripheral sensorimotor neuropathy,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Peritonitis,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Pneumonia,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Pseudomonal bacteraemia,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Rheumatoid arthritis,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Septic shock,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Therapeutic response decreased,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Vomiting,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Weight decreased,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158194088,15819408,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2020,Q4,Weight increased,,2020,Q4,8,F,,20201105.0,20190114,20201117,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20201117.0,,CN,CA,CA,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Acidosis,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Acute kidney injury,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Acute respiratory distress syndrome,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Acute respiratory failure,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Alkalosis hypochloraemic,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Anaemia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Asthenia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Bandaemia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Blood creatinine increased,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Blood urea increased,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Bronchial haemorrhage,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Bronchitis chronic,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Concomitant disease aggravated,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Constipation,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Cough,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Cystic fibrosis,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Diarrhoea,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Dysphagia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Dyspnoea,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Fungal disease carrier,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Gastroenteritis norovirus,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Gastrointestinal disorder,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Generalised oedema,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Glucose tolerance impaired,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Granulocytosis,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Haematuria,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Haemoptysis,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Hypercapnia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Hyperglycaemia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Hypernatraemia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Hypertension,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Hypertriglyceridaemia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Hypervolaemia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Hypokalaemia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Hypoxia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Illness,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Infective exacerbation of bronchiectasis,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Insomnia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Intensive care unit acquired weakness,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Iron deficiency,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Leukocytosis,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Metabolic acidosis,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Muscle atrophy,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Paresis,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Pneumonia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Pyrexia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Sepsis,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Stenotrophomonas test positive,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Tachycardia,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Thrombocytosis,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
158391235,15839123,76,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2020,Q4,Weight decreased,,2020,Q4,5,F,20160303.0,20200922.0,20190117,20201005,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.43,KG,20201005.0,,MD,US,US,2020,Q4,Adult
1619976610,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q4,Cutaneous sarcoidosis,,2020,Q4,10,F,20190404.0,20201224.0,20190415,20201230,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20201230.0,,HP,BR,BR,2020,Q4,Elderly
1619976610,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q4,Epiglottic oedema,,2020,Q4,10,F,20190404.0,20201224.0,20190415,20201230,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20201230.0,,HP,BR,BR,2020,Q4,Elderly
1619976610,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q4,Sarcoidosis,,2020,Q4,10,F,20190404.0,20201224.0,20190415,20201230,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20201230.0,,HP,BR,BR,2020,Q4,Elderly
162469592,16246959,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,2,F,,20201117.0,20190427,20201127,EXP,,CA-APOTEX-2019AP012252,APOTEX,,72.0,YR,,F,Y,,,20201127.0,,CN,CA,CA,2020,Q4,Elderly
162469592,16246959,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Dehydration,,2020,Q4,2,F,,20201117.0,20190427,20201127,EXP,,CA-APOTEX-2019AP012252,APOTEX,,72.0,YR,,F,Y,,,20201127.0,,CN,CA,CA,2020,Q4,Elderly
162469592,16246959,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Pyrexia,,2020,Q4,2,F,,20201117.0,20190427,20201127,EXP,,CA-APOTEX-2019AP012252,APOTEX,,72.0,YR,,F,Y,,,20201127.0,,CN,CA,CA,2020,Q4,Elderly
162469592,16246959,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Small intestinal obstruction,,2020,Q4,2,F,,20201117.0,20190427,20201127,EXP,,CA-APOTEX-2019AP012252,APOTEX,,72.0,YR,,F,Y,,,20201127.0,,CN,CA,CA,2020,Q4,Elderly
162469592,16246959,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Urinary tract obstruction,,2020,Q4,2,F,,20201117.0,20190427,20201127,EXP,,CA-APOTEX-2019AP012252,APOTEX,,72.0,YR,,F,Y,,,20201127.0,,CN,CA,CA,2020,Q4,Elderly
1627846010,16278460,8,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,12 UNITS,,,,,,,,,,UNKNOWN,,2020,Q4,Anaemia,,2020,Q4,10,F,20190417.0,20200226.0,20190506,20201028,EXP,,US-CELGENEUS-USA-20190411233,CELGENE,,74.0,YR,,M,Y,,,20201028.0,,HP,US,US,2020,Q4,Elderly
1627846010,16278460,8,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,12 UNITS,,,,,,,,,,UNKNOWN,,2020,Q4,Gastrointestinal haemorrhage,,2020,Q4,10,F,20190417.0,20200226.0,20190506,20201028,EXP,,US-CELGENEUS-USA-20190411233,CELGENE,,74.0,YR,,M,Y,,,20201028.0,,HP,US,US,2020,Q4,Elderly
1627846010,16278460,8,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,12 UNITS,,,,,,,,,,UNKNOWN,,2020,Q4,Hepatic failure,,2020,Q4,10,F,20190417.0,20200226.0,20190506,20201028,EXP,,US-CELGENEUS-USA-20190411233,CELGENE,,74.0,YR,,M,Y,,,20201028.0,,HP,US,US,2020,Q4,Elderly
162831582,16283158,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20151124.0,20201020.0,20190507,20201028,EXP,,US-ASTRAZENECA-2019SE59998,ASTRAZENECA,,26946.0,DY,,M,Y,90.7,KG,20201028.0,,,US,US,2020,Q4,Elderly
162831582,16283158,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20151124.0,20201020.0,20190507,20201028,EXP,,US-ASTRAZENECA-2019SE59998,ASTRAZENECA,,26946.0,DY,,M,Y,90.7,KG,20201028.0,,,US,US,2020,Q4,Elderly
162831582,16283158,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Gastrooesophageal reflux disease,,2020,Q4,2,F,20151124.0,20201020.0,20190507,20201028,EXP,,US-ASTRAZENECA-2019SE59998,ASTRAZENECA,,26946.0,DY,,M,Y,90.7,KG,20201028.0,,,US,US,2020,Q4,Elderly
162831582,16283158,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Nephrogenic anaemia,,2020,Q4,2,F,20151124.0,20201020.0,20190507,20201028,EXP,,US-ASTRAZENECA-2019SE59998,ASTRAZENECA,,26946.0,DY,,M,Y,90.7,KG,20201028.0,,,US,US,2020,Q4,Elderly
162996682,16299668,56,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20091026.0,20201214.0,20190510,20201218,EXP,,US-ASTRAZENECA-2019SE65112,ASTRAZENECA,,22025.0,DY,,F,Y,81.6,KG,20201218.0,,,US,US,2020,Q4,Elderly
162996682,16299668,56,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20091026.0,20201214.0,20190510,20201218,EXP,,US-ASTRAZENECA-2019SE65112,ASTRAZENECA,,22025.0,DY,,F,Y,81.6,KG,20201218.0,,,US,US,2020,Q4,Elderly
162996682,16299668,56,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,2,F,20091026.0,20201214.0,20190510,20201218,EXP,,US-ASTRAZENECA-2019SE65112,ASTRAZENECA,,22025.0,DY,,F,Y,81.6,KG,20201218.0,,,US,US,2020,Q4,Elderly
162996682,16299668,56,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,2,F,20091026.0,20201214.0,20190510,20201218,EXP,,US-ASTRAZENECA-2019SE65112,ASTRAZENECA,,22025.0,DY,,F,Y,81.6,KG,20201218.0,,,US,US,2020,Q4,Elderly
162996682,16299668,56,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hyperparathyroidism secondary,,2020,Q4,2,F,20091026.0,20201214.0,20190510,20201218,EXP,,US-ASTRAZENECA-2019SE65112,ASTRAZENECA,,22025.0,DY,,F,Y,81.6,KG,20201218.0,,,US,US,2020,Q4,Elderly
162996682,16299668,56,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,2,F,20091026.0,20201214.0,20190510,20201218,EXP,,US-ASTRAZENECA-2019SE65112,ASTRAZENECA,,22025.0,DY,,F,Y,81.6,KG,20201218.0,,,US,US,2020,Q4,Elderly
163032513,16303251,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,3,F,2016.0,20201221.0,20190513,20201229,EXP,,US-ASTRAZENECA-2019SE66177,ASTRAZENECA,,43.0,YR,,M,Y,59.0,KG,20201229.0,,,US,US,2020,Q4,Adult
163032513,16303251,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,3,F,2016.0,20201221.0,20190513,20201229,EXP,,US-ASTRAZENECA-2019SE66177,ASTRAZENECA,,43.0,YR,,M,Y,59.0,KG,20201229.0,,,US,US,2020,Q4,Adult
163032513,16303251,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,3,F,2016.0,20201221.0,20190513,20201229,EXP,,US-ASTRAZENECA-2019SE66177,ASTRAZENECA,,43.0,YR,,M,Y,59.0,KG,20201229.0,,,US,US,2020,Q4,Adult
163032513,16303251,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Nephrogenic anaemia,,2020,Q4,3,F,2016.0,20201221.0,20190513,20201229,EXP,,US-ASTRAZENECA-2019SE66177,ASTRAZENECA,,43.0,YR,,M,Y,59.0,KG,20201229.0,,,US,US,2020,Q4,Adult
163032513,16303251,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,3,F,2016.0,20201221.0,20190513,20201229,EXP,,US-ASTRAZENECA-2019SE66177,ASTRAZENECA,,43.0,YR,,M,Y,59.0,KG,20201229.0,,,US,US,2020,Q4,Adult
163061962,16306196,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20180813.0,20201207.0,20190513,20201210,EXP,,US-ASTRAZENECA-2019SE63874,ASTRAZENECA,,21414.0,DY,,M,Y,178.7,KG,20201210.0,,,US,US,2020,Q4,Elderly
163061962,16306196,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20180813.0,20201207.0,20190513,20201210,EXP,,US-ASTRAZENECA-2019SE63874,ASTRAZENECA,,21414.0,DY,,M,Y,178.7,KG,20201210.0,,,US,US,2020,Q4,Elderly
163061962,16306196,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,2,F,20180813.0,20201207.0,20190513,20201210,EXP,,US-ASTRAZENECA-2019SE63874,ASTRAZENECA,,21414.0,DY,,M,Y,178.7,KG,20201210.0,,,US,US,2020,Q4,Elderly
163061962,16306196,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hyperparathyroidism secondary,,2020,Q4,2,F,20180813.0,20201207.0,20190513,20201210,EXP,,US-ASTRAZENECA-2019SE63874,ASTRAZENECA,,21414.0,DY,,M,Y,178.7,KG,20201210.0,,,US,US,2020,Q4,Elderly
163061962,16306196,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Nephrogenic anaemia,,2020,Q4,2,F,20180813.0,20201207.0,20190513,20201210,EXP,,US-ASTRAZENECA-2019SE63874,ASTRAZENECA,,21414.0,DY,,M,Y,178.7,KG,20201210.0,,,US,US,2020,Q4,Elderly
163061962,16306196,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,2,F,20180813.0,20201207.0,20190513,20201210,EXP,,US-ASTRAZENECA-2019SE63874,ASTRAZENECA,,21414.0,DY,,M,Y,178.7,KG,20201210.0,,,US,US,2020,Q4,Elderly
163309992,16330999,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,2,F,201807.0,20201130.0,20190520,20201224,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011854,ACADIA PHARMACEUTICALS,,78.0,YR,,F,Y,,,20201224.0,,CN,US,US,2020,Q4,Elderly
163309992,16330999,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Limb discomfort,,2020,Q4,2,F,201807.0,20201130.0,20190520,20201224,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011854,ACADIA PHARMACEUTICALS,,78.0,YR,,F,Y,,,20201224.0,,CN,US,US,2020,Q4,Elderly
163309992,16330999,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Muscular weakness,,2020,Q4,2,F,201807.0,20201130.0,20190520,20201224,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011854,ACADIA PHARMACEUTICALS,,78.0,YR,,F,Y,,,20201224.0,,CN,US,US,2020,Q4,Elderly
163309992,16330999,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Peripheral swelling,,2020,Q4,2,F,201807.0,20201130.0,20190520,20201224,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011854,ACADIA PHARMACEUTICALS,,78.0,YR,,F,Y,,,20201224.0,,CN,US,US,2020,Q4,Elderly
163309992,16330999,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Underdose,,2020,Q4,2,F,201807.0,20201130.0,20190520,20201224,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011854,ACADIA PHARMACEUTICALS,,78.0,YR,,F,Y,,,20201224.0,,CN,US,US,2020,Q4,Elderly
163316553,16331655,8,C,Insulin Lispro Dci,,2,Oral,6 UNITS DAILY 3 TIMES BEFORE MEAL,,,,,,,,,,,,2020,Q4,Parkinson's disease,,2020,Q4,3,F,20181217.0,20201109.0,20190520,20201204,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011659,ACADIA PHARMACEUTICALS,,77.0,YR,,F,Y,68.0,KG,20201204.0,,HP,US,US,2020,Q4,Elderly
163316553,16331655,8,C,Insulin Lispro Dci,,2,Oral,6 UNITS DAILY 3 TIMES BEFORE MEAL,,,,,,,,,,,,2020,Q4,Seizure,,2020,Q4,3,F,20181217.0,20201109.0,20190520,20201204,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011659,ACADIA PHARMACEUTICALS,,77.0,YR,,F,Y,68.0,KG,20201204.0,,HP,US,US,2020,Q4,Elderly
163316553,16331655,8,C,Insulin Lispro Dci,,2,Oral,6 UNITS DAILY 3 TIMES BEFORE MEAL,,,,,,,,,,,,2020,Q4,Urinary tract infection,,2020,Q4,3,F,20181217.0,20201109.0,20190520,20201204,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011659,ACADIA PHARMACEUTICALS,,77.0,YR,,F,Y,68.0,KG,20201204.0,,HP,US,US,2020,Q4,Elderly
164089222,16408922,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,170.0,IU,INJECTION,TID,2020,Q4,Erythema,,2020,Q4,2,F,2019.0,20201116.0,20190610,20201202,PER,,US-JNJFOC-20190532709,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,86.26,KG,20201202.0,,CN,US,US,2020,Q4,Adult
164089222,16408922,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,170.0,IU,INJECTION,TID,2020,Q4,Liver sarcoidosis,,2020,Q4,2,F,2019.0,20201116.0,20190610,20201202,PER,,US-JNJFOC-20190532709,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,86.26,KG,20201202.0,,CN,US,US,2020,Q4,Adult
164089222,16408922,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,170.0,IU,INJECTION,TID,2020,Q4,Off label use,,2020,Q4,2,F,2019.0,20201116.0,20190610,20201202,PER,,US-JNJFOC-20190532709,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,86.26,KG,20201202.0,,CN,US,US,2020,Q4,Adult
164089222,16408922,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,170.0,IU,INJECTION,TID,2020,Q4,Product use in unapproved indication,,2020,Q4,2,F,2019.0,20201116.0,20190610,20201202,PER,,US-JNJFOC-20190532709,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,86.26,KG,20201202.0,,CN,US,US,2020,Q4,Adult
164089222,16408922,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,170.0,IU,INJECTION,TID,2020,Q4,Rash pruritic,,2020,Q4,2,F,2019.0,20201116.0,20190610,20201202,PER,,US-JNJFOC-20190532709,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,86.26,KG,20201202.0,,CN,US,US,2020,Q4,Adult
164133504,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,4,F,20180301.0,20201210.0,20190611,20201218,EXP,,US-ASTRAZENECA-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20201218.0,,,US,US,2020,Q4,Elderly
164133504,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,4,F,20180301.0,20201210.0,20190611,20201218,EXP,,US-ASTRAZENECA-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20201218.0,,,US,US,2020,Q4,Elderly
164133504,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Dyspepsia,,2020,Q4,4,F,20180301.0,20201210.0,20190611,20201218,EXP,,US-ASTRAZENECA-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20201218.0,,,US,US,2020,Q4,Elderly
164133504,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,4,F,20180301.0,20201210.0,20190611,20201218,EXP,,US-ASTRAZENECA-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20201218.0,,,US,US,2020,Q4,Elderly
164133504,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Gastrooesophageal reflux disease,,2020,Q4,4,F,20180301.0,20201210.0,20190611,20201218,EXP,,US-ASTRAZENECA-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20201218.0,,,US,US,2020,Q4,Elderly
164133504,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Nephrogenic anaemia,,2020,Q4,4,F,20180301.0,20201210.0,20190611,20201218,EXP,,US-ASTRAZENECA-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20201218.0,,,US,US,2020,Q4,Elderly
164133504,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,4,F,20180301.0,20201210.0,20190611,20201218,EXP,,US-ASTRAZENECA-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20201218.0,,,US,US,2020,Q4,Elderly
164133504,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Renal injury,,2020,Q4,4,F,20180301.0,20201210.0,20190611,20201218,EXP,,US-ASTRAZENECA-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20201218.0,,,US,US,2020,Q4,Elderly
164133504,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Tubulointerstitial nephritis,,2020,Q4,4,F,20180301.0,20201210.0,20190611,20201218,EXP,,US-ASTRAZENECA-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20201218.0,,,US,US,2020,Q4,Elderly
167530296,16753029,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"STRENGTH 100 UNIT/1 ML INSULN.PEN, BEFORE MEALS AND AT BEDTIME",,,,,,,,1.0,DF,,QD,2020,Q4,Fournier's gangrene,,2020,Q4,6,F,20171222.0,20201216.0,20190829,20201224,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-035002",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,68.4,KG,20201225.0,,MD,US,US,2020,Q4,Elderly
167530296,16753029,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"STRENGTH 100 UNIT/1 ML INSULN.PEN, BEFORE MEALS AND AT BEDTIME",,,,,,,,1.0,DF,,QD,2020,Q4,Sepsis,,2020,Q4,6,F,20171222.0,20201216.0,20190829,20201224,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-035002",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,68.4,KG,20201225.0,,MD,US,US,2020,Q4,Elderly
167775903,16777590,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, QD",,,D,,,,,5.0,IU,UNKNOWN,QD,2020,Q4,Gastric cancer,,2020,Q4,3,F,20190425.0,20190829.0,20190905,20201020,EXP,,DE-JNJFOC-20190444424,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,85.0,KG,20201020.0,,MD,DE,DE,2020,Q4,Elderly
169324974,16932497,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Leukopenia,,2020,Q4,4,F,20190723.0,20201205.0,20191017,20201216,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20201216.0,,MD,PL,PL,2020,Q4,Adult
169324974,16932497,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Neutropenia,,2020,Q4,4,F,20190723.0,20201205.0,20191017,20201216,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20201216.0,,MD,PL,PL,2020,Q4,Adult
1698641210,16986412,67,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,10,F,20191026.0,20201212.0,20191101,20201215,EXP,,NVSC2019US019491,NOVARTIS,,59.0,YR,,F,Y,66.65,KG,20201215.0,,HP,US,US,2020,Q4,Adult
1698641210,16986412,68,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,10,F,20191026.0,20201212.0,20191101,20201215,EXP,,NVSC2019US019491,NOVARTIS,,59.0,YR,,F,Y,66.65,KG,20201215.0,,HP,US,US,2020,Q4,Adult
170224212,17022421,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,,,2020,Q4,Cerebral haemorrhage,,2020,Q4,2,F,20191021.0,20191101.0,20191112,20201020,EXP,IT-MINISAL02-583429,IT-JNJFOC-20191107126,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,,,20201020.0,,MD,IT,IT,2020,Q4,Elderly
170224212,17022421,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,,,2020,Q4,Loss of consciousness,,2020,Q4,2,F,20191021.0,20191101.0,20191112,20201020,EXP,IT-MINISAL02-583429,IT-JNJFOC-20191107126,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,,,20201020.0,,MD,IT,IT,2020,Q4,Elderly
170224212,17022421,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,,,2020,Q4,Neurological symptom,,2020,Q4,2,F,20191021.0,20191101.0,20191112,20201020,EXP,IT-MINISAL02-583429,IT-JNJFOC-20191107126,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,,,20201020.0,,MD,IT,IT,2020,Q4,Elderly
170224212,17022421,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,,,2020,Q4,Respiratory arrest,,2020,Q4,2,F,20191021.0,20191101.0,20191112,20201020,EXP,IT-MINISAL02-583429,IT-JNJFOC-20191107126,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,,,20201020.0,,MD,IT,IT,2020,Q4,Elderly
172079212,17207921,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Fournier's gangrene,,2020,Q4,2,F,20150919.0,20201026.0,20191227,20201103,EXP,,US-ASTRAZENECA-2019SF85158,ASTRAZENECA,,18114.0,DY,,M,Y,102.1,KG,20201103.0,,,US,US,2020,Q4,Elderly
172079212,17207921,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Scrotal abscess,,2020,Q4,2,F,20150919.0,20201026.0,20191227,20201103,EXP,,US-ASTRAZENECA-2019SF85158,ASTRAZENECA,,18114.0,DY,,M,Y,102.1,KG,20201103.0,,,US,US,2020,Q4,Elderly
173547763,17354776,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,3,F,20200120.0,20201117.0,20200131,20201130,EXP,,MX-BAYER-2020-016811,BAYER,,67.0,YR,E,M,Y,,,20201130.0,,HP,MX,MX,2020,Q4,Elderly
173547763,17354776,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,3,F,20200120.0,20201117.0,20200131,20201130,EXP,,MX-BAYER-2020-016811,BAYER,,67.0,YR,E,M,Y,,,20201130.0,,HP,MX,MX,2020,Q4,Elderly
173547763,17354776,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q4,Gastric ulcer,,2020,Q4,3,F,20200120.0,20201117.0,20200131,20201130,EXP,,MX-BAYER-2020-016811,BAYER,,67.0,YR,E,M,Y,,,20201130.0,,HP,MX,MX,2020,Q4,Elderly
174008457,17400845,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2020,Q4,Dyspnoea,,2020,Q4,7,F,2020.0,20201123.0,20200211,20201128,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20201127.0,,HP,US,US,2020,Q4,Elderly
174008457,17400845,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2020,Q4,Ear haemorrhage,,2020,Q4,7,F,2020.0,20201123.0,20200211,20201128,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20201127.0,,HP,US,US,2020,Q4,Elderly
174008457,17400845,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2020,Q4,Enzyme level increased,,2020,Q4,7,F,2020.0,20201123.0,20200211,20201128,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20201127.0,,HP,US,US,2020,Q4,Elderly
174008457,17400845,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2020,Q4,Off label use,,2020,Q4,7,F,2020.0,20201123.0,20200211,20201128,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20201127.0,,HP,US,US,2020,Q4,Elderly
174008457,17400845,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2020,Q4,Product dispensing error,,2020,Q4,7,F,2020.0,20201123.0,20200211,20201128,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20201127.0,,HP,US,US,2020,Q4,Elderly
176811302,17681130,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20120707.0,20201109.0,20200417,20201117,EXP,,US-ASTRAZENECA-2020SE50856,ASTRAZENECA,,10842.0,DY,,F,Y,,,20201117.0,,,US,US,2020,Q4,Elderly
176811302,17681130,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20120707.0,20201109.0,20200417,20201117,EXP,,US-ASTRAZENECA-2020SE50856,ASTRAZENECA,,10842.0,DY,,F,Y,,,20201117.0,,,US,US,2020,Q4,Elderly
176811302,17681130,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,2,F,20120707.0,20201109.0,20200417,20201117,EXP,,US-ASTRAZENECA-2020SE50856,ASTRAZENECA,,10842.0,DY,,F,Y,,,20201117.0,,,US,US,2020,Q4,Elderly
176811302,17681130,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Nephrogenic anaemia,,2020,Q4,2,F,20120707.0,20201109.0,20200417,20201117,EXP,,US-ASTRAZENECA-2020SE50856,ASTRAZENECA,,10842.0,DY,,F,Y,,,20201117.0,,,US,US,2020,Q4,Elderly
176811302,17681130,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,2,F,20120707.0,20201109.0,20200417,20201117,EXP,,US-ASTRAZENECA-2020SE50856,ASTRAZENECA,,10842.0,DY,,F,Y,,,20201117.0,,,US,US,2020,Q4,Elderly
176811302,17681130,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Renal tubular necrosis,,2020,Q4,2,F,20120707.0,20201109.0,20200417,20201117,EXP,,US-ASTRAZENECA-2020SE50856,ASTRAZENECA,,10842.0,DY,,F,Y,,,20201117.0,,,US,US,2020,Q4,Elderly
179592894,17959289,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q4,Blood glucose abnormal,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q4,Device issue,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q4,Device leakage,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q4,Device malfunction,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q4,Drug dose omission by device,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q4,Frustration tolerance decreased,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q4,Injection site mass,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q4,Injection site urticaria,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q4,Product container seal issue,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 AC,BEFORE MEALS",,,,,,,,,,,,2020,Q4,Wrong technique in device usage process,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,6,C,LISPRO,INSULIN LISPRO,1,Unknown,5 UNITS THREE TIMES A DAY,,,,, MB0440,,,,,,,2020,Q4,Blood glucose abnormal,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,6,C,LISPRO,INSULIN LISPRO,1,Unknown,5 UNITS THREE TIMES A DAY,,,,, MB0440,,,,,,,2020,Q4,Device issue,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,6,C,LISPRO,INSULIN LISPRO,1,Unknown,5 UNITS THREE TIMES A DAY,,,,, MB0440,,,,,,,2020,Q4,Device leakage,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,6,C,LISPRO,INSULIN LISPRO,1,Unknown,5 UNITS THREE TIMES A DAY,,,,, MB0440,,,,,,,2020,Q4,Device malfunction,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,6,C,LISPRO,INSULIN LISPRO,1,Unknown,5 UNITS THREE TIMES A DAY,,,,, MB0440,,,,,,,2020,Q4,Drug dose omission by device,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,6,C,LISPRO,INSULIN LISPRO,1,Unknown,5 UNITS THREE TIMES A DAY,,,,, MB0440,,,,,,,2020,Q4,Frustration tolerance decreased,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,6,C,LISPRO,INSULIN LISPRO,1,Unknown,5 UNITS THREE TIMES A DAY,,,,, MB0440,,,,,,,2020,Q4,Injection site mass,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,6,C,LISPRO,INSULIN LISPRO,1,Unknown,5 UNITS THREE TIMES A DAY,,,,, MB0440,,,,,,,2020,Q4,Injection site urticaria,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,6,C,LISPRO,INSULIN LISPRO,1,Unknown,5 UNITS THREE TIMES A DAY,,,,, MB0440,,,,,,,2020,Q4,Product container seal issue,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179592894,17959289,6,C,LISPRO,INSULIN LISPRO,1,Unknown,5 UNITS THREE TIMES A DAY,,,,, MB0440,,,,,,,2020,Q4,Wrong technique in device usage process,,2020,Q4,4,F,202004.0,20200908.0,20200629,20201008,PER,,US-ASTRAZENECA-2020SE81296,ASTRAZENECA,,918.0,MON,,M,Y,99.8,KG,20201008.0,,,US,US,2020,Q4,Elderly
179698333,17969833,8,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Acute myocardial infarction,,2020,Q4,3,F,202006.0,20201117.0,20200701,20201124,EXP,,US-GILEAD-2020-0477758,GILEAD,,85.0,YR,E,F,Y,84.0,KG,20201124.0,,PH,US,US,2020,Q4,Elderly
179698333,17969833,8,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,3,F,202006.0,20201117.0,20200701,20201124,EXP,,US-GILEAD-2020-0477758,GILEAD,,85.0,YR,E,F,Y,84.0,KG,20201124.0,,PH,US,US,2020,Q4,Elderly
179698333,17969833,8,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,3,F,202006.0,20201117.0,20200701,20201124,EXP,,US-GILEAD-2020-0477758,GILEAD,,85.0,YR,E,F,Y,84.0,KG,20201124.0,,PH,US,US,2020,Q4,Elderly
179698333,17969833,8,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,3,F,202006.0,20201117.0,20200701,20201124,EXP,,US-GILEAD-2020-0477758,GILEAD,,85.0,YR,E,F,Y,84.0,KG,20201124.0,,PH,US,US,2020,Q4,Elderly
179698333,17969833,8,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,3,F,202006.0,20201117.0,20200701,20201124,EXP,,US-GILEAD-2020-0477758,GILEAD,,85.0,YR,E,F,Y,84.0,KG,20201124.0,,PH,US,US,2020,Q4,Elderly
179753294,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,4,F,20180726.0,20201009.0,20200702,20201013,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20201013.0,,MD,US,US,2020,Q4,Adult
179753294,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Encephalopathy,,2020,Q4,4,F,20180726.0,20201009.0,20200702,20201013,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20201013.0,,MD,US,US,2020,Q4,Adult
179753294,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Fournier's gangrene,,2020,Q4,4,F,20180726.0,20201009.0,20200702,20201013,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20201013.0,,MD,US,US,2020,Q4,Adult
179753294,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Muscular weakness,,2020,Q4,4,F,20180726.0,20201009.0,20200702,20201013,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20201013.0,,MD,US,US,2020,Q4,Adult
179753294,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Pain,,2020,Q4,4,F,20180726.0,20201009.0,20200702,20201013,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20201013.0,,MD,US,US,2020,Q4,Adult
179753294,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Sepsis,,2020,Q4,4,F,20180726.0,20201009.0,20200702,20201013,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20201013.0,,MD,US,US,2020,Q4,Adult
179753294,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Sinus tachycardia,,2020,Q4,4,F,20180726.0,20201009.0,20200702,20201013,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20201013.0,,MD,US,US,2020,Q4,Adult
179753294,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Tachypnoea,,2020,Q4,4,F,20180726.0,20201009.0,20200702,20201013,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20201013.0,,MD,US,US,2020,Q4,Adult
179753294,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Urinary tract candidiasis,,2020,Q4,4,F,20180726.0,20201009.0,20200702,20201013,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20201013.0,,MD,US,US,2020,Q4,Adult
180077813,18007781,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 UNIT,,,,,,,,,,,,2020,Q4,Salivary hypersecretion,,2020,Q4,3,F,20200408.0,20201014.0,20200710,20201023,PER,,US-VERTEX PHARMACEUTICALS-2020-014329,VERTEX,,41.0,YR,,M,Y,91.0,KG,20201023.0,,PH,US,US,2020,Q4,Adult
180077813,18007781,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 UNIT,,,,,,,,,,,,2020,Q4,Weight increased,,2020,Q4,3,F,20200408.0,20201014.0,20200710,20201023,PER,,US-VERTEX PHARMACEUTICALS-2020-014329,VERTEX,,41.0,YR,,M,Y,91.0,KG,20201023.0,,PH,US,US,2020,Q4,Adult
180221738,18022173,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Heparin-induced thrombocytopenia,,2020,Q4,8,F,,20201209.0,20200714,20201221,EXP,,CZ-MYLANLABS-2020M1063775,MYLAN,"POLAK P ET AL. HEPARIN-INDUCED THROMBOCYTOPENIA: A CASE REPORT AND LITERATURE REVIEW. VNITRNI LEARSTVI. 2020;66(4):242-244,246-248",62.0,YR,,F,Y,,,20201221.0,,MD,CZ,CZ,2020,Q4,Adult
180221738,18022173,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Incision site impaired healing,,2020,Q4,8,F,,20201209.0,20200714,20201221,EXP,,CZ-MYLANLABS-2020M1063775,MYLAN,"POLAK P ET AL. HEPARIN-INDUCED THROMBOCYTOPENIA: A CASE REPORT AND LITERATURE REVIEW. VNITRNI LEARSTVI. 2020;66(4):242-244,246-248",62.0,YR,,F,Y,,,20201221.0,,MD,CZ,CZ,2020,Q4,Adult
180221738,18022173,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Off label use,,2020,Q4,8,F,,20201209.0,20200714,20201221,EXP,,CZ-MYLANLABS-2020M1063775,MYLAN,"POLAK P ET AL. HEPARIN-INDUCED THROMBOCYTOPENIA: A CASE REPORT AND LITERATURE REVIEW. VNITRNI LEARSTVI. 2020;66(4):242-244,246-248",62.0,YR,,F,Y,,,20201221.0,,MD,CZ,CZ,2020,Q4,Adult
180306923,18030692,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,3,F,20200708.0,20201013.0,20200715,20201014,EXP,,US-GILEAD-2020-0483267,GILEAD,,55.0,YR,A,M,Y,121.0,KG,20201014.0,,PH,US,US,2020,Q4,Adult
180411833,18041183,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNITS/ML INJECTABLE SOLUTION, 10 UNIT(S)=0.1ML, SUBCUTANEOUS , TIDML",,,,,,,,0.1,ML,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Acute kidney injury,,2020,Q4,3,F,20180513.0,20201009.0,20200719,20201017,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-035235",BOEHRINGER INGELHEIM,,46.0,YR,A,M,Y,122.6,KG,20201017.0,,MD,US,US,2020,Q4,Adult
180411833,18041183,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNITS/ML INJECTABLE SOLUTION, 10 UNIT(S)=0.1ML, SUBCUTANEOUS , TIDML",,,,,,,,0.1,ML,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Fournier's gangrene,,2020,Q4,3,F,20180513.0,20201009.0,20200719,20201017,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-035235",BOEHRINGER INGELHEIM,,46.0,YR,A,M,Y,122.6,KG,20201017.0,,MD,US,US,2020,Q4,Adult
180411833,18041183,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNITS/ML INJECTABLE SOLUTION, 10 UNIT(S)=0.1ML, SUBCUTANEOUS , TIDML",,,,,,,,0.1,ML,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Sepsis,,2020,Q4,3,F,20180513.0,20201009.0,20200719,20201017,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-035235",BOEHRINGER INGELHEIM,,46.0,YR,A,M,Y,122.6,KG,20201017.0,,MD,US,US,2020,Q4,Adult
180549512,18054951,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D166927A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,2,F,20200719.0,20200923.0,20200722,20201001,PER,,US-ELI_LILLY_AND_COMPANY-US202007008693,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20201001.0,,CN,US,US,2020,Q4,Adult
180549512,18054951,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D166927A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20200719.0,20200923.0,20200722,20201001,PER,,US-ELI_LILLY_AND_COMPANY-US202007008693,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20201001.0,,CN,US,US,2020,Q4,Adult
180549512,18054951,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D166927A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Wrong technique in product usage process,,2020,Q4,2,F,20200719.0,20200923.0,20200722,20201001,PER,,US-ELI_LILLY_AND_COMPANY-US202007008693,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20201001.0,,CN,US,US,2020,Q4,Adult
180549512,18054951,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D207627A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,2,F,20200719.0,20200923.0,20200722,20201001,PER,,US-ELI_LILLY_AND_COMPANY-US202007008693,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20201001.0,,CN,US,US,2020,Q4,Adult
180549512,18054951,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D207627A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20200719.0,20200923.0,20200722,20201001,PER,,US-ELI_LILLY_AND_COMPANY-US202007008693,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20201001.0,,CN,US,US,2020,Q4,Adult
180549512,18054951,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D207627A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Wrong technique in product usage process,,2020,Q4,2,F,20200719.0,20200923.0,20200722,20201001,PER,,US-ELI_LILLY_AND_COMPANY-US202007008693,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20201001.0,,CN,US,US,2020,Q4,Adult
180649623,18064962,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Blood creatine phosphokinase increased,,2020,Q4,3,F,,20200922.0,20200724,20201003,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-03516,LUPIN,,73.0,YR,,M,Y,,,20201003.0,,MD,US,US,2020,Q4,Elderly
180649623,18064962,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Long QT syndrome,,2020,Q4,3,F,,20200922.0,20200724,20201003,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-03516,LUPIN,,73.0,YR,,M,Y,,,20201003.0,,MD,US,US,2020,Q4,Elderly
180649623,18064962,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Myalgia,,2020,Q4,3,F,,20200922.0,20200724,20201003,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-03516,LUPIN,,73.0,YR,,M,Y,,,20201003.0,,MD,US,US,2020,Q4,Elderly
180649623,18064962,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Off label use,,2020,Q4,3,F,,20200922.0,20200724,20201003,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-03516,LUPIN,,73.0,YR,,M,Y,,,20201003.0,,MD,US,US,2020,Q4,Elderly
180653552,18065355,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Azotaemia,,2020,Q4,2,F,,20201020.0,20200724,20201030,EXP,,KR-ACCORD-192290,ACCORD,"CHOI JY, CHO SG, JANG KS, KIM GH. VORICONAZOLE-INDUCED SEVERE HYPERKALEMIA PRECIPITATED BY MULTIPLE DRUG INTERACTIONS. ELECTROLYTE BLOOD PRESS. 2020 JUN;18(1):10-15.",69.0,YR,,M,Y,,,20201030.0,,HP,KR,KR,2020,Q4,Elderly
180653552,18065355,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Drug interaction,,2020,Q4,2,F,,20201020.0,20200724,20201030,EXP,,KR-ACCORD-192290,ACCORD,"CHOI JY, CHO SG, JANG KS, KIM GH. VORICONAZOLE-INDUCED SEVERE HYPERKALEMIA PRECIPITATED BY MULTIPLE DRUG INTERACTIONS. ELECTROLYTE BLOOD PRESS. 2020 JUN;18(1):10-15.",69.0,YR,,M,Y,,,20201030.0,,HP,KR,KR,2020,Q4,Elderly
180653552,18065355,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hypercalcaemia,,2020,Q4,2,F,,20201020.0,20200724,20201030,EXP,,KR-ACCORD-192290,ACCORD,"CHOI JY, CHO SG, JANG KS, KIM GH. VORICONAZOLE-INDUCED SEVERE HYPERKALEMIA PRECIPITATED BY MULTIPLE DRUG INTERACTIONS. ELECTROLYTE BLOOD PRESS. 2020 JUN;18(1):10-15.",69.0,YR,,M,Y,,,20201030.0,,HP,KR,KR,2020,Q4,Elderly
180653552,18065355,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hyperkalaemia,,2020,Q4,2,F,,20201020.0,20200724,20201030,EXP,,KR-ACCORD-192290,ACCORD,"CHOI JY, CHO SG, JANG KS, KIM GH. VORICONAZOLE-INDUCED SEVERE HYPERKALEMIA PRECIPITATED BY MULTIPLE DRUG INTERACTIONS. ELECTROLYTE BLOOD PRESS. 2020 JUN;18(1):10-15.",69.0,YR,,M,Y,,,20201030.0,,HP,KR,KR,2020,Q4,Elderly
180653552,18065355,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,2,F,,20201020.0,20200724,20201030,EXP,,KR-ACCORD-192290,ACCORD,"CHOI JY, CHO SG, JANG KS, KIM GH. VORICONAZOLE-INDUCED SEVERE HYPERKALEMIA PRECIPITATED BY MULTIPLE DRUG INTERACTIONS. ELECTROLYTE BLOOD PRESS. 2020 JUN;18(1):10-15.",69.0,YR,,M,Y,,,20201030.0,,HP,KR,KR,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Acute kidney injury,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Asthenia,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Constipation,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Contraindicated product administered,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Dehydration,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Drug clearance decreased,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Drug interaction,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Duplicate therapy error,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Fatigue,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,International normalised ratio increased,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Medication error,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Mobility decreased,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Myalgia,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Oedema peripheral,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Overdose,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Product administration error,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Product name confusion,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Rhabdomyolysis,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 IU, QD",,,U,,,,,42.0,IU,,QD,2020,Q4,Urinary incontinence,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Acute kidney injury,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Asthenia,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Bedridden,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Constipation,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Contraindicated product administered,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Dehydration,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Drug clearance decreased,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Drug interaction,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Duplicate therapy error,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Fatigue,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,International normalised ratio increased,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Labelled drug-drug interaction medication error,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Medication error,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Mobility decreased,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Myalgia,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Oedema peripheral,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Overdose,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Product administration error,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Product name confusion,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Rhabdomyolysis,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42 INTERNATIONAL UNIT, QD",,,U,U,,,,42.0,IU,,QD,2020,Q4,Urinary incontinence,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acidosis,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Arrhythmia supraventricular,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Decubitus ulcer,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Leukocytosis,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Normochromic normocytic anaemia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Pneumonia bacterial,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Sepsis syndrome,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Shock,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Staphylococcal infection,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acidosis,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Arrhythmia supraventricular,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Decubitus ulcer,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Leukocytosis,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Normochromic normocytic anaemia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Pneumonia bacterial,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Sepsis syndrome,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Shock,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Staphylococcal infection,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Acute kidney injury,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Alanine aminotransferase increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Asthenia,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Bedridden,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Blood creatine phosphokinase increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Blood creatinine increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Blood urea increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Constipation,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Contraindicated product administered,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Dehydration,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Drug clearance decreased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Drug interaction,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Fatigue,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Immobile,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Incorrect dose administered,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,International normalised ratio increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Medication error,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Mobility decreased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Myalgia,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Myoglobin blood increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Oedema peripheral,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Overdose,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Polyuria,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Product administration error,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Product name confusion,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Rhabdomyolysis,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Transaminases increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,42.0,IU,,QD,2020,Q4,Urinary incontinence,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180877613,18087761,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood insulin abnormal,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180877613,18087761,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180877613,18087761,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Drug ineffective,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180877613,18087761,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180877613,18087761,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Insulin C-peptide abnormal,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180877613,18087761,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Product administration interrupted,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180877613,18087761,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Treatment noncompliance,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180893492,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,,,,,,42.0,IU,,QD,2020,Q4,Acute kidney injury,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,,,,,,42.0,IU,,QD,2020,Q4,Bedridden,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,,,,,,42.0,IU,,QD,2020,Q4,Constipation,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,,,,,,42.0,IU,,QD,2020,Q4,Contraindicated product administered,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,,,,,,42.0,IU,,QD,2020,Q4,Drug clearance decreased,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,,,,,,42.0,IU,,QD,2020,Q4,Drug interaction,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,,,,,,42.0,IU,,QD,2020,Q4,International normalised ratio increased,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,,,,,,42.0,IU,,QD,2020,Q4,Overdose,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,,,,,,42.0,IU,,QD,2020,Q4,Product administration error,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,,,,,,42.0,IU,,QD,2020,Q4,Product name confusion,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,,,,,,42.0,IU,,QD,2020,Q4,Rhabdomyolysis,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 INTERNATIONAL UNIT, QD",,,,,,,,42.0,IU,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180899874,18089987,9,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,"18 INTERNATIONAL UNIT, 3 TIMES A DAY",,,Y,,,,,18.0,IU,,TID,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,9,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,"18 INTERNATIONAL UNIT, 3 TIMES A DAY",,,Y,,,,,18.0,IU,,TID,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,9,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,"18 INTERNATIONAL UNIT, 3 TIMES A DAY",,,Y,,,,,18.0,IU,,TID,2020,Q4,Hypoglycaemia,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,9,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,"18 INTERNATIONAL UNIT, 3 TIMES A DAY",,,Y,,,,,18.0,IU,,TID,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,9,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,"18 INTERNATIONAL UNIT, 3 TIMES A DAY",,,Y,,,,,18.0,IU,,TID,2020,Q4,Weight increased,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
181141333,18114133,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Heparin-induced thrombocytopenia,,2020,Q4,3,F,,20201006.0,20200805,20201014,EXP,CZ-EMA-DD-20200724-SAHARAN_H-115818,CZ-AXELLIA-003295,XELLIA PHARMACEUTICALS,,62.0,YR,A,F,Y,,,20201014.0,,HP,CZ,CZ,2020,Q4,Adult
181141333,18114133,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Incision site impaired healing,,2020,Q4,3,F,,20201006.0,20200805,20201014,EXP,CZ-EMA-DD-20200724-SAHARAN_H-115818,CZ-AXELLIA-003295,XELLIA PHARMACEUTICALS,,62.0,YR,A,F,Y,,,20201014.0,,HP,CZ,CZ,2020,Q4,Adult
181462223,18146222,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,,6.0,IU,,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,,6.0,IU,,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,,6.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,,6.0,IU,,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,,6.0,IU,,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,,6.0,IU,,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EACH MORNING",,,U,U,,,,8.0,IU,,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EACH MORNING",,,U,U,,,,8.0,IU,,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EACH MORNING",,,U,U,,,,8.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EACH MORNING",,,U,U,,,,8.0,IU,,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EACH MORNING",,,U,U,,,,8.0,IU,,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EACH MORNING",,,U,U,,,,8.0,IU,,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,,8.0,IU,,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,,8.0,IU,,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,,8.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,,8.0,IU,,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,,8.0,IU,,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,,8.0,IU,,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EVENING",,,U,U,,,,8.0,IU,,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EVENING",,,U,U,,,,8.0,IU,,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EVENING",,,U,U,,,,8.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EVENING",,,U,U,,,,8.0,IU,,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EVENING",,,U,U,,,,8.0,IU,,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, EVENING",,,U,U,,,,8.0,IU,,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,,7.0,IU,,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,,7.0,IU,,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,,7.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,,7.0,IU,,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,,7.0,IU,,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,,7.0,IU,,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 IU, AFTERNOON",,,U,U,,,,7.0,IU,,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 IU, AFTERNOON",,,U,U,,,,7.0,IU,,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 IU, AFTERNOON",,,U,U,,,,7.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 IU, AFTERNOON",,,U,U,,,,7.0,IU,,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 IU, AFTERNOON",,,U,U,,,,7.0,IU,,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 IU, AFTERNOON",,,U,U,,,,7.0,IU,,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 IU, MORNING",,,U,U,,,,4.0,IU,,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 IU, MORNING",,,U,U,,,,4.0,IU,,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 IU, MORNING",,,U,U,,,,4.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 IU, MORNING",,,U,U,,,,4.0,IU,,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 IU, MORNING",,,U,U,,,,4.0,IU,,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 IU, MORNING",,,U,U,,,,4.0,IU,,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,,2.0,IU,,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,,2.0,IU,,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,,2.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,,2.0,IU,,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,,2.0,IU,,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,,2.0,IU,,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 IU, EACH MORNING",,,U,U,,,,2.0,IU,,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 IU, EACH MORNING",,,U,U,,,,2.0,IU,,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 IU, EACH MORNING",,,U,U,,,,2.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 IU, EACH MORNING",,,U,U,,,,2.0,IU,,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 IU, EACH MORNING",,,U,U,,,,2.0,IU,,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 IU, EACH MORNING",,,U,U,,,,2.0,IU,,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 IU, EACH MORNING",,,U,U,,,,5.0,IU,,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 IU, EACH MORNING",,,U,U,,,,5.0,IU,,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 IU, EACH MORNING",,,U,U,,,,5.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 IU, EACH MORNING",,,U,U,,,,5.0,IU,,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 IU, EACH MORNING",,,U,U,,,,5.0,IU,,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 IU, EACH MORNING",,,U,U,,,,5.0,IU,,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"54 INTERNATIONAL UNIT, QD",,,U,U,,,,54.0,IU,,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"54 INTERNATIONAL UNIT, QD",,,U,U,,,,54.0,IU,,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"54 INTERNATIONAL UNIT, QD",,,U,U,,,,54.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"54 INTERNATIONAL UNIT, QD",,,U,U,,,,54.0,IU,,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"54 INTERNATIONAL UNIT, QD",,,U,U,,,,54.0,IU,,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"54 INTERNATIONAL UNIT, QD",,,U,U,,,,54.0,IU,,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181579082,18157908,86,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,86,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Anxiety,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,86,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,86,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,86,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Emotional distress,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,86,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,86,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Nephrolithiasis,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,86,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Pain,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,86,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181585855,18158585,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEDTIME,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,5,F,20200715.0,20201127.0,20200817,20201201,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20201201.0,,MD,US,US,2020,Q4,Adult
181585855,18158585,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEDTIME,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,5,F,20200715.0,20201127.0,20200817,20201201,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20201201.0,,MD,US,US,2020,Q4,Adult
181585855,18158585,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEDTIME,,,,,,,,,,,,2020,Q4,Septic shock,,2020,Q4,5,F,20200715.0,20201127.0,20200817,20201201,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20201201.0,,MD,US,US,2020,Q4,Adult
181585855,18158585,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,5,F,20200715.0,20201127.0,20200817,20201201,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20201201.0,,MD,US,US,2020,Q4,Adult
181585855,18158585,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,5,F,20200715.0,20201127.0,20200817,20201201,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20201201.0,,MD,US,US,2020,Q4,Adult
181585855,18158585,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Septic shock,,2020,Q4,5,F,20200715.0,20201127.0,20200817,20201201,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20201201.0,,MD,US,US,2020,Q4,Adult
181585855,18158585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,5,F,20200715.0,20201127.0,20200817,20201201,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20201201.0,,MD,US,US,2020,Q4,Adult
181585855,18158585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,5,F,20200715.0,20201127.0,20200817,20201201,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20201201.0,,MD,US,US,2020,Q4,Adult
181585855,18158585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Septic shock,,2020,Q4,5,F,20200715.0,20201127.0,20200817,20201201,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20201201.0,,MD,US,US,2020,Q4,Adult
181833372,18183337,15,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Pyrexia,,2020,Q4,2,F,20191101.0,20200928.0,20200822,20201005,PER,,US-CELGENEUS-USA-20200803693,CELGENE,,58.0,YR,,M,Y,68.0,KG,20201005.0,,MD,US,US,2020,Q4,Adult
181833372,18183337,15,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Vomiting,,2020,Q4,2,F,20191101.0,20200928.0,20200822,20201005,PER,,US-CELGENEUS-USA-20200803693,CELGENE,,58.0,YR,,M,Y,68.0,KG,20201005.0,,MD,US,US,2020,Q4,Adult
1820048010,18200480,23,C,Gereric lispro,,2,Subcutaneous,1-5 UNIT,,,,,,,,,,INJECTION,TID,2020,Q4,Abdominal pain upper,,2020,Q4,10,F,2020.0,20200925.0,20200826,20201005,EXP,,US-CELGENEUS-USA-20200806133,CELGENE,,70.0,YR,,M,Y,99.88,KG,20201005.0,,MD,US,US,2020,Q4,Elderly
1820048010,18200480,23,C,Gereric lispro,,2,Subcutaneous,1-5 UNIT,,,,,,,,,,INJECTION,TID,2020,Q4,Acidosis,,2020,Q4,10,F,2020.0,20200925.0,20200826,20201005,EXP,,US-CELGENEUS-USA-20200806133,CELGENE,,70.0,YR,,M,Y,99.88,KG,20201005.0,,MD,US,US,2020,Q4,Elderly
1820048010,18200480,23,C,Gereric lispro,,2,Subcutaneous,1-5 UNIT,,,,,,,,,,INJECTION,TID,2020,Q4,Bone lesion,,2020,Q4,10,F,2020.0,20200925.0,20200826,20201005,EXP,,US-CELGENEUS-USA-20200806133,CELGENE,,70.0,YR,,M,Y,99.88,KG,20201005.0,,MD,US,US,2020,Q4,Elderly
1820048010,18200480,23,C,Gereric lispro,,2,Subcutaneous,1-5 UNIT,,,,,,,,,,INJECTION,TID,2020,Q4,Chest pain,,2020,Q4,10,F,2020.0,20200925.0,20200826,20201005,EXP,,US-CELGENEUS-USA-20200806133,CELGENE,,70.0,YR,,M,Y,99.88,KG,20201005.0,,MD,US,US,2020,Q4,Elderly
1820048010,18200480,23,C,Gereric lispro,,2,Subcutaneous,1-5 UNIT,,,,,,,,,,INJECTION,TID,2020,Q4,Dyspnoea,,2020,Q4,10,F,2020.0,20200925.0,20200826,20201005,EXP,,US-CELGENEUS-USA-20200806133,CELGENE,,70.0,YR,,M,Y,99.88,KG,20201005.0,,MD,US,US,2020,Q4,Elderly
1820048010,18200480,23,C,Gereric lispro,,2,Subcutaneous,1-5 UNIT,,,,,,,,,,INJECTION,TID,2020,Q4,Hypoglycaemia,,2020,Q4,10,F,2020.0,20200925.0,20200826,20201005,EXP,,US-CELGENEUS-USA-20200806133,CELGENE,,70.0,YR,,M,Y,99.88,KG,20201005.0,,MD,US,US,2020,Q4,Elderly
1820048010,18200480,23,C,Gereric lispro,,2,Subcutaneous,1-5 UNIT,,,,,,,,,,INJECTION,TID,2020,Q4,Hypotension,,2020,Q4,10,F,2020.0,20200925.0,20200826,20201005,EXP,,US-CELGENEUS-USA-20200806133,CELGENE,,70.0,YR,,M,Y,99.88,KG,20201005.0,,MD,US,US,2020,Q4,Elderly
1820048010,18200480,23,C,Gereric lispro,,2,Subcutaneous,1-5 UNIT,,,,,,,,,,INJECTION,TID,2020,Q4,Leukopenia,,2020,Q4,10,F,2020.0,20200925.0,20200826,20201005,EXP,,US-CELGENEUS-USA-20200806133,CELGENE,,70.0,YR,,M,Y,99.88,KG,20201005.0,,MD,US,US,2020,Q4,Elderly
1820048010,18200480,23,C,Gereric lispro,,2,Subcutaneous,1-5 UNIT,,,,,,,,,,INJECTION,TID,2020,Q4,Myalgia,,2020,Q4,10,F,2020.0,20200925.0,20200826,20201005,EXP,,US-CELGENEUS-USA-20200806133,CELGENE,,70.0,YR,,M,Y,99.88,KG,20201005.0,,MD,US,US,2020,Q4,Elderly
1820048010,18200480,23,C,Gereric lispro,,2,Subcutaneous,1-5 UNIT,,,,,,,,,,INJECTION,TID,2020,Q4,Pneumonia pseudomonal,,2020,Q4,10,F,2020.0,20200925.0,20200826,20201005,EXP,,US-CELGENEUS-USA-20200806133,CELGENE,,70.0,YR,,M,Y,99.88,KG,20201005.0,,MD,US,US,2020,Q4,Elderly
1820048010,18200480,23,C,Gereric lispro,,2,Subcutaneous,1-5 UNIT,,,,,,,,,,INJECTION,TID,2020,Q4,Sepsis,,2020,Q4,10,F,2020.0,20200925.0,20200826,20201005,EXP,,US-CELGENEUS-USA-20200806133,CELGENE,,70.0,YR,,M,Y,99.88,KG,20201005.0,,MD,US,US,2020,Q4,Elderly
1820048010,18200480,23,C,Gereric lispro,,2,Subcutaneous,1-5 UNIT,,,,,,,,,,INJECTION,TID,2020,Q4,Systemic inflammatory response syndrome,,2020,Q4,10,F,2020.0,20200925.0,20200826,20201005,EXP,,US-CELGENEUS-USA-20200806133,CELGENE,,70.0,YR,,M,Y,99.88,KG,20201005.0,,MD,US,US,2020,Q4,Elderly
182053562,18205356,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,COVID-19,,2020,Q4,2,F,20200628.0,20201110.0,20200827,20201116,EXP,,US-GILEAD-2020-0480282,GILEAD,,68.0,YR,E,F,Y,102.0,KG,20201116.0,,HP,US,US,2020,Q4,Elderly
182053562,18205356,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Liver disorder,,2020,Q4,2,F,20200628.0,20201110.0,20200827,20201116,EXP,,US-GILEAD-2020-0480282,GILEAD,,68.0,YR,E,F,Y,102.0,KG,20201116.0,,HP,US,US,2020,Q4,Elderly
182053562,18205356,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Terminal state,,2020,Q4,2,F,20200628.0,20201110.0,20200827,20201116,EXP,,US-GILEAD-2020-0480282,GILEAD,,68.0,YR,E,F,Y,102.0,KG,20201116.0,,HP,US,US,2020,Q4,Elderly
182144453,18214445,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,26USP UNITS BEFORE MEALS,,,,,,,,,,,,2020,Q4,Appetite disorder,,2020,Q4,3,F,201912.0,20200921.0,20200831,20201021,PER,,US-ASTRAZENECA-2020SF05868,ASTRAZENECA,,70.0,YR,,F,Y,118.8,KG,20201021.0,,CN,US,US,2020,Q4,Elderly
182144453,18214445,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,26USP UNITS BEFORE MEALS,,,,,,,,,,,,2020,Q4,Device ineffective,,2020,Q4,3,F,201912.0,20200921.0,20200831,20201021,PER,,US-ASTRAZENECA-2020SF05868,ASTRAZENECA,,70.0,YR,,F,Y,118.8,KG,20201021.0,,CN,US,US,2020,Q4,Elderly
182144453,18214445,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,26USP UNITS BEFORE MEALS,,,,,,,,,,,,2020,Q4,Device issue,,2020,Q4,3,F,201912.0,20200921.0,20200831,20201021,PER,,US-ASTRAZENECA-2020SF05868,ASTRAZENECA,,70.0,YR,,F,Y,118.8,KG,20201021.0,,CN,US,US,2020,Q4,Elderly
182144453,18214445,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,26USP UNITS BEFORE MEALS,,,,,,,,,,,,2020,Q4,Device leakage,,2020,Q4,3,F,201912.0,20200921.0,20200831,20201021,PER,,US-ASTRAZENECA-2020SF05868,ASTRAZENECA,,70.0,YR,,F,Y,118.8,KG,20201021.0,,CN,US,US,2020,Q4,Elderly
182144453,18214445,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,26USP UNITS BEFORE MEALS,,,,,,,,,,,,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,3,F,201912.0,20200921.0,20200831,20201021,PER,,US-ASTRAZENECA-2020SF05868,ASTRAZENECA,,70.0,YR,,F,Y,118.8,KG,20201021.0,,CN,US,US,2020,Q4,Elderly
182144453,18214445,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,26USP UNITS BEFORE MEALS,,,,,,,,,,,,2020,Q4,Malaise,,2020,Q4,3,F,201912.0,20200921.0,20200831,20201021,PER,,US-ASTRAZENECA-2020SF05868,ASTRAZENECA,,70.0,YR,,F,Y,118.8,KG,20201021.0,,CN,US,US,2020,Q4,Elderly
182144453,18214445,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,26USP UNITS BEFORE MEALS,,,,,,,,,,,,2020,Q4,Visual impairment,,2020,Q4,3,F,201912.0,20200921.0,20200831,20201021,PER,,US-ASTRAZENECA-2020SF05868,ASTRAZENECA,,70.0,YR,,F,Y,118.8,KG,20201021.0,,CN,US,US,2020,Q4,Elderly
182144453,18214445,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,26USP UNITS BEFORE MEALS,,,,,,,,,,,,2020,Q4,Weight increased,,2020,Q4,3,F,201912.0,20200921.0,20200831,20201021,PER,,US-ASTRAZENECA-2020SF05868,ASTRAZENECA,,70.0,YR,,F,Y,118.8,KG,20201021.0,,CN,US,US,2020,Q4,Elderly
182144453,18214445,4,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,26USP UNITS BEFORE MEALS,,,,,,,,,,,,2020,Q4,Wrong technique in device usage process,,2020,Q4,3,F,201912.0,20200921.0,20200831,20201021,PER,,US-ASTRAZENECA-2020SF05868,ASTRAZENECA,,70.0,YR,,F,Y,118.8,KG,20201021.0,,CN,US,US,2020,Q4,Elderly
182197442,18219744,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,2,F,,20201001.0,20200901,20201002,EXP,,US-GILEAD-2020-0492866,GILEAD,,66.0,YR,E,M,Y,95.01,KG,20201002.0,,MD,US,US,2020,Q4,Elderly
182321123,18232112,56,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU (1IU, CO)",,,D,,,,,1.0,IU,,,2020,Q4,Toxic epidermal necrolysis,,2020,Q4,3,F,20200809.0,20201207.0,20200904,20201209,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,NVSC2020FR242298,NOVARTIS,,74.0,YR,,M,Y,,,20201209.0,,HP,FR,FR,2020,Q4,Elderly
182344322,18234432,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,2007.0,20201103.0,20200904,20201111,EXP,,US-ASTRAZENECA-2020SF09253,ASTRAZENECA,,46.0,YR,,M,Y,75.8,KG,20201111.0,,,US,US,2020,Q4,Adult
182344322,18234432,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,2007.0,20201103.0,20200904,20201111,EXP,,US-ASTRAZENECA-2020SF09253,ASTRAZENECA,,46.0,YR,,M,Y,75.8,KG,20201111.0,,,US,US,2020,Q4,Adult
182344322,18234432,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,2,F,2007.0,20201103.0,20200904,20201111,EXP,,US-ASTRAZENECA-2020SF09253,ASTRAZENECA,,46.0,YR,,M,Y,75.8,KG,20201111.0,,,US,US,2020,Q4,Adult
182344322,18234432,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Nephrogenic anaemia,,2020,Q4,2,F,2007.0,20201103.0,20200904,20201111,EXP,,US-ASTRAZENECA-2020SF09253,ASTRAZENECA,,46.0,YR,,M,Y,75.8,KG,20201111.0,,,US,US,2020,Q4,Adult
182344322,18234432,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,2,F,2007.0,20201103.0,20200904,20201111,EXP,,US-ASTRAZENECA-2020SF09253,ASTRAZENECA,,46.0,YR,,M,Y,75.8,KG,20201111.0,,,US,US,2020,Q4,Adult
182416595,18241659,41,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1IU, CO",,,D,,,,,1.0,IU,,,2020,Q4,Toxic epidermal necrolysis,,2020,Q4,5,F,20200809.0,20201204.0,20200908,20201211,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-ACCORD-199762,ACCORD,,75.0,YR,E,M,Y,,,20201211.0,,MD,FR,FR,2020,Q4,Elderly
182460412,18246041,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2020,Q4,Sopor,,2020,Q4,2,F,20200701.0,20201109.0,20200909,20201118,EXP,IT-MINISAL02-631316,IT-TEVA-2020-IT-1824531,TEVA,,85.0,YR,E,M,Y,,,20201118.0,,MD,IT,IT,2020,Q4,Elderly
182473395,18247339,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2020,Q4,Enteritis,,2020,Q4,5,F,20200831.0,20201214.0,20200909,20201221,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20201221.0,,HP,US,US,2020,Q4,Adult
182473395,18247339,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2020,Q4,Hospitalisation,,2020,Q4,5,F,20200831.0,20201214.0,20200909,20201221,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20201221.0,,HP,US,US,2020,Q4,Adult
182473395,18247339,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2020,Q4,Malaise,,2020,Q4,5,F,20200831.0,20201214.0,20200909,20201221,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20201221.0,,HP,US,US,2020,Q4,Adult
182473395,18247339,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2020,Q4,Speech disorder,,2020,Q4,5,F,20200831.0,20201214.0,20200909,20201221,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20201221.0,,HP,US,US,2020,Q4,Adult
182502633,18250263,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,3,F,20200828.0,20200924.0,20200910,20201001,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-071693,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,101.0,KG,20201001.0,,HP,US,US,2020,Q4,Adult
182502633,18250263,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,3,F,20200828.0,20200924.0,20200910,20201001,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-071693,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,101.0,KG,20201001.0,,HP,US,US,2020,Q4,Adult
182556835,18255683,41,SS,insulin lispro,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1IU, CO",,,U,,,,,1.0,IU,,,2020,Q4,Toxic epidermal necrolysis,,2020,Q4,5,F,20200809.0,20201207.0,20200910,20201216,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-BAXTER-2020BAX018061,BAXTER,,74.0,YR,,M,Y,,,20201216.0,,MD,FR,FR,2020,Q4,Elderly
182650592,18265059,1,PS,Insulin Lispro,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 INTERNATIONAL UNIT, UNKNOWN",,,U,, ASKED BUT UNKNOWN,,20563.0,1.0,IU,,,2020,Q4,Toxic epidermal necrolysis,,2020,Q4,2,F,20200809.0,20201204.0,20200914,20201207,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202009004654,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201207.0,,MD,FR,FR,2020,Q4,Elderly
182664342,18266434,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Blood pressure decreased,,2020,Q4,2,F,202009.0,20201208.0,20200915,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202009005497,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Adult
182664342,18266434,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Blood pressure increased,,2020,Q4,2,F,202009.0,20201208.0,20200915,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202009005497,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Adult
182664342,18266434,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,COVID-19,,2020,Q4,2,F,202009.0,20201208.0,20200915,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202009005497,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Adult
182664342,18266434,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Fall,,2020,Q4,2,F,202009.0,20201208.0,20200915,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202009005497,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Adult
182664342,18266434,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Product storage error,,2020,Q4,2,F,202009.0,20201208.0,20200915,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202009005497,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Adult
182664342,18266434,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Thinking abnormal,,2020,Q4,2,F,202009.0,20201208.0,20200915,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202009005497,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Adult
182664342,18266434,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Blood pressure decreased,,2020,Q4,2,F,202009.0,20201208.0,20200915,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202009005497,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Adult
182664342,18266434,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Blood pressure increased,,2020,Q4,2,F,202009.0,20201208.0,20200915,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202009005497,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Adult
182664342,18266434,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,COVID-19,,2020,Q4,2,F,202009.0,20201208.0,20200915,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202009005497,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Adult
182664342,18266434,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Fall,,2020,Q4,2,F,202009.0,20201208.0,20200915,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202009005497,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Adult
182664342,18266434,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Product storage error,,2020,Q4,2,F,202009.0,20201208.0,20200915,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202009005497,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Adult
182664342,18266434,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Thinking abnormal,,2020,Q4,2,F,202009.0,20201208.0,20200915,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202009005497,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Adult
182729162,18272916,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"SLIDING SCALE, UNKNOWN",,,,,,,,,,,,2020,Q4,Product adhesion issue,,2020,Q4,2,F,2020.0,20200929.0,20200916,20201103,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0440,BIODELIVERY SCIENCES INTERNATIONAL,,72.0,YR,E,M,Y,90.8,KG,20201103.0,,CN,US,US,2020,Q4,Elderly
182729162,18272916,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"SLIDING SCALE, UNKNOWN",,,,,,,,,,,,2020,Q4,Product physical consistency issue,,2020,Q4,2,F,2020.0,20200929.0,20200916,20201103,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0440,BIODELIVERY SCIENCES INTERNATIONAL,,72.0,YR,E,M,Y,90.8,KG,20201103.0,,CN,US,US,2020,Q4,Elderly
182729162,18272916,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"SLIDING SCALE, UNKNOWN",,,,,,,,,,,,2020,Q4,Product solubility abnormal,,2020,Q4,2,F,2020.0,20200929.0,20200916,20201103,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0440,BIODELIVERY SCIENCES INTERNATIONAL,,72.0,YR,E,M,Y,90.8,KG,20201103.0,,CN,US,US,2020,Q4,Elderly
182729162,18272916,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"SLIDING SCALE, UNKNOWN",,,,,,,,,,,,2020,Q4,Wrong technique in product usage process,,2020,Q4,2,F,2020.0,20200929.0,20200916,20201103,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0440,BIODELIVERY SCIENCES INTERNATIONAL,,72.0,YR,E,M,Y,90.8,KG,20201103.0,,CN,US,US,2020,Q4,Elderly
182800952,18280095,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,2,F,20200819.0,20200915.0,20200917,20201007,EXP,,US-GILEAD-2020-0495305,GILEAD,,71.0,YR,E,F,Y,44.9,KG,20201007.0,,PH,US,US,2020,Q4,Elderly
182800952,18280095,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,2,F,20200819.0,20200915.0,20200917,20201007,EXP,,US-GILEAD-2020-0495305,GILEAD,,71.0,YR,E,F,Y,44.9,KG,20201007.0,,PH,US,US,2020,Q4,Elderly
182843792,18284379,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE WITH MEALS,,,,,,,,,,,TID,2020,Q4,Proctalgia,,2020,Q4,2,F,20200911.0,20200923.0,20200918,20201001,EXP,,US-ABBVIE-20P-163-3565714-00,ABBVIE,,74.0,YR,,F,Y,72.0,KG,20201001.0,,MD,US,US,2020,Q4,Elderly
182843792,18284379,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-6, SLIDING SCALE NIGHTLY",,,,,,,,,,,,2020,Q4,Proctalgia,,2020,Q4,2,F,20200911.0,20200923.0,20200918,20201001,EXP,,US-ABBVIE-20P-163-3565714-00,ABBVIE,,74.0,YR,,F,Y,72.0,KG,20201001.0,,MD,US,US,2020,Q4,Elderly
182859904,18285990,58,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1IU, CO,",,,U,, ASKU,,,1.0,IU,,,2020,Q4,Toxic epidermal necrolysis,,2020,Q4,4,F,20200809.0,20201209.0,20200919,20201217,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-TEVA-2020-FR-1828416,TEVA,,74.0,YR,E,M,Y,,,20201217.0,,MD,FR,FR,2020,Q4,Elderly
182917952,18291795,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"44 IU, TID",,,,,,,,44.0,IU,,TID,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20200908.0,20200923.0,20200921,20201002,EXP,,CO-NOVOPROD-753329,NOVO NORDISK,,31.0,YR,,F,Y,85.0,KG,20201002.0,,CN,CO,CO,2020,Q4,Young Adult
182917952,18291795,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"44 IU, TID",,,,,,,,44.0,IU,,TID,2020,Q4,Maternal exposure during pregnancy,,2020,Q4,2,F,20200908.0,20200923.0,20200921,20201002,EXP,,CO-NOVOPROD-753329,NOVO NORDISK,,31.0,YR,,F,Y,85.0,KG,20201002.0,,CN,CO,CO,2020,Q4,Young Adult
182917952,18291795,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"44 IU, TID",,,,,,,,44.0,IU,,TID,2020,Q4,Pre-eclampsia,,2020,Q4,2,F,20200908.0,20200923.0,20200921,20201002,EXP,,CO-NOVOPROD-753329,NOVO NORDISK,,31.0,YR,,F,Y,85.0,KG,20201002.0,,CN,CO,CO,2020,Q4,Young Adult
182917952,18291795,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE INCREASED,,,,,,,,,,,,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20200908.0,20200923.0,20200921,20201002,EXP,,CO-NOVOPROD-753329,NOVO NORDISK,,31.0,YR,,F,Y,85.0,KG,20201002.0,,CN,CO,CO,2020,Q4,Young Adult
182917952,18291795,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE INCREASED,,,,,,,,,,,,2020,Q4,Maternal exposure during pregnancy,,2020,Q4,2,F,20200908.0,20200923.0,20200921,20201002,EXP,,CO-NOVOPROD-753329,NOVO NORDISK,,31.0,YR,,F,Y,85.0,KG,20201002.0,,CN,CO,CO,2020,Q4,Young Adult
182917952,18291795,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE INCREASED,,,,,,,,,,,,2020,Q4,Pre-eclampsia,,2020,Q4,2,F,20200908.0,20200923.0,20200921,20201002,EXP,,CO-NOVOPROD-753329,NOVO NORDISK,,31.0,YR,,F,Y,85.0,KG,20201002.0,,CN,CO,CO,2020,Q4,Young Adult
182952883,18295288,29,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,U,, UNK,,,1.0,IU,UNKNOWN,,2020,Q4,Toxic epidermal necrolysis,,2020,Q4,3,F,20200809.0,20201221.0,20200922,20201229,EXP,,FR-FRESENIUS KABI-FK202009537,FRESENIUS KABI,,75.0,YR,,M,Y,,,20201229.0,,HP,NL,FR,2020,Q4,Elderly
182952883,18295288,58,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1IU, CO",,,,, UNK,,,1.0,IU,UNKNOWN,,2020,Q4,Toxic epidermal necrolysis,,2020,Q4,3,F,20200809.0,20201221.0,20200922,20201229,EXP,,FR-FRESENIUS KABI-FK202009537,FRESENIUS KABI,,75.0,YR,,M,Y,,,20201229.0,,HP,NL,FR,2020,Q4,Elderly
183001372,18300137,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,2,F,20200919.0,20201007.0,20200922,20201009,EXP,,US-GILEAD-2020-0495926,GILEAD,,59.0,YR,A,F,Y,77.5,KG,20201009.0,,PH,US,US,2020,Q4,Adult
183098872,18309887,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,SLIDING SCALE,,,,,,,,,,,,2020,Q4,Blood lactate dehydrogenase increased,,2020,Q4,2,F,20200916.0,20201007.0,20200924,20201012,EXP,,US-GILEAD-2020-0496198,GILEAD,,47.0,YR,A,F,Y,85.1,KG,20201012.0,,PH,US,US,2020,Q4,Adult
183098872,18309887,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,SLIDING SCALE,,,,,,,,,,,,2020,Q4,Haemolytic anaemia,,2020,Q4,2,F,20200916.0,20201007.0,20200924,20201012,EXP,,US-GILEAD-2020-0496198,GILEAD,,47.0,YR,A,F,Y,85.1,KG,20201012.0,,PH,US,US,2020,Q4,Adult
183098872,18309887,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,SLIDING SCALE,,,,,,,,,,,,2020,Q4,Haptoglobin decreased,,2020,Q4,2,F,20200916.0,20201007.0,20200924,20201012,EXP,,US-GILEAD-2020-0496198,GILEAD,,47.0,YR,A,F,Y,85.1,KG,20201012.0,,PH,US,US,2020,Q4,Adult
183098872,18309887,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,SLIDING SCALE,,,,,,,,,,,,2020,Q4,Intentional product use issue,,2020,Q4,2,F,20200916.0,20201007.0,20200924,20201012,EXP,,US-GILEAD-2020-0496198,GILEAD,,47.0,YR,A,F,Y,85.1,KG,20201012.0,,PH,US,US,2020,Q4,Adult
183098872,18309887,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,SLIDING SCALE,,,,,,,,,,,,2020,Q4,Reticulocyte count increased,,2020,Q4,2,F,20200916.0,20201007.0,20200924,20201012,EXP,,US-GILEAD-2020-0496198,GILEAD,,47.0,YR,A,F,Y,85.1,KG,20201012.0,,PH,US,US,2020,Q4,Adult
183119732,18311973,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,2-15 U VIA SLIDING SCALE,,,,, D137576C,,20563.0,15.0,IU,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20201013.0,20201014.0,20200925,20201022,EXP,,US-ELI_LILLY_AND_COMPANY-US202009010768,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20201022.0,,CN,US,US,2020,Q4,Elderly
183119732,18311973,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,2-15 U VIA SLIDING SCALE,,,,, D137576C,,20563.0,15.0,IU,INJECTION,,2020,Q4,Visual impairment,,2020,Q4,2,F,20201013.0,20201014.0,20200925,20201022,EXP,,US-ELI_LILLY_AND_COMPANY-US202009010768,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20201022.0,,CN,US,US,2020,Q4,Elderly
183189953,18318995,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK, PRN (SLIDING SCALE)",,,U,, D049598F,,,,,INJECTION,,2020,Q4,Cerebrovascular accident,,2020,Q4,3,F,201908.0,20201124.0,20200928,20201204,EXP,,US-ELI_LILLY_AND_COMPANY-US202009008807,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20201204.0,,CN,US,US,2020,Q4,Elderly
183189953,18318995,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK, PRN (SLIDING SCALE)",,,U,, D049598F,,,,,INJECTION,,2020,Q4,Hemiplegia,,2020,Q4,3,F,201908.0,20201124.0,20200928,20201204,EXP,,US-ELI_LILLY_AND_COMPANY-US202009008807,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20201204.0,,CN,US,US,2020,Q4,Elderly
183189953,18318995,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK, PRN (SLIDING SCALE)",,,U,, D049598F,,,,,INJECTION,,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,3,F,201908.0,20201124.0,20200928,20201204,EXP,,US-ELI_LILLY_AND_COMPANY-US202009008807,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20201204.0,,CN,US,US,2020,Q4,Elderly
183189953,18318995,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"25 U, DAILY",,,U,, D049598F,,,25.0,IU,INJECTION,QD,2020,Q4,Cerebrovascular accident,,2020,Q4,3,F,201908.0,20201124.0,20200928,20201204,EXP,,US-ELI_LILLY_AND_COMPANY-US202009008807,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20201204.0,,CN,US,US,2020,Q4,Elderly
183189953,18318995,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"25 U, DAILY",,,U,, D049598F,,,25.0,IU,INJECTION,QD,2020,Q4,Hemiplegia,,2020,Q4,3,F,201908.0,20201124.0,20200928,20201204,EXP,,US-ELI_LILLY_AND_COMPANY-US202009008807,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20201204.0,,CN,US,US,2020,Q4,Elderly
183189953,18318995,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"25 U, DAILY",,,U,, D049598F,,,25.0,IU,INJECTION,QD,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,3,F,201908.0,20201124.0,20200928,20201204,EXP,,US-ELI_LILLY_AND_COMPANY-US202009008807,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20201204.0,,CN,US,US,2020,Q4,Elderly
183243812,18324381,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Cerebrovascular accident,,2020,Q4,2,F,20200820.0,20201202.0,20200929,20201204,EXP,,NVSC2020US232957,NOVARTIS,,61.0,YR,,M,Y,82.0,KG,20201204.0,,HP,US,US,2020,Q4,Adult
183307644,18330764,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,4,F,20200926.0,20201124.0,20200930,20201218,EXP,,US-GILEAD-2020-0496822,GILEAD,,70.0,YR,E,M,Y,,,20201218.0,,PH,US,US,2020,Q4,Elderly
183307644,18330764,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,4,F,20200926.0,20201124.0,20200930,20201218,EXP,,US-GILEAD-2020-0496822,GILEAD,,70.0,YR,E,M,Y,,,20201218.0,,PH,US,US,2020,Q4,Elderly
183307644,18330764,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Large intestine perforation,,2020,Q4,4,F,20200926.0,20201124.0,20200930,20201218,EXP,,US-GILEAD-2020-0496822,GILEAD,,70.0,YR,E,M,Y,,,20201218.0,,PH,US,US,2020,Q4,Elderly
183325441,18332544,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200831.0,20200928.0,20201001,20201001,EXP,,US-ROCHE-2687815,ROCHE,,64.0,YR,,F,Y,,,20201001.0,,CN,US,US,2020,Q4,Adult
183334781,18333478,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,20200616.0,20200924.0,20201001,20201001,EXP,IT-MINISAL02-635381,IT-ACCORD-203604,ACCORD,,84.0,YR,,M,Y,,,20201001.0,,MD,IT,IT,2020,Q4,Elderly
183348901,18334890,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IU, ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,300.0,IU,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20200921.0,20201001,20201001,EXP,,DE-TEVA-2020-DE-1831944,TEVA,,61.0,YR,A,F,Y,58.0,KG,20201001.0,,MD,DE,DE,2020,Q4,Adult
183348901,18334890,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IU, ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,300.0,IU,,,2020,Q4,Feeling hot,,2020,Q4,1,I,,20200921.0,20201001,20201001,EXP,,DE-TEVA-2020-DE-1831944,TEVA,,61.0,YR,A,F,Y,58.0,KG,20201001.0,,MD,DE,DE,2020,Q4,Adult
183348901,18334890,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IU, ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,300.0,IU,,,2020,Q4,Inflammation,,2020,Q4,1,I,,20200921.0,20201001,20201001,EXP,,DE-TEVA-2020-DE-1831944,TEVA,,61.0,YR,A,F,Y,58.0,KG,20201001.0,,MD,DE,DE,2020,Q4,Adult
183348901,18334890,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IU, ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,300.0,IU,,,2020,Q4,Localised infection,,2020,Q4,1,I,,20200921.0,20201001,20201001,EXP,,DE-TEVA-2020-DE-1831944,TEVA,,61.0,YR,A,F,Y,58.0,KG,20201001.0,,MD,DE,DE,2020,Q4,Adult
183348901,18334890,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IU, ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,300.0,IU,,,2020,Q4,Skin ulcer,,2020,Q4,1,I,,20200921.0,20201001,20201001,EXP,,DE-TEVA-2020-DE-1831944,TEVA,,61.0,YR,A,F,Y,58.0,KG,20201001.0,,MD,DE,DE,2020,Q4,Adult
183361271,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT(1 IE, 18-14-16-0, AMPULLEN)",,,,,,,,1.0,IU,,,2020,Q4,Cough,,2020,Q4,1,I,,20200924.0,20201001,20201001,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20201001.0,,PH,DE,DE,2020,Q4,Elderly
183361271,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT(1 IE, 18-14-16-0, AMPULLEN)",,,,,,,,1.0,IU,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20200924.0,20201001,20201001,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20201001.0,,PH,DE,DE,2020,Q4,Elderly
183361271,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT(1 IE, 18-14-16-0, AMPULLEN)",,,,,,,,1.0,IU,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20200924.0,20201001,20201001,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20201001.0,,PH,DE,DE,2020,Q4,Elderly
183361271,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT(1 IE, 18-14-16-0, AMPULLEN)",,,,,,,,1.0,IU,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20200924.0,20201001,20201001,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20201001.0,,PH,DE,DE,2020,Q4,Elderly
183361271,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT(1 IE, 18-14-16-0, AMPULLEN)",,,,,,,,1.0,IU,,,2020,Q4,Nausea,,2020,Q4,1,I,,20200924.0,20201001,20201001,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20201001.0,,PH,DE,DE,2020,Q4,Elderly
183361271,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT(1 IE, 18-14-16-0, AMPULLEN)",,,,,,,,1.0,IU,,,2020,Q4,Thirst,,2020,Q4,1,I,,20200924.0,20201001,20201001,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20201001.0,,PH,DE,DE,2020,Q4,Elderly
183379191,18337919,21,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q4,Acidosis,,2020,Q4,1,I,20200914.0,,20201001,20201001,DIR,,,FDA-CTU,,63.0,YR,,M,N,91.0,KG,20201001.0,Y,PH,US,US,2020,Q4,Adult
183379191,18337919,21,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q4,Hypernatraemia,,2020,Q4,1,I,20200914.0,,20201001,20201001,DIR,,,FDA-CTU,,63.0,YR,,M,N,91.0,KG,20201001.0,Y,PH,US,US,2020,Q4,Adult
183379191,18337919,21,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q4,Hypertriglyceridaemia,,2020,Q4,1,I,20200914.0,,20201001,20201001,DIR,,,FDA-CTU,,63.0,YR,,M,N,91.0,KG,20201001.0,Y,PH,US,US,2020,Q4,Adult
183379191,18337919,21,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q4,Leukocytosis,,2020,Q4,1,I,20200914.0,,20201001,20201001,DIR,,,FDA-CTU,,63.0,YR,,M,N,91.0,KG,20201001.0,Y,PH,US,US,2020,Q4,Adult
183379191,18337919,21,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20200914.0,,20201001,20201001,DIR,,,FDA-CTU,,63.0,YR,,M,N,91.0,KG,20201001.0,Y,PH,US,US,2020,Q4,Adult
183387781,18338778,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT (1 IE, NACH WERT, AMPULLEN)",,,,,,,,1.0,IU,,,2020,Q4,Aphasia,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,DE-MYLANLABS-2020M1082733,MYLAN,,78.0,YR,,F,Y,,,20201002.0,,MD,DE,DE,2020,Q4,Elderly
183387781,18338778,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT (1 IE, NACH WERT, AMPULLEN)",,,,,,,,1.0,IU,,,2020,Q4,Headache,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,DE-MYLANLABS-2020M1082733,MYLAN,,78.0,YR,,F,Y,,,20201002.0,,MD,DE,DE,2020,Q4,Elderly
183387781,18338778,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT (1 IE, NACH WERT, AMPULLEN)",,,,,,,,1.0,IU,,,2020,Q4,Paresis,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,DE-MYLANLABS-2020M1082733,MYLAN,,78.0,YR,,F,Y,,,20201002.0,,MD,DE,DE,2020,Q4,Elderly
183387781,18338778,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT (1 IE, NACH WERT, AMPULLEN)",,,,,,,,1.0,IU,,,2020,Q4,Thirst,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,DE-MYLANLABS-2020M1082733,MYLAN,,78.0,YR,,F,Y,,,20201002.0,,MD,DE,DE,2020,Q4,Elderly
183387931,18338793,19,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200921.0,,20201002,20201002,DIR,,,FDA-CTU,,60.0,YR,,M,N,75.0,KG,20201002.0,Y,PH,US,US,2020,Q4,Adult
183387931,18338793,19,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Acute respiratory distress syndrome,,2020,Q4,1,I,20200921.0,,20201002,20201002,DIR,,,FDA-CTU,,60.0,YR,,M,N,75.0,KG,20201002.0,Y,PH,US,US,2020,Q4,Adult
183387931,18338793,19,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Bacterial infection,,2020,Q4,1,I,20200921.0,,20201002,20201002,DIR,,,FDA-CTU,,60.0,YR,,M,N,75.0,KG,20201002.0,Y,PH,US,US,2020,Q4,Adult
183389801,18338980,27,C,INSULIN LISPRO SLIDING SCALE,,2,,,,,,,,,,,,,,2020,Q4,Electrocardiogram QT prolonged,,2020,Q4,1,I,,,20201001,20201001,DIR,,,FDA-CTU,,43.0,YR,,F,N,,,,N,MD,US,US,2020,Q4,Adult
183389801,18338980,27,C,INSULIN LISPRO SLIDING SCALE,,2,,,,,,,,,,,,,,2020,Q4,Heart rate increased,,2020,Q4,1,I,,,20201001,20201001,DIR,,,FDA-CTU,,43.0,YR,,F,N,,,,N,MD,US,US,2020,Q4,Adult
183389801,18338980,27,C,INSULIN LISPRO SLIDING SCALE,,2,,,,,,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,,,20201001,20201001,DIR,,,FDA-CTU,,43.0,YR,,F,N,,,,N,MD,US,US,2020,Q4,Adult
183389801,18338980,27,C,INSULIN LISPRO SLIDING SCALE,,2,,,,,,,,,,,,,,2020,Q4,Sepsis,,2020,Q4,1,I,,,20201001,20201001,DIR,,,FDA-CTU,,43.0,YR,,F,N,,,,N,MD,US,US,2020,Q4,Adult
183389801,18338980,27,C,INSULIN LISPRO SLIDING SCALE,,2,,,,,,,,,,,,,,2020,Q4,Sinus bradycardia,,2020,Q4,1,I,,,20201001,20201001,DIR,,,FDA-CTU,,43.0,YR,,F,N,,,,N,MD,US,US,2020,Q4,Adult
183394161,18339416,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK (NK MG, NACH SCHEMA)",,,U,,,,,,,,,2020,Q4,Angina pectoris,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,NVSC2020DE261870,NOVARTIS,,43.0,YR,,F,Y,,,20201002.0,,HP,DE,DE,2020,Q4,Adult
183394161,18339416,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK (NK MG, NACH SCHEMA)",,,U,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,NVSC2020DE261870,NOVARTIS,,43.0,YR,,F,Y,,,20201002.0,,HP,DE,DE,2020,Q4,Adult
183394161,18339416,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK (NK MG, NACH SCHEMA)",,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,NVSC2020DE261870,NOVARTIS,,43.0,YR,,F,Y,,,20201002.0,,HP,DE,DE,2020,Q4,Adult
183411831,18341183,7,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, BY VALUE, AMPOULES",,,,,,,,1.0,IU,,,2020,Q4,Aphasia,,2020,Q4,1,I,,20200923.0,20201003,20201003,EXP,,DE-TEVA-2020-DE-1833637,TEVA,,78.0,YR,E,F,Y,,,20201003.0,,MD,DE,DE,2020,Q4,Elderly
183411831,18341183,7,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, BY VALUE, AMPOULES",,,,,,,,1.0,IU,,,2020,Q4,Headache,,2020,Q4,1,I,,20200923.0,20201003,20201003,EXP,,DE-TEVA-2020-DE-1833637,TEVA,,78.0,YR,E,F,Y,,,20201003.0,,MD,DE,DE,2020,Q4,Elderly
183411831,18341183,7,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, BY VALUE, AMPOULES",,,,,,,,1.0,IU,,,2020,Q4,Paresis,,2020,Q4,1,I,,20200923.0,20201003,20201003,EXP,,DE-TEVA-2020-DE-1833637,TEVA,,78.0,YR,E,F,Y,,,20201003.0,,MD,DE,DE,2020,Q4,Elderly
183411831,18341183,7,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, BY VALUE, AMPOULES",,,,,,,,1.0,IU,,,2020,Q4,Thirst,,2020,Q4,1,I,,20200923.0,20201003,20201003,EXP,,DE-TEVA-2020-DE-1833637,TEVA,,78.0,YR,E,F,Y,,,20201003.0,,MD,DE,DE,2020,Q4,Elderly
183456081,18345608,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,,20200930.0,20201005,20201005,EXP,,CA-PFIZER INC-2020380722,PFIZER,,58.0,YR,,M,Y,98.0,KG,20201005.0,,PH,CA,CA,2020,Q4,Adult
183456081,18345608,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Dehydration,,2020,Q4,1,I,,20200930.0,20201005,20201005,EXP,,CA-PFIZER INC-2020380722,PFIZER,,58.0,YR,,M,Y,98.0,KG,20201005.0,,PH,CA,CA,2020,Q4,Adult
183456081,18345608,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20200930.0,20201005,20201005,EXP,,CA-PFIZER INC-2020380722,PFIZER,,58.0,YR,,M,Y,98.0,KG,20201005.0,,PH,CA,CA,2020,Q4,Adult
183456081,18345608,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Malaise,,2020,Q4,1,I,,20200930.0,20201005,20201005,EXP,,CA-PFIZER INC-2020380722,PFIZER,,58.0,YR,,M,Y,98.0,KG,20201005.0,,PH,CA,CA,2020,Q4,Adult
183456081,18345608,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Product dose omission issue,,2020,Q4,1,I,,20200930.0,20201005,20201005,EXP,,CA-PFIZER INC-2020380722,PFIZER,,58.0,YR,,M,Y,98.0,KG,20201005.0,,PH,CA,CA,2020,Q4,Adult
183456081,18345608,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Pyrexia,,2020,Q4,1,I,,20200930.0,20201005,20201005,EXP,,CA-PFIZER INC-2020380722,PFIZER,,58.0,YR,,M,Y,98.0,KG,20201005.0,,PH,CA,CA,2020,Q4,Adult
183468351,18346835,9,C,insulin lispro,INSULIN LISPRO,1,,"NK MG, NACH SCHEMA (NK MG, ACCORDING TO SCHEME)",,,,, UNKNOWN,,,,,,,2020,Q4,Angina pectoris,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-DRREDDYS-GER/GER/20/0127558,DR REDDYS,,43.0,YR,A,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183468351,18346835,9,C,insulin lispro,INSULIN LISPRO,1,,"NK MG, NACH SCHEMA (NK MG, ACCORDING TO SCHEME)",,,,, UNKNOWN,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-DRREDDYS-GER/GER/20/0127558,DR REDDYS,,43.0,YR,A,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183468351,18346835,9,C,insulin lispro,INSULIN LISPRO,1,,"NK MG, NACH SCHEMA (NK MG, ACCORDING TO SCHEME)",,,,, UNKNOWN,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-DRREDDYS-GER/GER/20/0127558,DR REDDYS,,43.0,YR,A,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183481191,18348119,11,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Transaminases increased,,2020,Q4,1,I,20201002.0,,20201005,20201005,DIR,,,FDA-CTU,,46.0,YR,,F,N,81.4,KG,20201005.0,N,HP,US,US,2020,Q4,Adult
183493971,18349397,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,Angina pectoris,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-PFIZER INC-2020378620,PFIZER,,43.0,YR,,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183493971,18349397,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-PFIZER INC-2020378620,PFIZER,,43.0,YR,,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183493971,18349397,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-PFIZER INC-2020378620,PFIZER,,43.0,YR,,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183493971,18349397,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,Product use issue,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-PFIZER INC-2020378620,PFIZER,,43.0,YR,,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Abdominal pain,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Abdominal pain lower,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Acute kidney injury,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Anaemia,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Anion gap increased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Anisocytosis,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Back pain,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Basophil count decreased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Benign prostatic hyperplasia,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood alkaline phosphatase increased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood count abnormal,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood creatinine decreased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood creatinine increased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood test abnormal,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood urea increased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood uric acid abnormal,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Chronic lymphocytic leukaemia,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Eosinophil count decreased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Erythema,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Flank pain,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Fungal infection,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Generalised anxiety disorder,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Haematocrit decreased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Haemodialysis,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Haemoglobin decreased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hyperkalaemia,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hyperphosphataemia,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hyperuricaemia,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypochromasia,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Lymphadenopathy,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Lymphocyte count increased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Mean cell haemoglobin concentration decreased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Mean cell haemoglobin decreased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Mean cell volume abnormal,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Monocyte count decreased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Nephrolithiasis,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Neutrophil count decreased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Neutrophil count increased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Pain,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Platelet count decreased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Poikilocytosis,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Protein total abnormal,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Red blood cell count decreased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Red blood cell morphology abnormal,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Red cell distribution width increased,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Renal cell carcinoma,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Renal injury,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Splenomegaly,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Stent placement,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Thrombocytopenia,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Tumour lysis syndrome,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Type 2 diabetes mellitus,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Ureteral stent insertion,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Ureteric obstruction,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Ureterolithiasis,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Urinary casts,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Urinary tract infection,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Urinary tract obstruction,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Urine leukocyte esterase,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Urobilinogen faeces abnormal,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Vomiting,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183504263,18350426,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"LOW DOSE, QID (WM AND BEDTIME)",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,White blood cell count abnormal,,2020,Q4,3,F,2020.0,20201109.0,20201006,20201113,EXP,,US-ABBVIE-20K-163-3594274-00,ABBVIE,,69.0,YR,,M,Y,96.7,KG,20201113.0,,HP,US,US,2020,Q4,Elderly
183510221,18351022,8,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Tremor,,2020,Q4,1,I,20200909.0,20200929.0,20201006,20201006,PER,,US-CELGENEUS-USA-20200908139,CELGENE,,53.0,YR,,M,Y,162.3,KG,20201006.0,,PH,US,US,2020,Q4,Adult
183523752,18352375,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-10 UNITS, Q6H",,,,,,,,,,,Q6H,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20200924.0,20201029.0,20201006,20201102,EXP,,US-GILEAD-2020-0497541,GILEAD,,88.0,YR,E,M,Y,71.6,KG,20201102.0,,MD,US,US,2020,Q4,Elderly
183523752,18352375,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-10 UNITS, Q6H",,,,,,,,,,,Q6H,2020,Q4,Alanine aminotransferase increased,,2020,Q4,2,F,20200924.0,20201029.0,20201006,20201102,EXP,,US-GILEAD-2020-0497541,GILEAD,,88.0,YR,E,M,Y,71.6,KG,20201102.0,,MD,US,US,2020,Q4,Elderly
183523752,18352375,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-10 UNITS, Q6H",,,,,,,,,,,Q6H,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,2,F,20200924.0,20201029.0,20201006,20201102,EXP,,US-GILEAD-2020-0497541,GILEAD,,88.0,YR,E,M,Y,71.6,KG,20201102.0,,MD,US,US,2020,Q4,Elderly
183523752,18352375,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-10 UNITS, Q6H",,,,,,,,,,,Q6H,2020,Q4,Fibrin D dimer increased,,2020,Q4,2,F,20200924.0,20201029.0,20201006,20201102,EXP,,US-GILEAD-2020-0497541,GILEAD,,88.0,YR,E,M,Y,71.6,KG,20201102.0,,MD,US,US,2020,Q4,Elderly
183523752,18352375,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-10 UNITS, Q6H",,,,,,,,,,,Q6H,2020,Q4,Leukopenia,,2020,Q4,2,F,20200924.0,20201029.0,20201006,20201102,EXP,,US-GILEAD-2020-0497541,GILEAD,,88.0,YR,E,M,Y,71.6,KG,20201102.0,,MD,US,US,2020,Q4,Elderly
183523752,18352375,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-10 UNITS, Q6H",,,,,,,,,,,Q6H,2020,Q4,Thrombocytopenia,,2020,Q4,2,F,20200924.0,20201029.0,20201006,20201102,EXP,,US-GILEAD-2020-0497541,GILEAD,,88.0,YR,E,M,Y,71.6,KG,20201102.0,,MD,US,US,2020,Q4,Elderly
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Acidosis,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Acute cardiac event,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood creatine increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood lactic acid increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood magnesium increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood phosphorus increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood potassium increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood urea increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Carbon dioxide decreased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Depression,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Haemodialysis,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hyperkalaemia,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hyperlipidaemia,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hypertension,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Anisocytosis,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Bacteraemia,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Haemodialysis,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hyperglycaemia,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Macrocytosis,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Microcytosis,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Platelet morphology abnormal,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Polychromasia,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Procalcitonin increased,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Pulseless electrical activity,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Red blood cell nucleated morphology,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood lactate dehydrogenase increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood magnesium increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood potassium increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Haemodialysis,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Haemoglobin decreased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Platelet count decreased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Red blood cell count decreased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,White blood cell count increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183541081,18354108,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200705.0,,20201006,20201006,DIR,,,FDA-CTU,,60.0,YR,,F,N,83.1,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183541081,18354108,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hyperkalaemia,,2020,Q4,1,I,20200705.0,,20201006,20201006,DIR,,,FDA-CTU,,60.0,YR,,F,N,83.1,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183541081,18354108,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,1,I,20200705.0,,20201006,20201006,DIR,,,FDA-CTU,,60.0,YR,,F,N,83.1,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183541081,18354108,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Renal tubular necrosis,,2020,Q4,1,I,20200705.0,,20201006,20201006,DIR,,,FDA-CTU,,60.0,YR,,F,N,83.1,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183541081,18354108,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20200705.0,,20201006,20201006,DIR,,,FDA-CTU,,60.0,YR,,F,N,83.1,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Band neutrophil count increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Basophil percentage increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Bilirubin conjugated increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Blood albumin decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Blood alkaline phosphatase increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Blood bilirubin increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Blood phosphorus decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Eosinophil count decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Eosinophil percentage decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Fibrin D dimer increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Haematocrit decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Haemoglobin decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Lymphocyte count decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Lymphocyte percentage decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Mean cell haemoglobin increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Mean cell volume increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Metabolic acidosis,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Monocyte count decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Monocyte percentage decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Neutrophil count increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Platelet morphology abnormal,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Procalcitonin increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Protein total decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Red blood cell count decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Red blood cell nucleated morphology present,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Respiratory acidosis,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Serum ferritin increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,White blood cell count decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183552231,18355223,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 U/ML,,,Y,,,,,6.0,IU,,Q8H,2020,Q4,Chronic kidney disease,,2020,Q4,1,I,20180412.0,20180523.0,20201007,20201007,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-027536",BOEHRINGER INGELHEIM,,60.0,YR,A,F,Y,67.5,KG,20201007.0,,MD,US,US,2020,Q4,Adult
183552231,18355223,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 U/ML,,,Y,,,,,6.0,IU,,Q8H,2020,Q4,Diabetes mellitus,,2020,Q4,1,I,20180412.0,20180523.0,20201007,20201007,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-027536",BOEHRINGER INGELHEIM,,60.0,YR,A,F,Y,67.5,KG,20201007.0,,MD,US,US,2020,Q4,Adult
183552231,18355223,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,,5.0,IU,,,2020,Q4,Chronic kidney disease,,2020,Q4,1,I,20180412.0,20180523.0,20201007,20201007,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-027536",BOEHRINGER INGELHEIM,,60.0,YR,A,F,Y,67.5,KG,20201007.0,,MD,US,US,2020,Q4,Adult
183552231,18355223,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,,5.0,IU,,,2020,Q4,Diabetes mellitus,,2020,Q4,1,I,20180412.0,20180523.0,20201007,20201007,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-027536",BOEHRINGER INGELHEIM,,60.0,YR,A,F,Y,67.5,KG,20201007.0,,MD,US,US,2020,Q4,Adult
183573052,18357305,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Cellulitis,,2020,Q4,2,F,20200831.0,20201009.0,20201007,20201021,EXP,,US-JNJFOC-20200953263,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,115.6,KG,20201021.0,,MD,US,US,2020,Q4,Elderly
183573052,18357305,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Wound abscess,,2020,Q4,2,F,20200831.0,20201009.0,20201007,20201021,EXP,,US-JNJFOC-20200953263,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,115.6,KG,20201021.0,,MD,US,US,2020,Q4,Elderly
183618591,18361859,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200704.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497913,GILEAD,,52.0,YR,A,M,Y,79.5,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183618591,18361859,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Bacteraemia,,2020,Q4,1,I,20200704.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497913,GILEAD,,52.0,YR,A,M,Y,79.5,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183618591,18361859,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,1,I,20200704.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497913,GILEAD,,52.0,YR,A,M,Y,79.5,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183618591,18361859,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,1,I,20200704.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497913,GILEAD,,52.0,YR,A,M,Y,79.5,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183618591,18361859,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,1,I,20200704.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497913,GILEAD,,52.0,YR,A,M,Y,79.5,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183630061,18363006,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,2020.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497917,GILEAD,,60.0,YR,A,F,Y,83.1,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183630061,18363006,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,1,I,2020.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497917,GILEAD,,60.0,YR,A,F,Y,83.1,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183630061,18363006,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,1,I,2020.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497917,GILEAD,,60.0,YR,A,F,Y,83.1,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183630061,18363006,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Hyperkalaemia,,2020,Q4,1,I,2020.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497917,GILEAD,,60.0,YR,A,F,Y,83.1,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183630061,18363006,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Renal tubular necrosis,,2020,Q4,1,I,2020.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497917,GILEAD,,60.0,YR,A,F,Y,83.1,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183630061,18363006,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Respiratory disorder,,2020,Q4,1,I,2020.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497917,GILEAD,,60.0,YR,A,F,Y,83.1,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183666231,18366623,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q4,Osteonecrosis of jaw,,2020,Q4,1,I,20200915.0,20201005.0,20201009,20201009,EXP,SE-MPA-1600259007473,NVSC2020SE268692,NOVARTIS,,82.0,YR,,M,Y,,,20201009.0,,HP,SE,SE,2020,Q4,Elderly
183678861,18367886,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Acidosis,,2020,Q4,1,I,2020.0,20201006.0,20201009,20201009,EXP,,US-GILEAD-2020-0497903,GILEAD,,53.0,YR,A,F,Y,129.0,KG,20201009.0,,PH,US,US,2020,Q4,Adult
183678861,18367886,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,2020.0,20201006.0,20201009,20201009,EXP,,US-GILEAD-2020-0497903,GILEAD,,53.0,YR,A,F,Y,129.0,KG,20201009.0,,PH,US,US,2020,Q4,Adult
183678861,18367886,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Cardiac disorder,,2020,Q4,1,I,2020.0,20201006.0,20201009,20201009,EXP,,US-GILEAD-2020-0497903,GILEAD,,53.0,YR,A,F,Y,129.0,KG,20201009.0,,PH,US,US,2020,Q4,Adult
183678861,18367886,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,1,I,2020.0,20201006.0,20201009,20201009,EXP,,US-GILEAD-2020-0497903,GILEAD,,53.0,YR,A,F,Y,129.0,KG,20201009.0,,PH,US,US,2020,Q4,Adult
183678861,18367886,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Hyperkalaemia,,2020,Q4,1,I,2020.0,20201006.0,20201009,20201009,EXP,,US-GILEAD-2020-0497903,GILEAD,,53.0,YR,A,F,Y,129.0,KG,20201009.0,,PH,US,US,2020,Q4,Adult
183688331,18368833,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"54 INTERNATIONAL UNIT, QD",,,,,,,,54.0,IU,,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"54 INTERNATIONAL UNIT, QD",,,,,,,,54.0,IU,,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"54 INTERNATIONAL UNIT, QD",,,,,,,,54.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"54 INTERNATIONAL UNIT, QD",,,,,,,,54.0,IU,,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"54 INTERNATIONAL UNIT, QD",,,,,,,,54.0,IU,,QD,2020,Q4,Weight increased,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183697981,18369798,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 UNITS AT LUNCH,,,,,,,,,,,QD,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052535",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, BOUCHARD J, WILLIAMSON D, ET.AL REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,PH,CA,CA,2020,Q4,Elderly
183697981,18369798,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 UNITS AT LUNCH,,,,,,,,,,,QD,2020,Q4,Blood lactic acid increased,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052535",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, BOUCHARD J, WILLIAMSON D, ET.AL REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,PH,CA,CA,2020,Q4,Elderly
183697981,18369798,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 UNITS AT LUNCH,,,,,,,,,,,QD,2020,Q4,Coagulopathy,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052535",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, BOUCHARD J, WILLIAMSON D, ET.AL REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,PH,CA,CA,2020,Q4,Elderly
183697981,18369798,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 UNITS AT LUNCH,,,,,,,,,,,QD,2020,Q4,Haematuria,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052535",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, BOUCHARD J, WILLIAMSON D, ET.AL REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,PH,CA,CA,2020,Q4,Elderly
183697981,18369798,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 UNITS AT LUNCH,,,,,,,,,,,QD,2020,Q4,Haemodynamic instability,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052535",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, BOUCHARD J, WILLIAMSON D, ET.AL REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,PH,CA,CA,2020,Q4,Elderly
183697981,18369798,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 UNITS AT LUNCH,,,,,,,,,,,QD,2020,Q4,Haemoglobin decreased,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052535",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, BOUCHARD J, WILLIAMSON D, ET.AL REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,PH,CA,CA,2020,Q4,Elderly
183697981,18369798,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 UNITS AT LUNCH,,,,,,,,,,,QD,2020,Q4,Haemorrhage,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052535",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, BOUCHARD J, WILLIAMSON D, ET.AL REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,PH,CA,CA,2020,Q4,Elderly
183697981,18369798,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 UNITS AT LUNCH,,,,,,,,,,,QD,2020,Q4,Intestinal obstruction,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052535",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, BOUCHARD J, WILLIAMSON D, ET.AL REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,PH,CA,CA,2020,Q4,Elderly
183697981,18369798,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 UNITS AT LUNCH,,,,,,,,,,,QD,2020,Q4,Melaena,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052535",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, BOUCHARD J, WILLIAMSON D, ET.AL REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,PH,CA,CA,2020,Q4,Elderly
183697981,18369798,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 UNITS AT LUNCH,,,,,,,,,,,QD,2020,Q4,Small intestinal haemorrhage,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052535",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, BOUCHARD J, WILLIAMSON D, ET.AL REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,PH,CA,CA,2020,Q4,Elderly
183704371,18370437,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"3 U, PRN(1-3)",,,U,, C939454C,,20563.0,3.0,IU,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20201006.0,20201007.0,20201012,20201012,PER,,US-ELI_LILLY_AND_COMPANY-US202010003540,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Elderly
183704371,18370437,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"3 U, PRN(1-3)",,,U,, C939454C,,20563.0,3.0,IU,INJECTION,,2020,Q4,Drug ineffective,,2020,Q4,1,I,20201006.0,20201007.0,20201012,20201012,PER,,US-ELI_LILLY_AND_COMPANY-US202010003540,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Elderly
183704371,18370437,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"3 U, PRN(1-3)",,,U,, C939454C,,20563.0,3.0,IU,INJECTION,,2020,Q4,Fatigue,,2020,Q4,1,I,20201006.0,20201007.0,20201012,20201012,PER,,US-ELI_LILLY_AND_COMPANY-US202010003540,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Elderly
183704371,18370437,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"3 U, PRN(1-3)",,,U,, C939454C,,20563.0,3.0,IU,INJECTION,,2020,Q4,Sleep disorder due to a general medical condition,,2020,Q4,1,I,20201006.0,20201007.0,20201012,20201012,PER,,US-ELI_LILLY_AND_COMPANY-US202010003540,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Elderly
183709121,18370912,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"INSULIN LISPRO 3 UNITS AT LUNCH,",,,,,,,,,,,QD,2020,Q4,Coagulopathy,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052540",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, DOBRESCU M, BOUCHARD J, WILLIAMSON D, BRINDAMOUR D, ET AL. REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,HP,CA,CA,2020,Q4,Elderly
183709121,18370912,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"INSULIN LISPRO 3 UNITS AT LUNCH,",,,,,,,,,,,QD,2020,Q4,Haematuria,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052540",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, DOBRESCU M, BOUCHARD J, WILLIAMSON D, BRINDAMOUR D, ET AL. REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,HP,CA,CA,2020,Q4,Elderly
183709121,18370912,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"INSULIN LISPRO 3 UNITS AT LUNCH,",,,,,,,,,,,QD,2020,Q4,Haemoglobin decreased,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052540",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, DOBRESCU M, BOUCHARD J, WILLIAMSON D, BRINDAMOUR D, ET AL. REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,HP,CA,CA,2020,Q4,Elderly
183709121,18370912,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"INSULIN LISPRO 3 UNITS AT LUNCH,",,,,,,,,,,,QD,2020,Q4,Haemorrhage,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052540",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, DOBRESCU M, BOUCHARD J, WILLIAMSON D, BRINDAMOUR D, ET AL. REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,HP,CA,CA,2020,Q4,Elderly
183709121,18370912,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"INSULIN LISPRO 3 UNITS AT LUNCH,",,,,,,,,,,,QD,2020,Q4,Melaena,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052540",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, DOBRESCU M, BOUCHARD J, WILLIAMSON D, BRINDAMOUR D, ET AL. REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,HP,CA,CA,2020,Q4,Elderly
183709121,18370912,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"INSULIN LISPRO 3 UNITS AT LUNCH,",,,,,,,,,,,QD,2020,Q4,Small intestinal haemorrhage,,2020,Q4,1,I,,20201001.0,20201012,20201012,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-052540",BOEHRINGER INGELHEIM,"FLYNN F, RICHARD G, DOBRESCU M, BOUCHARD J, WILLIAMSON D, BRINDAMOUR D, ET AL. REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;",86.0,YR,E,M,Y,69.0,KG,20201012.0,,HP,CA,CA,2020,Q4,Elderly
183720521,18372052,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,202002.0,20201008.0,20201012,20201012,PER,,US-ELI_LILLY_AND_COMPANY-US202010004354,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Elderly
183720521,18372052,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D166927A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,202002.0,20201008.0,20201012,20201012,PER,,US-ELI_LILLY_AND_COMPANY-US202010004354,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20201012.0,,CN,US,US,2020,Q4,Elderly
183723921,18372392,9,C,insulin lispro,INSULIN LISPRO,1,,"NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,Angina pectoris,,2020,Q4,1,I,,20201004.0,20201012,20201012,EXP,,DE-TEVA-2020-DE-1836386,TEVA,,43.0,YR,A,F,Y,,,20201012.0,,MD,DE,DE,2020,Q4,Adult
183723921,18372392,9,C,insulin lispro,INSULIN LISPRO,1,,"NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201004.0,20201012,20201012,EXP,,DE-TEVA-2020-DE-1836386,TEVA,,43.0,YR,A,F,Y,,,20201012.0,,MD,DE,DE,2020,Q4,Adult
183723921,18372392,9,C,insulin lispro,INSULIN LISPRO,1,,"NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201004.0,20201012,20201012,EXP,,DE-TEVA-2020-DE-1836386,TEVA,,43.0,YR,A,F,Y,,,20201012.0,,MD,DE,DE,2020,Q4,Adult
183754831,18375483,2,C,Insulin lispro (Humalog) 10 units,,2,,,,,,,,,,,,,,2020,Q4,Hepatic enzyme increased,,2020,Q4,1,I,20201002.0,,20201012,20201012,DIR,,,FDA-CTU,,70.0,YR,,M,N,68.0,KG,20201012.0,Y,PH,US,US,2020,Q4,Elderly
183754831,18375483,2,C,Insulin lispro (Humalog) 10 units,,2,,,,,,,,,,,,,,2020,Q4,Transaminases increased,,2020,Q4,1,I,20201002.0,,20201012,20201012,DIR,,,FDA-CTU,,70.0,YR,,M,N,68.0,KG,20201012.0,Y,PH,US,US,2020,Q4,Elderly
183767551,18376755,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,20200616.0,20201005.0,20201013,20201013,EXP,IT-MINISAL02-635381,IT-TEVA-2020-IT-1836963,TEVA,,84.0,YR,E,M,Y,,,20201013.0,,MD,IT,IT,2020,Q4,Elderly
183774811,18377481,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, ASKU,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20201008.0,20201008.0,20201013,20201013,PER,,US-ELI_LILLY_AND_COMPANY-US202010004104,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20201013.0,,CN,US,US,2020,Q4,Elderly
183774811,18377481,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D166927A,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20201008.0,20201008.0,20201013,20201013,PER,,US-ELI_LILLY_AND_COMPANY-US202010004104,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20201013.0,,CN,US,US,2020,Q4,Elderly
183871581,18387158,12,C,insulin lispro sliding scale,,2,,,,,,,,,,,,,,2020,Q4,Liver function test increased,,2020,Q4,1,I,20201010.0,,20201015,20201015,DIR,,,FDA-CTU,,74.0,YR,,M,N,87.9,KG,20201015.0,N,PH,US,US,2020,Q4,Elderly
183879222,18387922,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Illness,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Product storage error,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Renal failure,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Illness,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Product storage error,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2020,Q4,Renal failure,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Illness,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Product storage error,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Renal failure,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Illness,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Product storage error,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183879222,18387922,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Renal failure,,2020,Q4,2,F,2015.0,20201015.0,20201015,20201026,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
183919191,18391919,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (BEFORE EACH MEAL)",,,Y,U,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,COVID-19,,2020,Q4,1,I,20200901.0,20200924.0,20201016,20201016,PER,,US-ELI_LILLY_AND_COMPANY-US202009011204,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20201016.0,,CN,US,US,2020,Q4,Adult
183919191,18391919,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, DAILY (BEFORE EACH MEAL)",,,Y,U, D207627A,,,15.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,COVID-19,,2020,Q4,1,I,20200901.0,20200924.0,20201016,20201016,PER,,US-ELI_LILLY_AND_COMPANY-US202009011204,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20201016.0,,CN,US,US,2020,Q4,Adult
183924011,18392401,6,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20201015.0,,20201016,20201016,DIR,,,FDA-CTU,,68.0,YR,,M,N,122.9,KG,20201016.0,Y,HP,US,US,2020,Q4,Elderly
183924011,18392401,6,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Blood creatinine increased,,2020,Q4,1,I,20201015.0,,20201016,20201016,DIR,,,FDA-CTU,,68.0,YR,,M,N,122.9,KG,20201016.0,Y,HP,US,US,2020,Q4,Elderly
183924011,18392401,6,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Therapy cessation,,2020,Q4,1,I,20201015.0,,20201016,20201016,DIR,,,FDA-CTU,,68.0,YR,,M,N,122.9,KG,20201016.0,Y,HP,US,US,2020,Q4,Elderly
183958302,18395830,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q4,Bradycardia,,2020,Q4,2,F,20201012.0,20201106.0,20201018,20201112,EXP,,US-GILEAD-2020-0499349,GILEAD,,85.0,YR,E,F,Y,52.02,KG,20201112.0,,PH,US,US,2020,Q4,Elderly
183965542,18396554,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Blood pressure increased,,2020,Q4,2,F,,20201029.0,20201019,20201102,EXP,,US-GILEAD-2020-0497946,GILEAD,,82.0,YR,E,F,Y,81.4,KG,20201102.0,,CN,US,US,2020,Q4,Elderly
183965542,18396554,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Dialysis,,2020,Q4,2,F,,20201029.0,20201019,20201102,EXP,,US-GILEAD-2020-0497946,GILEAD,,82.0,YR,E,F,Y,81.4,KG,20201102.0,,CN,US,US,2020,Q4,Elderly
183965542,18396554,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hypertension,,2020,Q4,2,F,,20201029.0,20201019,20201102,EXP,,US-GILEAD-2020-0497946,GILEAD,,82.0,YR,E,F,Y,81.4,KG,20201102.0,,CN,US,US,2020,Q4,Elderly
183969681,18396968,16,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,1,I,20201016.0,,20201018,20201018,DIR,,,FDA-CTU,,70.0,YR,,F,N,109.0,KG,20201018.0,N,PH,US,US,2020,Q4,Elderly
183969681,18396968,16,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,1,I,20201016.0,,20201018,20201018,DIR,,,FDA-CTU,,70.0,YR,,F,N,109.0,KG,20201018.0,N,PH,US,US,2020,Q4,Elderly
183981181,18398118,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20201017.0,,20201019,20201019,DIR,,,FDA-CTU,,79.0,YR,,F,N,76.8,KG,20201019.0,N,PH,US,US,2020,Q4,Elderly
183981181,18398118,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hypovolaemia,,2020,Q4,1,I,20201017.0,,20201019,20201019,DIR,,,FDA-CTU,,79.0,YR,,F,N,76.8,KG,20201019.0,N,PH,US,US,2020,Q4,Elderly
183982481,18398248,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Back disorder,,2020,Q4,1,I,,20201015.0,20201019,20201019,PER,,US-ELI_LILLY_AND_COMPANY-US202010006780,ELI LILLY AND CO,,93.0,YR,,F,Y,,,20201019.0,,CN,US,US,2020,Q4,Elderly
183982481,18398248,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Malaise,,2020,Q4,1,I,,20201015.0,20201019,20201019,PER,,US-ELI_LILLY_AND_COMPANY-US202010006780,ELI LILLY AND CO,,93.0,YR,,F,Y,,,20201019.0,,CN,US,US,2020,Q4,Elderly
183985881,18398588,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,1,I,20200825.0,,20201019,20201019,DIR,,,FDA-CTU,,85.0,YR,,M,N,80.9,KG,20201019.0,Y,PH,US,US,2020,Q4,Elderly
183985881,18398588,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,20200825.0,,20201019,20201019,DIR,,,FDA-CTU,,85.0,YR,,M,N,80.9,KG,20201019.0,Y,PH,US,US,2020,Q4,Elderly
183985881,18398588,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,1,I,20200825.0,,20201019,20201019,DIR,,,FDA-CTU,,85.0,YR,,M,N,80.9,KG,20201019.0,Y,PH,US,US,2020,Q4,Elderly
183985881,18398588,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Coronary artery disease,,2020,Q4,1,I,20200825.0,,20201019,20201019,DIR,,,FDA-CTU,,85.0,YR,,M,N,80.9,KG,20201019.0,Y,PH,US,US,2020,Q4,Elderly
183985881,18398588,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Ejection fraction decreased,,2020,Q4,1,I,20200825.0,,20201019,20201019,DIR,,,FDA-CTU,,85.0,YR,,M,N,80.9,KG,20201019.0,Y,PH,US,US,2020,Q4,Elderly
183985881,18398588,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hypertension,,2020,Q4,1,I,20200825.0,,20201019,20201019,DIR,,,FDA-CTU,,85.0,YR,,M,N,80.9,KG,20201019.0,Y,PH,US,US,2020,Q4,Elderly
183988421,18398842,7,C,Insulin lispro Sanofi,,2,,,,,,, UNKNOWN,,,,,,,2020,Q4,Osteonecrosis of jaw,,2020,Q4,1,I,20200915.0,20201011.0,20201019,20201019,EXP,,SE-TEVA-2020-SE-1838711,TEVA,,82.0,YR,E,M,Y,,,20201019.0,,MD,SE,SE,2020,Q4,Elderly
184028061,18402806,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,200,,,,,,,,,,,,2020,Q4,Asthenia,,2020,Q4,1,I,,20201014.0,20201019,20201019,EXP,,DE-ASTRAZENECA-2020SF34637,ASTRAZENECA,,51.0,YR,,M,Y,,,20201019.0,,MD,DE,DE,2020,Q4,Adult
184028061,18402806,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,200,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201014.0,20201019,20201019,EXP,,DE-ASTRAZENECA-2020SF34637,ASTRAZENECA,,51.0,YR,,M,Y,,,20201019.0,,MD,DE,DE,2020,Q4,Adult
184033661,18403366,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cardiovascular disorder,,2020,Q4,1,I,20201017.0,,20201019,20201019,DIR,,,FDA-CTU,,72.0,YR,,F,N,78.9,KG,20201019.0,N,,US,US,2020,Q4,Elderly
184033661,18403366,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Chest pain,,2020,Q4,1,I,20201017.0,,20201019,20201019,DIR,,,FDA-CTU,,72.0,YR,,F,N,78.9,KG,20201019.0,N,,US,US,2020,Q4,Elderly
184033661,18403366,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20201017.0,,20201019,20201019,DIR,,,FDA-CTU,,72.0,YR,,F,N,78.9,KG,20201019.0,N,,US,US,2020,Q4,Elderly
184033661,18403366,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,20201017.0,,20201019,20201019,DIR,,,FDA-CTU,,72.0,YR,,F,N,78.9,KG,20201019.0,N,,US,US,2020,Q4,Elderly
184033661,18403366,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Tremor,,2020,Q4,1,I,20201017.0,,20201019,20201019,DIR,,,FDA-CTU,,72.0,YR,,F,N,78.9,KG,20201019.0,N,,US,US,2020,Q4,Elderly
184033661,18403366,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Ventricular extrasystoles,,2020,Q4,1,I,20201017.0,,20201019,20201019,DIR,,,FDA-CTU,,72.0,YR,,F,N,78.9,KG,20201019.0,N,,US,US,2020,Q4,Elderly
184035591,18403559,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"3 INTERNATIONAL UNIT, QD (AT LUNCH)",,,,, UNKNOWN,,,3.0,IU,,QD,2020,Q4,Coagulopathy,,2020,Q4,1,I,,20201005.0,20201020,20201020,EXP,,CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2020-06683,ALKEM,"FLYNN F, RICHARD G, DOBRESCU M, BOUCHARD J, ET.AL. REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;XX(X):1-6",86.0,YR,,M,Y,69.0,KG,20201020.0,,HP,CA,CA,2020,Q4,Elderly
184035591,18403559,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"3 INTERNATIONAL UNIT, QD (AT LUNCH)",,,,, UNKNOWN,,,3.0,IU,,QD,2020,Q4,Haematuria,,2020,Q4,1,I,,20201005.0,20201020,20201020,EXP,,CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2020-06683,ALKEM,"FLYNN F, RICHARD G, DOBRESCU M, BOUCHARD J, ET.AL. REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;XX(X):1-6",86.0,YR,,M,Y,69.0,KG,20201020.0,,HP,CA,CA,2020,Q4,Elderly
184035591,18403559,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"3 INTERNATIONAL UNIT, QD (AT LUNCH)",,,,, UNKNOWN,,,3.0,IU,,QD,2020,Q4,Haemorrhage,,2020,Q4,1,I,,20201005.0,20201020,20201020,EXP,,CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2020-06683,ALKEM,"FLYNN F, RICHARD G, DOBRESCU M, BOUCHARD J, ET.AL. REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;XX(X):1-6",86.0,YR,,M,Y,69.0,KG,20201020.0,,HP,CA,CA,2020,Q4,Elderly
184035591,18403559,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"3 INTERNATIONAL UNIT, QD (AT LUNCH)",,,,, UNKNOWN,,,3.0,IU,,QD,2020,Q4,Melaena,,2020,Q4,1,I,,20201005.0,20201020,20201020,EXP,,CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2020-06683,ALKEM,"FLYNN F, RICHARD G, DOBRESCU M, BOUCHARD J, ET.AL. REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;XX(X):1-6",86.0,YR,,M,Y,69.0,KG,20201020.0,,HP,CA,CA,2020,Q4,Elderly
184035591,18403559,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"3 INTERNATIONAL UNIT, QD (AT LUNCH)",,,,, UNKNOWN,,,3.0,IU,,QD,2020,Q4,Rebound effect,,2020,Q4,1,I,,20201005.0,20201020,20201020,EXP,,CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2020-06683,ALKEM,"FLYNN F, RICHARD G, DOBRESCU M, BOUCHARD J, ET.AL. REFRACTORY DABIGATRAN-INDUCED HEMORRHAGE DESPITE MULTIPLE IDARUCIZUMAB ADMINISTRATION AND RENAL REPLACEMENT THERAPY. JOURNAL OF PHARMACY PRACTICE. 2020;XX(X):1-6",86.0,YR,,M,Y,69.0,KG,20201020.0,,HP,CA,CA,2020,Q4,Elderly
184076001,18407600,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Hypertension,,2020,Q4,1,I,20200301.0,20201016.0,20201020,20201020,EXP,,FR-MYLANLABS-2020M1088026,MYLAN,,68.0,YR,,M,Y,104.0,KG,20201020.0,,MD,FR,FR,2020,Q4,Elderly
184099311,18409931,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,20201001.0,,20201021,20201021,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,20201021.0,Y,PH,US,US,2020,Q4,Adult
184099311,18409931,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Escherichia sepsis,,2020,Q4,1,I,20201001.0,,20201021,20201021,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,20201021.0,Y,PH,US,US,2020,Q4,Adult
184099311,18409931,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Urinary tract infection,,2020,Q4,1,I,20201001.0,,20201021,20201021,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,20201021.0,Y,PH,US,US,2020,Q4,Adult
184116141,18411614,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,200,,,U,,,,,,,,,2020,Q4,Asthenia,,2020,Q4,1,I,,20201014.0,20201021,20201021,EXP,,DE-ANIPHARMA-2020-DE-000241,ANI,,51.0,YR,,M,Y,,,20201021.0,,MD,DE,DE,2020,Q4,Adult
184116141,18411614,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,200,,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201014.0,20201021,20201021,EXP,,DE-ANIPHARMA-2020-DE-000241,ANI,,51.0,YR,,M,Y,,,20201021.0,,MD,DE,DE,2020,Q4,Adult
184160392,18416039,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Aphasia,,2020,Q4,2,F,20180801.0,20201023.0,20201022,20201028,EXP,,US-GILEAD-2018-0354760,GILEAD,,78.0,YR,E,M,Y,71.9,KG,20201028.0,,MD,US,US,2020,Q4,Elderly
184160392,18416039,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cytokine release syndrome,,2020,Q4,2,F,20180801.0,20201023.0,20201022,20201028,EXP,,US-GILEAD-2018-0354760,GILEAD,,78.0,YR,E,M,Y,71.9,KG,20201028.0,,MD,US,US,2020,Q4,Elderly
184160392,18416039,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Disorientation,,2020,Q4,2,F,20180801.0,20201023.0,20201022,20201028,EXP,,US-GILEAD-2018-0354760,GILEAD,,78.0,YR,E,M,Y,71.9,KG,20201028.0,,MD,US,US,2020,Q4,Elderly
184160392,18416039,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,2,F,20180801.0,20201023.0,20201022,20201028,EXP,,US-GILEAD-2018-0354760,GILEAD,,78.0,YR,E,M,Y,71.9,KG,20201028.0,,MD,US,US,2020,Q4,Elderly
184160392,18416039,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,2,F,20180801.0,20201023.0,20201022,20201028,EXP,,US-GILEAD-2018-0354760,GILEAD,,78.0,YR,E,M,Y,71.9,KG,20201028.0,,MD,US,US,2020,Q4,Elderly
184160392,18416039,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Ileus,,2020,Q4,2,F,20180801.0,20201023.0,20201022,20201028,EXP,,US-GILEAD-2018-0354760,GILEAD,,78.0,YR,E,M,Y,71.9,KG,20201028.0,,MD,US,US,2020,Q4,Elderly
184160392,18416039,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Pyrexia,,2020,Q4,2,F,20180801.0,20201023.0,20201022,20201028,EXP,,US-GILEAD-2018-0354760,GILEAD,,78.0,YR,E,M,Y,71.9,KG,20201028.0,,MD,US,US,2020,Q4,Elderly
184160392,18416039,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Restlessness,,2020,Q4,2,F,20180801.0,20201023.0,20201022,20201028,EXP,,US-GILEAD-2018-0354760,GILEAD,,78.0,YR,E,M,Y,71.9,KG,20201028.0,,MD,US,US,2020,Q4,Elderly
184160392,18416039,50,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Sepsis,,2020,Q4,2,F,20180801.0,20201023.0,20201022,20201028,EXP,,US-GILEAD-2018-0354760,GILEAD,,78.0,YR,E,M,Y,71.9,KG,20201028.0,,MD,US,US,2020,Q4,Elderly
184166522,18416652,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Aggression,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184166522,18416652,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Communication disorder,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184166522,18416652,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Confusional state,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184166522,18416652,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Disorientation,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184166522,18416652,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Hyperhidrosis,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184166522,18416652,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184166522,18416652,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Irritability,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184177842,18417784,60,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNIT, ACHS PRN",,,,,,,,,,,,2020,Q4,Cytokine release syndrome,,2020,Q4,2,F,20170608.0,20201028.0,20201022,20201105,EXP,,US-GILEAD-2018-0344891,GILEAD,,66.0,YR,E,M,Y,66.9,KG,20201105.0,,MD,US,US,2020,Q4,Elderly
184177842,18417784,60,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNIT, ACHS PRN",,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,2,F,20170608.0,20201028.0,20201022,20201105,EXP,,US-GILEAD-2018-0344891,GILEAD,,66.0,YR,E,M,Y,66.9,KG,20201105.0,,MD,US,US,2020,Q4,Elderly
184177842,18417784,60,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNIT, ACHS PRN",,,,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,2,F,20170608.0,20201028.0,20201022,20201105,EXP,,US-GILEAD-2018-0344891,GILEAD,,66.0,YR,E,M,Y,66.9,KG,20201105.0,,MD,US,US,2020,Q4,Elderly
184177842,18417784,60,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNIT, ACHS PRN",,,,,,,,,,,,2020,Q4,Status epilepticus,,2020,Q4,2,F,20170608.0,20201028.0,20201022,20201105,EXP,,US-GILEAD-2018-0344891,GILEAD,,66.0,YR,E,M,Y,66.9,KG,20201105.0,,MD,US,US,2020,Q4,Elderly
184227171,18422717,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,14 UNITS BEFORE EVERY MEAL,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201011.0,20201024,20201024,EXP,,TR-INDICUS PHARMA-000722,INDICUS,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS: CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE (BALTIMORE). 2020 OCT 9;99(41):E22492",65.0,YR,,F,Y,,,20201024.0,,MD,QA,TR,2020,Q4,Elderly
184227171,18422717,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,14 UNITS BEFORE EVERY MEAL,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,1,I,,20201011.0,20201024,20201024,EXP,,TR-INDICUS PHARMA-000722,INDICUS,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS: CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE (BALTIMORE). 2020 OCT 9;99(41):E22492",65.0,YR,,F,Y,,,20201024.0,,MD,QA,TR,2020,Q4,Elderly
184227171,18422717,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,14 UNITS BEFORE EVERY MEAL,,,,,,,,,,,,2020,Q4,Lactic acidosis,,2020,Q4,1,I,,20201011.0,20201024,20201024,EXP,,TR-INDICUS PHARMA-000722,INDICUS,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS: CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE (BALTIMORE). 2020 OCT 9;99(41):E22492",65.0,YR,,F,Y,,,20201024.0,,MD,QA,TR,2020,Q4,Elderly
184227171,18422717,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,14 UNITS BEFORE EVERY MEAL,,,,,,,,,,,,2020,Q4,Osmolar gap,,2020,Q4,1,I,,20201011.0,20201024,20201024,EXP,,TR-INDICUS PHARMA-000722,INDICUS,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS: CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE (BALTIMORE). 2020 OCT 9;99(41):E22492",65.0,YR,,F,Y,,,20201024.0,,MD,QA,TR,2020,Q4,Elderly
184227171,18422717,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,14 UNITS BEFORE EVERY MEAL,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,,20201011.0,20201024,20201024,EXP,,TR-INDICUS PHARMA-000722,INDICUS,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS: CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE (BALTIMORE). 2020 OCT 9;99(41):E22492",65.0,YR,,F,Y,,,20201024.0,,MD,QA,TR,2020,Q4,Elderly
184236461,18423646,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201011.0,20201024,20201024,EXP,,TR-INVENTIA-000430,INVENTIA HEALTHCARE,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS: CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE (BALTIMORE). 2020 OCT 9;99(41):E22492",65.0,YR,,F,Y,,,20201024.0,,MD,QA,TR,2020,Q4,Elderly
184236461,18423646,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,1,I,,20201011.0,20201024,20201024,EXP,,TR-INVENTIA-000430,INVENTIA HEALTHCARE,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS: CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE (BALTIMORE). 2020 OCT 9;99(41):E22492",65.0,YR,,F,Y,,,20201024.0,,MD,QA,TR,2020,Q4,Elderly
184236461,18423646,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Lactic acidosis,,2020,Q4,1,I,,20201011.0,20201024,20201024,EXP,,TR-INVENTIA-000430,INVENTIA HEALTHCARE,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS: CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE (BALTIMORE). 2020 OCT 9;99(41):E22492",65.0,YR,,F,Y,,,20201024.0,,MD,QA,TR,2020,Q4,Elderly
184236461,18423646,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Osmolar gap,,2020,Q4,1,I,,20201011.0,20201024,20201024,EXP,,TR-INVENTIA-000430,INVENTIA HEALTHCARE,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS: CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE (BALTIMORE). 2020 OCT 9;99(41):E22492",65.0,YR,,F,Y,,,20201024.0,,MD,QA,TR,2020,Q4,Elderly
184236461,18423646,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,,20201011.0,20201024,20201024,EXP,,TR-INVENTIA-000430,INVENTIA HEALTHCARE,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS: CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE (BALTIMORE). 2020 OCT 9;99(41):E22492",65.0,YR,,F,Y,,,20201024.0,,MD,QA,TR,2020,Q4,Elderly
184276231,18427623,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,1,I,20201024.0,,20201026,20201026,DIR,,,FDA-CTU,,34.0,YR,,M,N,138.15,KG,20201026.0,N,CN,US,US,2020,Q4,Young Adult
184276231,18427623,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Liver function test increased,,2020,Q4,1,I,20201024.0,,20201026,20201026,DIR,,,FDA-CTU,,34.0,YR,,M,N,138.15,KG,20201026.0,N,CN,US,US,2020,Q4,Young Adult
184297002,18429700,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Blood bilirubin increased,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,International normalised ratio increased,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Multiple organ dysfunction syndrome,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Sepsis,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Septic shock,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297292,18429729,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Apnoeic attack,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Areflexia,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Endotracheal intubation,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Extubation,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hypoxic-ischaemic encephalopathy,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Mechanical ventilation,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Pulse absent,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184309761,18430976,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, QID",,,U,, D214632C,,20563.0,,,INJECTION,QID,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20201019.0,20201023.0,20201027,20201027,PER,,US-ELI_LILLY_AND_COMPANY-US202010010500,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201027.0,,CN,US,US,2020,Q4,Adult
184309761,18430976,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, QID",,,U,, D214632C,,20563.0,,,INJECTION,QID,2020,Q4,Incorrect dose administered,,2020,Q4,1,I,20201019.0,20201023.0,20201027,20201027,PER,,US-ELI_LILLY_AND_COMPANY-US202010010500,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20201027.0,,CN,US,US,2020,Q4,Adult
184313021,18431302,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Liver function test increased,,2020,Q4,1,I,20201024.0,,20201027,20201027,DIR,,,FDA-CTU,,70.0,YR,,F,N,97.7,KG,20201027.0,N,PH,US,US,2020,Q4,Elderly
184329521,18432952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK 200,,,U,,,,,,,,,2020,Q4,Asthenia,,2020,Q4,1,I,,20201023.0,20201027,20201027,EXP,,NVSC2020DE285953,NOVARTIS,,51.0,YR,,M,Y,,,20201027.0,,HP,DE,DE,2020,Q4,Adult
184329521,18432952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK 200,,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201023.0,20201027,20201027,EXP,,NVSC2020DE285953,NOVARTIS,,51.0,YR,,M,Y,,,20201027.0,,HP,DE,DE,2020,Q4,Adult
184333401,18433340,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4-8 U, PRN",,,U,,,,20563.0,8.0,IU,INJECTION,,2020,Q4,Cerebrovascular accident,,2020,Q4,1,I,202008.0,20201021.0,20201027,20201027,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009925,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201027.0,,CN,US,US,2020,Q4,Adult
184333401,18433340,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4-8 U, PRN",,,U,,,,20563.0,8.0,IU,INJECTION,,2020,Q4,Limb injury,,2020,Q4,1,I,202008.0,20201021.0,20201027,20201027,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009925,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201027.0,,CN,US,US,2020,Q4,Adult
184333401,18433340,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4-8 U, PRN",,,U,,,,20563.0,8.0,IU,INJECTION,,2020,Q4,Underdose,,2020,Q4,1,I,202008.0,20201021.0,20201027,20201027,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009925,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201027.0,,CN,US,US,2020,Q4,Adult
184341222,18434122,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Product use issue,,2020,Q4,2,F,20200929.0,20201202.0,20201027,20201210,EXP,,US-OTSUKA-2020_026220,OTSUKA,,83.0,YR,,M,Y,,,20201210.0,,PH,US,US,2020,Q4,Elderly
184341222,18434122,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Toxic erythema of chemotherapy,,2020,Q4,2,F,20200929.0,20201202.0,20201027,20201210,EXP,,US-OTSUKA-2020_026220,OTSUKA,,83.0,YR,,M,Y,,,20201210.0,,PH,US,US,2020,Q4,Elderly
184344481,18434448,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Intracardiac,"16 INTERNATIONAL UNIT, QD (BEFORE EACH MEAL)",,,,,,,,16.0,IU,,QD,2020,Q4,Off label use,,2020,Q4,1,I,,20201019.0,20201028,20201028,EXP,,CO-LUPIN PHARMACEUTICALS INC.-2020-07907,LUPIN,,40.0,YR,,M,Y,,,20201028.0,,HP,CO,CO,2020,Q4,Adult
184386032,18438603,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Blood glucose decreased,,2020,Q4,2,F,20200921.0,20201117.0,20201028,20201124,EXP,,US-BIOGEN-2020BI00933296,BIOGEN,,45.0,YR,,M,Y,,,20201124.0,,CN,US,US,2020,Q4,Adult
184386032,18438603,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Hypoglycaemia,,2020,Q4,2,F,20200921.0,20201117.0,20201028,20201124,EXP,,US-BIOGEN-2020BI00933296,BIOGEN,,45.0,YR,,M,Y,,,20201124.0,,CN,US,US,2020,Q4,Adult
184386032,18438603,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Incorrect dose administered,,2020,Q4,2,F,20200921.0,20201117.0,20201028,20201124,EXP,,US-BIOGEN-2020BI00933296,BIOGEN,,45.0,YR,,M,Y,,,20201124.0,,CN,US,US,2020,Q4,Adult
184386032,18438603,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Multiple sclerosis relapse,,2020,Q4,2,F,20200921.0,20201117.0,20201028,20201124,EXP,,US-BIOGEN-2020BI00933296,BIOGEN,,45.0,YR,,M,Y,,,20201124.0,,CN,US,US,2020,Q4,Adult
184391296,18439129,26,C,INSULIN LISPRO DCI,,2,,,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,6,F,20201018.0,20201211.0,20201028,20201215,EXP,,US-GILEAD-2020-0501671,GILEAD,,77.0,YR,E,F,Y,59.41,KG,20201215.0,,HP,US,US,2020,Q4,Elderly
184419161,18441916,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TEXT:UNKNOWN-FREQ:UNKNOWN,,,,,,,,,,,,2020,Q4,Face oedema,,2020,Q4,1,I,20041204.0,20201026.0,20201029,20201029,PER,,US-009507513-2010USA009800,MERCK,,60.0,YR,,F,Y,,,20201029.0,,PH,US,US,2020,Q4,Adult
184441281,18444128,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Product dose omission issue,,2020,Q4,1,I,20201001.0,20201002.0,20201030,20201030,PER,,US-ELI_LILLY_AND_COMPANY-US202010001352,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20201030.0,,CN,US,US,2020,Q4,Adult
184441281,18444128,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2020,Q4,Vision blurred,,2020,Q4,1,I,20201001.0,20201002.0,20201030,20201030,PER,,US-ELI_LILLY_AND_COMPANY-US202010001352,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20201030.0,,CN,US,US,2020,Q4,Adult
184451201,18445120,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201020.0,20201030,20201030,EXP,,CA-APOTEX-2020AP020594,APOTEX,,64.0,YR,,M,Y,,,20201030.0,,CN,CA,CA,2020,Q4,Adult
184451201,18445120,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2020,Q4,Extradural abscess,,2020,Q4,1,I,,20201020.0,20201030,20201030,EXP,,CA-APOTEX-2020AP020594,APOTEX,,64.0,YR,,M,Y,,,20201030.0,,CN,CA,CA,2020,Q4,Adult
184451201,18445120,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2020,Q4,Post streptococcal glomerulonephritis,,2020,Q4,1,I,,20201020.0,20201030,20201030,EXP,,CA-APOTEX-2020AP020594,APOTEX,,64.0,YR,,M,Y,,,20201030.0,,CN,CA,CA,2020,Q4,Adult
184453882,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2020,Q4,Bone cancer,,2020,Q4,2,F,202009.0,20201023.0,20201030,20201103,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20201103.0,,CN,US,US,2020,Q4,Elderly
184453882,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2020,Q4,Dementia,,2020,Q4,2,F,202009.0,20201023.0,20201030,20201103,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20201103.0,,CN,US,US,2020,Q4,Elderly
184453882,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,2,F,202009.0,20201023.0,20201030,20201103,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20201103.0,,CN,US,US,2020,Q4,Elderly
184453882,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2020,Q4,Incorrect dose administered,,2020,Q4,2,F,202009.0,20201023.0,20201030,20201103,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20201103.0,,CN,US,US,2020,Q4,Elderly
184453882,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2020,Q4,Memory impairment,,2020,Q4,2,F,202009.0,20201023.0,20201030,20201103,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20201103.0,,CN,US,US,2020,Q4,Elderly
184453882,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2020,Q4,Recurrent cancer,,2020,Q4,2,F,202009.0,20201023.0,20201030,20201103,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20201103.0,,CN,US,US,2020,Q4,Elderly
184453882,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2020,Q4,Visual impairment,,2020,Q4,2,F,202009.0,20201023.0,20201030,20201103,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20201103.0,,CN,US,US,2020,Q4,Elderly
184463802,18446380,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 TIMES DAILY WITH MEALS,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,2,F,20201007.0,20201123.0,20201030,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021228,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184463802,18446380,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 TIMES DAILY WITH MEALS,,,,,,,,,,,,2020,Q4,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q4,2,F,20201007.0,20201123.0,20201030,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021228,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184463802,18446380,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 TIMES DAILY WITH MEALS,,,,,,,,,,,,2020,Q4,Lower respiratory tract infection fungal,,2020,Q4,2,F,20201007.0,20201123.0,20201030,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021228,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184463802,18446380,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 TIMES DAILY WITH MEALS,,,,,,,,,,,,2020,Q4,Pneumonia bacterial,,2020,Q4,2,F,20201007.0,20201123.0,20201030,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021228,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184463802,18446380,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 TIMES DAILY WITH MEALS,,,,,,,,,,,,2020,Q4,Sepsis,,2020,Q4,2,F,20201007.0,20201123.0,20201030,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021228,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184520271,18452027,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,,,,20563.0,,,INJECTION,,2020,Q4,Blood glucose decreased,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,,,,20563.0,,,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,,,,20563.0,,,INJECTION,,2020,Q4,Feeling abnormal,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,,,,20563.0,,,INJECTION,,2020,Q4,Hyperhidrosis,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,,,,20563.0,,,INJECTION,,2020,Q4,Blood glucose decreased,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,,,,20563.0,,,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,,,,20563.0,,,INJECTION,,2020,Q4,Feeling abnormal,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,,,,20563.0,,,INJECTION,,2020,Q4,Hyperhidrosis,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,, D214632C,,20563.0,,,INJECTION,,2020,Q4,Blood glucose decreased,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,, D214632C,,20563.0,,,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,, D214632C,,20563.0,,,INJECTION,,2020,Q4,Feeling abnormal,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,, D214632C,,20563.0,,,INJECTION,,2020,Q4,Hyperhidrosis,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,, D214632C,,20563.0,,,INJECTION,,2020,Q4,Blood glucose decreased,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,, D214632C,,20563.0,,,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,, D214632C,,20563.0,,,INJECTION,,2020,Q4,Feeling abnormal,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184520271,18452027,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, PRN(SLIDING SCALE)",,,Y,, D214632C,,20563.0,,,INJECTION,,2020,Q4,Hyperhidrosis,,2020,Q4,1,I,20200928.0,20201022.0,20201102,20201102,PER,,US-ELI_LILLY_AND_COMPANY-US202010010977,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20201102.0,,CN,US,US,2020,Q4,Elderly
184521301,18452130,5,C,insulin lispro 1-3 units,,2,,,,,,,,,,,,,,2020,Q4,Drug level above therapeutic,,2020,Q4,1,I,20200804.0,,20201031,20201031,DIR,,,FDA-CTU,,62.0,YR,,M,N,56.9,KG,20201031.0,N,PH,US,US,2020,Q4,Adult
184521301,18452130,5,C,insulin lispro 1-3 units,,2,,,,,,,,,,,,,,2020,Q4,Heart transplant rejection,,2020,Q4,1,I,20200804.0,,20201031,20201031,DIR,,,FDA-CTU,,62.0,YR,,M,N,56.9,KG,20201031.0,N,PH,US,US,2020,Q4,Adult
184521301,18452130,5,C,insulin lispro 1-3 units,,2,,,,,,,,,,,,,,2020,Q4,Product substitution issue,,2020,Q4,1,I,20200804.0,,20201031,20201031,DIR,,,FDA-CTU,,62.0,YR,,M,N,56.9,KG,20201031.0,N,PH,US,US,2020,Q4,Adult
184521301,18452130,5,C,insulin lispro 1-3 units,,2,,,,,,,,,,,,,,2020,Q4,Therapeutic product effect delayed,,2020,Q4,1,I,20200804.0,,20201031,20201031,DIR,,,FDA-CTU,,62.0,YR,,M,N,56.9,KG,20201031.0,N,PH,US,US,2020,Q4,Adult
184521301,18452130,6,C,insulin lispro 6 units,,2,,,,,,,,,,,,,,2020,Q4,Drug level above therapeutic,,2020,Q4,1,I,20200804.0,,20201031,20201031,DIR,,,FDA-CTU,,62.0,YR,,M,N,56.9,KG,20201031.0,N,PH,US,US,2020,Q4,Adult
184521301,18452130,6,C,insulin lispro 6 units,,2,,,,,,,,,,,,,,2020,Q4,Heart transplant rejection,,2020,Q4,1,I,20200804.0,,20201031,20201031,DIR,,,FDA-CTU,,62.0,YR,,M,N,56.9,KG,20201031.0,N,PH,US,US,2020,Q4,Adult
184521301,18452130,6,C,insulin lispro 6 units,,2,,,,,,,,,,,,,,2020,Q4,Product substitution issue,,2020,Q4,1,I,20200804.0,,20201031,20201031,DIR,,,FDA-CTU,,62.0,YR,,M,N,56.9,KG,20201031.0,N,PH,US,US,2020,Q4,Adult
184521301,18452130,6,C,insulin lispro 6 units,,2,,,,,,,,,,,,,,2020,Q4,Therapeutic product effect delayed,,2020,Q4,1,I,20200804.0,,20201031,20201031,DIR,,,FDA-CTU,,62.0,YR,,M,N,56.9,KG,20201031.0,N,PH,US,US,2020,Q4,Adult
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Asthma,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Blood count abnormal,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Chest discomfort,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Cough,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Diaphragmatic disorder,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Discomfort,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Dyspnoea,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Hypoxia,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Left ventricular hypertrophy,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Obstructive airways disorder,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Oedema peripheral,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Oropharyngeal pain,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Pyrexia,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Weight increased,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184534194,18453419,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,,,,BID,2020,Q4,Wheezing,,2020,Q4,4,F,,20201202.0,20201102,20201211,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20201211.0,,CN,CA,CA,2020,Q4,Elderly
184536962,18453696,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 X DAILY W/MEALS, HS",,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,2,F,202010.0,20201123.0,20201102,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021230,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184536962,18453696,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 X DAILY W/MEALS, HS",,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,2,F,202010.0,20201123.0,20201102,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021230,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184560371,18456037,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Constipation,,2020,Q4,1,I,20201005.0,20201009.0,20201103,20201103,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-003308,ACADIA PHARMACEUTICALS,,40.0,YR,,F,Y,185.0,KG,20201103.0,,CN,US,US,2020,Q4,Adult
184560371,18456037,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,20201005.0,20201009.0,20201103,20201103,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-003308,ACADIA PHARMACEUTICALS,,40.0,YR,,F,Y,185.0,KG,20201103.0,,CN,US,US,2020,Q4,Adult
184611322,18461132,3,C,INSULIN LISPRO/ISOPHANE INSULIN,,2,,12UI,,,,,,,,12.0,IU,,,2020,Q4,Colitis microscopic,,2020,Q4,2,F,,20201104.0,20201104,20201112,EXP,PT-EMA-DD-20201027-GONUGUNTLA_N1-112356,PT-ACCORD-207297,ACCORD,,69.0,YR,E,M,Y,,,20201112.0,,HP,PT,PT,2020,Q4,Elderly
184625471,18462547,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,,,,,,,,,,2020,Q4,Drug interaction,,2020,Q4,1,I,,20201027.0,20201104,20201104,EXP,,KR-STRIDES ARCOLAB LIMITED-2020SP013212,STRIDES,,69.0,YR,,M,Y,,,20201104.0,,MD,KR,KR,2020,Q4,Elderly
184627781,18462778,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"16 INTERNATIONAL UNIT, DAILY",3696.0,IU,U,,,,20563.0,16.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,20200919.0,20201029.0,20201104,20201104,EXP,IT-MINISAL02-640998,IT-ELI_LILLY_AND_COMPANY-IT202010013450,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20201104.0,,MD,IT,IT,2020,Q4,Elderly
184627781,18462778,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"16 INTERNATIONAL UNIT, DAILY",3696.0,IU,U,,,,20563.0,16.0,IU,,QD,2020,Q4,Sopor,,2020,Q4,1,I,20200919.0,20201029.0,20201104,20201104,EXP,IT-MINISAL02-640998,IT-ELI_LILLY_AND_COMPANY-IT202010013450,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20201104.0,,MD,IT,IT,2020,Q4,Elderly
184636181,18463618,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Spinal operation,,2020,Q4,1,I,20190430.0,20201027.0,20201104,20201104,EXP,,US-NOVOPROD-764149,NOVO NORDISK,,63.0,YR,,M,Y,,,20201104.0,,CN,US,US,2020,Q4,Adult
184646531,18464653,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, DAILY(1 UNIT INSULIN EVERY MEAL AND AT BEDTIME)",,,,,,,,1.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Escherichia infection,,2020,Q4,1,I,,20160425.0,20201104,20201104,PER,,US-PFIZER INC-2016232636,PFIZER,,43.0,YR,,M,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184646531,18464653,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, DAILY(1 UNIT INSULIN EVERY MEAL AND AT BEDTIME)",,,,,,,,1.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Limb injury,,2020,Q4,1,I,,20160425.0,20201104,20201104,PER,,US-PFIZER INC-2016232636,PFIZER,,43.0,YR,,M,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184646531,18464653,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, DAILY(1 UNIT INSULIN EVERY MEAL AND AT BEDTIME)",,,,,,,,1.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Sepsis,,2020,Q4,1,I,,20160425.0,20201104,20201104,PER,,US-PFIZER INC-2016232636,PFIZER,,43.0,YR,,M,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184672531,18467253,18,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Renal tubular necrosis,,2020,Q4,1,I,20201028.0,,20201104,20201104,DIR,,,FDA-CTU,,76.0,YR,,F,N,126.0,KG,20201104.0,N,PH,US,US,2020,Q4,Elderly
184679851,18467985,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,1,I,2010.0,20201102.0,20201105,20201105,EXP,,US-PFIZER INC-2020426518,PFIZER,,68.0,YR,,M,Y,,,20201105.0,,LW,US,US,2020,Q4,Elderly
184679851,18467985,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Gastrooesophageal reflux disease,,2020,Q4,1,I,2010.0,20201102.0,20201105,20201105,EXP,,US-PFIZER INC-2020426518,PFIZER,,68.0,YR,,M,Y,,,20201105.0,,LW,US,US,2020,Q4,Elderly
184682972,18468297,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12 IU,,,,,,,,12.0,IU,,,2020,Q4,Incorrect dose administered,,2020,Q4,2,F,,20201114.0,20201105,20201119,EXP,,DE-BAYER-2020-231788,BAYER,"BECKERS C, KLASING S, ECKARDT I, BARNERT A-K, JAEHDE U. MEDICATION REVIEW FOR A PATIENT WITH CTEPH. MEDIZINISCHE MONATSSCHRIFT FUR PHARMAZEUTEN (2020) 43:7 (273-278). 2020;43(7):273-278",67.0,YR,E,M,Y,,,20201119.0,,PH,DE,DE,2020,Q4,Elderly
184696623,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Abdominal distension,,2020,Q4,3,F,20200805.0,20201217.0,20201105,20201223,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20201223.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q4,Elderly
184696623,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Arthralgia,,2020,Q4,3,F,20200805.0,20201217.0,20201105,20201223,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20201223.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q4,Elderly
184696623,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,C-reactive protein increased,,2020,Q4,3,F,20200805.0,20201217.0,20201105,20201223,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20201223.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q4,Elderly
184696623,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,3,F,20200805.0,20201217.0,20201105,20201223,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20201223.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q4,Elderly
184696623,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Joint swelling,,2020,Q4,3,F,20200805.0,20201217.0,20201105,20201223,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20201223.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q4,Elderly
184696623,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Muscle spasms,,2020,Q4,3,F,20200805.0,20201217.0,20201105,20201223,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20201223.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q4,Elderly
184696623,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Myalgia,,2020,Q4,3,F,20200805.0,20201217.0,20201105,20201223,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20201223.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q4,Elderly
184696623,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Myositis,,2020,Q4,3,F,20200805.0,20201217.0,20201105,20201223,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20201223.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q4,Elderly
184696623,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Pain,,2020,Q4,3,F,20200805.0,20201217.0,20201105,20201223,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20201223.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q4,Elderly
184696623,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Pain in extremity,,2020,Q4,3,F,20200805.0,20201217.0,20201105,20201223,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20201223.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q4,Elderly
184696623,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Urinary tract infection,,2020,Q4,3,F,20200805.0,20201217.0,20201105,20201223,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20201223.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q4,Elderly
184702391,18470239,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, TID (SLIDING SCALE THREE TIMES)",,,U,, C939454C,,20563.0,,,INJECTION,TID,2020,Q4,Cystitis,,2020,Q4,1,I,20201101.0,20201102.0,20201106,20201106,PER,,US-ELI_LILLY_AND_COMPANY-US202011000990,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20201106.0,,CN,US,US,2020,Q4,Adult
184702391,18470239,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, TID (SLIDING SCALE THREE TIMES)",,,U,, C939454C,,20563.0,,,INJECTION,TID,2020,Q4,Visual impairment,,2020,Q4,1,I,20201101.0,20201102.0,20201106,20201106,PER,,US-ELI_LILLY_AND_COMPANY-US202011000990,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20201106.0,,CN,US,US,2020,Q4,Adult
184708622,18470862,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Hypersensitivity,,2020,Q4,2,F,,20201026.0,20201106,20201109,EXP,,GB-JNJFOC-20201034456,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,,,20201109.0,,CN,GB,GB,2020,Q4,Elderly
184708622,18470862,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Urticaria,,2020,Q4,2,F,,20201026.0,20201106,20201109,EXP,,GB-JNJFOC-20201034456,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,,,20201109.0,,CN,GB,GB,2020,Q4,Elderly
184725791,18472579,61,C,insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Burkholderia test positive,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725791,18472579,61,C,insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Product contamination microbial,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725791,18472579,61,C,insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Product quality issue,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725791,18472579,61,C,insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Recalled product administered,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725791,18472579,61,C,insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Respiratory disorder,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725791,18472579,61,C,insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Sputum culture positive,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725791,18472579,61,C,insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Syncope,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725951,18472595,39,C,Insulin lispro (Humalog),,2,,,,,,,,,,,,,,2020,Q4,Bronchoalveolar lavage,,2020,Q4,1,I,20201007.0,,20201104,20201104,DIR,,,FDA-CTU,,44.0,YR,,M,N,86.5,KG,20201029.0,N,PH,US,US,2020,Q4,Adult
184725951,18472595,39,C,Insulin lispro (Humalog),,2,,,,,,,,,,,,,,2020,Q4,Burkholderia cepacia complex infection,,2020,Q4,1,I,20201007.0,,20201104,20201104,DIR,,,FDA-CTU,,44.0,YR,,M,N,86.5,KG,20201029.0,N,PH,US,US,2020,Q4,Adult
184725951,18472595,39,C,Insulin lispro (Humalog),,2,,,,,,,,,,,,,,2020,Q4,Product contamination microbial,,2020,Q4,1,I,20201007.0,,20201104,20201104,DIR,,,FDA-CTU,,44.0,YR,,M,N,86.5,KG,20201029.0,N,PH,US,US,2020,Q4,Adult
184725951,18472595,39,C,Insulin lispro (Humalog),,2,,,,,,,,,,,,,,2020,Q4,Recalled product,,2020,Q4,1,I,20201007.0,,20201104,20201104,DIR,,,FDA-CTU,,44.0,YR,,M,N,86.5,KG,20201029.0,N,PH,US,US,2020,Q4,Adult
184725951,18472595,39,C,Insulin lispro (Humalog),,2,,,,,,,,,,,,,,2020,Q4,Sputum culture positive,,2020,Q4,1,I,20201007.0,,20201104,20201104,DIR,,,FDA-CTU,,44.0,YR,,M,N,86.5,KG,20201029.0,N,PH,US,US,2020,Q4,Adult
184725951,18472595,39,C,Insulin lispro (Humalog),,2,,,,,,,,,,,,,,2020,Q4,Suspected transmission of an infectious agent via product,,2020,Q4,1,I,20201007.0,,20201104,20201104,DIR,,,FDA-CTU,,44.0,YR,,M,N,86.5,KG,20201029.0,N,PH,US,US,2020,Q4,Adult
184729381,18472938,22,C,Insulin lispro (Humalog),,2,,,,,,,,,,,,,,2020,Q4,Burkholderia infection,,2020,Q4,1,I,20201016.0,,20201104,20201104,DIR,,,FDA-CTU,,45.0,YR,,M,N,76.2,KG,20201029.0,N,PH,US,US,2020,Q4,Adult
184729381,18472938,22,C,Insulin lispro (Humalog),,2,,,,,,,,,,,,,,2020,Q4,Product contamination microbial,,2020,Q4,1,I,20201016.0,,20201104,20201104,DIR,,,FDA-CTU,,45.0,YR,,M,N,76.2,KG,20201029.0,N,PH,US,US,2020,Q4,Adult
184729381,18472938,22,C,Insulin lispro (Humalog),,2,,,,,,,,,,,,,,2020,Q4,Recalled product,,2020,Q4,1,I,20201016.0,,20201104,20201104,DIR,,,FDA-CTU,,45.0,YR,,M,N,76.2,KG,20201029.0,N,PH,US,US,2020,Q4,Adult
184729381,18472938,22,C,Insulin lispro (Humalog),,2,,,,,,,,,,,,,,2020,Q4,Sputum culture positive,,2020,Q4,1,I,20201016.0,,20201104,20201104,DIR,,,FDA-CTU,,45.0,YR,,M,N,76.2,KG,20201029.0,N,PH,US,US,2020,Q4,Adult
184729381,18472938,22,C,Insulin lispro (Humalog),,2,,,,,,,,,,,,,,2020,Q4,Transmission of an infectious agent via product,,2020,Q4,1,I,20201016.0,,20201104,20201104,DIR,,,FDA-CTU,,45.0,YR,,M,N,76.2,KG,20201029.0,N,PH,US,US,2020,Q4,Adult
184732751,18473275,24,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Metabolic encephalopathy,,2020,Q4,1,I,20201005.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,102.0,KG,20201028.0,N,PH,US,US,2020,Q4,Elderly
184732751,18473275,24,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Pancreatitis,,2020,Q4,1,I,20201005.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,102.0,KG,20201028.0,N,PH,US,US,2020,Q4,Elderly
184732751,18473275,24,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Product contamination,,2020,Q4,1,I,20201005.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,102.0,KG,20201028.0,N,PH,US,US,2020,Q4,Elderly
184732751,18473275,24,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Recalled product administered,,2020,Q4,1,I,20201005.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,102.0,KG,20201028.0,N,PH,US,US,2020,Q4,Elderly
184733831,18473383,32,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2020,Q4,Burkholderia test positive,,2020,Q4,1,I,20201016.0,,20201104,20201104,DIR,,,FDA-CTU,,73.0,YR,,M,N,128.2,KG,20201029.0,N,PH,US,US,2020,Q4,Elderly
184733831,18473383,32,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,1,I,20201016.0,,20201104,20201104,DIR,,,FDA-CTU,,73.0,YR,,M,N,128.2,KG,20201029.0,N,PH,US,US,2020,Q4,Elderly
184733831,18473383,32,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20201016.0,,20201104,20201104,DIR,,,FDA-CTU,,73.0,YR,,M,N,128.2,KG,20201029.0,N,PH,US,US,2020,Q4,Elderly
184733831,18473383,32,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2020,Q4,Generalised oedema,,2020,Q4,1,I,20201016.0,,20201104,20201104,DIR,,,FDA-CTU,,73.0,YR,,M,N,128.2,KG,20201029.0,N,PH,US,US,2020,Q4,Elderly
184733831,18473383,32,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,20201016.0,,20201104,20201104,DIR,,,FDA-CTU,,73.0,YR,,M,N,128.2,KG,20201029.0,N,PH,US,US,2020,Q4,Elderly
184733831,18473383,32,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2020,Q4,Product contamination microbial,,2020,Q4,1,I,20201016.0,,20201104,20201104,DIR,,,FDA-CTU,,73.0,YR,,M,N,128.2,KG,20201029.0,N,PH,US,US,2020,Q4,Elderly
184738771,18473877,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 DOSAGE FORM, BEFORE MEAL",,,,,,,,14.0,DF,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,1,I,,20201026.0,20201106,20201106,EXP,,TR-AMNEAL PHARMACEUTICALS-2020-AMRX-03466,AMNEAL,,65.0,YR,,F,Y,,,20201106.0,,PH,QA,TR,2020,Q4,Elderly
184738771,18473877,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 DOSAGE FORM, BEFORE MEAL",,,,,,,,14.0,DF,,,2020,Q4,Lactic acidosis,,2020,Q4,1,I,,20201026.0,20201106,20201106,EXP,,TR-AMNEAL PHARMACEUTICALS-2020-AMRX-03466,AMNEAL,,65.0,YR,,F,Y,,,20201106.0,,PH,QA,TR,2020,Q4,Elderly
184738771,18473877,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 DOSAGE FORM, BEFORE MEAL",,,,,,,,14.0,DF,,,2020,Q4,Osmolar gap,,2020,Q4,1,I,,20201026.0,20201106,20201106,EXP,,TR-AMNEAL PHARMACEUTICALS-2020-AMRX-03466,AMNEAL,,65.0,YR,,F,Y,,,20201106.0,,PH,QA,TR,2020,Q4,Elderly
184738771,18473877,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 DOSAGE FORM, BEFORE MEAL",,,,,,,,14.0,DF,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,,20201026.0,20201106,20201106,EXP,,TR-AMNEAL PHARMACEUTICALS-2020-AMRX-03466,AMNEAL,,65.0,YR,,F,Y,,,20201106.0,,PH,QA,TR,2020,Q4,Elderly
184770691,18477069,10,C,Insulin Lispro Kwikpen,,2,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Thrombocytopenia,,2020,Q4,1,I,20201019.0,20201104.0,20201107,20201107,PER,,US-CELGENEUS-USA-20201101002,CELGENE,,76.0,YR,,M,Y,84.9,KG,20201107.0,,HP,US,US,2020,Q4,Elderly
184793471,18479347,14,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,"ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q4,Arrhythmia,,2020,Q4,1,I,20200211.0,20201030.0,20201109,20201109,EXP,DE-BFARM-20011809,DE-ACCORD-207551,ACCORD,,77.0,YR,E,F,Y,101.7,KG,20201109.0,,PH,DE,DE,2020,Q4,Elderly
184793471,18479347,14,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,"ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200211.0,20201030.0,20201109,20201109,EXP,DE-BFARM-20011809,DE-ACCORD-207551,ACCORD,,77.0,YR,E,F,Y,101.7,KG,20201109.0,,PH,DE,DE,2020,Q4,Elderly
184793471,18479347,14,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,"ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200211.0,20201030.0,20201109,20201109,EXP,DE-BFARM-20011809,DE-ACCORD-207551,ACCORD,,77.0,YR,E,F,Y,101.7,KG,20201109.0,,PH,DE,DE,2020,Q4,Elderly
184793471,18479347,14,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,"ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q4,Rhonchi,,2020,Q4,1,I,20200211.0,20201030.0,20201109,20201109,EXP,DE-BFARM-20011809,DE-ACCORD-207551,ACCORD,,77.0,YR,E,F,Y,101.7,KG,20201109.0,,PH,DE,DE,2020,Q4,Elderly
184793471,18479347,14,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,"ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200211.0,20201030.0,20201109,20201109,EXP,DE-BFARM-20011809,DE-ACCORD-207551,ACCORD,,77.0,YR,E,F,Y,101.7,KG,20201109.0,,PH,DE,DE,2020,Q4,Elderly
184793471,18479347,14,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,"ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q4,Wheezing,,2020,Q4,1,I,20200211.0,20201030.0,20201109,20201109,EXP,DE-BFARM-20011809,DE-ACCORD-207551,ACCORD,,77.0,YR,E,F,Y,101.7,KG,20201109.0,,PH,DE,DE,2020,Q4,Elderly
184821751,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2020,Q4,Cataract,,2020,Q4,1,I,20201019.0,20201104.0,20201110,20201110,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,60.0,YR,,F,Y,,,20201109.0,,MD,JP,JP,2020,Q4,Adult
184823973,18482397,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Diverticular perforation,,2020,Q4,3,F,20200814.0,20201203.0,20201109,20201210,EXP,,US-GILEAD-2020-0491789,GILEAD,,62.0,YR,A,M,Y,75.0,KG,20201210.0,,MD,US,US,2020,Q4,Adult
184823973,18482397,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Diverticular perforation,,2020,Q4,3,F,20200814.0,20201203.0,20201109,20201210,EXP,,US-GILEAD-2020-0491789,GILEAD,,62.0,YR,A,M,Y,75.0,KG,20201210.0,,MD,US,US,2020,Q4,Adult
184836703,18483670,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Anaphylactic reaction,,2020,Q4,3,F,20201103.0,20201130.0,20201109,20201216,EXP,,US-GILEAD-2020-0503521,GILEAD,,85.0,YR,E,M,Y,91.02,KG,20201216.0,,PH,US,US,2020,Q4,Elderly
184843361,18484336,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN(SLIDING SCALE)",,,,,,,,,,INJECTION,,2020,Q4,Cataract,,2020,Q4,1,I,201911.0,20201105.0,20201110,20201110,PER,,US-ELI_LILLY_AND_COMPANY-US202011003279,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20201110.0,,CN,US,US,2020,Q4,Elderly
184843361,18484336,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN(SLIDING SCALE)",,,,, D195320A,,,,,INJECTION,,2020,Q4,Cataract,,2020,Q4,1,I,201911.0,20201105.0,20201110,20201110,PER,,US-ELI_LILLY_AND_COMPANY-US202011003279,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20201110.0,,CN,US,US,2020,Q4,Elderly
184852662,18485266,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML INJECTION PEN,,,,,,,,,,INJECTION,,2020,Q4,Failure to thrive,,2020,Q4,2,F,20201102.0,20201110.0,20201110,20201116,EXP,,US-JNJFOC-20201111955,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,54.4,KG,20201116.0,,MD,US,US,2020,Q4,Elderly
184852662,18485266,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML INJECTION PEN,,,,,,,,,,INJECTION,,2020,Q4,Fatigue,,2020,Q4,2,F,20201102.0,20201110.0,20201110,20201116,EXP,,US-JNJFOC-20201111955,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,54.4,KG,20201116.0,,MD,US,US,2020,Q4,Elderly
184871001,18487100,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (AT BREAKFAST AND DINNER)",,,,, D214632C,,20563.0,,,INJECTION,,2020,Q4,Dementia,,2020,Q4,1,I,202005.0,20201030.0,20201110,20201110,EXP,,US-ELI_LILLY_AND_COMPANY-US202011000458,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20201110.0,,CN,US,US,2020,Q4,Elderly
184871001,18487100,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (AT BREAKFAST AND DINNER)",,,,, D214632C,,20563.0,,,INJECTION,,2020,Q4,Illness,,2020,Q4,1,I,202005.0,20201030.0,20201110,20201110,EXP,,US-ELI_LILLY_AND_COMPANY-US202011000458,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20201110.0,,CN,US,US,2020,Q4,Elderly
184902621,18490262,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Exposure during pregnancy,,2020,Q4,1,I,,20191113.0,20201111,20201111,PER,,BR-LUPIN PHARMACEUTICALS INC.-2019-07557,LUPIN,,18.0,YR,,F,Y,,,20201111.0,,HP,BR,BR,2020,Q4,Youth
184907691,18490769,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hypervolaemia,,2020,Q4,1,I,,20200806.0,20201111,20201111,PER,US-MLMSERVICE-20200731-2417155-1,US-STRIDES ARCOLAB LIMITED-2020SP009202,STRIDES,,46.0,YR,,M,Y,,,20201111.0,,,NL,US,2020,Q4,Adult
184907691,18490769,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,,20200806.0,20201111,20201111,PER,US-MLMSERVICE-20200731-2417155-1,US-STRIDES ARCOLAB LIMITED-2020SP009202,STRIDES,,46.0,YR,,M,Y,,,20201111.0,,,NL,US,2020,Q4,Adult
184907691,18490769,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Oedema peripheral,,2020,Q4,1,I,,20200806.0,20201111,20201111,PER,US-MLMSERVICE-20200731-2417155-1,US-STRIDES ARCOLAB LIMITED-2020SP009202,STRIDES,,46.0,YR,,M,Y,,,20201111.0,,,NL,US,2020,Q4,Adult
184907691,18490769,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Off label use,,2020,Q4,1,I,,20200806.0,20201111,20201111,PER,US-MLMSERVICE-20200731-2417155-1,US-STRIDES ARCOLAB LIMITED-2020SP009202,STRIDES,,46.0,YR,,M,Y,,,20201111.0,,,NL,US,2020,Q4,Adult
184907691,18490769,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20200806.0,20201111,20201111,PER,US-MLMSERVICE-20200731-2417155-1,US-STRIDES ARCOLAB LIMITED-2020SP009202,STRIDES,,46.0,YR,,M,Y,,,20201111.0,,,NL,US,2020,Q4,Adult
184911841,18491184,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"2 DOSAGE FORMS DAILY; 20 IE, 1-0-1-0",,,,,,,,1.0,DF,,BID,2020,Q4,Dehydration,,2020,Q4,1,I,,20201103.0,20201111,20201111,EXP,,DE-TEVA-2020-DE-1846755,TEVA,,80.0,YR,E,F,Y,,,20201111.0,,MD,DE,DE,2020,Q4,Elderly
184911841,18491184,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"2 DOSAGE FORMS DAILY; 20 IE, 1-0-1-0",,,,,,,,1.0,DF,,BID,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201103.0,20201111,20201111,EXP,,DE-TEVA-2020-DE-1846755,TEVA,,80.0,YR,E,F,Y,,,20201111.0,,MD,DE,DE,2020,Q4,Elderly
184911841,18491184,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"2 DOSAGE FORMS DAILY; 20 IE, 1-0-1-0",,,,,,,,1.0,DF,,BID,2020,Q4,Hypotension,,2020,Q4,1,I,,20201103.0,20201111,20201111,EXP,,DE-TEVA-2020-DE-1846755,TEVA,,80.0,YR,E,F,Y,,,20201111.0,,MD,DE,DE,2020,Q4,Elderly
184911841,18491184,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"2 DOSAGE FORMS DAILY; 20 IE, 1-0-1-0",,,,,,,,1.0,DF,,BID,2020,Q4,Syncope,,2020,Q4,1,I,,20201103.0,20201111,20201111,EXP,,DE-TEVA-2020-DE-1846755,TEVA,,80.0,YR,E,F,Y,,,20201111.0,,MD,DE,DE,2020,Q4,Elderly
184917051,18491705,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"BY SCHEME, AMPOULES",,,,, UNKNOWN,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,20200211.0,20201103.0,20201111,20201111,EXP,,DE-ASTRAZENECA-2020SF44504,ASTRAZENECA,,77.0,YR,,F,Y,101.7,KG,20201111.0,,PH,DE,DE,2020,Q4,Elderly
184917051,18491705,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"BY SCHEME, AMPOULES",,,,, UNKNOWN,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200211.0,20201103.0,20201111,20201111,EXP,,DE-ASTRAZENECA-2020SF44504,ASTRAZENECA,,77.0,YR,,F,Y,101.7,KG,20201111.0,,PH,DE,DE,2020,Q4,Elderly
184917051,18491705,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"BY SCHEME, AMPOULES",,,,, UNKNOWN,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200211.0,20201103.0,20201111,20201111,EXP,,DE-ASTRAZENECA-2020SF44504,ASTRAZENECA,,77.0,YR,,F,Y,101.7,KG,20201111.0,,PH,DE,DE,2020,Q4,Elderly
184917051,18491705,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"BY SCHEME, AMPOULES",,,,, UNKNOWN,,,,,,,2020,Q4,Rhonchi,,2020,Q4,1,I,20200211.0,20201103.0,20201111,20201111,EXP,,DE-ASTRAZENECA-2020SF44504,ASTRAZENECA,,77.0,YR,,F,Y,101.7,KG,20201111.0,,PH,DE,DE,2020,Q4,Elderly
184917051,18491705,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"BY SCHEME, AMPOULES",,,,, UNKNOWN,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200211.0,20201103.0,20201111,20201111,EXP,,DE-ASTRAZENECA-2020SF44504,ASTRAZENECA,,77.0,YR,,F,Y,101.7,KG,20201111.0,,PH,DE,DE,2020,Q4,Elderly
184917051,18491705,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"BY SCHEME, AMPOULES",,,,, UNKNOWN,,,,,,,2020,Q4,Wheezing,,2020,Q4,1,I,20200211.0,20201103.0,20201111,20201111,EXP,,DE-ASTRAZENECA-2020SF44504,ASTRAZENECA,,77.0,YR,,F,Y,101.7,KG,20201111.0,,PH,DE,DE,2020,Q4,Elderly
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Anxiety,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Asthenia,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Cardiac disorder,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Cardiac operation,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Constipation,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Diabetes mellitus,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Drug dependence,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Fluid retention,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Immobile,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Insomnia,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Kidney transplant rejection,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Overdose,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Respiratory disorder,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184919971,18491997,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 IU (8-10-12-0),,,,,,,,1.0,IU,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,,20201106.0,20201111,20201111,EXP,DE-ADRED-05958-03,DE-PFIZER INC-2020437269,PFIZER,,77.0,YR,,F,Y,99.0,KG,20201111.0,,PH,DE,DE,2020,Q4,Elderly
184919971,18491997,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 IU (8-10-12-0),,,,,,,,1.0,IU,,,2020,Q4,Depressed mood,,2020,Q4,1,I,,20201106.0,20201111,20201111,EXP,DE-ADRED-05958-03,DE-PFIZER INC-2020437269,PFIZER,,77.0,YR,,F,Y,99.0,KG,20201111.0,,PH,DE,DE,2020,Q4,Elderly
184919971,18491997,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 IU (8-10-12-0),,,,,,,,1.0,IU,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201106.0,20201111,20201111,EXP,DE-ADRED-05958-03,DE-PFIZER INC-2020437269,PFIZER,,77.0,YR,,F,Y,99.0,KG,20201111.0,,PH,DE,DE,2020,Q4,Elderly
184920441,18492044,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,2018.0,20201102.0,20201111,20201111,EXP,,"US-ARBOR PHARMACEUTICALS, LLC-US-2020ARB000939",ARBOR,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, HASHEM HA, RYAN ML. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36 ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57 (12):1220-1413",61.0,YR,,F,Y,,,20201111.0,,MD,US,US,2020,Q4,Adult
184920441,18492044,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,2018.0,20201102.0,20201111,20201111,EXP,,"US-ARBOR PHARMACEUTICALS, LLC-US-2020ARB000939",ARBOR,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, HASHEM HA, RYAN ML. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36 ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57 (12):1220-1413",61.0,YR,,F,Y,,,20201111.0,,MD,US,US,2020,Q4,Adult
184936632,18493663,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 INTERNATIONAL UNIT,,,U,U,,,,200.0,IU,,,2020,Q4,Blood glucose abnormal,,2020,Q4,2,F,201912.0,20201105.0,20201111,20201118,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20201118.0,,CN,CA,CA,2020,Q4,Adult
184936632,18493663,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 INTERNATIONAL UNIT,,,U,U,,,,200.0,IU,,,2020,Q4,Cystitis,,2020,Q4,2,F,201912.0,20201105.0,20201111,20201118,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20201118.0,,CN,CA,CA,2020,Q4,Adult
184936632,18493663,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 INTERNATIONAL UNIT,,,U,U,,,,200.0,IU,,,2020,Q4,Diabetes mellitus,,2020,Q4,2,F,201912.0,20201105.0,20201111,20201118,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20201118.0,,CN,CA,CA,2020,Q4,Adult
184936632,18493663,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 INTERNATIONAL UNIT,,,U,U,,,,200.0,IU,,,2020,Q4,Lung disorder,,2020,Q4,2,F,201912.0,20201105.0,20201111,20201118,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20201118.0,,CN,CA,CA,2020,Q4,Adult
184940201,18494020,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,58-78 IN 24 HOURS,,,,,,,20563.0,78.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Blood glucose fluctuation,,2020,Q4,1,I,202010.0,20201110.0,20201112,20201112,PER,,US-ELI_LILLY_AND_COMPANY-US202011004965,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20201112.0,,HP,US,US,2020,Q4,Adult
184940201,18494020,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,58-78 IN 24 HOURS,,,,,,,20563.0,78.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,1,I,202010.0,20201110.0,20201112,20201112,PER,,US-ELI_LILLY_AND_COMPANY-US202011004965,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20201112.0,,HP,US,US,2020,Q4,Adult
184941691,18494169,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, AMPOULES)",,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,20200211.0,20201030.0,20201112,20201112,EXP,DE-ADRED-05958-02,DE-LUPIN PHARMACEUTICALS INC.-2020-08608,LUPIN,,77.0,YR,,F,Y,101.7,KG,20201112.0,,CN,NL,DE,2020,Q4,Elderly
184941691,18494169,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, AMPOULES)",,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200211.0,20201030.0,20201112,20201112,EXP,DE-ADRED-05958-02,DE-LUPIN PHARMACEUTICALS INC.-2020-08608,LUPIN,,77.0,YR,,F,Y,101.7,KG,20201112.0,,CN,NL,DE,2020,Q4,Elderly
184941691,18494169,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, AMPOULES)",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200211.0,20201030.0,20201112,20201112,EXP,DE-ADRED-05958-02,DE-LUPIN PHARMACEUTICALS INC.-2020-08608,LUPIN,,77.0,YR,,F,Y,101.7,KG,20201112.0,,CN,NL,DE,2020,Q4,Elderly
184941691,18494169,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, AMPOULES)",,,,,,,,,,,,2020,Q4,Rhonchi,,2020,Q4,1,I,20200211.0,20201030.0,20201112,20201112,EXP,DE-ADRED-05958-02,DE-LUPIN PHARMACEUTICALS INC.-2020-08608,LUPIN,,77.0,YR,,F,Y,101.7,KG,20201112.0,,CN,NL,DE,2020,Q4,Elderly
184941691,18494169,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, AMPOULES)",,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200211.0,20201030.0,20201112,20201112,EXP,DE-ADRED-05958-02,DE-LUPIN PHARMACEUTICALS INC.-2020-08608,LUPIN,,77.0,YR,,F,Y,101.7,KG,20201112.0,,CN,NL,DE,2020,Q4,Elderly
184941691,18494169,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, AMPOULES)",,,,,,,,,,,,2020,Q4,Wheezing,,2020,Q4,1,I,20200211.0,20201030.0,20201112,20201112,EXP,DE-ADRED-05958-02,DE-LUPIN PHARMACEUTICALS INC.-2020-08608,LUPIN,,77.0,YR,,F,Y,101.7,KG,20201112.0,,CN,NL,DE,2020,Q4,Elderly
184948111,18494811,27,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Burkholderia test positive,,2020,Q4,1,I,20201102.0,,20201111,20201111,DIR,,,FDA-CTU,,81.0,YR,,F,N,74.2,KG,20201105.0,N,PH,US,US,2020,Q4,Elderly
184948111,18494811,27,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Product contamination microbial,,2020,Q4,1,I,20201102.0,,20201111,20201111,DIR,,,FDA-CTU,,81.0,YR,,F,N,74.2,KG,20201105.0,N,PH,US,US,2020,Q4,Elderly
184948111,18494811,27,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Product quality issue,,2020,Q4,1,I,20201102.0,,20201111,20201111,DIR,,,FDA-CTU,,81.0,YR,,F,N,74.2,KG,20201105.0,N,PH,US,US,2020,Q4,Elderly
184948111,18494811,27,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Recalled product,,2020,Q4,1,I,20201102.0,,20201111,20201111,DIR,,,FDA-CTU,,81.0,YR,,F,N,74.2,KG,20201105.0,N,PH,US,US,2020,Q4,Elderly
184951491,18495149,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cytokine release syndrome,,2020,Q4,1,I,20200925.0,,20201111,20201111,DIR,,,FDA-CTU,,64.0,YR,,F,N,57.15,KG,20201111.0,N,HP,US,US,2020,Q4,Adult
184951741,18495174,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"1 INTERNATIONAL UNIT, 3 TIMES A DAY (8-10-12-0)",,,U,,,,,1.0,IU,,TID,2020,Q4,Cardiac failure,,2020,Q4,1,I,,20201102.0,20201112,20201112,EXP,,DE-AUROBINDO-AUR-APL-2020-055591,AUROBINDO,,77.0,YR,,F,Y,99.0,KG,20201112.0,,PH,DE,DE,2020,Q4,Elderly
184951741,18495174,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"1 INTERNATIONAL UNIT, 3 TIMES A DAY (8-10-12-0)",,,U,,,,,1.0,IU,,TID,2020,Q4,Depressed mood,,2020,Q4,1,I,,20201102.0,20201112,20201112,EXP,,DE-AUROBINDO-AUR-APL-2020-055591,AUROBINDO,,77.0,YR,,F,Y,99.0,KG,20201112.0,,PH,DE,DE,2020,Q4,Elderly
184951741,18495174,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"1 INTERNATIONAL UNIT, 3 TIMES A DAY (8-10-12-0)",,,U,,,,,1.0,IU,,TID,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201102.0,20201112,20201112,EXP,,DE-AUROBINDO-AUR-APL-2020-055591,AUROBINDO,,77.0,YR,,F,Y,99.0,KG,20201112.0,,PH,DE,DE,2020,Q4,Elderly
184951771,18495177,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN",,,U,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,20200211.0,20201102.0,20201112,20201112,EXP,,DE-AUROBINDO-AUR-APL-2020-055606,AUROBINDO,,77.0,YR,,F,Y,101.7,KG,20201112.0,,PH,DE,DE,2020,Q4,Elderly
184951771,18495177,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN",,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200211.0,20201102.0,20201112,20201112,EXP,,DE-AUROBINDO-AUR-APL-2020-055606,AUROBINDO,,77.0,YR,,F,Y,101.7,KG,20201112.0,,PH,DE,DE,2020,Q4,Elderly
184951771,18495177,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN",,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200211.0,20201102.0,20201112,20201112,EXP,,DE-AUROBINDO-AUR-APL-2020-055606,AUROBINDO,,77.0,YR,,F,Y,101.7,KG,20201112.0,,PH,DE,DE,2020,Q4,Elderly
184951771,18495177,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN",,,U,,,,,,,,,2020,Q4,Rhonchi,,2020,Q4,1,I,20200211.0,20201102.0,20201112,20201112,EXP,,DE-AUROBINDO-AUR-APL-2020-055606,AUROBINDO,,77.0,YR,,F,Y,101.7,KG,20201112.0,,PH,DE,DE,2020,Q4,Elderly
184951771,18495177,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN",,,U,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200211.0,20201102.0,20201112,20201112,EXP,,DE-AUROBINDO-AUR-APL-2020-055606,AUROBINDO,,77.0,YR,,F,Y,101.7,KG,20201112.0,,PH,DE,DE,2020,Q4,Elderly
184951771,18495177,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN",,,U,,,,,,,,,2020,Q4,Wheezing,,2020,Q4,1,I,20200211.0,20201102.0,20201112,20201112,EXP,,DE-AUROBINDO-AUR-APL-2020-055606,AUROBINDO,,77.0,YR,,F,Y,101.7,KG,20201112.0,,PH,DE,DE,2020,Q4,Elderly
184956382,18495638,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO SCHEME, AMPOULES",,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,2,F,20200211.0,20201113.0,20201112,20201113,EXP,DE-ADRED-05958-02,DE-PFIZER INC-2020442342,PFIZER,,77.0,YR,,F,Y,101.7,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184956382,18495638,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO SCHEME, AMPOULES",,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,2,F,20200211.0,20201113.0,20201112,20201113,EXP,DE-ADRED-05958-02,DE-PFIZER INC-2020442342,PFIZER,,77.0,YR,,F,Y,101.7,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184956382,18495638,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO SCHEME, AMPOULES",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,2,F,20200211.0,20201113.0,20201112,20201113,EXP,DE-ADRED-05958-02,DE-PFIZER INC-2020442342,PFIZER,,77.0,YR,,F,Y,101.7,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184956382,18495638,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO SCHEME, AMPOULES",,,,,,,,,,,,2020,Q4,Rhonchi,,2020,Q4,2,F,20200211.0,20201113.0,20201112,20201113,EXP,DE-ADRED-05958-02,DE-PFIZER INC-2020442342,PFIZER,,77.0,YR,,F,Y,101.7,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184956382,18495638,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO SCHEME, AMPOULES",,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,2,F,20200211.0,20201113.0,20201112,20201113,EXP,DE-ADRED-05958-02,DE-PFIZER INC-2020442342,PFIZER,,77.0,YR,,F,Y,101.7,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184956382,18495638,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO SCHEME, AMPOULES",,,,,,,,,,,,2020,Q4,Wheezing,,2020,Q4,2,F,20200211.0,20201113.0,20201112,20201113,EXP,DE-ADRED-05958-02,DE-PFIZER INC-2020442342,PFIZER,,77.0,YR,,F,Y,101.7,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184964371,18496437,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, UNKNOWN",,,,, D137576E,,20563.0,15.0,IU,INJECTION,,2020,Q4,Blood glucose decreased,,2020,Q4,1,I,202010.0,20201030.0,20201112,20201112,PER,,US-ELI_LILLY_AND_COMPANY-US202011000541,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20201112.0,,CN,US,US,2020,Q4,Adult
184964371,18496437,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, UNKNOWN",,,,, D137576E,,20563.0,15.0,IU,INJECTION,,2020,Q4,Incorrect dose administered,,2020,Q4,1,I,202010.0,20201030.0,20201112,20201112,PER,,US-ELI_LILLY_AND_COMPANY-US202011000541,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20201112.0,,CN,US,US,2020,Q4,Adult
184964371,18496437,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, TID",,,,, D137576E,,20563.0,12.0,IU,INJECTION,TID,2020,Q4,Blood glucose decreased,,2020,Q4,1,I,202010.0,20201030.0,20201112,20201112,PER,,US-ELI_LILLY_AND_COMPANY-US202011000541,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20201112.0,,CN,US,US,2020,Q4,Adult
184964371,18496437,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, TID",,,,, D137576E,,20563.0,12.0,IU,INJECTION,TID,2020,Q4,Incorrect dose administered,,2020,Q4,1,I,202010.0,20201030.0,20201112,20201112,PER,,US-ELI_LILLY_AND_COMPANY-US202011000541,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20201112.0,,CN,US,US,2020,Q4,Adult
184964371,18496437,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, UNKNOWN",,,,, D137576E,,20563.0,15.0,IU,INJECTION,,2020,Q4,Blood glucose decreased,,2020,Q4,1,I,202010.0,20201030.0,20201112,20201112,PER,,US-ELI_LILLY_AND_COMPANY-US202011000541,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20201112.0,,CN,US,US,2020,Q4,Adult
184964371,18496437,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, UNKNOWN",,,,, D137576E,,20563.0,15.0,IU,INJECTION,,2020,Q4,Incorrect dose administered,,2020,Q4,1,I,202010.0,20201030.0,20201112,20201112,PER,,US-ELI_LILLY_AND_COMPANY-US202011000541,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20201112.0,,CN,US,US,2020,Q4,Adult
184968381,18496838,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Hypersensitivity,,2020,Q4,1,I,,20201028.0,20201112,20201112,EXP,,GB-MYLANLABS-2020M1091456,MYLAN,,73.0,YR,,M,Y,,,20201112.0,,MD,GB,GB,2020,Q4,Elderly
184968381,18496838,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,1,I,,20201028.0,20201112,20201112,EXP,,GB-MYLANLABS-2020M1091456,MYLAN,,73.0,YR,,M,Y,,,20201112.0,,MD,GB,GB,2020,Q4,Elderly
184968381,18496838,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Incorrect dose administered,,2020,Q4,1,I,,20201028.0,20201112,20201112,EXP,,GB-MYLANLABS-2020M1091456,MYLAN,,73.0,YR,,M,Y,,,20201112.0,,MD,GB,GB,2020,Q4,Elderly
184968381,18496838,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Urticaria,,2020,Q4,1,I,,20201028.0,20201112,20201112,EXP,,GB-MYLANLABS-2020M1091456,MYLAN,,73.0,YR,,M,Y,,,20201112.0,,MD,GB,GB,2020,Q4,Elderly
184981831,18498183,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0",,,U,,,,,,,AMPOULES,,2020,Q4,Anuria,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0",,,U,,,,,,,AMPOULES,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0",,,U,,,,,,,AMPOULES,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0",,,U,,,,,,,AMPOULES,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0",,,U,,,,,,,AMPOULES,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0",,,U,,,,,,,AMPOULES,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184983261,18498326,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN (ACCORDING TO SCHEME, AMPOULES)",,,,, UNKNOWN,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,20200211.0,20201104.0,20201113,20201113,EXP,,DE-DRREDDYS-GER/GER/20/0128767,DR REDDYS,,77.0,YR,E,F,Y,101.7,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184983261,18498326,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN (ACCORDING TO SCHEME, AMPOULES)",,,,, UNKNOWN,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200211.0,20201104.0,20201113,20201113,EXP,,DE-DRREDDYS-GER/GER/20/0128767,DR REDDYS,,77.0,YR,E,F,Y,101.7,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184983261,18498326,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN (ACCORDING TO SCHEME, AMPOULES)",,,,, UNKNOWN,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200211.0,20201104.0,20201113,20201113,EXP,,DE-DRREDDYS-GER/GER/20/0128767,DR REDDYS,,77.0,YR,E,F,Y,101.7,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184983261,18498326,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN (ACCORDING TO SCHEME, AMPOULES)",,,,, UNKNOWN,,,,,,,2020,Q4,Rhonchi,,2020,Q4,1,I,20200211.0,20201104.0,20201113,20201113,EXP,,DE-DRREDDYS-GER/GER/20/0128767,DR REDDYS,,77.0,YR,E,F,Y,101.7,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184983261,18498326,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN (ACCORDING TO SCHEME, AMPOULES)",,,,, UNKNOWN,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200211.0,20201104.0,20201113,20201113,EXP,,DE-DRREDDYS-GER/GER/20/0128767,DR REDDYS,,77.0,YR,E,F,Y,101.7,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184983261,18498326,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN (ACCORDING TO SCHEME, AMPOULES)",,,,, UNKNOWN,,,,,,,2020,Q4,Wheezing,,2020,Q4,1,I,20200211.0,20201104.0,20201113,20201113,EXP,,DE-DRREDDYS-GER/GER/20/0128767,DR REDDYS,,77.0,YR,E,F,Y,101.7,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184988811,18498881,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN ()",,,U,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,20200211.0,20201030.0,20201113,20201113,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-267700,RANBAXY,,77.0,YR,,F,Y,101.7,KG,20201113.0,,HP,NL,DE,2020,Q4,Elderly
184988811,18498881,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN ()",,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200211.0,20201030.0,20201113,20201113,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-267700,RANBAXY,,77.0,YR,,F,Y,101.7,KG,20201113.0,,HP,NL,DE,2020,Q4,Elderly
184988811,18498881,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN ()",,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200211.0,20201030.0,20201113,20201113,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-267700,RANBAXY,,77.0,YR,,F,Y,101.7,KG,20201113.0,,HP,NL,DE,2020,Q4,Elderly
184988811,18498881,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN ()",,,U,,,,,,,,,2020,Q4,Rhonchi,,2020,Q4,1,I,20200211.0,20201030.0,20201113,20201113,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-267700,RANBAXY,,77.0,YR,,F,Y,101.7,KG,20201113.0,,HP,NL,DE,2020,Q4,Elderly
184988811,18498881,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN ()",,,U,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200211.0,20201030.0,20201113,20201113,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-267700,RANBAXY,,77.0,YR,,F,Y,101.7,KG,20201113.0,,HP,NL,DE,2020,Q4,Elderly
184988811,18498881,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN ()",,,U,,,,,,,,,2020,Q4,Wheezing,,2020,Q4,1,I,20200211.0,20201030.0,20201113,20201113,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-267700,RANBAXY,,77.0,YR,,F,Y,101.7,KG,20201113.0,,HP,NL,DE,2020,Q4,Elderly
184990951,18499095,6,C,insulin lispro,INSULIN LISPRO,1,Unknown,"1 IE, 8-10-12-0 ()",,,U,,,,,,,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,,20201030.0,20201113,20201113,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-267558,RANBAXY,,77.0,YR,,F,Y,99.0,KG,20201113.0,,HP,NL,DE,2020,Q4,Elderly
184990951,18499095,6,C,insulin lispro,INSULIN LISPRO,1,Unknown,"1 IE, 8-10-12-0 ()",,,U,,,,,,,,,2020,Q4,Depressed mood,,2020,Q4,1,I,,20201030.0,20201113,20201113,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-267558,RANBAXY,,77.0,YR,,F,Y,99.0,KG,20201113.0,,HP,NL,DE,2020,Q4,Elderly
184990951,18499095,6,C,insulin lispro,INSULIN LISPRO,1,Unknown,"1 IE, 8-10-12-0 ()",,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201030.0,20201113,20201113,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-267558,RANBAXY,,77.0,YR,,F,Y,99.0,KG,20201113.0,,HP,NL,DE,2020,Q4,Elderly
185004001,18500400,18,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,20200211.0,20201030.0,20201113,20201113,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-07941,ALKEM,,77.0,YR,,F,Y,101.7,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185004001,18500400,18,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200211.0,20201030.0,20201113,20201113,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-07941,ALKEM,,77.0,YR,,F,Y,101.7,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185004001,18500400,18,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200211.0,20201030.0,20201113,20201113,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-07941,ALKEM,,77.0,YR,,F,Y,101.7,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185004001,18500400,18,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Rhonchi,,2020,Q4,1,I,20200211.0,20201030.0,20201113,20201113,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-07941,ALKEM,,77.0,YR,,F,Y,101.7,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185004001,18500400,18,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200211.0,20201030.0,20201113,20201113,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-07941,ALKEM,,77.0,YR,,F,Y,101.7,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185004001,18500400,18,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Wheezing,,2020,Q4,1,I,20200211.0,20201030.0,20201113,20201113,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-07941,ALKEM,,77.0,YR,,F,Y,101.7,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185004011,18500401,6,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD EVERY 1 DAY,,,U,U, UNKNOWN,,,,,,,2020,Q4,Drug interaction,,2020,Q4,1,I,,20201030.0,20201113,20201113,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-07936,ALKEM,,87.0,YR,,F,Y,60.0,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185004011,18500401,6,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE FOOD EVERY 1 DAY,,,U,U, UNKNOWN,,,,,,,2020,Q4,Gastrointestinal haemorrhage,,2020,Q4,1,I,,20201030.0,20201113,20201113,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-07936,ALKEM,,87.0,YR,,F,Y,60.0,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185004091,18500409,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"1 IE, 8-10-12-0",,,,, UNKNOWN,,,,,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,,20201030.0,20201113,20201113,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-07942,ALKEM,,77.0,YR,,F,Y,99.0,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185004091,18500409,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"1 IE, 8-10-12-0",,,,, UNKNOWN,,,,,,,2020,Q4,Depressed mood,,2020,Q4,1,I,,20201030.0,20201113,20201113,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-07942,ALKEM,,77.0,YR,,F,Y,99.0,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185004091,18500409,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"1 IE, 8-10-12-0",,,,, UNKNOWN,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201030.0,20201113,20201113,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-07942,ALKEM,,77.0,YR,,F,Y,99.0,KG,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185006011,18500601,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201106.0,20201113,20201113,EXP,DE-BFARM-20012110,DE-ACCORD-208264,ACCORD,,77.0,YR,E,F,Y,99.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185006011,18500601,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201106.0,20201113,20201113,EXP,DE-BFARM-20012110,DE-ACCORD-208264,ACCORD,,77.0,YR,E,F,Y,99.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185006011,18500601,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201106.0,20201113,20201113,EXP,DE-BFARM-20012110,DE-ACCORD-208264,ACCORD,,77.0,YR,E,F,Y,99.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185008483,18500848,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"14 U, EACH MORNING",,,,, D088599D,,,14.0,IU,INJECTION,QD,2020,Q4,Eye injury,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"14 U, EACH MORNING",,,,, D088599D,,,14.0,IU,INJECTION,QD,2020,Q4,Eye swelling,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"14 U, EACH MORNING",,,,, D088599D,,,14.0,IU,INJECTION,QD,2020,Q4,Fall,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"14 U, EACH MORNING",,,,, D088599D,,,14.0,IU,INJECTION,QD,2020,Q4,Incorrect dose administered,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"14 U, EACH MORNING",,,,, D088599D,,,14.0,IU,INJECTION,QD,2020,Q4,Myocardial infarction,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"14 U, EACH MORNING",,,,, D088599D,,,14.0,IU,INJECTION,QD,2020,Q4,Renal disorder,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"14 U, EACH MORNING",,,,, D088599D,,,14.0,IU,INJECTION,QD,2020,Q4,Scar,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"14 U, EACH MORNING",,,,, D088599D,,,14.0,IU,INJECTION,QD,2020,Q4,Visual impairment,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,,, D088599D,,,10.0,IU,INJECTION,QD,2020,Q4,Eye injury,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,,, D088599D,,,10.0,IU,INJECTION,QD,2020,Q4,Eye swelling,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,,, D088599D,,,10.0,IU,INJECTION,QD,2020,Q4,Fall,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,,, D088599D,,,10.0,IU,INJECTION,QD,2020,Q4,Incorrect dose administered,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,,, D088599D,,,10.0,IU,INJECTION,QD,2020,Q4,Myocardial infarction,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,,, D088599D,,,10.0,IU,INJECTION,QD,2020,Q4,Renal disorder,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,,, D088599D,,,10.0,IU,INJECTION,QD,2020,Q4,Scar,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185008483,18500848,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,,, D088599D,,,10.0,IU,INJECTION,QD,2020,Q4,Visual impairment,,2020,Q4,3,F,20201211.0,20201210.0,20201113,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202011003631,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20201217.0,,CN,US,US,2020,Q4,Elderly
185011771,18501177,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,200,,,,,,,,,,,,2020,Q4,Asthenia,,2020,Q4,1,I,,20201106.0,20201113,20201113,EXP,,DE-MYLANLABS-2020M1093518,MYLAN,,51.0,YR,,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Adult
185011771,18501177,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,200,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201106.0,20201113,20201113,EXP,,DE-MYLANLABS-2020M1093518,MYLAN,,51.0,YR,,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Adult
185014621,18501462,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,1,I,20101024.0,,20201112,20201112,DIR,,,FDA-CTU,,35.0,YR,,M,N,107.05,KG,20191024.0,N,HP,US,US,2020,Q4,Adult
185014621,18501462,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Product substitution issue,,2020,Q4,1,I,20101024.0,,20201112,20201112,DIR,,,FDA-CTU,,35.0,YR,,M,N,107.05,KG,20191024.0,N,HP,US,US,2020,Q4,Adult
185019511,18501951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"(1 IE, 75-25-46-0, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"(1 IE, 75-25-46-0, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"(1 IE, 75-25-46-0, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"(1 IE, 75-25-46-0, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"(1 IE, 75-25-46-0, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"(1 IE, 75-25-46-0, AMPULLEN)",,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185060051,18506005,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0",,,,,,,,,,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0",,,,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0",,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0",,,,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0",,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185062691,18506269,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK (1 IE, 8-10-12-0)",,,U,,,,,,,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,NVSC2020DE298923,NOVARTIS,,77.0,YR,,F,Y,99.0,KG,20201116.0,,HP,DE,DE,2020,Q4,Elderly
185062691,18506269,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK (1 IE, 8-10-12-0)",,,U,,,,,,,,,2020,Q4,Depressed mood,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,NVSC2020DE298923,NOVARTIS,,77.0,YR,,F,Y,99.0,KG,20201116.0,,HP,DE,DE,2020,Q4,Elderly
185062691,18506269,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK (1 IE, 8-10-12-0)",,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,NVSC2020DE298923,NOVARTIS,,77.0,YR,,F,Y,99.0,KG,20201116.0,,HP,DE,DE,2020,Q4,Elderly
185063611,18506361,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,2018.0,20201102.0,20201116,20201116,EXP,,US-VALIDUS PHARMACEUTICALS LLC-US-2020VAL000895,VALIDUS,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57(12):1220-1413",61.0,YR,,F,Y,,,20201116.0,,MD,US,US,2020,Q4,Adult
185063611,18506361,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,2018.0,20201102.0,20201116,20201116,EXP,,US-VALIDUS PHARMACEUTICALS LLC-US-2020VAL000895,VALIDUS,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57(12):1220-1413",61.0,YR,,F,Y,,,20201116.0,,MD,US,US,2020,Q4,Adult
185091721,18509172,6,C,insulin lispro,INSULIN LISPRO,1,,"1 IU, 8-10-12-0",,,,,,,,,,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,,20201108.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848577,TEVA,,77.0,YR,E,F,Y,99.0,KG,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185091721,18509172,6,C,insulin lispro,INSULIN LISPRO,1,,"1 IU, 8-10-12-0",,,,,,,,,,,,2020,Q4,Depressed mood,,2020,Q4,1,I,,20201108.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848577,TEVA,,77.0,YR,E,F,Y,99.0,KG,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185091721,18509172,6,C,insulin lispro,INSULIN LISPRO,1,,"1 IU, 8-10-12-0",,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201108.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848577,TEVA,,77.0,YR,E,F,Y,99.0,KG,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185094561,18509456,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,20200211.0,20201108.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848575,TEVA,,77.0,YR,E,F,Y,101.7,KG,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185094561,18509456,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200211.0,20201108.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848575,TEVA,,77.0,YR,E,F,Y,101.7,KG,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185094561,18509456,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200211.0,20201108.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848575,TEVA,,77.0,YR,E,F,Y,101.7,KG,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185094561,18509456,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,,,,,2020,Q4,Rhonchi,,2020,Q4,1,I,20200211.0,20201108.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848575,TEVA,,77.0,YR,E,F,Y,101.7,KG,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185094561,18509456,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200211.0,20201108.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848575,TEVA,,77.0,YR,E,F,Y,101.7,KG,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185094561,18509456,15,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, AMPOULES",,,,,,,,,,,,2020,Q4,Wheezing,,2020,Q4,1,I,20200211.0,20201108.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848575,TEVA,,77.0,YR,E,F,Y,101.7,KG,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185094761,18509476,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Rhabdomyolysis,,2020,Q4,1,I,,20201102.0,20201117,20201117,EXP,,"US-JIANGSU HENGRUI MEDICINE CO., LTD.-2095984",JIANGSU HENGRUI MEDICINE,A CASE OF DOCETAXEL-INDUCED RHABDOMYOLYSIS,48.0,YR,,F,Y,,,20201117.0,,MD,US,US,2020,Q4,Adult
185108842,18510884,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,INJECTION,,2020,Q4,Cardiac failure,,2020,Q4,2,F,20200926.0,20201209.0,20201117,20201211,EXP,,US-JNJFOC-20200951620,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,61.2,KG,20201211.0,,MD,US,US,2020,Q4,Elderly
185118551,18511855,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK(NACH SCHEMA, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,20200211.0,20201105.0,20201117,20201117,EXP,DE-ADRED-05958-02,NVSC2020DE297700,NOVARTIS,,77.0,YR,,F,Y,101.7,KG,20201117.0,,HP,DE,DE,2020,Q4,Elderly
185118551,18511855,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK(NACH SCHEMA, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200211.0,20201105.0,20201117,20201117,EXP,DE-ADRED-05958-02,NVSC2020DE297700,NOVARTIS,,77.0,YR,,F,Y,101.7,KG,20201117.0,,HP,DE,DE,2020,Q4,Elderly
185118551,18511855,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK(NACH SCHEMA, AMPULLEN)",,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200211.0,20201105.0,20201117,20201117,EXP,DE-ADRED-05958-02,NVSC2020DE297700,NOVARTIS,,77.0,YR,,F,Y,101.7,KG,20201117.0,,HP,DE,DE,2020,Q4,Elderly
185118551,18511855,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK(NACH SCHEMA, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Rhonchi,,2020,Q4,1,I,20200211.0,20201105.0,20201117,20201117,EXP,DE-ADRED-05958-02,NVSC2020DE297700,NOVARTIS,,77.0,YR,,F,Y,101.7,KG,20201117.0,,HP,DE,DE,2020,Q4,Elderly
185118551,18511855,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK(NACH SCHEMA, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200211.0,20201105.0,20201117,20201117,EXP,DE-ADRED-05958-02,NVSC2020DE297700,NOVARTIS,,77.0,YR,,F,Y,101.7,KG,20201117.0,,HP,DE,DE,2020,Q4,Elderly
185118551,18511855,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK(NACH SCHEMA, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Wheezing,,2020,Q4,1,I,20200211.0,20201105.0,20201117,20201117,EXP,DE-ADRED-05958-02,NVSC2020DE297700,NOVARTIS,,77.0,YR,,F,Y,101.7,KG,20201117.0,,HP,DE,DE,2020,Q4,Elderly
185125441,18512544,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 75-25-46-0,",,,,,,,,,,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848301,TEVA,,69.0,YR,E,F,Y,,,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185125441,18512544,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 75-25-46-0,",,,,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848301,TEVA,,69.0,YR,E,F,Y,,,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185125441,18512544,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 75-25-46-0,",,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848301,TEVA,,69.0,YR,E,F,Y,,,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185125441,18512544,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 75-25-46-0,",,,,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848301,TEVA,,69.0,YR,E,F,Y,,,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185125441,18512544,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 75-25-46-0,",,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848301,TEVA,,69.0,YR,E,F,Y,,,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185125441,18512544,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 75-25-46-0,",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-TEVA-2020-DE-1848301,TEVA,,69.0,YR,E,F,Y,,,20201117.0,,PH,DE,DE,2020,Q4,Elderly
185136411,18513641,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (KWIKPEN),,,,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,1,I,202007.0,20201109.0,20201118,20201118,PER,,US-AMGEN-USASP2020183177,AMGEN,,49.0,YR,A,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185136411,18513641,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (KWIKPEN),,,,,,,,,,,,2020,Q4,Rheumatoid arthritis,,2020,Q4,1,I,202007.0,20201109.0,20201118,20201118,PER,,US-AMGEN-USASP2020183177,AMGEN,,49.0,YR,A,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185142751,18514275,9,C,insulin lispro,INSULIN LISPRO,1,,NACH SCHEMA (ACCORDING TO SCHEME),,,,, UNKNOWN,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,DE-DRREDDYS-GER/GER/20/0128921,DR REDDYS,,77.0,YR,E,F,Y,99.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185142751,18514275,9,C,insulin lispro,INSULIN LISPRO,1,,NACH SCHEMA (ACCORDING TO SCHEME),,,,, UNKNOWN,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,DE-DRREDDYS-GER/GER/20/0128921,DR REDDYS,,77.0,YR,E,F,Y,99.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185142751,18514275,9,C,insulin lispro,INSULIN LISPRO,1,,NACH SCHEMA (ACCORDING TO SCHEME),,,,, UNKNOWN,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,DE-DRREDDYS-GER/GER/20/0128921,DR REDDYS,,77.0,YR,E,F,Y,99.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185154411,18515441,7,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK NACH SCHEMA,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201106.0,20201118,20201118,EXP,,DE-AUROBINDO-AUR-APL-2020-056494,AUROBINDO,,77.0,YR,,F,Y,99.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185154411,18515441,7,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK NACH SCHEMA,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201106.0,20201118,20201118,EXP,,DE-AUROBINDO-AUR-APL-2020-056494,AUROBINDO,,77.0,YR,,F,Y,99.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185154411,18515441,7,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK NACH SCHEMA,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201106.0,20201118,20201118,EXP,,DE-AUROBINDO-AUR-APL-2020-056494,AUROBINDO,,77.0,YR,,F,Y,99.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185162721,18516272,18,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,DE-BFARM-20012145,DE-ACCORD-208374,ACCORD,,78.0,YR,E,F,Y,98.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185162721,18516272,18,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,DE-BFARM-20012145,DE-ACCORD-208374,ACCORD,,78.0,YR,E,F,Y,98.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185162721,18516272,18,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,DE-BFARM-20012145,DE-ACCORD-208374,ACCORD,,78.0,YR,E,F,Y,98.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185162721,18516272,18,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,DE-BFARM-20012145,DE-ACCORD-208374,ACCORD,,78.0,YR,E,F,Y,98.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185162721,18516272,18,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,DE-BFARM-20012145,DE-ACCORD-208374,ACCORD,,78.0,YR,E,F,Y,98.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0, AMPOULES",,,,,,,,,,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0, AMPOULES",,,,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0, AMPOULES",,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0, AMPOULES",,,,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0, AMPOULES",,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 75-25-46-0, AMPOULES",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Basophil percentage decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Blood albumin decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Blood bicarbonate increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Blood calcium decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Blood chloride decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Blood fibrinogen increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Blood lactate dehydrogenase increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Blood potassium decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Blood sodium decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,C-reactive protein increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Eosinophil percentage decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Fibrin D dimer increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Lymphocyte count decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Lymphocyte percentage decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Mean cell haemoglobin concentration decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Mean cell haemoglobin decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Mean platelet volume increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Monocyte percentage decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Neutrophil count increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Neutrophil percentage increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,9,C,Insulin lispro sliding scale with meals SQ,,2,,,,,,,,,,,,,,2020,Q4,Serum ferritin increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185178051,18517805,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IE, 1-0-1-0",,,,,,,,20.0,IU,INJECTION,BID,2020,Q4,Dehydration,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,DE-MYLANLABS-2020M1094632,MYLAN,,80.0,YR,,F,Y,,,20201118.0,,MD,DE,DE,2020,Q4,Elderly
185178051,18517805,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IE, 1-0-1-0",,,,,,,,20.0,IU,INJECTION,BID,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,DE-MYLANLABS-2020M1094632,MYLAN,,80.0,YR,,F,Y,,,20201118.0,,MD,DE,DE,2020,Q4,Elderly
185178051,18517805,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IE, 1-0-1-0",,,,,,,,20.0,IU,INJECTION,BID,2020,Q4,Hypotension,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,DE-MYLANLABS-2020M1094632,MYLAN,,80.0,YR,,F,Y,,,20201118.0,,MD,DE,DE,2020,Q4,Elderly
185178051,18517805,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IE, 1-0-1-0",,,,,,,,20.0,IU,INJECTION,BID,2020,Q4,Syncope,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,DE-MYLANLABS-2020M1094632,MYLAN,,80.0,YR,,F,Y,,,20201118.0,,MD,DE,DE,2020,Q4,Elderly
185183471,18518347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO THE SCHEME,,,,,,,,,,AMPOULES,,2020,Q4,Arrhythmia,,2020,Q4,1,I,20200211.0,20201103.0,20201118,20201118,EXP,DE-ADRED-05958-02,DE-BAUSCH-BL-2020-032472,BAUSCH AND LOMB,,77.0,YR,,F,Y,101.7,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185183471,18518347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO THE SCHEME,,,,,,,,,,AMPOULES,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200211.0,20201103.0,20201118,20201118,EXP,DE-ADRED-05958-02,DE-BAUSCH-BL-2020-032472,BAUSCH AND LOMB,,77.0,YR,,F,Y,101.7,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185183471,18518347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO THE SCHEME,,,,,,,,,,AMPOULES,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200211.0,20201103.0,20201118,20201118,EXP,DE-ADRED-05958-02,DE-BAUSCH-BL-2020-032472,BAUSCH AND LOMB,,77.0,YR,,F,Y,101.7,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185183471,18518347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO THE SCHEME,,,,,,,,,,AMPOULES,,2020,Q4,Rhonchi,,2020,Q4,1,I,20200211.0,20201103.0,20201118,20201118,EXP,DE-ADRED-05958-02,DE-BAUSCH-BL-2020-032472,BAUSCH AND LOMB,,77.0,YR,,F,Y,101.7,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185183471,18518347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO THE SCHEME,,,,,,,,,,AMPOULES,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200211.0,20201103.0,20201118,20201118,EXP,DE-ADRED-05958-02,DE-BAUSCH-BL-2020-032472,BAUSCH AND LOMB,,77.0,YR,,F,Y,101.7,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185183471,18518347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO THE SCHEME,,,,,,,,,,AMPOULES,,2020,Q4,Wheezing,,2020,Q4,1,I,20200211.0,20201103.0,20201118,20201118,EXP,DE-ADRED-05958-02,DE-BAUSCH-BL-2020-032472,BAUSCH AND LOMB,,77.0,YR,,F,Y,101.7,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185183491,18518349,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 8-10-12-0",,,,,,,,1.0,IU,,TID,2020,Q4,Cardiac failure,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05958-03,DE-BAUSCH-BL-2020-032475,BAUSCH AND LOMB,,77.0,YR,,F,Y,99.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185183491,18518349,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 8-10-12-0",,,,,,,,1.0,IU,,TID,2020,Q4,Depressed mood,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05958-03,DE-BAUSCH-BL-2020-032475,BAUSCH AND LOMB,,77.0,YR,,F,Y,99.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185183491,18518349,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 8-10-12-0",,,,,,,,1.0,IU,,TID,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05958-03,DE-BAUSCH-BL-2020-032475,BAUSCH AND LOMB,,77.0,YR,,F,Y,99.0,KG,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185191751,18519175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (NACH SCHEMA),,,U,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,NVSC2020DE301652,NOVARTIS,,77.0,YR,,F,Y,99.0,KG,20201118.0,,HP,DE,DE,2020,Q4,Elderly
185191751,18519175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (NACH SCHEMA),,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,NVSC2020DE301652,NOVARTIS,,77.0,YR,,F,Y,99.0,KG,20201118.0,,HP,DE,DE,2020,Q4,Elderly
185191751,18519175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (NACH SCHEMA),,,U,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,NVSC2020DE301652,NOVARTIS,,77.0,YR,,F,Y,99.0,KG,20201118.0,,HP,DE,DE,2020,Q4,Elderly
185203211,18520321,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201109.0,20201119,20201119,EXP,DE-BFARM-20012161,DE-ACCORD-208452,ACCORD,,77.0,YR,E,F,Y,105.0,KG,20201119.0,,PH,DE,DE,2020,Q4,Elderly
185203211,18520321,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201109.0,20201119,20201119,EXP,DE-BFARM-20012161,DE-ACCORD-208452,ACCORD,,77.0,YR,E,F,Y,105.0,KG,20201119.0,,PH,DE,DE,2020,Q4,Elderly
185203211,18520321,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201109.0,20201119,20201119,EXP,DE-BFARM-20012161,DE-ACCORD-208452,ACCORD,,77.0,YR,E,F,Y,105.0,KG,20201119.0,,PH,DE,DE,2020,Q4,Elderly
185203211,18520321,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201109.0,20201119,20201119,EXP,DE-BFARM-20012161,DE-ACCORD-208452,ACCORD,,77.0,YR,E,F,Y,105.0,KG,20201119.0,,PH,DE,DE,2020,Q4,Elderly
185231941,18523194,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, NACH SCHEMA",,,U,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201111.0,20201119,20201119,EXP,DE-ADRED-05958-05,NVSC2020DE302721,NOVARTIS,,78.0,YR,,F,Y,98.0,KG,20201119.0,,HP,DE,DE,2020,Q4,Elderly
185231941,18523194,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, NACH SCHEMA",,,U,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201111.0,20201119,20201119,EXP,DE-ADRED-05958-05,NVSC2020DE302721,NOVARTIS,,78.0,YR,,F,Y,98.0,KG,20201119.0,,HP,DE,DE,2020,Q4,Elderly
185231941,18523194,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, NACH SCHEMA",,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201111.0,20201119,20201119,EXP,DE-ADRED-05958-05,NVSC2020DE302721,NOVARTIS,,78.0,YR,,F,Y,98.0,KG,20201119.0,,HP,DE,DE,2020,Q4,Elderly
185231941,18523194,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, NACH SCHEMA",,,U,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201111.0,20201119,20201119,EXP,DE-ADRED-05958-05,NVSC2020DE302721,NOVARTIS,,78.0,YR,,F,Y,98.0,KG,20201119.0,,HP,DE,DE,2020,Q4,Elderly
185231941,18523194,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, NACH SCHEMA",,,U,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201111.0,20201119,20201119,EXP,DE-ADRED-05958-05,NVSC2020DE302721,NOVARTIS,,78.0,YR,,F,Y,98.0,KG,20201119.0,,HP,DE,DE,2020,Q4,Elderly
185242351,18524235,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201110.0,20201119,20201119,EXP,,DE-ASTRAZENECA-2020SF47659,ASTRAZENECA,,77.0,YR,,F,Y,99.0,KG,20201119.0,,PH,DE,DE,2020,Q4,Elderly
185242351,18524235,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201110.0,20201119,20201119,EXP,,DE-ASTRAZENECA-2020SF47659,ASTRAZENECA,,77.0,YR,,F,Y,99.0,KG,20201119.0,,PH,DE,DE,2020,Q4,Elderly
185242351,18524235,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201110.0,20201119,20201119,EXP,,DE-ASTRAZENECA-2020SF47659,ASTRAZENECA,,77.0,YR,,F,Y,99.0,KG,20201119.0,,PH,DE,DE,2020,Q4,Elderly
185249391,18524939,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201106.0,20201120,20201120,EXP,DE-ADRED-05958-04,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08294,ALKEM,,77.0,YR,,F,Y,99.0,KG,20201120.0,,HP,DE,DE,2020,Q4,Elderly
185249391,18524939,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201106.0,20201120,20201120,EXP,DE-ADRED-05958-04,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08294,ALKEM,,77.0,YR,,F,Y,99.0,KG,20201120.0,,HP,DE,DE,2020,Q4,Elderly
185249391,18524939,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201106.0,20201120,20201120,EXP,DE-ADRED-05958-04,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08294,ALKEM,,77.0,YR,,F,Y,99.0,KG,20201120.0,,HP,DE,DE,2020,Q4,Elderly
185253392,18525339,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,2,F,20201117.0,20201201.0,20201119,20201203,EXP,,US-GILEAD-2020-0505237,GILEAD,,39.0,YR,A,M,Y,197.7,KG,20201203.0,,PH,US,US,2020,Q4,Adult
185257041,18525704,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE 54 UNITS THREE TIMES A DAY,,,,,,,,,,,TID,2020,Q4,Memory impairment,Memory impairment,2020,Q4,1,I,,20200107.0,20201119,20201119,PER,,US-ALVOGEN-2020-ALVOGEN-107581,ALVOGEN,,65.0,YR,,F,Y,81.65,KG,20201120.0,,MD,US,US,2020,Q4,Elderly
185257041,18525704,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE 54 UNITS THREE TIMES A DAY,,,,,,,,,,,TID,2020,Q4,Myalgia,Myalgia,2020,Q4,1,I,,20200107.0,20201119,20201119,PER,,US-ALVOGEN-2020-ALVOGEN-107581,ALVOGEN,,65.0,YR,,F,Y,81.65,KG,20201120.0,,MD,US,US,2020,Q4,Elderly
185257041,18525704,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE 54 UNITS THREE TIMES A DAY,,,,,,,,,,,TID,2020,Q4,Off label use,Off label use,2020,Q4,1,I,,20200107.0,20201119,20201119,PER,,US-ALVOGEN-2020-ALVOGEN-107581,ALVOGEN,,65.0,YR,,F,Y,81.65,KG,20201120.0,,MD,US,US,2020,Q4,Elderly
185258711,18525871,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BY SCHEME,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201106.0,20201120,20201120,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-08757,LUPIN,,77.0,YR,,F,Y,99.0,KG,20201120.0,,CN,NL,DE,2020,Q4,Elderly
185258711,18525871,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BY SCHEME,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201106.0,20201120,20201120,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-08757,LUPIN,,77.0,YR,,F,Y,99.0,KG,20201120.0,,CN,NL,DE,2020,Q4,Elderly
185258711,18525871,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BY SCHEME,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201106.0,20201120,20201120,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-08757,LUPIN,,77.0,YR,,F,Y,99.0,KG,20201120.0,,CN,NL,DE,2020,Q4,Elderly
185272511,18527251,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201116.0,20201120,20201120,EXP,DE-ADRED-05958-04,DE-PFIZER INC-2020452691,PFIZER,,77.0,YR,,F,Y,99.0,KG,20201120.0,,PH,DE,DE,2020,Q4,Elderly
185272511,18527251,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201116.0,20201120,20201120,EXP,DE-ADRED-05958-04,DE-PFIZER INC-2020452691,PFIZER,,77.0,YR,,F,Y,99.0,KG,20201120.0,,PH,DE,DE,2020,Q4,Elderly
185272511,18527251,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201116.0,20201120,20201120,EXP,DE-ADRED-05958-04,DE-PFIZER INC-2020452691,PFIZER,,77.0,YR,,F,Y,99.0,KG,20201120.0,,PH,DE,DE,2020,Q4,Elderly
185278511,18527851,2,SS,INSULIN LISPRO SANOFI,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,INJECTION,,2020,Q4,Injection site erythema,,2020,Q4,1,I,20200903.0,20201111.0,20201120,20201120,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202011006594,ELI LILLY AND CO,,41.0,YR,,M,Y,58.0,KG,20201120.0,,PH,JP,JP,2020,Q4,Adult
185278511,18527851,2,SS,INSULIN LISPRO SANOFI,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,INJECTION,,2020,Q4,Injection site pruritus,,2020,Q4,1,I,20200903.0,20201111.0,20201120,20201120,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202011006594,ELI LILLY AND CO,,41.0,YR,,M,Y,58.0,KG,20201120.0,,PH,JP,JP,2020,Q4,Adult
185278511,18527851,2,SS,INSULIN LISPRO SANOFI,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,INJECTION,,2020,Q4,Malaise,,2020,Q4,1,I,20200903.0,20201111.0,20201120,20201120,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202011006594,ELI LILLY AND CO,,41.0,YR,,M,Y,58.0,KG,20201120.0,,PH,JP,JP,2020,Q4,Adult
185278511,18527851,2,SS,INSULIN LISPRO SANOFI,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,INJECTION,,2020,Q4,Nausea,,2020,Q4,1,I,20200903.0,20201111.0,20201120,20201120,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202011006594,ELI LILLY AND CO,,41.0,YR,,M,Y,58.0,KG,20201120.0,,PH,JP,JP,2020,Q4,Adult
185278511,18527851,2,SS,INSULIN LISPRO SANOFI,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,INJECTION,,2020,Q4,Vomiting,,2020,Q4,1,I,20200903.0,20201111.0,20201120,20201120,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202011006594,ELI LILLY AND CO,,41.0,YR,,M,Y,58.0,KG,20201120.0,,PH,JP,JP,2020,Q4,Adult
185285691,18528569,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK; ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201118.0,20201120,20201120,EXP,,DE-PFIZER INC-2020458476,PFIZER,,77.0,YR,,F,Y,105.0,KG,20201120.0,,PH,DE,DE,2020,Q4,Elderly
185285691,18528569,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK; ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201118.0,20201120,20201120,EXP,,DE-PFIZER INC-2020458476,PFIZER,,77.0,YR,,F,Y,105.0,KG,20201120.0,,PH,DE,DE,2020,Q4,Elderly
185285691,18528569,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK; ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201118.0,20201120,20201120,EXP,,DE-PFIZER INC-2020458476,PFIZER,,77.0,YR,,F,Y,105.0,KG,20201120.0,,PH,DE,DE,2020,Q4,Elderly
185285691,18528569,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK; ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201118.0,20201120,20201120,EXP,,DE-PFIZER INC-2020458476,PFIZER,,77.0,YR,,F,Y,105.0,KG,20201120.0,,PH,DE,DE,2020,Q4,Elderly
185302431,18530243,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (ACCORDING TO SCHEME),,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201109.0,20201121,20201121,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-08867,LUPIN,,77.0,YR,,F,Y,105.0,KG,20201121.0,,CN,NL,DE,2020,Q4,Elderly
185302431,18530243,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (ACCORDING TO SCHEME),,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201109.0,20201121,20201121,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-08867,LUPIN,,77.0,YR,,F,Y,105.0,KG,20201121.0,,CN,NL,DE,2020,Q4,Elderly
185302431,18530243,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (ACCORDING TO SCHEME),,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201109.0,20201121,20201121,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-08867,LUPIN,,77.0,YR,,F,Y,105.0,KG,20201121.0,,CN,NL,DE,2020,Q4,Elderly
185302431,18530243,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (ACCORDING TO SCHEME),,,,,,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201109.0,20201121,20201121,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-08867,LUPIN,,77.0,YR,,F,Y,105.0,KG,20201121.0,,CN,NL,DE,2020,Q4,Elderly
185302771,18530277,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, ACCORDING TO SCHEME",,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201109.0,20201121,20201121,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-08868,LUPIN,,78.0,YR,,F,Y,98.0,KG,20201121.0,,CN,NL,DE,2020,Q4,Elderly
185302771,18530277,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, ACCORDING TO SCHEME",,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201109.0,20201121,20201121,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-08868,LUPIN,,78.0,YR,,F,Y,98.0,KG,20201121.0,,CN,NL,DE,2020,Q4,Elderly
185302771,18530277,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, ACCORDING TO SCHEME",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201121,20201121,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-08868,LUPIN,,78.0,YR,,F,Y,98.0,KG,20201121.0,,CN,NL,DE,2020,Q4,Elderly
185302771,18530277,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, ACCORDING TO SCHEME",,,,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201109.0,20201121,20201121,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-08868,LUPIN,,78.0,YR,,F,Y,98.0,KG,20201121.0,,CN,NL,DE,2020,Q4,Elderly
185302771,18530277,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, ACCORDING TO SCHEME",,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201109.0,20201121,20201121,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-08868,LUPIN,,78.0,YR,,F,Y,98.0,KG,20201121.0,,CN,NL,DE,2020,Q4,Elderly
185303111,18530311,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201109.0,20201120,20201120,EXP,,DE-AUROBINDO-AUR-APL-2020-056797,AUROBINDO,,77.0,YR,,F,Y,105.0,KG,20201121.0,,PH,DE,DE,2020,Q4,Elderly
185303111,18530311,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201109.0,20201120,20201120,EXP,,DE-AUROBINDO-AUR-APL-2020-056797,AUROBINDO,,77.0,YR,,F,Y,105.0,KG,20201121.0,,PH,DE,DE,2020,Q4,Elderly
185303111,18530311,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201109.0,20201120,20201120,EXP,,DE-AUROBINDO-AUR-APL-2020-056797,AUROBINDO,,77.0,YR,,F,Y,105.0,KG,20201121.0,,PH,DE,DE,2020,Q4,Elderly
185303111,18530311,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201109.0,20201120,20201120,EXP,,DE-AUROBINDO-AUR-APL-2020-056797,AUROBINDO,,77.0,YR,,F,Y,105.0,KG,20201121.0,,PH,DE,DE,2020,Q4,Elderly
185303161,18530316,13,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,U,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201109.0,20201120,20201120,EXP,,DE-AUROBINDO-AUR-APL-2020-056801,AUROBINDO,,78.0,YR,,F,Y,98.0,KG,20201121.0,,PH,DE,DE,2020,Q4,Elderly
185303161,18530316,13,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,U,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201109.0,20201120,20201120,EXP,,DE-AUROBINDO-AUR-APL-2020-056801,AUROBINDO,,78.0,YR,,F,Y,98.0,KG,20201121.0,,PH,DE,DE,2020,Q4,Elderly
185303161,18530316,13,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201120,20201120,EXP,,DE-AUROBINDO-AUR-APL-2020-056801,AUROBINDO,,78.0,YR,,F,Y,98.0,KG,20201121.0,,PH,DE,DE,2020,Q4,Elderly
185303161,18530316,13,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,U,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201109.0,20201120,20201120,EXP,,DE-AUROBINDO-AUR-APL-2020-056801,AUROBINDO,,78.0,YR,,F,Y,98.0,KG,20201121.0,,PH,DE,DE,2020,Q4,Elderly
185303161,18530316,13,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,U,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201109.0,20201120,20201120,EXP,,DE-AUROBINDO-AUR-APL-2020-056801,AUROBINDO,,78.0,YR,,F,Y,98.0,KG,20201121.0,,PH,DE,DE,2020,Q4,Elderly
185315351,18531535,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201108.0,20201122,20201122,EXP,DE-ADRED-05958-04,DE-BAUSCH-BL-2020-033131,BAUSCH AND LOMB,,77.0,YR,,F,Y,99.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185315351,18531535,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201108.0,20201122,20201122,EXP,DE-ADRED-05958-04,DE-BAUSCH-BL-2020-033131,BAUSCH AND LOMB,,77.0,YR,,F,Y,99.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185315351,18531535,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201108.0,20201122,20201122,EXP,DE-ADRED-05958-04,DE-BAUSCH-BL-2020-033131,BAUSCH AND LOMB,,77.0,YR,,F,Y,99.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185316141,18531614,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201113.0,20201123,20201123,EXP,DE-ADRED-05958-04,DE-009507513-2011DEU009239,MERCK,,77.0,YR,,F,Y,99.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185316141,18531614,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201113.0,20201123,20201123,EXP,DE-ADRED-05958-04,DE-009507513-2011DEU009239,MERCK,,77.0,YR,,F,Y,99.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185316141,18531614,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201113.0,20201123,20201123,EXP,DE-ADRED-05958-04,DE-009507513-2011DEU009239,MERCK,,77.0,YR,,F,Y,99.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185319831,18531983,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA (),,,U,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201109.0,20201123,20201123,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-268415,RANBAXY,,77.0,YR,,F,Y,105.0,KG,20201123.0,,HP,NL,DE,2020,Q4,Elderly
185319831,18531983,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA (),,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201109.0,20201123,20201123,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-268415,RANBAXY,,77.0,YR,,F,Y,105.0,KG,20201123.0,,HP,NL,DE,2020,Q4,Elderly
185319831,18531983,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA (),,,U,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201109.0,20201123,20201123,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-268415,RANBAXY,,77.0,YR,,F,Y,105.0,KG,20201123.0,,HP,NL,DE,2020,Q4,Elderly
185319831,18531983,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA (),,,U,,,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201109.0,20201123,20201123,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-268415,RANBAXY,,77.0,YR,,F,Y,105.0,KG,20201123.0,,HP,NL,DE,2020,Q4,Elderly
185322711,18532271,9,C,insulin lispro,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201115.0,20201123,20201123,EXP,,DE-TEVA-2020-DE-1850647,TEVA,,77.0,YR,E,F,Y,99.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185322711,18532271,9,C,insulin lispro,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201115.0,20201123,20201123,EXP,,DE-TEVA-2020-DE-1850647,TEVA,,77.0,YR,E,F,Y,99.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185322711,18532271,9,C,insulin lispro,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201115.0,20201123,20201123,EXP,,DE-TEVA-2020-DE-1850647,TEVA,,77.0,YR,E,F,Y,99.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185325171,18532517,18,C,insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA (),,,U,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201109.0,20201123,20201123,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-268531,RANBAXY,,78.0,YR,,F,Y,98.0,KG,20201123.0,,HP,NL,DE,2020,Q4,Elderly
185325171,18532517,18,C,insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA (),,,U,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201109.0,20201123,20201123,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-268531,RANBAXY,,78.0,YR,,F,Y,98.0,KG,20201123.0,,HP,NL,DE,2020,Q4,Elderly
185325171,18532517,18,C,insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA (),,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201123,20201123,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-268531,RANBAXY,,78.0,YR,,F,Y,98.0,KG,20201123.0,,HP,NL,DE,2020,Q4,Elderly
185325171,18532517,18,C,insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA (),,,U,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201109.0,20201123,20201123,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-268531,RANBAXY,,78.0,YR,,F,Y,98.0,KG,20201123.0,,HP,NL,DE,2020,Q4,Elderly
185325171,18532517,18,C,insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA (),,,U,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201109.0,20201123,20201123,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-268531,RANBAXY,,78.0,YR,,F,Y,98.0,KG,20201123.0,,HP,NL,DE,2020,Q4,Elderly
185330171,18533017,16,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cholelithiasis,,2020,Q4,1,I,20201122.0,,20201122,20201122,DIR,,,FDA-CTU,,52.0,YR,,F,N,99.0,KG,20201122.0,N,PH,US,US,2020,Q4,Adult
185330171,18533017,16,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Pancreatitis acute,,2020,Q4,1,I,20201122.0,,20201122,20201122,DIR,,,FDA-CTU,,52.0,YR,,F,N,99.0,KG,20201122.0,N,PH,US,US,2020,Q4,Adult
185342791,18534279,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201111.0,20201123,20201123,EXP,,DE-ASTRAZENECA-2020SF48631,ASTRAZENECA,,78.0,YR,,F,Y,98.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185342791,18534279,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201111.0,20201123,20201123,EXP,,DE-ASTRAZENECA-2020SF48631,ASTRAZENECA,,78.0,YR,,F,Y,98.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185342791,18534279,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201111.0,20201123,20201123,EXP,,DE-ASTRAZENECA-2020SF48631,ASTRAZENECA,,78.0,YR,,F,Y,98.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185342791,18534279,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201111.0,20201123,20201123,EXP,,DE-ASTRAZENECA-2020SF48631,ASTRAZENECA,,78.0,YR,,F,Y,98.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185342791,18534279,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201111.0,20201123,20201123,EXP,,DE-ASTRAZENECA-2020SF48631,ASTRAZENECA,,78.0,YR,,F,Y,98.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185342801,18534280,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BY SCHEME,,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201111.0,20201123,20201123,EXP,,DE-ASTRAZENECA-2020SF48671,ASTRAZENECA,,77.0,YR,,F,Y,105.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185342801,18534280,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BY SCHEME,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201111.0,20201123,20201123,EXP,,DE-ASTRAZENECA-2020SF48671,ASTRAZENECA,,77.0,YR,,F,Y,105.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185342801,18534280,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BY SCHEME,,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201111.0,20201123,20201123,EXP,,DE-ASTRAZENECA-2020SF48671,ASTRAZENECA,,77.0,YR,,F,Y,105.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185342801,18534280,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BY SCHEME,,,,,,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201111.0,20201123,20201123,EXP,,DE-ASTRAZENECA-2020SF48671,ASTRAZENECA,,77.0,YR,,F,Y,105.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185352082,18535208,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Chest pain,,2020,Q4,2,F,20201114.0,20201119.0,20201123,20201204,EXP,,NVSC2020US307981,NOVARTIS,,61.0,YR,,M,Y,82.0,KG,20201204.0,,HP,US,US,2020,Q4,Adult
185364701,18536470,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201109.0,20201124,20201124,EXP,DE-ADRED-05958-06,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08291,ALKEM,,77.0,YR,,F,Y,105.0,KG,20201124.0,,HP,DE,DE,2020,Q4,Elderly
185364701,18536470,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201109.0,20201124,20201124,EXP,DE-ADRED-05958-06,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08291,ALKEM,,77.0,YR,,F,Y,105.0,KG,20201124.0,,HP,DE,DE,2020,Q4,Elderly
185364701,18536470,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201109.0,20201124,20201124,EXP,DE-ADRED-05958-06,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08291,ALKEM,,77.0,YR,,F,Y,105.0,KG,20201124.0,,HP,DE,DE,2020,Q4,Elderly
185364701,18536470,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201109.0,20201124,20201124,EXP,DE-ADRED-05958-06,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08291,ALKEM,,77.0,YR,,F,Y,105.0,KG,20201124.0,,HP,DE,DE,2020,Q4,Elderly
185364721,18536472,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201109.0,20201124,20201124,EXP,DE-ADRED-05958-05,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08295,ALKEM,,78.0,YR,,F,Y,98.0,KG,20201124.0,,HP,DE,DE,2020,Q4,Elderly
185364721,18536472,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201109.0,20201124,20201124,EXP,DE-ADRED-05958-05,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08295,ALKEM,,78.0,YR,,F,Y,98.0,KG,20201124.0,,HP,DE,DE,2020,Q4,Elderly
185364721,18536472,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201124,20201124,EXP,DE-ADRED-05958-05,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08295,ALKEM,,78.0,YR,,F,Y,98.0,KG,20201124.0,,HP,DE,DE,2020,Q4,Elderly
185364721,18536472,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201109.0,20201124,20201124,EXP,DE-ADRED-05958-05,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08295,ALKEM,,78.0,YR,,F,Y,98.0,KG,20201124.0,,HP,DE,DE,2020,Q4,Elderly
185364721,18536472,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201109.0,20201124,20201124,EXP,DE-ADRED-05958-05,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08295,ALKEM,,78.0,YR,,F,Y,98.0,KG,20201124.0,,HP,DE,DE,2020,Q4,Elderly
185379601,18537960,10,C,insulin lispro,INSULIN LISPRO,1,,NACH SCHEMA,,,,, UNKNOWN,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201117.0,20201124,20201124,EXP,,DE-DRREDDYS-GER/GER/20/0129214,DR REDDYS,,77.0,YR,E,F,Y,105.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185379601,18537960,10,C,insulin lispro,INSULIN LISPRO,1,,NACH SCHEMA,,,,, UNKNOWN,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201117.0,20201124,20201124,EXP,,DE-DRREDDYS-GER/GER/20/0129214,DR REDDYS,,77.0,YR,E,F,Y,105.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185379601,18537960,10,C,insulin lispro,INSULIN LISPRO,1,,NACH SCHEMA,,,,, UNKNOWN,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201117.0,20201124,20201124,EXP,,DE-DRREDDYS-GER/GER/20/0129214,DR REDDYS,,77.0,YR,E,F,Y,105.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185379601,18537960,10,C,insulin lispro,INSULIN LISPRO,1,,NACH SCHEMA,,,,, UNKNOWN,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201117.0,20201124,20201124,EXP,,DE-DRREDDYS-GER/GER/20/0129214,DR REDDYS,,77.0,YR,E,F,Y,105.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185380443,18538044,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Muscular weakness,,2020,Q4,3,F,20191008.0,20201202.0,20201123,20201203,EXP,,US-GILEAD-2019-0432608,GILEAD,,81.0,YR,E,M,Y,86.9,KG,20201203.0,,MD,US,US,2020,Q4,Elderly
185380443,18538044,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Toxic encephalopathy,,2020,Q4,3,F,20191008.0,20201202.0,20201123,20201203,EXP,,US-GILEAD-2019-0432608,GILEAD,,81.0,YR,E,M,Y,86.9,KG,20201203.0,,MD,US,US,2020,Q4,Elderly
185381401,18538140,18,C,insulin lispro,INSULIN LISPRO,1,,NACH SCHEMA (BY SCHEME),,,,, UNKNOWN,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201117.0,20201124,20201124,EXP,,DE-DRREDDYS-GER/GER/20/0129207,DR REDDYS,,78.0,YR,E,F,Y,98.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185381401,18538140,18,C,insulin lispro,INSULIN LISPRO,1,,NACH SCHEMA (BY SCHEME),,,,, UNKNOWN,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201117.0,20201124,20201124,EXP,,DE-DRREDDYS-GER/GER/20/0129207,DR REDDYS,,78.0,YR,E,F,Y,98.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185381401,18538140,18,C,insulin lispro,INSULIN LISPRO,1,,NACH SCHEMA (BY SCHEME),,,,, UNKNOWN,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201117.0,20201124,20201124,EXP,,DE-DRREDDYS-GER/GER/20/0129207,DR REDDYS,,78.0,YR,E,F,Y,98.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185381401,18538140,18,C,insulin lispro,INSULIN LISPRO,1,,NACH SCHEMA (BY SCHEME),,,,, UNKNOWN,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201117.0,20201124,20201124,EXP,,DE-DRREDDYS-GER/GER/20/0129207,DR REDDYS,,78.0,YR,E,F,Y,98.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185381401,18538140,18,C,insulin lispro,INSULIN LISPRO,1,,NACH SCHEMA (BY SCHEME),,,,, UNKNOWN,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201117.0,20201124,20201124,EXP,,DE-DRREDDYS-GER/GER/20/0129207,DR REDDYS,,78.0,YR,E,F,Y,98.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185401871,18540187,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO THE SCHEME,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201118.0,20201124,20201124,EXP,,DE-PFIZER INC-2020458450,PFIZER,,78.0,YR,,F,Y,98.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185401871,18540187,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO THE SCHEME,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201118.0,20201124,20201124,EXP,,DE-PFIZER INC-2020458450,PFIZER,,78.0,YR,,F,Y,98.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185401871,18540187,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO THE SCHEME,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201118.0,20201124,20201124,EXP,,DE-PFIZER INC-2020458450,PFIZER,,78.0,YR,,F,Y,98.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185401871,18540187,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO THE SCHEME,,,,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201118.0,20201124,20201124,EXP,,DE-PFIZER INC-2020458450,PFIZER,,78.0,YR,,F,Y,98.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185401871,18540187,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO THE SCHEME,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201118.0,20201124,20201124,EXP,,DE-PFIZER INC-2020458450,PFIZER,,78.0,YR,,F,Y,98.0,KG,20201124.0,,PH,DE,DE,2020,Q4,Elderly
185420621,18542062,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"25 U, BID",,,U,,,,20563.0,25.0,IU,INJECTION,BID,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,1,I,202008.0,20201104.0,20201125,20201125,PER,,US-ELI_LILLY_AND_COMPANY-US202011005540,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Adult
185420621,18542062,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"25 U, BID",,,U,,,,20563.0,25.0,IU,INJECTION,BID,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,1,I,202008.0,20201104.0,20201125,20201125,PER,,US-ELI_LILLY_AND_COMPANY-US202011005540,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Adult
185420621,18542062,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"25 U, BID",,,U,, D182601C,,20563.0,25.0,IU,INJECTION,BID,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,1,I,202008.0,20201104.0,20201125,20201125,PER,,US-ELI_LILLY_AND_COMPANY-US202011005540,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Adult
185420621,18542062,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"25 U, BID",,,U,, D182601C,,20563.0,25.0,IU,INJECTION,BID,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,1,I,202008.0,20201104.0,20201125,20201125,PER,,US-ELI_LILLY_AND_COMPANY-US202011005540,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Adult
185440901,18544090,18,C,insulin lispro,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-TEVA-2020-DE-1851621,TEVA,,78.0,YR,E,F,Y,98.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185440901,18544090,18,C,insulin lispro,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-TEVA-2020-DE-1851621,TEVA,,78.0,YR,E,F,Y,98.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185440901,18544090,18,C,insulin lispro,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-TEVA-2020-DE-1851621,TEVA,,78.0,YR,E,F,Y,98.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185440901,18544090,18,C,insulin lispro,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-TEVA-2020-DE-1851621,TEVA,,78.0,YR,E,F,Y,98.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185440901,18544090,18,C,insulin lispro,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-TEVA-2020-DE-1851621,TEVA,,78.0,YR,E,F,Y,98.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185443311,18544331,11,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Blood creatinine increased,,2020,Q4,1,I,20201121.0,,20201124,20201124,DIR,,,FDA-CTU,,69.0,YR,,M,N,71.4,KG,20201124.0,N,PH,US,US,2020,Q4,Elderly
185443311,18544331,11,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hepatic enzyme increased,,2020,Q4,1,I,20201121.0,,20201124,20201124,DIR,,,FDA-CTU,,69.0,YR,,M,N,71.4,KG,20201124.0,N,PH,US,US,2020,Q4,Elderly
185456301,18545630,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN",,,,,,,,,,INJECTION,,2020,Q4,Arrhythmia,,2020,Q4,1,I,20200211.0,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096312,MYLAN,,77.0,YR,,F,Y,102.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185456301,18545630,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN",,,,,,,,,,INJECTION,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200211.0,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096312,MYLAN,,77.0,YR,,F,Y,102.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185456301,18545630,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN",,,,,,,,,,INJECTION,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200211.0,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096312,MYLAN,,77.0,YR,,F,Y,102.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185456301,18545630,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN",,,,,,,,,,INJECTION,,2020,Q4,Rhonchi,,2020,Q4,1,I,20200211.0,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096312,MYLAN,,77.0,YR,,F,Y,102.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185456301,18545630,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN",,,,,,,,,,INJECTION,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200211.0,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096312,MYLAN,,77.0,YR,,F,Y,102.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185456301,18545630,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, AMPULLEN",,,,,,,,,,INJECTION,,2020,Q4,Wheezing,,2020,Q4,1,I,20200211.0,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096312,MYLAN,,77.0,YR,,F,Y,102.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185456351,18545635,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 8-10-12-0",,,,,,,,1.0,IU,,TID,2020,Q4,Cardiac failure,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096322,MYLAN,,77.0,YR,,F,Y,99.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185456351,18545635,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 8-10-12-0",,,,,,,,1.0,IU,,TID,2020,Q4,Depressed mood,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096322,MYLAN,,77.0,YR,,F,Y,99.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185456351,18545635,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 8-10-12-0",,,,,,,,1.0,IU,,TID,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096322,MYLAN,,77.0,YR,,F,Y,99.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185465901,18546590,10,C,insulin lispro,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-TEVA-2020-DE-1851636,TEVA,,77.0,YR,E,F,Y,105.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185465901,18546590,10,C,insulin lispro,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-TEVA-2020-DE-1851636,TEVA,,77.0,YR,E,F,Y,105.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185465901,18546590,10,C,insulin lispro,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-TEVA-2020-DE-1851636,TEVA,,77.0,YR,E,F,Y,105.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185465901,18546590,10,C,insulin lispro,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-TEVA-2020-DE-1851636,TEVA,,77.0,YR,E,F,Y,105.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185469731,18546973,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, PRN",,,U,,,,20563.0,12.0,IU,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, PRN",,,U,,,,20563.0,12.0,IU,INJECTION,,2020,Q4,Infection,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, PRN",,,U,,,,20563.0,12.0,IU,INJECTION,,2020,Q4,Oncologic complication,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, PRN",,,U,,,,20563.0,12.0,IU,INJECTION,,2020,Q4,Pain,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (EACH NIGHT)",,,U,,,,20563.0,14.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (EACH NIGHT)",,,U,,,,20563.0,14.0,IU,INJECTION,QD,2020,Q4,Infection,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (EACH NIGHT)",,,U,,,,20563.0,14.0,IU,INJECTION,QD,2020,Q4,Oncologic complication,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (EACH NIGHT)",,,U,,,,20563.0,14.0,IU,INJECTION,QD,2020,Q4,Pain,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,3,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, PRN",,,U,,,,,12.0,IU,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,3,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, PRN",,,U,,,,,12.0,IU,INJECTION,,2020,Q4,Infection,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,3,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, PRN",,,U,,,,,12.0,IU,INJECTION,,2020,Q4,Oncologic complication,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,3,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, PRN",,,U,,,,,12.0,IU,INJECTION,,2020,Q4,Pain,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,4,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (EACH NIGHT)",,,U,,,,,14.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,4,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (EACH NIGHT)",,,U,,,,,14.0,IU,INJECTION,QD,2020,Q4,Infection,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,4,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (EACH NIGHT)",,,U,,,,,14.0,IU,INJECTION,QD,2020,Q4,Oncologic complication,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185469731,18546973,4,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (EACH NIGHT)",,,U,,,,,14.0,IU,INJECTION,QD,2020,Q4,Pain,,2020,Q4,1,I,202008.0,20201116.0,20201125,20201125,EXP,,US-ELI_LILLY_AND_COMPANY-US202011008540,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201125.0,,CN,US,US,2020,Q4,Elderly
185484501,18548450,9,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Fungal peritonitis,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-2011-001424,FRESENIUS MEDICAL CARE,,62.0,YR,A,F,Y,63.4,KG,20201126.0,,HP,US,US,2020,Q4,Adult
185484501,18548450,9,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-2011-001424,FRESENIUS MEDICAL CARE,,62.0,YR,A,F,Y,63.4,KG,20201126.0,,HP,US,US,2020,Q4,Adult
185489421,18548942,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS PER SCHEDULE,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-009507513-2011DEU010485,MERCK,,78.0,YR,,F,Y,98.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185489421,18548942,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS PER SCHEDULE,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-009507513-2011DEU010485,MERCK,,78.0,YR,,F,Y,98.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185489421,18548942,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS PER SCHEDULE,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-009507513-2011DEU010485,MERCK,,78.0,YR,,F,Y,98.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185489421,18548942,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS PER SCHEDULE,,,,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-009507513-2011DEU010485,MERCK,,78.0,YR,,F,Y,98.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185489421,18548942,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS PER SCHEDULE,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,DE-009507513-2011DEU010485,MERCK,,78.0,YR,,F,Y,98.0,KG,20201125.0,,PH,DE,DE,2020,Q4,Elderly
185497101,18549710,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201111.0,20201126,20201126,EXP,,DE-BAUSCH-BL-2020-033481,BAUSCH AND LOMB,,78.0,YR,,F,Y,98.0,KG,20201126.0,,PH,DE,DE,2020,Q4,Elderly
185497101,18549710,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201111.0,20201126,20201126,EXP,,DE-BAUSCH-BL-2020-033481,BAUSCH AND LOMB,,78.0,YR,,F,Y,98.0,KG,20201126.0,,PH,DE,DE,2020,Q4,Elderly
185497101,18549710,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201111.0,20201126,20201126,EXP,,DE-BAUSCH-BL-2020-033481,BAUSCH AND LOMB,,78.0,YR,,F,Y,98.0,KG,20201126.0,,PH,DE,DE,2020,Q4,Elderly
185497101,18549710,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201111.0,20201126,20201126,EXP,,DE-BAUSCH-BL-2020-033481,BAUSCH AND LOMB,,78.0,YR,,F,Y,98.0,KG,20201126.0,,PH,DE,DE,2020,Q4,Elderly
185497101,18549710,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201111.0,20201126,20201126,EXP,,DE-BAUSCH-BL-2020-033481,BAUSCH AND LOMB,,78.0,YR,,F,Y,98.0,KG,20201126.0,,PH,DE,DE,2020,Q4,Elderly
185512481,18551248,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201111.0,20201126,20201126,EXP,DE-ADRED-05958-06,DE-BAUSCH-BL-2020-033482,BAUSCH AND LOMB,,77.0,YR,,F,Y,105.0,KG,20201126.0,,PH,DE,DE,2020,Q4,Elderly
185512481,18551248,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201111.0,20201126,20201126,EXP,DE-ADRED-05958-06,DE-BAUSCH-BL-2020-033482,BAUSCH AND LOMB,,77.0,YR,,F,Y,105.0,KG,20201126.0,,PH,DE,DE,2020,Q4,Elderly
185512481,18551248,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201111.0,20201126,20201126,EXP,DE-ADRED-05958-06,DE-BAUSCH-BL-2020-033482,BAUSCH AND LOMB,,77.0,YR,,F,Y,105.0,KG,20201126.0,,PH,DE,DE,2020,Q4,Elderly
185512481,18551248,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201111.0,20201126,20201126,EXP,DE-ADRED-05958-06,DE-BAUSCH-BL-2020-033482,BAUSCH AND LOMB,,77.0,YR,,F,Y,105.0,KG,20201126.0,,PH,DE,DE,2020,Q4,Elderly
185529731,18552973,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Dehydration,,2020,Q4,1,I,,20201117.0,20201127,20201127,EXP,,CA-APOTEX-2020AP022298,APOTEX,,72.0,YR,,F,Y,,,20201127.0,,CN,CA,CA,2020,Q4,Elderly
185537681,18553768,10,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,U,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,20200211.0,20201119.0,20201127,20201127,EXP,DE-ADRED-05958-02,DE-TORRENT-00018969,TORRENT,,77.0,YR,E,F,Y,101.0,KG,20201127.0,,PH,DE,DE,2020,Q4,Elderly
185537681,18553768,10,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20200211.0,20201119.0,20201127,20201127,EXP,DE-ADRED-05958-02,DE-TORRENT-00018969,TORRENT,,77.0,YR,E,F,Y,101.0,KG,20201127.0,,PH,DE,DE,2020,Q4,Elderly
185537681,18553768,10,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20200211.0,20201119.0,20201127,20201127,EXP,DE-ADRED-05958-02,DE-TORRENT-00018969,TORRENT,,77.0,YR,E,F,Y,101.0,KG,20201127.0,,PH,DE,DE,2020,Q4,Elderly
185537681,18553768,10,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,U,,,,,,,,,2020,Q4,Rhonchi,,2020,Q4,1,I,20200211.0,20201119.0,20201127,20201127,EXP,DE-ADRED-05958-02,DE-TORRENT-00018969,TORRENT,,77.0,YR,E,F,Y,101.0,KG,20201127.0,,PH,DE,DE,2020,Q4,Elderly
185537681,18553768,10,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,U,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,20200211.0,20201119.0,20201127,20201127,EXP,DE-ADRED-05958-02,DE-TORRENT-00018969,TORRENT,,77.0,YR,E,F,Y,101.0,KG,20201127.0,,PH,DE,DE,2020,Q4,Elderly
185537681,18553768,10,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,U,,,,,,,,,2020,Q4,Wheezing,,2020,Q4,1,I,20200211.0,20201119.0,20201127,20201127,EXP,DE-ADRED-05958-02,DE-TORRENT-00018969,TORRENT,,77.0,YR,E,F,Y,101.0,KG,20201127.0,,PH,DE,DE,2020,Q4,Elderly
185592531,18559253,8,C,Insulin Lispro Kwikpen,,2,,,,,,,,,,,,,,2020,Q4,Oedema peripheral,,2020,Q4,1,I,20201114.0,,20201127,20201127,DIR,,,FDA-CTU,,63.0,YR,,F,N,,,20201127.0,N,PH,US,US,2020,Q4,Adult
185609581,18560958,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Back pain,,2020,Q4,1,I,20191101.0,20201119.0,20201130,20201130,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202011008956,ELI LILLY AND CO,,15.0,YR,,F,Y,95.0,KG,20201130.0,,MD,DE,DE,2020,Q4,Youth
185609581,18560958,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Ketoacidosis,,2020,Q4,1,I,20191101.0,20201119.0,20201130,20201130,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202011008956,ELI LILLY AND CO,,15.0,YR,,F,Y,95.0,KG,20201130.0,,MD,DE,DE,2020,Q4,Youth
185609581,18560958,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Nausea,,2020,Q4,1,I,20191101.0,20201119.0,20201130,20201130,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202011008956,ELI LILLY AND CO,,15.0,YR,,F,Y,95.0,KG,20201130.0,,MD,DE,DE,2020,Q4,Youth
185609581,18560958,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Pain,,2020,Q4,1,I,20191101.0,20201119.0,20201130,20201130,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202011008956,ELI LILLY AND CO,,15.0,YR,,F,Y,95.0,KG,20201130.0,,MD,DE,DE,2020,Q4,Youth
185609581,18560958,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Product administration error,,2020,Q4,1,I,20191101.0,20201119.0,20201130,20201130,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202011008956,ELI LILLY AND CO,,15.0,YR,,F,Y,95.0,KG,20201130.0,,MD,DE,DE,2020,Q4,Youth
185609581,18560958,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Product dose omission issue,,2020,Q4,1,I,20191101.0,20201119.0,20201130,20201130,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202011008956,ELI LILLY AND CO,,15.0,YR,,F,Y,95.0,KG,20201130.0,,MD,DE,DE,2020,Q4,Youth
185609581,18560958,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Treatment noncompliance,,2020,Q4,1,I,20191101.0,20201119.0,20201130,20201130,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202011008956,ELI LILLY AND CO,,15.0,YR,,F,Y,95.0,KG,20201130.0,,MD,DE,DE,2020,Q4,Youth
185609581,18560958,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Vomiting,,2020,Q4,1,I,20191101.0,20201119.0,20201130,20201130,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202011008956,ELI LILLY AND CO,,15.0,YR,,F,Y,95.0,KG,20201130.0,,MD,DE,DE,2020,Q4,Youth
185616751,18561675,3,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Antibiotic therapy,,2020,Q4,1,I,20200319.0,20200420.0,20201130,20201130,EXP,,US-ROCHE-2588076,ROCHE,,48.0,YR,,M,Y,95.34,KG,20201130.0,,PH,US,US,2020,Q4,Adult
185616751,18561675,3,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Off label use,,2020,Q4,1,I,20200319.0,20200420.0,20201130,20201130,EXP,,US-ROCHE-2588076,ROCHE,,48.0,YR,,M,Y,95.34,KG,20201130.0,,PH,US,US,2020,Q4,Adult
185616751,18561675,3,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Thrombocytopenia,,2020,Q4,1,I,20200319.0,20200420.0,20201130,20201130,EXP,,US-ROCHE-2588076,ROCHE,,48.0,YR,,M,Y,95.34,KG,20201130.0,,PH,US,US,2020,Q4,Adult
185617061,18561706,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN(SLIDING SCALE)",,,,, C999324C,,20563.0,,,INJECTION,,2020,Q4,Arthralgia,,2020,Q4,1,I,20201102.0,20201103.0,20201201,20201201,PER,,US-ELI_LILLY_AND_COMPANY-US202011002232,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20201201.0,,CN,US,US,2020,Q4,Elderly
185617061,18561706,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN(SLIDING SCALE)",,,,, C999324C,,20563.0,,,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20201102.0,20201103.0,20201201,20201201,PER,,US-ELI_LILLY_AND_COMPANY-US202011002232,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20201201.0,,CN,US,US,2020,Q4,Elderly
185617061,18561706,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN(SLIDING SCALE)",,,,, C999324C,,20563.0,,,INJECTION,,2020,Q4,Fatigue,,2020,Q4,1,I,20201102.0,20201103.0,20201201,20201201,PER,,US-ELI_LILLY_AND_COMPANY-US202011002232,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20201201.0,,CN,US,US,2020,Q4,Elderly
185617061,18561706,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN(SLIDING SCALE)",,,,, C999324C,,20563.0,,,INJECTION,,2020,Q4,Neck pain,,2020,Q4,1,I,20201102.0,20201103.0,20201201,20201201,PER,,US-ELI_LILLY_AND_COMPANY-US202011002232,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20201201.0,,CN,US,US,2020,Q4,Elderly
185617061,18561706,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN(SLIDING SCALE)",,,,, C999324C,,20563.0,,,INJECTION,,2020,Q4,Pain in extremity,,2020,Q4,1,I,20201102.0,20201103.0,20201201,20201201,PER,,US-ELI_LILLY_AND_COMPANY-US202011002232,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20201201.0,,CN,US,US,2020,Q4,Elderly
185644031,18564403,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 UNITS THREE TIMES A DAY BEFORE MEALS,,,U,U,,,,,,INJECTION,,2020,Q4,Drug ineffective,,2020,Q4,1,I,,20201119.0,20201201,20201201,EXP,US-MLMSERVICE-20201028-2547353-1,US-MYLANLABS-2020M1097790,MYLAN,,18.0,YR,,F,Y,80.0,KG,20201201.0,,PH,US,US,2020,Q4,Youth
185644031,18564403,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 UNITS THREE TIMES A DAY BEFORE MEALS,,,U,U,,,,,,INJECTION,,2020,Q4,Nausea,,2020,Q4,1,I,,20201119.0,20201201,20201201,EXP,US-MLMSERVICE-20201028-2547353-1,US-MYLANLABS-2020M1097790,MYLAN,,18.0,YR,,F,Y,80.0,KG,20201201.0,,PH,US,US,2020,Q4,Youth
185671301,18567130,2,C,DEGLUDEC LISPRO,,2,Unknown,,,,,,,,,,,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,,20201125.0,20201201,20201201,EXP,,GR-ASTRAZENECA-2020SF56120,ASTRAZENECA,,39.0,YR,,F,Y,,,20201201.0,,HP,GR,GR,2020,Q4,Adult
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Acute myocardial infarction,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Aortic valve incompetence,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Cough,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Diastolic dysfunction,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Dyslipidaemia,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Haematoma,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Hepatotoxicity,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Neuropathy peripheral,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Off label use,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Polyneuropathy,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Pulmonary congestion,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Right ventricular failure,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Tricuspid valve incompetence,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Vascular stent thrombosis,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185671461,18567146,10,C,LISPRO,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Weight decreased,,2020,Q4,1,I,2010.0,20201125.0,20201201,20201201,EXP,,DE-ASTRAZENECA-2020SF58403,ASTRAZENECA,,78.0,YR,,M,Y,,,20201201.0,,MD,DE,DE,2020,Q4,Elderly
185679131,18567913,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"30 U, DAILY",,,U,,,,20563.0,30.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20201106.0,20201106.0,20201202,20201202,PER,,US-ELI_LILLY_AND_COMPANY-US202011005918,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20201202.0,,CN,US,US,2020,Q4,Elderly
185682361,18568236,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,15.0,IU,UNKNOWN,,2020,Q4,Nausea,,2020,Q4,1,I,,20201020.0,20201202,20201202,PER,,US-JNJFOC-20201040842,JOHNSON AND JOHNSON,"MARINUCCI V, BUSH L, CHAHINE E. INVASIVE FUNGAL RHINOSINUSITIS CAUSED BY CURVULARIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: A CASE REPORT. J PHARM PRACT. 2020;.",18.0,YR,A,F,Y,80.0,KG,20201202.0,,HP,US,US,2020,Q4,Youth
185682361,18568236,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,15.0,IU,UNKNOWN,,2020,Q4,Off label use,,2020,Q4,1,I,,20201020.0,20201202,20201202,PER,,US-JNJFOC-20201040842,JOHNSON AND JOHNSON,"MARINUCCI V, BUSH L, CHAHINE E. INVASIVE FUNGAL RHINOSINUSITIS CAUSED BY CURVULARIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: A CASE REPORT. J PHARM PRACT. 2020;.",18.0,YR,A,F,Y,80.0,KG,20201202.0,,HP,US,US,2020,Q4,Youth
185682361,18568236,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,15.0,IU,UNKNOWN,,2020,Q4,Product use in unapproved indication,,2020,Q4,1,I,,20201020.0,20201202,20201202,PER,,US-JNJFOC-20201040842,JOHNSON AND JOHNSON,"MARINUCCI V, BUSH L, CHAHINE E. INVASIVE FUNGAL RHINOSINUSITIS CAUSED BY CURVULARIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: A CASE REPORT. J PHARM PRACT. 2020;.",18.0,YR,A,F,Y,80.0,KG,20201202.0,,HP,US,US,2020,Q4,Youth
185682361,18568236,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,15.0,IU,UNKNOWN,,2020,Q4,Therapeutic response unexpected,,2020,Q4,1,I,,20201020.0,20201202,20201202,PER,,US-JNJFOC-20201040842,JOHNSON AND JOHNSON,"MARINUCCI V, BUSH L, CHAHINE E. INVASIVE FUNGAL RHINOSINUSITIS CAUSED BY CURVULARIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: A CASE REPORT. J PHARM PRACT. 2020;.",18.0,YR,A,F,Y,80.0,KG,20201202.0,,HP,US,US,2020,Q4,Youth
185685001,18568500,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Product substitution issue,,2020,Q4,1,I,20191024.0,,20201130,20201130,DIR,,,FDA-CTU,,35.0,YR,,M,N,107.05,KG,20191024.0,N,HP,US,US,2020,Q4,Adult
185685001,18568500,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Therapeutic response changed,,2020,Q4,1,I,20191024.0,,20201130,20201130,DIR,,,FDA-CTU,,35.0,YR,,M,N,107.05,KG,20191024.0,N,HP,US,US,2020,Q4,Adult
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Acute myocardial infarction,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Aortic valve incompetence,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Cough,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Diastolic dysfunction,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Dyslipidaemia,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Haematoma,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Hepatotoxicity,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Neuropathy peripheral,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Polyneuropathy,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Pulmonary congestion,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Right ventricular failure,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Tricuspid valve incompetence,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Vascular stent thrombosis,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185708591,18570859,23,C,INSULIN LISPRO GENETICAL RECOMBINATION,,2,,50 MG WITH MEALS,,,,,,,,,,,,2020,Q4,Weight decreased,,2020,Q4,1,I,2010.0,20201201.0,20201202,20201202,EXP,,DE-ANIPHARMA-2020-DE-000301,ANI,,78.0,YR,,M,Y,,,20201202.0,,MD,DE,DE,2020,Q4,Elderly
185748541,18574854,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Decreased appetite,,2020,Q4,1,I,20200823.0,20201123.0,20201203,20201203,EXP,,NVSC2020US314130,NOVARTIS,,71.0,YR,,F,Y,69.8,KG,20201203.0,,CN,US,US,2020,Q4,Elderly
185748541,18574854,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,20200823.0,20201123.0,20201203,20201203,EXP,,NVSC2020US314130,NOVARTIS,,71.0,YR,,F,Y,69.8,KG,20201203.0,,CN,US,US,2020,Q4,Elderly
185748541,18574854,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Drug interaction,,2020,Q4,1,I,20200823.0,20201123.0,20201203,20201203,EXP,,NVSC2020US314130,NOVARTIS,,71.0,YR,,F,Y,69.8,KG,20201203.0,,CN,US,US,2020,Q4,Elderly
185748541,18574854,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,"Hallucination, visual",,2020,Q4,1,I,20200823.0,20201123.0,20201203,20201203,EXP,,NVSC2020US314130,NOVARTIS,,71.0,YR,,F,Y,69.8,KG,20201203.0,,CN,US,US,2020,Q4,Elderly
185748541,18574854,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Mental status changes,,2020,Q4,1,I,20200823.0,20201123.0,20201203,20201203,EXP,,NVSC2020US314130,NOVARTIS,,71.0,YR,,F,Y,69.8,KG,20201203.0,,CN,US,US,2020,Q4,Elderly
185748541,18574854,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Near death experience,,2020,Q4,1,I,20200823.0,20201123.0,20201203,20201203,EXP,,NVSC2020US314130,NOVARTIS,,71.0,YR,,F,Y,69.8,KG,20201203.0,,CN,US,US,2020,Q4,Elderly
185748541,18574854,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Product dose omission issue,,2020,Q4,1,I,20200823.0,20201123.0,20201203,20201203,EXP,,NVSC2020US314130,NOVARTIS,,71.0,YR,,F,Y,69.8,KG,20201203.0,,CN,US,US,2020,Q4,Elderly
185748541,18574854,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Sinus tachycardia,,2020,Q4,1,I,20200823.0,20201123.0,20201203,20201203,EXP,,NVSC2020US314130,NOVARTIS,,71.0,YR,,F,Y,69.8,KG,20201203.0,,CN,US,US,2020,Q4,Elderly
185748541,18574854,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Ventricular extrasystoles,,2020,Q4,1,I,20200823.0,20201123.0,20201203,20201203,EXP,,NVSC2020US314130,NOVARTIS,,71.0,YR,,F,Y,69.8,KG,20201203.0,,CN,US,US,2020,Q4,Elderly
185748541,18574854,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Weight decreased,,2020,Q4,1,I,20200823.0,20201123.0,20201203,20201203,EXP,,NVSC2020US314130,NOVARTIS,,71.0,YR,,F,Y,69.8,KG,20201203.0,,CN,US,US,2020,Q4,Elderly
185771031,18577103,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"29 U, PRN",,,U,, D214632C,,20563.0,29.0,IU,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20201118.0,20201118.0,20201203,20201203,PER,,US-ELI_LILLY_AND_COMPANY-US202011011053,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20201203.0,,CN,US,US,2020,Q4,Elderly
185775241,18577524,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Agitation,,2020,Q4,1,I,,20201126.0,20201204,20201204,EXP,,GR-EMD SERONO-9203035,EMD SERONO INC,,65.0,YR,E,F,Y,,,20201204.0,,HP,GR,GR,2020,Q4,Elderly
185775241,18577524,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Confusional state,,2020,Q4,1,I,,20201126.0,20201204,20201204,EXP,,GR-EMD SERONO-9203035,EMD SERONO INC,,65.0,YR,E,F,Y,,,20201204.0,,HP,GR,GR,2020,Q4,Elderly
185789401,18578940,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cytokine release syndrome,,2020,Q4,1,I,20200902.0,,20201202,20201202,DIR,,,FDA-CTU,,76.0,YR,,F,N,68.4,KG,20201202.0,N,HP,US,US,2020,Q4,Elderly
185789401,18578940,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Neurotoxicity,,2020,Q4,1,I,20200902.0,,20201202,20201202,DIR,,,FDA-CTU,,76.0,YR,,F,N,68.4,KG,20201202.0,N,HP,US,US,2020,Q4,Elderly
185799461,18579946,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 UNITS THRICE DAILY BEFORE MEALS,,,D,, UNKNOWN,,,15.0,DF,,TID,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,,20201119.0,20201204,20201204,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-09642,LUPIN,,18.0,YR,,F,Y,80.0,KG,20201204.0,,MD,US,US,2020,Q4,Youth
185799461,18579946,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 UNITS THRICE DAILY BEFORE MEALS,,,D,, UNKNOWN,,,15.0,DF,,TID,2020,Q4,Drug ineffective,,2020,Q4,1,I,,20201119.0,20201204,20201204,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-09642,LUPIN,,18.0,YR,,F,Y,80.0,KG,20201204.0,,MD,US,US,2020,Q4,Youth
185809851,18580985,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,1,I,20200909.0,20201127.0,20201204,20201204,EXP,,SE-BAUSCH-BL-2020-035311,BAUSCH AND LOMB,,61.0,YR,,M,Y,101.0,KG,20201204.0,,MD,SE,SE,2020,Q4,Adult
185809851,18580985,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,20200909.0,20201127.0,20201204,20201204,EXP,,SE-BAUSCH-BL-2020-035311,BAUSCH AND LOMB,,61.0,YR,,M,Y,101.0,KG,20201204.0,,MD,SE,SE,2020,Q4,Adult
185814241,18581424,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2020,Q4,Coronary artery occlusion,,2020,Q4,1,I,201912.0,20201124.0,20201204,20201204,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202011011333,ELI LILLY AND CO,,40.0,YR,,M,Y,,,20201204.0,,CN,GB,GB,2020,Q4,Adult
185814241,18581424,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2020,Q4,Myocardial infarction,,2020,Q4,1,I,201912.0,20201124.0,20201204,20201204,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202011011333,ELI LILLY AND CO,,40.0,YR,,M,Y,,,20201204.0,,CN,GB,GB,2020,Q4,Adult
185848581,18584858,11,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20201203.0,,20201205,20201205,DIR,,,FDA-CTU,,75.0,YR,,F,N,103.5,KG,20201205.0,N,PH,US,US,2020,Q4,Elderly
185848581,18584858,11,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Respiratory disorder,,2020,Q4,1,I,20201203.0,,20201205,20201205,DIR,,,FDA-CTU,,75.0,YR,,F,N,103.5,KG,20201205.0,N,PH,US,US,2020,Q4,Elderly
185857871,18585787,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201126.0,20201207,20201207,EXP,,DE-MYLANLABS-2020M1098741,MYLAN,,77.0,YR,,F,Y,99.0,KG,20201207.0,,PH,DE,DE,2020,Q4,Elderly
185857871,18585787,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201126.0,20201207,20201207,EXP,,DE-MYLANLABS-2020M1098741,MYLAN,,77.0,YR,,F,Y,99.0,KG,20201207.0,,PH,DE,DE,2020,Q4,Elderly
185857871,18585787,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,ACCORDING TO SCHEME,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201126.0,20201207,20201207,EXP,,DE-MYLANLABS-2020M1098741,MYLAN,,77.0,YR,,F,Y,99.0,KG,20201207.0,,PH,DE,DE,2020,Q4,Elderly
185858011,18585801,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Myasthenia gravis,,2020,Q4,1,I,20201104.0,,20201206,20201206,DIR,,,FDA-CTU,,73.0,YR,,F,N,67.5,KG,20201206.0,N,CN,US,US,2020,Q4,Elderly
185858851,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2020,Q4,Blood glucose fluctuation,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2020,Q4,Dizziness,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2020,Q4,Hyperglycaemia,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2020,Q4,Malaise,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2020,Q4,Pancreatic disorder,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2020,Q4,Postprandial hypoglycaemia,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2020,Q4,Blood glucose fluctuation,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2020,Q4,Hyperglycaemia,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2020,Q4,Malaise,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2020,Q4,Pancreatic disorder,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2020,Q4,Postprandial hypoglycaemia,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2020,Q4,Blood glucose fluctuation,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2020,Q4,Dizziness,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2020,Q4,Hyperglycaemia,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2020,Q4,Malaise,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2020,Q4,Pancreatic disorder,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2020,Q4,Postprandial hypoglycaemia,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2020,Q4,Blood glucose fluctuation,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2020,Q4,Hyperglycaemia,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2020,Q4,Malaise,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2020,Q4,Pancreatic disorder,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2020,Q4,Postprandial hypoglycaemia,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185860691,18586069,5,C,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201126.0,20201207,20201207,EXP,DE-ADRED-05958-04,DE-TORRENT-00019052,TORRENT,,77.0,YR,E,F,Y,99.0,KG,20201207.0,,PH,DE,DE,2020,Q4,Elderly
185860691,18586069,5,C,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201126.0,20201207,20201207,EXP,DE-ADRED-05958-04,DE-TORRENT-00019052,TORRENT,,77.0,YR,E,F,Y,99.0,KG,20201207.0,,PH,DE,DE,2020,Q4,Elderly
185860691,18586069,5,C,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201126.0,20201207,20201207,EXP,DE-ADRED-05958-04,DE-TORRENT-00019052,TORRENT,,77.0,YR,E,F,Y,99.0,KG,20201207.0,,PH,DE,DE,2020,Q4,Elderly
185909421,18590942,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201130.0,20201208,20201208,EXP,,DE-MYLANLABS-2020M1099271,MYLAN,,78.0,YR,,F,Y,98.0,KG,20201208.0,,PH,DE,DE,2020,Q4,Elderly
185909421,18590942,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201130.0,20201208,20201208,EXP,,DE-MYLANLABS-2020M1099271,MYLAN,,78.0,YR,,F,Y,98.0,KG,20201208.0,,PH,DE,DE,2020,Q4,Elderly
185909421,18590942,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201130.0,20201208,20201208,EXP,,DE-MYLANLABS-2020M1099271,MYLAN,,78.0,YR,,F,Y,98.0,KG,20201208.0,,PH,DE,DE,2020,Q4,Elderly
185909421,18590942,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201130.0,20201208,20201208,EXP,,DE-MYLANLABS-2020M1099271,MYLAN,,78.0,YR,,F,Y,98.0,KG,20201208.0,,PH,DE,DE,2020,Q4,Elderly
185909421,18590942,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201130.0,20201208,20201208,EXP,,DE-MYLANLABS-2020M1099271,MYLAN,,78.0,YR,,F,Y,98.0,KG,20201208.0,,PH,DE,DE,2020,Q4,Elderly
185924031,18592403,4,C,LISPRO KWIKPEN,,2,,,,,U,,,,,,,,,2020,Q4,Death,,2020,Q4,1,I,20201112.0,20201203.0,20201209,20201209,EXP,,US-TAIHO ONCOLOGY  INC-EU-2020-04214,TAIHO ONCOLOGY INC,,62.0,YR,,F,Y,50.85,KG,20201209.0,,CN,US,US,2020,Q4,Adult
185924031,18592403,4,C,LISPRO KWIKPEN,,2,,,,,U,,,,,,,,,2020,Q4,Intentional product use issue,,2020,Q4,1,I,20201112.0,20201203.0,20201209,20201209,EXP,,US-TAIHO ONCOLOGY  INC-EU-2020-04214,TAIHO ONCOLOGY INC,,62.0,YR,,F,Y,50.85,KG,20201209.0,,CN,US,US,2020,Q4,Adult
185932552,18593255,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q4,Back pain,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q4,Balance disorder,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q4,Dizziness,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q4,Dyspnoea,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q4,Fall,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q4,Gait disturbance,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q4,Mass,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2020,Q4,Vision blurred,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D214632C,,,,,INJECTION,,2020,Q4,Back pain,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D214632C,,,,,INJECTION,,2020,Q4,Balance disorder,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D214632C,,,,,INJECTION,,2020,Q4,Dizziness,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D214632C,,,,,INJECTION,,2020,Q4,Dyspnoea,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D214632C,,,,,INJECTION,,2020,Q4,Fall,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D214632C,,,,,INJECTION,,2020,Q4,Gait disturbance,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D214632C,,,,,INJECTION,,2020,Q4,Mass,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185932552,18593255,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D214632C,,,,,INJECTION,,2020,Q4,Vision blurred,,2020,Q4,2,F,202011.0,20201210.0,20201209,20201214,PER,,US-ELI_LILLY_AND_COMPANY-US202012003961,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
185933401,18593340,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 UNITS, TID AC",,,D,,,,,,,,,2020,Q4,Hypersensitivity,,2020,Q4,1,I,20201110.0,20201123.0,20201208,20201208,EXP,,"US-RIGEL PHARMACEUTICALS, INC.-2020FOS000640",RIGEL PHARMACEUTICALS,,68.0,YR,,F,Y,61.8,KG,20201208.0,,HP,US,US,2020,Q4,Elderly
185947541,18594754,10,C,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201130.0,20201209,20201209,EXP,DE-ADRED-05958-06,DE-TORRENT-00019069,TORRENT,,77.0,YR,E,F,Y,105.0,KG,20201209.0,,PH,DE,DE,2020,Q4,Elderly
185947541,18594754,10,C,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201130.0,20201209,20201209,EXP,DE-ADRED-05958-06,DE-TORRENT-00019069,TORRENT,,77.0,YR,E,F,Y,105.0,KG,20201209.0,,PH,DE,DE,2020,Q4,Elderly
185947541,18594754,10,C,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201130.0,20201209,20201209,EXP,DE-ADRED-05958-06,DE-TORRENT-00019069,TORRENT,,77.0,YR,E,F,Y,105.0,KG,20201209.0,,PH,DE,DE,2020,Q4,Elderly
185947541,18594754,10,C,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201130.0,20201209,20201209,EXP,DE-ADRED-05958-06,DE-TORRENT-00019069,TORRENT,,77.0,YR,E,F,Y,105.0,KG,20201209.0,,PH,DE,DE,2020,Q4,Elderly
185947671,18594767,10,C,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201130.0,20201209,20201209,EXP,DE-ADRED-05958-05,DE-TORRENT-00019061,TORRENT,,78.0,YR,E,F,Y,98.0,KG,20201209.0,,PH,DE,DE,2020,Q4,Elderly
185947671,18594767,10,C,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201130.0,20201209,20201209,EXP,DE-ADRED-05958-05,DE-TORRENT-00019061,TORRENT,,78.0,YR,E,F,Y,98.0,KG,20201209.0,,PH,DE,DE,2020,Q4,Elderly
185947671,18594767,10,C,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201130.0,20201209,20201209,EXP,DE-ADRED-05958-05,DE-TORRENT-00019061,TORRENT,,78.0,YR,E,F,Y,98.0,KG,20201209.0,,PH,DE,DE,2020,Q4,Elderly
185947671,18594767,10,C,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,Pallor,,2020,Q4,1,I,,20201130.0,20201209,20201209,EXP,DE-ADRED-05958-05,DE-TORRENT-00019061,TORRENT,,78.0,YR,E,F,Y,98.0,KG,20201209.0,,PH,DE,DE,2020,Q4,Elderly
185947671,18594767,10,C,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,Wound,,2020,Q4,1,I,,20201130.0,20201209,20201209,EXP,DE-ADRED-05958-05,DE-TORRENT-00019061,TORRENT,,78.0,YR,E,F,Y,98.0,KG,20201209.0,,PH,DE,DE,2020,Q4,Elderly
185951001,18595100,8,C,"Insulin (glargine, lispro and regular)",,2,,,,,,,,,,,,,,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,20201207.0,,20201209,20201209,DIR,,,FDA-CTU,,80.0,YR,,F,N,83.9,KG,20201209.0,Y,PH,US,US,2020,Q4,Elderly
185953592,18595359,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Aggression,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Agitation,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Communication disorder,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Confusional state,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Disorientation,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Hyperhidrosis,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2020,Q4,Mental disorder,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185986001,18598600,58,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,0-15 UNIT,,,,,,,,,,,QD,2020,Q4,COVID-19 pneumonia,,2020,Q4,1,I,20201109.0,20201203.0,20201210,20201210,PER,,US-AMGEN-USASP2020198569,AMGEN,,72.0,YR,E,M,Y,113.4,KG,20201210.0,,MD,US,US,2020,Q4,Elderly
185986001,18598600,58,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,0-15 UNIT,,,,,,,,,,,QD,2020,Q4,Immunosuppression,,2020,Q4,1,I,20201109.0,20201203.0,20201210,20201210,PER,,US-AMGEN-USASP2020198569,AMGEN,,72.0,YR,E,M,Y,113.4,KG,20201210.0,,MD,US,US,2020,Q4,Elderly
185986001,18598600,58,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,0-15 UNIT,,,,,,,,,,,QD,2020,Q4,Inappropriate antidiuretic hormone secretion,,2020,Q4,1,I,20201109.0,20201203.0,20201210,20201210,PER,,US-AMGEN-USASP2020198569,AMGEN,,72.0,YR,E,M,Y,113.4,KG,20201210.0,,MD,US,US,2020,Q4,Elderly
185986001,18598600,59,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"0-30 UNIT, TID",,,,,,,,,,,TID,2020,Q4,COVID-19 pneumonia,,2020,Q4,1,I,20201109.0,20201203.0,20201210,20201210,PER,,US-AMGEN-USASP2020198569,AMGEN,,72.0,YR,E,M,Y,113.4,KG,20201210.0,,MD,US,US,2020,Q4,Elderly
185986001,18598600,59,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"0-30 UNIT, TID",,,,,,,,,,,TID,2020,Q4,Immunosuppression,,2020,Q4,1,I,20201109.0,20201203.0,20201210,20201210,PER,,US-AMGEN-USASP2020198569,AMGEN,,72.0,YR,E,M,Y,113.4,KG,20201210.0,,MD,US,US,2020,Q4,Elderly
185986001,18598600,59,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"0-30 UNIT, TID",,,,,,,,,,,TID,2020,Q4,Inappropriate antidiuretic hormone secretion,,2020,Q4,1,I,20201109.0,20201203.0,20201210,20201210,PER,,US-AMGEN-USASP2020198569,AMGEN,,72.0,YR,E,M,Y,113.4,KG,20201210.0,,MD,US,US,2020,Q4,Elderly
185987791,18598779,4,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3 TIMES A DAY (15 UNITS  THRICE  DAILY  BEFORE  MEALS  )",,,U,U,,,,,,,TID,2020,Q4,Drug ineffective,,2020,Q4,1,I,,20201130.0,20201210,20201210,EXP,,US-AUROBINDO-AUR-APL-2020-060008,AUROBINDO,,18.0,YR,,F,Y,80.0,KG,20201210.0,,HP,US,US,2020,Q4,Youth
186005411,18600541,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20201208.0,,20201210,20201210,DIR,,,FDA-CTU,,52.0,YR,,F,N,163.0,KG,20201210.0,N,PH,US,US,2020,Q4,Adult
186005411,18600541,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,White blood cell count decreased,,2020,Q4,1,I,20201208.0,,20201210,20201210,DIR,,,FDA-CTU,,52.0,YR,,F,N,163.0,KG,20201210.0,N,PH,US,US,2020,Q4,Adult
186006471,18600647,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,20200906.0,20201130.0,20201210,20201210,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-102070,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20201210.0,,PH,IT,IT,2020,Q4,Elderly
186006471,18600647,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Haemorrhoids,,2020,Q4,1,I,20200906.0,20201130.0,20201210,20201210,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-102070,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20201210.0,,PH,IT,IT,2020,Q4,Elderly
186006471,18600647,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Iron deficiency anaemia,,2020,Q4,1,I,20200906.0,20201130.0,20201210,20201210,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-102070,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20201210.0,,PH,IT,IT,2020,Q4,Elderly
186017411,18601741,2,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,15 UNITS THREE TIMES A DAY BEFORE MEALS,,,U,,,,,,,,TID,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201130.0,20201210,20201210,EXP,,US-TEVA-2020-US-1856289,TEVA,"MARINUCCI V, CHAHINE EB, BUSH LM. INVASIVE FUNGAL RHINOSINUSITIS CAUSED BY CURVULARIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: A CASE REPORT. J-PHARM-PRACT 2020;:NO PAGINATION.",18.0,YR,A,F,Y,80.0,KG,20201210.0,,PH,US,US,2020,Q4,Youth
186017411,18601741,2,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,15 UNITS THREE TIMES A DAY BEFORE MEALS,,,U,,,,,,,,TID,2020,Q4,Drug ineffective,,2020,Q4,1,I,,20201130.0,20201210,20201210,EXP,,US-TEVA-2020-US-1856289,TEVA,"MARINUCCI V, CHAHINE EB, BUSH LM. INVASIVE FUNGAL RHINOSINUSITIS CAUSED BY CURVULARIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: A CASE REPORT. J-PHARM-PRACT 2020;:NO PAGINATION.",18.0,YR,A,F,Y,80.0,KG,20201210.0,,PH,US,US,2020,Q4,Youth
186017411,18601741,2,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,15 UNITS THREE TIMES A DAY BEFORE MEALS,,,U,,,,,,,,TID,2020,Q4,Nausea,,2020,Q4,1,I,,20201130.0,20201210,20201210,EXP,,US-TEVA-2020-US-1856289,TEVA,"MARINUCCI V, CHAHINE EB, BUSH LM. INVASIVE FUNGAL RHINOSINUSITIS CAUSED BY CURVULARIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: A CASE REPORT. J-PHARM-PRACT 2020;:NO PAGINATION.",18.0,YR,A,F,Y,80.0,KG,20201210.0,,PH,US,US,2020,Q4,Youth
186021911,18602191,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2020,Q4,COVID-19,,2020,Q4,1,I,20201204.0,20201207.0,20201210,20201210,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-105136,BRISTOL MYERS SQUIBB,,95.0,YR,,M,Y,96.6,KG,20201210.0,,HP,US,US,2020,Q4,Elderly
186049511,18604951,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201130.0,20201211,20201211,EXP,DE-ADRED-05958-06,DE-MYLANLABS-2020M1099281,MYLAN,,77.0,YR,,F,Y,105.0,KG,20201211.0,,PH,DE,DE,2020,Q4,Elderly
186049511,18604951,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201130.0,20201211,20201211,EXP,DE-ADRED-05958-06,DE-MYLANLABS-2020M1099281,MYLAN,,77.0,YR,,F,Y,105.0,KG,20201211.0,,PH,DE,DE,2020,Q4,Elderly
186049511,18604951,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201130.0,20201211,20201211,EXP,DE-ADRED-05958-06,DE-MYLANLABS-2020M1099281,MYLAN,,77.0,YR,,F,Y,105.0,KG,20201211.0,,PH,DE,DE,2020,Q4,Elderly
186049511,18604951,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,,,,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201130.0,20201211,20201211,EXP,DE-ADRED-05958-06,DE-MYLANLABS-2020M1099281,MYLAN,,77.0,YR,,F,Y,105.0,KG,20201211.0,,PH,DE,DE,2020,Q4,Elderly
186066991,18606699,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,,,,,50.0,IU,INJECTION,QD,2020,Q4,Arthralgia,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,,,,,50.0,IU,INJECTION,QD,2020,Q4,Arthropathy,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,,,,,50.0,IU,INJECTION,QD,2020,Q4,COVID-19,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,,,,,50.0,IU,INJECTION,QD,2020,Q4,Facial bones fracture,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,,,,,50.0,IU,INJECTION,QD,2020,Q4,Mobility decreased,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,,,,,50.0,IU,INJECTION,QD,2020,Q4,Periarthritis,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,,,,,50.0,IU,INJECTION,QD,2020,Q4,Sinus disorder,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,,,,,50.0,IU,INJECTION,QD,2020,Q4,"Sleep disorder due to general medical condition, insomnia type",,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,, D195320A,,,50.0,IU,INJECTION,QD,2020,Q4,Arthralgia,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,, D195320A,,,50.0,IU,INJECTION,QD,2020,Q4,Arthropathy,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,, D195320A,,,50.0,IU,INJECTION,QD,2020,Q4,COVID-19,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,, D195320A,,,50.0,IU,INJECTION,QD,2020,Q4,Facial bones fracture,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,, D195320A,,,50.0,IU,INJECTION,QD,2020,Q4,Mobility decreased,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,, D195320A,,,50.0,IU,INJECTION,QD,2020,Q4,Periarthritis,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,, D195320A,,,50.0,IU,INJECTION,QD,2020,Q4,Sinus disorder,,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186066991,18606699,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"50 U, DAILY",,,,, D195320A,,,50.0,IU,INJECTION,QD,2020,Q4,"Sleep disorder due to general medical condition, insomnia type",,2020,Q4,1,I,1995.0,20201130.0,20201211,20201211,EXP,,US-ELI_LILLY_AND_COMPANY-US202012001200,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201211.0,,CN,US,US,2020,Q4,Adult
186118871,18611887,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"25 U, EACH MORNING (AM)",,,,,,,21017.0,25.0,IU,INJECTION,QD,2020,Q4,Arthralgia,,2020,Q4,1,I,20201124.0,20201202.0,20201214,20201214,EXP,,US-ELI_LILLY_AND_COMPANY-US202012002746,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20201214.0,,CN,US,US,2020,Q4,Adult
186118871,18611887,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"25 U, EACH MORNING (AM)",,,,,,,21017.0,25.0,IU,INJECTION,QD,2020,Q4,Joint swelling,,2020,Q4,1,I,20201124.0,20201202.0,20201214,20201214,EXP,,US-ELI_LILLY_AND_COMPANY-US202012002746,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20201214.0,,CN,US,US,2020,Q4,Adult
186118871,18611887,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"25 U, EACH MORNING (AM)",,,,,,,21017.0,25.0,IU,INJECTION,QD,2020,Q4,Peripheral swelling,,2020,Q4,1,I,20201124.0,20201202.0,20201214,20201214,EXP,,US-ELI_LILLY_AND_COMPANY-US202012002746,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20201214.0,,CN,US,US,2020,Q4,Adult
186118871,18611887,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"45 U, EACH EVENING (PM)",,,,,,,21017.0,45.0,IU,INJECTION,QD,2020,Q4,Arthralgia,,2020,Q4,1,I,20201124.0,20201202.0,20201214,20201214,EXP,,US-ELI_LILLY_AND_COMPANY-US202012002746,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20201214.0,,CN,US,US,2020,Q4,Adult
186118871,18611887,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"45 U, EACH EVENING (PM)",,,,,,,21017.0,45.0,IU,INJECTION,QD,2020,Q4,Joint swelling,,2020,Q4,1,I,20201124.0,20201202.0,20201214,20201214,EXP,,US-ELI_LILLY_AND_COMPANY-US202012002746,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20201214.0,,CN,US,US,2020,Q4,Adult
186118871,18611887,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"45 U, EACH EVENING (PM)",,,,,,,21017.0,45.0,IU,INJECTION,QD,2020,Q4,Peripheral swelling,,2020,Q4,1,I,20201124.0,20201202.0,20201214,20201214,EXP,,US-ELI_LILLY_AND_COMPANY-US202012002746,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20201214.0,,CN,US,US,2020,Q4,Adult
186174281,18617428,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,N,,,,,,,INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20201115.0,20201116.0,20201215,20201215,PER,,US-ELI_LILLY_AND_COMPANY-US202011008059,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201215.0,,CN,US,US,2020,Q4,Elderly
186174281,18617428,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,N,,,,,,,INJECTION,,2020,Q4,Feeling hot,,2020,Q4,1,I,20201115.0,20201116.0,20201215,20201215,PER,,US-ELI_LILLY_AND_COMPANY-US202011008059,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201215.0,,CN,US,US,2020,Q4,Elderly
186174281,18617428,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,N,,,,,,,INJECTION,,2020,Q4,Product storage error,,2020,Q4,1,I,20201115.0,20201116.0,20201215,20201215,PER,,US-ELI_LILLY_AND_COMPANY-US202011008059,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201215.0,,CN,US,US,2020,Q4,Elderly
186174281,18617428,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,N,,,,,,,INJECTION,,2020,Q4,Visual impairment,,2020,Q4,1,I,20201115.0,20201116.0,20201215,20201215,PER,,US-ELI_LILLY_AND_COMPANY-US202011008059,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20201215.0,,CN,US,US,2020,Q4,Elderly
186177321,18617732,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,1,I,20201215.0,,20201215,20201215,DIR,,,FDA-CTU,,50.0,YR,,F,N,85.28,KG,20201215.0,N,HP,US,US,2020,Q4,Adult
186177881,18617788,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Agitation,,2020,Q4,1,I,,20201201.0,20201215,20201215,EXP,,GR-BAUSCH-BL-2020-035509,BAUSCH AND LOMB,UNKNOWN. UNKNOWN. UNKNOWN. 2020;31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
186177881,18617788,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Confusional state,,2020,Q4,1,I,,20201201.0,20201215,20201215,EXP,,GR-BAUSCH-BL-2020-035509,BAUSCH AND LOMB,UNKNOWN. UNKNOWN. UNKNOWN. 2020;31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
186186431,18618643,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q4,Euglycaemic diabetic ketoacidosis,,2020,Q4,1,I,,20201208.0,20201215,20201215,EXP,,CN-ASTRAZENECA-2020SF66477,ASTRAZENECA,,57.0,YR,,F,Y,65.0,KG,20201215.0,,MD,CN,CN,2020,Q4,Adult
186186481,18618648,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 U, 1 TIME/D,",,,,,,,,,,INJECTION,,2020,Q4,Euglycaemic diabetic ketoacidosis,,2020,Q4,1,I,,20201208.0,20201215,20201215,EXP,,CN-ASTRAZENECA-2020SF66454,ASTRAZENECA,,46.0,YR,,M,Y,78.0,KG,20201215.0,,MD,CN,CN,2020,Q4,Adult
186193481,18619348,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 INTERNATIONAL UNIT, QD (WITH DINNER (PRANDIAL))",,,Y,, UNKNOWN,,,10.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201027.0,20201215,20201215,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-08403,LUPIN,,50.0,YR,,F,Y,,,20201215.0,,MD,US,US,2020,Q4,Adult
186193481,18619348,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 INTERNATIONAL UNIT, TID",,,Y,, UNKNOWN,,,50.0,IU,,TID,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201027.0,20201215,20201215,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-08403,LUPIN,,50.0,YR,,F,Y,,,20201215.0,,MD,US,US,2020,Q4,Adult
186193481,18619348,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 INTERNATIONAL UNIT, TID",,,Y,, UNKNOWN,,,20.0,IU,,TID,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201027.0,20201215,20201215,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-08403,LUPIN,,50.0,YR,,F,Y,,,20201215.0,,MD,US,US,2020,Q4,Adult
186195011,18619501,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20170612.0,20201207.0,20201215,20201215,EXP,,US-ASTRAZENECA-2020SF64312,ASTRAZENECA,,15905.0,DY,,F,Y,86.2,KG,20201215.0,,,US,US,2020,Q4,Elderly
186195011,18619501,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,1,I,20170612.0,20201207.0,20201215,20201215,EXP,,US-ASTRAZENECA-2020SF64312,ASTRAZENECA,,15905.0,DY,,F,Y,86.2,KG,20201215.0,,,US,US,2020,Q4,Elderly
186195011,18619501,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,1,I,20170612.0,20201207.0,20201215,20201215,EXP,,US-ASTRAZENECA-2020SF64312,ASTRAZENECA,,15905.0,DY,,F,Y,86.2,KG,20201215.0,,,US,US,2020,Q4,Elderly
186195011,18619501,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2020,Q4,Nephrogenic anaemia,,2020,Q4,1,I,20170612.0,20201207.0,20201215,20201215,EXP,,US-ASTRAZENECA-2020SF64312,ASTRAZENECA,,15905.0,DY,,F,Y,86.2,KG,20201215.0,,,US,US,2020,Q4,Elderly
186225883,18622588,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Pyrexia,,2020,Q4,3,F,20201210.0,20201223.0,20201216,20201228,EXP,,NVSC2020US330022,NOVARTIS,,68.0,YR,,M,Y,87.5,KG,20201228.0,,HP,US,US,2020,Q4,Elderly
186225883,18622588,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2020,Q4,Pyrexia,,2020,Q4,3,F,20201210.0,20201223.0,20201216,20201228,EXP,,NVSC2020US330022,NOVARTIS,,68.0,YR,,M,Y,87.5,KG,20201228.0,,HP,US,US,2020,Q4,Elderly
186230391,18623039,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNKNOWN,,,15.0,DF,UNK,,2020,Q4,Drug ineffective,,2020,Q4,1,I,,20201202.0,20201216,20201216,EXP,,US-GRANULES-US-2020GRALIT00094,GRANULES INDIA,,18.0,YR,T,F,Y,80.0,KG,20201216.0,,HP,US,US,2020,Q4,Youth
186232281,18623228,15,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,1,I,20190112.0,,20201215,20201215,DIR,,,FDA-CTU,,69.0,YR,,F,N,57.3,KG,20201215.0,N,CN,US,US,2020,Q4,Elderly
186232281,18623228,15,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,20190112.0,,20201215,20201215,DIR,,,FDA-CTU,,69.0,YR,,F,N,57.3,KG,20201215.0,N,CN,US,US,2020,Q4,Elderly
186232281,18623228,15,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20190112.0,,20201215,20201215,DIR,,,FDA-CTU,,69.0,YR,,F,N,57.3,KG,20201215.0,N,CN,US,US,2020,Q4,Elderly
186232281,18623228,15,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Sepsis,,2020,Q4,1,I,20190112.0,,20201215,20201215,DIR,,,FDA-CTU,,69.0,YR,,F,N,57.3,KG,20201215.0,N,CN,US,US,2020,Q4,Elderly
186232281,18623228,15,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Viral infection,,2020,Q4,1,I,20190112.0,,20201215,20201215,DIR,,,FDA-CTU,,69.0,YR,,F,N,57.3,KG,20201215.0,N,CN,US,US,2020,Q4,Elderly
186246102,18624610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Aggression,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Agitation,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Communication disorder,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Confusional state,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Disorientation,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hyperhidrosis,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Mental disorder,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Back pain,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Blood glucose decreased,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Dizziness,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Drug titration error,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Feeling hot,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Headache,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Mental disorder,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Poor quality sleep,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Restlessness,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU-6 IU-4 IU , TID (MODIFY ACCORDING TO GUIDELINE)",,,,,,,20563.0,14.0,IU,,,2020,Q4,Vision blurred,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Back pain,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Blood glucose decreased,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Drug titration error,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Feeling hot,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Headache,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Mental disorder,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Poor quality sleep,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Restlessness,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186246611,18624661,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2020,Q4,Vision blurred,,2020,Q4,1,I,2020.0,20201208.0,20201216,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202012004643,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
186277251,18627725,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Fournier's gangrene,,2020,Q4,1,I,20200214.0,,20201216,20201216,DIR,,,FDA-CTU,,56.0,YR,,M,N,119.25,KG,20201216.0,N,CN,US,US,2020,Q4,Adult
186277251,18627725,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Septic shock,,2020,Q4,1,I,20200214.0,,20201216,20201216,DIR,,,FDA-CTU,,56.0,YR,,M,N,119.25,KG,20201216.0,N,CN,US,US,2020,Q4,Adult
186297521,18629752,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201210.0,20201217,20201217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005931,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Adult
186297521,18629752,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201210.0,20201217,20201217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005931,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Adult
186297521,18629752,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,,,,,,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201210.0,20201217,20201217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005931,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Adult
186297521,18629752,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201210.0,20201217,20201217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005931,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Adult
186308661,18630866,9,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,20201207.0,20201209.0,20201217,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202012005262,ELI LILLY AND CO,,80.0,YR,,F,Y,83.9,KG,20201217.0,,PH,US,US,2020,Q4,Elderly
186314971,18631497,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION)",,,,,,,,,,INJECTION,,2020,Q4,Cardiac failure,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061444,AUROBINDO,,67.0,YR,,M,Y,114.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186314971,18631497,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION)",,,,,,,,,,INJECTION,,2020,Q4,Cough,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061444,AUROBINDO,,67.0,YR,,M,Y,114.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186314971,18631497,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION)",,,,,,,,,,INJECTION,,2020,Q4,Dyspnoea exertional,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061444,AUROBINDO,,67.0,YR,,M,Y,114.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186314971,18631497,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION)",,,,,,,,,,INJECTION,,2020,Q4,Peripheral swelling,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061444,AUROBINDO,,67.0,YR,,M,Y,114.0,KG,20201218.0,,MD,DE,DE,2020,Q4,Elderly
186315991,18631599,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION)",,,,,,,,,,INJECTION,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061412,AUROBINDO,,55.0,YR,,M,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Adult
186315991,18631599,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION)",,,,,,,,,,INJECTION,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061412,AUROBINDO,,55.0,YR,,M,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Adult
186315991,18631599,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION)",,,,,,,,,,INJECTION,,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061412,AUROBINDO,,55.0,YR,,M,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Adult
186315991,18631599,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION)",,,,,,,,,,INJECTION,,2020,Q4,Fall,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061412,AUROBINDO,,55.0,YR,,M,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Adult
186386961,18638696,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ,,,,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,DE-BFARM-20013304,DE-ACCORD-211583,ACCORD,,59.0,YR,A,M,Y,,,20201219.0,,MD,DE,DE,2020,Q4,Adult
186386961,18638696,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ,,,,,,,,,,,,2020,Q4,Dehydration,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,DE-BFARM-20013304,DE-ACCORD-211583,ACCORD,,59.0,YR,A,M,Y,,,20201219.0,,MD,DE,DE,2020,Q4,Adult
186386961,18638696,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,DE-BFARM-20013304,DE-ACCORD-211583,ACCORD,,59.0,YR,A,M,Y,,,20201219.0,,MD,DE,DE,2020,Q4,Adult
186386961,18638696,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ,,,,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,DE-BFARM-20013304,DE-ACCORD-211583,ACCORD,,59.0,YR,A,M,Y,,,20201219.0,,MD,DE,DE,2020,Q4,Adult
186391891,18639189,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Aggression,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Agitation,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Communication disorder,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Confusional state,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Disorientation,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hyperhidrosis,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Mental disorder,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186396011,18639601,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, DAILY",,,U,, D195320A,,20563.0,25.0,IU,INJECTION,QD,2020,Q4,Blood glucose decreased,,2020,Q4,1,I,202010.0,20201215.0,20201220,20201220,PER,,US-ELI_LILLY_AND_COMPANY-US202012008775,ELI LILLY AND CO,,44.0,YR,,F,Y,,,20201220.0,,CN,US,US,2020,Q4,Adult
186396011,18639601,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, DAILY",,,U,, D195320A,,20563.0,25.0,IU,INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,1,I,202010.0,20201215.0,20201220,20201220,PER,,US-ELI_LILLY_AND_COMPANY-US202012008775,ELI LILLY AND CO,,44.0,YR,,F,Y,,,20201220.0,,CN,US,US,2020,Q4,Adult
186396011,18639601,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, DAILY",,,U,, D195320A,,20563.0,25.0,IU,INJECTION,QD,2020,Q4,Drug ineffective,,2020,Q4,1,I,202010.0,20201215.0,20201220,20201220,PER,,US-ELI_LILLY_AND_COMPANY-US202012008775,ELI LILLY AND CO,,44.0,YR,,F,Y,,,20201220.0,,CN,US,US,2020,Q4,Adult
186428521,18642852,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,1,I,,20200828.0,20201221,20201221,PER,,DE-LUPIN PHARMACEUTICALS INC.-2020-05737,LUPIN,,42.0,YR,,M,Y,,,20201221.0,,HP,DE,DE,2020,Q4,Adult
186428521,18642852,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,1,I,,20200828.0,20201221,20201221,PER,,DE-LUPIN PHARMACEUTICALS INC.-2020-05737,LUPIN,,42.0,YR,,M,Y,,,20201221.0,,HP,DE,DE,2020,Q4,Adult
186438411,18643841,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Bradycardia,,2020,Q4,1,I,,,20201221,20201221,DIR,,,FDA-CTU,,90.0,YR,,F,N,,,,N,MD,US,US,2020,Q4,Elderly
186444661,18644466,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH BZ,,,U,, UNK,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201214.0,20201221,20201221,EXP,DE-ADRED-06065-01,NVSC2020DE332264,NOVARTIS,,59.0,YR,,M,Y,,,20201221.0,,HP,DE,DE,2020,Q4,Adult
186444661,18644466,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH BZ,,,U,, UNK,,,,,,,2020,Q4,Dehydration,,2020,Q4,1,I,,20201214.0,20201221,20201221,EXP,DE-ADRED-06065-01,NVSC2020DE332264,NOVARTIS,,59.0,YR,,M,Y,,,20201221.0,,HP,DE,DE,2020,Q4,Adult
186444661,18644466,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH BZ,,,U,, UNK,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,,20201214.0,20201221,20201221,EXP,DE-ADRED-06065-01,NVSC2020DE332264,NOVARTIS,,59.0,YR,,M,Y,,,20201221.0,,HP,DE,DE,2020,Q4,Adult
186444661,18644466,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH BZ,,,U,, UNK,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20201214.0,20201221,20201221,EXP,DE-ADRED-06065-01,NVSC2020DE332264,NOVARTIS,,59.0,YR,,M,Y,,,20201221.0,,HP,DE,DE,2020,Q4,Adult
186468541,18646854,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION",,,,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201210.0,20201222,20201222,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10472,LUPIN,,55.0,YR,,M,Y,,,20201222.0,,CN,NL,DE,2020,Q4,Adult
186468541,18646854,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION",,,,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201210.0,20201222,20201222,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10472,LUPIN,,55.0,YR,,M,Y,,,20201222.0,,CN,NL,DE,2020,Q4,Adult
186468541,18646854,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION",,,,,,,,,,,,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201210.0,20201222,20201222,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10472,LUPIN,,55.0,YR,,M,Y,,,20201222.0,,CN,NL,DE,2020,Q4,Adult
186468541,18646854,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION",,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201210.0,20201222,20201222,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10472,LUPIN,,55.0,YR,,M,Y,,,20201222.0,,CN,NL,DE,2020,Q4,Adult
186471721,18647172,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ,,,,, UNKNOWN,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201215.0,20201222,20201222,EXP,,DE-DRREDDYS-GER/GER/20/0130107,DR REDDYS,,59.0,YR,A,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Adult
186471721,18647172,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ,,,,, UNKNOWN,,,,,,,2020,Q4,Dehydration,,2020,Q4,1,I,,20201215.0,20201222,20201222,EXP,,DE-DRREDDYS-GER/GER/20/0130107,DR REDDYS,,59.0,YR,A,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Adult
186471721,18647172,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ,,,,, UNKNOWN,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,,20201215.0,20201222,20201222,EXP,,DE-DRREDDYS-GER/GER/20/0130107,DR REDDYS,,59.0,YR,A,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Adult
186471721,18647172,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ,,,,, UNKNOWN,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20201215.0,20201222,20201222,EXP,,DE-DRREDDYS-GER/GER/20/0130107,DR REDDYS,,59.0,YR,A,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Adult
186473631,18647363,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2020,Q4,Suspected suicide,,2020,Q4,1,I,,20201214.0,20201222,20201222,EXP,,US-009507513-2012USA008667,MERCK,,61.0,YR,,M,Y,,,20201222.0,,HP,US,US,2020,Q4,Adult
186505001,18650500,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, TID",,,,,,,,10.0,IU,INJECTION,TID,2020,Q4,Cardiac failure,,2020,Q4,1,I,202005.0,20201215.0,20201222,20201222,EXP,,US-ELI_LILLY_AND_COMPANY-US202012009800,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20201222.0,,CN,US,US,2020,Q4,Elderly
186505001,18650500,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, TID",,,,,,,,10.0,IU,INJECTION,TID,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,1,I,202005.0,20201215.0,20201222,20201222,EXP,,US-ELI_LILLY_AND_COMPANY-US202012009800,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20201222.0,,CN,US,US,2020,Q4,Elderly
186505001,18650500,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, TID",,,,, D214632C,,,10.0,IU,INJECTION,TID,2020,Q4,Cardiac failure,,2020,Q4,1,I,202005.0,20201215.0,20201222,20201222,EXP,,US-ELI_LILLY_AND_COMPANY-US202012009800,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20201222.0,,CN,US,US,2020,Q4,Elderly
186505001,18650500,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, TID",,,,, D214632C,,,10.0,IU,INJECTION,TID,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,1,I,202005.0,20201215.0,20201222,20201222,EXP,,US-ELI_LILLY_AND_COMPANY-US202012009800,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20201222.0,,CN,US,US,2020,Q4,Elderly
186505091,18650509,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, TID",,,U,,,,20563.0,8.0,IU,INJECTION,TID,2020,Q4,Diabetic foot,,2020,Q4,1,I,20201031.0,20201216.0,20201222,20201222,EXP,,US-ELI_LILLY_AND_COMPANY-US202012009277,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20201222.0,,CN,US,US,2020,Q4,Adult
186505201,18650520,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,,20201218.0,20201222,20201222,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202012010584,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20201222.0,,CN,CN,CN,2020,Q4,Adult
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Acute myocardial infarction,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Aortic valve incompetence,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Chronic kidney disease,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Cough,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Diastolic dysfunction,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Dyslipidaemia,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Haematoma,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Hepatotoxicity,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Neuropathy peripheral,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Off label use,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Polyneuropathy,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Pulmonary congestion,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Right ventricular failure,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Tricuspid valve incompetence,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Vascular stent thrombosis,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186514061,18651406,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,50 MG WITH MEALS,,,,,,,,50.0,MG,,,2020,Q4,Weight decreased,,2020,Q4,1,I,2010.0,20201209.0,20201222,20201222,EXP,,DE-MYLANLABS-2020M1103787,MYLAN,,78.0,YR,,M,Y,,,20201222.0,,MD,DE,DE,2020,Q4,Elderly
186531231,18653123,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Antibiotic level above therapeutic,,2020,Q4,1,I,20201017.0,20201218.0,20201223,20201223,EXP,FR-AFSSAPS-ST20201680,FR-JNJFOC-20201234734,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,52.0,KG,20201223.0,,MD,FR,FR,2020,Q4,Adult
186531231,18653123,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Drug interaction,,2020,Q4,1,I,20201017.0,20201218.0,20201223,20201223,EXP,FR-AFSSAPS-ST20201680,FR-JNJFOC-20201234734,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,52.0,KG,20201223.0,,MD,FR,FR,2020,Q4,Adult
186531231,18653123,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Status epilepticus,,2020,Q4,1,I,20201017.0,20201218.0,20201223,20201223,EXP,FR-AFSSAPS-ST20201680,FR-JNJFOC-20201234734,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,52.0,KG,20201223.0,,MD,FR,FR,2020,Q4,Adult
186637791,18663779,22,C,Insuline lispro,,2,Unknown,UNK,,,,,,,,,,,,2020,Q4,Antibiotic level above therapeutic,,2020,Q4,1,I,20201017.0,20201216.0,20201224,20201224,EXP,,FR-AUROBINDO-AUR-APL-2020-062432,AUROBINDO,,64.0,YR,,M,Y,52.0,KG,20201225.0,,MD,FR,FR,2020,Q4,Adult
186637791,18663779,22,C,Insuline lispro,,2,Unknown,UNK,,,,,,,,,,,,2020,Q4,Status epilepticus,,2020,Q4,1,I,20201017.0,20201216.0,20201224,20201224,EXP,,FR-AUROBINDO-AUR-APL-2020-062432,AUROBINDO,,64.0,YR,,M,Y,52.0,KG,20201225.0,,MD,FR,FR,2020,Q4,Adult
186639093,18663909,8,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Cytomegalovirus enteritis,,2020,Q4,3,F,20200504.0,20201222.0,20201225,20201230,EXP,,IT-ROCHE-2628853,ROCHE,,53.0,YR,,M,Y,,,20201230.0,,MD,IT,IT,2020,Q4,Adult
186639093,18663909,8,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Parasitic gastroenteritis,,2020,Q4,3,F,20200504.0,20201222.0,20201225,20201230,EXP,,IT-ROCHE-2628853,ROCHE,,53.0,YR,,M,Y,,,20201230.0,,MD,IT,IT,2020,Q4,Adult
186643651,18664365,3,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO INSULIN SCHEDULE,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860870,TEVA,,55.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186643651,18664365,3,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO INSULIN SCHEDULE,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860870,TEVA,,55.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186643651,18664365,3,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO INSULIN SCHEDULE,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860870,TEVA,,55.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186643651,18664365,3,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO INSULIN SCHEDULE,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Fall,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860870,TEVA,,55.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186649201,18664920,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ,,,,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860796,TEVA,,59.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186649201,18664920,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ,,,,,,,,,,,,2020,Q4,Dehydration,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860796,TEVA,,59.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186649201,18664920,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860796,TEVA,,59.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186649201,18664920,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ,,,,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860796,TEVA,,59.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186650161,18665016,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO THE SCHEME,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Cardiac failure,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860867,TEVA,,67.0,YR,E,M,Y,114.0,KG,20201225.0,,MD,DE,DE,2020,Q4,Elderly
186650161,18665016,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO THE SCHEME,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Cough,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860867,TEVA,,67.0,YR,E,M,Y,114.0,KG,20201225.0,,MD,DE,DE,2020,Q4,Elderly
186650161,18665016,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO THE SCHEME,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Dyspnoea exertional,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860867,TEVA,,67.0,YR,E,M,Y,114.0,KG,20201225.0,,MD,DE,DE,2020,Q4,Elderly
186650161,18665016,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO THE SCHEME,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Peripheral swelling,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860867,TEVA,,67.0,YR,E,M,Y,114.0,KG,20201225.0,,MD,DE,DE,2020,Q4,Elderly
186711601,18671160,2,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH INSULINPLAN, INJEKTIONS-/INFUSIONSLSUNG",,,U,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06077-01,DE-TORRENT-00019241,TORRENT,,55.0,YR,A,M,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711601,18671160,2,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH INSULINPLAN, INJEKTIONS-/INFUSIONSLSUNG",,,U,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06077-01,DE-TORRENT-00019241,TORRENT,,55.0,YR,A,M,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711601,18671160,2,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH INSULINPLAN, INJEKTIONS-/INFUSIONSLSUNG",,,U,,,,,,,,,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06077-01,DE-TORRENT-00019241,TORRENT,,55.0,YR,A,M,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711601,18671160,2,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"NACH INSULINPLAN, INJEKTIONS-/INFUSIONSLSUNG",,,U,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06077-01,DE-TORRENT-00019241,TORRENT,,55.0,YR,A,M,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Adult
186751461,18675146,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,U,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201223.0,20201229,20201229,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051141,GLENMARK,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY.. 2020;58 (12):1360-1541",46.0,YR,,F,Y,,,20201229.0,,MD,US,US,2020,Q4,Adult
186751461,18675146,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"UNK, ROUTE: ASPIRATION (WITH INGESTION)",,,U,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201223.0,20201229,20201229,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051141,GLENMARK,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY.. 2020;58 (12):1360-1541",46.0,YR,,F,Y,,,20201229.0,,MD,US,US,2020,Q4,Adult
186751461,18675146,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,UNK,,,U,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201223.0,20201229,20201229,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051141,GLENMARK,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY.. 2020;58 (12):1360-1541",46.0,YR,,F,Y,,,20201229.0,,MD,US,US,2020,Q4,Adult
186755811,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,2020.0,20200615.0,20201229,20201229,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,,,20201229.0,,CN,US,US,2020,Q4,Elderly
186755811,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q4,Ascites,,2020,Q4,1,I,2020.0,20200615.0,20201229,20201229,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,,,20201229.0,,CN,US,US,2020,Q4,Elderly
186755811,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,1,I,2020.0,20200615.0,20201229,20201229,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,,,20201229.0,,CN,US,US,2020,Q4,Elderly
186755811,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q4,Eye discharge,,2020,Q4,1,I,2020.0,20200615.0,20201229,20201229,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,,,20201229.0,,CN,US,US,2020,Q4,Elderly
186755811,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q4,Hospitalisation,,2020,Q4,1,I,2020.0,20200615.0,20201229,20201229,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,,,20201229.0,,CN,US,US,2020,Q4,Elderly
186755811,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q4,Insurance issue,,2020,Q4,1,I,2020.0,20200615.0,20201229,20201229,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,,,20201229.0,,CN,US,US,2020,Q4,Elderly
186755811,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q4,Intentional product use issue,,2020,Q4,1,I,2020.0,20200615.0,20201229,20201229,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,,,20201229.0,,CN,US,US,2020,Q4,Elderly
186755811,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q4,Somnolence,,2020,Q4,1,I,2020.0,20200615.0,20201229,20201229,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,,,20201229.0,,CN,US,US,2020,Q4,Elderly
186755811,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q4,Therapy interrupted,,2020,Q4,1,I,2020.0,20200615.0,20201229,20201229,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,,,20201229.0,,CN,US,US,2020,Q4,Elderly
186765931,18676593,8,C,"Insulin (Regular, Lispro)",,2,,,,,,,,,,,,,,2020,Q4,Dyspnoea exertional,,2020,Q4,1,I,20201226.0,,20201229,20201229,DIR,,,FDA-CTU,,67.0,YR,,M,N,122.9,KG,20201229.0,Y,PH,US,US,2020,Q4,Elderly
186765931,18676593,8,C,"Insulin (Regular, Lispro)",,2,,,,,,,,,,,,,,2020,Q4,Respiratory rate increased,,2020,Q4,1,I,20201226.0,,20201229,20201229,DIR,,,FDA-CTU,,67.0,YR,,M,N,122.9,KG,20201229.0,Y,PH,US,US,2020,Q4,Elderly
186766081,18676608,10,C,"Insulin (glargine, regular and lispro)",,2,,,,,,,,,,,,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,20201223.0,,20201229,20201229,DIR,,,FDA-CTU,,67.0,YR,,F,N,86.7,KG,20201229.0,Y,PH,US,US,2020,Q4,Elderly
186766081,18676608,10,C,"Insulin (glargine, regular and lispro)",,2,,,,,,,,,,,,,,2020,Q4,Dyspnoea exertional,,2020,Q4,1,I,20201223.0,,20201229,20201229,DIR,,,FDA-CTU,,67.0,YR,,F,N,86.7,KG,20201229.0,Y,PH,US,US,2020,Q4,Elderly
186766081,18676608,10,C,"Insulin (glargine, regular and lispro)",,2,,,,,,,,,,,,,,2020,Q4,Pulmonary congestion,,2020,Q4,1,I,20201223.0,,20201229,20201229,DIR,,,FDA-CTU,,67.0,YR,,F,N,86.7,KG,20201229.0,Y,PH,US,US,2020,Q4,Elderly
186774712,18677471,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,0-6  UNIT,,,,,,,,,,,,2020,Q4,Ischaemic stroke,,2020,Q4,2,F,20201221.0,20201229.0,20201229,20201231,EXP,,US-GLAXOSMITHKLINE-US2020GSK254269,GLAXOSMITHKLINE,,69.0,YR,,F,Y,74.4,KG,20201231.0,,MD,US,US,2020,Q4,Elderly
186800191,18680019,7,SS,INSULIN (LISPRO),INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201224.0,20201230,20201230,EXP,,US-ASTRAZENECA-2020SF74309,ASTRAZENECA,,61.0,YR,,M,Y,,,20201230.0,,HP,US,US,2020,Q4,Adult
186800191,18680019,7,SS,INSULIN (LISPRO),INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,,20201224.0,20201230,20201230,EXP,,US-ASTRAZENECA-2020SF74309,ASTRAZENECA,,61.0,YR,,M,Y,,,20201230.0,,HP,US,US,2020,Q4,Adult
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Aortic valve thickening,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Cardiac disorder,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Discharge,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Dizziness,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Drug ineffective,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Dyspnoea paroxysmal nocturnal,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Fluid overload,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Gait disturbance,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Hypotension,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Left ventricular dilatation,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Left ventricular dysfunction,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Mitral valve stenosis,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Obesity,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Oedema,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Off label use,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Orthopnoea,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Pericardial effusion,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Peripheral swelling,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Pneumonia,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Product prescribing error,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Product use in unapproved indication,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Pulmonary vascular disorder,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Skin disorder,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Tricuspid valve incompetence,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Underdose,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Ventricular remodelling,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"14 UL,TDS",,,U,,,,,24.0,UL,,,2020,Q4,Wrong technique in product usage process,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Aortic valve thickening,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Cardiac disorder,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Discharge,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Dizziness,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Drug ineffective,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Dyspnoea paroxysmal nocturnal,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Fluid overload,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Gait disturbance,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Hypotension,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Left ventricular dilatation,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Left ventricular dysfunction,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Mitral valve stenosis,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Obesity,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Oedema,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Off label use,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Orthopnoea,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Pericardial effusion,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Peripheral swelling,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Pneumonia,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Product prescribing error,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Product use in unapproved indication,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Pulmonary vascular disorder,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Skin disorder,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Tricuspid valve incompetence,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Underdose,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Ventricular remodelling,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186817021,18681702,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 UL DOSE REDUCED,,,U,,,,,12.0,UL,,,2020,Q4,Wrong technique in product usage process,,2020,Q4,1,I,202006.0,20201212.0,20201229,20201229,EXP,,NVSC2020MY333299,NOVARTIS,,70.0,YR,,M,Y,,,20201230.0,,MD,MY,MY,2020,Q4,Elderly
186833311,18683331,3,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Extra dose administered,,2020,Q4,1,I,20201226.0,,20201230,20201230,DIR,,,FDA-CTU,,62.0,YR,,M,N,82.2,KG,20201230.0,Y,PH,US,US,2020,Q4,Adult
186833311,18683331,3,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Transcription medication error,,2020,Q4,1,I,20201226.0,,20201230,20201230,DIR,,,FDA-CTU,,62.0,YR,,M,N,82.2,KG,20201230.0,Y,PH,US,US,2020,Q4,Adult
186848801,18684880,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,, D195320A,,,,,INJECTION,BID,2020,Q4,Back pain,,2020,Q4,1,I,,20201222.0,20201230,20201230,PER,,US-ELI_LILLY_AND_COMPANY-US202012014003,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20201230.0,,CN,US,US,2020,Q4,Adult
186848801,18684880,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,, D195320A,,,,,INJECTION,BID,2020,Q4,Blood pressure increased,,2020,Q4,1,I,,20201222.0,20201230,20201230,PER,,US-ELI_LILLY_AND_COMPANY-US202012014003,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20201230.0,,CN,US,US,2020,Q4,Adult
186848801,18684880,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,, D195320A,,,,,INJECTION,BID,2020,Q4,Maternal exposure during pregnancy,,2020,Q4,1,I,,20201222.0,20201230,20201230,PER,,US-ELI_LILLY_AND_COMPANY-US202012014003,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20201230.0,,CN,US,US,2020,Q4,Adult
186848801,18684880,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,, D195320A,,,,,INJECTION,BID,2020,Q4,Seasonal allergy,,2020,Q4,1,I,,20201222.0,20201230,20201230,PER,,US-ELI_LILLY_AND_COMPANY-US202012014003,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20201230.0,,CN,US,US,2020,Q4,Adult
186862541,18686254,6,SS,INSUL LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),,,,,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201228.0,20201231,20201231,EXP,,US-BAYER-2020-287440,BAYER,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020;58:12:1360-1541",61.0,YR,A,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186862541,18686254,6,SS,INSUL LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),,,,,,,,,,,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,,20201228.0,20201231,20201231,EXP,,US-BAYER-2020-287440,BAYER,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020;58:12:1360-1541",61.0,YR,A,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186873351,18687335,15,SS,LISPRO INSULIN,INSULIN LISPRO,1,Oral,UNK,,,U,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201223.0,20201231,20201231,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051223,GLENMARK,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY.. 2020;58 (12):1360-1541",61.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186873351,18687335,16,SS,LISPRO INSULIN,INSULIN LISPRO,1,Parenteral,UNK,,,U,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201223.0,20201231,20201231,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051223,GLENMARK,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY.. 2020;58 (12):1360-1541",61.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186879781,18687978,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 INTERNATIONAL UNIT, DAILY",11760.0,IU,Y,,,,20563.0,15.0,IU,,QD,2020,Q4,Drug interaction,,2020,Q4,1,I,20200423.0,20200602.0,20201231,20201231,EXP,IT-MINISAL02-621412,IT-ELI_LILLY_AND_COMPANY-IT202006001562,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20201231.0,,MD,IT,IT,2020,Q4,Elderly
186879781,18687978,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 INTERNATIONAL UNIT, DAILY",11760.0,IU,Y,,,,20563.0,15.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,20200423.0,20200602.0,20201231,20201231,EXP,IT-MINISAL02-621412,IT-ELI_LILLY_AND_COMPANY-IT202006001562,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20201231.0,,MD,IT,IT,2020,Q4,Elderly
186879781,18687978,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 INTERNATIONAL UNIT, DAILY",11760.0,IU,Y,,,,20563.0,15.0,IU,,QD,2020,Q4,Syncope,,2020,Q4,1,I,20200423.0,20200602.0,20201231,20201231,EXP,IT-MINISAL02-621412,IT-ELI_LILLY_AND_COMPANY-IT202006001562,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20201231.0,,MD,IT,IT,2020,Q4,Elderly
186884401,18688440,4,C,LISPRO INSULINPUMP,,2,,,,,,,,,,,,,,2020,Q4,Euglycaemic diabetic ketoacidosis,,2020,Q4,1,I,20201114.0,20201222.0,20201231,20201231,EXP,,SE-ASTRAZENECA-2020SF72147,ASTRAZENECA,,29.0,YR,,F,Y,,,20201231.0,,MD,SE,SE,2020,Q4,Young Adult
186886361,18688636,11,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,International normalised ratio increased,,2020,Q4,1,I,20201226.0,,20201231,20201231,DIR,,,FDA-CTU,,62.0,YR,,M,N,76.95,KG,20201231.0,N,PH,US,US,2020,Q4,Adult
186886361,18688636,11,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2020,Q4,Prothrombin time prolonged,,2020,Q4,1,I,20201226.0,,20201231,20201231,DIR,,,FDA-CTU,,62.0,YR,,M,N,76.95,KG,20201231.0,N,PH,US,US,2020,Q4,Adult
186886481,18688648,10,C,insulin lispro and insulin glulisine,,2,,,,,,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,20201224.0,,20201231,20201231,DIR,,,FDA-CTU,,58.0,YR,,F,N,104.3,KG,20201231.0,Y,PH,US,US,2020,Q4,Adult
186886481,18688648,10,C,insulin lispro and insulin glulisine,,2,,,,,,,,,,,,,,2020,Q4,Blood electrolytes abnormal,,2020,Q4,1,I,20201224.0,,20201231,20201231,DIR,,,FDA-CTU,,58.0,YR,,F,N,104.3,KG,20201231.0,Y,PH,US,US,2020,Q4,Adult
186886481,18688648,10,C,insulin lispro and insulin glulisine,,2,,,,,,,,,,,,,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20201224.0,,20201231,20201231,DIR,,,FDA-CTU,,58.0,YR,,F,N,104.3,KG,20201231.0,Y,PH,US,US,2020,Q4,Adult
186886481,18688648,10,C,insulin lispro and insulin glulisine,,2,,,,,,,,,,,,,,2020,Q4,Diabetic ketosis,,2020,Q4,1,I,20201224.0,,20201231,20201231,DIR,,,FDA-CTU,,58.0,YR,,F,N,104.3,KG,20201231.0,Y,PH,US,US,2020,Q4,Adult
186886481,18688648,10,C,insulin lispro and insulin glulisine,,2,,,,,,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,20201224.0,,20201231,20201231,DIR,,,FDA-CTU,,58.0,YR,,F,N,104.3,KG,20201231.0,Y,PH,US,US,2020,Q4,Adult
186886481,18688648,10,C,insulin lispro and insulin glulisine,,2,,,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20201224.0,,20201231,20201231,DIR,,,FDA-CTU,,58.0,YR,,F,N,104.3,KG,20201231.0,Y,PH,US,US,2020,Q4,Adult
186886481,18688648,10,C,insulin lispro and insulin glulisine,,2,,,,,,,,,,,,,,2020,Q4,Headache,,2020,Q4,1,I,20201224.0,,20201231,20201231,DIR,,,FDA-CTU,,58.0,YR,,F,N,104.3,KG,20201231.0,Y,PH,US,US,2020,Q4,Adult
186886481,18688648,10,C,insulin lispro and insulin glulisine,,2,,,,,,,,,,,,,,2020,Q4,Infusion related reaction,,2020,Q4,1,I,20201224.0,,20201231,20201231,DIR,,,FDA-CTU,,58.0,YR,,F,N,104.3,KG,20201231.0,Y,PH,US,US,2020,Q4,Adult
186886481,18688648,10,C,insulin lispro and insulin glulisine,,2,,,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,20201224.0,,20201231,20201231,DIR,,,FDA-CTU,,58.0,YR,,F,N,104.3,KG,20201231.0,Y,PH,US,US,2020,Q4,Adult
186886481,18688648,10,C,insulin lispro and insulin glulisine,,2,,,,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,20201224.0,,20201231,20201231,DIR,,,FDA-CTU,,58.0,YR,,F,N,104.3,KG,20201231.0,Y,PH,US,US,2020,Q4,Adult
186886481,18688648,10,C,insulin lispro and insulin glulisine,,2,,,,,,,,,,,,,,2020,Q4,Troponin increased,,2020,Q4,1,I,20201224.0,,20201231,20201231,DIR,,,FDA-CTU,,58.0,YR,,F,N,104.3,KG,20201231.0,Y,PH,US,US,2020,Q4,Adult
186886481,18688648,10,C,insulin lispro and insulin glulisine,,2,,,,,,,,,,,,,,2020,Q4,Unresponsive to stimuli,,2020,Q4,1,I,20201224.0,,20201231,20201231,DIR,,,FDA-CTU,,58.0,YR,,F,N,104.3,KG,20201231.0,Y,PH,US,US,2020,Q4,Adult
186896291,18689629,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,WITH MEALS,,,,,,,,,,,,2020,Q4,Euglycaemic diabetic ketoacidosis,,2020,Q4,1,I,,20201229.0,20201231,20201231,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-073117",BOEHRINGER INGELHEIM,"JOSHI M, LIEB D, GRESENS A, JENKINS E, ARE SGLT-2 INHIBITORS SAFE IN PATIENTS UNDERGOING BARIATRIC SURGERY?. ENDOCRINE PRACTICE. 2020; 26(2): 118-",36.0,YR,A,M,Y,,,20201231.0,,HP,US,US,2020,Q4,Adult
186896291,18689629,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,WITH MEALS,,,,,,,,,,,,2020,Q4,Metabolic acidosis,,2020,Q4,1,I,,20201229.0,20201231,20201231,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-073117",BOEHRINGER INGELHEIM,"JOSHI M, LIEB D, GRESENS A, JENKINS E, ARE SGLT-2 INHIBITORS SAFE IN PATIENTS UNDERGOING BARIATRIC SURGERY?. ENDOCRINE PRACTICE. 2020; 26(2): 118-",36.0,YR,A,M,Y,,,20201231.0,,HP,US,US,2020,Q4,Adult
